measure_id,measure_name,location_id,location_name,sex_id,sex_name,age_id,age_name,cause_id,cause_name,metric_id,metric_name,year_start,year_end,val,upper,lower
1,Deaths,263,Western Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4970843818708118,1.4561042192068288,0.07302096258129114
1,Deaths,263,Western Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8374329060959816,1.9557322833068778,0.11644641075964993
1,Deaths,263,Western Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6235394162967296,1.4699086632664997,0.15294880634654842
1,Deaths,263,Western Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.05615527982038973,0.7100403724302835,-0.2194986991139569
1,Deaths,263,Western Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.37639649485913684,1.08040594921743,-0.1264889621748784
1,Deaths,263,Western Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.17747520399208297,0.7721508516982531,-0.14898056438935908
1,Deaths,263,Western Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3869814462071796,0.005713154619323802,-0.5606247940086218
1,Deaths,263,Western Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2795534993141592,0.15892502708960216,-0.5622480107074772
1,Deaths,263,Western Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.34968627203137936,-0.010670455901473594,-0.5381827944021034
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2780830739112081,0.18839019658765555,-0.48930239975362333
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18157069280193242,0.3481188209241408,-0.5162802093186603
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2544334510577122,0.15588146693831686,-0.4795644025886909
1,Deaths,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4426080244891387,1.42369887137824,0.026843556481508955
1,Deaths,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.726225174805419,1.8351133887896918,0.03500737509583508
1,Deaths,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5115807172426396,1.3690908796464556,0.07487900196684866
1,Deaths,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.017421256581751223,0.6793795067557276,-0.2454822618387127
1,Deaths,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.29250593837784905,1.0257803702155905,-0.18903072509242272
1,Deaths,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.09591057344754027,0.723490009905408,-0.19732979301253453
1,Deaths,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.40928814997245444,-0.007556023592401681,-0.5795332851050408
1,Deaths,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3231573885183245,0.1116310768271474,-0.5941797716270565
1,Deaths,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.394531674754312,-0.051053330535360326,-0.5694538956875583
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3301530600266027,0.11896951275209493,-0.5270632517935109
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30017172524266644,0.16353291379049528,-0.5883855422850207
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.34957308646753876,0.02183034662434992,-0.5446882411103131
1,Deaths,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5281862566029907,1.4589545209158243,0.09094052374677809
1,Deaths,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7927101075968211,1.9832302854218034,0.05802698372661667
1,Deaths,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.698128323819849,1.56046024513865,0.11541463838554498
1,Deaths,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.07865496605837123,0.7566883411690286,-0.23246339913460384
1,Deaths,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3430141741731756,1.115817728601285,-0.17528207875212412
1,Deaths,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.23172740905942316,0.881610626798586,-0.18013926822349927
1,Deaths,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.37424600757763465,0.0068802817717280515,-0.553287182579838
1,Deaths,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2970890422843001,0.16970682997003633,-0.5851539201632111
1,Deaths,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.31980945473358346,0.02560025991216168,-0.5532172213140147
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.23606538004884986,0.22305095433009287,-0.4656568661391021
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.18305187613303225,0.3780229796269211,-0.5207012852767408
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19180880852476026,0.23439517428975754,-0.47271486977529026
1,Deaths,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5864523874711135,1.6424857040279195,0.12098439743126856
1,Deaths,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1405000183481533,2.588753975389034,0.2517917935093331
1,Deaths,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7241711733188066,1.6654064033080418,0.2121872219535135
1,Deaths,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.11953944662619946,0.8427302250384338,-0.19628943731250714
1,Deaths,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.60435615852222,1.513746000615931,-0.012820850990509789
1,Deaths,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2511501531120864,0.9501988011459768,-0.10813933095660856
1,Deaths,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.35038748649998724,0.08203170396923153,-0.540984968877371
1,Deaths,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16072268934518086,0.40712906295168605,-0.5091798921043473
1,Deaths,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.30937791092590466,0.06763676772346836,-0.5144546640557569
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.21670506004176315,0.2981312825863074,-0.44920367061173877
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0615528312446495,0.5798808949555062,-0.4579028801712851
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20055560593875035,0.25878208538816816,-0.4399830904133073
1,Deaths,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6132296658892424,1.7427477138178626,0.1474430289050712
1,Deaths,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9658188790291904,2.2217967068801867,0.19389529200710598
1,Deaths,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8137395121532558,1.7496339684042663,0.24818325043036396
1,Deaths,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.13857167381668253,0.9136166672371893,-0.1745675159632661
1,Deaths,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.47279278194125224,1.3011226830021732,-0.05892914889853698
1,Deaths,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3155842780828297,0.9870411836377185,-0.07511966167381154
1,Deaths,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.33942286173389735,0.12308648550732136,-0.5301508220531692
1,Deaths,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2292141238572332,0.26324730317622275,-0.5318807655734399
1,Deaths,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.273501036148051,0.10137437908395196,-0.5000363436652115
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2402719490377505,0.2843150901604441,-0.46018599599863774
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.17846642514117958,0.3579413946203963,-0.508346910157259
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.19572795188793643,0.2202688059354085,-0.4539605956597377
1,Deaths,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.42749148975144574,1.0030698935748539,0.029836455247640517
1,Deaths,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6721245355365724,1.1105741867633414,0.31516985292711325
1,Deaths,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.49904362945349096,0.9416661672241916,0.16299335705339812
1,Deaths,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.011410174468715232,0.4181652993127388,-0.2688810695583983
1,Deaths,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.13985421725382394,0.43900647259810205,-0.10686730750258754
1,Deaths,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.04309612816662448,0.34744493074686683,-0.18725812419372054
1,Deaths,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.06198208991059077,0.3162358226466588,-0.32328490472929045
1,Deaths,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.09141185499899786,0.37759218248011767,-0.14157591835028407
1,Deaths,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.01829517504290721,0.27157275970337097,-0.23837027316636233
1,Deaths,70,Australasia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1916933330107205,0.6754299532084732,-0.14363071683255052
1,Deaths,70,Australasia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.4076014089433159,0.7748366238153116,0.10271776735123914
1,Deaths,70,Australasia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.25581123585565124,0.6298391356963047,-0.02838875858180282
1,Deaths,70,Australasia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,4.648043490168785,5.611429417767117,3.8247187823769524
1,Deaths,70,Australasia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,5.676667660671478,6.7337535062030565,4.698462953275911
1,Deaths,70,Australasia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,4.942059705938156,5.748094423399246,4.229997541435834
1,Deaths,70,Australasia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.002064274157104,3.683106405344149,2.419475630672102
1,Deaths,70,Australasia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.5512806947447113,4.264361706145018,2.881234564949725
1,Deaths,70,Australasia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.1347729096884724,3.676617906897636,2.636021678797274
1,Deaths,70,Australasia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.7113818112251535,3.3444316478814,2.170367502367635
1,Deaths,70,Australasia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.3579255503280705,4.047895704491604,2.7194418778635883
1,Deaths,70,Australasia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.891380189934363,3.4192421918581797,2.4250596313951944
1,Deaths,70,Australasia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.4249594384596556,1.8208908731257534,1.0818108677215184
1,Deaths,70,Australasia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.9764674989961148,2.3934349597123923,1.5643472458484111
1,Deaths,70,Australasia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.6306559514543961,1.9746948549239145,1.3191050647622553
1,Deaths,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.357708711660978,4.208615161976517,2.671197794285113
1,Deaths,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.7181541058013403,4.5780639249769255,2.9644382358681236
1,Deaths,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.430174216486732,4.126989078657667,2.806617848379845
1,Deaths,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.0877539688885776,2.685093396267849,1.6021005823536254
1,Deaths,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.21608947577425,2.7800137338175674,1.7057892556725192
1,Deaths,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.0827095659831776,2.5679474147838817,1.6503818157814498
1,Deaths,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.863490849393694,2.4226293773197405,1.4123781523347474
1,Deaths,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.079584812820991,2.640856267747112,1.5876271755376965
1,Deaths,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.9012653923295717,2.3576006842812887,1.4929061670370956
1,Deaths,70,Australasia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0310638156577114,1.38793567511357,0.7189944032589407
1,Deaths,70,Australasia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2575709765794236,1.6067522657242528,0.9389140422743083
1,Deaths,70,Australasia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.1029963771095184,1.4225042969228003,0.8155767653568866
1,Deaths,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.679684784801707,7.088820042281484,4.580004269006103
1,Deaths,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,6.18788402145118,7.556941552067096,5.0211566033028525
1,Deaths,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.905422798805952,6.882454606820781,5.0166194858441475
1,Deaths,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.7330425973730526,4.721523207398084,2.937497096637114
1,Deaths,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.8999096009830927,4.811809447695924,3.0875390427887064
1,Deaths,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.8052104784395504,4.482820674516936,3.1844788026525848
1,Deaths,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.389282883211235,4.315238742664116,2.6666726073543536
1,Deaths,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.6916014128411105,4.585198502851159,2.930067143917283
1,Deaths,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.5222745667702666,4.162120413294684,2.9402084523299816
1,Deaths,70,Australasia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.691298935024518,2.1970230500856722,1.265478612901918
1,Deaths,70,Australasia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.130526885207984,2.6708330913651763,1.6477461382193586
1,Deaths,70,Australasia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.9208688270829832,2.284828262877801,1.56487766584981
1,Deaths,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.3762480760073865,5.377198592056126,3.525018564014597
1,Deaths,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.907892800305828,6.094132181093808,3.861261666535207
1,Deaths,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.457842728545811,5.341453987613339,3.676198155644605
1,Deaths,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.809482741439476,3.5415525359753035,2.2069157813309124
1,Deaths,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.0269905363589493,3.836754314236358,2.317738547162049
1,Deaths,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.797773118738868,3.4188282657177442,2.2614423805618835
1,Deaths,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.5327825213562214,3.190516397815568,1.9734317066028948
1,Deaths,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.8561387643581884,3.6304086799917266,2.172992501665655
1,Deaths,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.5742725796605153,3.152938483286857,2.0623833767436
1,Deaths,70,Australasia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3284328190853802,1.7478419190878394,0.9660423940324177
1,Deaths,70,Australasia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7153766377345743,2.1855136927034815,1.2628871023888637
1,Deaths,70,Australasia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.4678130228220323,1.8503726232007591,1.1340772633328802
1,Deaths,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,4.668761297298091,6.186192469580277,3.6399766938638347
1,Deaths,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,4.98374440417556,6.419531208094705,3.833125615121857
1,Deaths,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,4.82457897777125,5.973502371964487,3.9550705770115218
1,Deaths,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.016841137723672,4.0885776001572465,2.273623575706388
1,Deaths,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.0789026306765304,4.057488361727639,2.2931568600624606
1,Deaths,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.053073446845315,3.8498374418478147,2.4481600608400704
1,Deaths,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.724995674624401,3.722113785063363,2.048971760945176
1,Deaths,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.9056478397438594,3.8427997717592755,2.1546278288121834
1,Deaths,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.8144435381819495,3.5668590232447683,2.2450134191414843
1,Deaths,70,Australasia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5488597911013413,2.1784408977151144,1.0935489028766634
1,Deaths,70,Australasia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.8000211104365633,2.415478804281728,1.3172180067289536
1,Deaths,70,Australasia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6797251639374038,2.144259981535114,1.32970726638448
1,Deaths,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8916125780859373,2.2088659103685613,0.3247368092917805
1,Deaths,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2704250048982761,2.74807664305591,0.33891815684932586
1,Deaths,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1140305706494402,2.232864378512433,0.40417096177840456
1,Deaths,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3360581352737203,1.227256469258932,-0.05769257314738507
1,Deaths,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7013625472255255,1.6856655934986864,0.04247969324207296
1,Deaths,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5340669565119528,1.3017052959103992,0.03937496292013703
1,Deaths,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.22543203242459914,0.313950211163825,-0.4575534600305246
1,Deaths,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10977987581378794,0.4695985321876626,-0.47501816387060786
1,Deaths,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.15321852513163564,0.29493381244963557,-0.43755498407160043
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07595428531473312,0.5471684714982084,-0.36300255954258703
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.012903227477105867,0.6600974846620815,-0.40899857049673216
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.014342657107865727,0.5181236676126533,-0.3497362203613385
1,Deaths,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.10924661331522223,0.6486917050791191,-0.2400060944183953
1,Deaths,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.04962115673774389,0.4607115411064367,-0.22679103081636923
1,Deaths,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.07833430718735736,0.4655086490366489,-0.2190889908676863
1,Deaths,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.21869618817653796,0.13686742008594074,-0.44688428834025484
1,Deaths,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.21409218912236072,0.06033013309138503,-0.41118897838540597
1,Deaths,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.218977118086089,0.006420080277439961,-0.3940633890171516
1,Deaths,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5457912974522238,-0.32490204497702424,-0.6888015328108634
1,Deaths,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.58844979486939,-0.4272637031751391,-0.6968293675926175
1,Deaths,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5680698625087743,-0.4129859839811265,-0.687203683222584
1,Deaths,263,Western Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.49925435788508854,-0.24114456081537144,-0.6593388724532712
1,Deaths,263,Western Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5050975715095727,-0.3117195288577702,-0.6325584369114527
1,Deaths,263,Western Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5018560430209486,-0.3183928740982152,-0.6419027349048951
1,Deaths,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.098833507512294,2.4818320816155492,1.733096834703323
1,Deaths,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7402909968039084,2.0342538152111547,1.4428476110536756
1,Deaths,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.9133360322271062,2.21152564700565,1.655946550532474
1,Deaths,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3015468338966909,0.4421004696794223,0.1653213487322017
1,Deaths,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.15734121811472612,0.267792922301071,0.04931187010063565
1,Deaths,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2265177994021214,0.32457021475967834,0.13561760328083464
1,Deaths,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.039689021139242,1.2917832316918882,0.7989567990472849
1,Deaths,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7588705421615615,0.9475521611539737,0.5679549022652631
1,Deaths,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8931703140100945,1.086942580717446,0.725911158014205
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.10970897360980698,0.24943839079400087,-0.020239592924592945
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.12150422888657036,-0.027002097093691096,-0.21519008192433894
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.015769655833176025,0.08481845069478969,-0.10179408233696714
1,Deaths,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.275651348121596,1.575575277476953,0.9649749914875875
1,Deaths,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9966370022175935,1.2437462025553483,0.7541574592342682
1,Deaths,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.153308120741886,1.4158949769458873,0.8955239661170998
1,Deaths,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0448156571537441,0.05780950516469809,-0.1518246327821274
1,Deaths,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1572310448572345,-0.07284112860922694,-0.24568460798944827
1,Deaths,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.09401079935545166,-0.015147688452557002,-0.17160105219802943
1,Deaths,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.49786074645571227,0.6952742391135255,0.2933698784507901
1,Deaths,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2815522186097203,0.4401605903768448,0.12591541736211673
1,Deaths,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.39928211713670964,0.5699186779438151,0.23176649121532913
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14583529699687695,-0.03176431479813381,-0.25802266598482865
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3169070841652932,-0.2347405381172129,-0.3963792871757592
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22941057418420824,-0.13740372808060852,-0.3119487149155879
1,Deaths,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.563974385153116,3.0952008941928604,2.124849153591785
1,Deaths,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9986058108175282,2.3136381332258096,1.6486208288522244
1,Deaths,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.203881856248801,2.54707302830249,1.8846007605458277
1,Deaths,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4976076018960648,0.6965293301480164,0.31687436763781657
1,Deaths,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.26675240612548035,0.407006043469384,0.13620510170441175
1,Deaths,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3492920611114356,0.48490314779093957,0.2314125770391066
1,Deaths,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3458502715281697,1.6955098694380732,1.0568128283904374
1,Deaths,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9246712974471892,1.12687649111419,0.7000315509035979
1,Deaths,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0819754236208088,1.3049910084264142,0.8744973004235289
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.17351038235053892,0.3408735188762656,0.03215536048358147
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09954590434306754,-0.008469663145772825,-0.19792778493213894
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.005243151643082953,0.10949676450468933,-0.08911123237892615
1,Deaths,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3227816968787267,2.8103991887358206,1.9077292674112578
1,Deaths,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8021898484145795,2.2040937213439116,1.4527840124678975
1,Deaths,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.165748685523873,2.568725357270834,1.824968454512463
1,Deaths,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3953868722995965,0.5864340971500404,0.24181320636445494
1,Deaths,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1831672794846043,0.33754658573617236,0.05603127269687315
1,Deaths,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.33252268674767493,0.4909089925723166,0.20861643144869113
1,Deaths,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.187094379332057,1.5080500041648335,0.9139019404579836
1,Deaths,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7986006536054266,1.0565648200755278,0.5743326350545731
1,Deaths,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0571953824594302,1.3190613202540251,0.8357464971212303
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1292700199100267,0.2901010147108788,-0.007688002349741326
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12668648312212027,-0.001832595076806894,-0.23553256597116876
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.026150937621812472,0.1554755799490142,-0.08514447985216092
1,Deaths,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7483425177168888,2.165754687892165,1.395085598779398
1,Deaths,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3526955827372613,1.6754361200290044,1.0530795170281289
1,Deaths,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4906173711330792,1.8104637009797837,1.2157209793915322
1,Deaths,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.15419089882000647,0.3019055089042419,0.024880811202230887
1,Deaths,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.006494889479179451,0.11248724513727307,-0.11820366017943601
1,Deaths,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.048423108499323284,0.16222189763759434,-0.04583685433967495
1,Deaths,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8089916886879059,1.083737336923747,0.5764737888228312
1,Deaths,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5100903371125854,0.7172430900377017,0.3177801508773364
1,Deaths,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6184754585218583,0.8263208872717859,0.43983980423526625
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.05186756979216274,0.21475202412083103,-0.08631530556364389
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.18824990536868544,-0.0743475353564737,-0.29012511356511306
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09914635554340835,0.012706554590524863,-0.1922504918966725
1,Deaths,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.612217554055399,3.367557363338192,1.978331436180922
1,Deaths,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.4295877446426286,4.346385168735556,2.7110637919697793
1,Deaths,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9780351451305647,3.623534728274476,2.4320148528938716
1,Deaths,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.375243451594082,1.7726233225272459,0.9896723111219726
1,Deaths,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.250845060616781,2.7739286993321475,1.7512808313058548
1,Deaths,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7478543236273774,2.1236596170373234,1.4157481357366553
1,Deaths,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.181624751531998,1.6378176577147316,0.7987846751210668
1,Deaths,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5684691457424322,2.1000684801335012,1.15183746141715
1,Deaths,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3555199928464423,1.7377406414826753,1.0322041678372678
1,Deaths,159,South Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5486807363023519,0.8685456735724869,0.27852732146657466
1,Deaths,159,South Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6238598477613259,0.9669160829566558,0.3496792614162149
1,Deaths,159,South Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5783619862559944,0.8328514862387186,0.3606567398715144
1,Deaths,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.41609631586102486,0.0489916496865413,-0.5878717386571338
1,Deaths,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.22897216470207366,0.5834067999755559,-0.5224294614138869
1,Deaths,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.32909633391252,0.22851815543591067,-0.5423163409840732
1,Deaths,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6155688837495922,-0.30295594306111623,-0.7357897600768176
1,Deaths,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4330508074797402,0.14604634242191505,-0.6523050651503649
1,Deaths,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5361914032604467,-0.16379343057037207,-0.6810360907692065
1,Deaths,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6473471736501131,-0.36645395443104917,-0.7510921747384717
1,Deaths,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5529242630160205,-0.08187132858701342,-0.7230836673779465
1,Deaths,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6027367931433478,-0.27255567858761465,-0.7289910797970726
1,Deaths,159,South Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4246397302751344,0.04018901595475939,-0.5939548638871663
1,Deaths,159,South Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2334614923669906,0.5784108076884311,-0.5253325354077657
1,Deaths,159,South Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3360410234657847,0.2195984280498263,-0.5463464610585035
1,Deaths,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7656311983238355,2.3877201960074688,1.2279539440257885
1,Deaths,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9847955768811587,1.3120791042653253,0.6727640963274482
1,Deaths,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2710718078674577,1.6291557211354297,0.9458488658893907
1,Deaths,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.48336839112723956,0.8303373478902675,0.16661424029592928
1,Deaths,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.13886428953627175,0.3298529636955239,-0.02806342340308033
1,Deaths,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2558566682496205,0.4641911856667603,0.06649945987002515
1,Deaths,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.053098937022844,1.5149140411668598,0.6539478861055226
1,Deaths,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.47848197148046673,0.7222767483513318,0.2460485038193068
1,Deaths,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6888753884707924,0.9551633614140451,0.4470243732056365
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.35559802094655724,0.6473444934853677,0.09133361293670222
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09861391360153356,0.05547436065993806,-0.24171068414517263
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.06739953432939359,0.22985624279228067,-0.0826229043685739
1,Deaths,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.40954934566383433,-0.11754268544086306,-0.6116246607677438
1,Deaths,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4000353009244438,-0.02945619208319669,-0.6035073344759868
1,Deaths,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.404490727327186,-0.1122429817610884,-0.5942533845106678
1,Deaths,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6836778728653876,-0.5420282022827894,-0.7898867248453805
1,Deaths,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6554636556723304,-0.441409791498436,-0.7730733554521763
1,Deaths,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6707677646590615,-0.5256048167294577,-0.7719341099510443
1,Deaths,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5616719931722158,-0.34489740512492995,-0.7116849865495828
1,Deaths,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5530839541159333,-0.2770381296436596,-0.7046510660192852
1,Deaths,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5571514072169947,-0.33982229278176246,-0.6982678088462942
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.37729122882827154,-0.06808019823354153,-0.5910963155750848
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.35902684551676484,0.03299496214285851,-0.5777209706646649
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.36785492187615576,-0.055390015368700724,-0.5685903953706379
1,Deaths,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7662948180378466,0.940106694032063,0.5793846183490418
1,Deaths,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5251155149921712,0.6984768822971475,0.36806596106267475
1,Deaths,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.661179336155683,0.8095351839546531,0.5312857143318759
1,Deaths,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2890212185174867,0.4134048876714982,0.16295653970133817
1,Deaths,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.09560019464366942,0.21548989808902522,-0.011960903083440033
1,Deaths,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.20231676514081512,0.3015820158603453,0.11075096298293602
1,Deaths,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9438412157646741,1.135124508279946,0.7381429676061301
1,Deaths,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.663915195050188,0.8530540572923078,0.4925726727360751
1,Deaths,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8197119133011742,0.9822259163181133,0.6774220557583838
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3281078220127713,0.46108935715739463,0.1883183102547973
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.22039325261674383,0.3537924393886188,0.10119406797328083
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3287455591485343,0.44717045424534513,0.2257512384421438
1,Deaths,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4440535590722164,0.6096504106059052,0.2842556153984675
1,Deaths,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.14784222023891777,0.2947842748055464,0.020895461288562883
1,Deaths,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3492267686089191,0.48602463805523716,0.2267667049214708
1,Deaths,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.05392055128249366,0.16027544986371636,-0.04959586756472469
1,Deaths,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.17540644098307223,-0.08477000664502818,-0.2604270317481781
1,Deaths,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.023344760213400793,0.06434330450310938,-0.10105116420541303
1,Deaths,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.589208549575273,0.7714510506146156,0.4133478575009215
1,Deaths,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2523065256374927,0.4126216722489008,0.11380643229803383
1,Deaths,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4779885417214207,0.6278415451435361,0.3438416546602246
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.158364940805119,0.28576607186047326,0.034610705540085274
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.01461257749392608,0.10774210508167681,-0.12269044901641846
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1497558013824178,0.265262400037854,0.05272854130713849
1,Deaths,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9969814078195859,1.2165829234744086,0.7836007905093535
1,Deaths,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6552407559322373,0.8502064705524709,0.4871594261281216
1,Deaths,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.778075174897703,0.9437737204622506,0.6302773629600306
1,Deaths,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4574618331845947,0.6135552696461478,0.30060365968535857
1,Deaths,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.18911853693502473,0.3338066611109381,0.07263626884785977
1,Deaths,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.286993885500846,0.4051194401379313,0.18152395635314025
1,Deaths,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1977162181496634,1.4393918845304536,0.9628867693299503
1,Deaths,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8058830417682438,1.018592447633866,0.6225047494906627
1,Deaths,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9477635605522533,1.1292753400560072,0.7858608488527226
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4177006795563952,0.5670225808867568,0.27301530021102033
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3118519364913126,0.4666431310235145,0.1796735621153842
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.37536415825465563,0.5064312482203467,0.26010030657955036
1,Deaths,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9141838700956236,1.1216697510465563,0.7075491394383229
1,Deaths,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5300421297115038,0.6988259677619983,0.36647364693243756
1,Deaths,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7968984896075388,0.9687844174243737,0.6402312171043628
1,Deaths,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3968393189061415,0.5442234116533846,0.24821203505765077
1,Deaths,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.09908215826335859,0.22110913677814747,-0.01809903469898066
1,Deaths,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3003930021655861,0.43216621426809027,0.18483732187593757
1,Deaths,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1065959449381604,1.3349381236972573,0.8791904733497313
1,Deaths,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6692901774768094,0.8534349127774341,0.49083544322752304
1,Deaths,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.968383254813906,1.156672901674649,0.7967646366470139
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.40950465390762947,0.5522322297741771,0.2590304359372319
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.25790804013482393,0.39474160187921253,0.11999855649644177
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4511766384258925,0.5815845445740537,0.32423663923557106
1,Deaths,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6442131039840943,0.8350418384783194,0.45733475544056573
1,Deaths,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.36304280086700064,0.5417476836598815,0.21869288795378336
1,Deaths,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4757190187742475,0.6189139986263352,0.3577094983537448
1,Deaths,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.20002666571784658,0.32901723413370565,0.07000985589926358
1,Deaths,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.02100009919982224,0.10467715831514857,-0.12093721332973315
1,Deaths,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.06806114113504011,0.1768028085678396,-0.014542851761164894
1,Deaths,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8094879554564695,1.0194986260840138,0.6038247600922353
1,Deaths,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.48709235829786396,0.6820610455780937,0.3296052623110999
1,Deaths,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6165524219456999,0.7734130360229166,0.4872808101947916
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.29132615432475534,0.43313938615726394,0.15543578953558954
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1409772669790766,0.2830033913608742,0.026326638322187727
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.21916506143649483,0.33798957696012444,0.12552409148234045
1,Deaths,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.747725527759731,1.9236202669465359,0.31610169099724644
1,Deaths,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.821141765785035,1.5584695561206314,0.2633077218215302
1,Deaths,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7683699599923465,1.6937196092895115,0.35906879041976963
1,Deaths,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.20538936363513638,0.9789601474581199,-0.061761771117350005
1,Deaths,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.35425396972485534,0.831197967481655,-0.034428133278768085
1,Deaths,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.26166419202618274,0.8913067280588917,-0.0059451080778896515
1,Deaths,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19922958491564371,0.3395402067009577,-0.39699038512987206
1,Deaths,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.17300669661779136,0.1618190464743632,-0.426323065185933
1,Deaths,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1934018184697085,0.22867351717216922,-0.38009441478416534
1,Deaths,44559,Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2524680619069562,0.2490352237575859,-0.43290992544616724
1,Deaths,44559,Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.24601810021307285,0.07575465685397194,-0.48914674209137926
1,Deaths,44559,Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2611514852686683,0.140896594931883,-0.4374799320825181
1,Deaths,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4461081551574055,2.4081820534517098,0.7338449064414396
1,Deaths,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9346775197286566,1.7921922692709014,0.29590748085581836
1,Deaths,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1693482150208097,2.014110341507408,0.5072987497794509
1,Deaths,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6870215216004087,1.3099240005647248,0.20045916546488401
1,Deaths,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4393990100639123,1.0366191072297668,-0.020719601867896377
1,Deaths,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5481666516899385,1.0834260626537322,0.1074965838974462
1,Deaths,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.12075438141446275,0.5615560419969837,-0.20558938839630056
1,Deaths,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12144931104251273,0.2679541767838225,-0.41151928498620305
1,Deaths,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.01050551359211054,0.37481181845117983,-0.31248298823157605
1,Deaths,44559,Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.11282136710208424,0.5414083733093026,-0.216814215122715
1,Deaths,44559,Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17063627528754474,0.21365650533913189,-0.44876437942001995
1,Deaths,44559,Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.047092973580262716,0.3261130885995879,-0.3368354037276715
1,Deaths,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0729058657201431,2.3595808261533797,0.5875979360641352
1,Deaths,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.206539287435215,2.09396721111661,0.519382339618838
1,Deaths,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1083695638602742,2.150097986037814,0.6441240654015894
1,Deaths,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.43018536092153703,1.2906608769488963,0.1275846467909686
1,Deaths,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6420493614972983,1.235611084508137,0.15574971824572667
1,Deaths,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5050663378339846,1.2182285073267491,0.19735143979199463
1,Deaths,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05023891671867098,0.5392880002826883,-0.2725966188302335
1,Deaths,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.002005032580237577,0.40499230348198,-0.3100377775365977
1,Deaths,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.038319415802068234,0.43683921615097315,-0.250073507599705
1,Deaths,44559,Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0685720509172827,0.5171547156752658,-0.2904883224757549
1,Deaths,44559,Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0604364274568453,0.3360515974084604,-0.3626528180000431
1,Deaths,44559,Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08113384815017367,0.3794262685401782,-0.28732898203222323
1,Deaths,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2807404067544936,2.433554534777774,0.7026059686778375
1,Deaths,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1275841668976612,1.9675002935142505,0.48018001541346755
1,Deaths,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1883797729240684,1.9921386980980158,0.6338504353697278
1,Deaths,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5734111666227025,1.313723757696406,0.2217582606790694
1,Deaths,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5827578466566284,1.1599298173377446,0.12625878973001697
1,Deaths,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.561775848959606,1.0768117150133145,0.18431172226143847
1,Deaths,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.044986419897125554,0.573181169673202,-0.2199024008015259
1,Deaths,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.03384904379044118,0.3475627854062929,-0.32783982908687015
1,Deaths,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0018247395777609182,0.3647899972145625,-0.2547595696166431
1,Deaths,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,7.144426895474545,9.019044704812687,5.577876147062047
1,Deaths,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,7.452157155911077,9.305812427883101,5.985734910889299
1,Deaths,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,7.288678010356556,8.73726180957878,6.124385671016691
1,Deaths,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.770980339766713,6.117460170182958,3.645851633164917
1,Deaths,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.761694605963754,6.0014942012936565,3.7584118994971303
1,Deaths,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.767763879355903,5.776142697002542,3.9571473718371073
1,Deaths,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,4.351778522125706,5.583607287730408,3.322383482207982
1,Deaths,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,4.516804714139195,5.726703436343189,3.5596567334492004
1,Deaths,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,4.42815101268889,5.3768103292756715,3.66567059868837
1,Deaths,70,Australasia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.3693748270029578,3.1457026051453756,1.7747690509627356
1,Deaths,70,Australasia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.7556160921835837,3.5102999980411407,2.1696726507064974
1,Deaths,70,Australasia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.5798369809914106,3.1434217404703437,2.0899165309418315
1,Deaths,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.397639391952816,4.026447085591505,2.7830765071885994
1,Deaths,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.574128775602781,3.0397768329907433,2.1472550554223684
1,Deaths,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.876889028978812,3.3175432422114257,2.447241083059665
1,Deaths,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8467086272387835,1.094359114457842,0.6224014787062307
1,Deaths,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5090500742546856,0.691344327433679,0.3483059760288778
1,Deaths,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6317655278344855,0.8073453274348601,0.48757174750100296
1,Deaths,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8945784808866564,2.3084671735232507,1.4900658906444233
1,Deaths,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.29407381355913,1.5929525283050072,1.0200826160826801
1,Deaths,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.519315018653486,1.805664916505034,1.2401173127617515
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5077894676062126,0.7192186574628733,0.2997751864780161
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.11043639858693922,0.2564992486851736,-0.024215810545977868
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.26220691997030016,0.39566975212896544,0.12328232833726832
1,Deaths,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5132900362991029,-0.36054605534491657,-0.6362846927304774
1,Deaths,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5927289000560981,-0.48466015915097466,-0.6805259426048158
1,Deaths,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5496441407409794,-0.4057711173004564,-0.6542237583481979
1,Deaths,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.796095926922279,-0.7424853424980521,-0.8385305182167274
1,Deaths,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8283234404610329,-0.7930336138171968,-0.8590855504124155
1,Deaths,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8108357472866903,-0.7650372639189252,-0.8470595790729593
1,Deaths,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6796417209788223,-0.57910381849323,-0.7605982647149401
1,Deaths,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7385908499496752,-0.6692263462790043,-0.7949438547976841
1,Deaths,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7073456909679192,-0.6138528243876583,-0.7753045619372811
1,Deaths,124,Central Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.45379733963686486,-0.28100934788821613,-0.5929559601627444
1,Deaths,124,Central Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5401029639359308,-0.4161727269226101,-0.6405498961808189
1,Deaths,124,Central Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.49303687972649685,-0.3281377968660862,-0.6125007103342291
1,Deaths,21,Oceania,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9030780541559001,2.0145608287457057,0.36839209401028794
1,Deaths,21,Oceania,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9392714937865503,1.7966316904448754,0.3357950483460715
1,Deaths,21,Oceania,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9145602828404752,1.8642549439137572,0.44317671716741175
1,Deaths,21,Oceania,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1433310310590692,0.3818661935569692,-0.39882148833615116
1,Deaths,21,Oceania,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.06675154230264269,0.30686899239830107,-0.3413300634220681
1,Deaths,21,Oceania,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.11354853309537069,0.32510475906132985,-0.34406058197878836
1,Deaths,21,Oceania,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.10223692652502676,0.4220968965943949,-0.3544710952055928
1,Deaths,21,Oceania,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.09100150811641396,0.31087060120940746,-0.3738701938833374
1,Deaths,21,Oceania,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0996087131669831,0.3470195834952536,-0.32129390067051666
1,Deaths,21,Oceania,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.25753627949062624,0.17681020897364488,-0.4520332355400829
1,Deaths,21,Oceania,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23112356821539445,0.10341077525362803,-0.47843474105699996
1,Deaths,21,Oceania,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.24690064312766027,0.11256779373126105,-0.4359688471188702
1,Deaths,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8309974855457699,1.94296261981087,0.3070194552343895
1,Deaths,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7738900851136256,1.605076842612751,0.22985348225024393
1,Deaths,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8172434486045768,1.7672841972187723,0.35526424928802036
1,Deaths,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.17543660257943217,0.33845786822606144,-0.43360407380232396
1,Deaths,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1461497497761318,0.21257804961980112,-0.3961929002063407
1,Deaths,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1583428217261409,0.2792080983181866,-0.39429261765940704
1,Deaths,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13624040455996014,0.3883209681881628,-0.38342318610611986
1,Deaths,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16852105684949858,0.22108272553017227,-0.42352838981796626
1,Deaths,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14537547767866452,0.30141557917927647,-0.36263792143185536
1,Deaths,21,Oceania,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29391209448977906,0.12102825766952047,-0.48749949430729994
1,Deaths,21,Oceania,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3019605761077543,0.016751809744116424,-0.5227943826728633
1,Deaths,21,Oceania,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2944100215009317,0.06634306640704471,-0.4722610194005851
1,Deaths,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9945514577767611,2.1862646115911453,0.42788267885084313
1,Deaths,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0437744264839999,1.949417707644391,0.382600485207816
1,Deaths,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.019324741581399,1.9863380980223084,0.4615929373351834
1,Deaths,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.10147412263327313,0.44141238018735435,-0.3838373330135643
1,Deaths,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.016423514434534558,0.4172452977279813,-0.32195456254174176
1,Deaths,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.06469690079379918,0.36947697718084854,-0.30767089634109696
1,Deaths,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.05908502122269584,0.5030968931410282,-0.326406849405139
1,Deaths,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.042017645607346235,0.38248628764642256,-0.3519309906023135
1,Deaths,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.05033943360157093,0.4044336065550804,-0.31263300640457115
1,Deaths,21,Oceania,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2363662525052074,0.20571512570327066,-0.4344506214697128
1,Deaths,21,Oceania,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.21094526409100578,0.14310652741333382,-0.4665554407907461
1,Deaths,21,Oceania,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22130759567482314,0.13572103126314358,-0.4353259842938316
1,Deaths,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0471946612705718,2.2792849455059727,0.47515410997696345
1,Deaths,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0430837434295497,2.0520823684776945,0.36863924613402566
1,Deaths,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0463430692980846,2.1336447040924758,0.5027676086017513
1,Deaths,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.08061877680635916,0.4826560969886755,-0.3685292978350431
1,Deaths,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.018762951257767353,0.421061168182304,-0.3352358056693944
1,Deaths,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.054593688553223496,0.4434032752052243,-0.3183214037320834
1,Deaths,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03425097720491938,0.5469785514307003,-0.30410689948838715
1,Deaths,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04234139081624258,0.4306084934160725,-0.3584750692955562
1,Deaths,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03763308683415104,0.4737098710776811,-0.2932691265733084
1,Deaths,21,Oceania,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20032180015791778,0.2729184862156468,-0.4165178850936795
1,Deaths,21,Oceania,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1925187447273781,0.19605891487782798,-0.4573231829424248
1,Deaths,21,Oceania,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.19438081014926065,0.23374806778742813,-0.40219544499448023
1,Deaths,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9170725949002715,2.0851933595315297,0.3570927889556101
1,Deaths,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9079656620469083,1.846143687211292,0.30040046189976116
1,Deaths,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.912076604047188,1.8401127972864302,0.39426887296492075
1,Deaths,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.13653363433917898,0.40254114489676823,-0.4190507894470324
1,Deaths,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.08084341966137477,0.33533005698779267,-0.36963150750723267
1,Deaths,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.11378122130317747,0.2797555658551609,-0.35884777827467157
1,Deaths,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09563510486926104,0.45541727343712135,-0.35980145925023427
1,Deaths,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10567555140002005,0.3340784555686442,-0.39046076709787914
1,Deaths,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10077675303745226,0.3356658650129917,-0.34429458504300164
1,Deaths,21,Oceania,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2521893639840141,0.20024632742709322,-0.45840673854172687
1,Deaths,21,Oceania,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.23913342566292525,0.11075665741869942,-0.4771876854341991
1,Deaths,21,Oceania,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24438563742363983,0.10459613565111239,-0.4459142933525165
1,Deaths,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3178939824013183,2.6558534559621676,0.701694589976197
1,Deaths,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2952494360399105,2.3425637422445975,0.5651748108952821
1,Deaths,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3067708937407807,2.3572088283281,0.6710791646207164
1,Deaths,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.04294936185484793,0.6419632398576067,-0.28047076829950857
1,Deaths,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.10417510835646147,0.5809837580927859,-0.2288246174741953
1,Deaths,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.06770222422761575,0.5560515757760415,-0.19211768034538443
1,Deaths,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.09344943634102706,0.7246219762932685,-0.19723809442467918
1,Deaths,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07585672379639151,0.5667663916373363,-0.2663525725013374
1,Deaths,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.08484252601476354,0.5788489943084023,-0.2141145238840965
1,Deaths,21,Oceania,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10496234753234199,0.41196960650025083,-0.3417810071608912
1,Deaths,21,Oceania,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09377896822007979,0.29962404685432403,-0.38076586950448027
1,Deaths,21,Oceania,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09708579676992156,0.3026495072053446,-0.34405011389772855
1,Deaths,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.35088912937173883,2.1072342240927737,-0.3792259874207596
1,Deaths,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.34658286920264836,1.2923615134924595,-0.2341653248397392
1,Deaths,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3499093950918816,1.7180442094200588,-0.3234379547775313
1,Deaths,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.39431008703898146,0.3194056037808346,-0.7268876956071504
1,Deaths,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3525557272148478,0.12413067655517601,-0.6376054094788515
1,Deaths,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.37672624320730125,0.2380908319575511,-0.6765543524417785
1,Deaths,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3627279900263341,0.4658148891667213,-0.7071544258263641
1,Deaths,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3688135976714322,0.0745030622545608,-0.6410288260394257
1,Deaths,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3651562354821775,0.2782586922558993,-0.6818222043045525
1,Deaths,21,Oceania,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.29967794855211627,0.6100282726929795,-0.678672299061495
1,Deaths,21,Oceania,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2944887840575937,0.20883815538077993,-0.6022390345910851
1,Deaths,21,Oceania,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2967669302588199,0.4092166921259209,-0.6473875184096194
1,Deaths,159,South Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.0472177510216296,2.6443824580290425,1.570378286966201
1,Deaths,159,South Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.5571450480232656,3.2572877529845985,1.990363219839242
1,Deaths,159,South Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.205554390594762,2.6571216612907773,1.7932999004367431
1,Deaths,159,South Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0035514299111599,1.2989652301455616,0.756357041777968
1,Deaths,159,South Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6110163921795906,2.0251127323058538,1.2772872897242789
1,Deaths,159,South Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2142090418855638,1.4904848143889817,0.9669124525229239
1,Deaths,159,South Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8403890600312687,1.2010509764449424,0.5523984388344209
1,Deaths,159,South Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.062588626634232,1.468562057792647,0.7339436777179742
1,Deaths,159,South Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8981097903183183,1.1654970042150024,0.6540009128749857
1,Deaths,159,South Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.34533971542659964,0.6024993281203902,0.1271990149691049
1,Deaths,159,South Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3817739178628314,0.643775179103557,0.15888293575198267
1,Deaths,159,South Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3269996471682518,0.5245511230586524,0.14999913583216415
1,Deaths,44559,Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.010771355495269048,0.5156968019190488,-0.25268247269222216
1,Deaths,44559,Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09756971907562928,0.29261080773078707,-0.39111341205099376
1,Deaths,44559,Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.05136711238819005,0.3116398212891216,-0.30762096679271084
1,Deaths,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.846582112208786,3.502765470979694,1.1356620915960336
1,Deaths,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.541066782982478,2.6496526596160663,0.7043338190100997
1,Deaths,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6655544789809105,2.7622812038166273,0.9591231499702801
1,Deaths,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9650134400178033,2.1103608988333677,0.49707210378522376
1,Deaths,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8906209847780464,1.6575060598156566,0.29850278158632926
1,Deaths,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9029958860933802,1.6209958453694062,0.42188744887598145
1,Deaths,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3042429737162349,1.0630707270413018,-0.021485357738400865
1,Deaths,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.15391632461277124,0.6573329797158765,-0.22605000800605135
1,Deaths,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.21582669020526846,0.7160714364415112,-0.10639447292648996
1,Deaths,44559,Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2759021138723849,1.0393261761558528,-0.04469298304043154
1,Deaths,44559,Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0836040230009592,0.5988151672608963,-0.2880052213517816
1,Deaths,44559,Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.16312890594318163,0.6575832901060121,-0.16007973257179178
1,Deaths,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.00837598121976509,0.575477102352372,-0.2978669812082904
1,Deaths,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.11281083216039973,0.3199908524099662,-0.39638427931630654
1,Deaths,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.06504663242590014,0.35228530178269846,-0.32960959582597193
1,Deaths,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.31708609198599125,0.06818562827025007,-0.5035430051959884
1,Deaths,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3405239867115512,-0.047871238417260716,-0.5312787103584156
1,Deaths,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.33355175812840165,-0.039830504123257324,-0.5022060545777981
1,Deaths,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5456591069284716,-0.27815012530958244,-0.6782976846353168
1,Deaths,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5971211498077368,-0.40058285632790996,-0.725893849561758
1,Deaths,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5735441660046336,-0.3831885352017711,-0.6942180125450288
1,Deaths,44559,Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.45431084158583745,-0.12019196125748526,-0.6145712203391686
1,Deaths,44559,Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5021091075015123,-0.25157777548458626,-0.6637237792166231
1,Deaths,44559,Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.480059139577462,-0.23975821685184473,-0.6294068249594919
1,Deaths,44560,America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.824082649002302,2.969736236074689,2.654694020169021
1,Deaths,44560,America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1177534409426,2.2495652657258156,1.9595691254171932
1,Deaths,44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.519972402533236,2.6411644918186448,2.3905885049591262
1,Deaths,44560,America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0381721569921551,1.113103283852313,0.9580126986967006
1,Deaths,44560,America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6667742624101758,0.7284263867620892,0.5958419517822792
1,Deaths,44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8786693875911571,0.9367769162602263,0.8156829563596637
1,Deaths,44560,America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.6745550003650669,1.7764247990544824,1.5560849656315754
1,Deaths,44560,America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1684163337638442,1.260092253382668,1.0583981876763129
1,Deaths,44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.4548814145636384,1.5394025907424038,1.3646471487296539
1,Deaths,44560,America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.6857632213705075,0.7502271590034667,0.6125958877417073
1,Deaths,44560,America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.43951807862021597,0.5022147839629356,0.3705255794329917
1,Deaths,44560,America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.596731839957154,0.651356585271823,0.5391354911571875
1,Deaths,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9168664697388538,2.1286010751889837,1.7102327889502846
1,Deaths,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.413316656144413,1.5824624247711874,1.247655681628163
1,Deaths,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.738115344938461,1.9207038620575614,1.5607025534188488
1,Deaths,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5544075717355637,0.653636291992724,0.4612895549391608
1,Deaths,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.28994510484131836,0.3650815730318641,0.2134484863946644
1,Deaths,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.46114667116845554,0.541417635159344,0.38426270960029424
1,Deaths,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0400499984153306,1.1881367161291116,0.8955308561993308
1,Deaths,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6784762986728577,0.796118201544578,0.563258091135681
1,Deaths,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9096026055157338,1.0369425689955138,0.7858722705012006
1,Deaths,44560,America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3544851274104353,0.44351839128128306,0.2705268748382844
1,Deaths,44560,America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15116681061703127,0.23015996999003327,0.07449996526081668
1,Deaths,44560,America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.29315518000365903,0.37218154064773995,0.2167599342082663
1,Deaths,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.3215209799447845,3.499608257757359,3.100223962335123
1,Deaths,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.323861461220671,2.463257633087974,2.1552865598857345
1,Deaths,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.7662057450506135,2.9103760544783848,2.6175340206443605
1,Deaths,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3035285542077424,1.4109816577365848,1.1823435681087753
1,Deaths,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.777102278519195,0.8512766107429259,0.6935136852718917
1,Deaths,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0102579670557705,1.0835737354788972,0.9282698834927515
1,Deaths,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.022462275785115,2.1470161264973315,1.86768762802267
1,Deaths,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3117657057256,1.4087165845128022,1.1945208445005269
1,Deaths,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6266082314434498,1.7271547621183527,1.5229223466185051
1,Deaths,44560,America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.829688307442357,0.9027400629387035,0.7406027151875845
1,Deaths,44560,America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5059261733895036,0.5708673200292547,0.4330991197970311
1,Deaths,44560,America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6619811104358924,0.7233494405351538,0.5994106529099593
1,Deaths,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.933295006718472,3.1196731762097047,2.715861420687237
1,Deaths,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1673534424416934,2.3403016658933438,1.9794007898090824
1,Deaths,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.7477104576607503,2.9097589398003096,2.564854331588392
1,Deaths,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0963341704757372,1.198577162414954,0.9851758252495589
1,Deaths,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.693224618854646,0.7824363507162174,0.611433155730623
1,Deaths,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0001838524599629,1.0816090659946764,0.909389660067535
1,Deaths,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7509378833311668,1.881290365462198,1.5988653111238496
1,Deaths,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2029134341416277,1.3231999672917945,1.0721912299446248
1,Deaths,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6137093413164378,1.7267243771094334,1.4861827433490542
1,Deaths,44560,America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7127335625938968,0.7922202096935511,0.6208950193347679
1,Deaths,44560,America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.45661420729173735,0.5358880157744176,0.3699055524119803
1,Deaths,44560,America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6878939509358681,0.7598618163091216,0.6084844092802704
1,Deaths,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.519540960036562,2.6920304786804907,2.344984283113465
1,Deaths,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8262695283848756,1.9685816610821556,1.6717903813645245
1,Deaths,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.138907065626464,2.2782892306654934,1.9918895260676963
1,Deaths,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8759783107617027,0.9749589084993517,0.7863983075523443
1,Deaths,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5109499436490827,0.584836957277626,0.4372287535519739
1,Deaths,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6753425882305224,0.7451356881189511,0.5980749246830023
1,Deaths,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.461559212406495,1.5821980026585936,1.3394746561970248
1,Deaths,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9656875134795663,1.0646664606217915,0.8582463344479222
1,Deaths,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1891207476238603,1.2863279547683542,1.0865885160592146
1,Deaths,44560,America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5912917209593471,0.6621631970693247,0.5248391494435543
1,Deaths,44560,America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33979355822062174,0.4023883836403318,0.2750677548142836
1,Deaths,44560,America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.457618374302428,0.5128470814327446,0.3980405756956866
1,Deaths,44561,Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8725830242352421,1.321428923075759,0.5112963114496871
1,Deaths,44561,Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0816024819821648,1.5579528839214878,0.7225558848608464
1,Deaths,44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9320725281852105,1.2923640892657915,0.6255502063773021
1,Deaths,44561,Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.21358956002824145,0.43969087130164825,0.04755787914533551
1,Deaths,44561,Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.49001737255190436,0.7308562674474294,0.2799220602922145
1,Deaths,44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3083478679720269,0.5241497101997825,0.1416882462622509
1,Deaths,44561,Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.29479261342107616,0.6051459311974106,0.044981864852018535
1,Deaths,44561,Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.41976040817094895,0.7446559859499338,0.1748720840582935
1,Deaths,44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3270143332707419,0.5744750567869094,0.11648418568431125
1,Deaths,44561,Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.15943958208476974,0.03235630955898334,-0.3137354683357742
1,Deaths,44561,Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.17927867773155834,0.0069119279677605,-0.32020367394292576
1,Deaths,44561,Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.17886098925785768,-0.029174340154769045,-0.30329784864149206
1,Deaths,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6767955908508625,1.1546133326093624,0.2923386270971918
1,Deaths,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6685793058815777,1.118392678152686,0.3335001939389585
1,Deaths,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.675379067263238,1.110404963492072,0.33825179885302686
1,Deaths,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.08638392619298496,0.3489320277819834,-0.11262532958983233
1,Deaths,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.19411135811490884,0.4366613531462925,-5.607649980579523e-05
1,Deaths,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.134287736414022,0.38903952185259466,-0.0726429481499797
1,Deaths,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15941590687943066,0.48980172934148664,-0.10641585086057448
1,Deaths,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1380572692862119,0.4448532221850862,-0.09048399200600385
1,Deaths,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15070837325572367,0.4494992267139337,-0.08084231171621752
1,Deaths,44561,Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23587707262889335,-0.01812338245447243,-0.4056832683265101
1,Deaths,44561,Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30474905836475524,-0.11411493424936943,-0.44435164274993905
1,Deaths,44561,Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2623435627066049,-0.07639830956432014,-0.4096410965918616
1,Deaths,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.064797934698351,1.3864810796279452,0.803887851795916
1,Deaths,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3669984622608249,1.8560344241203899,0.9666221940205523
1,Deaths,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2033571415485536,1.5198690065749432,0.9360380936683824
1,Deaths,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.33876296171684245,0.5031320465055595,0.21537857638015376
1,Deaths,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6946645874004732,0.9559323098480114,0.4583121742414293
1,Deaths,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.49249763790730394,0.6624416835395458,0.3464196107434822
1,Deaths,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.42769910837270786,0.6501260739738737,0.24729351687850856
1,Deaths,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6144152075181056,0.9479629923760742,0.3413379130110903
1,Deaths,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5133420021741035,0.7307333140493296,0.32973802099929567
1,Deaths,44561,Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11876316284869443,0.009634982491819823,-0.22487964693136334
1,Deaths,44561,Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14600682935028525,0.021223512687481114,-0.2904431464012193
1,Deaths,44561,Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14590150387593134,-0.029149842098535838,-0.24856872953611103
1,Deaths,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5102396004238279,2.0284446991451905,1.1299514350861417
1,Deaths,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.484751060086969,2.0627605520817855,1.041841548156265
1,Deaths,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5038893130210218,1.9087827591279023,1.1607041212585192
1,Deaths,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6270162699350649,0.8917630677338095,0.4514146947559116
1,Deaths,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7781981815393739,1.0853554236500929,0.5284762013642451
1,Deaths,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6954056496285609,0.9373907937262764,0.51667188167518
1,Deaths,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7356985781034963,1.094010132452644,0.47274932507810064
1,Deaths,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6947285611962951,1.0889608891188707,0.39264139763625405
1,Deaths,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7197579070301935,0.9978527500513793,0.484046430472489
1,Deaths,44561,Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.04848568642462436,0.24991567854111166,-0.10621026637159553
1,Deaths,44561,Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.032384459841282194,0.1917261926595046,-0.20323023631506965
1,Deaths,44561,Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.015213633512625871,0.1739465733645003,-0.11926481084382606
1,Deaths,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.767006432130852,1.2698393883294006,0.3762424279285068
1,Deaths,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.703721136750414,1.1605521688013505,0.34481952934330096
1,Deaths,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7362733316467183,1.088127491750649,0.4229452968006338
1,Deaths,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.14490435024666587,0.3924873798475517,-0.0619458803862525
1,Deaths,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2194304534474619,0.49078515226251207,0.009654251338187862
1,Deaths,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1757026105287636,0.371559424016797,0.01183195397816567
1,Deaths,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2217919561269847,0.5694744829065155,-0.04840078816464546
1,Deaths,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.16202581302598804,0.4736081723591606,-0.08276362061281163
1,Deaths,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19253266322001525,0.43419828750039896,-0.022671883809519133
1,Deaths,44561,Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1884105074103494,0.030194601736392677,-0.3565907855240909
1,Deaths,44561,Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.27760116624981734,-0.08620721994069092,-0.42961442611624473
1,Deaths,44561,Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.23611889560008628,-0.07910209019631101,-0.3661330860812326
1,Deaths,1,Global,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9939285730602277,1.379577179660129,0.6959027596510132
1,Deaths,1,Global,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0909761713597286,1.448235813448075,0.7874653910940913
1,Deaths,1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0248442715970092,1.321670025213618,0.7669707541934427
1,Deaths,1,Global,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.31267699455447573,0.5250376107401176,0.16112353215731803
1,Deaths,1,Global,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.47420733653282016,0.6714101001020986,0.28658393631024626
1,Deaths,1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3751382911737687,0.5630010719196102,0.2272255441892914
1,Deaths,1,Global,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3525259653079305,0.6141199666971814,0.15036844752416406
1,Deaths,1,Global,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4081150956809756,0.6487025791696349,0.20372342577684938
1,Deaths,1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3685557379938458,0.5691749135001053,0.19426367668833333
1,Deaths,1,Global,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.03915987037535027,0.14195782307312946,-0.17423033277402022
1,Deaths,1,Global,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.024766710607926568,0.13928962573622708,-0.16378602267558307
1,Deaths,1,Global,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.037171356410907005,0.10080021392153031,-0.1568578314388502
1,Deaths,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7027706589097722,1.156375806507668,0.33892319731791287
1,Deaths,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6942368243832424,1.0737427492238463,0.38179220876073783
1,Deaths,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7011302547508145,1.0937374434493228,0.4002492492851368
1,Deaths,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.12068017920774723,0.38529786302870944,-0.08171257381282096
1,Deaths,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.19423465511768198,0.4282255940218998,0.007185840136117068
1,Deaths,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.15507418136313908,0.4057068165170401,-0.038988811660348045
1,Deaths,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15502709588303415,0.46271752592782045,-0.09177870541961106
1,Deaths,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1409410019824735,0.39650968276802323,-0.0694669337216389
1,Deaths,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1497632701294016,0.4151193907989691,-0.05359677699098388
1,Deaths,1,Global,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.15714318045633344,0.06437321745985157,-0.33307489549721486
1,Deaths,1,Global,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18040105541679616,-0.00012814634488948328,-0.325767440301082
1,Deaths,1,Global,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16427025624182898,0.029592100102825133,-0.31180357171584455
1,Deaths,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.274152321731062,1.5486128309989524,1.031834758077436
1,Deaths,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2959715068414883,1.6699102780722594,0.9596789974248284
1,Deaths,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.284766350904624,1.537956079969447,1.0210473293010232
1,Deaths,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4975690871676501,0.6590349629565786,0.3582736304659643
1,Deaths,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6189751477089654,0.8463400125697021,0.4008950400437789
1,Deaths,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5519597146799441,0.7073528254428179,0.3890350095057678
1,Deaths,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5426079478292667,0.7287805972671166,0.37823857115260695
1,Deaths,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5461640272708282,0.7979836490544874,0.3196963297618242
1,Deaths,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.544232385357536,0.7153587585672049,0.36598945314967896
1,Deaths,1,Global,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.03908120850268703,0.15495118703434646,-0.06552645458932298
1,Deaths,1,Global,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.020413375410003053,0.17982175557431113,-0.12928837465938156
1,Deaths,1,Global,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.023174453388909486,0.13403852387579554,-0.09546876609776976
1,Deaths,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4557790846735272,1.8145391889622622,1.2016238980024843
1,Deaths,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2904130891721615,1.6583651676984232,0.9862995191948107
1,Deaths,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4161343649677742,1.6996640288661105,1.1882380067757368
1,Deaths,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.616821075410559,0.8152329281713437,0.48318574235175804
1,Deaths,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6146785339737973,0.8263721643474354,0.4294396481394896
1,Deaths,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6408049759417722,0.8153466506505793,0.5038220655572316
1,Deaths,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6658094086004936,0.9091643426352527,0.4934103097387475
1,Deaths,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5424208512674493,0.7902088860412244,0.3376232478552238
1,Deaths,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6330216576768243,0.8246542458528513,0.4789906178351164
1,Deaths,1,Global,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.11207441469689833,0.26618768952366256,0.004819509578500221
1,Deaths,1,Global,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.05530791792813195,0.21966965319380433,-0.08515048568258059
1,Deaths,1,Global,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.11053448518921571,0.23651388074434052,0.010159077312436685
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7388800671386474,1.4405056514960057,0.19716008856684752
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0899188289436994,1.9178491450923354,0.45571704174031974
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8140399468158216,1.5417423003336064,0.28034620416140804
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2202777110540298,0.6311641703393979,-0.13870254863991566
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5216994772010853,0.9680259372814882,0.10056425832085455
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.29489559037558233,0.6792115400409479,-0.048546698278399
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3070510162751783,-0.027451091689348554,-0.5229280716907712
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.15508133301255914,0.1796368241669526,-0.4114783381133569
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2718488680095505,0.020249050449291067,-0.48607221162012326
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.25083913276518127,0.05853000493378517,-0.48525354191305725
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1648796102747499,0.17710639935557107,-0.412217617727743
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2575184271752939,0.03643049334385888,-0.4766245084692764
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6592895129246222,1.3975239540490514,0.1194988927348831
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0104739190748269,1.808317419564296,0.3696249596203128
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.860878471482081,1.5918303843525177,0.31316109532478986
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.16464327514815888,0.570062498579568,-0.18871029090580418
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4660727772997613,0.9033849117205884,0.04307431105370892
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.32849994476372185,0.7034134108148222,-0.014544048568143368
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.33876809366249544,-0.04457942855828812,-0.553876293907826
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.18719956000574367,0.1353550088905382,-0.4462839038873036
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.25304800046726533,0.04035428304994113,-0.47290039575757775
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.32517928382938466,-0.04434873041777654,-0.5343067172099277
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1993244499190569,0.09695933624163877,-0.4516829258426235
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24424465938011714,0.06210525686612345,-0.4644237899458526
1,Deaths,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8678019319751779,-0.823841830203694,-0.8999102219526031
1,Deaths,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8851945252057193,-0.846935520466778,-0.9140830973804316
1,Deaths,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8748340997747331,-0.8371997868475706,-0.9041027596952852
1,Deaths,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8955468278238781,-0.8617647155999005,-0.920190720508156
1,Deaths,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.9163917288408174,-0.8881297166200415,-0.9374069464993242
1,Deaths,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.9048494000744561,-0.8767110167991764,-0.9268937425798801
1,Deaths,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8558056796256862,-0.8078564388142805,-0.8908276214804409
1,Deaths,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8760030515411751,-0.834680981777506,-0.9072044798825988
1,Deaths,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8641616024139254,-0.8233183315783541,-0.895925907675535
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7857121085724966,-0.7140320148823865,-0.8378749354414584
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8123478726646933,-0.7489648309672167,-0.8597954492771273
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7960558862543794,-0.7330136254501401,-0.8441285310300968
1,Deaths,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9948196561958158,1.3933391859535125,0.6509100592422072
1,Deaths,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8750443534766974,1.2351803235162067,0.5649520243120161
1,Deaths,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9333372210986088,1.235092424580267,0.6653435676613461
1,Deaths,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3132727971389029,0.5429834023996833,0.13403889911409847
1,Deaths,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.321995585040046,0.5433603788378991,0.14613557362473106
1,Deaths,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3130320839428924,0.49306719436455854,0.16209546567076905
1,Deaths,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.35313040675804425,0.6234550407304327,0.11984890115002593
1,Deaths,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2627012662152859,0.5052257401219278,0.0538774184199657
1,Deaths,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3067077723092058,0.5106586741079955,0.12557569351075468
1,Deaths,1,Global,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02191765720686897,0.1739959212513288,-0.1901748595760424
1,Deaths,1,Global,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09296276705243268,0.08208776584639588,-0.24060231633999946
1,Deaths,1,Global,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06083770375741428,0.08204549887311682,-0.18580404405293924
1,Deaths,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7951622062240806,2.348737413670578,1.2908816686508366
1,Deaths,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.200284912117126,2.879656776257196,1.6828891651930553
1,Deaths,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.877996804360378,2.3575275126619624,1.4624077865565521
1,Deaths,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8378289544710243,1.1293755825294451,0.5672542056951517
1,Deaths,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.3487011288605995,1.709583257988834,1.0250763552494286
1,Deaths,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9878252654312389,1.2919293816250665,0.7231399549008894
1,Deaths,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6881583023146293,1.0224940272058016,0.38359444755717237
1,Deaths,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8556654768379719,1.2495950639964406,0.5556567426797858
1,Deaths,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7041526192440279,0.9880978659246284,0.4580692628808705
1,Deaths,159,South Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.23140346563250702,0.47981827682885986,0.00921149686375904
1,Deaths,159,South Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.25859652958859886,0.5134301416545842,0.054328891690066286
1,Deaths,159,South Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1918403447839444,0.38848036528016416,0.016710798523676473
1,Deaths,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1423115806815614,2.8013839647815657,1.6000067518362182
1,Deaths,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.8678756399663357,3.668750526641305,2.2109337861039284
1,Deaths,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.476190184451322,3.027938159966555,1.9937102157974722
1,Deaths,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0666453024815878,1.4320309188232248,0.7329979513250664
1,Deaths,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8392531006550996,2.369551013408257,1.3840238529393647
1,Deaths,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4015900248171047,1.7486634972646284,1.0693032669144256
1,Deaths,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.897821661860904,1.2958731647637445,0.570292763122214
1,Deaths,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2427638447477778,1.7071462104684885,0.8618401607699181
1,Deaths,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0583617740116515,1.3850691408205076,0.7726701773189439
1,Deaths,159,South Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.28474247348361226,0.5553156906534017,0.061857742245452776
1,Deaths,159,South Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.33705079355657386,0.6221378984984685,0.11489371879969344
1,Deaths,159,South Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.30858700920351795,0.5229401996954504,0.12666068715340856
1,Deaths,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.718325245994017,3.4354854540547315,2.0613728195968726
1,Deaths,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.4551936981407363,4.356003637424532,2.7009636843453353
1,Deaths,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.857468546075105,3.4951451593297174,2.2518815543911104
1,Deaths,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.444105682125274,1.8336701041470485,1.091297758652791
1,Deaths,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.269037437484464,2.81761080191876,1.755846659293201
1,Deaths,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.663718005053786,2.075092038159165,1.2987934078751848
1,Deaths,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.245709254637669,1.6788433162787177,0.848938115424878
1,Deaths,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5833166000200387,2.1056456899058564,1.1459809762773223
1,Deaths,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2841287094154086,1.6617171310085397,0.9255415641848043
1,Deaths,159,South Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5684314720607009,0.876546666305697,0.30327985543890246
1,Deaths,159,South Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6044847224080513,0.9378019158975867,0.33218789648796926
1,Deaths,159,South Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5131757905620358,0.7685260433546433,0.27994945674721566
1,Deaths,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8847147010777985,2.4835351528266507,1.3983090941616225
1,Deaths,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.402253603331614,3.0744174749738904,1.8186737837753826
1,Deaths,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.128292094664493,2.6095518160687967,1.7201285209768638
1,Deaths,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8968426240420694,1.1980380873228191,0.6345193156081214
1,Deaths,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4970289175343474,1.8808562630177643,1.1529865156535324
1,Deaths,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1609687491596514,1.4347412017244032,0.90883710002561
1,Deaths,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7422441751643901,1.1039060905139164,0.4484760132382235
1,Deaths,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.972775777320855,1.3625258544660683,0.634390616665445
1,Deaths,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8523603496730436,1.1373293995084053,0.6106738328131422
1,Deaths,159,South Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.27740724994970656,0.5372168696923871,0.06441396046309643
1,Deaths,159,South Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3630696052266023,0.6278010676464095,0.13629530528768624
1,Deaths,159,South Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3147465414554855,0.5197840192314089,0.1451820842855918
1,Deaths,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.7622811267705125,4.011556405069511,3.5303572823951974
1,Deaths,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7367375080360636,2.934598602309665,2.512589884517277
1,Deaths,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1850848536729863,3.3545849368855465,2.9799813133352426
1,Deaths,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5380958090730694,1.6728067631849268,1.4172768843554175
1,Deaths,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9974917103849268,1.0922058261188925,0.8956852946590498
1,Deaths,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.233477797517676,1.3221995408845804,1.1398387104010563
1,Deaths,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.330728953797927,2.5050715355974926,2.1685219267506124
1,Deaths,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5989234879855272,1.736537073141113,1.4430274631011692
1,Deaths,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.918740788495886,2.0369526823579083,1.7756985109842867
1,Deaths,44560,America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.040116726095769,1.1423507535188842,0.9471926102433019
1,Deaths,44560,America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7193489735632507,0.806895207869015,0.6221704498588582
1,Deaths,44560,America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8708199102816363,0.942900943339911,0.7875928574201173
1,Deaths,44559,Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0276438913229071,2.124090723340052,0.5465343612568347
1,Deaths,44559,Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9564223902689373,1.7074456762122523,0.36993190432315676
1,Deaths,44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9982460333427553,1.8185603333784837,0.5255670421246362
1,Deaths,44559,Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3986567523354213,1.1147157108079395,0.10628102613013926
1,Deaths,44559,Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.45542413644778507,0.9540352939393542,0.04593664683818797
1,Deaths,44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4260511074821732,0.9478921167831827,0.11220932934728615
1,Deaths,44559,Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.07097698425269129,0.43139147741172956,-0.2914110695669226
1,Deaths,44559,Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.11157481216626897,0.22947015194803586,-0.3779042728853584
1,Deaths,44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.08854953815696197,0.28561652305286495,-0.30415035890702347
1,Deaths,44559,Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0766159483438839,0.42696506856541033,-0.2915243272074951
1,Deaths,44559,Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14308685005306576,0.21971858667307392,-0.41800217216402197
1,Deaths,44559,Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.11161640721992902,0.2656331401097207,-0.33952297630974954
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3356888710591137,3.2236770487285997,0.5634483735859325
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3921989833655601,2.091052618931739,0.8988018950851532
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3715832686163,2.219151982417624,0.8440717543105154
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9469827806503008,2.498036490970039,0.31862572623489555
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1454297628541341,1.7043601589081572,0.707255050566704
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.041907071200821,1.7275461721269874,0.6184025493972575
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04639081121867424,0.8922112906847685,-0.2995736580303739
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07095773208160815,0.3838258127920047,-0.14993000775725782
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.06209686155702876,0.44167453980888044,-0.17414545436479772
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.058365230461677506,0.9531449772785314,-0.2913465169643801
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.01843464115188078,0.3417440328099466,-0.20489563431351362
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.05298093330391264,0.4292390835594929,-0.19138123998611892
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.15038061692303528,1.113310412983999,-0.5621304227041753
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.094631185753576,0.8331044949078533,-0.4911110688119278
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1167416402841968,0.8154990376589175,-0.4955936976091802
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.29339704331583927,0.7172737731368051,-0.6228944153771353
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1885147229703573,0.6207572140645278,-0.5129318962132273
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.24057929253998003,0.5642338151942207,-0.54358552876534
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6193697172167095,-0.05323494717150989,-0.8038340175047399
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5946776423094078,-0.17934191671081468,-0.7721767547698482
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6044389652211114,-0.1869415442526836,-0.7741051904825396
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5217809512865922,0.20018394559581454,-0.7533969432285895
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48595853594802724,0.05533033746144079,-0.7127182011928737
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5004637905798437,0.03201746674591693,-0.7155304076010971
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.891054952486199,2.297051181916846,0.32996254180406565
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2491683074168072,2.635458590178593,0.33774130588339735
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0975023616834407,2.1997813505135118,0.4080720153203573
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.28396613408554866,1.1867447310274621,-0.08656172206855375
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6345354788138472,1.5512246753069285,0.006837923612827206
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.469079250741282,1.2095883724328842,0.009720549447918206
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.24062310630453107,0.32397235817358555,-0.46593681881178817
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.12854268113335066,0.40858600283516244,-0.48168198532850925
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.17287093965818384,0.2618017457798439,-0.4447408955521796
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09571130460475916,0.5434428528541341,-0.3701353748654348
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0009350555127644154,0.6239979341550467,-0.4113556493200033
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.03248832888983853,0.48159045945066264,-0.360251871028403
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2570370991835276,3.011935342395915,0.6936542796438222
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3499003715240991,2.3438840019797986,0.6125332706587406
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3120769363835032,2.3134824642848963,0.7422671865002427
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6106185662816979,1.7705472721305968,0.24919155315843836
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7756711356611525,1.4355726847547494,0.25852273514312213
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6928663587432196,1.3819213917517752,0.2960300259166643
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.012279849047245935,0.7556952800808844,-0.2588263341543138
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.017405610102546525,0.4477576940591242,-0.3018425734444422
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0063409052123263275,0.44220674063267046,-0.24167110964444102
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0633789920885615,0.8769452779090013,-0.20883594601038996
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.028065139255341466,0.4833841360725439,-0.30095790665828204
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.049301175951400905,0.5244878517470278,-0.2182791455464462
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.011633616882206134,0.6855871089691602,-0.3108018204527566
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.06355550189885845,0.37397867340493,-0.3518175682338072
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.029174064312633287,0.4190995974156937,-0.3145227058174435
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2799256587524544,0.18434727793764435,-0.49399739841074536
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.29309034111703336,0.005211006150790287,-0.49251698076026196
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2903602720051589,0.02422466921740758,-0.47939106113268193
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5572908796504811,-0.262356673571163,-0.6983944436779452
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5945598811494138,-0.4051264353914771,-0.7193649354499564
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.577444056662147,-0.38233111927341373,-0.7016432152949138
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47363988883998687,-0.1048012119729532,-0.6411950977649422
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5012880355394198,-0.2613300817685722,-0.6576105635862549
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48850575039301136,-0.24188606178118793,-0.6398571485857559
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.816036126964636,5.52545668107595,4.199653716564731
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.242651455791365,4.788734309965882,3.747033109678854
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.492273901195118,4.968672145405493,4.022715295607081
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.560353315409972,4.103239349672583,3.0826396219850025
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.3066987863518547,3.7373612229572024,2.9132263595344776
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.405193922441937,3.793756111903682,3.034874362893244
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.3861857407698897,3.92119794680241,2.921338604277228
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.997587720094242,3.4139827695096656,2.619672493232436
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.165280340820851,3.526575548727214,2.8091722398950094
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9078032920798653,2.2204188877017788,1.6198725272628909
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.045657153994908,2.3229274707839487,1.7937770182671766
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9833604631456956,2.215677908895683,1.7648852006716351
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.28211762838807736,0.491832905851337,0.10428580652146732
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.32936935334739276,0.48360088469234525,0.20338616488575068
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.30069795610232897,0.4656164172258626,0.15161667654590977
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.005170675872430081,0.16573219763307756,-0.132013705480102
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.092013013178391,0.21708759678466025,-0.011310418646336065
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.043159081898569616,0.1694739894073944,-0.07203443348214063
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.033086119676419626,0.12507145354880392,-0.16719866373544975
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.013660863634314393,0.1312643474735506,-0.08240290321714082
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.013564923497355795,0.11150743019694949,-0.126626532239347
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2534410700038383,0.46110003288990836,0.076117211493571
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.3061571159240609,0.45481174858132645,0.1821198008445976
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2743255904031017,0.4370640693355271,0.12717975952894423
1,Deaths,44562,Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0425504201416504,1.1743664131787344,0.9044459808225199
1,Deaths,44562,Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7887546076824956,0.8852986002200057,0.6581073645344901
1,Deaths,44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9467035553688936,1.049221764278432,0.8328108046334768
1,Deaths,44562,Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5957552858958562,0.6987336680813782,0.48969420166925054
1,Deaths,44562,Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3815343483676427,0.45073279365937463,0.2836651266254334
1,Deaths,44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5122024749061949,0.5881744629302632,0.4247838969656926
1,Deaths,44562,Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9227869415626547,1.046873998411535,0.7927801569682069
1,Deaths,44562,Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6992075737024401,0.7909184671981935,0.575100676039124
1,Deaths,44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8411476086690788,0.938106981172546,0.7334304551852158
1,Deaths,44562,Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.24024058956101546,0.31844368600367573,0.157242882665358
1,Deaths,44562,Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.17172708228399503,0.2290699525748134,0.10683433476689931
1,Deaths,44562,Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2527512414032634,0.3148287416969046,0.18373411027755418
1,Deaths,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6987608966414968,0.8642481818527086,0.5547332373478983
1,Deaths,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.41615325212160575,0.53323840827558,0.30877609740014716
1,Deaths,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6145927608667965,0.7504860978480111,0.48788234712544637
1,Deaths,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.32722823741115037,0.453635284578046,0.21606988613764413
1,Deaths,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.09385311545309649,0.1804710740106784,0.008384748238351121
1,Deaths,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2543235619537707,0.35810012365519683,0.16001151002871916
1,Deaths,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5991552701416406,0.7549393271034763,0.46357256932666363
1,Deaths,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.34525905408904384,0.4564827978325902,0.24325731848948562
1,Deaths,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5270448304497968,0.6555696342017553,0.4072050250464792
1,Deaths,44562,Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12301744237141589,0.21564641713221103,0.030434019451797807
1,Deaths,44562,Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0023980383670136334,0.0640269973239295,-0.06883722266442735
1,Deaths,44562,Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12037830960757594,0.2010857140991313,0.039579641753400584
1,Deaths,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2508718991053316,1.435297935804261,1.05480841231935
1,Deaths,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9107640547219228,1.0258033343281399,0.7637273245401582
1,Deaths,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0743852737364896,1.1973388795133626,0.9288436234574197
1,Deaths,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7585623796034827,0.9046047587799869,0.6096759776633404
1,Deaths,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4757810047606029,0.5651093980116263,0.36048381533234325
1,Deaths,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6114086968824544,0.7010098794989176,0.4950102023741638
1,Deaths,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1188936400551257,1.2925059883976764,0.9343261951627811
1,Deaths,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8151090928835713,0.924389378922026,0.6754331840337792
1,Deaths,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9619060517278181,1.078192754255792,0.824256094376052
1,Deaths,44562,Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3038110482417469,0.40248920884843403,0.20590879037643728
1,Deaths,44562,Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2204978834456111,0.28229029403195716,0.14289383042850423
1,Deaths,44562,Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2776734159737871,0.3432415760259519,0.19887251733289293
1,Deaths,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0192670440363965,1.1834100055994832,0.8626056022199583
1,Deaths,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6101854856560426,0.7301071656534587,0.5003924907322439
1,Deaths,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9318417531968632,1.0641252979406834,0.7995650217529546
1,Deaths,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5775013307743567,0.7065799102910734,0.461850841730178
1,Deaths,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.24355874215619996,0.3287362645552747,0.1574001356953041
1,Deaths,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5005879982209961,0.6028206176779476,0.40269792775017044
1,Deaths,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.900868769512065,1.055387326278479,0.7533930589491216
1,Deaths,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5295778194177748,0.643496087484033,0.42528118324826647
1,Deaths,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8270916567733292,0.9522024017553549,0.7019873556542213
1,Deaths,44562,Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.22439848015075345,0.3155062135602726,0.1370064113381937
1,Deaths,44562,Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.10856701433168517,0.17470344453031203,0.04768794819398866
1,Deaths,44562,Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.27522939227970966,0.3561354405523027,0.19366678387427694
1,Deaths,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1187806771213538,1.35862891732855,0.9038456154740119
1,Deaths,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7633893943031248,0.9249393812832141,0.6037674233033933
1,Deaths,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9187488859809999,1.075583751823181,0.7573333176124448
1,Deaths,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6553289372439974,0.831765858760091,0.4938602274463658
1,Deaths,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.361826015987268,0.48007585476815406,0.24124652549686462
1,Deaths,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.49042794781897303,0.6095399579882506,0.3689926013504321
1,Deaths,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9945474921112072,1.2203324028186728,0.7922149936112122
1,Deaths,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6751121709581528,0.8285747869196295,0.5234810523647209
1,Deaths,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8147087230191781,0.9630395448358314,0.6620455777323203
1,Deaths,44562,Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33765981737114314,0.4592626963741622,0.22308129283010666
1,Deaths,44562,Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.20783971914330046,0.29523784220276134,0.11459671556349922
1,Deaths,44562,Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.26978884268197667,0.351263116802616,0.1764597092115393
1,Deaths,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.1097727400695003,4.034167065197398,2.2847070815163506
1,Deaths,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,3.032491045180731,3.5142601337354753,2.469977541312413
1,Deaths,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.0804858965182444,3.715820964034981,2.4873740211576854
1,Deaths,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.8320599322992916,2.473390057777105,1.2591369520894935
1,Deaths,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4537705809752548,1.7375089421672325,1.124772479426635
1,Deaths,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6556992134698139,2.047002868429059,1.2667320912259243
1,Deaths,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.0145433570595146,2.6925922294335813,1.4093526671024643
1,Deaths,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.944364631614467,2.2961332652090793,1.5336396363104379
1,Deaths,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9860773772724896,2.4510121228424686,1.5520413339872898
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1997155268751771,1.6844109557982647,0.7669230215875091
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.089606866844116,1.3301912056314535,0.8029511169432278
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1506222787032618,1.4755803911628154,0.8344514563656186
1,Deaths,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.506324852842923,3.3646979069156053,1.731392083665803
1,Deaths,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.3337746724978787,2.7968879291270126,1.8610558158128723
1,Deaths,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.459037112146917,3.1130758155527523,1.8368675436866337
1,Deaths,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4160290405520517,1.995365796149573,0.8822817605147458
1,Deaths,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.028583872412115,1.3058974429434405,0.7457665126199693
1,Deaths,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2511291382145084,1.6666957211567541,0.8438877226411974
1,Deaths,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.571910653300877,2.2015325209056416,1.0034927432995826
1,Deaths,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4341897168515432,1.7723366037194594,1.089029202736084
1,Deaths,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.5313045381534707,2.009926502701181,1.0760042331599187
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9347556554179214,1.3870776391043946,0.5184055204641783
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8133765320636467,1.049509240432056,0.573466909170075
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8963648492853256,1.2418598494037403,0.5597696636867869
1,Deaths,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.748645967431172,4.898613560728795,2.762457119589472
1,Deaths,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.2463403993788615,3.831590207636794,2.6657784957746826
1,Deaths,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.481539442497734,4.122187230466997,2.878981324778095
1,Deaths,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2726472903794406,3.061874789067919,1.594679275688052
1,Deaths,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5840451286394506,1.9402019802820538,1.239301596407442
1,Deaths,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.9169513643102196,2.335286905030237,1.5099283865219604
1,Deaths,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.4831607637518687,3.3266690033705943,1.7597852322821879
1,Deaths,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.100508927519865,2.527835068306517,1.6766057083229353
1,Deaths,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.279566180100141,2.7483887455909306,1.8386174280532863
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4646962902286658,2.0195630308197154,0.9699762854671123
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1492158825851506,1.4278127818681676,0.851819106478241
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2858731778608956,1.5962544617337329,0.9796834834533007
1,Deaths,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.8541497457439107,3.787233822177064,2.015709629103914
1,Deaths,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5671102423338574,3.1289680772320367,2.0276529922869138
1,Deaths,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.7948049080377273,3.529192141274093,2.1003584780190567
1,Deaths,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.655828071760459,2.319213954650926,1.084286940496417
1,Deaths,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1703671526683277,1.513033591440504,0.8406696003371672
1,Deaths,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4696375157990191,1.956981470539529,1.0166507300228558
1,Deaths,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8270423325033798,2.511465190430563,1.2120413960120509
1,Deaths,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6045620726547196,2.0148083245457866,1.21067183718737
1,Deaths,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7770175842840032,2.314438165787795,1.2688254652582318
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0578363001823383,1.5542463519958802,0.6156897904826338
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8912678928677279,1.1786902594408624,0.6076296737373622
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0249599835686545,1.416364771631187,0.6600037017607487
1,Deaths,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.136241691717901,4.3757607019919655,2.161567892265126
1,Deaths,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.849493133051821,3.5601748757134177,2.248601439542788
1,Deaths,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.9779893041480934,3.6227316573049304,2.3648113417005607
1,Deaths,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.8503446042014167,2.6894792904784803,1.1829538726086757
1,Deaths,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3423208633750552,1.7582079036221732,0.9931159541212579
1,Deaths,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5889743103326694,2.0053918574306335,1.1867351890523916
1,Deaths,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.03395849444219,2.9431532442977395,1.3190293211588395
1,Deaths,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.8107468320720224,2.329658384257049,1.3719996085875845
1,Deaths,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.9110709286568468,2.382889874673502,1.4623506320203745
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2592037318449791,1.9000272298856788,0.7423488983349787
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0658938320717326,1.4205487072696268,0.7453596837296091
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1436373781735953,1.4968931661245424,0.8314992746853633
1,Deaths,44563,African Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7267929338566748,1.9328886352649701,0.31500376814942976
1,Deaths,44563,African Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9292104721504103,1.6230733912235844,0.3873725944060008
1,Deaths,44563,African Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8092165061727956,1.6541497758341408,0.42861397306543747
1,Deaths,44563,African Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2186453049041744,1.0328092316621555,-0.03170251415233017
1,Deaths,44563,African Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.43983453826092694,0.9018440100432786,0.06933088826445019
1,Deaths,44563,African Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3094837774303189,0.8888012663909942,0.05384879283513138
1,Deaths,44563,African Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.23453843486194068,0.3001058095086507,-0.41707843320740906
1,Deaths,44563,African Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.15430548387231663,0.14985835624537347,-0.3918271687551172
1,Deaths,44563,African Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.202520772181501,0.16991488112407158,-0.37028544444302575
1,Deaths,44563,African Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21228194667437061,0.3478550988814882,-0.39649503953302984
1,Deaths,44563,African Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1492092471574187,0.19301268249039646,-0.4063733663072488
1,Deaths,44563,African Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19151173628354315,0.20154336245056848,-0.370405809107091
1,Deaths,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7952877591893432,2.195926375071209,1.4498188536293988
1,Deaths,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4228331302724098,1.6718248257520707,1.1846297301744348
1,Deaths,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5957013205935353,1.843292853229532,1.3574648522316914
1,Deaths,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3557620615633246,1.6969704193400805,1.0663573112113487
1,Deaths,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.070513837644402,1.2868924239622233,0.8713446592708302
1,Deaths,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2028036031012679,1.4121720728871014,1.0030360368144629
1,Deaths,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.434605176710853,1.783548445613923,1.1337129400873185
1,Deaths,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1479044716443583,1.3686420740160736,0.9367309732145296
1,Deaths,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.281310399463433,1.4989136859973509,1.0719290933426482
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5618912398156508,0.7336030251002346,0.40903592673484146
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5589832513975662,0.6730371678214421,0.4355202469613792
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5634378918513857,0.6741518321744339,0.4553940662023563
1,Deaths,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3365381132199029,-0.2178121743099344,-0.4464250921484261
1,Deaths,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.34938325515058005,-0.2847846296710012,-0.41743512327667526
1,Deaths,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.34156174468662215,-0.25282060920177746,-0.42249377877137567
1,Deaths,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.44090005157294476,-0.343110176869228,-0.5327910536688569
1,Deaths,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4440139464441315,-0.38936304411238787,-0.5020338455475183
1,Deaths,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4412604385600366,-0.36777669636183363,-0.5090564459458229
1,Deaths,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4221461676726916,-0.31873971710965826,-0.5178541701397029
1,Deaths,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.42321136436183493,-0.36594300576296274,-0.48354111222001966
1,Deaths,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4213116789155482,-0.3433188553053659,-0.4924412382151751
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.28382837840280567,-0.15343877238851455,-0.40443812316145117
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.29783950879624316,-0.22697805873066462,-0.3728359872977701
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2893584951302296,-0.19130497821471168,-0.37797673247234626
1,Deaths,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37793004393493335,-0.2436470923707015,-0.4975828623949842
1,Deaths,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5032108087607203,-0.4069726509492123,-0.5814040300237013
1,Deaths,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.43552136909388467,-0.32734600640309247,-0.5347347939809867
1,Deaths,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6687365456489012,-0.6063715073375376,-0.7266559451933527
1,Deaths,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7345691043868454,-0.6883735477114608,-0.7721710395487172
1,Deaths,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6989560255079756,-0.648775048576675,-0.7479143910013967
1,Deaths,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5649256398773774,-0.47100843867263964,-0.6486105581423094
1,Deaths,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6544801193788753,-0.5875458998253482,-0.7088639766620212
1,Deaths,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6063241578449653,-0.5308810415318397,-0.6755170846574796
1,Deaths,44560,America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3502441990954991,-0.2079466520220238,-0.4761010059004822
1,Deaths,44560,America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4768107706681389,-0.374363395650361,-0.5596983798128771
1,Deaths,44560,America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4080632764250814,-0.29381013058156263,-0.5130830674464102
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9485813096008355,1.0625606652120672,0.8288883816890608
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0891406032435624,1.2230055146475924,0.8980973467249427
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9937056021803166,1.100596802400352,0.861466906275951
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.39264916920105375,0.47878232171843726,0.30375460074997984
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.48216099927487155,0.577968758691776,0.3478572544938334
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4197998339780248,0.4984203877938219,0.32936478416339554
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6638164324569558,0.761138891567308,0.5616153801696947
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8194916350892334,0.9360783723119165,0.6531066600252506
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7195935718796755,0.8117884378558075,0.6055362049433455
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.059805147366488766,0.11896980763269296,-0.00385556800907842
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1730704442478475,0.24049790605599242,0.0850672229534473
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.11276000781916627,0.16945113375764365,0.04752058761866598
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4255842612895915,0.6615578401085439,0.21245726440401524
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5135954338403903,0.7078635055147592,0.3291969850531502
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4440772437829985,0.6684840814849236,0.25257040996982594
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.018909496735043625,0.19559378329661198,-0.13731669194875423
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.07387936773636071,0.21224619353509722,-0.05449406415391963
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.028433643027713333,0.18860166171250772,-0.10987795776408701
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2172499592903914,0.4187384556288257,0.03526925472791931
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.318233069859478,0.4874266276447451,0.15763524577291455
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.24553291267843655,0.4390863416180284,0.08035610822143692
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16423460039469334,-0.036851538576024294,-0.2877926744780846
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0896104008466484,0.009780385778087479,-0.1786070615224232
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13455162289971453,-0.014048082326704374,-0.24963087472941162
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0513370882575723,1.180784323042607,0.9273554230168286
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2612737422412192,1.4261675862946772,1.0286593470559415
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.13775027138822,1.262889397203271,0.9851015398565317
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4661171423940298,0.5589032193390766,0.3724239490276485
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.604292902792466,0.7201355410329063,0.4446577829599914
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5223963575761178,0.6089776149468571,0.4101139181872321
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.751555523567308,0.8620853923032283,0.6456924882735998
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9694072540004881,1.113017966207778,0.7668167985836338
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8438337239676059,0.9517676316151937,0.7121724710672731
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.07020610518469363,0.1261537935504371,0.012845878318374072
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.22680267952789102,0.2974417841934326,0.13195394646942643
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1353036736074199,0.19352843065369896,0.07007912761641318
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1986216035087485,1.3403730461715744,1.0466320297702219
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8763885376585955,1.0100723283392858,0.7214624698468979
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1345100748432175,1.2593188991974078,0.99796990736305
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5712575579621988,0.6718763460656358,0.4667926004174152
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3311815043538669,0.42535712587689134,0.22505470044440717
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5199990006566185,0.6111403485058076,0.4252856084931927
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8773159398835015,0.9983518845807265,0.7475380604066176
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6341998442548605,0.7506288383172471,0.49927035027872546
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8410390178965002,0.9486880368081283,0.7232715832032849
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.18770543493199762,0.25017996143050975,0.12123387997229308
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1286647918524733,0.19559036227781723,0.05768289205434147
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2370415430318224,0.297995569724741,0.17103954498123572
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.206974420951521,1.3938622947945922,1.0242491993749527
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0641056944483283,1.226780797094275,0.8613662254329634
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1354044571000423,1.2870486552138105,0.9714133000685041
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5773927909818346,0.7071863553492576,0.4499461932944634
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.46432661684864895,0.5818954447685257,0.32326647471334435
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5207012783013053,0.6257774183045629,0.4042561780735826
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8844480799949399,1.0440242362451195,0.7284262477082936
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7976880249983577,0.939366372564831,0.6211164876862312
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8418104326820935,0.9726052641778317,0.700366209839889
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24227046753151016,0.3273867885127385,0.1624796186860586
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24327940113556243,0.31936298679406855,0.15532730085177393
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24586823960039306,0.31195421986642347,0.1758837185431193
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7569152942612958,1.2659340482266017,0.37307175522189284
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8321221279273104,1.2754540614772625,0.49439873262637773
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7792713547944949,1.181575741032543,0.44434380391147443
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.17182791660829935,0.4000102680822178,-0.016214052679539452
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22294662000502508,0.4226174040513183,0.05008188344733977
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1875124858370483,0.396883842884225,0.01259723880204444
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.42492928540382346,0.8377640599168934,0.11361666744391195
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5025460204255138,0.8661280231365504,0.22557488630789269
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4511249517066023,0.7792333829910848,0.177967220711449
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.09935714915532186,0.15122804122878433,-0.28987292049803737
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.07552018481938957,0.14828209733682987,-0.24554603997187477
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0826460954255673,0.12638597943629548,-0.2538799391776561
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6183969250533844,1.2100938620681043,0.17887903641308783
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5981405565543653,1.0944523573186284,0.2270658539149833
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6151588532262391,1.1552549521074795,0.20596920606124733
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.07885353359663157,0.37896779030487127,-0.1515727713019888
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.06648340895549891,0.3277555935567001,-0.13803263217869027
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.07758426388053004,0.3717759121754984,-0.1551432741563779
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3125852916464446,0.7924754129231865,-0.04388147315893408
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3106548393954215,0.717686286568768,0.006331885574571876
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.31727929333023147,0.7577668689291112,-0.01644456805892869
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13509831781270618,0.17161847991088292,-0.3648176393106095
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1509146731500272,0.11539263009619337,-0.34494980813352966
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.12572145941560037,0.17065901452707635,-0.34523322758115527
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0371595878299051,1.449823510359135,0.676219758159144
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9698034855342753,1.3841143807757634,0.6385637284054269
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0020266221501206,1.3209006240210848,0.7144199362956427
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3595531346104533,0.5303326022019845,0.20987578482877955
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3150703539788089,0.505243568148539,0.14510155487061344
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.33666699061432487,0.49087963449463656,0.19263578663692016
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.652218729737061,0.9869058430897557,0.3594819454160038
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6154602049144908,0.9552416951191236,0.34380638266426716
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6327980426113631,0.8928629390188819,0.3982339121899659
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04204296338271877,0.14749481790251012,-0.20562958638185805
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04301012818412899,0.1522954394523415,-0.20197965759881917
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04339760869013972,0.10316084386371903,-0.17745191885683473
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9045233640126539,1.228948409966252,0.6613264295865265
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8550856583026389,1.2557203584227017,0.5499752883932352
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8917634170810737,1.1601785343158681,0.6650590649190654
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2711055789316918,0.39076912433330796,0.16817103850697823
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.23822327357731335,0.4095551222159804,0.10034034678767977
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2628515935564401,0.3780141805103255,0.16416887327308266
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5446453935381523,0.8077672130178608,0.3474028542329614
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5213786957447049,0.8499441691560125,0.27115390717312254
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5428703945886602,0.7617824076355145,0.35797653835009713
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08436017028368917,0.06253425940054723,-0.1988482013230747
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04967320935576128,0.15612923382704358,-0.20747870767301596
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04799467356983663,0.08123430186857002,-0.1581912221433727
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.661751255979356,1.1856219677015558,0.24601730736084212
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6072787542813622,1.0750204607599112,0.24167363806791606
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.635956699851697,1.0194287286383505,0.31939900308345787
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.10809310408598596,0.3522365936178965,-0.0960940954166055
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.07276687473445406,0.3068310158910754,-0.11694401848010255
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.09180199567875603,0.29109192009169854,-0.07301393240088605
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3477474056011074,0.7726277178942325,0.010570377056790457
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.31814918839064926,0.701749947828811,0.018311910056375738
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33424144702232567,0.6469907237160644,0.07606566557261095
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11620510657724702,0.1577516273032466,-0.3275414531964747
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.14573966734961172,0.11095960825550809,-0.3394923652338917
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1281320892818576,0.07485405493673049,-0.29764278906912917
1,Deaths,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.67510778192695,6.154328130871568,3.5239129680287533
1,Deaths,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.008707500783268,4.89402226844219,3.1449569792031564
1,Deaths,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.313304720224977,5.138250642038753,3.499410297796932
1,Deaths,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.9106862603702255,3.8986556499738008,2.114715919920799
1,Deaths,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.0476032666631534,2.5612542586496447,1.5247510268135571
1,Deaths,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.45791272060497,2.9700440041768643,1.9301011565817927
1,Deaths,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.1627261521802152,4.247743295114212,2.318317738770109
1,Deaths,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.6571590736780966,3.3035807174052816,2.026482785055346
1,Deaths,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.8882474847313775,3.4919384218090452,2.2926439747733123
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9713166356881713,2.7288597854260535,1.3757475274263016
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.564426947170839,2.0263656984779987,1.1243839212168152
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7370461532812014,2.1459844604769382,1.3330898277663397
1,Deaths,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7254010721200526,2.3106452094716117,1.238399243777798
1,Deaths,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.754787784921786,2.346536195649617,1.283585092273079
1,Deaths,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7394534760174092,2.16195139022792,1.3402325974347367
1,Deaths,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.766622534948394,1.0815788039706375,0.5286155934652887
1,Deaths,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9714251939915041,1.2564245425255305,0.7024241986502392
1,Deaths,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8550363835019462,1.1086523756172944,0.6378390474829239
1,Deaths,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8844714125463637,1.2891369340659038,0.5477352775396768
1,Deaths,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8789075550201043,1.2825105351383115,0.5575229808582134
1,Deaths,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8815515333775146,1.1717377348556617,0.6073528062118465
1,Deaths,44561,Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.15435680748740688,0.40531542657784964,-0.03114418037203204
1,Deaths,44561,Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.062149923467803306,0.2844094268206268,-0.1153910961338602
1,Deaths,44561,Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.10175954513492966,0.2759673553430303,-0.0456586311888683
1,Deaths,42,Central Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5627590196280348,0.7841964255693294,0.3753679268123559
1,Deaths,42,Central Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.22060780865984214,0.3670112469006524,0.08876801799233264
1,Deaths,42,Central Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.42160120263923473,0.6082855806531434,0.2637312327950959
1,Deaths,42,Central Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2349138806664332,0.40657964727376694,0.0967762768342377
1,Deaths,42,Central Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.11098593620975973,-0.00624475130850623,-0.2030316549470591
1,Deaths,42,Central Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.08082471700581641,0.2205786309615233,-0.03234667951100623
1,Deaths,42,Central Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7045708618206333,0.9461025024279693,0.5001750512276696
1,Deaths,42,Central Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3183312364679419,0.4764559218827257,0.1759361829435805
1,Deaths,42,Central Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5428166060037497,0.7454189658966837,0.37148556702273045
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.05110571470159525,0.20169722562063203,-0.07140759139303089
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21441399395526034,-0.11761960346602224,-0.301445117954965
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.052131345776967444,0.07308190251058069,-0.1585750658378366
1,Deaths,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.23714157236349728,0.4482978735560429,0.07742336723950857
1,Deaths,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.09155952643011984,0.04199045648894628,-0.2117771573558951
1,Deaths,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.1314193784072338,0.3128277770418205,-0.00552011426142757
1,Deaths,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.022406203341417314,0.13746566770333213,-0.14769001778110175
1,Deaths,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.338379428632684,-0.24476781064728872,-0.42544802675307175
1,Deaths,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.13982197765405713,-0.0027660346853300385,-0.24221027428315564
1,Deaths,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3494054103745992,0.5797229921526936,0.17519365082804952
1,Deaths,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.01882861613524449,0.12541354982736036,-0.14867102489193934
1,Deaths,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22789190253949354,0.42476841710798535,0.07927601580929997
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10942285011871705,0.023721820375867522,-0.22515394040715617
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.35274336220448566,-0.26895903105633945,-0.4298250303194141
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.17883531786372694,-0.06290472398751756,-0.2780295031034022
1,Deaths,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6893698332755558,1.0331066094875998,0.4418397591348021
1,Deaths,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.3100969325999751,0.49995036942311877,0.15600694228196296
1,Deaths,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.45519155405912864,0.6821422638337786,0.2866834650700221
1,Deaths,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3350342405542315,0.6037226329019844,0.1394639017302663
1,Deaths,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.04573649553575243,0.09467181365286871,-0.15326998371535897
1,Deaths,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.10643413251813705,0.27298857515478836,-0.02039034919221319
1,Deaths,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8426709150113829,1.2175999255037837,0.5726788391345455
1,Deaths,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4149849745297699,0.6200383211813418,0.24855834181281455
1,Deaths,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5792710996239737,0.8255731730427498,0.3963948629862325
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.07742295098618084,0.2724269832816015,-0.06806497983863488
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1915486684994525,-0.07973988171681237,-0.2826280282366076
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09089197395639034,0.04314655979270753,-0.19466003826006
1,Deaths,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.693560242399394,0.9408612503951889,0.46024219930090093
1,Deaths,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.2395417024740262,0.43170328985662915,0.07950225304338088
1,Deaths,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5684753562367268,0.7931559806611386,0.37153987402350513
1,Deaths,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3382645688950088,0.526696747723104,0.15590099488447648
1,Deaths,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.09722840970407651,0.040782475317610645,-0.21448020463963932
1,Deaths,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.19247639211424794,0.3565617893736192,0.04105182220871479
1,Deaths,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8472415808670223,1.1169838040978552,0.5927512001956873
1,Deaths,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3387810021224908,0.5463272928298185,0.1659285889602315
1,Deaths,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7022142505346335,0.9460526756609773,0.4884867074614813
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.12470895592085642,0.29131987140966864,-0.014050828820053499
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1777447906417345,-0.06075520787360821,-0.2833737522546789
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.059235728406107184,0.21588153943089364,-0.06427843531761465
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5201787307592562,2.2196461076983542,0.989025828022662
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.453116852222649,2.101530618055338,0.941836840792275
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4879606407113637,1.9724419411061886,1.0493349620114454
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6395260587569074,0.9526096895457318,0.4183333186977443
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7387914073970402,1.0243070447395053,0.47480068456071767
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.680568556767739,0.9447241971921999,0.48221634115416584
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.983481021181423,1.5339897014432695,0.565442534837219
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.916767590417408,1.4234122251409858,0.5172737975921496
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9511524878520216,1.3311009802497422,0.6071657019571995
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.05700663001064996,0.32566744992033725,-0.1490141919935131
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.042192751789690154,0.20731532210046716,-0.23364396604835388
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.004688702434053667,0.198863944976552,-0.15715472609453143
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.806958108039,-0.7316209343041421,-0.8561736534838909
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8127883252097579,-0.7495783874634138,-0.8650389365101826
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8095266115403434,-0.7495283357236232,-0.8547224051293596
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8740322445551161,-0.8184093411005454,-0.9114522031804244
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8669652935179993,-0.8169218022304939,-0.9047201066112321
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8710724140997627,-0.8275999501061233,-0.905289483713829
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.848068343596312,-0.7887749877447134,-0.8868029377525063
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8537202700064729,-0.8043305477212431,-0.894546812056196
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8506235911929851,-0.8035706823924849,-0.8860678356310487
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7556642089710558,-0.6584290012850684,-0.8185693782302357
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7591315049881531,-0.6771519283321001,-0.8267750403674746
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7569843978954385,-0.6795255353758771,-0.8153965018396437
1,Deaths,44635,High SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9887408489478205,1.1454556475922502,0.831575028616886
1,Deaths,44635,High SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3027846742450484,1.4818279707475988,1.0693171665623171
1,Deaths,44635,High SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0832275621615852,1.2263070282256288,0.9175322734403629
1,Deaths,44635,High SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.382910693707924,0.48614486984164995,0.2807901659134443
1,Deaths,44635,High SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6343976273593559,0.7597288946854425,0.4673877550321563
1,Deaths,44635,High SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.46290797214051765,0.5611613512841492,0.35060634296119836
1,Deaths,44635,High SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5794924091759589,0.703958015137329,0.45466859398356885
1,Deaths,44635,High SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8735179583401763,1.0191854343615432,0.6835715976471541
1,Deaths,44635,High SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6747612772797639,0.7897866128169365,0.5415544887280337
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.010016629433638452,0.06514917859754701,-0.08329353316437692
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.18472341666440684,0.2685710831780174,0.0904845639252613
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.05731584110959679,0.12653462372563104,-0.016545025560189094
1,Deaths,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6880979192926782,-0.5620016268951737,-0.7596774586901286
1,Deaths,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6299311983447197,-0.44486720955271974,-0.73492695260942
1,Deaths,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6619204559723262,-0.524165276656177,-0.7407419742647735
1,Deaths,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7976213202947946,-0.7111094856857187,-0.8444994733296127
1,Deaths,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7348744768883351,-0.6007695677426822,-0.8103111461341214
1,Deaths,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7709034911734175,-0.6864038362369931,-0.8253013515724177
1,Deaths,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7843361255635459,-0.697147175400574,-0.833829610062986
1,Deaths,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7475939630946621,-0.6213707641220709,-0.8192064905687447
1,Deaths,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7677952591501509,-0.6731802305898522,-0.8219326080427863
1,Deaths,44561,Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6595002084107383,-0.5222252850674004,-0.7376599348522261
1,Deaths,44561,Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5907928730503025,-0.38562932251224213,-0.7076481502340795
1,Deaths,44561,Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6286205261907695,-0.4767514248320331,-0.7147070151274054
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8384209658941241,1.607193675955194,0.28278766313186876
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.19326370737922,2.049541232670358,0.5439774104084774
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.034742406368079,1.8097002517742191,0.4425085860910094
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2897373790937282,0.766852596538123,-0.06687466093991852
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.597916886815247,1.1033057696955557,0.18919455006838323
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.45160836600565885,0.8907964986647795,0.09995038603706917
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.26738366604488345,0.03897459190489726,-0.48880522337306603
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.11330075487792594,0.2328776972325611,-0.3757961709353086
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.18325944855484974,0.12780670705426647,-0.42098063401976776
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.18906920667284557,0.15244693340128387,-0.4344310928722336
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.14033268690155898,0.19854527860693985,-0.3880531572064196
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.15080872520058214,0.17044504173803135,-0.38781547183574344
1,Deaths,73,Western Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1807498893449742,1.3496000097553984,1.01170190651322
1,Deaths,73,Western Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.020271140576328,1.1408891093473241,0.8592840409314685
1,Deaths,73,Western Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1238226314790212,1.2430109899637918,0.9948387835561464
1,Deaths,73,Western Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8378671124953263,0.9823832347855934,0.6984250500724397
1,Deaths,73,Western Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7265422289540718,0.8274083369791825,0.5904117876637212
1,Deaths,73,Western Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8023810588161773,0.898291122447556,0.6961565000286203
1,Deaths,73,Western Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.899362579847818,1.0464255703710863,0.7521272575588265
1,Deaths,73,Western Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7910228164537519,0.8979537772561399,0.6483035730672421
1,Deaths,73,Western Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8665855803089872,0.9713378642289651,0.7532242350360314
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.24848895411710495,0.34445210357464684,0.15462457741588106
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.28830986700986044,0.34788272762348,0.21262295700793912
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.29884157920351595,0.3684122531760593,0.22961983733746338
1,Deaths,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9078328203235271,1.1240552465057256,0.7231679963920129
1,Deaths,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8011468528555109,0.9285815891111406,0.6560998781377411
1,Deaths,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8765859434703883,1.0428819514317185,0.7264013266894856
1,Deaths,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6078288872359252,0.7945433398728371,0.45372581111954036
1,Deaths,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5392564160741423,0.6490352606787217,0.4188800338375336
1,Deaths,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5925377155560971,0.7360464331943811,0.4639306774749546
1,Deaths,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6616606449153412,0.8499833806958008,0.500823559423134
1,Deaths,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5967634464786898,0.709737648633302,0.4681755376779892
1,Deaths,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.649294159678963,0.7954484222443841,0.5172998792186217
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18399817770029217,0.29365428704628455,0.09138436916227029
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22883215686261066,0.29533428035728226,0.15230399210019624
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22581808836006695,0.31396192236130055,0.14445233279402106
1,Deaths,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3287827866706596,1.544877978662235,1.1163804031341047
1,Deaths,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0770820268260526,1.2220837992951397,0.8942101619564783
1,Deaths,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2075409126073828,1.351875595734153,1.0407825866277087
1,Deaths,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.962658592729688,1.1396875879729371,0.7855619620651719
1,Deaths,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.775103015669667,0.8983665235809332,0.6167007106308412
1,Deaths,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8734460349535615,0.997863308447377,0.7339114126141822
1,Deaths,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0282944427545315,1.2165063616725316,0.8432988404936099
1,Deaths,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8413871420398674,0.9699349778735687,0.679266486108792
1,Deaths,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9401639168641579,1.0670168066816441,0.7936033321634653
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2805378437237669,0.3871782633131056,0.17480884870097202
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.28680086013871975,0.35761620143913975,0.19705854396154632
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2976413542604148,0.37367380778945863,0.21871294693372606
1,Deaths,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0910626324966362,1.3059780970674566,0.8950333592522038
1,Deaths,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7727660445714392,0.9169314202458256,0.626202218818383
1,Deaths,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0351614362707027,1.2071516842116676,0.8570292462436341
1,Deaths,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.76226896264919,0.9438618645576133,0.5994049770635856
1,Deaths,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5150286294151197,0.6399317103875152,0.38907438200731026
1,Deaths,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7271340459006345,0.8770858434101951,0.576869720766851
1,Deaths,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8212478816060576,1.0084322961191037,0.6505127285403977
1,Deaths,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5716031231115617,0.6994094714722079,0.4416704864875553
1,Deaths,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7886630146220559,0.9398218317483275,0.6321061664346755
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.21036400374302686,0.3171832102127645,0.10235818251449563
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1994912292482359,0.28151608336817324,0.11267628638084098
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2852376455604875,0.38001452139791914,0.18121914050037483
1,Deaths,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.303669607204438,1.6201940456584674,1.0308537950809942
1,Deaths,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0177880923219298,1.2063436758282247,0.8069021432276017
1,Deaths,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1489586621666026,1.3271929782963563,0.954243574275945
1,Deaths,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9414475176329319,1.204921775806789,0.7134134133062582
1,Deaths,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7244199051465043,0.8876495405528878,0.5487186988195789
1,Deaths,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8237002782795001,0.9788420846516661,0.6580529306985938
1,Deaths,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0064216761561255,1.282104218635818,0.7688079327049212
1,Deaths,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7888215297112623,0.9559809497746461,0.6018656608125494
1,Deaths,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8886771390541534,1.0453237438473009,0.7175459108911942
1,Deaths,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9711624819371514,1.5626908801348185,0.5041411411987878
1,Deaths,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.984946243592582,1.5801447761569303,0.5425633942282971
1,Deaths,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9753185277363221,1.4630634785986374,0.5762077207916761
1,Deaths,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.17274568634427823,0.416491834312125,-0.014410269951759747
1,Deaths,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.28812586247330507,0.5387990907234617,0.07721542140973855
1,Deaths,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22056235532776802,0.4434506722546247,0.04744461474426123
1,Deaths,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4512439041135581,0.8867493430922775,0.10740524035641133
1,Deaths,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.449434721259102,0.8840567781163302,0.12640075294487638
1,Deaths,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4484118610135023,0.8060532044519254,0.155761932143671
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14016907227214281,0.11584167208446887,-0.3361057860521935
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21507757496773106,0.020209972672533407,-0.39083618018503286
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.17291145960645704,0.025728157956654146,-0.334545474607804
1,Deaths,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7186462386200788,1.2920769820933011,0.26538877043595555
1,Deaths,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.620450152771885,1.1409064917172407,0.2302545616360217
1,Deaths,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7013955509803304,1.2239414128258825,0.31039660787668755
1,Deaths,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0220957193060694,0.2677879212174217,-0.17965951595311316
1,Deaths,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.05138626159952635,0.2816069503994659,-0.13204543054018067
1,Deaths,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.051009976600257675,0.30287090949696144,-0.1554701684376614
1,Deaths,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2653319551181545,0.6875132204996798,-0.06837322835800476
1,Deaths,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18327472246612453,0.5633190138427285,-0.10165140069725183
1,Deaths,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.24755651390541797,0.6307157935826939,-0.039145351582602954
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2312079785284156,0.023499637435080066,-0.4282120226408463
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32526522912149786,-0.10960619525333773,-0.48414006758532885
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2588080789233146,-0.037713079324534556,-0.4272783151938598
1,Deaths,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6004748758259204,2.241755089629626,1.0545227193406923
1,Deaths,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.247059888597867,1.8992205010171102,0.7251427254231771
1,Deaths,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4062947877762528,1.9111803409599746,0.9493544968379772
1,Deaths,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5478970031202656,0.8209906025393292,0.31342612908278716
1,Deaths,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4584700209078826,0.7483914292577674,0.20545175297860865
1,Deaths,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.48734453748926443,0.7360158213587399,0.26637935459614565
1,Deaths,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.914567340807956,1.3867019363267776,0.5126168439325318
1,Deaths,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.64083366680376,1.1170502084503493,0.25972266172319913
1,Deaths,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7644272874330814,1.13463706039749,0.4293736098227037
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.001934305453117763,0.2546385088807282,-0.20505025595585677
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.18433582462352985,0.05387885722236959,-0.3725169838604583
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.10798211085534078,0.0778048637824807,-0.2768811791609272
1,Deaths,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7049462989016144,2.3695290474728883,1.1749121130990678
1,Deaths,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3858497672415206,2.0881003692656184,0.8776290654819868
1,Deaths,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6111791525477346,2.166476515270467,1.1710530567291306
1,Deaths,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.609968402886753,0.9102452487397671,0.3963470951422128
1,Deaths,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5482758265573147,0.857518488804455,0.30117056150321403
1,Deaths,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6136349650588917,0.8844307737495314,0.411922040750195
1,Deaths,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9914831289695091,1.4807739263954323,0.6012520403776616
1,Deaths,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7421799222576863,1.2549728550056205,0.3710702594288862
1,Deaths,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9146597385058182,1.321834214552897,0.5919351507626076
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.08335101724832238,0.33915603055563937,-0.12893662912151058
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0757432138153411,0.188511830022989,-0.27716564835463764
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.032315569924813006,0.245125696278725,-0.14360006845688084
1,Deaths,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8720382112488374,1.4650194674490056,0.39073170902199883
1,Deaths,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.670144196087942,1.2158284603813798,0.27497214461995856
1,Deaths,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7697933737809856,1.2039225807188716,0.39821435768996916
1,Deaths,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.11356713671042407,0.3553025058313061,-0.08798600669725795
1,Deaths,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.08390423564307177,0.32005502557888654,-0.10633653602829773
1,Deaths,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0936065240274232,0.284878292077282,-0.057238528760835926
1,Deaths,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.378264890508986,0.8148399781539059,0.023908953965144412
1,Deaths,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.21956198820672165,0.6180280535043484,-0.06899801391817544
1,Deaths,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2977095481735226,0.6160368881503326,0.025247438061727443
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.15772663276329565,0.10489458939924325,-0.365241913330009
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.28890627737061214,-0.061701346503817776,-0.45925011369895813
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2279219926245346,-0.040819963299226374,-0.38212516373049304
1,Deaths,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3958932627624148,0.6624454054134898,0.16667937116150844
1,Deaths,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.609618777516607,0.8472583064094629,0.3997057993319819
1,Deaths,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.43588723002228025,0.6786127702783048,0.21621596210983482
1,Deaths,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.02935894403262622,0.15242090376714823,-0.1849352835648293
1,Deaths,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.14238947390707843,0.31002171362142217,-0.009003986055703026
1,Deaths,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.008301786269345978,0.17566902453009972,-0.14699829902911635
1,Deaths,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.10864259348802731,0.32034291944538595,-0.07340304712565614
1,Deaths,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.30956650853497364,0.5029071755854971,0.1387838301907628
1,Deaths,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15434740546855558,0.3494808336216507,-0.02225208846717762
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2508060711798455,-0.11930952130932669,-0.37183870896093224
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.11918099376122313,-0.0013888604758267734,-0.21767790415874763
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21706351360778767,-0.09125761884588154,-0.3316239044110556
1,Deaths,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.093705429944531,1.2268836134641627,0.9523808710676038
1,Deaths,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5068310679948687,1.7066657869868214,1.237282737209122
1,Deaths,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2535806424345548,1.3922736646690557,1.080311823288505
1,Deaths,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4559362717283566,0.5501632685425908,0.35972325461917537
1,Deaths,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7792513382012821,0.9200914780676268,0.5841533964009872
1,Deaths,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5825658809448777,0.6805225895298562,0.4545116932810928
1,Deaths,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6628570964374281,0.7686295152261271,0.5506146853186811
1,Deaths,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0395276540361857,1.202110781724415,0.8202263689374022
1,Deaths,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8117125866271021,0.9232115449196063,0.6724172383240633
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.004571519868932546,0.052127961968081366,-0.061154501710945254
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2440133795280561,0.327221496726821,0.13618042707626463
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.08515923176518483,0.14683726671549052,0.016221674501517937
1,Deaths,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.428369410922668,1.605137744612998,1.2350434689091305
1,Deaths,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1829901292864038,1.35351409093667,0.9838286638967543
1,Deaths,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.382717103050315,1.5443135704005624,1.1952641744540995
1,Deaths,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6885692443772274,0.812433620582517,0.5544283903989383
1,Deaths,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5494083449807448,0.6687591894526764,0.4120794488126131
1,Deaths,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6732018053881158,0.7878402718940138,0.5454660271473958
1,Deaths,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.928653023472992,1.0690454941130318,0.7751102136751576
1,Deaths,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7760545550956739,0.9147908025843055,0.6140191784536173
1,Deaths,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9155287743794553,1.0454404129248782,0.764830448460667
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.20004321338887807,0.2747463035484615,0.11833022105545347
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2095458942839971,0.29305451251459647,0.12597194872198664
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2580959433706998,0.3317461106100512,0.1687431276833248
1,Deaths,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2499501681003033,1.4590630015850201,1.051436897880077
1,Deaths,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.151076595820693,1.3375762269435532,0.9278986672509427
1,Deaths,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.20072993593946,1.36687953114612,1.0252756485170553
1,Deaths,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5645486311028357,0.7067789037410952,0.4316770784930286
1,Deaths,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5267263464844674,0.6559607006606892,0.3709382469361936
1,Deaths,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5454250222356676,0.6589903679328787,0.4196875147025168
1,Deaths,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7869493722215225,0.9530304045114437,0.6292866965644945
1,Deaths,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7500900874965921,0.9018239478268247,0.5685152048091047
1,Deaths,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7692245174777991,0.9027965349289764,0.6281722139057105
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1618392952554245,0.24767399548640018,0.08239673071710772
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19343604161487363,0.28089910275544056,0.09426343438177849
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1772385841531413,0.2500059859682768,0.10202566601569897
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37912481752206034,0.7932541207903585,-0.6967603691768904
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.343060581948997,0.6716474383995898,-0.7039708421548104
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3620431665798952,0.6584883796238485,-0.6880635340910024
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.564963194800319,0.2163607829341834,-0.7785469176268992
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.520230747756918,0.20605922546536948,-0.7833930914595035
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5445489201623561,0.1885638481302178,-0.762903406910261
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7525793556159341,-0.2853827908863195,-0.8791580868772993
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7344105571450822,-0.3241813482108199,-0.8803204421281806
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7439257105493855,-0.3342868809830451,-0.8747894768472825
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.702799869436706,-0.11813016621047064,-0.8544224833435337
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6753258040140183,-0.15472870376045728,-0.8554019515376843
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6898080410323543,-0.1745787483320698,-0.8494366536596525
1,Deaths,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.875787323645005,2.4373793646395923,1.4668372896357025
1,Deaths,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7067262139683614,2.172895574890156,1.2676358756537187
1,Deaths,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7887230308433661,2.1683118176749496,1.407667517050409
1,Deaths,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8935295035652387,1.2025593840666455,0.6722796689894841
1,Deaths,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9079635095357993,1.1822528955899319,0.6252723450811792
1,Deaths,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8938696844712072,1.1487525803849719,0.6696982550761553
1,Deaths,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.950710310532165,1.3316506449141932,0.6733104342355707
1,Deaths,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8227764113092593,1.1367063944668785,0.5270821120545515
1,Deaths,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8848476196770251,1.1414048372287566,0.6272990678151897
1,Deaths,1,Global,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3195037370083608,0.5661633336209903,0.1456601479778081
1,Deaths,1,Global,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.24417420567394824,0.45640122674513073,0.04839478324946645
1,Deaths,1,Global,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2777657191386602,0.4448948920973299,0.11594186183511276
1,Deaths,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5217745630359298,-0.3579922058470702,-0.6204995321994587
1,Deaths,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.47477899196870255,-0.2405435606834971,-0.6123640814145029
1,Deaths,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.49958055477764557,-0.3065425429844421,-0.6073172552357338
1,Deaths,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.685218098756513,-0.5759409815897586,-0.745520594363187
1,Deaths,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6297179581327221,-0.46528204515811755,-0.7253264759560238
1,Deaths,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6602217627939441,-0.5395306116751863,-0.7310057729949764
1,Deaths,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6756090817376038,-0.5645118770783187,-0.7425764174897386
1,Deaths,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.646303176426579,-0.4885632407669777,-0.7389563802472926
1,Deaths,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6617755188538008,-0.5313046068946559,-0.7345928123477602
1,Deaths,1,Global,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5492373541283472,-0.3923874251994786,-0.6427002146962579
1,Deaths,1,Global,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5006420887829829,-0.27733214234518466,-0.6322128163763803
1,Deaths,1,Global,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5262874815603914,-0.34361110096017733,-0.6284757493378347
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.563818944195535,6.637828201863034,2.5775985779707136
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.738626426617371,4.982919770043779,1.2292565568564229
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.530355658806934,5.4641608113863365,1.8941337225680348
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9575541239816985,2.966640344797989,0.9260629566628168
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4146457260399357,2.697242697104623,0.4465538801993656
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.617234515407283,2.6558898513496048,0.7037430404538016
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9613302531538983,3.06521706572883,0.9041688827127861
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0600039498385876,2.296622061543813,0.22833275869255162
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4517830314738858,2.498338979030454,0.5662761350788365
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9850569113931666,1.708357464895676,0.261888645642338
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.33812580421200256,1.1279079143357729,-0.2081439724901526
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6115839766700834,1.3022487472463793,0.03236583015967307
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3799639427233874,-0.05731978043077751,-0.5568373749864713
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5606910875163952,-0.1709771886035873,-0.729408302374515
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.47461829266322414,-0.16198288265554878,-0.6297233203139257
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6705355412566412,-0.5067402190822539,-0.7559670769001292
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7161963701656529,-0.4643485989972088,-0.8245288701658546
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6964979192929142,-0.5249518785266057,-0.7827772954879015
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6699871881389953,-0.49826055066503766,-0.7641276789050132
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7579383464278557,-0.5432038211081525,-0.8509024699730783
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7156686909137033,-0.5464735435515734,-0.7996099757775117
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46593681572027684,-0.18844371249273048,-0.6192114197852042
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6169892049036785,-0.2752165382069836,-0.7638440683397626
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5447959317036806,-0.2744857977895677,-0.6795971209156855
1,Deaths,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.211718803724498,1.4641685347821929,0.9832153807040653
1,Deaths,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9446536674136061,1.2054791706606738,0.7138649883381565
1,Deaths,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0577550368491202,1.2608310332929429,0.878132629984013
1,Deaths,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6141503270121557,0.7814598696331332,0.4411639736155621
1,Deaths,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.39699205634267126,0.5771235424737003,0.23994796715793804
1,Deaths,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4893782515558243,0.6389128454327513,0.3625119307732574
1,Deaths,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.434038827752092,1.7118645831850288,1.182566442126308
1,Deaths,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1216352168158101,1.406198263905154,0.8698426239372478
1,Deaths,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2541343211476814,1.4765906219162173,1.0573698740141788
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6158269597631517,0.7835319240249973,0.45861412562044584
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5561972623222287,0.7455538429031128,0.37788207094190174
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6226832415476616,0.7744136874367842,0.49562465902640335
1,Deaths,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7528562492768905,-0.7258156915334437,-0.7794546298274581
1,Deaths,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.716164443969231,-0.6896370580952811,-0.7405764500228328
1,Deaths,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7381480609275624,-0.7146454636687566,-0.761247431387312
1,Deaths,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8195100732356317,-0.7957123347110386,-0.8416892300753771
1,Deaths,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7960037177152158,-0.7754692928657035,-0.8154789985671255
1,Deaths,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8104217318917469,-0.7909695178429101,-0.8277714642348787
1,Deaths,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7280135773664719,-0.6982549266009294,-0.7572856036775856
1,Deaths,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6903327715621987,-0.6613911471365559,-0.7169664969521435
1,Deaths,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7131585478580315,-0.6874130095561025,-0.7384623779144772
1,Deaths,56,Eastern Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.606133928902154,-0.562661391007476,-0.6492770006470061
1,Deaths,56,Eastern Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.541931808801164,-0.49805569830939705,-0.5819032528168232
1,Deaths,56,Eastern Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5800139683549405,-0.5423557695129154,-0.6168012105758836
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4930602934755521,1.0896262024539989,0.03844591363312618
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8626134147724,1.5246264842812605,0.2620965471496242
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.638970816774211,1.203915299474032,0.16301225697384394
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.04782977846789932,0.38100481117274915,-0.26009390684804107
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.35787858161960917,0.690104135652284,-0.031807830054602776
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.17004739804840738,0.5036148809916555,-0.12160717417805406
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.40501094206787824,-0.16727761694458224,-0.5861761520509199
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.24697704919102412,0.020663584727949293,-0.489755813738429
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.34212118226599275,-0.11535386916922197,-0.5331697667844952
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3394732157439485,-0.07594143472035596,-0.5427813035529646
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.22878737126116433,0.05590890914116099,-0.45374652237069607
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2990073771586374,-0.03655215649890547,-0.4971830567618135
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4914912541346102,1.0977475342507512,0.005156696626979349
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7825702665555976,1.4746943302347413,0.24263017286600788
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5746057054353518,1.205817899345747,0.10526914692026575
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.04649088880830503,0.4165361535635484,-0.26023428207508614
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.29880970493859516,0.6537947064287147,-0.04642133245148135
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1238636599365005,0.4720836902731641,-0.1682070692093408
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.40563620900679764,-0.16404124157781408,-0.5994420060504788
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.279337133781966,0.0004768633813981969,-0.49762573805463056
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3679571781956032,-0.11459017030319335,-0.5563477078347817
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.41405971097093025,-0.17572221535304233,-0.5990806382453998
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29858162887358614,-0.03495196100074264,-0.49966997500444194
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.386200631907868,-0.14944346764675157,-0.5621899250134311
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4542392363236538,1.0711934624218231,-0.013367738105127073
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9467513273341601,1.6709303556682138,0.34271296540540147
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6796347655819293,1.3209898573313352,0.20471091602116148
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.020943270700252366,0.3567082728338153,-0.2957191674231079
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4197790569642757,0.8076337392440391,0.038575706543686514
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.19941013219450635,0.5433025899455799,-0.08954856232234973
1,Deaths,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.42048125115296475,-0.1746231197851423,-0.6068240495072266
1,Deaths,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.21296152096081244,0.0798117536785324,-0.457163965812737
1,Deaths,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.32579877414729996,-0.06836043223818199,-0.5164320285438991
1,Deaths,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3383130016318861,-0.05627452764360605,-0.5485538191175111
1,Deaths,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22260408650407612,0.07473352888386112,-0.43951880862261805
1,Deaths,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2860396966542052,-0.012119605961310294,-0.48716680875822005
1,Deaths,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6105783887055,1.904318385509133,1.3286983486583555
1,Deaths,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1510323714540063,1.3512177874188196,0.9656798366488665
1,Deaths,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3527320136350458,1.5474102721662737,1.1548515687129768
1,Deaths,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0395183493273203,1.2602612434294207,0.8335694422733525
1,Deaths,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6613130478283399,0.805470928728505,0.5236846874057294
1,Deaths,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8275939107487317,0.963716009401367,0.6812849255017165
1,Deaths,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4575089976875617,1.7340257605048595,1.192156791570553
1,Deaths,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.043349311949073,1.2335132245904468,0.8672757300317159
1,Deaths,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2251600192523935,1.4092822545902308,1.0380092294129009
1,Deaths,44562,Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5490831354028477,0.6797097539830859,0.42677956248751375
1,Deaths,44562,Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.416138179833675,0.5122168992088095,0.31980609093718
1,Deaths,44562,Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4875176102417897,0.575531631783561,0.39578309285854535
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4482094921105548,1.9711399945588528,1.0191672059938837
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3990239724075753,2.0279350393417332,0.7739178100629764
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4294065364440935,1.919490383794911,0.9874914828251408
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6559421938178843,0.9984137283132372,0.37752830053382985
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7941085523612633,1.2391314942464795,0.35094969864758563
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7191121726271926,1.0422174777396742,0.4158104418344767
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4988779344897268,0.8190339480650525,0.23620351153055757
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4317000986860667,0.8070244168048097,0.05864648829638926
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.46870005873926474,0.764980720124515,0.2015398879438405
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.14450703988942087,0.38388471453457695,-0.0700970709607038
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.014857911433184238,0.27695129079710484,-0.29214756400393477
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.06503489951589272,0.2831199597004156,-0.14423262910716572
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.085460644085283,1.730537128628005,0.7183951114421967
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1367129672114598,1.689161503710037,0.5881077886959751
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0989136451297543,1.6663879968288435,0.7218841574880388
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4106393872448408,0.84106301054381,0.16378531631981444
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5977170359115013,0.9674765234646499,0.20931440512731062
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4852470473316722,0.8806126515478312,0.22917644982202148
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.27679063116916486,0.6717286100697152,0.05206050526962753
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2751569810077454,0.6048496532448708,-0.052242035114664125
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2689002633551802,0.6119674285952135,0.04096672389235857
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.028067289330545156,0.2675157455071925,-0.19955313362622143
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10338281258248934,0.1406328301855781,-0.33935740455688684
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07147712477902166,0.17359982556608325,-0.24244123034672063
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7217847900780952,2.409000198945536,1.0485538566208588
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4075956979304938,2.197447943689395,0.6800265283048503
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5661947371637273,2.2399093594814805,0.8954893538019948
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8412006931697088,1.2569839765134654,0.3801896463832963
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.80069530664602,1.3557145227150484,0.27289344194070886
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8160436538036546,1.2578488579379696,0.3655151426895819
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.666370127811591,1.0871070034393209,0.2541950283248821
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.43681557081899347,0.9081870749001152,0.002613635392478201
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5513954970769844,0.9586903201245432,0.14591991233522494
1,Deaths,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3046866571731959,2.035351816710854,0.7640234061743538
1,Deaths,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1960995473453295,1.8831013026842949,0.5159721035026075
1,Deaths,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2723766314971843,1.886747473581302,0.7224388893356267
1,Deaths,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3583442187367203,0.8159879922804457,0.041442749206367806
1,Deaths,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3967886713141131,0.8473998740440742,-0.030333819376540127
1,Deaths,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3848786167988454,0.7987959618441671,0.05215432411872232
1,Deaths,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5239982811814128,1.0071582993941868,0.16647902247627322
1,Deaths,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.47577908217539194,0.9374443200616225,0.01873338219798805
1,Deaths,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5148218505010486,0.9243764828625749,0.14821989874067198
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0611653408654909,0.23927616513690247,-0.28341484363337993
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.123125759939997,0.16282837504055256,-0.40071382820626117
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.08394041205016886,0.15619819270510968,-0.3077242708350441
1,Deaths,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9570644589979076,1.6791087500566615,0.4749865851857744
1,Deaths,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8340003872853001,1.4474670882185776,0.23903352344663337
1,Deaths,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9302234121319932,1.5462347285958016,0.44402036339193296
1,Deaths,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.15431437053899869,0.5820415026788404,-0.1435141697711342
1,Deaths,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.16671378100175874,0.5611942311409102,-0.20887095776025377
1,Deaths,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.17702516405532215,0.5747036618771357,-0.11828496131345448
1,Deaths,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.29412944809265196,0.7715888263927273,-0.024649614040856842
1,Deaths,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2324484158875946,0.6446980909730736,-0.16736936710042316
1,Deaths,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.28673414455936996,0.697382357272454,-0.03738070145821419
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.20687270612627157,0.08636915546306187,-0.4024078196728782
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25893092051703614,-0.004295028007981981,-0.5014881528914534
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21950053582327697,0.026195111609222173,-0.41336994334038235
1,Deaths,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4872011759717847,2.2350594169105893,0.9106505110737535
1,Deaths,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3874940261312463,2.1791068665328717,0.6388164426890576
1,Deaths,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4392802542445664,2.0289641835676133,0.849264310133373
1,Deaths,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4663945141420706,0.8864515888349472,0.1223185540680289
1,Deaths,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.51866355923582,0.9987175661931358,0.04993581056629359
1,Deaths,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4870531922933265,0.8624482040288763,0.12598884391926182
1,Deaths,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6446879255085415,1.1392170495483471,0.2634377370788802
1,Deaths,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6043961881611194,1.1363600840866723,0.10128478855575944
1,Deaths,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6260838882993092,1.0191816207114426,0.23276482670749268
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.03225010966791512,0.251777363612029,-0.2657359023570061
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09661553284574792,0.20335877470460442,-0.3841047262235816
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0637304452509576,0.16599277611884958,-0.2982845691762395
1,Deaths,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9572512603222123,2.959649602776915,1.226286950370436
1,Deaths,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6873767952129386,2.5958899418409076,0.8341895301845118
1,Deaths,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9079970794527104,2.8525695450442203,1.1805739643784996
1,Deaths,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7407509185441082,1.3899336221114327,0.299887134365324
1,Deaths,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7078521055457392,1.2949356909493757,0.17731115608223474
1,Deaths,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7701298251022076,1.3778691867987516,0.32932022597809374
1,Deaths,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.955513485412581,1.618359927554872,0.4721556508435091
1,Deaths,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8059174344318414,1.4164383460615664,0.23257551993191572
1,Deaths,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9385419899543022,1.5682171020931408,0.4536239468797499
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.15562491248195887,0.5410456511034821,-0.13376375654963255
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.03327847954736197,0.39000240174976053,-0.30024519069782035
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.12231060965955157,0.4777763090911154,-0.15340759933425024
1,Deaths,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1440229373617157,1.834034519248463,0.6022630282859462
1,Deaths,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9646016284887665,1.615907001954761,0.3355806638632097
1,Deaths,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.062660620175303,1.6007513490315903,0.5668918249322886
1,Deaths,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.26334850417180555,0.6654240659435312,-0.048018026478904914
1,Deaths,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.249833851104478,0.6359407016399492,-0.13861256775037975
1,Deaths,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.25713248163937086,0.5989246159445724,-0.05723524207641793
1,Deaths,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4177577074015359,0.8740351200023799,0.05951327201388265
1,Deaths,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3202124610590454,0.7578897272974713,-0.1024896805475672
1,Deaths,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3750200271822625,0.7337244700661392,0.04452842054402064
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11318682904452657,0.1692077776185822,-0.32840366055464865
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.18179748206037616,0.1061638891437427,-0.4494618550088718
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.14390138300424454,0.07571687937998751,-0.3583651932548564
1,Deaths,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.964438066359506,4.267928023898554,3.688486402924
1,Deaths,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9364138722788495,3.135165031671352,2.7287155275673958
1,Deaths,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.435265013329639,3.625762775744992,3.245715498493004
1,Deaths,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.038828788152946,2.2169695895859065,1.8654510550610535
1,Deaths,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4540841702528333,1.5714065691638226,1.3247812146569422
1,Deaths,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.738721008296478,1.8535633775877878,1.6280361068384572
1,Deaths,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.752717110060207,2.982131182945082,2.5441197793892294
1,Deaths,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.008810348421607,2.1607264234441725,1.850055464104512
1,Deaths,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.3717204819335116,2.5165382561517275,2.2276235723701574
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3982553118807315,1.533412895399225,1.2735415401654173
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2746803701138938,1.378700372124242,1.1585066282953331
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3730584598198188,1.4632524067511268,1.2790929828008586
1,Deaths,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2381829482407667,0.3925922273450719,0.07947727184927754
1,Deaths,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.11902882689595257,0.21528751119770523,0.017180650057301773
1,Deaths,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1894864858989909,0.3196525986188671,0.06085351701474686
1,Deaths,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.24206560464689847,-0.15017400634290365,-0.33551854744771603
1,Deaths,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.30233420634710156,-0.24011363340020236,-0.36487113334823656
1,Deaths,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2654894841619646,-0.18539291981507303,-0.34090210722123826
1,Deaths,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.06403297349315275,0.0526880603683336,-0.1840017392017668
1,Deaths,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.14466678967436394,-0.07109116098039785,-0.2225147646035346
1,Deaths,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.09574378634978166,0.0032094322272942033,-0.19353149791503266
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.29352719196594856,0.45775767974001386,0.12711673153238542
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.17332751373186575,0.2758059888358245,0.06484060977375665
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.24407718656915128,0.3811767035423088,0.10905243116297308
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.493131235015268,3.4026928513522794,1.8376978293367254
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.532579303728693,3.598055541907187,1.6034992030355373
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5136953797970434,3.2727689412567615,1.7905981574582646
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1556738479430249,1.6825177439275063,0.7727266933712603
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3882832796542302,2.0187546770298725,0.7812422625577478
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.25953656278231,1.7310589495751694,0.8066406867854946
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9884653713581284,1.5062334297330593,0.6153598271521987
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9332031352537808,1.5162847385488327,0.424764283883591
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9620363917665382,1.3859006687255198,0.5582611888359014
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5199640569694647,0.916412288500439,0.23070574275992647
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2986697959167684,0.7129341971655754,-0.050508633737312715
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.39732840071177916,0.7260157267515975,0.09959097974738228
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.24251009281245775,0.24592031514977702,-0.4607737762455844
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.09245854118881365,0.4536153371578989,-0.37730816744787554
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.16829846325801628,0.320032932178149,-0.39073074583852047
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.532314360219915,-0.2285012186765802,-0.6665768716019149
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3856970639361984,-0.031175105990417066,-0.5752423102252939
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4650609909479277,-0.1658205139421993,-0.6035695977220308
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5687987801611673,-0.29075971228544173,-0.6930454079377928
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5033481649811207,-0.20450937243489944,-0.6592320512900965
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5355804912518677,-0.2628977838672474,-0.6597859746400879
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3728519658812929,0.03918864675624906,-0.5541744480415832
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.24159111334561126,0.21968230909617906,-0.4811214296059544
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3083272414746165,0.10251672231217007,-0.49396823919057836
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5358481753432667,1.8192755481953067,1.2756913505663743
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1235334030881021,1.3111623756611004,0.9480902621807726
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3051181645292307,1.4972995621588232,1.114042682244362
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9692919812924814,1.177583319563557,0.7784018485597788
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6376786413010274,0.7790449955174744,0.5084473753427476
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7839380337206743,0.922350837186038,0.6492948858470077
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3293964958974194,1.5897491209411434,1.0904198876321962
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.972029103744379,1.1462716158148447,0.8091030205386988
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1293722221231328,1.3069013987260263,0.9528646440878519
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5054474605318411,0.6337063501290772,0.38485513981838576
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.40196239675679185,0.49301372904423724,0.30843120287226017
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4581109981833707,0.5489990213761192,0.36874475144547153
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6580320744129694,-0.6055797388961056,-0.7043012005884068
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6498990701020271,-0.5837821417198196,-0.695252367571723
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6546963290558077,-0.6036181621133109,-0.6969042080916479
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7344461527890503,-0.6944601456102807,-0.7693035101802941
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7299967376057613,-0.680323231783624,-0.7664097724149554
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7327816166710903,-0.6933098564160302,-0.7638337069067412
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6858727997531203,-0.6376907801264605,-0.728375005298888
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6748771542737397,-0.61347736332612,-0.7169947034636668
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6810228402083351,-0.6338389554435674,-0.7200127221834345
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5781662042522215,-0.5138276362867457,-0.6361356390339176
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5633517689552149,-0.47872398068407707,-0.6206964238904542
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5717027779761267,-0.5064748011139062,-0.6253530992262998
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4947618395661164,1.7799438976244504,1.2265483917173607
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.080954557167783,1.32749152492144,0.8769264341173514
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3356743623502478,1.5904200760380145,1.099230265035989
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.20749000796049538,0.328502991884759,0.09674090512841096
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0235678750738606,0.059097346195132364,-0.10479280027262952
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.11538432525668532,0.2121786184199979,0.02519990208598803
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6708045150484961,0.8617980851191218,0.4911752484166331
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.37151651316972495,0.5340042144106081,0.2370455613890469
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5515750476524509,0.7208011603442186,0.3945065934744632
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.039251317728466725,0.15272234028011233,-0.06719560738583918
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18602276482304472,-0.09101537944665072,-0.26583859757743095
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.057549899351452584,0.04246437634782735,-0.15173277445951716
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.66088455932076,3.0168590777046784,2.334200551684892
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9316933354053456,2.1522051948257346,1.6799588982571096
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.210432116341984,2.4469101640913684,1.9718737258333747
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7728977949736365,0.941823843691795,0.6283415654162698
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3763370865527511,0.4719502788567618,0.2717455592648035
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5339243176892405,0.6393256710445022,0.4327918437721494
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4517861199320934,1.6901911745250024,1.232997654317646
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9322218292601895,1.077556889799159,0.7663085774339726
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1326715933491527,1.2897626006059664,0.9741986263603679
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3520358239837569,0.47949588997512416,0.2329763383214961
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.014876496746720157,0.088381600246659,-0.0686577914444552
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.14431442283341292,0.22436579823178995,0.06511026966438081
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3413112189373186,2.685220653735961,2.0297710415036345
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7785189126139895,2.027900739650614,1.5334176261407522
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1566011830913845,2.437950000645919,1.8970610963218402
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6176339962055857,0.7714141169623385,0.4831107183939055
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.30409337055843366,0.4108665860846484,0.21407997474460855
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5077973321831446,0.6353992518305019,0.3976815835097573
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2377598463481354,1.4680846121499465,1.0291135832780993
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8312675582839378,0.9956302507257533,0.6697260865399739
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0969120139446702,1.2838104155544259,0.9245010267846449
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.28416154534275523,0.41125480700882316,0.16430154458680338
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0071880994959942985,0.09683859361938503,-0.07909393554445743
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.17641239216198343,0.27856952224315795,0.07717301124938716
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.792337028533002,2.10135598121453,1.5206914655343742
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3880610020257764,1.6372574787350735,1.1544602274101812
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5312587485333586,1.7600588831001966,1.3095641332460024
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.35182830355113315,0.4823695509382196,0.23193173920827304
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.12083678137369605,0.21783550395674595,0.028650433346788677
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.20907820793349643,0.30666534368679443,0.1222302490170702
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8700980754224827,1.0770558111018345,0.6881702352764539
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5739243740106902,0.7381649056711591,0.4199626650579563
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6815006306891128,0.8334912443704701,0.5342301726049425
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1757324123953817,0.30009426109677556,0.06676704744476042
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06446053324278546,0.025204289601186737,-0.14982092901791835
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.022897970534776272,0.1103739514397781,-0.057594303975944956
1,Deaths,73,Western Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.37541389404837816,0.5201231792404888,0.23580501282158897
1,Deaths,73,Western Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3508078906556792,0.45594764703643825,0.22896069955183793
1,Deaths,73,Western Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.36028087171236545,0.4493788181035701,0.258237230486026
1,Deaths,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6713323039091226,-0.6300484989365451,-0.7094407790819413
1,Deaths,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6735977619816181,-0.6199384693830498,-0.7127661304538652
1,Deaths,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.672258899318,-0.6315584866437756,-0.7069324884300809
1,Deaths,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.74323272580233,-0.7103355374096936,-0.772361329394222
1,Deaths,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7478943565981625,-0.707170434696281,-0.7789451516517198
1,Deaths,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7454160541144281,-0.7142177705558039,-0.772388090096613
1,Deaths,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6906034984863695,-0.6517403398017549,-0.7264775105560833
1,Deaths,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6899378190098242,-0.6389647699446243,-0.7271453756370794
1,Deaths,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6900299780523644,-0.6515364605055731,-0.7228234639951095
1,Deaths,44562,Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.568959526180615,-0.5130394748187664,-0.6199625830346711
1,Deaths,44562,Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5687676634079847,-0.4954064246840051,-0.62121216107576
1,Deaths,44562,Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.568597190561188,-0.5128214375419579,-0.6149535016112996
1,Deaths,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6401089812226018,1.8765980406966478,0.2401630386418148
1,Deaths,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7844774799454448,1.5376373488572743,0.24015285116294335
1,Deaths,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.679514219494258,1.6684856072821737,0.29400413881106324
1,Deaths,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.15708575106385061,0.9946764095772679,-0.10006535112650637
1,Deaths,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.331270989893702,0.8112180427921534,-0.04098186305449558
1,Deaths,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2151372877373318,0.9053976365894401,-0.030367853948795848
1,Deaths,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2729641388097988,0.27515302809751435,-0.4502542128980433
1,Deaths,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21775107447916003,0.11240635525747536,-0.4563628590406883
1,Deaths,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2596918620282863,0.1762339301457377,-0.4296197177661445
1,Deaths,44563,African Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2919858389158627,0.25131311119126276,-0.46745090925767757
1,Deaths,44563,African Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.26634333309019803,0.05751492361353932,-0.49908235705451776
1,Deaths,44563,African Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2989319917347544,0.1149720067204528,-0.46569570461370846
1,Deaths,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7528750914543769,1.8196583530369148,0.34081326018566926
1,Deaths,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.982574069886324,1.7638455833802322,0.4160865807571096
1,Deaths,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8922651640368932,1.611954545623786,0.46251009019997563
1,Deaths,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.23761208297367517,0.976386103304934,-0.014810008989597476
1,Deaths,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4798857547754064,1.013134820268167,0.08831449909668998
1,Deaths,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3699791181680933,0.8652028999177188,0.07170276870846384
1,Deaths,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22297660322279445,0.24991251339541476,-0.405637470146856
1,Deaths,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13091285636091418,0.21156767860741177,-0.37924001917043226
1,Deaths,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16591399829962686,0.15131576957994783,-0.3553444745666901
1,Deaths,44563,African Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17506883094280046,0.33149608018297166,-0.3593974556786179
1,Deaths,44563,African Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13895972414908328,0.21418853004478403,-0.39093438743823894
1,Deaths,44563,African Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14498408428073326,0.1846362569202724,-0.34326336301822
1,Deaths,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8745070073852602,2.2196831351050137,0.42905443788832676
1,Deaths,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1721027369796146,2.0496024997753497,0.5179175226533046
1,Deaths,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9538062955138521,2.055074301061606,0.5407367669331229
1,Deaths,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3231587225238651,1.2368017341553403,0.028602452581292893
1,Deaths,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6216951558433307,1.2007264043679275,0.16249935231569823
1,Deaths,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4145217933080736,1.17424110500033,0.12720274712030633
1,Deaths,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1690589881377892,0.4272375358530713,-0.3665214715406745
1,Deaths,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04783049872104524,0.336832941589079,-0.3346011006196031
1,Deaths,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1387874637793639,0.34663722458104673,-0.32086316757932215
1,Deaths,44563,African Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13919121008813104,0.4858072445577205,-0.34168931180874595
1,Deaths,44563,African Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.07214661640830455,0.3131072113796403,-0.36204291587637777
1,Deaths,44563,African Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13889983681706256,0.35037373957731077,-0.321338654315466
1,Deaths,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8792450725302691,2.210310145596327,0.4368229325557969
1,Deaths,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0441533073913918,1.8122730207592699,0.4663906849770117
1,Deaths,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9777337550038597,1.769888428047333,0.5231836031619005
1,Deaths,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.32657841255884984,1.2312933221326503,0.03205266672046795
1,Deaths,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5256529283722299,1.033493743295265,0.12491866108894331
1,Deaths,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.431611603138183,0.9877556864936607,0.13014435828124307
1,Deaths,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.16695867449246718,0.42308262933320423,-0.3630778136646562
1,Deaths,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10391879624299113,0.23279647598995884,-0.35718856045630504
1,Deaths,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12824054921571426,0.22093098156358115,-0.3286003750623878
1,Deaths,44563,African Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1693009245914904,0.4242930288790053,-0.36898511456595456
1,Deaths,44563,African Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.13876517269772598,0.2113651239207382,-0.3988693542977277
1,Deaths,44563,African Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1441103446255451,0.20438376486614515,-0.35556224393555774
1,Deaths,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.55997630852602,3.284330611898759,1.9462213875216419
1,Deaths,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.3098304250455035,4.137599683149247,2.581401676394532
1,Deaths,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.899742493681547,3.544062872973276,2.3515938519938726
1,Deaths,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.340804991472429,1.7279537559378582,0.9704970647607821
1,Deaths,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.15102260546502,2.640761281064644,1.6783573313184377
1,Deaths,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.689130921903196,2.0645232920168066,1.3447989584330846
1,Deaths,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1399738841818061,1.5753979313587305,0.7710333664902017
1,Deaths,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.490126730909935,1.9683938907153826,1.0692563671856112
1,Deaths,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2995486105658054,1.6794829358091063,0.9763235644457836
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5333587160274943,0.8477760127360189,0.270584746277168
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5822169950889796,0.9000151935781886,0.3132206631956905
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5516052296200328,0.8048042684865248,0.336892178157092
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.3421243444433227,0.6094172357073788,0.10911943978593684
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.4801686337330933,0.8170442385755718,0.15016291876347448
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.3661938791654777,0.6149507280771739,0.13307911649589713
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.15648613774274786,0.012439820499499127,-0.3029923788650164
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.17293638611977505,0.015317456057275202,-0.356488937318142
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.18715941937679823,-0.039960987431388595,-0.3257885597048494
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2612425455907847,0.5124272945985431,0.042279451521351326
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3769740056671618,0.6903632644582935,0.06997568069339326
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2773008432461177,0.5098720307793541,0.059353970937732536
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3992993367060629,-0.3004351700453971,-0.4920478284188714
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3925330885830662,-0.2797940346597441,-0.49336283935517183
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.38172223907694236,-0.28043402195851064,-0.4740176226829136
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.15342456711424868,0.3921204384363405,-0.02689441516916119
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4311543754826074,0.7932211028064701,0.08065656851774897
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.2739294378293957,0.5500197434547638,0.0435913621078799
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.27506291607332944,-0.12668042723728676,-0.38911920236066055
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.20033861702849934,0.003668864527118885,-0.3937392851109113
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.24205266189328994,-0.08005863404732358,-0.3776788582414934
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.08391457408330785,0.30822567432875847,-0.08553766271953267
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33137693113129685,0.6682010337908333,0.005315185033667125
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19103969794498185,0.44916585819595345,-0.024311155866843834
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.4572330099174602,-0.3620366571766194,-0.5334204221454377
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.4298908971728348,-0.3090660182253222,-0.5299747194582451
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.44485236601847705,-0.3575871292672596,-0.5211754296593318
1,Deaths,5,East Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.795111128340744,1.497110390873205,0.27853780512502924
1,Deaths,5,East Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8876350693729955,1.606269034894796,0.4105909844324456
1,Deaths,5,East Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8210581292973326,1.3640429197329267,0.37587108187294216
1,Deaths,5,East Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22644991682446106,0.467308469892219,0.04024221228652232
1,Deaths,5,East Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.45162800747846055,0.7029687687905485,0.23003733788209593
1,Deaths,5,East Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3092413568314853,0.5564467479102423,0.11712592360385654
1,Deaths,5,East Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.49504889638269445,1.0797053035215225,0.0648235111229827
1,Deaths,5,East Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5481057417725361,1.1374788607126274,0.15686767941739937
1,Deaths,5,East Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5053411461561051,0.9541886231419405,0.13733621021138184
1,Deaths,5,East Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18104435583190795,0.12468544549433144,-0.4079155378366509
1,Deaths,5,East Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.26687977747575453,0.00836885508845134,-0.45111891991120906
1,Deaths,5,East Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2175995286437248,0.004959779297127755,-0.4038182366049105
1,Deaths,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.649319418266013,1.2755483192197097,0.17166183869906088
1,Deaths,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5431793909975461,1.1932143436812026,0.13591576603686462
1,Deaths,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6321783821096268,1.1902377212113886,0.2143695182594148
1,Deaths,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.12666373346749,0.3587874294598287,-0.05306217086642532
1,Deaths,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.18664466679641759,0.4003642353072132,-0.015545362673153058
1,Deaths,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.17297621780015845,0.44946478238545107,-0.03877628309272396
1,Deaths,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.37362703463398067,0.895178493188616,-0.024187577456625375
1,Deaths,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2656073806585304,0.7987204060150002,-0.06840164812379129
1,Deaths,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3492074947679808,0.8105160447980213,0.0038341846775796365
1,Deaths,5,East Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2259165626141391,0.060981418694485895,-0.443321518298691
1,Deaths,5,East Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.35311924094123004,-0.09051023223291295,-0.5209638640701675
1,Deaths,5,East Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2576364556560927,-0.007101275394848302,-0.4443583809559012
1,Deaths,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4250312712243298,2.3224403206930013,0.7270119351031736
1,Deaths,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2480114467258994,2.1148970010202763,0.6907035979080876
1,Deaths,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3223422344832174,1.9634043342181229,0.8162383390921369
1,Deaths,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6581701555435551,1.0208577469449185,0.41276325295246397
1,Deaths,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7294624299885311,1.0460075190322518,0.46680539869127013
1,Deaths,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6711479479948131,0.9460432748823934,0.4237445874303391
1,Deaths,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.019674586435563,1.7670770106253721,0.4383328401525244
1,Deaths,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8436611423005225,1.5546198047227906,0.3865963766112867
1,Deaths,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9197175887914224,1.449638704678342,0.5013569633367909
1,Deaths,5,East Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.07593595155427191,0.24723718338013045,-0.32598619167839804
1,Deaths,5,East Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2265442891885687,0.055935996308922736,-0.41164965255078434
1,Deaths,5,East Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17893941752847417,0.04031487760992715,-0.35720056469261213
1,Deaths,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4662979834145244,2.4896198980526867,0.7400151880275985
1,Deaths,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.302913796971628,2.22234629994079,0.7092749216852259
1,Deaths,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4095020126119502,2.207115008980696,0.8242596673167715
1,Deaths,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.685598550721382,1.0347785149606212,0.4290615609111307
1,Deaths,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.77043055985338,1.1159831642191484,0.4879429161494022
1,Deaths,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7326078189198847,1.053873980290817,0.49524911518858933
1,Deaths,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0540433514347034,1.906311645564296,0.4491625312101558
1,Deaths,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8886881949502942,1.6427421750406586,0.40182727236978444
1,Deaths,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9917664697119113,1.651097241654934,0.5079876332913106
1,Deaths,5,East Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.027574985369959643,0.42164153417499833,-0.2742519511545675
1,Deaths,5,East Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10623388023229159,0.2379445556068594,-0.33763125540037464
1,Deaths,5,East Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.02573229751536952,0.2793101781891141,-0.25767684657558093
1,Deaths,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7089748381877857,1.3622215727925457,0.20931668290741648
1,Deaths,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5346749502603219,1.1376763565505832,0.12020538911223459
1,Deaths,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6228388692520755,1.0889552859177865,0.24582237706507432
1,Deaths,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.16737966025738835,0.40124531878702774,-0.025951433386902988
1,Deaths,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.18029856645253306,0.4040076493070015,0.004296198469190468
1,Deaths,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1669810933824766,0.36657428011441967,0.0015470532476838563
1,Deaths,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4233107385056906,0.9673638582360379,0.007173062220986075
1,Deaths,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.25863263551341464,0.7531720486240984,-0.08128619615801977
1,Deaths,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3414871739482696,0.7267929528343493,0.02983405901583965
1,Deaths,5,East Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.19567469827622222,0.09951939288993,-0.4211624514642976
1,Deaths,5,East Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3389910114313255,-0.0776438851974537,-0.5179050191774295
1,Deaths,5,East Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2710882186094002,-0.06139730245023504,-0.43921101523234535
1,Deaths,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8541603904918977,-0.7922867186664609,-0.8969278288828405
1,Deaths,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8702913991577296,-0.8033146692412755,-0.9171646610022514
1,Deaths,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8615598165957187,-0.7985050421006179,-0.9038514191046263
1,Deaths,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8995533460160683,-0.8435451028799349,-0.9359539733083394
1,Deaths,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8995873048721835,-0.8360634589267502,-0.935738797809908
1,Deaths,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8999249524676582,-0.8522015296086536,-0.9329683854525725
1,Deaths,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8785382454592058,-0.8270070821137544,-0.9141568824104425
1,Deaths,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8936221132043811,-0.8386925021629569,-0.9320642713177155
1,Deaths,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8855612014756086,-0.8334382379183196,-0.9205207057162021
1,Deaths,5,East Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7868016908671999,-0.6935725394872133,-0.8491143976166137
1,Deaths,5,East Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8057303796628827,-0.7029859325730722,-0.8776953092371454
1,Deaths,5,East Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7951424597025246,-0.7010753225136717,-0.858812431101776
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5122605652880169,1.5350632196584655,0.07220256692713126
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.823938042345553,1.8637211720090412,0.12834562214368167
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6251832273874703,1.475552892409897,0.15572639004455724
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.025563799236323403,0.6880115910910283,-0.24552348556174386
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3250063267646795,1.0110373113361242,-0.14908895274400416
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1375741650092259,0.7176262721778242,-0.17175879103784478
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3927327553243322,0.017986510933996856,-0.5694435777157165
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.29330137236955806,0.1095704871490451,-0.5628139310936713
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3591252623556502,-0.023790497150108357,-0.5442508669012567
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2900180876694168,0.18694750801192994,-0.4974100679385515
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18984396143753185,0.29831654580516226,-0.5140432330776034
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2648117404034523,0.13089709974900865,-0.4867348945280436
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.45425484659176013,1.4785635130191792,0.028086930071095178
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7118822519346819,1.75827026682493,0.04584288514865325
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.51487052147211,1.3884947214377295,0.08329310524810206
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.014109486356633219,0.6418186796519464,-0.27779570008547894
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2429843101365573,0.9064904715915086,-0.2043129016832087
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.059938089825397965,0.6573148794121279,-0.22183604263442286
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.41602568101230747,-0.004701656676383337,-0.5871587663912706
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.33671823821856023,0.06871273417396859,-0.59478024226023
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.402625973703743,-0.05812101542113087,-0.5728142077039238
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.34211085642232747,0.10921322546069524,-0.5371562073672307
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3067150998708341,0.13476307714688476,-0.5843141631656611
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.35737447912303805,0.008149856322337681,-0.54496741478783
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5113991231321214,1.4565792466002196,0.07902771161267719
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7731686735191838,1.8376246480946754,0.07054666556478582
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6773923650188507,1.4959540871563155,0.12234886537604954
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.025555698526886023,0.6692953785924174,-0.25764697564057
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.28826287974150744,0.9836636555121325,-0.19418019189388258
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.17438056034770238,0.7292095388328856,-0.19916087857682163
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3930786782535333,-0.013529715280103365,-0.566702855050033
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3129723493667365,0.09945919103698496,-0.5852085751794153
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3385371115439176,-0.01574549021771457,-0.5574129596454294
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2591023976292752,0.19288784529935565,-0.4761729997252581
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19372172832121456,0.3115625062656884,-0.5250803809561841
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.20913839487460079,0.18934779065862836,-0.4763995610163128
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1599306193406465,7.008041680695939,0.5982248839993769
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.547407324023855,2.705015706619102,0.588120057779822
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8674015536096598,4.0773397138659435,0.6752400408446809
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.29766321077106056,2.3115506702280957,-0.3420074696245866
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.002547321296819124,0.44261506297941206,-0.3615644697896418
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.15483733293731247,1.035870568181165,-0.3116419127232563
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0492094307117132,4.193200899150988,0.0364460170878812
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6731394848001593,1.433457740381031,0.04307872173238916
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8716899491072732,2.314222139094142,0.09350918877889534
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.611437208046167,3.0476552310771683,-0.2016516409370023
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2299018967557487,0.7967578675010363,-0.23842764573418437
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4020072166274665,1.4589276223348813,-0.18501443318333904
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9504255481778783,6.45045408227065,0.5451640235758579
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2519243275262288,2.33335342124527,0.4316923061453935
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7043974529921628,4.117786770014247,0.5554996481203491
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.21152737478435327,2.069353162702345,-0.36065842093950884
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.11391073862940364,0.2769100161952755,-0.43029411849585314
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.08904943816927834,1.0699162363550863,-0.3706279115649919
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9133457617498135,3.831606325476641,0.002036142733031782
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4790659796073076,1.1893496078473744,-0.05966317011577277
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7652893871054215,2.3406238645059374,0.01534891531382822
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.44561640994441276,2.5973103090510268,-0.25500355005330844
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.10132018965270426,0.6259790508960756,-0.3083831761218326
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3038225783159436,1.4639881137372839,-0.25457370152533193
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.282108727346865,3.757326872113105,2.843808294318618
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.436740195181247,2.7864071259594523,2.1194092473143074
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7404128377625985,3.079688271885406,2.423342221543069
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0728626774161503,1.2728187350634272,0.8823433750282642
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.612819965866548,0.7544396021611338,0.477356171930571
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7864260163525342,0.9244014312382505,0.6518931662726433
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8678355112342198,2.1861010102954457,1.5742947287687228
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2650883523282863,1.4955469983471616,1.0559417212112447
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4847347389434906,1.7101134588334945,1.2741065518981949
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.638793585149205,0.8113995268232337,0.46599802341902363
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.22607754064462504,0.3400731641887706,0.11008605553682563
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.37650807378988244,0.4924984982886222,0.25569149737556657
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.49893849579444166,-0.3598003799289845,-0.6163672435135807
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5989177594850429,-0.49595044429462326,-0.6763131314953877
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5457896982503754,-0.43530664546760417,-0.6455888219342468
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.757786791317768,-0.7011508524418929,-0.8077640342377361
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8119562601895225,-0.7709940325909465,-0.8443588805453294
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.783330302925899,-0.7393755887770058,-0.8241910840305149
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6644265555668264,-0.5712422729966813,-0.7430715303191074
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7356545273366955,-0.6677907805701073,-0.7866643057047407
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6982707084765574,-0.6248774518439317,-0.7645666924465421
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47470046882429906,-0.328690183623677,-0.598315593699931
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.57502795797324,-0.4652385525578491,-0.6577774381214597
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.521317597178269,-0.40362180222402483,-0.6271938752684098
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7192001998198333,1.9280007255168272,0.3218768224792892
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9251266555783738,1.6006622714447647,0.39323069840513697
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8030256885210114,1.6468762395066354,0.4328387819506262
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22579758480767217,1.0443916361469028,-0.023160208906293188
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4544725106054613,0.9057038749611837,0.0890915473662841
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.31961095451836186,0.9027126403867427,0.0676189961517049
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.24764697864367302,0.28134593784188533,-0.4215228561761359
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1665031065665737,0.12597470812511238,-0.3967911380833868
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.21522572412947308,0.15206366576041916,-0.37635108323560357
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19758575891593824,0.37921909452044034,-0.38216955340552855
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1369110397262912,0.20654325944009577,-0.3938724024475262
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.17839205581181103,0.2259688683615465,-0.35882768845095653
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6383171300661615,1.8782634019870577,0.24174640350788293
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7881976908634586,1.5262440343670596,0.2519045740669323
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6793218129023466,1.6663699320657326,0.3032626112780079
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.16771140285286953,1.012630608571951,-0.09307261502413243
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.350449254955789,0.8286980648221766,-0.021301159153146253
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.22858624895290114,0.9274926788293488,-0.015451638917673562
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2830428690769854,0.25957998781714653,-0.4565893730495075
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22578744839427783,0.09375481794836739,-0.4579792605664192
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.26906833992195706,0.16054837485774603,-0.4327496393721456
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27852746365078207,0.27605577624473077,-0.4531551139557556
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25525229846394576,0.06803348978611193,-0.48567125854422893
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2875754827991567,0.13308524535688293,-0.45258834845172663
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7373259558197517,1.8049753986503623,0.33717929326117957
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.974836861769703,1.7393328490311775,0.4157698356709994
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8810821513445273,1.598062209724362,0.46384964247977145
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.23934997784819637,0.995221553255444,-0.01385200675086767
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4922600491431969,1.0162131877212968,0.10379520918996099
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.37713770396942603,0.8746378151951915,0.08132613886109434
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.23971482083428128,0.2275078354608859,-0.41482621890947047
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14498072916228366,0.18601309328485116,-0.3870326627969274
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1812513307088293,0.13081716044516245,-0.3628534798621071
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16018259272197938,0.3654104999436654,-0.34415224235133995
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12583938326147542,0.22833004301966675,-0.38016959916590504
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13028153372284138,0.205872842538273,-0.33163849130680706
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8580554300362776,2.202367174124863,0.4272084036700172
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.161558663410402,2.031455371885142,0.5206944657367356
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9386157904553605,2.039111385643926,0.5333694666117947
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3250895761349378,1.2472155633519357,0.0352160491123448
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6336914173179248,1.1997523169907671,0.17367187586811983
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4192640313247334,1.183276424109557,0.13636705146495487
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.18688142498946975,0.40141364525065193,-0.37542785609331353
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06413823438260892,0.31248955892163505,-0.3416048188932396
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.15620957991246026,0.3227856109554194,-0.33259469320743273
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12557417654131317,0.5142967587485171,-0.3283814318856461
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06107420780344691,0.3261123880251392,-0.3483654147259671
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12813173076494916,0.37252196957465555,-0.3114609937590458
1,Deaths,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.270227615935305,3.0158768859237592,0.6927182419399479
1,Deaths,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.356104882216291,2.3645820010786345,0.600656556178084
1,Deaths,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.321225720054211,2.340041664492565,0.7411722908676028
1,Deaths,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6034714396324358,1.7434316941287054,0.24147765315990943
1,Deaths,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7586978057732177,1.4331144421410331,0.23049588244487
1,Deaths,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6807523373273191,1.3755384693718424,0.284069421777913
1,Deaths,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.006358058364465638,0.7801783562059095,-0.24964323781473088
1,Deaths,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.03282923614392809,0.47490830495153397,-0.2983313685547467
1,Deaths,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.023166264792232025,0.4722471514013196,-0.23251378191469735
1,Deaths,44563,African Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04137631322602266,0.8352235271488585,-0.23400690245466252
1,Deaths,44563,African Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.012331532536626305,0.4684003532780531,-0.32040189758097265
1,Deaths,44563,African Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0303294473949587,0.4942826600256182,-0.23818177482296743
1,Deaths,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9143713588291572,1.3202512247973668,0.5384729399404742
1,Deaths,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5122684368493693,0.7998246230688782,0.2443072347283776
1,Deaths,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6439352036258362,0.9256276156062139,0.4023539348233505
1,Deaths,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.026971019152554773,0.2659092313032077,-0.18078084161895266
1,Deaths,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1320421599694546,0.019559509454484994,-0.25238864276938555
1,Deaths,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.09068773790578565,0.050121739975204124,-0.2256330716509888
1,Deaths,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.42115615569465786,0.7224658610101565,0.14210353120999825
1,Deaths,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.12649466069150336,0.34069638608091884,-0.07311068456760707
1,Deaths,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.22250723029821268,0.43198690419692476,0.042856081539873477
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.021247504813940898,0.20041456943051789,-0.2100489977503882
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2618073446884769,-0.12840908863274958,-0.3893864359372798
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.18107364068837606,-0.04002630942391247,-0.3046102431566757
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6148695244532434,1.762878548071643,0.12823462618614276
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.130566533525222,2.465417229536318,0.25986564461913764
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7392813775578015,1.763029559510125,0.23060916174467208
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0955576136117059,0.8412491322534306,-0.2041351165258777
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5487492301674338,1.3854345002323578,-0.035870378294373687
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2181244821483786,0.917457543775417,-0.12666063054255547
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.35152883759905845,0.10946862053592521,-0.5469431997909353
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.17449583792804738,0.3427021880254364,-0.5118555009104815
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.31413179895788595,0.0895730488808807,-0.5147215954574829
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.22161768642276375,0.33638345114399326,-0.45561863510134315
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06769132436137092,0.5280092080001114,-0.4480149376410697
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20441629085251634,0.26697440056266747,-0.43187252654649516
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6240425321533541,1.7984317217582846,0.14791875703480095
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9492610610154435,2.1462871012086513,0.19322985918868946
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.806726009943805,1.7167147292222478,0.2491039535777278
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.10180070338777814,0.865215219784969,-0.194073329835394
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4161222595845185,1.1890278318942438,-0.08517292419007527
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.26478373904760993,0.8652968435979356,-0.0981057769098847
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3478453010185916,0.12374544446411534,-0.5390387895466443
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24474401831019468,0.2190527994559305,-0.5376740413550986
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.28753568329689533,0.07130925916807353,-0.5074283594308903
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2552855493692873,0.2778223668633005,-0.4749316585222908
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.18686929080037815,0.3200475153964538,-0.5107288582429141
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2094477397591327,0.1901248326255813,-0.4590771132680284
1,Deaths,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5961562297639302,2.6220343948132974,0.8394816152719653
1,Deaths,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4958931583424449,2.4370971969556217,0.8402367432927398
1,Deaths,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5477799404484407,2.216553380840471,0.9538646489134668
1,Deaths,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7744333072213068,1.1439194232668968,0.49246820216658876
1,Deaths,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9184389716385223,1.2581053755078313,0.600685719842006
1,Deaths,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.832036785808482,1.1559799327560392,0.5736266802392321
1,Deaths,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1621951114153346,2.0165923653044744,0.5320026239103071
1,Deaths,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0469563169136127,1.8188657818297045,0.5092329628409443
1,Deaths,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1060711429283514,1.658899282284314,0.6151229896017603
1,Deaths,5,East Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.09602636786024962,0.5039634276647191,-0.19844109402464102
1,Deaths,5,East Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.04002569820140182,0.31974149023399817,-0.2888982722780945
1,Deaths,5,East Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0215193869617123,0.29037580249505707,-0.20036755665769862
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.329276281660698,2.621951370276277,2.0634444286774842
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.663961464418615,1.814193518496087,1.4871134712414806
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.0251768569544897,2.207066761245627,1.847235868758008
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6989193034013783,0.8372680036327212,0.5635768246553168
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1958625462695889,0.2689932331303882,0.1203701159074844
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4616248101089048,0.5431724498597416,0.37623583957344653
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.2589559014747642,1.4575396364097986,1.0785856401046656
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7657036405459263,0.865279136796275,0.6484868003074914
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0283299867693196,1.1502840954410787,0.909023559641077
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2589905428619076,0.3638256190873118,0.16180383624336908
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.09616443889970201,-0.049308978232907356,-0.14753618866136908
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.08153755575196958,0.14168364813232515,0.023679571219816665
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7488858787258141,2.0069054836650095,1.5020627275575433
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1937509264112,1.3445713744976822,1.0376957830339595
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5742206215328136,1.7734187168036302,1.3919528791117837
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4027442600862948,0.5400472273196024,0.27897807269264346
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.015237332047762458,0.0574659760233952,-0.08220280900877099
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.24373016534408065,0.34411940253854933,0.15508266828838485
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8651537009511453,1.0402232535996387,0.6976810832463614
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.45404280390392554,0.5540082943256105,0.35060769852891627
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7259714476565958,0.8595304060415535,0.6037640049005008
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.11360545965452036,0.2094392323619733,0.019355438834514033
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.17260930664621263,-0.12396975265405974,-0.22186793023150236
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.006812347057946759,0.07707748763539789,-0.058831951082898806
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.9216552749035625,3.2907715216683626,2.603959702589163
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8443146788056868,2.0283279202052853,1.6346470486810236
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.29911383680137,2.4952745704854244,2.108828244825272
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0011688348045973,1.1824870388232427,0.8254436760693916
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.27678987641228175,0.3655169448488493,0.18565239291184157
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5939414635793303,0.6857211936327849,0.506232086413065
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.660892511562333,1.9113425353565823,1.4453320632134683
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8852437808523188,1.007209828254896,0.7462737158718341
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2120001049084055,1.3435225636510604,1.0844168294486582
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.34770963950494244,0.46506075441624456,0.23781933541115008
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11076733062782906,-0.05879763036007925,-0.16528711243873973
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.07483379263370381,0.13587338182456177,0.015534518969875885
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5489294312014645,2.8634950474094607,2.2664054389986754
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7862472268163807,1.97332032639536,1.6083521502040214
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2757576924665783,2.501754769439203,2.0782450302599242
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8109860755690624,0.9638789045615392,0.6539667925447682
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.25078181738785876,0.3403877740423751,0.1636725737877382
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5826941299925842,0.6840528648682238,0.4822322310668399
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.4079933307700978,1.6214300644675586,1.21629724264119
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8467560201454963,0.9707501759869704,0.728845161221641
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1963402046216898,1.347867427597763,1.0639113006389653
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.29111442826868045,0.40411513819291134,0.19285526270423303
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.059607202649781456,-0.0008795347116593865,-0.11506319812100095
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.14698033672136385,0.22348242161196072,0.07789110948981753
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8052961820540177,2.0660164076611105,1.564853479843904
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.406675289557028,1.5753228245612414,1.235675367646226
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.568310190210162,1.726916187930826,1.422167538964701
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4314802060798283,0.5686696725318888,0.3062592253875621
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.08034128324797267,0.15678195031984643,0.008049389686893308
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.24084925142638122,0.3217504364948967,0.16673140020015884
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9034288024526776,1.080330760248505,0.7402853997510168
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5951714681841987,0.7069529524524121,0.4818307953990285
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7220086032830765,0.8283512458689908,0.6240224240004687
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.12994951465609733,0.22996668607499185,0.034055439373784746
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10211043311900984,-0.05247093061282176,-0.15686462482349284
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.00955867542349913,0.040627226423924676,-0.060914191246429564
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8783222865674122,2.2116255450924878,0.44631167210167116
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0426153265686633,1.8033138820902102,0.47544281189180587
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9763011496739707,1.7784214230434001,0.5264428561948045
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3396610494984092,1.2595831978954288,0.04838091097482671
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5432867443462711,1.037601315315699,0.1448870666431955
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.446602993203475,1.0010253400690219,0.1502750803864091
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1780122829627351,0.4054652754046387,-0.3670679212097311
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11563557429264666,0.2137141238320301,-0.3611968352383368
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.13980687379463214,0.20931924276720068,-0.33560952860819154
1,Deaths,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.15240417077860177,0.45477977040145634,-0.3468622298660338
1,Deaths,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1288458013356773,0.2212209104361453,-0.38778745570782247
1,Deaths,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.13080887476295577,0.2335609815827851,-0.3384390811520125
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.30942733819657614,0.4903370253750591,0.1494779014873946
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7977386601117058,1.1012756558286134,0.47761886789990704
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4358124164000365,0.6200680725515056,0.24838743407529462
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.17701412849454404,-0.06575640695907188,-0.2773930082576885
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.004510356528894051,0.17266411695315534,-0.17628018467355114
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.145731154965102,-0.03626232664694571,-0.25762257714107517
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.23051599215139443,0.400523335601871,0.08020575036483682
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6724036353300517,0.9547785913553974,0.37460200480670575
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.34238956723423636,0.514656409125594,0.1671596151610997
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.4234343744880249,-0.34717048050786903,-0.4910949238566205
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3711821825342187,-0.2772323360178878,-0.455905787307931
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.4041664727023209,-0.33023930187127976,-0.4712582604044779
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.0313464541222061,0.36418849925754315,-0.20583975998612086
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.15971893816308616,0.49880342516869486,-0.09703151101656513
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.05229453057961229,0.37142616389667066,-0.17479039288202622
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3517831760487423,-0.1418218231936132,-0.5005727890291561
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.35199453898126604,-0.16336231958929837,-0.49591842298989214
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3739140085313165,-0.1844845248372596,-0.5087215343612574
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.030806621928425298,0.28197702589390317,-0.253699042961968
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.07886547203948471,0.39430961380198476,-0.15998480920995456
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.016174269442901793,0.2821926831241711,-0.2284836412307515
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.45586897379392105,-0.2912033273882101,-0.5766561271807773
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.4818902459898693,-0.35384583634074623,-0.5765791361029292
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.4465017564814132,-0.2960120965552445,-0.5640412520402945
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5208200231027312,0.6376843129986564,0.39836979285275015
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0960366033414415,1.3925548326736115,0.7238213303571842
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7021137774940868,0.8645847398154832,0.5051461440695373
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.044150865389457165,0.027785989853238775,-0.12076764301932678
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.17118942490373756,0.3362762197291529,-0.03828136530189937
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.012714096753638472,0.10912677794686224,-0.10599533940653007
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.429169305560216,0.5389908843783333,0.3140984175697885
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9499047959480632,1.2257503210400944,0.603639685520083
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5913637123173597,0.7432633074926002,0.4072120131317012
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.4098650416024141,-0.3706883911763716,-0.44656968887411597
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3279488870306085,-0.25073051248612366,-0.4200320018452144
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.38537066378122314,-0.3418965209372815,-0.43626939068540693
1,Deaths,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.007282328672757798,0.6765021591863112,-0.3187363253585196
1,Deaths,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.06954872214799361,0.3361766433221737,-0.34975693851710005
1,Deaths,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.034750482471768145,0.41469149667033073,-0.3175421608672748
1,Deaths,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.29031444104293397,0.16120363564975418,-0.5060774136706945
1,Deaths,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3061635046486994,-0.020526695810123733,-0.49682649822363234
1,Deaths,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.30223177816263824,0.0044575344858096624,-0.48483600324070314
1,Deaths,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5534867599210621,-0.25683158555558244,-0.6980059690781336
1,Deaths,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5921245739837095,-0.41426958014803966,-0.714957492101312
1,Deaths,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5745305013168636,-0.3764222919054546,-0.6991814143230753
1,Deaths,44563,African Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46791376050713773,-0.09765306820127022,-0.6406400474948443
1,Deaths,44563,African Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4963930609907904,-0.2689144421798679,-0.6509312385558144
1,Deaths,44563,African Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4833839932646642,-0.23399980494035819,-0.6357155378657308
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.824082649002302,2.969736236074689,2.654694020169021
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1177534409426,2.2495652657258156,1.9595691254171932
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.519972402533236,2.6411644918186448,2.3905885049591262
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0381721569921551,1.113103283852313,0.9580126986967006
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6667742624101758,0.7284263867620892,0.5958419517822792
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8786693875911571,0.9367769162602263,0.8156829563596637
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.6745550003650669,1.7764247990544824,1.5560849656315754
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1684163337638442,1.260092253382668,1.0583981876763129
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.4548814145636384,1.5394025907424038,1.3646471487296539
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.6857632213705075,0.7502271590034667,0.6125958877417073
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.43951807862021597,0.5022147839629356,0.3705255794329917
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.596731839957154,0.651356585271823,0.5391354911571875
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9168664697388538,2.1286010751889837,1.7102327889502846
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.413316656144413,1.5824624247711874,1.247655681628163
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.738115344938461,1.9207038620575614,1.5607025534188488
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5544075717355637,0.653636291992724,0.4612895549391608
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.28994510484131836,0.3650815730318641,0.2134484863946644
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.46114667116845554,0.541417635159344,0.38426270960029424
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0400499984153306,1.1881367161291116,0.8955308561993308
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6784762986728577,0.796118201544578,0.563258091135681
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9096026055157338,1.0369425689955138,0.7858722705012006
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3544851274104353,0.44351839128128306,0.2705268748382844
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15116681061703127,0.23015996999003327,0.07449996526081668
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.29315518000365903,0.37218154064773995,0.2167599342082663
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.3215209799447845,3.499608257757359,3.100223962335123
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.323861461220671,2.463257633087974,2.1552865598857345
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.7662057450506135,2.9103760544783848,2.6175340206443605
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3035285542077424,1.4109816577365848,1.1823435681087753
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.777102278519195,0.8512766107429259,0.6935136852718917
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0102579670557705,1.0835737354788972,0.9282698834927515
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.022462275785115,2.1470161264973315,1.86768762802267
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3117657057256,1.4087165845128022,1.1945208445005269
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6266082314434498,1.7271547621183527,1.5229223466185051
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.829688307442357,0.9027400629387035,0.7406027151875845
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5059261733895036,0.5708673200292547,0.4330991197970311
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6619811104358924,0.7233494405351538,0.5994106529099593
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.933295006718472,3.1196731762097047,2.715861420687237
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1673534424416934,2.3403016658933438,1.9794007898090824
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.7477104576607503,2.9097589398003096,2.564854331588392
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0963341704757372,1.198577162414954,0.9851758252495589
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.693224618854646,0.7824363507162174,0.611433155730623
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0001838524599629,1.0816090659946764,0.909389660067535
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7509378833311668,1.881290365462198,1.5988653111238496
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2029134341416277,1.3231999672917945,1.0721912299446248
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6137093413164378,1.7267243771094334,1.4861827433490542
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7127335625938968,0.7922202096935511,0.6208950193347679
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.45661420729173735,0.5358880157744176,0.3699055524119803
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6878939509358681,0.7598618163091216,0.6084844092802704
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.519540960036562,2.6920304786804907,2.344984283113465
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8262695283848756,1.9685816610821556,1.6717903813645245
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.138907065626464,2.2782892306654934,1.9918895260676963
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8759783107617027,0.9749589084993517,0.7863983075523443
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5109499436490827,0.584836957277626,0.4372287535519739
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6753425882305224,0.7451356881189511,0.5980749246830023
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.461559212406495,1.5821980026585936,1.3394746561970248
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9656875134795663,1.0646664606217915,0.8582463344479222
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1891207476238603,1.2863279547683542,1.0865885160592146
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5912917209593471,0.6621631970693247,0.5248391494435543
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33979355822062174,0.4023883836403318,0.2750677548142836
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.457618374302428,0.5128470814327446,0.3980405756956866
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.3340540931631284,3.482762812969911,1.1903221911010455
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2658936720719292,2.465845773640866,0.38829817191094446
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8798647353618327,2.968402473133966,0.8814453784091217
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7711184369903018,1.3285076793137893,0.17123381433927423
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4634169535333158,1.1664026417278222,-0.09464950196232898
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6630919956535232,1.2489393954206616,0.11874608618256356
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7745428725778061,1.3859405327360952,0.16579411259035925
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.24852001289834877,0.9097002932414813,-0.2350399875930352
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5585539023573314,1.1476596052176533,0.018219363078273605
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.21961923453861598,0.6225146129046978,-0.20464025713830186
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16729871914949646,0.2978642424035079,-0.5085425902805071
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.05212465517825239,0.4662040834447985,-0.32046773866688216
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.018901544776956,2.7663476773123254,1.1125552566331303
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3138754192336646,2.19968536414744,0.5608775626815948
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.790591543429054,2.535171241803728,0.9721383994611076
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6047953832455513,0.9611093799826935,0.1105612765730935
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.49439464384831344,1.019480143508088,0.04054029759453669
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6122505815428431,0.9990852520962443,0.15153832623854668
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.606803629936174,1.0046301708571443,0.12440283475678983
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.27495822238876977,0.7630444276156676,-0.13994778364423435
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.510240146522117,0.9131992092407641,0.06730151618828377
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.09120054742208966,0.36037751235331983,-0.2392123764594118
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14161319980225265,0.19793972506893834,-0.42811661175186777
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.019203043073430417,0.2912543592159527,-0.2754281388518966
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.2642361127927044,3.706214458028995,0.9573893482790048
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0402020120003796,2.3803416462558604,0.14564721886241308
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7167565919807324,3.0307179651457425,0.6609860485823211
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.73331627411312,1.4512339167316424,0.06458920133437887
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.31770269155888853,1.1197528439239246,-0.24705547511137924
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5685189373259406,1.304595955170348,-0.019530848519211566
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7373824078756357,1.5048721736229373,0.041816125290524996
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.12416265323198505,0.862587043603437,-0.3687420119924979
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4702814115519858,1.1813841243104117,-0.10109101445217389
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.15824973762179032,0.6308876319412421,-0.2991865427726822
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2838555532552917,0.18550328220603146,-0.6007899472460572
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.045760335662436494,0.4175061934886502,-0.41309949794253537
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.9968482756612977,4.4319023689812616,1.5998202017296035
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7522403717563744,3.2329268794542516,0.6232160327462214
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.686922330374741,4.01448254787768,1.4025030475444797
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1220588386693844,1.8213899279091608,0.38766498774789504
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7766193464218619,1.6825689233223091,0.0692115982952616
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1279894107671538,1.8848875602379578,0.41007843738129474
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1273136014481089,1.8911179495198958,0.3837485175851146
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5164997487735353,1.3323662479279048,-0.10559894000322512
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9953253759232465,1.713787646806115,0.30021054607114256
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4235795122329234,0.9194560958179154,-0.07487115942709972
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.016176345077218258,0.51611556093342,-0.4230886718588084
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3148144666387338,0.7766021385464396,-0.14290006862205185
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.5845303504161072,3.96134970184936,1.2036477662922342
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.494020822985547,2.797979607739282,0.5608205093575153
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9200734473275747,3.091953274764739,0.8841323410316425
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9042829473223523,1.5442576108215185,0.2254630895354345
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6104154198766424,1.3735866103209877,0.02631024240955063
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6862301785854568,1.2962164784664318,0.10317763427258081
1,Deaths,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9078583031731587,1.640667339452203,0.17288662033551355
1,Deaths,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3742193415613248,1.0927078826723453,-0.13997922034304938
1,Deaths,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5803144538768119,1.214524059529194,0.01967352029246382
1,Deaths,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3222531719822246,0.8161516373794334,-0.18409082437498336
1,Deaths,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06106845019201263,0.4652454277739888,-0.4203083306791231
1,Deaths,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.08615297000177347,0.545604059159756,-0.3056084195212859
1,Deaths,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3196675267838799,0.193747783574548,-0.5157853643782832
1,Deaths,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1930105137799594,0.3518348502393922,-0.4539378555243393
1,Deaths,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2560241436048379,0.23822477937063424,-0.4642156040920799
1,Deaths,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5314781102216939,-0.18754641670236116,-0.6612687215184323
1,Deaths,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.39008140573290057,0.00028495262963137015,-0.5836117754561152
1,Deaths,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.46595071696701146,-0.13400137921780655,-0.6090796880373137
1,Deaths,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6220408296339404,-0.3368126031478868,-0.730994228316733
1,Deaths,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5678200885085617,-0.27603038713171113,-0.7075586568373617
1,Deaths,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5940766025468719,-0.32440763375282355,-0.7076687093810794
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46136215336584097,-0.0484316867113871,-0.6163116136934103
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3568890658594677,0.0830118178238221,-0.565291476296227
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.40911111982399717,-0.012154826802922637,-0.5748114304589914
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9245013762352431,2.6597859702158937,0.24762780134737616
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9435941177740986,1.4089036337620449,0.5848513490987496
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9339158771531733,1.8502053201729183,0.4490122189382301
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6028391888439912,1.999198143135864,0.048202556696799626
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7431929183538876,1.104943080469392,0.4338184272823752
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6644920815779158,1.3903126227607145,0.272168812790589
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.13782157323158184,0.6395875571066203,-0.44106157145884217
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.12987708675887136,0.07843619630144859,-0.29048176246218893
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.13390939680641886,0.27644437596113514,-0.3510700845051902
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.11087310237498842,0.7089600505154529,-0.42059873144333376
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1270748340016686,0.12703240308856348,-0.3005132793615497
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.11446120642334928,0.31532458663959373,-0.33187651879059216
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9625413486476048,3.09288540921427,0.1882019721650659
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8098276553010646,1.278284147918729,0.4400803145179516
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9049198894801834,2.189322182140239,0.3150371398338561
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6333574640762673,2.3887318490246754,0.0027498471203861214
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6223380008411623,0.9780834493407777,0.3303074307215361
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6383775034568275,1.7259496477597251,0.1611273011244709
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.12077962980987034,0.8336165131577594,-0.4676843988293487
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18976266829906469,0.019959477058128523,-0.35529395406659736
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1468950456397379,0.4283154738740091,-0.41106987996952243
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.15803227430318356,0.7918789985069112,-0.4940043488881749
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2389627756762502,-0.014998193942688852,-0.39401169012729015
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19546791758960155,0.36914039314971864,-0.4425061076455567
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8750465555814357,2.2156917230413558,0.2848518556861017
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0489346819848355,1.6108535936499973,0.6567373742446371
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9855630221563333,1.6625524325080163,0.5929450676255191
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5626092581223747,1.6573037637711445,0.08562959211955183
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8383420593756161,1.295128722362644,0.4768593337931079
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7098187504831213,1.255562617450744,0.3846294293737456
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1599773794024385,0.4406329166506781,-0.424385160101586
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08271742632602265,0.16884668160785538,-0.2582992830806916
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11077958671620074,0.19240535203629067,-0.2866107720750917
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12547579623313906,0.5050054591588182,-0.4030335706837918
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12060177357680421,0.1477480133365243,-0.2964475746735692
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.10234770122655697,0.19150608997763832,-0.28075336625143577
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0208077957297768,2.6423853651943845,0.32563765370000813
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1623627553001352,1.810422241563615,0.7261293095534771
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0643250991025368,2.2433824886909126,0.5038300701097255
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6838136087047338,2.00481036443663,0.12153961068413954
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9395832938202732,1.4219424626816204,0.5665023664554129
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7772535607873532,1.7132981167523358,0.3111347383490218
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09467620671075817,0.6317920696897125,-0.40611308422761894
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03193708865476628,0.25819108316071754,-0.22723337669921032
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.07550654535127031,0.45252600136511467,-0.32652029599174925
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0687175499641351,0.7151959411323909,-0.3879046159188296
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.07155586756571287,0.22853396710275012,-0.25976772340778775
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0862240179320388,0.4316601398743082,-0.33758499998614094
1,Deaths,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.39473220618787064,0.09373612228564582,-0.5739213769300088
1,Deaths,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.20655783194704644,0.6291278066200893,-0.5037383012853993
1,Deaths,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.30675004551764345,0.27961601266165353,-0.5230587971335143
1,Deaths,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6015760312925603,-0.28391176082035396,-0.7241072884703498
1,Deaths,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4188571877454985,0.18331863432051207,-0.6391753512528203
1,Deaths,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5216290770736411,-0.1301532906733465,-0.672355538581348
1,Deaths,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6361612664128692,-0.34253305779817017,-0.7438755073189105
1,Deaths,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5415662897969046,-0.05872521671417614,-0.713270732343732
1,Deaths,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5912135295631418,-0.24545294240801,-0.7187636152514711
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.41628577521614346,0.05765749218405787,-0.5901314531550585
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.22757748928679122,0.5886413697990629,-0.5159171726792855
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.32836773810192077,0.2409233648992537,-0.5393224343845145
1,Deaths,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8647776414197033,1.3853748899339213,0.5534501353028868
1,Deaths,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1075301433570177,1.5725778385834752,0.7369603533744018
1,Deaths,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0193257114120642,1.4215346416753458,0.6964165750444161
1,Deaths,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6037188231037227,1.0503242390819447,0.3445569504389362
1,Deaths,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9460505796156553,1.3770820147932015,0.5991509099757559
1,Deaths,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7917158666771389,1.15663856239787,0.5022043080177738
1,Deaths,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15550947927970285,0.08025023368458206,-0.29649847545566493
1,Deaths,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04727081889933016,0.16295844460250122,-0.21479044070099979
1,Deaths,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0863344540656047,0.09564928425450944,-0.23243815130434411
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13516627133272133,0.11591131616275364,-0.2852964954691308
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09899439396136205,0.11828287724613253,-0.25461743119641
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09739508651035797,0.0877995898878462,-0.2415126438506854
1,Deaths,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8417903187508131,1.4769420058337197,0.4928864791281602
1,Deaths,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2509043450810844,1.8052574335671085,0.8428467471401345
1,Deaths,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9683955762854892,1.5199152127653106,0.6502907026610055
1,Deaths,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5832791832153933,1.1355622671227807,0.29153376109299123
1,Deaths,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0775972350648855,1.5177561106626407,0.692075635023751
1,Deaths,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.74602914726033,1.2034591835342459,0.4725783828439872
1,Deaths,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1659196084336754,0.12171767713172954,-0.32392557046350806
1,Deaths,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.017542861811282066,0.26814348344350425,-0.16692348252718237
1,Deaths,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10937833918624283,0.14016262734040252,-0.25330829629121665
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16675205065033263,0.11859294849753826,-0.32557028011984157
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.040670349333638875,0.2060519531349922,-0.21290735869396882
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13741974116339994,0.09928782985363004,-0.2731771525617385
1,Deaths,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0147443423336957,1.6619695184876446,0.6771190387589577
1,Deaths,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2007558644686547,1.6769198952215814,0.7900360490731777
1,Deaths,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1352476524584945,1.5927056502845898,0.7933471067262312
1,Deaths,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.732256991718411,1.283772915605027,0.44195628528437847
1,Deaths,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0311253922484718,1.4633616864549235,0.6678446037280714
1,Deaths,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8937628541148096,1.263972824011981,0.6037840567893852
1,Deaths,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.08759497058302947,0.20550996262359883,-0.2404932905173606
1,Deaths,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.005127239025910214,0.21012727039060397,-0.1907970642556708
1,Deaths,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.033884330267644716,0.17309744041141997,-0.1885808940791848
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1185066853560013,0.15792684961644118,-0.26580547674493815
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.07556447025918112,0.14913833311590854,-0.24402846683503054
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.08015188797883338,0.1199981292347536,-0.2236134275804464
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.673143309348439,2.1476569364584193,1.2347729892484498
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.832130050634426,2.3458140417926674,1.3666561774582169
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7233415000517478,2.1231562948634006,1.353683613649032
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7614139344765355,1.054676906422602,0.4860806885733446
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0746780299089687,1.4100064894688416,0.7570781688206639
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.881658478249134,1.1385444358014438,0.614140835586405
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7104461385091326,1.0140699653057768,0.4299490852348708
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7642212192736276,1.084210831685502,0.47426317730765366
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7198250878162059,0.972313258904591,0.48638139119114926
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.16393063759534823,0.37302269654589154,-0.02931698400939299
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.08233619149773136,0.29727693735488553,-0.10926895906595242
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.11462061238831746,0.2851133172777991,-0.0432027396898687
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.277633317584935,1.7845941355605595,0.8808400764015103
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3060318980584578,1.7809676499051923,0.881001767166353
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.283917374087602,1.7031162944584348,0.9146118363412766
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5010076353107243,0.8148104667887478,0.24538818963285772
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6891501838735999,0.9969049522499744,0.39857546670166044
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5781681277760973,0.8703758800883719,0.32464504999859567
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4573738337853835,0.78175942525343,0.2034804249302744
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.43649844256453396,0.7323505807853709,0.17173405592115737
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4423231160618384,0.7070526110684447,0.2091019321326439
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0009427743816335755,0.20871773886424208,-0.17212539894616194
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.09435010094998839,0.10229490211186007,-0.2648693288052733
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.04984575868204947,0.11913622088131362,-0.2014369678935257
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.052404577861835,2.608959155974761,1.5485450555861269
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1435219693422765,2.792124832951376,1.5745545918544195
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.099332891087679,2.5965046851349047,1.6530560778126973
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0118837071106375,1.3511668027228951,0.6642937583057427
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3031580726081642,1.7682053255542736,0.9002474777663607
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1418590665428376,1.4567140145424258,0.8321182153984525
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.953121482530594,1.3092402980365498,0.6307202961768406
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9581968562228014,1.3622315984142792,0.6037695162022817
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.957268473852888,1.2712388386935671,0.67543894216676
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.23637866795607598,0.4570996920551641,0.025158478032411186
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.09212520896267617,0.32949183640917123,-0.11800303399948749
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.15758909444053573,0.3545952525219535,-0.014582181557687705
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2897036592312383,2.9203007837282127,1.726012046416472
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4421072096349694,3.113489630105968,1.8185145175501958
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3188755686099953,2.878745450200199,1.781568827358474
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1668364648449596,1.5495385307442677,0.8075905000189958
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5206033193252804,1.9813012399736478,1.0927949995168322
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2922880671332588,1.6599413085599382,0.9244061435148176
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1049604415495904,1.508456360671755,0.7442748998963797
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1441948179224344,1.5624196491503992,0.7557396834862636
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0959124906396343,1.4494775019513733,0.7565963918545303
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3571697000692434,0.6102760067495753,0.11785663021572512
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2514264702016295,0.5086902933438276,0.02424825898425346
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.29165714240711776,0.5071697784132088,0.08071691733959123
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4836809882832558,1.9694100517097206,1.0592667158483566
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5293273495112247,2.04073660552138,1.0551444937340224
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5054691729214698,1.9053334198788578,1.122032594233163
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6366944103961439,0.9167660157611106,0.35961389935418353
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8527500897708091,1.1840905220934357,0.5522221344061395
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7311924134294114,0.9807548216627454,0.45809681188096874
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.589216163922431,0.9000163361368992,0.31764907252268765
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5755960710551494,0.8941686807359593,0.2802129350333741
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5822359187265276,0.8347553194792379,0.3400908011927816
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.09489953609671811,0.30254554192491034,-0.09284082660769835
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.017937129426913744,0.22574475760112925,-0.18101720149010486
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.05360595612708558,0.222986500515256,-0.1113273218068409
1,Deaths,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1587064854858807,0.3930997911831894,-0.4751005099636995
1,Deaths,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5105995274568079,-0.06671688876992826,-0.7162086864654389
1,Deaths,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.34783033553572495,0.022820432960935548,-0.563126400570689
1,Deaths,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5406999615348974,-0.23576652110020418,-0.6998443760981036
1,Deaths,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6735485451399761,-0.37353800989886954,-0.8090994740052178
1,Deaths,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6108960396248353,-0.39516199566597815,-0.7363606132131751
1,Deaths,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5202529955038477,-0.20558587430649555,-0.7006764539818088
1,Deaths,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7171941918608662,-0.4606913983501905,-0.8360078580432418
1,Deaths,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6256745294426096,-0.4129323077633133,-0.749247895768332
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3438209291809148,0.092558160447443,-0.5912540929645272
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6141606132645749,-0.26130336537476945,-0.7759560706095613
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4886322452614923,-0.19505488145674799,-0.6575788576322786
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0900852378044965,2.6979672321473696,0.39540329554853193
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1010688179741575,1.6275053919326194,0.6779384358702916
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.097197720364593,1.8313052412022195,0.6343278147621131
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7412708105277662,2.0745891110688257,0.18574157148009474
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.884197663718478,1.3229969216715702,0.5425691878258394
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.805158473253885,1.373606658503207,0.45086818240274945
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06363984749787852,0.6566927983657924,-0.374858011056865
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.05937762205748083,0.1763014845936622,-0.24880783147728472
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06078477347186677,0.2679801087251501,-0.2680778002676002
1,Deaths,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.08045623505393007,0.6660222894149771,-0.3872021140925696
1,Deaths,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10740390942075638,0.15197621916481766,-0.2939655457379045
1,Deaths,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.08322830897125581,0.25298109754969156,-0.29462409222409425
1,Deaths,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.9893801097333494,2.5502300598732424,1.5262100200486286
1,Deaths,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.432340297247302,3.0535014385023613,1.9187535752965506
1,Deaths,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1302276588113958,2.570403835061229,1.7281417123256553
1,Deaths,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.965469563550692,1.2503906373316256,0.7261396274184493
1,Deaths,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.5099276832371127,1.8647019944435272,1.2075246892650333
1,Deaths,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.158469709588477,1.431007293201906,0.921394635449697
1,Deaths,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7969769488074602,1.1341152166576056,0.5185560240710655
1,Deaths,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9831319288309655,1.34202539086907,0.68639263775863
1,Deaths,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8457912734589406,1.105348543237513,0.6086945469270183
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.32420209101159775,0.5647194495771565,0.11368736926521075
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.33145558113012935,0.5735200975906791,0.11256120712729431
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.29733224688657584,0.49594178330387584,0.12078726360517753
1,Deaths,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7374026313507538,2.270280271380708,1.2486279607763726
1,Deaths,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.081292862811644,2.6572616480056857,1.6050528155225703
1,Deaths,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8102776428131824,2.269436608777195,1.409781473269216
1,Deaths,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7998057426339087,1.0849904189422255,0.5400899575659018
1,Deaths,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.252937310488802,1.5885361523061914,0.9408284951002559
1,Deaths,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9377356904104228,1.2138727502192144,0.6814819115689358
1,Deaths,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6455081814874799,0.9658317270114931,0.3516958244294611
1,Deaths,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7803043198313924,1.1130866167511748,0.5051431289889907
1,Deaths,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6571273768218496,0.9278781671425189,0.42096808894478677
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.20971786379775523,0.4478184271663393,-0.006725527714702136
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21105784349505322,0.4365576902449883,0.02665962551525006
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1658188198694425,0.352859418915172,-0.0042244250926132786
1,Deaths,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.054688767824156,2.6688696210232954,1.5291814929949936
1,Deaths,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.6845518274178213,3.4244446920156166,2.0277613323149146
1,Deaths,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3504737030255174,2.8861749123587073,1.8746008614341667
1,Deaths,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0089776102893646,1.3585090836895397,0.6951099246677415
1,Deaths,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6945280745129079,2.17937827346792,1.2363287400918839
1,Deaths,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.310786387190666,1.638406435645922,0.9917813281304463
1,Deaths,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8362353063393738,1.2054318605026377,0.5203422366611732
1,Deaths,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1288542917043658,1.5563483734755852,0.7493749602301918
1,Deaths,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9756630498071934,1.2915482585348121,0.6950566422147976
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.25386523926786975,0.5118797851911874,0.040806199886879425
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.27633802639025407,0.5462083297646622,0.060832043621075686
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.26443146283717595,0.48204958715327817,0.08172296854519617
1,Deaths,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.6737212065912717,3.3990800800538556,2.0374072647348154
1,Deaths,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.3706919735332312,4.261661512780867,2.636630924149643
1,Deaths,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.8062669427863685,3.4235469010944732,2.2081430446281893
1,Deaths,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4147062314897092,1.8013700744122272,1.0699528948004886
1,Deaths,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.1949164318516705,2.7182285686583953,1.7139849024412006
1,Deaths,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6238313646567837,2.018618204065915,1.2582759728367865
1,Deaths,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.208348246880681,1.6443761614912034,0.8258470447090871
1,Deaths,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.525291216244014,2.0400741304890926,1.1011666310706683
1,Deaths,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2444291831853689,1.6084186703777594,0.8917353883554995
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5582653950486886,0.8646833377861086,0.3001704567539571
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5796868092899503,0.9025127507419589,0.31498665198951054
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.49926876634277484,0.750289971872647,0.27144529007545287
1,Deaths,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8140568348220831,2.3906360774091753,1.3465231741630115
1,Deaths,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.251820035336528,2.839423039684624,1.7285777936125908
1,Deaths,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0275006660933785,2.5056732572909652,1.636704230944762
1,Deaths,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8503747813349036,1.1458038390905316,0.5943424335277978
1,Deaths,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3776254361622229,1.7326306147717134,1.06011367072392
1,Deaths,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0877817089500699,1.3420708933470191,0.850163423870224
1,Deaths,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.691586576208405,1.0381800404240644,0.4105426205533801
1,Deaths,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8788312289605875,1.2183355258784265,0.5765131875624152
1,Deaths,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7852165781412193,1.0671790716855056,0.5547769014404903
1,Deaths,244,South Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24718498134833092,0.49362070231181865,0.041767638087905755
1,Deaths,244,South Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2955735862160921,0.5405581133830234,0.0810035253135125
1,Deaths,244,South Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2695631723237872,0.47039225593135764,0.09942901446089965
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8770463490869214,2.1381323447609804,1.634403917897487
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6326301634028064,1.913286285081275,1.357248914086526
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7522220998808462,1.9890659995447963,1.5328877134381182
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.068665315428982,1.2589453713933807,0.8865576701767639
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8883078300802671,1.0854769235375532,0.69295586393543
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9765867301290406,1.1427241660530727,0.8224268884069709
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.351891867687897,1.565321182161022,1.1535395676453373
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2028294127990662,1.4376658772253224,0.9724066499818306
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2765227276400328,1.4724300712047953,1.09509851928437
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.45247242868321524,0.5588859713560209,0.3498899897296075
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.43699208780285503,0.5489740178454334,0.3147493228502203
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4492240848742141,0.5376149766660773,0.3558387084834065
1,Deaths,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.047082296725048,3.0073249629122007,1.30364368215236
1,Deaths,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6864516040203983,2.635741143524745,0.8381695971704654
1,Deaths,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8751745377700768,2.6263735605983314,1.1446766873981793
1,Deaths,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7953694498762839,1.3784352344397663,0.354973123608779
1,Deaths,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.708537172973398,1.3618902118979954,0.15804247143467087
1,Deaths,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7517825543791076,1.2728997371475395,0.3044169170643018
1,Deaths,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0149152026258788,1.649885760654456,0.5233086029841109
1,Deaths,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8052957058719438,1.4432183569748471,0.23525012528422198
1,Deaths,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9166616807482152,1.4174293255490429,0.4296939439086094
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2192534787538231,0.6071611486730901,-0.0809084524302226
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04872900271981396,0.43345842872876617,-0.29563125724727457
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1345011858168069,0.4435878018892767,-0.1644239432744817
1,Deaths,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.012209149471106363,0.3830286269020022,-0.3189087807908542
1,Deaths,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.18383768750345109,0.03749129375565603,-0.3798974724204576
1,Deaths,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0885799099636159,0.17478814641108503,-0.29441782055400834
1,Deaths,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.31950620313676187,-0.04550780991849335,-0.5284383314057929
1,Deaths,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5034673360127825,-0.37929704017779625,-0.6203030015432356
1,Deaths,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4069664228396112,-0.23899182595980578,-0.5408234190798533
1,Deaths,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.27544938979382866,0.014459928453382984,-0.500415438936467
1,Deaths,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.40407072956963996,-0.24246510737008195,-0.5472257892892333
1,Deaths,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3330277371203432,-0.14029642644291568,-0.48365880013258594
1,Deaths,96,Southern Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.11671505182889293,0.5573519555395965,-0.23393638969682012
1,Deaths,96,Southern Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.055705672199467614,0.1915137550506532,-0.2797564234056013
1,Deaths,96,Southern Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.04118367239213428,0.347555893082727,-0.2003530919860746
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.96144783225455,3.1076129761914273,0.1734240778616221
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0995284027471721,1.9873250677447758,0.49805222997934745
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9973490489579244,2.58093288781174,0.29925014898472113
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6599270722921137,2.3298009573974148,0.07557086387847572
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9503914768041948,1.584205282119098,0.45201089972027086
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.762150731560859,2.0379733022640107,0.23600593398063974
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08340178511679039,1.2688318077057845,-0.3518615587175499
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1064372142248322,0.5743000292897507,-0.21053664530908264
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.07743495590851833,0.931671517356344,-0.2991422667380871
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2223312126954873,0.6051282565665218,-0.5320881385077889
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.24459254967504457,0.09522372698879455,-0.473473177533801
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2493446333928229,0.34024996282735803,-0.5123917334211548
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.347301208191362,2.7897345692147257,0.5862084763931894
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6308083205969477,2.653080062968279,0.8847383987500768
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4924355059121863,2.423159949456376,0.8118836539067299
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9894774835406639,2.091487788777101,0.43159988100133184
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4478217879877593,2.1847391796752302,0.8072149645250354
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2022793235855673,1.9469448067418516,0.7340454766588115
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.296527125189068,1.0932523057147545,-0.12386092220639583
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3864181239901607,0.9251483918589438,-0.0067556596390924584
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3445006724379978,0.8465636695471902,-0.022611102562731786
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.05424899675902155,0.5294067821663196,-0.3531652102095906
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.07547697489206169,0.28492756403798924,-0.3499019630022619
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.05676135646273906,0.3037394551066338,-0.30889940435442825
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2593667315328305,3.144726524908093,0.47462958872212646
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5733003744309906,2.67328525949277,0.8278896542190615
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3316595987900326,2.8790712347042837,0.6224169942087536
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9129604916268754,2.359876755931846,0.34904290552078415
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3916699432262274,2.2005379224233894,0.7462536878374562
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0581766918594127,2.273545905393218,0.5384485113765828
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.24795669297132214,1.2893314020719715,-0.1854912975323747
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.356111826791039,0.9357963932511473,-0.03671456205202168
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.25777292573209015,1.092497025950547,-0.12481557315555492
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1125936567813924,0.6248478338698438,-0.4154482265898871
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09662497649902631,0.29886348506598276,-0.366358005701063
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1340754489806759,0.43941685443957096,-0.3961512147573125
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2536949549790477,3.33802815632476,0.4463749145575293
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4160600652083701,2.4493026444308126,0.7335445444907016
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3470012745858573,2.486676622605787,0.6972955575852867
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.908510561126665,2.4808097678099905,0.30783277540072096
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.245938847153788,1.9884716257832458,0.6401083393241551
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.071883045794793,1.946998921432573,0.6212514593158381
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24482389854156245,1.3961011713714622,-0.2010977102671107
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.27324725135949085,0.817759075766099,-0.08643379435533095
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.26604872399241797,0.8808266262246404,-0.08442364382693816
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10102062885241551,0.74603647776426,-0.4266424457655173
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12036987571525008,0.2791428737435045,-0.38623013165356557
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10103060065885462,0.3527907940668449,-0.3517418054074257
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.5347746913452456,3.8184158701074846,3.2488213292204344
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,3.296848255187701,3.5353347343101014,2.9929702723288014
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.44265318063963,3.641988966833172,3.2053649339052397
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.555774454785228,2.7778771985106485,2.327315291233515
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.529818482263159,2.7225680858881143,2.2881890165111676
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.563385367979753,2.7240971882022906,2.3733004169265017
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.4199175614755726,2.633826634016255,2.2042647470678274
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.276400875566867,2.458249817535929,2.0446900889682613
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.3692594883836353,2.520433564256532,2.1893026823300334
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3271400751302138,1.4659060247386777,1.1897929800530116
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.4797641337996035,1.603883037828777,1.3334999683707254
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.4328471627058896,1.538826327980264,1.3057480905224133
1,Deaths,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6701765936159655,-0.49362644891517093,-0.7748206737092534
1,Deaths,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5861913228804663,-0.42829432966819664,-0.6966529507568792
1,Deaths,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6380534681828817,-0.48749987147490675,-0.730771481966182
1,Deaths,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.805523803072666,-0.6828707929553774,-0.8683144496601548
1,Deaths,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7365582357449427,-0.6313059087475983,-0.8114425716210721
1,Deaths,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7793665512756048,-0.6811797615349202,-0.8405729582483678
1,Deaths,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7819008051015527,-0.6651551658499426,-0.8510978031844016
1,Deaths,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7219205338601848,-0.6158137410225213,-0.7961507571668236
1,Deaths,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7587175877845566,-0.6583548773061877,-0.8205256838841292
1,Deaths,9,Southeast Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6618673483767018,-0.47943575230421537,-0.7696824438362355
1,Deaths,9,Southeast Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5699769533926881,-0.4034396281650272,-0.6855690124623935
1,Deaths,9,Southeast Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6265560513603852,-0.4710471899450979,-0.7225030878140594
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4287288552854046,-0.3605928846386608,-0.4970223469324759
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.43498561781970757,-0.3716622377374241,-0.495488756478192
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4312240568689866,-0.3783933810858345,-0.4837261759968268
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5892536983589344,-0.5418765053935353,-0.6375948638009603
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5947262476508887,-0.5507996584564974,-0.638335034324842
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5915213310114694,-0.554798646015715,-0.6281422249916105
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.53300440921801,-0.477305468075836,-0.5888321186574957
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5272293400632886,-0.4742440760857571,-0.5778547926074088
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5295323871105081,-0.48583306715295915,-0.5729599387782914
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.342595941117716,-0.26375004451990214,-0.42096419883962566
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3495512721864564,-0.2770147564721961,-0.4182714936431069
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3454665738585073,-0.283601886960344,-0.4072449620707055
1,Deaths,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8052445239820244,1.3738174026915344,0.503299169098481
1,Deaths,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.019946972298545,1.4806191007320229,0.6514348350437857
1,Deaths,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9145970789400635,1.3270251049663297,0.6053763680297716
1,Deaths,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5516489896972916,1.00850595206488,0.3056386036593676
1,Deaths,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8644524174131194,1.2799643587915304,0.5415290976387698
1,Deaths,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6980728409335357,1.0542921445397087,0.4468294700481467
1,Deaths,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.18246988047089988,0.07501626465645135,-0.3192100388205822
1,Deaths,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.08686362999327851,0.12138761664332838,-0.2534530701771063
1,Deaths,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.13372004551413744,0.05288743213464149,-0.2736302680460508
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16715762527737876,0.08781316796101364,-0.30834582863725496
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.09767910460192303,0.10005572354545883,-0.25251759964279014
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.12692442215382332,0.06647320762169655,-0.25688937940283624
1,Deaths,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7967388601322473,1.3465710780319646,0.4795974372633046
1,Deaths,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9078218763926099,1.3855069018971755,0.5479042059500897
1,Deaths,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8424386884611338,1.284702148237038,0.53710271446892
1,Deaths,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5436768251795845,0.9969220859460455,0.2835955494266946
1,Deaths,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7600690275639969,1.1791978585239882,0.4338420200136201
1,Deaths,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6333528252845521,1.0011602256260077,0.37021560880863563
1,Deaths,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18632178878105077,0.06267738714719674,-0.3299436981131842
1,Deaths,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1375508532057251,0.0783912364519313,-0.3002550823742646
1,Deaths,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16636888213226683,0.03373795706626027,-0.3045214138384703
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23498251408157736,-0.002259333700451463,-0.36424674082144326
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.20831437026286237,-0.02378189586785487,-0.35301829354728703
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22734087004524714,-0.04371169784580387,-0.34792828251194013
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6060355292876312,3.8213642074228984,0.6621867185720954
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8217702748633642,3.0152567134965884,0.9614970685325545
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7248344111047176,3.0422798714361097,0.9684054730779674
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2082569791493156,2.9112056137030886,0.5188265053009071
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.62372573971602,2.498795618764126,0.8861568061041531
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4064464223615964,2.41725238451854,0.8436624066001227
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.43943850969654163,1.663070871997722,-0.08189449217799837
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4870537774183288,1.1160130278140872,0.03369563820979673
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.46986419079746566,1.1805370660290644,0.061821850919019004
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.030524861025021787,0.9305677624948578,-0.3367121064429516
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0018919885558856848,0.430825106561252,-0.3241517228101523
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.025847858665586976,0.5360317804615693,-0.25979890451760174
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4052163110842344,0.6181966463364479,-0.691695701567513
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.22337138880320362,0.631640297728319,-0.5530194251185383
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.31362861674647147,0.47524328145159667,-0.5926198761137748
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.49495308006551597,0.37294762178667745,-0.7390916376092428
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.27497645230844736,0.5051763642074344,-0.572049925410907
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3919500744379322,0.31703893884989326,-0.6409724439167986
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6714724196416643,-0.10619232054936853,-0.8297087377047363
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.590721994551002,-0.1401366405554202,-0.7644442716576989
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6297489808111091,-0.20420585438763628,-0.7802459284488297
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5243056880836694,0.30754722870092516,-0.7530437317886995
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.37965356785046983,0.31891947158042167,-0.645181074176425
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4513876763100802,0.18801429170827347,-0.6761046043509561
1,Deaths,44566,European Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9850404563215605,1.1103472432881993,0.8477103517072078
1,Deaths,44566,European Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.764290094128031,0.8594179344770168,0.6392624684449059
1,Deaths,44566,European Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9017438266984267,0.9989915333731958,0.7880733162775685
1,Deaths,44566,European Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5382629229104499,0.6323520551119991,0.440938034140074
1,Deaths,44566,European Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3576827534885737,0.42831443702874694,0.2629787907783277
1,Deaths,44566,European Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4686016816818424,0.5440091261339566,0.38412344463894454
1,Deaths,44566,European Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8148183297577751,0.9293797499574981,0.6892646211227753
1,Deaths,44566,European Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6310945310379968,0.7190406690677351,0.5155059001438222
1,Deaths,44566,European Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7486812810695721,0.8381019705976341,0.6441595831457941
1,Deaths,44566,European Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.20093861683968017,0.277038609927428,0.11855045404913372
1,Deaths,44566,European Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.15493307961204866,0.21256817680278017,0.09041185054379738
1,Deaths,44566,European Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.21796960099750462,0.277281365624973,0.14984213945025449
1,Deaths,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.623880061576269,0.783535376273332,0.4816857275981284
1,Deaths,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3985781745975414,0.5097501806656921,0.2921479097079202
1,Deaths,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5577725692636132,0.6912311364201513,0.4343286406935459
1,Deaths,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.25841149361163257,0.37344178457082905,0.1527892503802582
1,Deaths,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0763194956305298,0.1583921800363739,-0.0030805220191511976
1,Deaths,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.20303958694521534,0.30111272746176737,0.11303486860814095
1,Deaths,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4846283317257471,0.6305928084862847,0.35462751342029647
1,Deaths,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2929921328740462,0.3957711779448069,0.19459684993494109
1,Deaths,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4323946757666549,0.5551117814612551,0.3188861768186539
1,Deaths,44566,European Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.06505155033373781,0.14936647792272958,-0.018768870930753537
1,Deaths,44566,European Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.019150214244688765,0.048407949010553994,-0.08046426049064241
1,Deaths,44566,European Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.07049329668966325,0.14849699496949229,-0.007926116632459426
1,Deaths,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1970542701337146,1.3702592639060889,1.012206932011485
1,Deaths,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8851258739052134,1.002394267706358,0.7404307506550535
1,Deaths,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.035123203941557,1.1535145798455797,0.8919282854117954
1,Deaths,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.702644577503418,0.8359441478954599,0.559757879658678
1,Deaths,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4506977372111429,0.540694918383039,0.34113310182976264
1,Deaths,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5716490930031828,0.6623595267190463,0.45879758635390716
1,Deaths,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0086514348931503,1.1670036722506547,0.83965521299609
1,Deaths,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7428077805791289,0.8512229649239637,0.6090364552246951
1,Deaths,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8713255704798302,0.9801881733062341,0.7396557472040037
1,Deaths,44566,European Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2712749890584692,0.3639579141557081,0.17591639760144492
1,Deaths,44566,European Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.20577192001546693,0.2671981686910099,0.1325915869504814
1,Deaths,44566,European Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2521111305290418,0.3166266907650471,0.17431510290049096
1,Deaths,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9783589580831322,1.139979682039828,0.8304255014024194
1,Deaths,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5955312041180444,0.7088470701177908,0.486984117234907
1,Deaths,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8963379107048149,1.025132964062722,0.7648664894775407
1,Deaths,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5330211023871213,0.65442118058634,0.41570945561731726
1,Deaths,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.22774758464708578,0.3122307238826138,0.14883602381094754
1,Deaths,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.46435390415046846,0.5640665035119189,0.3652346144369589
1,Deaths,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8087097865113503,0.9564711338286028,0.6734619894633793
1,Deaths,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4750761395753509,0.5798371932859486,0.3747238446979633
1,Deaths,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7437104621967267,0.8621393987019829,0.6228205662663837
1,Deaths,44566,European Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19223629977486112,0.2808423253185234,0.10761829020562613
1,Deaths,44566,European Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.09201145626624012,0.15690351805053465,0.030020377024697766
1,Deaths,44566,European Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.24142803829795456,0.321425530266416,0.16091801914419693
1,Deaths,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0601416887040462,1.2830592634839266,0.8500866890556154
1,Deaths,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.742126730438719,0.8941000957300658,0.5880288299160517
1,Deaths,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8812348897523067,1.0435230913118136,0.7229811710888149
1,Deaths,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5964791350206583,0.7683276053177779,0.4410467248023942
1,Deaths,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3405070463021676,0.45423176388176745,0.2219751725755209
1,Deaths,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4527028395232511,0.5695652684088494,0.33780773105062517
1,Deaths,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8834794457975473,1.0872812874412894,0.6914371816687555
1,Deaths,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6106043965508375,0.7511044910733702,0.4681401591652146
1,Deaths,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7298230133950119,0.8790493898508976,0.5843064030075177
1,Deaths,44566,European Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2927395613387951,0.4108720635212893,0.18637271820808785
1,Deaths,44566,European Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.18814874813756347,0.27208184555326714,0.095663035554158
1,Deaths,44566,European Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.23721027509188858,0.3134180220652706,0.14983034286190897
1,Deaths,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3125318788739821,2.037700567764084,0.8701356242863592
1,Deaths,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.544898826268027,2.1057936603397676,1.0909556294721061
1,Deaths,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4604895222307752,1.990228845855982,1.0664755616754338
1,Deaths,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9885905339095761,1.555175892217326,0.6244293976497547
1,Deaths,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3488854124615053,1.8575351566429565,0.9497125120139441
1,Deaths,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1825550020687592,1.6420466589372742,0.8506875256166484
1,Deaths,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04726226183502174,0.3756650000964174,-0.153083042132147
1,Deaths,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1504458820562015,0.40400376241826397,-0.05476348660350917
1,Deaths,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.11327483718454916,0.3529610678840494,-0.06500099931972143
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.044991214297439235,0.3603282802434798,-0.15726352573602342
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07759150871370447,0.32011989370048305,-0.1207568352227833
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.08137748956633058,0.30604285984386814,-0.09593655338944898
1,Deaths,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.09574347513873127,0.8498716031416723,-0.45494031515285355
1,Deaths,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.03262335818538707,1.0235077919885236,-0.4541147175082221
1,Deaths,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05806572382246257,0.8383899661513599,-0.4190183004290617
1,Deaths,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.22403293690383136,0.6014507857655925,-0.5244267911622135
1,Deaths,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.10780934185716673,0.8447967889579403,-0.464859631046384
1,Deaths,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.16570495526199303,0.6096580718728982,-0.4655317710073709
1,Deaths,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5904948415386178,-0.16225988627069815,-0.7531621321189956
1,Deaths,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5626881263468493,-0.08525392735724739,-0.753227331147502
1,Deaths,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.573811748241316,-0.16820076990479965,-0.7371286074770061
1,Deaths,248,Eastern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.476940615310349,0.08240668404350908,-0.6843013848871514
1,Deaths,248,Eastern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.43757103503940276,0.19344795754398958,-0.6846989951613179
1,Deaths,248,Eastern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4534951071685143,0.07629439170168968,-0.6638877289241609
1,Deaths,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.227544451873302,3.6974544140179475,0.8999015653540342
1,Deaths,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0420784267163208,2.6563783513117425,0.08467409561174649
1,Deaths,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7255667347477528,3.1613013718462435,0.6043188701052261
1,Deaths,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7608054297651512,1.501332178260379,0.06018034340813845
1,Deaths,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3605495785957361,1.3006982546829178,-0.2533790002473452
1,Deaths,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6243978295414578,1.4123311626405544,0.004492210306173644
1,Deaths,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8405048368388477,1.6787199057202706,0.08341746262308852
1,Deaths,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.18003899086965122,1.1128811525899964,-0.37320834084402954
1,Deaths,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5643920686775703,1.3884599039530887,-0.07916996343343909
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.28463612686690504,0.8374334731377402,-0.25044606809426784
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1902863047832266,0.49971812934236404,-0.5802060936767467
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.08740583464758107,0.6709872341819134,-0.37413212009781827
1,Deaths,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5491331507227835,2.726186381628513,0.5214588916354332
1,Deaths,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9881190768057527,2.369005599635548,0.0645401961265656
1,Deaths,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3700421230298583,2.5135339197800275,0.3967605800773481
1,Deaths,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3911493222163406,0.9823801012169138,-0.13541348162887948
1,Deaths,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3234541129699468,1.157404866861365,-0.24907081580944
1,Deaths,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.41238501033322217,1.0322407484437108,-0.129625150793798
1,Deaths,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.45364129405822023,1.1248550285248067,-0.13238919219805265
1,Deaths,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14885794709415143,0.9468194345605356,-0.3848429510137125
1,Deaths,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.36033179904611723,1.0166611688714284,-0.1983020832118021
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.009889350451483182,0.4656851729243418,-0.3986267201711406
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18855099071254777,0.37931862234162117,-0.5663283655422017
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.04513130152863282,0.40952260389783096,-0.4415478530375315
1,Deaths,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.238817821860087,3.9759053942312965,0.8290160907738248
1,Deaths,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8219627955965739,2.357581671480201,-0.0786420248853747
1,Deaths,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6223290983198355,3.1697882561920845,0.5109648317800705
1,Deaths,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.766822915228401,1.6116356163043712,0.04226114030066719
1,Deaths,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.21430427771991556,1.1990015391065387,-0.36979337851250516
1,Deaths,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.562964316151513,1.434660725500874,-0.0720897190960145
1,Deaths,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8469334677369054,1.837506371266154,0.0429950731651311
1,Deaths,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05284258948615889,0.9402179835702907,-0.4675824782438666
1,Deaths,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5051368181794382,1.3933311163835729,-0.13275233045936027
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2614080364431869,0.8960879815135311,-0.2802459757722013
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3018149050606004,0.32638240391224954,-0.6567097337125274
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.01659321815292498,0.6192847292589705,-0.41613088512288354
1,Deaths,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.8313121751301265,4.708677997541158,1.2027704349592683
1,Deaths,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.550423826709145,3.746566228266662,0.27909489987433345
1,Deaths,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.512202715382013,4.303626667514993,1.0300997262744278
1,Deaths,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0888627478148525,2.0069180805948665,0.25380567409435895
1,Deaths,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6982656998099196,2.08917720564142,-0.1132099419769092
1,Deaths,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0918186258214904,2.0719096802672525,0.24170591870802988
1,Deaths,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1848029345262139,2.2553694064017384,0.25612821153711474
1,Deaths,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.47379234773036244,1.7428590150214875,-0.2608599967919331
1,Deaths,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.015897098201097,2.0441197377818643,0.1652152449322218
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.48494910194197094,1.2074742295704088,-0.1374784508516691
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0006272368783211779,0.8849785064688173,-0.5093263682971219
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3768544421472076,1.0934020354728355,-0.20945356755715683
1,Deaths,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.6811248937294643,4.673596280841153,1.0487568513909533
1,Deaths,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3802036767154107,3.2082243353607915,0.2814677654198819
1,Deaths,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8779611828971776,3.6293020137595624,0.6170241487146937
1,Deaths,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0075193663190387,1.9539312420922883,0.16583252035854254
1,Deaths,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5851261586661199,1.7333638518798036,-0.10761522081975201
1,Deaths,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7146676887606153,1.603213176314598,0.008257215928290436
1,Deaths,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0991587483743557,2.2353640833972817,0.16830207940380107
1,Deaths,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.37542863583939423,1.4317718326016573,-0.25948880858133094
1,Deaths,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6518618278862066,1.6570779799705764,-0.07187752152270052
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4876609046989445,1.2540819853853,-0.17766548059082546
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02043009204393142,0.7844240114986931,-0.4919879372292131
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.17432400254529656,0.9235727118051374,-0.3482800579741276
1,Deaths,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.4585351008281675,7.248721030332889,2.2183515095699913
1,Deaths,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.428715096447674,5.511656205631464,0.7222525168448679
1,Deaths,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.285717418368922,6.000780921195267,1.3856384838734763
1,Deaths,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.979567494373765,3.4209071028671874,0.7493792311322597
1,Deaths,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.284158723037356,3.1466128815448067,0.1897349183639646
1,Deaths,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5550562977646607,3.0116531770951624,0.47975860960267813
1,Deaths,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.11272560453747,3.7038270674321234,0.8352625682887741
1,Deaths,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9813232682241693,2.7628369788614844,-0.004776165591088297
1,Deaths,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.459870915070494,3.01823444938717,0.36928363386745156
1,Deaths,254,Northern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1329428041790817,2.17850058391577,0.26032127468734856
1,Deaths,254,Northern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.33352658060849943,1.601403272049311,-0.3413339496983649
1,Deaths,254,Northern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.670376226340959,1.7501824852207784,-0.0831720287787726
1,Deaths,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4447237503834234,5.8526454901064096,0.42189338733105186
1,Deaths,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1831034906503513,2.225176876988424,0.49555848923271356
1,Deaths,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.335180156819768,3.550769179695451,0.4921560583786359
1,Deaths,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3593003881271359,2.77391077595955,-0.19852497378086387
1,Deaths,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.23967629108554875,0.765928185628567,-0.13706744918160874
1,Deaths,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3107072291139883,1.5196733045441366,-0.13536435583130624
1,Deaths,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.25366690639184997,2.5140718336108066,-0.2708457616797099
1,Deaths,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.117868901124395,0.6514677141287589,-0.2341919052001579
1,Deaths,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.19659381223151617,1.3319066948279765,-0.23538888375478376
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2264027012705949,2.406787264640514,-0.29311831797007165
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.028605235083502923,0.5666750910000049,-0.30613532066136007
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.11943485082356675,1.1654930607092524,-0.28820162713049385
1,Deaths,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4341359284853352,5.954328360608464,0.33133167254079976
1,Deaths,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9616258843614726,1.9093102684964705,0.315423024832257
1,Deaths,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2902033152043042,4.023608660959258,0.37293503540859146
1,Deaths,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.353068359884729,2.8415342261843373,-0.24684857665415966
1,Deaths,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.11361342596451765,0.6120061389080007,-0.2306683334376589
1,Deaths,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2851392356168088,1.775931187919336,-0.20330396033330725
1,Deaths,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2482374168954092,2.566215332308915,-0.3172862745600834
1,Deaths,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.004460201341656526,0.48972666060151643,-0.3264311574872231
1,Deaths,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.17354676371424915,1.5741992630508825,-0.29648016099831376
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1365793194047405,2.2302750028713234,-0.38123600949840364
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10708708594275794,0.3403085211250383,-0.40692516550392416
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.03529610421264771,1.2628112920366337,-0.38174634865173024
1,Deaths,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2113032191594293,5.473015767352402,0.3377177552131597
1,Deaths,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.388915832375206,2.703929306162696,0.5853176966337575
1,Deaths,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3098423605636211,3.0860699227309714,0.516088341086827
1,Deaths,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.22997892982334378,2.5769207730001296,-0.2514714710153426
1,Deaths,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3567390107940989,1.0357423180124268,-0.08295279456260828
1,Deaths,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2967153098990853,1.2547984942420345,-0.11568005570024353
1,Deaths,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.13396765807308764,2.319395760281553,-0.3140114585377969
1,Deaths,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2232561249858058,0.8966152548677668,-0.18823026070051468
1,Deaths,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.18361021003399705,1.0937853431162692,-0.22312549528877473
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.16343180739453175,2.358730404120747,-0.30855470843918026
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0862362032332084,0.6914740612999293,-0.2852258306594833
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.11436133136264362,0.9453847038614572,-0.2706784345398909
1,Deaths,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6580485116682064,6.112611546968409,0.5179934233691736
1,Deaths,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2828049599682037,2.430452132836785,0.5322865485196095
1,Deaths,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.553008736303186,4.3554491911764,0.583673521007109
1,Deaths,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4779534980206758,2.931830693407679,-0.13994593362470695
1,Deaths,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2964607149819893,0.8560191469232769,-0.11147988725094035
1,Deaths,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.43313834159886533,1.9891435284506374,-0.08954956851617496
1,Deaths,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3630609405827171,2.647383763935022,-0.2215651691934782
1,Deaths,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.16892152983584027,0.7565799205202555,-0.2153851214396487
1,Deaths,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3082136072078532,1.7442411006991738,-0.1884934743481288
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3045617455159501,2.5126470076080363,-0.2534550295945394
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.023079109876316114,0.558692006437756,-0.31961561835363844
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.17506654835052693,1.4620761485657725,-0.26933849462231824
1,Deaths,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5963218267709627,6.074713888973941,0.4277403885223654
1,Deaths,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.151357681699143,2.2334756458337837,0.43978053325045074
1,Deaths,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3241360725821465,2.9730203681255345,0.5105642764040936
1,Deaths,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4436557150155513,2.9449634600659333,-0.19312520107111636
1,Deaths,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2214645788683572,0.7713183707483071,-0.16214417206948956
1,Deaths,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3044575989515466,1.213808683993251,-0.12592748406795629
1,Deaths,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33140717925904695,2.6279496501011095,-0.26784738941207276
1,Deaths,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.10161330320171783,0.6557171396138899,-0.2627532824449361
1,Deaths,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19093459882054592,1.035856451796543,-0.22595613839715376
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2594381113992101,2.473812310145865,-0.3177503262816393
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0010912832923007164,0.5488866914108947,-0.34595445528764013
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.10437850213847975,0.9122950663229773,-0.29134239899136083
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.20081663627399324,0.7626444925414877,-0.164242604120258
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.031807742244952315,0.43871127848913544,-0.23611649964808762
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.11312178448304219,0.518545585803525,-0.18825254867425725
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.18681721853359126,0.16579801285479778,-0.4071572119262728
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.25079344517415747,-0.011592665304323051,-0.42422318461149067
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2217570407775496,0.009018714783653937,-0.40224601284614925
1,Deaths,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5177969810170066,-0.2921879410876874,-0.6643911091363143
1,Deaths,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.600218264823698,-0.44256040366524363,-0.7040275443380655
1,Deaths,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.561051566632554,-0.40117674887202504,-0.6798955181575818
1,Deaths,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46573415519760397,-0.20300310983706019,-0.6292459440830942
1,Deaths,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5212135160039437,-0.334613820885172,-0.6437519031589956
1,Deaths,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4935238528911164,-0.3084475436827971,-0.6289733398424688
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7673288234679299,1.259847833932886,0.3926028979760921
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9364062753418285,1.4460098794972902,0.5667576289805785
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8144057794235389,1.2230962563691163,0.4886021397348759
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.14955892012309252,0.34807874113011117,0.005417002257181272
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3732062799442212,0.5660246960059873,0.18952232481541212
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22569135929478865,0.41270287004940065,0.0834436682172483
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3909581637011289,0.778590238325447,0.09603393777776141
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5130305705140651,0.9112144856096986,0.22420187303683556
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4229253841745319,0.743435856810381,0.1674178927264258
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.20482332945174123,0.011932138228482866,-0.36557049453627993
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23247543095985995,-0.033884365321161215,-0.37671249214680724
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21938414536083733,-0.04719564457443959,-0.35655086862841695
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6071975414587683,1.113215671493327,0.21219943072722944
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5458129591964417,1.0323944046333617,0.19109322856867145
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5968835289440703,1.0548236551212435,0.2525505450018441
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.04482215710307197,0.26396350071307284,-0.12092032270179937
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.09584791118391973,0.30164622471712593,-0.06699391513615661
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.07829180766225723,0.32543146643126936,-0.10473232881169085
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.26492846791564956,0.6631848872113081,-0.045950775082520774
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2078365440889502,0.5880318633078044,-0.06932729453246249
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2523362384938206,0.6114701419234111,-0.017702662956120944
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25151659861020603,-0.017164095832449367,-0.43100939739236
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.33512767650674874,-0.12764702282697624,-0.4848107152786034
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2707854288413411,-0.06670766830440317,-0.42729565533873054
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9655085791623635,1.3164187263534717,0.6830827965296667
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2497416395694771,1.7691359443453285,0.8446613308161735
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.094886098067864,1.431901470200098,0.8146618038461169
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.27971525702801686,0.463578104105371,0.13835911224221906
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5959736252830573,0.8080131552831,0.3978204720455131
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.41601261459945577,0.592577556275514,0.2674028928340902
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5469335234661274,0.8231137834605663,0.324653185604736
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7578583171169321,1.1636922948745378,0.4413447329266362
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6428886193485088,0.9071887738687097,0.42312616817444143
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19017373326254255,-0.05273124105209033,-0.2959395550565775
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19030054261358567,-0.012648843780123055,-0.33327352219166795
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2026719846146429,-0.0827844667229422,-0.3027774427738651
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3224149301867336,1.9049059641438553,0.8731047128191676
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2696361038532276,1.9216285704180383,0.80668310750799
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3086401955739952,1.7780104139418063,0.9418595869922723
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5112638349158509,0.8013561218699109,0.31694634983549924
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6090541274561939,0.8778173007166119,0.3695277389695698
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5596286970506997,0.8137575651846539,0.3822766438267942
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8278330346617817,1.2862766746944931,0.4742080008916659
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7734030574065193,1.2828439460357852,0.41167006516150106
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8105226374728536,1.1786204499166004,0.5228794628905197
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03426994043405388,0.20195901929168933,-0.20553389781172296
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.093534390796899,0.16645837023790483,-0.28008601616477474
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.050077135115051664,0.14322117176818167,-0.19682956857384232
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6783658120454485,1.2068297659776812,0.2597105851403457
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5750527661966309,1.058927961884828,0.21142192367967688
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6284897118699695,1.0015077197373652,0.3058145838076123
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0911070631978436,0.3057135005837693,-0.0718354114455993
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.11672980184758742,0.3334379986965825,-0.05969538829147482
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.09998144225260397,0.2764837094217718,-0.043877536189302374
1,Deaths,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3209407309730648,0.736862907527296,-0.008557604541618363
1,Deaths,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2306833621511418,0.6087641258382316,-0.05344326360709194
1,Deaths,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.27712299815483177,0.5696577762998666,0.02406900341525967
1,Deaths,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.21767914650349335,0.025589981164359576,-0.39933147215043746
1,Deaths,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3139826097382713,-0.1001628771315866,-0.4738858020951632
1,Deaths,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.26691540490052096,-0.09627750725488528,-0.4028723683061306
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.9954917773334415,2.8529238575147966,1.0924595202882892
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2894441511706334,2.3453643201062517,0.5013228810539896
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6900237974653338,2.526350118148597,0.8966132200313573
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7111302649462111,1.167455530014668,0.1982747071344537
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5194349009662897,1.115926960719921,0.02900995626131933
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6403765525870201,1.1042855092144903,0.18688126041329817
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4887868355916361,0.9149384288116041,0.03997153702312738
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.14713202415731028,0.6762036069344182,-0.24775821477167462
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.34219589554344376,0.7594835626688088,-0.05367882553376296
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.26804442130409,0.6229578631731784,-0.1296103441000261
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.08183826165922602,0.37529093709435124,-0.41500024064403257
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.10878390134057943,0.47191659666316027,-0.23738586520399926
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8044039831830718,2.4420507781132677,1.0130257489356718
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3456645073642963,2.1973770477394745,0.6535736723261354
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.649558637555867,2.3126058641099605,0.9421313624402702
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6030350146735923,0.9329520000245196,0.14850231055315463
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5572316578735165,1.0329054347176474,0.1355892528972204
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6164886016501424,0.9669817309371846,0.21452069571400648
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.39381445258394426,0.7107307470076751,0.0004922254836888904
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.17530138175718937,0.6020541941990961,-0.17147255465532463
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.32200567581595674,0.6528351899901095,-0.030967404180698817
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.13918665993922108,0.3996477982896166,-0.1860059253745666
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.08084481799945037,0.26546331885797986,-0.3565026051096116
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.05820562247665397,0.3227214786216561,-0.2322941728184738
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9786453776116926,3.0227644046501996,0.941952221319536
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1308933573723448,2.3460530104537884,0.292820421155818
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.594031677928279,2.5899450401249,0.706311559744226
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7009355897448989,1.2986381907456357,0.1205959131556933
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.41417682360705305,1.129353739658054,-0.11994430847957849
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5815866182357665,1.1482208802721432,0.05912147025152883
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4804140207094082,0.9993507355447444,-0.034831968384790205
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.06768973117602627,0.6765486770476083,-0.35222892166464287
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.29430032340443796,0.7912144504529343,-0.14863044179573093
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.23490361087368908,0.6353283215219047,-0.19355282431675144
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1766757847736019,0.2973406970858058,-0.5035449443813701
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.03739690710646706,0.4405216726211433,-0.32640301870158994
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2414821954450304,3.16032338925461,1.2486824582101337
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6239602243058568,2.8975837788049734,0.7156198530083002
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.077451977583774,2.992765069459331,1.1637150473629312
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8506417959313886,1.35236455023532,0.30165372969326737
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.739886109220904,1.4585483810248836,0.17265046465296446
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8756113429949882,1.3833198732762524,0.3475250370998424
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6110463253146342,1.067718810178121,0.11761576731460036
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.31474218398258896,0.9528946216998204,-0.14038415234563356
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5355044133576006,0.9922027801936601,0.07959247737232654
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3332673050358935,0.7180283791610015,-0.07183647437705282
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.01487930642673256,0.5003614443077579,-0.3362285939937446
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.22963986686063945,0.593586196756775,-0.13828004466534635
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.2883367957775262,3.3747096526788227,1.1356575007981375
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.499033503249933,2.602258441969431,0.6495149000952621
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8020658407026078,2.7913702357560624,0.9019290828445584
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8785321556151835,1.4638841888098635,0.26681103124075495
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6583075401377322,1.3244300017868458,0.11712868730201179
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7084414467173369,1.2471055927310888,0.1901853520130619
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6343334906107525,1.1742707457009671,0.061441328792830346
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2521473212413674,0.8049210835570044,-0.17350621317563153
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3980996279576611,0.8917161899133506,-0.051026458942852786
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.38052114143805227,0.8286094056759892,-0.10864368520916348
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0029230380406204725,0.4856436473767724,-0.34929600336727573
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1513953679728249,0.5856780957648315,-0.22945769593320084
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7655530247410423,2.626320406398154,1.1130655807463894
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4989321566845468,2.2214197754679788,0.9649031234504262
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6299016134339206,2.1897879981491677,1.145107517561262
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7082073007552763,1.0435026729945744,0.4310878289269795
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6322433418314938,0.8953467600591382,0.3712117673072298
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6655355706482957,0.9172875418910942,0.45638532596195014
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1868641099939625,1.8675168681075707,0.6709089427169914
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9503204491580673,1.5141942515770757,0.5335313253819095
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.066118159759076,1.5059792636699485,0.6852514839450649
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.20558205374796668,0.5772734953666706,-0.06400113566502752
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.05353201070469649,0.34977459718819826,-0.1633197367988533
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.12478647115139976,0.36281313672634347,-0.0743328494392198
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8006204615372824,-0.7455687643800563,-0.8445256236824924
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8234788547910906,-0.7556271910247581,-0.8715415852898841
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8110444060100663,-0.7555710903895156,-0.8538976017945533
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8765319314325138,-0.8341018101967271,-0.9064631936327939
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8844377604952888,-0.8371934593166581,-0.9163614395685015
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8801191624254482,-0.8433815322551478,-0.907837213361258
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8423404096646799,-0.7988082193105761,-0.8770584651421428
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8622320344756779,-0.8092764202150459,-0.8997431473257907
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8515516389904396,-0.8079703794481813,-0.8852182087061143
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7493753441644869,-0.6784803811654755,-0.8046842977433206
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7747210141818961,-0.6860429166331391,-0.8364058072270835
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.760694684801571,-0.6881576874387398,-0.8152934114434539
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1843147264830176,1.8072264196150616,0.7980135317459663
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.24314583461783,1.8391502188969453,0.6739091575517232
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1987897934142668,1.7458320416719535,0.8038551233727896
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3995945684459897,0.7918214448617936,0.15737611591170905
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5937839432124504,0.9587753207828514,0.21220410697160053
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.475910626957176,0.8322676568119487,0.21093116572595916
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.28433211702675326,0.6505913762174468,0.05719496264541482
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.291461805127797,0.6346035153574039,-0.036268748616603536
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2795052478343501,0.5978364632735215,0.04968747062648845
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.037525063952403064,0.2357658761279347,-0.20686602510901111
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07321197291272545,0.18553448927208133,-0.31766881165034033
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0626300281204127,0.1729538982065237,-0.23640430709945415
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7324602750318054,2.2503889729348874,1.1392460597776206
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5395889985123992,2.2890344879496083,0.8103246545597292
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.637658848511139,2.208941405510153,0.9932974359965389
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7511114373499373,1.0698857174340417,0.3627847679518778
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8046765960818532,1.3108525869611016,0.29076481533110515
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7706850912236172,1.1497340847675415,0.3589007452726573
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6066304215114593,0.9111618395263925,0.2578326682891087
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4621350701704548,0.893618484978556,0.042270685286667595
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5348890324919074,0.8673260084437733,0.1599264911504
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.14180756605001,0.35326278587786475,-0.11432817939860215
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.012791044887601341,0.2847420700523495,-0.3036140782870332
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05938116471665222,0.29173410852680415,-0.2005021367103211
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0860780807005934,2.822523164837511,1.567083717328569
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1572055465725635,2.894412768211566,1.3711380000936775
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.101605813319493,2.7559700308035056,1.5734439816682564
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9765009661897556,1.4385053211118766,0.641879972247812
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2427147317385894,1.735965990254581,0.7137376050314279
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0812144421928316,1.501550851481522,0.7290745557200043
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8145504155794356,1.2475649727382487,0.509392408194771
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8177197003469733,1.2421570929221937,0.36515161633697807
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8048659888917882,1.1856492964974321,0.4975215409015144
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.31369681197126786,0.6244002505875764,0.08806088525164006
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.251874371967511,0.5601935422709073,-0.06543728429662127
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2763413965511513,0.5485895501842918,0.05803458680734208
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5065237404650653,2.035951537057437,1.0259595424459091
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.45260053906259,2.1137282183598125,0.7945922867696344
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4775268824513086,2.0054481442116505,0.9523367792947175
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6060872322414391,0.9525351835290161,0.3003892905109676
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7426506232790189,1.1888117689714706,0.30566905667476457
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6629670556649309,1.0019913415120196,0.32620504677389894
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4737843878169445,0.7850770392679095,0.1912225269614017
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4120526051195477,0.7926881986455544,0.033212980793463395
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4417060954356882,0.7489105525824566,0.1360909360820181
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1167082361544374,0.35014870356277017,-0.10611694734851071
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.028579673949667785,0.32427109097152806,-0.25841855121874074
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.06732596021280127,0.30288251977501296,-0.16330822441047282
1,Deaths,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.42754909740939384,0.6839339932513031,0.21688912922389247
1,Deaths,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.0832232144234441,0.26865722842796036,-0.06061391268692553
1,Deaths,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.2142182286197697,0.4117127512623546,0.056755893272858286
1,Deaths,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.12797811617381077,0.3204430956304105,-0.03764979344702924
1,Deaths,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.21108125883242848,-0.07788011331200204,-0.3168928523707972
1,Deaths,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0768996525786983,0.0665702200923425,-0.19332720926278235
1,Deaths,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5570913779410345,0.8367418022060956,0.3273151686784318
1,Deaths,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.16994745528422522,0.37022755445399563,0.014594543162840194
1,Deaths,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3177507467981817,0.5320849978962258,0.14686210000867703
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0005531516150331704,0.1675090936954168,-0.14288912934927622
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.26963573171935323,-0.14938851601817574,-0.3575510251919748
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.16795106450364652,-0.04599845214659908,-0.2726730390707584
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9425402285578425,2.2168922222176826,0.47746086986684994
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.173177627086964,1.8766358308931252,0.6469319125986659
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0713947263236376,1.8228524635093315,0.6537042453573014
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5276440213928646,1.4817598162817445,0.21341044390360722
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8605934259179531,1.4077280625341795,0.4443473736313057
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6921321426163827,1.2733472656569216,0.37796972089793296
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.12148737852363152,0.454837525421804,-0.3318192319347207
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.009786431216297702,0.31074597708702084,-0.24957154611235316
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.059661833015505,0.2814727572060557,-0.2492781800339473
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10975988331593867,0.4815468216134295,-0.3134031927884493
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.05909857413239671,0.27572048770346647,-0.2990704095006143
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07564671868615577,0.27815939765916464,-0.2723714962800656
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.024137631560092316,0.6656923265025084,-0.3248700117133828
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.12454716018664004,0.4264353208359816,-0.4357745611544701
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.07909598118621497,0.4644320456893973,-0.3687308971366785
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.23433961589429875,0.2861447593723573,-0.457025941558654
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.25098991978863583,0.19965152384533344,-0.5014641677587388
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.24878977846656275,0.17198531370949208,-0.4578125472166581
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.558666845147011,-0.24669167164935396,-0.6946728787762012
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6010978255949424,-0.35004134403064074,-0.7429093331194019
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5819429363147315,-0.33520090206999476,-0.7134266957828985
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4620104316294173,-0.07077566831156588,-0.6276758465273586
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5104128042263967,-0.190432576515431,-0.6855774540704692
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.488379431624479,-0.1759850491441324,-0.6502473062281143
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.294666811421224,3.0013211256419168,1.7070787524458424
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.264289432858167,3.1326659279262103,1.3953866157815928
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.279001238095307,2.9161252242091726,1.5951641680921043
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1111055636115412,1.5730962289643664,0.7295525575705661
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3191693325753262,1.8959008534759014,0.7179803177390145
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2008833447301366,1.6414047741175115,0.7546679627212014
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9371962975424722,1.3526944949338564,0.591706608454227
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8793718439340067,1.3793282259684312,0.3791124389036038
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9080947639308136,1.2788457498574768,0.5101608084642859
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.42493973002285246,0.7281234312245135,0.17077402857957824
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3065003700965007,0.6739461204958794,-0.06005416082417795
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.35858588737498626,0.6497692144049293,0.061802473279828414
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.39821940852522875,-0.04640086237685513,-0.5489390659164972
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2794875407861051,0.16069719628224768,-0.4935138033099826
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.342933861008695,0.02259999231139353,-0.5092274132491177
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6146172724466744,-0.3995594237527793,-0.7081229392410547
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.48794916617163103,-0.1838790078946324,-0.6438672238217112
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5591416804712986,-0.3226264166447062,-0.6654041911608575
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6461653938126237,-0.4393033273229913,-0.7347854513107257
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5851743980114528,-0.33174380676286724,-0.7083972126310535
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6176444080595062,-0.4049353601164015,-0.7144128546886143
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48204004046242827,-0.17637230565019255,-0.6109434654508624
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.37376062343621613,0.011187216980701783,-0.55964908030285
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4317919556224063,-0.11349621000083607,-0.5759881193044627
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5611882203244432,1.535669812956384,0.21742239487284076
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7861116010610929,1.2777884062476932,0.4330759387072854
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6474820187652746,1.3324469611121939,0.34444965383009885
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22684263112975986,0.9627314707450538,-0.010788483615865695
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5291439445957022,0.8818510148914784,0.25437432148829275
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.34535850418297326,0.8672984937014545,0.13882181159813006
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.29395358927856835,0.14675511056602827,-0.44942147202902505
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.18615398912262796,0.03787971980369303,-0.34701553065979046
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2521028454990834,0.05884642464717621,-0.38966856146759843
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.28255177433810985,0.18645047219986438,-0.43761903163783517
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19211091384836856,0.058295014324516274,-0.3737683888172163
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.24902330228094566,0.07877353392829424,-0.3886404725793955
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5025925698246014,1.5397580727123679,0.14970723950182138
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6748370223917908,1.2134438799946166,0.2905301281270025
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5458022470029222,1.3636867246642628,0.21780874930269603
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1803078803831057,0.9704844442611479,-0.07249599413452022
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.43318693866289576,0.8421228042383059,0.12833000190773075
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2617417132560554,0.8959053088081118,0.021601955621417052
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32045343611363086,0.14860402352170587,-0.4800456093231281
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23685651628177706,0.008560982955586202,-0.41196686922067616
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29826177840710794,0.07302814560179045,-0.447158944403888
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.33919075943482685,0.12193005519882943,-0.49299272641287184
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2757518535277071,-0.031646141175744824,-0.4532567907066874
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32983892913067986,0.03021823008408797,-0.4712956403143428
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6223617806633538,1.445696421409392,0.301409334777167
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8785699687658101,1.4356852652533239,0.4934040536400568
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7714364446534606,1.3127739961201699,0.4667906094967852
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2757900238931199,0.9155931781043051,0.05759830976472561
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.608863175055632,1.0313559812191475,0.29778812290257
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4473132635336158,0.8488456862786898,0.21366336397844926
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2662878843071579,0.10606469967567059,-0.41143843020553317
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14402511336592047,0.10982580019164737,-0.3195268812088717
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19583202654407547,0.049915611217626145,-0.3341301995432526
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2390177913589485,0.16150105461450212,-0.38970519068151727
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.18121744106874216,0.07265936010420719,-0.3638114616072847
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19800883426574337,0.05313076012268179,-0.33596333748796525
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6608935498574056,1.766109620137087,0.28308972906259744
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9555466935406637,1.6130502173258034,0.5002308640751443
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.730544564184401,1.62052016008462,0.37662086819239377
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.30562265107769154,1.1307786689769503,0.034779293820430185
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6740312391804458,1.1817263831930065,0.3072997034741633
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4134755975631922,1.1063985643983865,0.16196444022101905
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.24886191543035424,0.25097137137887354,-0.4197234606023906
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10895048513372867,0.19064256361667076,-0.3164162287522664
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2143954589194535,0.1896212211823913,-0.3750639955880679
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2347641960478949,0.2795526120922902,-0.41013962466469367
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13539966810977008,0.1612503367739428,-0.34580781482224093
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.22395859176891428,0.17959027387900262,-0.3831049198400381
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4584767020916458,2.0626732219219455,0.9500645996878929
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3353204154814238,1.831814506464125,0.9321876247649432
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3980131236446176,1.844071911894005,1.0257393126312828
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6402456249886291,0.8933472679778542,0.39993465107515774
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5585281752152392,0.7845376291253666,0.34051849560963887
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6005820132913037,0.8127348910932625,0.4153292717833945
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9939239311854983,1.4839517191257454,0.5815811755983837
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9152251606009018,1.3224061062373198,0.5846109721901502
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9557537802560228,1.319547102625032,0.6521374630637801
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.20779081146811604,0.5074236160043475,-0.02671398374503166
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.17741139032184933,0.43633274095495167,-0.026803649404955693
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.19582896498587435,0.4063986111824057,0.010068631654159952
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7904476115927824,-0.7321520934014164,-0.8315814829075264
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8143594271219229,-0.7515624113964847,-0.8624674704938278
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8011515227415366,-0.7505129663532059,-0.8427199496877344
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8598869364939733,-0.8187479039180059,-0.8890312116800053
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8758844814989964,-0.8333969751659545,-0.9085016156707512
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.867098944328231,-0.8324840204777174,-0.8947651188671619
1,Deaths,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8300445468013826,-0.7827645263302793,-0.8634057783017635
1,Deaths,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8477538698126933,-0.7962532604184934,-0.8872078712774808
1,Deaths,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8378246318746887,-0.7965252131573026,-0.871726701608053
1,Deaths,44634,High-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7282866955968029,-0.6534084504594463,-0.7827165260929083
1,Deaths,44634,High-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7543265891412892,-0.6656374886899374,-0.8199458865117926
1,Deaths,44634,High-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.739622410810406,-0.6707250032087513,-0.7953545062572955
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.442153336521645,10.440887808223307,1.1343742092814502
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8819414379388,3.3098285096472106,0.8042259429194687
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5062553208636653,4.871490337879539,1.1197403233100371
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8244536737811595,3.7036591061457353,-0.12615593481301302
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.13428842302845434,0.6481103542752179,-0.27914116949740647
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4123138158449469,1.3724408929283862,-0.14775831351499422
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.880728600227008,6.419395555342241,0.3841379084582675
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8928618000047805,1.8306993483938971,0.18501726682288955
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2887003164251545,2.8326021822284346,0.38365575371271815
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3199766206606631,4.9067886562501215,0.09826488193127117
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.389939738674371,1.0842995341280843,-0.13464850614251944
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7268414305039504,1.8941078493381973,0.03472248058347756
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3422346323819606,2.5026687638304326,-0.27720554593450086
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.06853071805865572,0.5556351663899786,-0.2912588533588414
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2034989561347477,0.9779982260506462,-0.22739998533023134
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4496491321650231,0.45335118888166354,-0.7030469170378526
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5798226804794218,-0.39873673807590093,-0.715205763937974
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5158249710008785,-0.2139307182141351,-0.6837983020984725
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.12956320937232912,1.2714745126265967,-0.5312690719626613
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.29818803681469647,0.021742615044143432,-0.5344981598487556
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.21441874887637669,0.2911339168350703,-0.49568706890141073
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.22977447249507912,2.2003423476688813,-0.3372964646558304
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.01080661818793458,0.4372126401725943,-0.3414573216507845
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1081636864548405,0.8203058386361473,-0.2865396876774171
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.31499320277614,3.679385675781268,2.9665468308290968
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.326469891014556,2.5582697044726457,2.089716859670217
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.6962641463847903,2.9322908744062914,2.468249823827254
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2018573500692713,1.393300651651255,1.0230353001173977
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4931963624860617,0.611253571994782,0.38655650292438315
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7857954630867569,0.9000610681226752,0.6725429388718056
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9277772511485602,2.175022134933725,1.6913519978305553
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.204821681988058,1.3584612071717064,1.047899108242713
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4782826795390118,1.6365346141406178,1.3254029274699235
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5609434688214454,0.685299319592699,0.439239495958104
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.09978757349566814,0.16539090077236454,0.034910602955852965
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.26943309751718103,0.34024376492804603,0.20514007343337975
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4547195961834913,-0.2718963780808285,-0.603850243310726
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6120294733747297,-0.5119650619800473,-0.7055360997433235
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5278989181907094,-0.39979187002848676,-0.6450120109540729
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7217259959180568,-0.6348758526618509,-0.7965023621028028
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8258146017939844,-0.7848255329414366,-0.8663721851836
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7718816181889641,-0.7114860260815132,-0.8265633928558646
1,Deaths,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6300203762165937,-0.5059725194092239,-0.7312073991364144
1,Deaths,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.74284876848387,-0.6765249504224715,-0.8048260128244619
1,Deaths,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.683464198524897,-0.5975705864847978,-0.7619865491600827
1,Deaths,134,Tropical Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.45622845675831825,-0.27364070565256504,-0.6062278439086437
1,Deaths,134,Tropical Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6104205809132992,-0.5090656528689286,-0.7052124071139398
1,Deaths,134,Tropical Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5275426619974721,-0.3999103142412462,-0.644820654694951
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7237349053195214,1.7962446068335756,0.34984557531767224
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9191750933730701,1.479627869781928,0.4810563229599865
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8371389042465796,1.4916186452705475,0.47639130461348916
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.35519157487548436,1.1623418119124767,0.08530521720906223
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6433145529919583,1.0532381537614994,0.28579130283670967
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5006899171567902,0.9860038704246656,0.23615818282916987
1,Deaths,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22044195114207976,0.26459990054480087,-0.38953317026489864
1,Deaths,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12552329149590585,0.12984835274766957,-0.3251531541424294
1,Deaths,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1660054900394582,0.1311046030692814,-0.329771831757002
1,Deaths,44578,World Bank Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22925581519615992,0.25512385618625555,-0.3983731620264382
1,Deaths,44578,World Bank Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.168072500717394,0.09033149801175051,-0.36729859871216713
1,Deaths,44578,World Bank Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.18919402939732705,0.10613054534080393,-0.3546452771964504
1,Deaths,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9642072810474527,1.3118845905487018,0.6949917696508782
1,Deaths,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.4924768022863459,0.724993782853798,0.29095201133947024
1,Deaths,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.6683197575062368,0.9203250494003467,0.4636028813981143
1,Deaths,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5520877709489896,0.8140293247218974,0.3423549687394479
1,Deaths,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.08694594607109019,0.24789853172468534,-0.05701573542153163
1,Deaths,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2683435531803657,0.45174737451584207,0.1173872028992202
1,Deaths,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1424483594702457,1.5216754851169625,0.848803011394784
1,Deaths,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6119664106672954,0.8630989991338885,0.39430728630069395
1,Deaths,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8105720656582516,1.0840650455553158,0.5883996340350514
1,Deaths,42,Central Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2773585247747734,0.4716165284343229,0.10323414383725511
1,Deaths,42,Central Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0666402966452772,0.05319147077415949,-0.17958537574623956
1,Deaths,42,Central Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.059703713292836524,0.19739043541925214,-0.0561838049084284
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.5999540991723427,0.9293320413004559,0.30836868184162564
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8794350107380516,1.4151240497814437,0.4824350008955141
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.7333786681468648,1.0768933710059254,0.4187341769910787
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.005593443937326196,0.21183107766814258,-0.17295264056656853
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.050162865235250216,0.3536461799527114,-0.17283517161611603
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.03131709612387242,0.2350310311926324,-0.1556715427202138
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5035344446460515,0.8130627502095882,0.22952113467671093
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7484042670193093,1.2467460539434223,0.3790823658896597
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6205943155309973,0.9417578241080812,0.3264225438630411
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.3283640256202873,-0.21211844330690208,-0.4378840778548988
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.32120932982358524,-0.1687055998681146,-0.4404940210595992
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.32432812896213986,-0.21336403843459537,-0.4298977678233403
1,Deaths,100,High-income North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.2745966517774385,3.4379948613206452,3.1159215540767393
1,Deaths,100,High-income North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.542954356665641,2.649459982287583,2.416644047411317
1,Deaths,100,High-income North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.994728779943172,3.104486642782153,2.867146161020953
1,Deaths,100,High-income North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6165403207037303,1.7194455676698546,1.5167568693908948
1,Deaths,100,High-income North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2088486161931449,1.2782988296491902,1.1351504899867118
1,Deaths,100,High-income North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4667307584598468,1.5332572838433647,1.3982343530869068
1,Deaths,100,High-income North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.23125231482536,2.3547682593309673,2.1113066641550597
1,Deaths,100,High-income North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.7080683277212778,1.7894762383053593,1.6115226447906525
1,Deaths,100,High-income North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.036821657020241,2.120260376707848,1.9398324290787512
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1020573175652084,1.1812583627092714,1.0253000791607902
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.014172387921715,1.0742470420789132,0.9471465740408274
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1268321860222377,1.185344648688062,1.0637214832969126
1,Deaths,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.424778766316075,2.627406674199328,2.195791115745155
1,Deaths,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9599028722875464,2.0900630394251114,1.7989351805504536
1,Deaths,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.28014890498008,2.4441612633244927,2.0848189138788924
1,Deaths,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.096379828988926,1.2191655939646135,0.9583964876610855
1,Deaths,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.845275232088746,0.9278441274438292,0.751042177716831
1,Deaths,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0254477389891161,1.1283976384438843,0.9047107250940887
1,Deaths,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.5888581351463962,1.7420285860060611,1.4157618324423613
1,Deaths,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2624110882187125,1.361899422154766,1.1393749257687193
1,Deaths,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4935928774209468,1.6182762562625892,1.3451016080712144
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7762233851542947,0.869243642023601,0.6785787937041521
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7397656624090841,0.8091170782760277,0.6662856528396816
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8087225380891256,0.8812320842725139,0.7233025361120788
1,Deaths,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.7065985307617995,3.9681409877074993,3.4740988870810563
1,Deaths,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.671488985584176,2.804404704956353,2.505080111238331
1,Deaths,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.179606793956779,3.3245742883426614,3.0179878443927115
1,Deaths,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.880980723929847,2.028531810219742,1.7408794083757597
1,Deaths,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.288995700631415,1.3687227209135853,1.1855817624998266
1,Deaths,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5808949802693126,1.6706217075519534,1.48948228053566
1,Deaths,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.5578110957331854,2.755516221684542,2.3820600078435046
1,Deaths,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.806314176396922,1.907908725367301,1.6791190288726832
1,Deaths,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.1773672579337116,2.2875725937065337,2.0545033657252345
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2525353084355202,1.3712641611759648,1.1453273775617856
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0707268818239721,1.1436278336263217,0.9872295208413259
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1971191256404108,1.2710183520603906,1.1178038992773367
1,Deaths,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.245829744542985,3.4535058228300985,2.99372075308639
1,Deaths,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5967210049808958,2.8113269161985066,2.393859187508359
1,Deaths,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.126211832121464,3.307285809625935,2.9030893596087486
1,Deaths,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5988834027279997,1.7279188495915732,1.4544433619794919
1,Deaths,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.242443517722212,1.3756425378894543,1.1219750703823033
1,Deaths,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5479227766316068,1.6705262942612968,1.419496129916088
1,Deaths,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.2095068395995137,2.3664933025024086,2.0189326571456756
1,Deaths,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7491650348003094,1.9131997393447753,1.594106965320021
1,Deaths,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.136776022480777,2.274429767378125,1.9671567081241859
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0936555363008367,1.1904192467655517,0.9817151969844272
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0580381831495438,1.1682342558315575,0.954836314955935
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2016173715792202,1.2919531260463593,1.091923358375115
1,Deaths,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7683131085683277,2.987981215336228,2.570500431311384
1,Deaths,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.092005629642053,2.2426395963026096,1.9353867960774567
1,Deaths,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.4294272292404258,2.587739980066499,2.2738820991730626
1,Deaths,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3068056370784467,1.4304479703987816,1.1886497689784181
1,Deaths,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9277040609422654,1.028213543829393,0.8363356411806946
1,Deaths,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.117734187235148,1.2190206740382672,1.02864589332264
1,Deaths,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.8485425519586889,2.0145940268251925,1.6990120293484352
1,Deaths,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3633842471089304,1.478521794231153,1.2436721481079995
1,Deaths,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.60707533718482,1.7274258332447598,1.488828806405499
1,Deaths,100,High-income North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9001616900794153,0.9952232033824412,0.8166121397960909
1,Deaths,100,High-income North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7785921984372728,0.8594105225085744,0.6961395535386068
1,Deaths,100,High-income North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.857745401915913,0.9323963186919498,0.7888945811950594
1,Deaths,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8378918262997574,1.2846788954425126,0.5151815385945315
1,Deaths,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9659495783455705,1.3971212028191775,0.6118150918942761
1,Deaths,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9100428167063477,1.2984173428524415,0.6193390783037122
1,Deaths,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2711494043884766,0.5550709622461746,0.05142091352357112
1,Deaths,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4604179440981513,0.7584393550710588,0.21291068830428464
1,Deaths,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3653637693474647,0.6311819044552062,0.14664986253856088
1,Deaths,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3120586011568649,0.6310168818161986,0.0816778994166998
1,Deaths,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4407188715731802,0.7566970142012124,0.18119632667932078
1,Deaths,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3817991763730518,0.6627643964503386,0.1714927985369726
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.00013490945826860975,0.23293174958898877,-0.17023706127721616
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2495765585471904,0.5237906312851616,0.03503116705754635
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.14437264222311796,0.3760728153800855,-0.030686872530845247
1,Deaths,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6580158358744862,-0.5313180285157872,-0.7706752219955254
1,Deaths,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6295333348760553,-0.4549268169817173,-0.7536908398155321
1,Deaths,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6456028057942655,-0.5079950455498569,-0.752850614435803
1,Deaths,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7634686086272863,-0.6743562057276945,-0.8354776737534872
1,Deaths,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.724741229143352,-0.5898570723589963,-0.81335860970385
1,Deaths,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7466606935091135,-0.6497623064013514,-0.8215592708408505
1,Deaths,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7558598076451005,-0.6654110959669063,-0.836286584915643
1,Deaths,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7285086445696062,-0.6005506805399535,-0.8194957494190993
1,Deaths,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7436153018250943,-0.6440645021754042,-0.8212025330392283
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6843842639064325,-0.5669976336979038,-0.7877880114921824
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6443439241651401,-0.47787170113638616,-0.762199379043186
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.666593500646833,-0.5384468104060303,-0.7663516465729638
1,Deaths,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9612656102566557,2.235112567623395,1.6943957292259286
1,Deaths,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7480626678136804,2.0556042198189717,1.4454439654895597
1,Deaths,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.852739507180806,2.1033140790433222,1.611067850572622
1,Deaths,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.059168434270118,1.2566181402310819,0.8643540502063836
1,Deaths,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.950257113421369,1.1673605452514764,0.7394447909824494
1,Deaths,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0031987241411295,1.1796612641538735,0.834986614403424
1,Deaths,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3518884099096309,1.5693824039941442,1.1399357306308058
1,Deaths,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2357907868572466,1.4860029005046638,0.9895838445951757
1,Deaths,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.293392113070553,1.494835583600894,1.099105929623806
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.43400819466933016,0.5433088412796938,0.32725330309234874
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.45360353244923246,0.5844142253280413,0.3192795388103438
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.44824310658106054,0.5468582304766137,0.3473256546465509
1,Deaths,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4079778108518192,-0.33290285356044297,-0.4762321233505204
1,Deaths,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.412449352692348,-0.340611543942379,-0.4797079805804018
1,Deaths,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.40976294053710693,-0.34940200132937055,-0.46473731613890806
1,Deaths,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5883240525441887,-0.5350880487681955,-0.6350910042806154
1,Deaths,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5829896213321855,-0.5334443269442314,-0.6312637874243453
1,Deaths,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5855195189403034,-0.5421457154420052,-0.6224797685026713
1,Deaths,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5298057289274201,-0.4701798982297312,-0.5840144854591006
1,Deaths,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5219758488595249,-0.4635294703135166,-0.5766966608446497
1,Deaths,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5254929468299471,-0.4769672046203628,-0.5696882892749168
1,Deaths,44635,High SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.32284353907085417,-0.23645462990030733,-0.40155794390793464
1,Deaths,44635,High SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.32695163386335485,-0.24584657111067396,-0.4043853936075854
1,Deaths,44635,High SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.32454113595108597,-0.2546110211440206,-0.3883037165337871
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.19821225873137097,0.479900239802446,-0.09764195379159517
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08000222690105119,0.23236224256854152,-0.36254891547418616
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.04941675366264936,0.33047070208671314,-0.2297015826951947
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8932263722787417,2.489958571823048,1.4336590165910243
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.022028266303298,2.771982601988355,1.3012010852255853
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9241574541688262,2.467127323650735,1.469623374241074
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9563004079186601,1.3592381083547813,0.6509234905239107
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2595851812965126,1.7778795168709154,0.7376262810862525
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0687466881284065,1.4750747508799926,0.7495039185593317
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7713325525724822,1.136672499819161,0.4899696336425844
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8034993467599466,1.251060400238208,0.37332092497082436
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7678022020088727,1.0960551589507601,0.493013186718736
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.1517002781261,5.893567916379669,2.438449146301843
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5848009682097146,4.512698007607279,1.2102462754028709
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.2728085430732485,4.891417871358303,1.86973064379836
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.931094987313326,2.8256001937142754,0.9495044008687202
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.388586440303586,2.5825753905666335,0.4887110653052679
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.60155080954986,2.52072856920051,0.7662337841711646
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7678281049851174,2.7036725726442326,0.8473582838476132
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9795360015091519,2.044125536753652,0.2205034848968353
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3263268901340783,2.207577329289748,0.5624223497990389
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9092889528312795,1.5400869683533112,0.26141358560891426
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.32357152289420865,1.048741075060356,-0.18702490487644885
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5758109777411747,1.1842319141319884,0.04093551460523212
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.31458736036236123,0.03599664226126908,-0.5047161830262767
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.47715005850257597,-0.030846955435805644,-0.6611047015979176
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.39784670967900937,-0.023325179356546155,-0.5673255629364835
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6102307119198035,-0.41596440872191554,-0.708972809396361
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6514618589565401,-0.35884259691233966,-0.7719535329610785
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6333908544806275,-0.4085272650474711,-0.7324189791342517
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6317517974490647,-0.44339529314310794,-0.7339013540083479
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7112809632223472,-0.46483128081581165,-0.8128611741967524
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6721581654934398,-0.4682502444760729,-0.7644307795521954
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4299931240171366,-0.14305779918972503,-0.5875931602362652
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.559812782478184,-0.18420042039272508,-0.7147955263197323
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4962632100453621,-0.18371117032529313,-0.6364867485824575
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3010622940419342,0.5636985481565621,0.09036346155612739
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19430185726997676,0.49696262687480564,-0.09724039729421045
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2363313654497968,0.469319020579541,0.03963883144618279
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5495097136275129,2.1202319156746405,1.0411605152530994
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3518867902359741,2.104036383026126,0.6871108341317098
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4363337231333735,2.035085925543402,0.8970699438089267
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7246736369424612,1.1063070528041088,0.3947179944579026
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7586697147146215,1.2629794994988224,0.28338365094532825
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7239504162665249,1.1076437123107203,0.3540750635606492
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.560897409244643,0.9103131427137456,0.2496685708162433
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.40356936337743454,0.8524405120653106,0.006841438644172236
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4728878961163445,0.834864116093518,0.14687545954447118
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19249463311871534,0.45055810415247854,-0.048709636200805484
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.008917891042274638,0.32687325495271913,-0.30024108291832446
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07895667870716944,0.3619285869118483,-0.16800713140754217
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.320353112594707,7.6659706724280055,0.6173742502925129
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7719238901223413,3.1578241974126384,0.6795559165827971
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9404019764302147,3.812329011871447,0.8053010070835886
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3636625669870385,2.592478949264027,-0.32437415157367794
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.09096973129458624,0.6086432241606998,-0.32876215103395856
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1843084151583023,0.926498721421425,-0.2700667064651987
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1532431345096454,4.61986668932499,0.04886434733851029
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8206021729178002,1.7308627756318204,0.10313387830162474
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9193408117852929,2.141236996254785,0.17840619351619633
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.733913845595038,3.5522914612431467,-0.16924176054185963
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.29456945332952195,0.9368878623895612,-0.21245883286585796
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4234142411527235,1.33934973162872,-0.12569375883016862
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1281327989710044,6.85840834878336,0.5595326224891084
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4558345386595866,2.636016756036103,0.5475048989520057
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9064790840768808,4.628495748443623,0.6160271757893407
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2846780706509851,2.2442812938192387,-0.35760436807014495
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.033333547781363056,0.3846131043901946,-0.37731164896169544
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.17068318432680057,1.2956676256550004,-0.3451379014202258
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0285886003115956,4.096163947444734,0.011354153773821967
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6129943947389142,1.3881391658674602,0.016402647876674364
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8971977196946745,2.673988007606779,0.054858123586296735
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5522941646580807,2.9066137778055636,-0.23214903910932264
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.13975332917546546,0.679158547616316,-0.2829659547701871
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3728097791168366,1.6464127749412298,-0.24424138107463453
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.1167418904203545,7.176186256746625,0.5312065682748792
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3880874196240693,2.5726646080570585,0.477758637188848
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6396200693887808,3.2594664483053295,0.6179203677746682
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2798504304236822,2.370844254926049,-0.3666124556169373
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.060297551036614015,0.3741558922782472,-0.4054027765335822
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.06302512892091255,0.7309833019042169,-0.3384822875531632
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0212016162166007,4.302242360016349,-0.007015242400693317
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5684980243427067,1.3465294165230917,-0.02940676131070907
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7230060948796464,1.7803571947628287,0.0560939004192301
1,Deaths,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.592554845827913,3.0949734524973738,-0.22539861824658705
1,Deaths,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1957673378342347,0.7802494331303291,-0.25584928142401264
1,Deaths,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3316535812676855,1.1697536096357022,-0.17968779715131278
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8052570185792751,2.048741955884939,1.5708771578463292
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5187554119462339,1.7665933249051706,1.2637674859000398
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6565292394342752,1.883939481893665,1.4621240854844169
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0049211468463317,1.1843031962260893,0.8413593229039551
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.786933343236822,0.9628662718768901,0.6121932260726856
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8918113031226949,1.0544400257904951,0.7524469663676626
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3952979030336359,1.6032000509957824,1.195170219470695
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.193655322076767,1.409504369664393,0.9715791258794013
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2912864359942864,1.4874303354171068,1.1236097977248936
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.48138813036528977,0.5774055815030166,0.38339431919768846
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4431383959891701,0.5483144508276278,0.32534638414760225
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4710987068922659,0.5604788747549551,0.3880089977995939
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1048936062348447,3.0125297339410024,1.129071519799818
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2134463838954015,2.264277526038634,0.4295709759175097
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7302883432539902,2.6276266235250043,0.8660906693188767
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7654918360765961,1.2499975062033564,0.21872390807221237
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.47484019497373536,1.1180867574911058,-0.02593483673501886
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6618366865309143,1.1594132701853328,0.16751510701165853
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.668150575998054,1.155791674613896,0.14387555018414433
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.22227059275746266,0.8025421603637275,-0.21058735515947916
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.48650311070643143,0.9750581559179048,0.015991439752742562
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.18621746621979293,0.5366845702135136,-0.2016043787939548
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1596534521854512,0.2729439340662387,-0.47732631592153957
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0368796071923596,0.39898084820692903,-0.3067110187779033
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7175265265130268,2.339814076375818,0.9896087696429803
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1815391444881158,1.9367319704686257,0.5352276560666419
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5536168859623716,2.1585883677624826,0.8752377312141909
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5459507496960728,0.8493389588162412,0.13102745568345664
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.45337177161354875,0.8952686843903273,0.04884020377788491
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5547201295063147,0.875567558280702,0.15625873264051224
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.46003181280982314,0.7943651157788904,0.0689470996448942
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2046513358794311,0.6216706907521353,-0.1522434738645583
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3903144896452395,0.7196906860482781,0.020971549635570432
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.024911042314293922,0.25499870527727725,-0.2566671044654785
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1697291056807901,0.12788339036526827,-0.420424967727952
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.03383408614757156,0.19560095502228056,-0.29261068878037566
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1891929950306506,3.527657237828605,0.9444261322581776
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0391335991899957,2.298120086937435,0.1994449467023582
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.654837018383541,2.889865303571226,0.6577591311428077
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8126366750572732,1.544445794014854,0.13311993871666647
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.35880945207945586,1.1169235341795312,-0.18785743918427386
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6155469881039329,1.3288722986379546,0.02749089993301617
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7134416847476782,1.4325516384970345,0.044672051241555
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1260146399423203,0.821230106577907,-0.3376635202675362
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.445423702590446,1.1178337768882767,-0.097434484773564
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.17429043772809827,0.6329700325147934,-0.2733456065489201
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.26185860974199676,0.19226219336425776,-0.570736849448583
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.03521488831988345,0.408203454577989,-0.3995116737168335
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.510920750415118,3.5908941185292047,1.371273690453504
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5361291693622778,2.800375262786857,0.5846914421625045
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2765259312234694,3.365435515510835,1.257259644026498
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9958257795165996,1.5715116007082148,0.36911740935446247
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6892818312719449,1.4611861153894001,0.07274452521723962
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9937424831715642,1.5887941435643411,0.39270877903447365
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.886294738192552,1.4665265994274823,0.27400229258607556
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4004568286359695,1.0985766625945925,-0.12492944828377192
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7839016897640827,1.3767575646099095,0.22896304736753226
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3034482695604809,0.6954593587107728,-0.1305434384468423
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06887720671894464,0.39887285623892704,-0.42388042848275653
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.21020329744781516,0.6044694275263742,-0.16829346963413852
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.3254771287402076,3.3954459985796106,1.190141541660383
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4007690974284934,2.4914236948024437,0.5664051389966662
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7609808316128996,2.74448326752397,0.8598161642004218
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8912694010537793,1.4344100597821006,0.2644413230478964
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5994633726315509,1.2641721547208888,0.06175485042235577
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6805976193931969,1.2179918310740443,0.16061632420088698
1,Deaths,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7866623760108129,1.3615191707616667,0.176686333760865
1,Deaths,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3257106605959599,0.9279728391267361,-0.13502719032643973
1,Deaths,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5032136092636856,1.0386806539739704,0.012575290905397569
1,Deaths,138,North Africa and Middle East,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2742952061842224,0.6767313720194416,-0.16289996063738277
1,Deaths,138,North Africa and Middle East,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.07186557496936254,0.3787005039028607,-0.40813785996619445
1,Deaths,138,North Africa and Middle East,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.061490818893475956,0.443517830398142,-0.28540059074701446
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.342200917060184,3.0470555956330125,1.7032804161265453
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2335982068430575,3.191763412452013,1.321585613306749
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.283729940329892,3.0567801347418566,1.5796692073616758
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2608087907728451,1.7340597306799397,0.8374433340335171
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4177828477092456,2.100479598699937,0.7552157099356597
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3235100501988903,1.8343631912694973,0.8263287492028404
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.046210188856921,1.4777464312165918,0.6550411145482644
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9297609882581718,1.5015790422691977,0.3854860934731558
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.985182094432623,1.4525303331523138,0.5595415009978304
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.516663869363678,0.8348435079218361,0.22238201382898734
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2800215337030045,0.6926218081455194,-0.09228650556371502
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.38694496888278523,0.7193933129345021,0.0790853457199859
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37721385731618035,0.00285806379037188,-0.5488456770790893
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.331406306920436,0.07401893999839412,-0.5455442380095995
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.35533796608067053,0.014171461432285174,-0.5203050873717678
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5789810252567464,-0.3224840932397487,-0.6886812583350577
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4999125694813491,-0.1998672141121044,-0.6574308395209157
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5440349456032141,-0.28716697446822503,-0.6588397449442336
1,Deaths,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6187089339442047,-0.38601585032470614,-0.7237878286743973
1,Deaths,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6009937093699588,-0.3590422438158253,-0.7287878875853231
1,Deaths,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6102689472178093,-0.38688166734025775,-0.7099999790956258
1,Deaths,44636,Low-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.43765066320995966,-0.09047408759370289,-0.5930594924716133
1,Deaths,44636,Low-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.39293389161511455,-0.020615895105828064,-0.5875485596771716
1,Deaths,44636,Low-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.41634833936634896,-0.07936804919044649,-0.5656446252191475
1,Deaths,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6553504130035191,1.5709000756756093,0.339610073634991
1,Deaths,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9512523009190625,1.4862897088053608,0.555843552453944
1,Deaths,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7708362222447089,1.4308706173572807,0.4804674823560546
1,Deaths,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.25741201759654414,0.9308439200802017,0.033194427072896625
1,Deaths,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6421067385543957,1.0378092905984682,0.3370031588854511
1,Deaths,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.40878894246883624,0.9094421511966262,0.19978875353889605
1,Deaths,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.25291976953836515,0.16027918073530334,-0.39541731184028805
1,Deaths,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.12981935501280767,0.10878597371248307,-0.30615587469859734
1,Deaths,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.20553511795759524,0.09058156481069872,-0.335805644269747
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2378645625330471,0.20027644852520063,-0.3837849706761693
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13034426014575232,0.15301408094271307,-0.3378289578245649
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1979462282585823,0.11661779748656657,-0.34111329447999994
1,Deaths,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5801313197248202,1.564771491306658,0.25395105365935455
1,Deaths,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8369701277446884,1.41238587222966,0.399054705338212
1,Deaths,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6466425637658341,1.4317806762144623,0.3297885694135328
1,Deaths,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.19994723561128444,0.9235513677828716,-0.022798627511208244
1,Deaths,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5454014726641142,0.9695739682332009,0.20279045120690303
1,Deaths,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.309531101839585,0.9120601029310289,0.09153256928180327
1,Deaths,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28686708190215904,0.1575132743829121,-0.43407629297311257
1,Deaths,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18078464285209764,0.07582781235724423,-0.37607744252747494
1,Deaths,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.26125314483913403,0.09098985203316454,-0.4034059696377336
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30342841950872024,0.14200503660804056,-0.4462843027781205
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2271453085731021,0.03213013458212013,-0.42191205474235277
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29371785503393405,0.04919085083446254,-0.429970005080757
1,Deaths,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.730666477949212,1.5158650906796307,0.414620801717461
1,Deaths,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0256918728630449,1.6286969029403204,0.5901177108976365
1,Deaths,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9045362801778443,1.4627032902707986,0.5814879378562755
1,Deaths,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.31523546560641824,0.8994284167510193,0.09020239527749177
1,Deaths,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7052519124157375,1.1870534535241781,0.3519792203926022
1,Deaths,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5157673424123379,0.9414520937268539,0.2572360698517095
1,Deaths,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2189286926551321,0.13544120748730273,-0.36156403728117653
1,Deaths,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09662227706636702,0.1722938983334085,-0.29087096803282275
1,Deaths,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14555215656308026,0.10486291980764738,-0.29048400285836956
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1991639807607351,0.17218542924358377,-0.3464025463172432
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12737572783392648,0.15692335197227225,-0.33215865908615827
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14723320087590855,0.10508225164892467,-0.30207642708863786
1,Deaths,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8190058943923333,1.8531343522245975,0.44568922967064023
1,Deaths,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.245267250603562,1.9676483869754078,0.7253367418324875
1,Deaths,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9210581001684073,1.7958325418298395,0.5647018620287462
1,Deaths,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.38205567106792665,1.1381508275848462,0.12651205160075027
1,Deaths,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8898938620375744,1.4278597759493035,0.4716888382617079
1,Deaths,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.528656710969138,1.1748198486405041,0.2788573963966653
1,Deaths,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.17906001525804424,0.28765502014190675,-0.34754246932008986
1,Deaths,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0012995773937413365,0.32345273148793896,-0.23056867729471062
1,Deaths,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13813983598535373,0.2543174476855818,-0.29801487871506976
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16029516045136052,0.31516232578039444,-0.32990907203548864
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03045891559110167,0.29203155662302993,-0.26828943819107204
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.14314416343439418,0.24517288265063764,-0.3038731022998675
1,Deaths,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7525665451083694,1.7837900049666564,0.38765888123415826
1,Deaths,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.078249127779608,1.7125908211204242,0.6022408798906216
1,Deaths,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9419403695793919,1.5669410398675583,0.5847375159244332
1,Deaths,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.331408859078548,1.0981476329482605,0.08179534842692296
1,Deaths,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7487377653279451,1.2334933324638289,0.38009750997368
1,Deaths,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5449122726604319,1.0124695184859935,0.2806536202574233
1,Deaths,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.20904491995548843,0.25635905372674966,-0.373732287344803
1,Deaths,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.07318383911525699,0.20970723734552918,-0.28546451853952276
1,Deaths,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1287712509654777,0.15162796244540272,-0.2890261178071286
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.21930757029040354,0.25387167482431455,-0.381829064164823
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12142762969593535,0.15731562458699752,-0.3394938514247471
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.15527771081549108,0.1257911575347557,-0.3201346235551477
1,Deaths,104,Caribbean,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0563872870884214,1.4508705198354248,0.6747707903957685
1,Deaths,104,Caribbean,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6173632879112217,0.8460591643356064,0.39388383405740646
1,Deaths,104,Caribbean,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8466216251748355,1.1193607826287886,0.572283594288704
1,Deaths,104,Caribbean,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.10334369183064454,0.3362329380411229,-0.0994659740879634
1,Deaths,104,Caribbean,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.07155020747169995,0.06294087023143231,-0.18080043003957935
1,Deaths,104,Caribbean,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.021525441524674446,0.1847229108207888,-0.12133688617385976
1,Deaths,104,Caribbean,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5265833549271948,0.8194326351627775,0.24328584794762437
1,Deaths,104,Caribbean,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2047802254117429,0.3751366763147074,0.0383095080402526
1,Deaths,104,Caribbean,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3732343485449713,0.5760559629477188,0.1692237369561692
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.029479805617994525,0.2248566330286785,-0.1600881659783292
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2473100842042377,-0.14347723129476828,-0.35224650470261176
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.10873518150378281,0.022153354312521356,-0.24187180263029012
1,Deaths,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8160095062138782,1.1877246450671712,0.4711344672828352
1,Deaths,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3951677351017466,0.6480214883199344,0.1823059699444361
1,Deaths,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6632624510616218,0.9336220434838095,0.3992475638295991
1,Deaths,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.026213129163275447,0.1968453409916967,-0.2089220148468612
1,Deaths,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.19981065474367882,-0.08269696623304229,-0.30668701766121675
1,Deaths,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0805592314122635,0.07739369532411225,-0.22360684864498737
1,Deaths,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.34813607435828253,0.6240831915724374,0.0921140218647425
1,Deaths,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.03926589093899293,0.2276176385490404,-0.11929566868374852
1,Deaths,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.23687987690855072,0.43793193527899094,0.04054603854579809
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07129884407936028,0.11757273553110335,-0.24696487129328587
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.31338815503843526,-0.19426359169430288,-0.4121243574563871
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16601411980761638,-0.03471146497524621,-0.29639675455281894
1,Deaths,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0895679877512885,1.526620094116522,0.6854696967872206
1,Deaths,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.63760529910263,0.8913967162756029,0.4201847584204732
1,Deaths,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7987369023535296,1.061502221131458,0.5473756483259472
1,Deaths,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.12205600116420641,0.37484363321180214,-0.09107963496182529
1,Deaths,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.059295313792333236,0.0848775912637602,-0.1870748444317162
1,Deaths,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.004184775632220639,0.14890936011277586,-0.14689448113423767
1,Deaths,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5512154393865768,0.8756662249959808,0.2512283072867112
1,Deaths,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2198585785487596,0.4089087956982433,0.05790116924556856
1,Deaths,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3376250254154719,0.5330296261376462,0.1507010214840587
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0016718015494460467,0.21050830194302184,-0.1888144157328619
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2762897473529911,-0.1686360405134208,-0.37144360880638905
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17609654706603056,-0.05686517046699685,-0.2962988584051999
1,Deaths,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.177199265654743,1.6281039271964153,0.7547874377646459
1,Deaths,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.687138058331367,0.9440712776338549,0.4485436363223193
1,Deaths,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0190008520952567,1.3576695183839738,0.6909704001530785
1,Deaths,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.16828412540518384,0.414393450949271,-0.05561026926100542
1,Deaths,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.03169730884497743,0.10936425763758638,-0.1659773303400449
1,Deaths,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.11684234550316822,0.3119495016883715,-0.06054072803225498
1,Deaths,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6162695520327509,0.9510039453498775,0.3026871498120016
1,Deaths,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.25675572421473775,0.4481462820323233,0.07902580807370396
1,Deaths,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5014236170749239,0.7532735028248245,0.2574848058779721
1,Deaths,104,Caribbean,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0787673715338854,0.2936810311894803,-0.13084863516644626
1,Deaths,104,Caribbean,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.21120135712002405,-0.08990205663243485,-0.32367071047680257
1,Deaths,104,Caribbean,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.02777315538335953,0.1284015330498169,-0.1868663247193008
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9832855526650698,1.1075066162073792,0.8473079491324917
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7655045495449796,0.8596333686154773,0.6389364252227205
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.901218148749937,0.999243251544428,0.7865765485188402
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5402132366831958,0.6345321857587971,0.44205658685993166
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.36159123901792645,0.4313317586821434,0.26726095580263926
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4713816099023788,0.5467784128634421,0.3867030379058103
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8218198004368407,0.9359276216170003,0.6969125775718744
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6395439551046082,0.7269571177316572,0.5220058818127717
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7562661977336255,0.8468177079222552,0.6503650587862925
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9050301172780688,2.438435389370085,0.42822228795671263
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1741601945754985,2.1396417780868977,0.5692779988750436
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0495732664266757,2.011099103544773,0.5673682828950493
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.31205555463118906,1.3384456767830475,-0.013722020444368108
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6314017485110861,1.2473879967052353,0.21107837737662768
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.46743611566531146,1.0896421303632722,0.17596356633204596
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.24265481602085615,0.3669508208529687,-0.4322098839144996
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.11669279086375874,0.27555836207872303,-0.3624413817327459
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.17622589150871515,0.21023508660710688,-0.37003598208984795
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.021477290679924134,0.7940738129877815,-0.2634769992573352
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.014611155688382994,0.4717369113276275,-0.27934482469292427
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.006119726902669339,0.4889403442127697,-0.23561094418276174
1,Deaths,32,Central Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4874531129396443,0.796656974977444,0.23963145256825488
1,Deaths,32,Central Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6966969415943806,1.0313894835238098,0.414217740332562
1,Deaths,32,Central Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5683400063126409,0.8720544310633247,0.3247517006652687
1,Deaths,32,Central Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.029134135874057523,0.22172044195837687,-0.12842031321832323
1,Deaths,32,Central Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2607513399794727,0.4895259578433918,0.053128947599358184
1,Deaths,32,Central Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.12141920849341398,0.3143692270966836,-0.05022908473176499
1,Deaths,32,Central Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.06188276302378257,0.2826213184122133,-0.1150354518517351
1,Deaths,32,Central Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.24340081252370913,0.48867559812544276,0.03638984918694573
1,Deaths,32,Central Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.13459808860865421,0.3543169023977521,-0.041623154796799865
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19841058454054225,-0.030070611669263076,-0.3255246551919257
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.06653949486066316,0.2807534074517056,-0.10721219706427534
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.07518051038095407,0.09822901667576991,-0.2173358699981073
1,Deaths,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.29617181817933697,0.5583422026064853,0.07134836154199624
1,Deaths,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4160422899759175,0.7092015540163105,0.16188449669635835
1,Deaths,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.32822981205806484,0.5848192208521721,0.11352157284161442
1,Deaths,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.10359648400769365,0.07622624258746251,-0.24854056602107746
1,Deaths,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.051536453530458354,0.2529074677049306,-0.1222668971966854
1,Deaths,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.050747348728489176,0.11764341011191334,-0.2000238565318296
1,Deaths,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07467166550097341,0.11249000687491607,-0.23517161756655788
1,Deaths,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.03772694507803788,0.25256464423965,-0.14852906736934132
1,Deaths,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.03910695389498662,0.1465197926033646,-0.194435235289953
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.314588098613957,-0.17276501858753826,-0.4318762343675802
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16375501448587013,0.0023945325364271705,-0.31412911507775365
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25153291014821194,-0.10935639316566723,-0.37337987371502845
1,Deaths,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6209940446340708,0.9733125401459288,0.3327052260357321
1,Deaths,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8016289819171785,1.1723794497995839,0.4951147567180679
1,Deaths,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7160029401121694,1.0500396411562951,0.45195674874607517
1,Deaths,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.12176552040360923,0.35434535499163844,-0.07430080665162064
1,Deaths,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3390907104865481,0.6002707674553859,0.11482766065665274
1,Deaths,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.22733721653861508,0.44208765962991586,0.027810637645316272
1,Deaths,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.15721673509379955,0.40873453704934426,-0.048590711594094185
1,Deaths,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3202988023760027,0.5919981387202601,0.09567410522501002
1,Deaths,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.24142319143899663,0.4830783178811735,0.05040191874142122
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1369265628136042,0.04339868389190092,-0.2871715871508748
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.13866903203935596,0.36883505951243317,-0.047393916958666404
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.016254925875841358,0.21553981653003798,-0.14971904593102464
1,Deaths,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6062027437662162,0.9591836334704493,0.3227883518019671
1,Deaths,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7953837064900426,1.180778967463068,0.49402763093862884
1,Deaths,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6508012342980241,0.9970531413351175,0.36927003667808644
1,Deaths,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.11157828229990636,0.36213635132058897,-0.06987344475201443
1,Deaths,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.33411042453383755,0.5977713424920003,0.11199773053564081
1,Deaths,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1805706078078789,0.4221092984072116,-0.003989086516935336
1,Deaths,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.14665732498692652,0.398648005696828,-0.05567030134405155
1,Deaths,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.31572203893041034,0.5981536086993414,0.09487742018106823
1,Deaths,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19425374444855598,0.4447458254514761,-0.009416861043612373
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16049532811088946,0.02934124998113599,-0.3073274736955728
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.101370402111341,0.33969847220848776,-0.0961074286235425
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05471101241867039,0.1472504265654239,-0.2123309947839619
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.20356202901986498,0.27929138192604,0.12107806556506917
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.15977901960052218,0.21783547530341826,0.09582742079069138
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.22168885882938946,0.28169360871445803,0.15415227914700347
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6223591153232404,0.7821201984381341,0.48113264956001967
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.401228379560437,0.5117180764528451,0.2941785763628107
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5576181542816295,0.692332986808164,0.43385173054955734
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2599402255737733,0.375996267020922,0.15482161506205247
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.08072085390956453,0.1636908092804809,-0.0003518509097202759
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.20553105590792298,0.30447011051417966,0.11534329482375981
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.49027756277626305,0.6370319744981842,0.3605488046922765
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3012572071940781,0.40386397458415785,0.20184491297312013
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.43886282336392374,0.5633067788643842,0.324532552238577
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.06795529271560795,0.15347499412577315,-0.016219259171883302
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.01352621593080964,0.05386950875666187,-0.07648096666583808
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.07432307779332539,0.15266463678855277,-0.0041308019521015555
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.194175115140531,1.3668444123173737,1.0094861333761531
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8849908500106362,1.0023397981635795,0.7402522712524909
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0338448971108394,1.1531967065129964,0.8912258370817376
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7040728718324338,0.8381001576418591,0.561032094858408
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4537669609923752,0.5438330784888711,0.3440826718816831
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5740673113000975,0.6653319035166031,0.46132238607189513
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0155401550811716,1.1741518810132103,0.8458873063278863
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7505054599598513,0.8594821027170846,0.6160933102236648
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8787812679872589,0.9890335021294494,0.7470357160913121
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.27323033820254694,0.366701986514249,0.17766532151604417
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.20973055696154497,0.2722905931207429,0.13626569188860532
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.25531178115339775,0.31981599300564495,0.17738076649825063
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9768365233787092,1.1371188273870068,0.8269698392734891
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5975477169782744,0.7120892995030715,0.490553722220108
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8957204456912771,1.0239056047799797,0.763791370405203
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5351422554042431,0.656105400402986,0.4189250605833943
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.23199354715820017,0.3167021054434274,0.15247614138710988
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4670557958952529,0.5667304690733956,0.3683166780815246
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8158958076806277,0.9631290060012453,0.6782302596399956
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.48357006671999325,0.5899396364189483,0.3842095992641282
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7511876484606539,0.8695997634021303,0.6293170595566236
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19495633090101971,0.28181889359793916,0.10981813188466757
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.09746948477192575,0.1631897437155575,0.037416904131372976
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.24527587800209705,0.32466809327456075,0.16419461071733216
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.057747062622454,1.2828146489850005,0.8474209360456917
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7436843853981135,0.8962441090773632,0.5906792774637712
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8812575108142203,1.0449671154870523,0.7206911996713533
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5980596533721687,0.7724920574641274,0.4422015746482799
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3446413611615906,0.4603591046401812,0.2261226835530576
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4558724827987962,0.5745606949638786,0.3401600833722569
1,Deaths,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8902191557533262,1.0969632550691422,0.6970163658515708
1,Deaths,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6192805588785225,0.7609558509729045,0.4771916586383446
1,Deaths,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7378273911638753,0.889055510420092,0.589502915647794
1,Deaths,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2954877741278907,0.41482297977606036,0.18767200280433732
1,Deaths,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19349626394796468,0.2782607286508407,0.10126125007549486
1,Deaths,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24143606260977107,0.3196131429768522,0.15194547811086723
1,Deaths,44638,North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.2745048603422293,3.437763623621846,3.1158358052664745
1,Deaths,44638,North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.542426288313714,2.648934742001187,2.4161300696654258
1,Deaths,44638,North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.994445937218246,3.1041216695580918,2.8669400131833562
1,Deaths,44638,North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6163120576658925,1.7191399584290763,1.5164561929872415
1,Deaths,44638,North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2083577905144733,1.277920510364877,1.134611966458259
1,Deaths,44638,North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4663852035569886,1.532760014415085,1.3978948501950352
1,Deaths,44638,North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.2311093037323686,2.354517026072963,2.111170953719912
1,Deaths,44638,North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.7076504230487515,1.789060066105135,1.611116019219204
1,Deaths,44638,North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.036564850764522,2.119939986900922,1.9396352607102358
1,Deaths,44638,North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1019986146535965,1.1811719026978782,1.0251709995678544
1,Deaths,44638,North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.013841635314276,1.0738475203514553,0.946939477741834
1,Deaths,44638,North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1266751714708674,1.1850688233301225,1.0636618797586062
1,Deaths,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.424314409478639,2.6268331058153294,2.195655858368803
1,Deaths,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.959055178696338,2.08907791231381,1.7982926525130838
1,Deaths,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.2795520219037315,2.4435505921942076,2.0844125803303357
1,Deaths,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0959577500213766,1.218540897279754,0.9581260826578637
1,Deaths,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8446117811596373,0.9271700636884487,0.7504896626930877
1,Deaths,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0249388705634976,1.1277015221304048,0.904254724487004
1,Deaths,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.5884481381746278,1.7415325456774098,1.4156045466925997
1,Deaths,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.261751227641128,1.3611339899153134,1.1388725319103328
1,Deaths,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.493104814156486,1.6177759955785795,1.344760443349389
1,Deaths,44638,North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7759595512619089,0.8688292983917182,0.6783098120978851
1,Deaths,44638,North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7392449324614513,0.8084956289203389,0.6658434513959597
1,Deaths,44638,North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.808389490821477,0.8808767979865577,0.7229539957582325
1,Deaths,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.7067069472472216,3.96827626604862,3.4740581478052146
1,Deaths,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.6711464372707785,2.804046472799009,2.5047181834123964
1,Deaths,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.1794552905302655,3.3243435805053374,3.017980047964896
1,Deaths,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8808578638069662,2.02835562077746,1.7407615739476272
1,Deaths,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2886147445098042,1.3682428169259762,1.1852575823412437
1,Deaths,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.580622780775565,1.6702968600590902,1.4892204597067458
1,Deaths,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.5578119815202958,2.7555329076072645,2.381952150980981
1,Deaths,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.8060375558814898,1.907619581344752,1.6788282661769975
1,Deaths,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.1772083613188853,2.28735196960416,2.054455405452332
1,Deaths,44638,North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2525646344640702,1.371266983503747,1.14540164224822
1,Deaths,44638,North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0704997896632151,1.143407975435237,0.9869259948473881
1,Deaths,44638,North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1970168760485644,1.2707913726770788,1.1177109323848968
1,Deaths,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.2456036879155326,3.453236790765358,2.993538549186448
1,Deaths,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5954137626989353,2.8100089664229326,2.392449524316355
1,Deaths,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.1257528537851775,3.3066655136579772,2.9025001673392214
1,Deaths,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5985739071418743,1.7276809468856025,1.454150274036541
1,Deaths,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2414642274918166,1.3744621792540912,1.1210277987304191
1,Deaths,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5474626278677037,1.6698882254168608,1.4191162590389188
1,Deaths,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.209262832581282,2.3662132332242174,2.0187261408464328
1,Deaths,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7481513525695012,1.9121770081108362,1.5930158151743206
1,Deaths,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.136383943018181,2.2739131605022544,1.9666679746071392
1,Deaths,44638,North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0935408179994297,1.190381289453888,0.981595560614807
1,Deaths,44638,North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0572675033630874,1.1676229706147627,0.9540481254383353
1,Deaths,44638,North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2013897649444862,1.2916305919222024,1.0917708962809771
1,Deaths,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7687257680940762,2.988247337227651,2.5709976790106897
1,Deaths,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0919438501449332,2.242571691203287,1.9353992205690878
1,Deaths,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.429580946327603,2.5880779584731304,2.2739494825053086
1,Deaths,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3069067105749819,1.4305003859652825,1.1888142817238372
1,Deaths,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9275245643468376,1.028064600370135,0.8361954272473453
1,Deaths,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1176824824280198,1.2188509358106656,1.0285930074547969
1,Deaths,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.848789576889094,2.0147265000116064,1.6993264018266583
1,Deaths,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3633245669800977,1.4784568250344279,1.2436698168176556
1,Deaths,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6071563160828795,1.7276452308402235,1.488845781870237
1,Deaths,44638,North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9003517196731926,0.9953891539632964,0.8168442109884044
1,Deaths,44638,North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7785525850695375,0.859405504038355,0.6962185086056254
1,Deaths,44638,North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8578262442495566,0.9324804995357014,0.7890073475849946
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2117530289914997,1.0665627431806262,-0.18408189679815107
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.010462925193457612,0.5265100260266526,-0.2997746578290346
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.10597118864577112,0.6596483148721737,-0.2220578803319638
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.16740748121281598,0.37398834078792326,-0.4136246969700075
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.24211090000273627,0.10855341738722811,-0.45769778796057253
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.20921999231738167,0.15696983074650617,-0.4172341065352831
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5182672901832681,-0.17843748151613972,-0.6756315606893258
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5894740467536969,-0.3798169453326043,-0.7155158601915861
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5554828681327801,-0.3329463584502714,-0.6873258513931331
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.45736596565526094,-0.05427921729754845,-0.6371321526912821
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5368080399649175,-0.2890503198007558,-0.6824511014796021
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.49854460201651585,-0.23651880013345936,-0.6497348556864883
1,Deaths,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3670080013419965,7.975443057751618,0.8446470029514768
1,Deaths,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5340404607936962,2.818398766147398,0.6666528514794151
1,Deaths,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8816171767674787,4.022760412213753,0.8266430682233449
1,Deaths,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8730930813283354,3.9577294744684357,0.050172494347637896
1,Deaths,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.43892872276750816,1.102853868441883,-0.04391754052705816
1,Deaths,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6178533566863248,1.7703243558217403,0.05491711112822852
1,Deaths,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7266190113206045,3.602653338620738,-0.0540555344085489
1,Deaths,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2975679061684428,0.955229905979557,-0.14658219382714271
1,Deaths,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4765992563228799,1.573764603139466,-0.06399093611331108
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.723455794723607,3.519704949896013,-0.06744400258391356
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.16983289355473874,0.791171484294009,-0.23906654780754275
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3801443496348301,1.3928955981764801,-0.13548530525511163
1,Deaths,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.21293185095579506,1.2660466179989813,-0.6134861768242892
1,Deaths,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.26537244179637254,0.291404350008509,-0.5768393345602337
1,Deaths,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.23862263645384274,0.5845838824291848,-0.5797643139687666
1,Deaths,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5632777298802399,0.2619199357736901,-0.7886571106542212
1,Deaths,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.583033420277699,-0.27176614982966835,-0.7521812805982745
1,Deaths,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.573205730873056,-0.11843942241731467,-0.7592376934449377
1,Deaths,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5963874072164376,0.16204035440852696,-0.801793724586517
1,Deaths,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6238303384416554,-0.33873003829918524,-0.7833184958477166
1,Deaths,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6098547517493356,-0.1880269866378042,-0.7846626864675563
1,Deaths,261,Southern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5154673801436828,0.4187435302890107,-0.764827650197432
1,Deaths,261,Southern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5418994499000727,-0.18833225598399256,-0.7377950062893406
1,Deaths,261,Southern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5282898361622549,-0.002327258613344698,-0.7407741818917755
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.7622811267705125,4.011556405069511,3.5303572823951974
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7367375080360636,2.934598602309665,2.512589884517277
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1850848536729863,3.3545849368855465,2.9799813133352426
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5380958090730694,1.6728067631849268,1.4172768843554175
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9974917103849268,1.0922058261188925,0.8956852946590498
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.233477797517676,1.3221995408845804,1.1398387104010563
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.330728953797927,2.5050715355974926,2.1685219267506124
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5989234879855272,1.736537073141113,1.4430274631011692
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.918740788495886,2.0369526823579083,1.7756985109842867
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.040116726095769,1.1423507535188842,0.9471926102433019
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7193489735632507,0.806895207869015,0.6221704498588582
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8708199102816363,0.942900943339911,0.7875928574201173
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37793004393493335,-0.2436470923707015,-0.4975828623949842
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5032108087607203,-0.4069726509492123,-0.5814040300237013
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.43552136909388467,-0.32734600640309247,-0.5347347939809867
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6687365456489012,-0.6063715073375376,-0.7266559451933527
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7345691043868454,-0.6883735477114608,-0.7721710395487172
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6989560255079756,-0.648775048576675,-0.7479143910013967
1,Deaths,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5649256398773774,-0.47100843867263964,-0.6486105581423094
1,Deaths,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6544801193788753,-0.5875458998253482,-0.7088639766620212
1,Deaths,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6063241578449653,-0.5308810415318397,-0.6755170846574796
1,Deaths,44564,Region of the Americas,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3502441990954991,-0.2079466520220238,-0.4761010059004822
1,Deaths,44564,Region of the Americas,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4768107706681389,-0.374363395650361,-0.5596983798128771
1,Deaths,44564,Region of the Americas,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4080632764250814,-0.29381013058156263,-0.5130830674464102
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8450274686892588,-0.7780981870365211,-0.8871200214960883
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7769938930255178,-0.6725143556848525,-0.8430167934949039
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8184473874583323,-0.7523089327307851,-0.8619407836934879
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.9025973447190734,-0.8606003320714078,-0.9288564541243175
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8753910540773938,-0.8171975742303541,-0.9124556165562329
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8919792520528308,-0.852620113120686,-0.9179118407792348
1,Deaths,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8543667353205803,-0.7914708807630253,-0.893922621980635
1,Deaths,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7925414676337047,-0.6953460510010819,-0.8539613732128468
1,Deaths,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8302603249586659,-0.7684252477541819,-0.8709237714387047
1,Deaths,65,High-income Asia Pacific,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7517218854643882,-0.6482087392093798,-0.8170658307338257
1,Deaths,65,High-income Asia Pacific,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.643175180097887,-0.47540412896765094,-0.7475184902585501
1,Deaths,65,High-income Asia Pacific,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7091433196748111,-0.60569724884304,-0.7763122889478569
1,Deaths,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6230330626359278,1.4294438302822339,0.20937744440823566
1,Deaths,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7522975270952744,1.334540726779236,0.398815939669303
1,Deaths,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6751720427855166,1.2672570013227564,0.31388128244519753
1,Deaths,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.03525627972176908,0.502572144051242,-0.18976189030476331
1,Deaths,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22758660367289785,0.5309571320706464,0.00951774890075365
1,Deaths,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.11481403783031675,0.4547452050079071,-0.09223237822181121
1,Deaths,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3638336235944738,-0.047751697872777825,-0.5259706753809104
1,Deaths,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.28595293161194063,-0.04869353736261509,-0.42999381926249386
1,Deaths,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3304391166621579,-0.09378466104574305,-0.4748458727783937
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3313357676791519,-0.0035081145126083487,-0.48569735033392336
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.22604867943440266,0.03203914155223038,-0.38841868654462597
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.28723791240885915,-0.04108718152625906,-0.4364857473797532
1,Deaths,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.647017508181784,1.5929280449241916,0.15439431523938188
1,Deaths,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6872319603620197,1.3465118225262935,0.3034064283782425
1,Deaths,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6573490944207229,1.4193721371145596,0.22486686513537496
1,Deaths,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.049873545375891386,0.6098357100084596,-0.22803054944125706
1,Deaths,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.18095392245846528,0.5609302892173567,-0.0387749997529903
1,Deaths,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.10215727916530601,0.5853051297658165,-0.1532139861367197
1,Deaths,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3544326457806144,0.016327810316271906,-0.5475219418658821
1,Deaths,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.31246662375639317,-0.043815412676935325,-0.46887242336955487
1,Deaths,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3375628918601816,-0.03298473000077635,-0.5104246493825344
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3708515353293694,-0.009754373858357304,-0.5469721662281526
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3024306876736647,-0.019170342233641433,-0.46340383658667494
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.35418336704743497,-0.04939468160415779,-0.5148906944476708
1,Deaths,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4269997990010385,0.9116756315953777,0.07148168154637431
1,Deaths,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7732905202389379,1.3435583018749893,0.364578652577901
1,Deaths,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6205460488147099,1.1180987637573754,0.26868446734387563
1,Deaths,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.08858506767059612,0.1712871401326154,-0.29866839292307285
1,Deaths,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.24298764832268607,0.5719036167092153,-0.006171635416125785
1,Deaths,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.07938424656329528,0.3367612859936781,-0.13206980103464555
1,Deaths,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.4406711038975683,-0.2506968666185607,-0.5800204971627504
1,Deaths,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2773984567130515,-0.04501894845204042,-0.44394523681525444
1,Deaths,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3522729509443258,-0.15340272936983304,-0.49291089456145654
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3623553133351828,-0.1508360952546877,-0.508036166853784
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22576048356915507,0.029007057609303753,-0.3913067835025485
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2796162587410648,-0.059171240253622505,-0.4263407368450489
1,Deaths,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7451197751500023,1.7411596016967599,0.27555734523305986
1,Deaths,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.913645445244928,1.6463909399973897,0.4618747454944971
1,Deaths,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7867551361010089,1.6609381684019289,0.36328890528018065
1,Deaths,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1131290145524525,0.6886803606458113,-0.140492621083937
1,Deaths,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3400689964931185,0.7782196496929115,0.04696592453082373
1,Deaths,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.18890355414124507,0.7168476755051594,-0.05438581062429535
1,Deaths,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3159803399520565,0.07442886476294124,-0.5000307061542641
1,Deaths,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.22020496006954343,0.07838290204418825,-0.4042978659558819
1,Deaths,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.28583971276949344,0.06356843657681141,-0.45509780467309885
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.25459640626708563,0.17696747472206487,-0.4425766144837607
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.17015520409645707,0.15602597809147464,-0.3687717751167747
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.24298616904517029,0.11490481289088632,-0.4157737357379179
1,Deaths,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7762564384817546,1.7174693538013188,0.29196590395620986
1,Deaths,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8959106769707097,1.6763358917641007,0.4595109968222076
1,Deaths,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8477999027799457,1.5200754230122422,0.44994649445368506
1,Deaths,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1332003358575455,0.6826410833257012,-0.13839722167982854
1,Deaths,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3282019448688609,0.7408136864270787,0.054157008152551825
1,Deaths,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2298594011598703,0.6324927300770049,-0.007398628163098565
1,Deaths,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3037759685556093,0.06514320108378302,-0.4935991838487415
1,Deaths,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22743173468911024,0.09058522767178073,-0.4052610744200589
1,Deaths,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.26144031565877257,0.007266049822743495,-0.42046104470278667
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.30314059413971184,0.05005687547340306,-0.47960357130540415
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.20484577043579225,0.11478721861452999,-0.38805511386491354
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2422922590248953,0.026607100654755987,-0.4070414989273204
1,Deaths,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9907403509676754,2.150646853197034,0.5650820476444687
1,Deaths,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3616648665569184,2.1250828820272254,0.773162356751034
1,Deaths,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1997742927034736,1.9269672220882927,0.7685775099287528
1,Deaths,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5130531245380736,1.3767451323030042,0.220522764990964
1,Deaths,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9875308824543415,1.59038302985271,0.5223162516040936
1,Deaths,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7505509789678843,1.3028385778355782,0.43293220980376984
1,Deaths,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10155411899060778,0.4219261122597497,-0.29365900557327396
1,Deaths,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.05320826827782725,0.3936622325262703,-0.20924036192661202
1,Deaths,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.013097088246100959,0.3131494825030874,-0.20654846272156688
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0881698267327192,0.45163311743290085,-0.2804544271370655
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.011011235201397166,0.3765765379759776,-0.25848667992142604
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.023364155883653145,0.30956691690744587,-0.22549290732035915
1,Deaths,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.017564690173495063,0.7103790984776164,-0.30672215370844463
1,Deaths,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.03064292039530376,0.5314727185409845,-0.35365795529046473
1,Deaths,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.02471096871016845,0.5472142146283387,-0.313521301791028
1,Deaths,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2551239731508586,0.26705028235161865,-0.4479734240113938
1,Deaths,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.18506235032892884,0.264342379922816,-0.43271672088983515
1,Deaths,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.22525069694183966,0.19703525588930346,-0.43432527985700203
1,Deaths,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5566147252489476,-0.2280846393429421,-0.6871150850521821
1,Deaths,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5677054328873776,-0.317024293899572,-0.7117572458042609
1,Deaths,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5624480257023706,-0.3058605064217093,-0.6920193910954182
1,Deaths,44637,Low SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46346200429731343,-0.05367399865902479,-0.6224641632238309
1,Deaths,44637,Low SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4624644359170478,-0.13622793854087017,-0.6439682025953369
1,Deaths,44637,Low SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4630632046716823,-0.13346962462772463,-0.6240193271921447
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.124400921687605,2.4127277778024965,1.837608650687836
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6822670238280462,1.8981872426684352,1.4656304125240995
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.908067420826547,2.1239970199825033,1.694956741685472
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5126695766986106,0.639650884807838,0.39638392193209354
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2590108669988623,0.34093859040559227,0.17264480306129495
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.38914508536364995,0.4795825619316465,0.30302166321839635
1,Deaths,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0924895851722793,1.2855893053003893,0.900417615147775
1,Deaths,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7678298179262787,0.9101386178213904,0.6250488577476554
1,Deaths,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9318124648614365,1.0752532558811452,0.7902442661974567
1,Deaths,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2482979266542678,0.3639037403581697,0.13394740665901955
1,Deaths,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.012451092618357076,0.06806208609002742,-0.0903029859411678
1,Deaths,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.11296500939332269,0.1948707264041908,0.03131457906351737
1,Deaths,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.964533287831554,4.267320409109094,3.688565848844551
1,Deaths,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9358476088575673,3.1347469384001774,2.7283439539129364
1,Deaths,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.4349786851726845,3.625425762975322,3.245567068374993
1,Deaths,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.0386872431010965,2.2167968757573986,1.8653778962044516
1,Deaths,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.453551518178867,1.5707932934227629,1.3242417642245774
1,Deaths,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7383544125354817,1.8530612127845016,1.6278160827166706
1,Deaths,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.752703580670939,2.9815811504888994,2.5440990782147823
1,Deaths,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.008361663963256,2.160390191855795,1.849756427504703
1,Deaths,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.3714564174734685,2.5162336685555093,2.2274663204902265
1,Deaths,44638,North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3982693903027532,1.5333829411065003,1.2736383397500728
1,Deaths,44638,North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2742876573293886,1.378277448243684,1.1583028853073858
1,Deaths,44638,North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3728705647045645,1.4628177146928294,1.2790136867223616
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4898548953461836,3.185007250788474,1.8492706866104902
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.6578542703190915,3.383563661976766,2.0533892959554785
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5681640159696504,3.1121608649515915,2.00292632327328
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2995316494305549,1.6828395585313236,0.8821845570990082
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6789738107014118,2.161262994270467,1.2258129850549615
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4651325071736945,1.8374367239087463,1.0810869094435278
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2330298599505416,1.6778322982947835,0.8231435727507098
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2785903208300762,1.7306570991553911,0.9020504321194229
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2533413426083435,1.5968823302348778,0.8963864897336336
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.46208348160267687,0.7400788642584538,0.19863052715849608
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.344839406127836,0.6173677853109949,0.1028035978062169
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.39787354928844715,0.6163363736533831,0.17747564007096198
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5832431715224982,-0.26518732650888804,-0.6997583681625522
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5136727335868608,-0.030213233190652045,-0.6767615901301162
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5524211704092269,-0.20096537841508388,-0.6830109369942345
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7252685731962112,-0.5154673983738384,-0.802733371571593
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6433264528405488,-0.2811487015216254,-0.7654417157625577
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.690633471014289,-0.4498222811628379,-0.7808762075501796
1,Deaths,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7333326254998263,-0.5298203820554637,-0.8078864167139561
1,Deaths,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6970517357685606,-0.3958898914996673,-0.7986448180764264
1,Deaths,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7173482283103324,-0.49539938777073883,-0.7998173408989259
1,Deaths,44565,South-East Asia Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5520937727304532,-0.21336018342799656,-0.6776087600708174
1,Deaths,44565,South-East Asia Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47043657748198336,0.0577026021000781,-0.6481623305655346
1,Deaths,44565,South-East Asia Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5158768659127697,-0.13559505049565845,-0.6570961692399565
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.3692695767559204,2.6355917308679273,2.119448579988467
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.430806344987451,2.659478713365086,2.2058879043244297
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.3871170297512627,2.6111469990264755,2.162089824223007
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6418434740703278,1.8530061529660677,1.4494509008727605
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.8183217118506536,2.0057243047581883,1.6307458848901417
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.716711975537048,1.8944699088497041,1.539935188327211
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.540947451454249,1.7417953157585029,1.3525439976507083
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.61603301886355,1.790398577867377,1.4445298769897916
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.5687524384048799,1.7386543121212759,1.398094271642154
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8368726792009333,0.9605273421813423,0.7153500835868908
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.036314052116894,1.144199063308854,0.9211413052073468
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9262638870421008,1.0347310771850498,0.8195037823312367
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.068479162570751,4.411483982357237,3.693811433135472
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.385580773092994,3.6429758340607563,3.0504217539025267
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.677144516161667,3.916545131210157,3.385274091789266
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.974421908456741,3.249791502391096,2.683239799518438
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.6027757976244126,2.8151554740618656,2.3401691251076397
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.751571524132261,2.9422641684767297,2.529621654393768
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.8224128160392934,3.081091203985974,2.539855724490881
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.344060537274765,2.5403275108880807,2.0884975667639933
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.5470951476230974,2.7286539506581975,2.3257438161753257
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.479138488711154,1.6313254529749337,1.3275688353786446
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5003486754725845,1.6319226578966262,1.339733189735918
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4924808979577595,1.6080737672086869,1.358695796460807
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.6152553256988265,3.961805516940616,3.278738074290501
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.1874135610131282,3.508476534025413,2.8692784327648484
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.5258318455724202,3.833561558004542,3.2243286138555773
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.6188296796604624,2.896289888197638,2.352081805698231
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.439848607556702,2.6973735024928693,2.183054482502037
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.6300451251498616,2.8747627960043105,2.3922199054437856
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.480612337626155,2.7419644809250143,2.226826574018695
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.192955543891942,2.437770101776207,1.9503735044906672
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.432341276374005,2.66572011809584,2.2036845293951575
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3885620563446632,1.5562923955868326,1.2270652851029493
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.4844870883056804,1.6673268560074064,1.2977353853962224
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5276323992374277,1.690581478850456,1.3770273933867958
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.310954018972832,3.752756396256639,2.9063247031366384
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.9677379104424357,3.3217635831635097,2.613339952330868
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.1155323809125908,3.4129230319587838,2.8038979389737513
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.380339820966644,2.7226375100253764,2.0570427657477617
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.2594840073755287,2.5491342205464624,1.9633894784404438
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.3010564907500473,2.541555757376579,2.0555020907776926
1,Deaths,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.251122351092011,2.5843092923656736,1.9459696153327068
1,Deaths,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.025450095450375,2.295399126737692,1.7552171918671684
1,Deaths,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.1211746585501885,2.346712469415209,1.8848345127595627
1,Deaths,44535,Commonwealth High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2861410679375431,1.476934589861163,1.1020931814062798
1,Deaths,44535,Commonwealth High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.339499948841418,1.5251733919030759,1.1509025935303228
1,Deaths,44535,Commonwealth High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3110193794986411,1.4501192735919746,1.1677444066523082
1,Deaths,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5377151588984739,1.8199634156596403,1.2771249494798205
1,Deaths,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1207922210759296,1.3094586859303687,0.9432949022403324
1,Deaths,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3041511627054154,1.4954211353997768,1.114699556987496
1,Deaths,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.966502157994461,1.1711578648221572,0.774718565218844
1,Deaths,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.631989889231021,0.7707046053983062,0.5004304681637707
1,Deaths,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7793256601499972,0.9177001303875234,0.6445502900497181
1,Deaths,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3200998102615316,1.5781445812288395,1.0818558555338977
1,Deaths,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9606824324287319,1.135105470929352,0.7965853222141391
1,Deaths,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1187007158438846,1.2945762550125766,0.9444971917222134
1,Deaths,44566,European Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5019706103544272,0.6299626068576615,0.3818864373780024
1,Deaths,44566,European Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.39525113489365027,0.48557452972708537,0.30162582122601334
1,Deaths,44566,European Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.452743674342746,0.5436199514945147,0.36328446387504937
1,Deaths,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6584168161060743,-0.6062427528445964,-0.7044011306878996
1,Deaths,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6506431819590561,-0.5850610622391721,-0.6959957546668443
1,Deaths,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6552241932315053,-0.6039631268706527,-0.697153724783783
1,Deaths,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7353162541211211,-0.6957853367625303,-0.7701052789589309
1,Deaths,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7311600169358115,-0.6811732555904926,-0.7673125730236726
1,Deaths,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7337688337944063,-0.6945740204783566,-0.7645651305915993
1,Deaths,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6877084185898845,-0.64000841023825,-0.7297494645134978
1,Deaths,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.677017970466444,-0.6163869908078239,-0.7189466382962869
1,Deaths,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6829735998100163,-0.6358382990747391,-0.7215284177198376
1,Deaths,44566,European Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5823112915636601,-0.5188555217850941,-0.6393617086711745
1,Deaths,44566,European Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5681740225007256,-0.48487150630417286,-0.6253463477673283
1,Deaths,44566,European Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5761287170936786,-0.5114505847742087,-0.6286670766578423
1,Deaths,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1090482535685062,4.498121321183216,2.070917041577364
1,Deaths,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.656442087170949,3.805708877239676,1.7453137122698403
1,Deaths,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7631122529801706,3.865128558708652,1.8388318353648299
1,Deaths,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6918871487747787,1.2375524377029359,0.31322687295719714
1,Deaths,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7122164420064458,1.1745524324088545,0.330000602163223
1,Deaths,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6398694264624649,1.0721147805216464,0.29027101796503996
1,Deaths,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3420520068701853,2.133787991686388,0.7503438695109033
1,Deaths,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1172141832897855,1.7826818401835551,0.5896374099814596
1,Deaths,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1618983868615278,1.795003942445932,0.6309016454627425
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.43958116193298247,0.9379139989306441,0.06517336128339213
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2138814026704498,0.5961937902551032,-0.09514590453175145
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.27521169278116003,0.6470807193816219,-0.03520854389175906
1,Deaths,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5938769387791497,-0.26402652729363746,-0.7696850791403983
1,Deaths,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6890990485311992,-0.3789757923968571,-0.8290530272807449
1,Deaths,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6422458323109097,-0.380027779136643,-0.7828153961562613
1,Deaths,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8329663542086082,-0.7041542339647292,-0.9034099565293745
1,Deaths,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8545579629825089,-0.725044969076399,-0.9168026722083585
1,Deaths,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8442959847117985,-0.7239881970946116,-0.900736247813162
1,Deaths,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7685202821012094,-0.5805140162911891,-0.8687264083251085
1,Deaths,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8199769370455618,-0.6404041882361694,-0.9010154279479672
1,Deaths,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7944711435574314,-0.6438275411205197,-0.8752279992899239
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6565968244155173,-0.37524052460595264,-0.8050521638727157
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7314801120258506,-0.46189611721092483,-0.8524536248860093
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6943394827813639,-0.46946393308645595,-0.8145327039123382
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5703235356521594,-0.5259099755763827,-0.6143652743498638
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5695226150221129,-0.5161329825957279,-0.6163929862181077
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5699994960283992,-0.5322049319440704,-0.6093571199901175
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6929173489117952,-0.6634241037187532,-0.7231604013187015
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6945847562441653,-0.6570488080974387,-0.7277630869116777
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6937830240701229,-0.6671149226232082,-0.7214392255824281
1,Deaths,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6331162787513402,-0.595193298214731,-0.6707217757342838
1,Deaths,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6250850709395566,-0.5785865301283365,-0.6659058027716956
1,Deaths,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6291197147031387,-0.5965214768387663,-0.6630661093438595
1,Deaths,95467,Advanced Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47380502814986036,-0.41899433810694975,-0.5287690084176546
1,Deaths,95467,Advanced Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4706538850076007,-0.40428328868497737,-0.5288397108003742
1,Deaths,95467,Advanced Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4724191743747416,-0.42509050602165915,-0.5215856592918151
1,Deaths,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9258407136882205,2.0796052988125595,0.402458652102003
1,Deaths,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1083895927394798,2.0241746326059307,0.5921752435007921
1,Deaths,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0320096252717792,1.875429619828187,0.5611389232381927
1,Deaths,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.22870722820582526,0.9374741410349433,-0.06294625256884749
1,Deaths,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4766832595941947,1.0154339466688407,0.16908389854251676
1,Deaths,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.35226994575429255,0.8436900395575877,0.0809855078621543
1,Deaths,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.24514470064366936,0.2070865275677423,-0.4502902871754733
1,Deaths,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1408482952029735,0.2323267009828927,-0.3512014669869639
1,Deaths,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.18781228142656334,0.14929998057188348,-0.3760177881679907
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.17474083919220113,0.31835226935327693,-0.3871228323349991
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10753322328017093,0.3047661950128467,-0.3402821269788219
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1310045989522726,0.21289864757194665,-0.3375106049715637
1,Deaths,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1137273849263416,1.708498778499349,0.6354591782277923
1,Deaths,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.050112124290062,1.6035056586359737,0.6314252987827758
1,Deaths,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0938878105847494,1.5712534726589567,0.7283851180777485
1,Deaths,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.21600308918651767,0.4814083268440875,0.015499246960269279
1,Deaths,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2881627405850107,0.5327736830229762,0.08647188486510496
1,Deaths,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2516024992871336,0.48158394054374304,0.07850759723326077
1,Deaths,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5033043977909297,0.9263118575110473,0.1631551885878862
1,Deaths,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.42681591584771,0.8119610467782402,0.13542257237562058
1,Deaths,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.47335471807251384,0.8092509140900175,0.21617039628069223
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.09014391643072378,0.15803687691052154,-0.29104230983256013
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21035853461092546,0.003250799486056457,-0.37158616710628334
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14244720045937842,0.04710392089092459,-0.2882577170136931
1,Deaths,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8166977623945358,1.412401539521476,0.3513243188035741
1,Deaths,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6304906234470924,1.1275246877032394,0.26378844933111845
1,Deaths,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7810495204679629,1.284750642877519,0.38462172419486695
1,Deaths,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.044832511705744586,0.30952767816163357,-0.16284176090328997
1,Deaths,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.024405723304850642,0.2637736555488167,-0.1610312759623336
1,Deaths,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.06442128287970054,0.32381773058588326,-0.13920115355791954
1,Deaths,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2920539115595615,0.715724491938973,-0.038924411072984645
1,Deaths,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.13477206666459296,0.4806927142217213,-0.12044153468212425
1,Deaths,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2532274655963706,0.6076544895510527,-0.025717166041244584
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19986246421002404,0.06539893569250346,-0.4058791733492204
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3431695836485149,-0.14902769463553917,-0.48542158374671524
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.24409260271067681,-0.0348605834040415,-0.40768050862565125
1,Deaths,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8027650892445422,2.469739252620925,1.274122196981269
1,Deaths,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3894798276061817,2.0176161466940203,0.9131924437900215
1,Deaths,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5634358036625322,2.08366066871834,1.1565446041416567
1,Deaths,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6127198296563017,0.9287090731909581,0.3931703626022483
1,Deaths,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.501506850201101,0.7865401637205448,0.26646590031975576
1,Deaths,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5325411236950667,0.7932131172430634,0.34320533634544426
1,Deaths,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9933550157335164,1.4677138191283898,0.6173788182032017
1,Deaths,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6630055538090008,1.100169398058195,0.3315239671705652
1,Deaths,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8037500465449701,1.1698039275189298,0.5174428883840737
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05412331826122803,0.3042720336302092,-0.13469775535124398
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16397782139072326,0.054011782038793504,-0.33512259937758393
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0794042862480793,0.10340923367395084,-0.21999330508601403
1,Deaths,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.072915808572207,2.8087247067853616,1.5132252240973878
1,Deaths,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5357748357628425,2.217100410007808,1.0355742518996818
1,Deaths,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9185678949405016,2.485438602603742,1.4455055625853575
1,Deaths,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7682585677036845,1.1404434089349398,0.5085046529832501
1,Deaths,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.593370869884217,0.9110562054501644,0.32669342018799974
1,Deaths,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.744614569197557,1.0470390497729785,0.5017574299462251
1,Deaths,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.185488952838089,1.7088037192104244,0.7874313210718773
1,Deaths,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7648224464432457,1.2390044005368186,0.4166979971917534
1,Deaths,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0536371415356214,1.452513159367492,0.7207689640742926
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.20254164089112278,0.4916376159582681,-0.0115061637183515
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05127200747310529,0.19980840595840507,-0.2448876116899565
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.11951330399675822,0.32560204457599173,-0.057853504168989614
1,Deaths,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9870694146643724,1.5853984558730279,0.5070411168112688
1,Deaths,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6913875064740822,1.190161321376623,0.32369913473167333
1,Deaths,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8331558060144508,1.2265238121852335,0.5031262734236854
1,Deaths,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.142969579052756,0.4116389707715244,-0.07014785293283864
1,Deaths,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.06282778280796426,0.3054414659899266,-0.12452900577121692
1,Deaths,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.09579058589301423,0.2792710997743558,-0.06100852261660213
1,Deaths,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.41322396212645995,0.8387616570011175,0.07182295820663834
1,Deaths,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.17715445194925572,0.5242859132382166,-0.0787455130616198
1,Deaths,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2898918185111056,0.5666834426376415,0.05766802577119371
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11999855873960577,0.14567697111359873,-0.3255443152479312
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3007660610539259,-0.09183233691631157,-0.45038439966362065
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.21842869199862683,-0.05186625500426264,-0.3563419484601956
1,Deaths,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.37445930574567177,0.6659991680849577,0.1253958483991432
1,Deaths,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5768142741062128,0.9381951145601373,0.28637857634740777
1,Deaths,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.490765547953293,0.7946701542638906,0.23456817457577622
1,Deaths,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.04894176671444116,0.1416457085958886,-0.21814669504307227
1,Deaths,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1713218630097715,0.416609003111011,-0.043174077283678725
1,Deaths,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.06584942858595805,0.24575160504565774,-0.11461103378297335
1,Deaths,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.018782755199231796,0.18934558972761392,-0.1965874805748815
1,Deaths,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.15554646298841618,0.42037939787227635,-0.0572953084123382
1,Deaths,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07847771176109344,0.29833411027895046,-0.10686542108681088
1,Deaths,32,Central Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24746159587185237,-0.09048445875890103,-0.38272538259783007
1,Deaths,32,Central Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.025675005159882518,0.21157080522049546,-0.21182785595878423
1,Deaths,32,Central Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11890570668515882,0.06669663944292979,-0.27140645221319365
1,Deaths,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.23892296425442486,0.39337942185982283,0.08033073631157095
1,Deaths,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.11922665467383202,0.21539339581719721,0.017573850236183377
1,Deaths,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.18999783442201737,0.32025330716578204,0.06153241228047607
1,Deaths,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.24166280663003237,-0.14975035160580602,-0.33503003405651355
1,Deaths,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3022621291735159,-0.23996044398063063,-0.3646989634209501
1,Deaths,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2652249060770266,-0.18506894903184395,-0.3405461311222544
1,Deaths,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.06349491994970989,0.053259116715579966,-0.18337519613326866
1,Deaths,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.144520089235894,-0.07101512508207128,-0.22221832105166658
1,Deaths,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0953675044583861,0.0036522836098645556,-0.19302650186248976
1,Deaths,44638,North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.29431583699016844,0.4586016037213471,0.128022133557643
1,Deaths,44638,North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.17353920442342943,0.275819329189482,0.06511292406804332
1,Deaths,44638,North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2446211529982997,0.38196826370308634,0.10976802272227085
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.8456596156260354,5.39387163658296,2.291843888239196
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4810289236619774,4.281641370109434,1.2132522637728298
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.057180006955066,4.5460617368187535,1.7222859071522079
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7696664608421764,2.6014333731026875,0.8676409906454656
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3102845483814352,2.347164770327838,0.48301593805156257
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.474630186768248,2.347198461886328,0.7160431505434812
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4083371886014844,2.177812736138203,0.6360765476699121
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.74417871399427,1.6463803245292854,0.10895587822672617
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0243428173189515,1.767225073102574,0.3582931773757068
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0349967858607603,1.6760738643117044,0.3695497429950918
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3697363326100969,1.093882591937048,-0.13828770152774228
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6482861792135384,1.2793458215487692,0.1047201576006304
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05853276364111275,0.45178235880691847,-0.3369411409235258
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.04472422416354554,0.7133626279348358,-0.4015197548875653
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05119939467397751,0.4904859201238255,-0.34524970323483617
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.46232932469692656,-0.16354884191037863,-0.6078425953846581
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3660175794532989,0.11904909748441998,-0.5950337192609917
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.42168175779341044,-0.10330851938057223,-0.5838669752049032
1,Deaths,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5320821648591931,-0.27845087731805795,-0.6704536770605926
1,Deaths,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.52135655556245,-0.14151514091601547,-0.7001298963143733
1,Deaths,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5265929322418443,-0.25631732840412835,-0.6733102652280981
1,Deaths,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3308196788611657,0.030285934877496347,-0.529306868452869
1,Deaths,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3158440550775998,0.22696780914515105,-0.5714428087888156
1,Deaths,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.32310793359325474,0.06353932412536709,-0.5332366433841386
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7239992587621034,1.2127134215093578,0.328378535760101
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9016582249872392,1.4312833533930542,0.5200257545019131
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7725970113566392,1.2025491209269565,0.44543132065822666
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.13332431230725425,0.3335058906970371,-0.0011301527998400405
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3649312703415174,0.5331184414219141,0.20301091303834642
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.21061462321087443,0.39771773523464476,0.0741968921253976
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3867345595466973,0.7798419322889428,0.06850882582239343
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5153163408328872,0.9373425498770681,0.21121652356802725
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4192638544506165,0.763513271745366,0.15731235828440296
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2203304645777555,-0.005336462891373419,-0.3908201107307683
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2504288904634596,-0.04768173533311282,-0.399159424671423
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23486571816417173,-0.05427744203945382,-0.3735489935648993
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5885831735155387,1.1043731589863752,0.1609600915688036
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5178494701635097,1.0440158155075994,0.16877021141343532
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5770396020419442,1.0502136462396496,0.20738992814428098
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.04359315622244198,0.24760214745053735,-0.11624087199846395
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.08888993195602042,0.2638875952846459,-0.07563496468236752
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.07643063227901215,0.31823889869098027,-0.10285688540752849
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2778098228476991,0.6926961951504829,-0.06615767202303807
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2094823742992724,0.6287524884658555,-0.06867775883052138
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2626870573939998,0.6415429470809904,-0.033280056175085004
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25222902988957835,-0.017067362215373083,-0.44521015639530764
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.34506212608730713,-0.12848430318289517,-0.49298547187307856
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27171069740641146,-0.05583802585955654,-0.441487540407899
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.898451454119974,1.2673930271922822,0.6132879783233152
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2123881337508646,1.7557928904042563,0.789684143050205
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.039033604941089,1.3592313599849404,0.7635057296015441
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.24963743093680954,0.43115588216912815,0.10375668353407537
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5887152574624275,0.7827399000484768,0.3924937162136039
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3936929896118388,0.5566533057594363,0.234477782854474
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5270588010230299,0.8238246071755569,0.2976816449727255
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7629181980689302,1.19592455884584,0.4260909722154087
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6325914322106347,0.8889639168184926,0.4119847450405418
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2247534594633616,-0.08719309515240765,-0.3295643007169033
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.21303190472562483,-0.03223480531245272,-0.35744485845344326
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.23237918026549095,-0.12360903762027853,-0.33274259232488995
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2549018215260068,1.8622958703854149,0.7671559323830657
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2732488423142154,1.9455920449424866,0.7996321437195488
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2598668606761703,1.7642204231330154,0.8861938750796816
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4833954937548846,0.7776354876663758,0.28995942662435426
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6313080878266573,0.8782743066231744,0.4117749807396079
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5438171237772691,0.7885228080152314,0.3676107316433099
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8137770468301644,1.3023470473887095,0.4214485250435503
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8114144131032219,1.3471640174241435,0.43401793184190735
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8094058213342965,1.2132261913746103,0.5102173659527436
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.059077866997115154,0.1859297422073678,-0.2501316706899904
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08964461062418448,0.1771805091225384,-0.27662340475123987
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06684217422625909,0.12737511271357163,-0.22046398810917378
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6476854951809986,1.1788159088167385,0.22744514422086148
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5493493963960482,1.0575848653429964,0.1817044663228916
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6002872875316952,0.9815602190490276,0.28201942873184516
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.08249983845446505,0.291728921085638,-0.07771178096361979
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.11173942747713345,0.30117945570827487,-0.05644681535355103
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.09279646162389212,0.25531489032432636,-0.04979518756667629
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.32535000106203815,0.7525757649198915,-0.012679041021716355
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.23458275896777145,0.6395648430072669,-0.05837123394436386
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.28130076344441646,0.5865742615469703,0.02647348734384875
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22662947201542813,0.025141792632020737,-0.4210393790069942
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3242264502792605,-0.1000542101562037,-0.484808776323377
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2762264134879521,-0.10374299932963965,-0.4150145413649734
1,Deaths,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9655228683779284,2.774252953725541,1.3139843915072331
1,Deaths,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6669665763435275,2.414929833636993,1.046291509244837
1,Deaths,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8157655314104026,2.4162948590335542,1.2624683752205772
1,Deaths,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7650172272357717,1.1117473145754917,0.5028575511957153
1,Deaths,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7303241439563131,1.0494396885628432,0.4276008149063898
1,Deaths,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7398765650965388,1.0270344519787569,0.4880220187756953
1,Deaths,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.183329393025677,1.7787468774740116,0.7036422786865238
1,Deaths,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9474552364669789,1.493628171299223,0.49422986788247586
1,Deaths,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0646736899701832,1.5050147229744248,0.6589658750342391
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.21844105641784162,0.5542653605378752,-0.039550263679095234
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.03124719197968047,0.3253328022771186,-0.21094359891913372
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.11655778759777145,0.35200292625456314,-0.10288252964864288
1,Deaths,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7733950472401698,2.6870725806645597,1.0755475762323503
1,Deaths,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6935107186967815,2.444220941568259,1.0225033732290605
1,Deaths,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7303787986333956,2.5061453738750945,1.0789898048566233
1,Deaths,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.14136786135117127,0.4880697940720679,-0.1113234129335221
1,Deaths,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.26108160264507885,0.5708408583887002,0.014068544313666817
1,Deaths,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1893263069760179,0.48644251695225216,-0.04826417036377874
1,Deaths,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5807639714602315,1.1015367073195403,0.18300882985444403
1,Deaths,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5596415752013689,0.9943303501120312,0.17110369191300576
1,Deaths,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5685956526042387,1.014271570527744,0.19437433785336886
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.04367260727891789,0.3847655334917066,-0.22239352788700137
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.05216396447515703,0.21461737120681226,-0.2877376930855313
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.008794691194782026,0.270891329081108,-0.2446644520315186
1,Deaths,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4171466085559594,2.232967735623274,0.7628509915694504
1,Deaths,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1639223768256932,1.7859480842693725,0.6184657668299861
1,Deaths,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3054121217529877,2.00018622404962,0.7381236102557714
1,Deaths,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.005536561239185889,0.29050108077811315,-0.23131824616816585
1,Deaths,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.01255205128514251,0.2543835660631468,-0.19157185378584551
1,Deaths,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0037231309848405284,0.24022084744091654,-0.20906860931597301
1,Deaths,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3777115079024872,0.8427086045502948,0.004779804917784682
1,Deaths,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2529904859776592,0.6131662029106121,-0.06284891295716696
1,Deaths,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3244533811399566,0.7235993300280699,-0.001452421143684998
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.09403783093087084,0.2110519040041981,-0.33636176917460303
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22757550354017506,-0.005002822759949438,-0.4224715173009552
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.15666342803022368,0.09360774268713419,-0.35861613610924875
1,Deaths,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3630443833651773,3.47012865202866,1.4718919731439508
1,Deaths,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.165018296541444,3.149765188423167,1.3168435368119675
1,Deaths,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.21671161381962,3.077455414932864,1.4233119200045643
1,Deaths,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3849702490869746,0.7818375878340784,0.0718636832414349
1,Deaths,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4829335081992258,0.8993666791989916,0.1279752372212835
1,Deaths,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.402262059814137,0.7525872469548525,0.10326451075186055
1,Deaths,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9168489541133109,1.5478585634421766,0.40891496015905154
1,Deaths,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8326617701181493,1.4028663670288175,0.3415374507946435
1,Deaths,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8479926139349285,1.3424877312820354,0.3921865143861226
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1376555671593991,0.49929004951612477,-0.16871812487892834
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.019848385524612867,0.334909063491597,-0.2513917679152485
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05741551265784583,0.34483777439214164,-0.196431328124516
1,Deaths,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.559773511440367,3.9016028193219707,1.5726139876088108
1,Deaths,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2198787656772074,3.376837556018518,1.3606727184807779
1,Deaths,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.401350402051664,3.4988150371892224,1.5587379247782733
1,Deaths,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.465323013194405,0.9349083882903659,0.11107933406936749
1,Deaths,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5075072260271623,0.9774561827953206,0.15946840385024674
1,Deaths,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4817083898839572,0.9064313486844547,0.1796229457886635
1,Deaths,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0289795061987457,1.7937877609258859,0.4663239224190029
1,Deaths,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8644279954779578,1.534349602875181,0.3669161557922623
1,Deaths,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9540671266244694,1.5845577590690596,0.46998840855697005
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2404619995012253,0.7025364214072375,-0.10893984159769456
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.07031580859446071,0.4525886479779649,-0.21940292638052475
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.15609239220598223,0.5273101831621295,-0.1280952495545876
1,Deaths,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5824787651482166,2.5071987352513547,0.8354132886752927
1,Deaths,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5152941088621348,2.33744557149567,0.8392353369036752
1,Deaths,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.530794052974289,2.3242410668717706,0.8815518223402821
1,Deaths,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.06276080321927652,0.4291836041106109,-0.19922951972547936
1,Deaths,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.17771327793206212,0.49563272438616557,-0.0785745266251575
1,Deaths,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.10266907082807183,0.39134584948400475,-0.13575225163221838
1,Deaths,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.47194659234345937,0.9990132336008758,0.04613845126910466
1,Deaths,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.45644761641733556,0.9325034915007928,0.06498477177116142
1,Deaths,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4539347255110088,0.9097680103264206,0.0809467207076835
1,Deaths,120,Andean Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.005248272774499784,0.36882659713258203,-0.2768271755208299
1,Deaths,120,Andean Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09788136053335386,0.19805998593076882,-0.3366207862128696
1,Deaths,120,Andean Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0682020808666073,0.20481833232913524,-0.29876279986146903
1,Deaths,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1525658876722784,2.92018794515483,1.5250121811532213
1,Deaths,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7827066324108685,2.487107159850088,1.2233473200052123
1,Deaths,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9643202260345463,2.5032117313870867,1.4833840553864186
1,Deaths,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8140510203587075,1.1921559433139552,0.5482598937864678
1,Deaths,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7481230740649054,1.0584830368295395,0.46022315689295373
1,Deaths,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7718488422902466,1.0618429153665827,0.521545302063403
1,Deaths,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2421368985710262,1.788077507130185,0.7958143247198265
1,Deaths,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9366794943636205,1.4269209166613623,0.5473823626789848
1,Deaths,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.085830563045347,1.4650191413095421,0.7474219947666744
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.26614821811004086,0.580806957114478,0.02655679518721899
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.03792475282655227,0.2972455169678013,-0.1752629437589429
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.14069128070345088,0.3544682433366422,-0.04297192472709666
1,Deaths,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.747345875520772,-0.6622851924724283,-0.8044609464538307
1,Deaths,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7553988916469299,-0.6568098474107824,-0.8188333649392225
1,Deaths,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7509111004554132,-0.6719246899210845,-0.803784043847812
1,Deaths,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8544884735039554,-0.8014168030153083,-0.889722459580068
1,Deaths,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8461938538463306,-0.7827224773207839,-0.8859114368449708
1,Deaths,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8509866030358137,-0.8033747428380347,-0.8854135487168427
1,Deaths,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8203098189680335,-0.7598137967195768,-0.8609306378712239
1,Deaths,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8297650405082078,-0.7611500531727899,-0.8739135117232651
1,Deaths,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8247297187994912,-0.7691512871203525,-0.8619335270511933
1,Deaths,44639,Middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7170869537587303,-0.6210026335519564,-0.7816850398619866
1,Deaths,44639,Middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7215178201420135,-0.606952220458758,-0.7950093931951724
1,Deaths,44639,Middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7188547025293596,-0.6287289985593133,-0.7790703614694695
1,Deaths,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7458853847667652,-0.6692716521471467,-0.8038240145003428
1,Deaths,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7718293925446096,-0.6878187819260239,-0.8284427303884566
1,Deaths,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7575809555804386,-0.6903789612666213,-0.8105981114100386
1,Deaths,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8485405439272206,-0.7994897751985712,-0.8842841222180731
1,Deaths,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8517684007832944,-0.7966058559623388,-0.8907338845094877
1,Deaths,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8500445060026092,-0.8070233797920205,-0.8841186697053676
1,Deaths,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.812911269526105,-0.7565053600922256,-0.8555678663231961
1,Deaths,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8333867217390974,-0.772041032213336,-0.8747265503728076
1,Deaths,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8222450635972964,-0.7729688763489339,-0.861120149444233
1,Deaths,95468,Basic Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7058601003755294,-0.6146143158021488,-0.7738082758347774
1,Deaths,95468,Basic Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7324203128366794,-0.6324456245875215,-0.7997869665755193
1,Deaths,95468,Basic Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7176022579507844,-0.6384826560247141,-0.7801987222898362
1,Deaths,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.35186153759191,1.9910205332594098,0.972611983221097
1,Deaths,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5396723338080864,2.1034175238619373,1.000387322748937
1,Deaths,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4224962775794259,1.926837729977966,1.0535668708513846
1,Deaths,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6203701827788728,1.0589975472748452,0.3845904984248438
1,Deaths,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.91916510792448,1.291564336580072,0.5286714091791944
1,Deaths,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7398999994337448,1.1027369040499513,0.4807485334649568
1,Deaths,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3065782842350202,0.6616635010151236,0.09588593516327774
1,Deaths,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.36011110824206694,0.6620225339812147,0.0712992311011365
1,Deaths,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.32174708474718633,0.5969226755600684,0.12045415714461159
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.052181362072594446,0.3433100251512972,-0.11998755197956282
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.008755537492484002,0.23772311280087433,-0.2509711540750994
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.012753842096642085,0.24241292037833362,-0.16251070703342255
1,Deaths,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.087357970456099,1.7628045725508381,0.7197803123196654
1,Deaths,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2115768264715516,1.7815516664625737,0.6744190939612158
1,Deaths,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1194121696287467,1.7050419538355233,0.7448125494853697
1,Deaths,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4380653718081674,0.911011506704343,0.20123316853626083
1,Deaths,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.670900347408312,1.0472799143490816,0.2891844873436387
1,Deaths,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5220423816836294,0.9499858878901052,0.2635472211437165
1,Deaths,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15963314677756132,0.5348779681036229,-0.04457487236576883
1,Deaths,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18440090415301347,0.48964859338065064,-0.10327171768082263
1,Deaths,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15638025226755128,0.4759078681324021,-0.048006421286657074
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07831314666043468,0.2188131293723638,-0.24215410413562527
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14156351717805923,0.09936938562328547,-0.3604317145130836
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.12145050115701081,0.12064828268478857,-0.2823227592147943
1,Deaths,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5068112280881256,2.1495890666430095,1.0668420489917716
1,Deaths,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.707030035445761,2.401425114202698,1.0483333619777617
1,Deaths,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.617056088687714,2.1763533094192895,1.1425140001890108
1,Deaths,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7276008096623049,1.1345727843535165,0.42513735686080195
1,Deaths,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0458736239579665,1.525243206041079,0.5787933801293085
1,Deaths,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8799718317956643,1.2476198832261443,0.5311272075866545
1,Deaths,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.39266069066723547,0.7497563580861831,0.14823551258953363
1,Deaths,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4497388393541097,0.8216192774536929,0.09697653587909293
1,Deaths,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4279015773345955,0.7330617865993261,0.16898492682493108
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05047138652138098,0.2957131517616044,-0.14150588328487132
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.03127727510513888,0.23289866432881398,-0.2791722674735439
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.009200286424817026,0.22968826108720172,-0.18568629355320918
1,Deaths,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9569433770854092,2.71116320401324,1.4682359835442877
1,Deaths,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.225086754868626,2.9985260753507506,1.480123427452249
1,Deaths,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0205815448721824,2.6820992230388594,1.5294805925692534
1,Deaths,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0367751248181374,1.5176090840864473,0.7116526165783685
1,Deaths,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4367781753423632,1.9624139967945478,0.8913806501139516
1,Deaths,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1691593901359834,1.6302360832341023,0.8132180210072744
1,Deaths,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6427319136177546,1.0617392538255466,0.3712301872024618
1,Deaths,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7271819919240945,1.1413942496768805,0.32821993553444256
1,Deaths,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6480705824510998,1.0090036706534908,0.3801191894889808
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2675075450391207,0.590968377101123,0.05941540054861824
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19495281909846363,0.49316519474027753,-0.09273646121535027
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.20922048209416758,0.4738164240681232,0.003556797735471664
1,Deaths,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2497230511641273,1.9679444559044963,0.8721295289805922
1,Deaths,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4200882768009395,2.034316424668337,0.8625522968405827
1,Deaths,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3459674546590445,1.8636094287250133,0.9360613730334414
1,Deaths,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5503051087671685,1.0268859390615563,0.3169539643254496
1,Deaths,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8286999434564286,1.2312617437609072,0.42896509537655314
1,Deaths,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6849959068565508,1.0379447789377327,0.39862942336724594
1,Deaths,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24983517830888485,0.6488435704727291,0.0400628390503538
1,Deaths,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.29606835668749876,0.6250157235538127,-0.0025177520376624273
1,Deaths,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2799919128072615,0.5624244500609925,0.05634155122646254
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.004390102152066022,0.303321713658992,-0.17526402622277307
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.05225488739258907,0.20186494616786652,-0.2924510381710749
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02642992521871606,0.19776738215390124,-0.21440506918818417
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8294692771093202,2.5533732782276175,1.3223486971776783
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8451421706014655,2.633639407111761,1.1340051431731013
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8352294907700906,2.4291117406344256,1.3111661732515798
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7459363818891641,1.1622209566079496,0.4466153274557332
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9237958153135355,1.3975481726497805,0.4500469422259368
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8232236786584528,1.2023304680351932,0.5089595472597767
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6106757228172153,1.02275816162803,0.3219972723230067
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5570033370925016,0.9885082514058744,0.16783377773725486
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.583183184258258,0.9148051550636277,0.29054788454693103
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2632482411159215,0.587396709945782,0.02679015414970293
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.09067747329538452,0.4267463400367319,-0.20633180076933608
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1729468977549871,0.43687300298944615,-0.05996271775783735
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5539345146682122,2.284311989591142,1.070729198370978
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.469074460776724,2.2194379710316388,0.7946637250252804
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.532349843455265,2.170905295332713,1.031762388276805
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5760358428542907,1.0151926803514817,0.2822032095927718
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6693638268857305,1.1273527469323266,0.2333141558879109
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6284207052252284,1.0440608753259757,0.32912842170073625
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.45382752649768987,0.8695949910424027,0.17876284267426648
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.35120037750048,0.7618366197141191,-0.017870727974023743
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4140561467313391,0.7706234923094997,0.13452969433333187
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1368487130738807,0.46382937416338127,-0.0805627618321291
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.04112188869276013,0.26873665543727243,-0.3153764178651938
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.05370410082284925,0.32813549445845974,-0.15912189508000465
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9781151932111056,2.674084741772121,1.432874864924202
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.009374688031578,2.9822350172696965,1.1531004161056513
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9954337542073657,2.649075599308279,1.3702540573038957
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8379181269637621,1.2236765195010797,0.49882639437466025
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.034953336392503,1.6387594583844352,0.4788414673859986
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9264956020667671,1.358442065535235,0.5281225815020405
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6952924282531058,1.091473176620347,0.3849143064698562
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6468795409391935,1.179277111366557,0.17828366104568277
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6726407384866095,1.0376322783461305,0.32354237219936444
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.23569749534662307,0.5190880837235459,0.01185921715887421
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05561136268003503,0.4027466492696019,-0.257871503230822
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.13578681648558072,0.3997889164073197,-0.11264129787949016
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.407893056894205,3.275815050224608,1.7806038422332593
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.508028357349628,3.5155400622594035,1.5797479906188587
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4314814676739185,3.203047232499486,1.787396839801161
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.102223658414508,1.6015492946454184,0.7308323048529689
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3715694130424434,1.998798565603648,0.7744660970301251
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2061638232772138,1.7144500150055506,0.8100110745699693
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9399435283158781,1.4340082263374774,0.5828590681970276
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.919767636024256,1.4711281630704873,0.411766438863796
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9161284031507483,1.3469682869759596,0.5564735831769256
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4662222635192414,0.8452408768672274,0.18470416659025815
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.28329020679141026,0.6754765383535787,-0.06279479578621334
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3691556189908141,0.6945233814420102,0.10109016531497429
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6487011213078018,2.428888552623649,1.1475017129715077
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6276631997417428,2.425536215845873,0.9142799909149644
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6371532476198272,2.257298577317109,1.0839328641118977
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6345833074828595,1.11364095878345,0.33859010916017174
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7766436773725595,1.2681116555058047,0.31404893468692424
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6959273631392578,1.0841111454967105,0.36218975584077123
1,Deaths,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.507773428608387,0.9518952167591901,0.22246560574969165
1,Deaths,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4379880250019832,0.8746238323393613,0.04758924344153819
1,Deaths,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4725780362879028,0.8188652278430234,0.1636615231061896
1,Deaths,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.18372564953395426,0.5324746392333196,-0.05088509155368047
1,Deaths,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.028499358311215552,0.3576588646631507,-0.2693377667535253
1,Deaths,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.09787885328647976,0.3639241716916196,-0.14939721246716778
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.399331103677226,2.17213028576252,0.8422238751803554
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3923910937682984,2.08460392494438,0.8817042043835613
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.396021299717278,1.8698803017325933,0.9549405448675683
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.57734553158621,0.8926442586328565,0.3660886041201057
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7160526166549472,0.9697395956066077,0.46912119270560754
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6362472697815618,0.8770950257875412,0.4503297415842416
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9299517353932092,1.5515687853660731,0.48183098174241407
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9063516621523796,1.4579341708454732,0.4994161895392603
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9184204889186364,1.2978248032425448,0.5652607079637547
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.007220945859352262,0.3248367270144248,-0.21515602907577994
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.069716184119243,0.17780350881398396,-0.2661255561740156
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0338875424850637,0.15257067615427666,-0.20190371433261248
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.822000886046818,-0.7469950726511061,-0.8698269294373233
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8353500561426277,-0.7613270841467158,-0.8869118919202414
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.827877472556876,-0.7604962988857762,-0.8725108119221645
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.882446029607385,-0.8236758356830406,-0.9191824049168583
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8814179854599359,-0.819203528938822,-0.9191703605619405
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8820805179389735,-0.8339901810714228,-0.9157147810502105
1,Deaths,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8568227209884028,-0.7964902393622624,-0.895292590902161
1,Deaths,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8688004252467775,-0.8098159991345756,-0.9098869313762814
1,Deaths,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8621867913735527,-0.808236760064033,-0.8979233320868307
1,Deaths,44568,Western Pacific Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7661567173576892,-0.6648777497049821,-0.8307745569024552
1,Deaths,44568,Western Pacific Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7799395486221863,-0.6792221896238998,-0.8506459836012351
1,Deaths,44568,Western Pacific Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7719291208039338,-0.6812689722922994,-0.8326491598570493
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.973025110987471,1.0990006630751668,0.8390936220870362
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1888821946244645,1.3422610208514496,0.9782618605393346
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.03994534926314,1.162529884963007,0.898665044700444
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4186547922476234,0.5117750288139092,0.3255354136956451
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5700709796078105,0.6786828719067891,0.41339000903723494
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.46507056319324647,0.5513292761226936,0.3656423778782664
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6128838921027949,0.7158648109109246,0.5033992535698664
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8315273244604187,0.9598656662488767,0.6552926701189208
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6873572634062429,0.7887540516923459,0.570496118980869
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.01879143811819598,0.07951304414659618,-0.04622661841885632
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.16421570057384233,0.23799631962104573,0.07315115378460299
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.07468949163941208,0.1338914098028293,0.010374597697350638
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.41237007550064564,0.6988330860929414,0.17351158052622218
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5915575794779975,0.8035893732951723,0.3768896736736651
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.447947030447616,0.7066311329216536,0.22678211042404203
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.015545428568572472,0.22234472810360387,-0.15595798484473145
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1415927468708765,0.29952594530342286,-0.013367081716597217
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.03989831076003917,0.22698136931230167,-0.12064626371218466
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15456662552201522,0.3887408247730031,-0.04069242966727997
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.33172137012432573,0.5091370505954893,0.15209994685591485
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1976810750032144,0.4116537186306339,0.014742726018896113
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21430736079551402,-0.06634907313905986,-0.3446658246524418
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.09772348704732632,0.013419870610021511,-0.19809604863352812
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18183745183913028,-0.04544624979708599,-0.3062834497717658
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0572730663274237,1.190428763543988,0.9303319498901309
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3392019294511324,1.5167608480714805,1.0854657351874872
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1688765401931434,1.3002292166369325,1.0053637091650192
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.47926495269532526,0.572075570777083,0.38759249444857435
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6779143581446428,0.8060146488807303,0.49501157948777025
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.557694076849308,0.6500024899187303,0.44251455229196224
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6817538569875295,0.7906043110371621,0.5779836207107163
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9573059992638424,1.1058768140630424,0.7449945399538149
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7940037388002726,0.9026531654848358,0.658752780633633
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.01609896875024452,0.07047394103390828,-0.04018391564386728
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.19938007864452453,0.26912097177268957,0.10233591435099913
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.08505527695816797,0.14377831415279796,0.019408349828996568
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.26405482085864,1.4192035131227425,1.0958285711724653
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9954796038826383,1.1458145762040486,0.8249185976916338
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.214366503251829,1.3546875075701013,1.0600014700734994
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6278431519514157,0.7379740524637436,0.5068684427628944
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4313329423432718,0.5402145138723772,0.30896542284259954
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5902981955972727,0.6928638342770694,0.48103372867844707
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8507912195668774,0.9776202321527081,0.7132717288940535
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6696994607064898,0.7954908853454467,0.5269840856655377
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8316311289687806,0.9476987804528861,0.7039468456405608
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.17246516365634382,0.24020127262171162,0.10217619706139666
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1462821110546999,0.21920318858976956,0.06818076350154922
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.22131082631824645,0.2872681787916712,0.14762156787605668
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2503354884585256,1.4439307780285613,1.0641352185287065
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1565299674126692,1.3273354616643158,0.9348468162029551
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.204283582542832,1.3617917203873713,1.0308034163596407
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6180878935454298,0.7584292458035349,0.48585392597240273
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5468527159026226,0.6700883594301704,0.3898053798461664
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.583109967797234,0.6964248913193014,0.4582967531614088
1,Deaths,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.839576111297188,0.9978339674165198,0.6873634433475668
1,Deaths,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8044568917568796,0.9473768399652053,0.6189655255197197
1,Deaths,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8232909597084503,0.9535750874345094,0.679795439805497
1,Deaths,44575,World Bank High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.21053088045228724,0.2979619652240288,0.1296369892701697
1,Deaths,44575,World Bank High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24088373841082858,0.31585382368794024,0.14873496728645658
1,Deaths,44575,World Bank High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.22532152002982417,0.29183571321055696,0.15078795038430062
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0718415360982985,2.845827853444276,0.3180633369794103
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3130276301483057,2.1390995102827666,0.7427555833310865
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1631829143141108,2.3743386642081354,0.5219015153029668
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7544967209783934,2.136488875768024,0.2103743971754266
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.151065507882291,1.7077406902629715,0.6690520630690454
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.910018369930669,1.845578344098189,0.4605742097007026
1,Deaths,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.14437752652741057,1.1242353190113687,-0.271970353379673
1,Deaths,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.21894985758596516,0.6542841300871158,-0.08157963942161481
1,Deaths,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.16689112958101826,0.8202278824466435,-0.17903688747188953
1,Deaths,44537,Commonwealth Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13945495387477058,0.5924610473124209,-0.4474655883958202
1,Deaths,44537,Commonwealth Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.11583810362004028,0.2200374307219016,-0.37037905380007574
1,Deaths,44537,Commonwealth Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13820316130203897,0.35583117454549396,-0.38637107977897034
1,Deaths,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0119087464274155,2.809821393273141,1.4917906556822063
1,Deaths,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2365073099337347,3.0746032951008746,1.461030206178183
1,Deaths,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1321096979213974,2.759624223499192,1.5410220344398948
1,Deaths,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0754482134635097,1.6134363053208698,0.7206060854081169
1,Deaths,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4454713496659366,1.995713086856602,0.8835754871727978
1,Deaths,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2496527058019222,1.7040411152011257,0.8392264033463429
1,Deaths,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6732679621135156,1.1165488782819768,0.3843160014035784
1,Deaths,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.733298223376304,1.1821370928731771,0.3179946391443205
1,Deaths,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7089218673526939,1.0513023706770286,0.38641635794595053
1,Deaths,95469,Limited Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.30497795419948415,0.6613335384695901,0.08018582058880815
1,Deaths,95469,Limited Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.20147065188838342,0.5387050966191146,-0.10262390446219918
1,Deaths,95469,Limited Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.25082873882349627,0.5228589853415415,-0.0007883973961092411
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5906516352202837,1.7214484051218377,0.20914405272892558
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8480497384991114,1.5033861728629903,0.4314233304269584
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6820794104823252,1.5078749266417075,0.33387361264192317
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0947051537863165,0.8353468768103348,-0.14335120258383835
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.38661297404707917,0.785243491876127,0.1041655993267059
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.20382281296703358,0.7437224080310421,-0.0032595692014714185
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.36763605761578166,0.08191247181521459,-0.5193044893276045
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.24918335781723203,0.017063535271653017,-0.41844830466192545
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3239307472050346,0.007976863156370282,-0.4638832560448707
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21580556525073147,0.3709044743949039,-0.39995185225932206
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.11428796101809247,0.23742844155822534,-0.3363065900351225
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.184674790886287,0.23970226159003324,-0.3577635897145866
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5532426805705161,1.7466513381123339,0.15405987357546466
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7752034522508555,1.4889542763512273,0.3334324271671627
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6036960427539976,1.5429295727958694,0.222406891831533
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.06859694677836256,0.839453701963375,-0.16988953336569124
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.33154808414155473,0.7879771126809472,0.017408918690456684
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.14731493987232536,0.7968187865627472,-0.08464038924336224
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.38250799658657997,0.0919319039225525,-0.5412032180757488
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2787789920131042,0.01120021468370655,-0.4582595713271445
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.355434958315048,0.022066191094603914,-0.5086844837277996
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2832885702971533,0.2732078989476547,-0.46228968489793454
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.20687925094244664,0.11440328771021768,-0.41831297934273737
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27911331588643834,0.15814062094149448,-0.4507212062661024
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5720799770596162,1.4935817113561953,0.2134335923279653
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8913523590330796,1.5637961586677973,0.47307956813414787
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7509259046997745,1.3571220532003807,0.42162461958493463
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0825130796897227,0.7426939847893242,-0.1453476926894548
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.41945205436793376,0.858979692285327,0.11707369773724731
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.25358341044013477,0.6385188115834266,0.030787293278721005
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3750192248103152,-0.008675987415674184,-0.5175991818223026
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.23159058016102274,0.041606609925644966,-0.40152441139773226
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.29625964106516517,-0.0526144394117691,-0.4286139594074685
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15930683301213308,0.37578473105341964,-0.343842864024051
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09718303043753253,0.2511307098587419,-0.30625098407274326
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11381550871035269,0.21632625123557317,-0.2867159471277564
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6572438954698473,1.9830068885238699,0.23074558073039758
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9697032447541987,1.8142535892956644,0.4455251296866377
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7227125965768707,1.8130734037018814,0.30682144325538835
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.14091211664164993,1.0021642126127996,-0.13191494918996585
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4774650601901185,1.0287673813854068,0.10958150275888127
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.23305881387761102,0.9629518873762885,-0.018872065970750446
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3411622884439056,0.18589511016659732,-0.5107167966448869
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.19975856411531334,0.14336123435824333,-0.41271909437698656
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.30759926630679113,0.13064366774026814,-0.4747561909548778
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1541466826205755,0.5318775741244106,-0.3749966187955039
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06701086134559447,0.3377331311477326,-0.3264606410992803
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1611449653725255,0.37837850927995487,-0.36165659080495166
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7587670516121121,2.078130418054318,0.31161123983523
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0286916259576937,1.8351943951443135,0.5071131488476988
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9089834956883028,1.7003356998504637,0.48009943720618103
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.21091808804553697,1.1278191209485666,-0.07323627193392057
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5225519647698529,1.0347946905916572,0.1693809353272054
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.36673950329483307,0.8950654531828527,0.1061374079830121
1,Deaths,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3008017331595802,0.22371149234322982,-0.4785686343051498
1,Deaths,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.17579305205124074,0.15186896291356522,-0.38769741407159036
1,Deaths,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2327323921301422,0.08533160058715257,-0.4051114862125899
1,Deaths,95470,Minimal Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1683505170163185,0.4883453034945921,-0.3793244221329344
1,Deaths,95470,Minimal Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.08659574471563286,0.283031718137379,-0.33521519130232724
1,Deaths,95470,Minimal Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11532347472248042,0.2642169314069988,-0.3196755569548257
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8680848753555039,1.4716681525574036,0.4004498688967398
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.896677383032063,1.4638876226777184,0.49037916347281296
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8767183943052584,1.349879335987768,0.48232068926099086
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.15328214165252935,0.3877207831933185,-0.0442355314926651
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2391444152338737,0.45146932284480823,0.06316289725005515
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.18839844095659078,0.3990486915689813,0.004426445421403717
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.47719017924815765,0.9544743225991841,0.10740728119751204
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4802837586798879,0.922969538041132,0.163183622950614
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4743981050169489,0.8461254765297017,0.16454915234252995
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1279099222270544,0.1534787155517774,-0.3371659349449467
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18612624766769553,0.05517029837176892,-0.3601767415538122
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1501498095753889,0.06096308263373299,-0.32362544485591815
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6759704584369931,1.2578355744430771,0.22137547014068273
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5347714909863388,1.0721741495900114,0.16325507430910832
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6516073425084247,1.1852422697144753,0.25861591923669647
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.03425798585405965,0.2816544779422392,-0.169547317212588
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.00241445281501282,0.22830997437617104,-0.1659729923287435
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.04547851725157376,0.2944282921428112,-0.16032846061199266
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3252754918012063,0.7853859751900838,-0.034195997479467374
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.19783012742003614,0.6172522360607233,-0.09212414873160782
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.29754508903183496,0.7167823746208226,-0.011199052613478692
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19403856550655768,0.08306071080591257,-0.40700270596166976
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3042605298165509,-0.06408222942083339,-0.47317128262654196
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21735102391930244,0.03347636360852142,-0.4005464515281782
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4616342749644742,2.1825380487261077,0.8909788498617094
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2039012246362157,1.8523984285424784,0.7468857831088532
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3103360294577842,1.8193767467854143,0.8795678630283487
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5203797194873035,0.8059431712773943,0.3103113993470045
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4401375648509111,0.6808963599632137,0.24159684751307248
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.46356588686602046,0.6809773327908393,0.2799954175644171
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9465400228060696,1.5165954784399913,0.4952936148846596
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.720060152427385,1.2261872814160564,0.3633771753375313
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8150592407050664,1.2149746842163285,0.4766367207295554
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0033054188665133846,0.28803966380238544,-0.21451192277600506
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1247783680441447,0.12425314776650871,-0.3027616653366435
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.07934531662218121,0.11961871871088302,-0.24457933728267067
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.438349144794494,2.0514499288443204,0.9405254880886477
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1844478379774044,1.803952233456985,0.7519854128834228
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3587188236277425,1.8082503675897168,0.949601599872928
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5065372721911927,0.7394206845645641,0.3386240583346571
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.42728485161696284,0.6737188709303874,0.23942089234156788
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.49410773650563433,0.6966633543738436,0.3276241704490635
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9281272803962394,1.4129374028032349,0.5344726738070581
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7048775322411728,1.1883768892025695,0.36735724026481364
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8530700047366226,1.2062335153485777,0.5316570206340215
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.035649545462828475,0.28063403738577464,-0.16498114944300996
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.07497034981502954,0.18355925818725363,-0.2589742678781232
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.007866624180820311,0.2007739276065534,-0.15934423204821824
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7711085435706514,1.3712589293470148,0.29593888002169877
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5792617442779449,1.106698312631398,0.1967825449206121
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6736073095464457,1.1151301911990585,0.3216433367426818
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.09320336427239172,0.3302023868173642,-0.11461415682410589
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.03178466830666695,0.24363766257322694,-0.14250009988296214
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.05983965258443419,0.2427376804670982,-0.09548968019213398
1,Deaths,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4005060377394186,0.8750756184026758,0.024765101269608993
1,Deaths,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.23255305919340696,0.6441970176505596,-0.06595724725441157
1,Deaths,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3148288273964827,0.6617005274904237,0.03831690311910083
1,Deaths,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.14628626135544162,0.12980726085805094,-0.36435381353767465
1,Deaths,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.27110641520138085,-0.028576446352449457,-0.44566526929614797
1,Deaths,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.21158137467978808,-0.012405832312072188,-0.3725188440200785
1,Deaths,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.26470231183669696,1.1263433946938055,-0.1836399339915461
1,Deaths,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.29840786028487426,0.29858225410634914,-0.5784008902549779
1,Deaths,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05619949175910364,0.4641749019557421,-0.38460576819070574
1,Deaths,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.19313743436413408,0.305090168277048,-0.4678174572594253
1,Deaths,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5080594577173136,-0.09343392673873563,-0.6982223722512625
1,Deaths,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.37151031465790546,-0.04124011481755147,-0.5792497918295598
1,Deaths,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5042854606755981,-0.16655538107197812,-0.6800183329652418
1,Deaths,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7141068780721658,-0.47083823536379354,-0.8282017729903006
1,Deaths,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6227659691946107,-0.4147739959386928,-0.7540289027471547
1,Deaths,94365,Central Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.39121596495105154,0.04605239464138612,-0.6067820519940401
1,Deaths,94365,Central Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6507417563949413,-0.34224324844012755,-0.7933165982909637
1,Deaths,94365,Central Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5370443878235486,-0.2708531470860762,-0.7001725291772215
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5204279045485234,2.0955457219105,1.1108324202534325
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5127689117239111,2.1465948949651543,0.8742912844226174
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.517713697803852,2.0275290934512196,1.049906773925341
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6148567212452184,0.9729371922221884,0.334597546326934
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7854443217899777,1.1954126668509886,0.36588344264969014
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.689931953472918,1.0293066012829295,0.38965150304964724
1,Deaths,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4819597502206727,0.8201171938147105,0.241126032857825
1,Deaths,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4466937568313952,0.8116107567968026,0.07909863378460442
1,Deaths,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4650913418523016,0.7617597528624536,0.19286822354031538
1,Deaths,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.11624752972177949,0.36455860571379345,-0.07635648723492197
1,Deaths,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.03885538659093823,0.3188766117792981,-0.24235454251508343
1,Deaths,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.07550619282220927,0.29722822195153287,-0.137780906810898
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8709705175443163,2.7748589292024146,1.1826031194945323
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.393369619131582,2.211888472772367,0.6511190697333756
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6525087477599112,2.358746735085857,1.0229083744038867
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4473426326282162,2.2360513994528595,0.8605061440835884
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.139118213851361,1.8278084145779179,0.48789880706101085
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3095294002997506,1.9238443189208643,0.756465669247161
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8984594371829345,1.4961651519530057,0.4432692584295601
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6083445871559473,1.1583893262614358,0.10955215497353266
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7682272181722457,1.2390227368492548,0.3485202077129186
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.16733741652465933,0.5344535921287121,-0.11861869580390469
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.02063633138992793,0.3266754569083667,-0.3292199993979814
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.08059909950933246,0.3736226885775819,-0.1893537829458193
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,6.130311867540888,7.853992389852181,4.745630913745973
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,6.326567001674866,7.7829363972115795,5.119138284757808
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,6.218618456889425,7.417726774234311,5.215948392841451
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.512283255407377,5.879192872963438,3.464402992626594
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.124782007626733,5.088220521757301,3.2727697314813406
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.318851221731765,5.193922690301941,3.545812625248078
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.6853941226935,4.818040595760589,2.775507413214433
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.7821211351978996,4.732707523810656,2.9940207349566967
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.727382465336397,4.512663425579576,3.0707464472941552
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.261426281714904,3.0478703837235672,1.678231450918985
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.4939282542047816,3.1179624295220174,1.9342559951544636
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.38393071788226,2.900625883108945,1.9369395593180603
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.9962842161138084,3.149633447785998,2.8476535624660375
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.3690168258997213,2.467790279205029,2.2574586863201542
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.776042565670533,2.8846362978166162,2.660851674732977
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6548814189722763,1.7656163706319408,1.555305304471065
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1971425694806517,1.2678221328437775,1.1231338324474356
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4866968987231466,1.5603299849081433,1.4118326646316333
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.020870429645889,2.1367901526474524,1.9085175732766992
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.575118627936674,1.6506164282435096,1.4898488123866822
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.8705748182037265,1.9531285573345656,1.7830058713337966
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.0500789282812661,1.128196086345521,0.9743925950228887
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.9237436944131785,0.978174728180219,0.8658844771741933
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.0431536344606938,1.1013348070781843,0.9835476661936322
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.062431108448044,2.2778202993150027,1.8265299357142908
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7641490630278926,1.9234220049508846,1.5999810111697808
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9772386401158981,2.1544191187454564,1.7706895470919308
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0345079035592046,1.171035006702395,0.883343185962514
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8026749949642483,0.9051745890402858,0.7013149597974362
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9606490946659868,1.0778031421157726,0.8332155442908609
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.314952360253977,1.4777693177996265,1.136629989148156
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.1127860472159972,1.2345268223047725,0.9873036794219405
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.263318307319498,1.398012186264419,1.1062981956958011
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7055474111833351,0.7974846416986742,0.6083236197940158
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6874416634665321,0.7540873197350069,0.6169686249870272
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7231159624169925,0.7970672210188015,0.6355038779869415
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.5493990455374593,3.8229293059831884,3.305562755771235
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.601350536754891,2.7320352307777407,2.4574031125640907
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.097487017971274,3.255272364926509,2.922248387307901
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.0222742728796503,2.2037128265175188,1.84933090928453
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3486092665957017,1.4355709017139668,1.2472722693951162
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6983002165956687,1.8229618777150507,1.580412829514678
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.438980889774615,2.6457478339429157,2.2546602064610455
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.752703632001188,1.8525928897149937,1.6426769646875745
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.1149392113953422,2.2348887712252683,1.9817215392927907
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.240235863407537,1.3692496148101796,1.127881971706663
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.017734314807192,1.0886019397431272,0.9457243623220837
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1619410624337758,1.243275210084297,1.0739257417956471
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.109781045787739,3.341125398191598,2.8548577559904604
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.552026231472402,2.754982934261979,2.3513679613376572
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.016018951902759,3.225971717555731,2.778697828082402
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7302806730484015,1.8879556521937422,1.5557620141700093
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3164928347774336,1.4535443671487602,1.1814632232363649
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6447627267040927,1.7890928127071368,1.4913547529064348
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.10666493225861,2.2815427125787444,1.9139633659206818
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7150024438187688,1.8701330391901592,1.5616286626903446
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.0530065994406597,2.2126142075685187,1.872593367857942
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0889469370454323,1.1939315265636652,0.973066260682725
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0262766058993817,1.1270643761167518,0.9283663097218904
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1546811152970553,1.2552011477027278,1.0460876137882174
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.403640763789099,2.6337912465504587,2.205918884204574
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8546451052162571,2.006384638641911,1.6947441778093624
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.1422145663632017,2.3128801943328865,1.9763935564797943
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2612467909004295,1.414116504600228,1.1251884145722937
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8616754582612565,0.9680815073670588,0.7621613834981308
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0693059745841162,1.1899989615211486,0.9617051951189403
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5728795001639189,1.7468548107634736,1.4234176133135001
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1819569822503,1.2979395728134895,1.0597362044778775
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3887341974370517,1.5184754398787168,1.2626758686385549
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8246360704529664,0.923799076380955,0.7415733521847525
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6890704285093967,0.7589584330672641,0.6079684151342799
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7710527547635568,0.8418806649331543,0.7002497999692672
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5579622275025504,0.7178386014389889,0.38288747946904955
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.2807545423498304,0.4257986323661571,0.1489274756856333
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4479032164600297,0.5811103023077077,0.3299583442733163
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.42244420203089034,0.5544730066494157,0.2857842706220951
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.11662214014771793,0.23504061891041494,0.0017102783942774006
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.29348077245029264,0.39674959452669445,0.19326659066178808
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7145672169203605,0.890514222998251,0.5218941095819194
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3973151038046922,0.5555595534597918,0.2534905494117876
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5860820532458615,0.7320015911171396,0.4568812593522693
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.24645525567223453,0.3685574487675203,0.11411180486227887
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0669767706065288,0.1850407059463955,-0.03745253368001571
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2045492928411029,0.31192287874993674,0.11202744505536663
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3328803199793626,0.48570149821300096,0.18578299003661752
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.031034107525270374,0.15815742956010947,-0.08321437651236505
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2420181364732977,0.3674212991965825,0.12861259286764806
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.21700736187406225,0.33553757715835963,0.09785549648737127
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.10104027876667551,-0.001700705670233344,-0.19944372651857223
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.10965117841530346,0.21024441634782462,0.01782579094689392
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4668602745127784,0.6350429028365532,0.304976850663253
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12486778952944338,0.2635605148343294,0.0002216320856619745
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3605485875516384,0.497919444632792,0.2363203273981208
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14194283348347744,0.2704827181243959,0.020853512056727183
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.05593484316005179,0.06108893976330096,-0.1618678923964761
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.11161098395394607,0.21774023782646407,0.01634749781961419
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.830356720385841,1.0338191535854415,0.6218985504353469
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4449575083253414,0.6177167291259484,0.2921063235616893
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5970308965466917,0.7534053749221594,0.4619252776376556
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6712198284040566,0.8438601673474936,0.49242606605738826
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.25975451826286944,0.3962279882330318,0.13095554574588633
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4267712112788931,0.5554806388354094,0.3194039165209749
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0143425640518482,1.238256861639222,0.784930362660249
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5764620651155926,0.7649439799275588,0.40970000256391276
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7494415474017875,0.9207394289987358,0.6014422923354081
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3886990060479734,0.5355323896189452,0.24296107089627816
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2056533618109685,0.34973091336383355,0.07513725001857946
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.30012138290181034,0.42536405614374,0.1928764086911266
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7878239145612805,0.9875732032894252,0.5850653405379969
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.39106735622892497,0.5573323549076619,0.24047656018767377
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6770954364614713,0.8440639579499005,0.521283982450649
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6321837323411437,0.8091076133767656,0.4643116311274744
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2127678299285449,0.3455030022408806,0.08891554247102744
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.49804606705016097,0.6482403921209792,0.36335304761915665
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9675343980879522,1.1873623091955565,0.7443947109806965
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5176674085434617,0.6990640666896955,0.35337145108674073
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8371469467797216,1.020049900774989,0.6664658210751184
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.39033010021041953,0.5358155566368856,0.23693350582155587
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1865324276523155,0.32553249516983684,0.055567319778961094
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4051635132173317,0.5393299285590297,0.28046945010593005
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.44511437441431345,0.6144053017926695,0.28227415093385677
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.16102796358193508,0.3059362499988121,0.038142982294622985
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.28281932303475144,0.40561073471679876,0.17684442566572975
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3194420361300033,0.4597912863123572,0.1783543188737302
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.01205227610051789,0.1275584028983407,-0.08780476134828225
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.14596504485925352,0.2566885275624055,0.056135519925499505
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5903759971402098,0.7766838992709775,0.4111672179754304
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2666922941191585,0.42478858078565673,0.13262363794365195
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.40524358444133146,0.5397534412795404,0.2891551049761595
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.22434570512258814,0.3546380340683227,0.096751415782114
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.053720093310104494,0.18140459735756054,-0.05287456471672343
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1340271569007854,0.23394260432792024,0.0464353917230367
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.9300097327677435,4.7474484465160085,3.2120743830702363
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,4.730114661970649,5.509139839459421,3.9667624753065382
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,4.144194625649386,4.800237347082348,3.5524040434872974
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.8104932480657054,3.488382579799074,2.250142973870193
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.0082924940605413,3.5505323819513164,2.463560372937161
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.789978210615019,3.3099061261258207,2.3414313312884545
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.2395551633421293,2.7767017308707604,1.7677931800746678
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.740101254223575,3.248578521307694,2.2418538998198687
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.368868380675123,2.79850251029917,1.9813121691961486
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3116436187513627,1.6835333984817522,0.9851276622642786
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.7273869756322793,2.0818218852727632,1.3970462792480358
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.4404417556735496,1.7439637065310085,1.1740931319356314
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.777745423200176,3.5075375997655054,2.1600042645065036
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.0613636784028944,3.7312260963743284,2.4640023635760073
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.8332932777928197,3.474902853317416,2.316557320250554
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.919493970016786,2.475548502489212,1.4395553006077542
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.8411931396812125,2.3304744041792382,1.4159144744648562
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.8238805721727114,2.279282567420468,1.4273529739841297
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4823915884339642,1.9619448027095931,1.0764681382318608
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.6508913492193056,2.0881170274835874,1.2609878421156113
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.5103755703606405,1.9305576142020242,1.1719716888585388
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9348325472411941,1.2787930058302759,0.6288301270972201
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.120370570690986,1.413229695030907,0.8380338188497967
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9693197790854862,1.2585854903713112,0.7036269338697401
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.899759659913056,6.063619524798098,3.94307656467448
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.3564258129367674,6.490378388075882,4.357128919793221
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.093086730449229,5.918476444991525,4.353675688095888
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.559639230463319,4.433962007045055,2.840843558151766
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.446282139266965,4.236975755502631,2.771114101101981
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.4887338467243256,4.130349903864154,2.9619395757425977
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.876786843181137,3.6415699651362097,2.248141499894496
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.1489005993412076,3.8890424112764883,2.49664985326233
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.9902858893738604,3.5308232355293794,2.5060548945965655
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6112801818461708,2.09176192212049,1.211552759646978
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.9312512906207,2.4053268413194826,1.49923660742094
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.7676631421292475,2.1251641417835816,1.443863449636965
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.891789538872699,4.710298513645661,3.12197399314986
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.351067888307598,5.260704789440543,3.4990935334810978
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.959103555570321,4.6905513264333045,3.26213283636341
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.7813230383392504,3.4894075817450245,2.1850593136773266
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.7439735417637277,3.380843331099178,2.130305851216093
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.6540785666271107,3.252266604824964,2.1434460000675077
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.2144403191150017,2.752290165098782,1.708587377407453
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.4926937593971035,3.086422561613661,1.9366018587933116
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.2476545660916645,2.7266705144947743,1.7912172053267328
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2794892764510049,1.650601829734982,0.9339997834137492
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5703629746055316,1.9804546422242209,1.2076091790260708
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3555970060140576,1.6924162467532233,1.031055050303854
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.850959837422324,5.026771711450877,2.884970729396147
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,4.039247862638353,5.152941239996628,3.1794328524971447
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.943111187234491,4.8207257826056535,3.2715181595651863
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.7486580311663826,3.6710609092583235,2.00041037184469
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.523474401936242,3.3262691045832478,1.9225536689807563
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.6405699921209043,3.2674904559861075,2.1460611462498047
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.1876107432478102,2.9602476413680456,1.5528503325657106
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.2891658131174957,3.0160842507401133,1.7279562409649807
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.2371813651458727,2.811920129115497,1.7973635354867992
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.4151536416744472,1.9593852994296381,0.9730165203320142
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.591683959536503,2.0783745204626216,1.1714361082772897
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5040908680456917,1.926972113456518,1.2159184081709342
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.7363136799391089,1.0615478535429896,0.5038231432734742
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.28685970376812264,0.5012573820804671,0.11497715717020632
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.4667833082516945,0.7039911693844891,0.28547940769947616
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7345708273777976,1.0565773299896581,0.4938197467532211
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.19414916810640204,0.38649733602904707,0.03328780046002548
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4169085834711318,0.6391590556180955,0.24407432252901043
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8938746592607795,1.2486220570556372,0.6402868767096308
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.38988734333271763,0.6214499749495845,0.20424365944339323
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5918512457492068,0.8492850651289852,0.3950881394814898
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.22340804436789505,0.4275795270582816,0.06908378330662157
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10639971748063284,0.01734171973269266,-0.22502266689955147
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.026239688471265715,0.16612026461084833,-0.09446957081650723
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0046917151461996,1.2303750401303968,0.7899976806904876
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.668028116261906,0.8692926605359006,0.4764745910303376
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8229340031201909,0.9949924663151265,0.6733637031569484
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8303545882877293,1.0284370510708956,0.638379406914698
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4543714433770293,0.6182559767241698,0.2921693614540203
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6286007377250017,0.7890411885918203,0.4956179389156603
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2062015587703883,1.4545703725918782,0.9699266692718083
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8198341706814046,1.0394156582148728,0.6108474951377689
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9969034350718269,1.1853820830091883,0.8330590801636918
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5770153280007333,0.7378212129221711,0.419337348244479
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.42229019508218385,0.5832749078266934,0.2643716663181651
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5252655527490322,0.6715969343406306,0.4061466668163748
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.4337427356794672,1.0103951443442052,0.03174596884569997
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6796843360715211,1.1114011680982936,0.3204128442469623
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.5058603985722654,0.9550318681749133,0.16609383538613864
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.10771657335799054,0.568871754530129,-0.20583785646300007
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.17487854247723428,0.4774109731155697,-0.07897832170046543
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.1091089309802198,0.43149403807515496,-0.14112035266219247
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.057874338177601334,0.32104931293145494,-0.3220301456169606
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.0963462099169023,0.37813196119494896,-0.1381537672122985
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.01383095865652021,0.28032578920461404,-0.23633980888959155
2,DALYs (Disability-Adjusted Life Years),70,Australasia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.19918414988444913,0.684307955005647,-0.1409003674414363
2,DALYs (Disability-Adjusted Life Years),70,Australasia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.4166878861762917,0.7852342380916745,0.11059498400738482
2,DALYs (Disability-Adjusted Life Years),70,Australasia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.26393190064698585,0.6461969020153993,-0.023936225228997327
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.311028781418804,3.0100760196744885,1.715171366634501
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9031376586120574,3.7150662025511445,2.2133372909165243
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5783743532796337,3.112887607147238,2.0867992220235863
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.167717350157398,2.781587725645962,1.6618947529348953
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.9863696149489636,3.7043587303271943,2.350826526612012
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.531652083899193,3.022758949381639,2.0765545292654544
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9997196277584207,1.4219142311140611,0.6398472598779563
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2632103088724915,1.7340020696130574,0.8632338182181225
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1188682411106454,1.4353703860119413,0.8277911119713758
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.45323186096011114,0.7546092427036832,0.19753317051365
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5450386628101979,0.8515485916284776,0.2848281377037272
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4887308738952209,0.7179209100079251,0.28934733378182476
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.7955463488020715,4.081537432942592,3.5313273008267725
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.8832874447067263,3.0737825356419197,2.6917826425596676
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.357893072211061,3.563474097640791,3.1597705508782354
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.185773812901255,2.381650685680394,2.0040158710049867
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5325086192712818,1.6620710077115908,1.4078139788259687
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8697502546590397,2.008978756288537,1.7423561760873554
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.625048513986856,2.8412348417107145,2.425320099836684
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9682029960851823,2.1138085191643596,1.8218256970592122
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.3129017737362614,2.469185953386208,2.1622876027447777
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.41742414295819,1.5542922348921289,1.2936574944807844
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.254600254298243,1.3558118296849109,1.147904597340006
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3691249237155367,1.4640191785473116,1.2805909330434375
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6521344723691695,2.144139260979572,1.242676819136953
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8457138218509537,2.5548170322324912,1.3489075076899462
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7142978155025945,2.135643196168978,1.3703100505356098
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.5371548042308614,1.936664416084076,1.2046114312388503
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.9069503799224379,2.5748176229620547,1.4488862687083404
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6788337604976056,2.055757341342309,1.3567455977756762
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6017756745620165,0.8989255025117941,0.35448078226165436
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6500696160442964,1.0612387410299478,0.3619995375418702
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6072212883242251,0.8567131685727056,0.4035352905606978
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.26346396698713065,0.5021082728641502,0.06464873686652259
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2979690681882405,0.5618732142533602,0.07953138801248762
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2482677438481455,0.4296713689548463,0.08945690018237576
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6060714157598315,2.133676632735258,1.1470585525910884
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8727073914554588,2.520337098433295,1.3800458534577364
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6629062251003435,2.1188850710735894,1.275818793403455
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4928689079133621,1.9297094024365649,1.090053235562709
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.9337083395912804,2.4652744317261788,1.478223284057039
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6276885594984645,2.026892855686057,1.255028796699834
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5739555604835286,0.8926065229923441,0.296731443005815
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6657216709666708,1.0412457639820074,0.38005491537037317
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5767907078390678,0.8467901545055398,0.34758403894934997
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18594478087203656,0.4249761594918008,-0.02346337591173627
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21607182971839758,0.4736781457923128,0.022350483534246242
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1547919930454724,0.3469122892661072,-0.016593638652293137
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0034596826442073,2.635336694275967,1.4457556175780852
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.6171256211970966,3.372411404634666,1.9790936954343947
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.280203023074366,2.8293453201449497,1.7906302336413336
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8734309269933767,2.464216098931894,1.3673169530804112
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.6940811733154235,3.3855555270863102,2.09308133306794
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.237187746121924,2.747360397942199,1.7664941405794599
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8139610601605966,1.1955877224174918,0.4771316820373761
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0973679922145276,1.5353157974755378,0.727409113467373
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9423115984545751,1.2674760609281508,0.6524201190203808
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2663278934139409,0.5348967636324777,0.03489469039089077
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.32652369646151425,0.6073844077174724,0.09967323897080478
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.29213396013286586,0.5099111439871746,0.10493629521061817
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.489101150302726,3.2017946135032194,1.8573486103721941
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.1272999113834485,3.960580166117386,2.4305190261832808
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.6063855382172294,3.212667147022958,2.028587706276679
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.337360650688143,2.934798598956121,1.8240438822232865
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.2154589333775987,4.003408024475877,2.4851170128054925
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.5588483525983374,3.138382173045166,2.031538291863421
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1072677146904994,1.5377040536722553,0.7257162280120925
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3931894092029444,1.8763618278166279,0.9891653085077388
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1354545465947963,1.4944529965167725,0.7933222387328928
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5082934885270334,0.8082129430960925,0.24388990111925954
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5611185099421556,0.8716621019994717,0.2981401095672012
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.46261533996291826,0.7036141527231892,0.22813843409096085
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6665224389009567,2.1998267603390538,1.2145295451190599
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9773100197737656,2.610483927233031,1.483738730655636
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8210435047063651,2.2475588107255584,1.4323166517145434
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5508618082892176,2.005675907041369,1.1828370914337845
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.040739776859115,2.6440841317222765,1.5391079596262014
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7840606230931957,2.1827816241196136,1.444249901754341
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.610465390350238,0.9325583679567819,0.33748103383380873
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7263748601317467,1.0935168469148793,0.44018059095681583
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.670428775411773,0.9229819314121724,0.44025135350051886
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2311983439858759,0.4756607645537879,0.020702888474755026
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.32804671301862676,0.5961053746489584,0.1068513973055929
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2741326537068575,0.46240084316529,0.11198241156624728
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8832221935888964,2.4566323334090283,0.21594385412094969
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7305570165797324,1.2120095212129598,0.36176180677010955
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8067564314623227,1.634616950140059,0.33424217114821686
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.944287158885492,2.557556081893948,0.27216599355329035
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.828607665543188,1.3163072736994987,0.4536284972396535
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8852994569517733,1.7212786651751086,0.42593397756323065
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.15631468588496625,0.5485745367277689,-0.45525600961868007
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2252511473327847,-0.00971084903301823,-0.39035617590553523
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.19085685885542625,0.17989464303369268,-0.40246904197449473
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.12042088732864355,0.6780000289763735,-0.4258558434169548
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.17997449850482145,0.019201797589375423,-0.3317707011478268
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14821240783889328,0.2641226817223434,-0.363509967424009
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0648097049782947,3.246575440602654,0.2815287036071777
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8021099263254493,1.2705360530205336,0.42326743506331443
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9636535322113293,2.232123776201577,0.3694003656310867
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1306578712567135,3.3253795747286503,0.33757805130485696
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9036275020078968,1.3839187774071773,0.535368488758162
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0480674353619313,2.359139401688311,0.4676848756210561
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07496330997856061,0.9024697917829173,-0.42587393535875095
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1932177995728484,0.016490751338477057,-0.362820871089682
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.12059159745891505,0.44748386628247294,-0.3867236922275915
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1435680890405836,0.7787979142474379,-0.4778648284078527
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2575319812207304,-0.07105090387430615,-0.4074814786640968
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19208082762216702,0.3601838503136227,-0.44422486226686597
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9059357368646408,2.2670350823583574,0.3174653724309492
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9577045829202255,1.4752421512850293,0.5899174720170254
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9384257705891279,1.5905030311563502,0.5536481679535997
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9685981697493911,2.31874174790792,0.36960959790504144
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0692514004586824,1.5518771701499188,0.6535266370402286
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0235095969885628,1.6542939558694427,0.6241051826240633
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14613899713273154,0.4636347899190332,-0.4097742739231285
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12356000701066056,0.10813512551682593,-0.28821372224114933
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13188967279855116,0.16013853515268406,-0.30420961178811534
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13097207843808323,0.5036376022083001,-0.3994586467580596
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16002378355829536,0.06433785934868506,-0.3201692037799151
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1348872954913508,0.1598065000891804,-0.30645150859283743
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0943200168994007,2.7526617855299342,0.3812851387382807
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1219008180892185,1.701324544497818,0.6973395556942643
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1026561033126578,2.298307386728133,0.5232950970232058
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1643853678591851,2.8094110911355976,0.44258170070290076
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.243890636056595,1.791342551648614,0.7844587829818261
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.196091867444204,2.3965223853727293,0.6155687443798836
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06174266248006343,0.6811960097277034,-0.38118295858760887
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05005139470219341,0.20934940107767733,-0.2401221914318678
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.058340275117103546,0.47712373006333897,-0.31780302079904954
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06746071509758582,0.7004673282870302,-0.38536892876625184
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09901794068685854,0.1625447119960849,-0.2782283600472186
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0915411621231406,0.43043475190313046,-0.3378410711231517
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1671904456598852,2.7075216160649225,0.46237888891219747
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.068782373551703,1.578526679589272,0.6385389850921106
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1023196449379637,1.8382372305025982,0.6309607549142429
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2383364798701721,2.8699331716341914,0.548348104345161
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1858813578470146,1.6782131930834832,0.7730853147334974
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1940087841021436,1.8978421002186505,0.7507625546145226
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.029096641852341783,0.6609731713478537,-0.34485288223168925
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0738318616655121,0.15437432424610953,-0.2664464755633622
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.058490955630219325,0.2710845513048007,-0.26958571430309775
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0777186782772318,0.6147733601757528,-0.3824030686407862
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.13337878233986136,0.08425943973466832,-0.3055444638764854
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10551133092923067,0.21831741122857642,-0.30461623068151106
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8676399336847193,-0.8232460718562685,-0.8998346271403226
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8853031364373121,-0.8471007481833501,-0.9143069071512162
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8747952231699082,-0.8368714582255374,-0.9042187178233698
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8677784552709168,-0.8247715318610336,-0.8990552113102039
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8935514145588009,-0.8571684802450243,-0.9201971867900312
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8790500173407264,-0.8429463155595643,-0.9067841821907261
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8556289808755195,-0.8072066186520208,-0.8907451668519923
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8761203583273718,-0.8348594378371363,-0.9074462081508916
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8641194109249214,-0.8229620074212286,-0.8960517531835985
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7854308335623821,-0.7136840203640931,-0.8383696948877348
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8125755030903761,-0.7492904000137957,-0.8601787565270599
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7960046724629024,-0.7324879754992866,-0.8443404620693749
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.24416365507282503,0.4019103921376921,0.08445673321988668
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.12510911093577476,0.22310885499811361,0.021820793987232676
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.19543680066404193,0.3270121009738034,0.06774076147158528
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.17331120556481205,-0.0734735101911203,-0.2758290235960328
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2661643967534784,-0.2023655146902459,-0.3325850848918078
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.21262389185650718,-0.1289996428942564,-0.297654364726815
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.05951203868463677,0.059731845784569026,-0.18023766567832133
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.14001930540722568,-0.06511289219851074,-0.21896805596782415
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.09122031410923562,0.008804179046796683,-0.1882957649589603
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.30301820050050166,0.47104857710157144,0.13520556278619233
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1824973053838337,0.2866116666889855,0.07288391884258466
2,DALYs (Disability-Adjusted Life Years),100,High-income North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.25336767200681454,0.3933167144106433,0.11859302373202607
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.898615755966619,1.046206418129917,0.7618983450297186
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8193226101800013,0.9066574436995646,0.7077840850150985
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8738848678358822,0.978547672673085,0.7696982039253912
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.822896111000468,0.9612348778672819,0.6799621209813065
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6559139566329695,0.7373834739307075,0.5508404229701229
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7523291059082777,0.8525791963300742,0.6439372102312095
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.653632880144564,0.7821795705365262,0.5345564396889282
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6128767272263443,0.6903013245306963,0.5139949289015138
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6469202378853243,0.7389063008494272,0.5553526457364493
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.18128442905928352,0.2694293389027651,0.10115074241096547
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.24942906996597453,0.3035356636211725,0.19155241116753582
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2308768574346291,0.2999526590770719,0.16397957032817345
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6874581140197649,0.8652729892333373,0.5342766146826461
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6402005431284018,0.748950291272708,0.5264920581802044
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.675035224633278,0.8140026477832151,0.5465985983084831
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6201102437434388,0.789293402627618,0.4800190887483835
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4928520008767582,0.5910773063055653,0.3851089199541501
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5663466763896443,0.7002258068894562,0.44917805924198584
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.46972140752574504,0.6245924093637504,0.33630527888694395
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4540803644132534,0.5504898395070212,0.3532748404039795
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4721552310763115,0.5942909425710736,0.3592748280106166
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1443578693962462,0.245129470508759,0.05928986039622408
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.20617298954494098,0.270912425019233,0.14000282227452487
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18090833396429828,0.26612554153962353,0.10907858287938231
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9967915126746977,1.1736725591485744,0.8202462969731501
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8662613916669423,0.9726597375363953,0.732083753202109
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9403389338736131,1.0693863165534803,0.8132277084765653
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9171629497137089,1.1000393346687738,0.7424335079069384
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6985525699499939,0.8003442350683116,0.5778627558635074
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8144314549636116,0.9407570643228209,0.6866931716800937
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.739140787057987,0.8931984542844295,0.5853756175660392
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6544891756404038,0.7488140715703466,0.5355372156179274
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7053253982694337,0.8187425829799595,0.5936098637870135
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.20032876235402375,0.30758592937462026,0.10365932711213925
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2534047169173635,0.3188821304843789,0.1811429698575704
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.23675874188002674,0.31480809544289695,0.1605496582863889
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.867361484699012,1.0436134732159223,0.6961725036082261
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6730147173159406,0.7938908788167369,0.5489081685657102
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.837115267067387,0.9871025421907338,0.6867101842462481
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7929286282194941,0.9615234111985631,0.6219598153353018
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5228972661861634,0.6330733318431404,0.4074711029669522
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7180028980417292,0.8633089304317514,0.5749671476618856
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6264114213261338,0.7799211994297286,0.4773113588408482
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.48317098175296486,0.5903308371135267,0.37314730422838205
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6146041651724187,0.7464250059646218,0.48241612148272106
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1588995456279514,0.25788105193978833,0.06347409260831707
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19052735986213218,0.2682801008683671,0.10941514865728502
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.22000595617601781,0.31090783174745407,0.12778688324099788
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9877661594605702,1.2263793458555825,0.7848328378219437
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8212179198298304,0.9731992931689006,0.6648265551782282
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.904218914289925,1.0576316604875347,0.749207685927396
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.908171043869165,1.1395152306967913,0.7078567551452835
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6576389418038346,0.7898627919437597,0.5052699115774247
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.780509697314334,0.9190977365833574,0.6331881803856378
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7312799964883896,0.9391043598008941,0.5545316407012857
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6145569684369945,0.7492924016465203,0.47591196343660136
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6735802295740415,0.8084116489419761,0.5373439359406205
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.30840891928720715,0.44254599082660917,0.18736691451381807
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3166050821729511,0.40885884264606775,0.21712079501091489
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3139949879117165,0.39616004682636086,0.2283690856968169
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.9533352558696535,3.212651824661232,2.7109452137472405
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.8446281611230058,3.027180132679038,2.6247362846788818
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.9150455309602337,3.0975886846097556,2.7274170994731817
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.274246853682083,2.50207961761172,2.073879311633443
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.1228852193657795,2.280763258502306,1.9285130898754435
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.211853213827087,2.3768647903243836,2.046898254279484
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.981422802273424,2.176987377793457,1.7986234311462739
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.931577362110541,2.0707755380574184,1.7639070387190334
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9691276285362695,2.107566355906072,1.8268322821803706
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.166388327905434,1.3070751314751727,1.0357299275911247
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.2887103910163402,1.3874986683465602,1.1805175426995813
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.2374250113336267,1.3392361690370291,1.1363788097813292
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9352280054947129,2.164305001036336,1.7060536755189508
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.068857259903662,2.239499294009198,1.892331610673293
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.971043852979575,2.1604207192612135,1.781282148207429
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4309605698764525,1.625061582340055,1.234486257354995
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4927007251986175,1.6333774614763041,1.3465902413907909
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4373398102626609,1.591411848762678,1.2769879331190506
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.213613351526497,1.3863726379973453,1.0407806599223641
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.3400422859240269,1.4701589846640588,1.205439256598961
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2532071005853473,1.3968284407296405,1.1092939031470195
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7254151544843016,0.8435152151217995,0.6110251068080246
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9163910819214341,1.0037745707335137,0.8317724871607444
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7900646270661583,0.8850227779133093,0.6956562382705741
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8074848598933897,-0.7320005165695855,-0.8567103864985399
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8137398704231441,-0.750402360475545,-0.8661665783660208
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.810246299436798,-0.7497876361693128,-0.8554553421655892
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8183882513791826,-0.7462280340480731,-0.8684074108457542
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8186763750716178,-0.7586180634164719,-0.8665944579290606
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8185350102857152,-0.7616816355403968,-0.8628920476726882
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8484829182823459,-0.7890737341035707,-0.8872253680091403
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8544637694546072,-0.8049743673434517,-0.8954279063917188
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8511879975612636,-0.80377403557317,-0.8866426324740042
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7551718841920683,-0.6575739831670944,-0.8184254062498102
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7593394973829052,-0.6768899833074329,-0.8275013672248379
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7568136741848385,-0.6785801916249841,-0.8154958763427917
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5822288934091766,-0.2656706981927616,-0.6993333724585489
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5121460615242571,-0.027168789768591342,-0.6756158864592247
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5511986127308266,-0.19958811078058142,-0.6813097356261685
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5911850139547731,-0.29250484949928757,-0.7015714437701501
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.48821920807255403,0.023608835368804655,-0.6553415435165301
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.546336893889998,-0.210641977714339,-0.6740815796835441
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7326836262201246,-0.5301296738271599,-0.8076144775858691
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.696100724621627,-0.39399341372850216,-0.7979311238988819
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7165761674554685,-0.49452962559423275,-0.7987430104147866
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5503124530291077,-0.2111707196534095,-0.6764636080594224
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.467860159507755,0.06278509041556456,-0.6465573588086988
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.513763446838276,-0.1326244930424752,-0.6547909918461599
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.3700675547022869,0.5695783577465341,0.19788440428144588
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.04031198701487836,0.17209727731365138,-0.07540079936526538
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.2438905822661578,0.41180775758362964,0.10425426104161394
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.36880093408006254,0.5652042212861313,0.20874509561917265
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.03455313779986813,0.08239225714244969,-0.14014434889477456
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.20171511848642917,0.3620340762266746,0.06961589050474434
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4943936993095887,0.7120090176128535,0.3065858687883434
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.12360069993288803,0.26593688971904106,-0.0013762006418961774
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3499531674629011,0.5321881051036945,0.19841050220168419
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.014084725881407335,0.1320352156475142,-0.13689245183474424
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2669238138315353,-0.17238511821482494,-0.35083079209047086
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.10342457424604454,0.020540910605795312,-0.20331628075549207
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.08880719817774992,0.2883870809025607,-0.059328948892956465
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.21792952122131076,-0.09929390859799901,-0.3234908946403401
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.005430589241070288,0.16437598955170835,-0.13227117226524243
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.08777578215394757,0.2788124086903883,-0.058468944171040774
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.27424577007673356,-0.17483283768333513,-0.37197760988392525
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.03917958890834125,0.12134833674445877,-0.1578677769087624
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18761050222324346,0.40530116881063727,0.026031809214512605
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.15531595490496214,-0.027182222866543024,-0.269328707367654
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.07937317434279301,0.2636586188709846,-0.058282700906597804
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.15605231981321718,-0.02451353597279579,-0.26652858354146514
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3859866815804781,-0.3061068074205262,-0.46327547896431204
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2180209274417896,-0.10367365558745231,-0.3145935557073352
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5117501210573674,0.8290168018106683,0.2904212086263993
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.1521201416374385,0.32607397265544347,0.016163272444027307
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.2994016236768975,0.5067392479221483,0.1508802559425258
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5105202157427583,0.8267024263254504,0.2882950904287491
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.06921877216661695,0.22287864059774834,-0.05005412057203987
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2553927599229466,0.4484303902232118,0.1134453937226676
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6489331844147944,0.9949900829168716,0.4075198825110401
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.24436035891999133,0.43224115691856535,0.09751860827868494
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4101974584399014,0.635214101040559,0.24901214707299074
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.038291533140589834,0.23600960101414853,-0.09685397923753497
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2137427341257213,-0.09101934608399426,-0.30707082239666433
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11066632516843217,0.03380601365471602,-0.21567694870536927
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5473540363462235,0.7853358776212809,0.3313382388300333
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.12151026805091535,0.29644685524791003,-0.03181829003806227
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.43786822669104414,0.6484043416107318,0.2500166195453226
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5458777375389906,0.7800698150524812,0.33760938447974587
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.04082640510742935,0.19823587692477299,-0.10157539423787237
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3890814978094382,0.5863447352398385,0.20545700111658743
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6877679604780697,0.947345353527725,0.4521499096370073
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.21129981956644217,0.4002420544650605,0.0456955803200747
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5604706673472529,0.788958525727353,0.35660155241484554
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.09309677140555743,0.25628535366376537,-0.04327368242039671
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.19473752425408677,-0.08018723769963654,-0.29674693004706426
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.03819418819099471,0.18918300193249427,-0.08566336882255805
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.21993168440439856,0.45263121871295986,0.03499452241676115
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,-0.09808165092399125,0.05620864111964679,-0.23001263069889227
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.030736326008795847,0.20540269615988715,-0.10781437094220031
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2186056805148284,0.43470774314004434,0.039430735375796166
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.16299544476241262,-0.02542610096773107,-0.2825851851081118
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.004307119034688025,0.16214697910688491,-0.13891286216443594
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3306338191171968,0.5844495647054151,0.12891462016676533
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02587291028722516,0.1407700605685959,-0.1683664536359571
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.11862392717827767,0.30818354198390163,-0.031740546087881474
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06518866054053889,0.0966173268932055,-0.20434918876327746
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3191593793465986,-0.21181902450498735,-0.4072880316741897
2,DALYs (Disability-Adjusted Life Years),42,Central Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2155831463843013,-0.09824198849433469,-0.31828972875780204
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.11499799310541374,0.2964722354718383,-0.039311577490847974
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2950405096816902,0.49157447841587343,0.10215108521362914
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.027219634778004008,0.23223198822555086,-0.16656814873057416
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.24027189629953236,-0.11986433248986905,-0.34524681812151226
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1013588708284471,0.03492812563801913,-0.23632072024490952
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7471033738499256,1.1200326401388732,0.40759712046286245
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.32841116600414905,0.6018513816699207,0.10927646451172755
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5958322786798527,0.8688550887424961,0.3353068279316531
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.30449298302989336,0.6048898605162882,0.06626612027590538
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.039803679022745786,0.2176117161748964,-0.10874525003708364
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.21827333238388105,0.4332517283683859,0.026708471910922543
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2969827943415774,0.5738312333766146,0.04494632311430955
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.010461337919399263,0.19322534591271778,-0.1736956323001826
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18673564184675884,0.38976819361750725,-0.007003288078159916
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.06335317864601166,0.1339704895666628,-0.24150779014715246
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29638082180220204,-0.15615156771817806,-0.4040650532913088
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1514360780448092,-0.00804903751465088,-0.2895479998846532
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0852436756565995,1.5402328254893427,0.6772307511819033
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5834026161770433,0.832829409496694,0.3550408147035352
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7648960877979152,1.0316443094697898,0.515665645778053
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5583999345317401,0.9141536282976015,0.2684176233591052
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.24056749226658353,0.4090092149992075,0.07910791309250712
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3485904514948735,0.5291886014878306,0.17729199197326573
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5480052353035653,0.885771796674683,0.2451120288491821
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.17948278849521715,0.36528178030210434,0.009375191326988223
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3124594103826072,0.5108258842824391,0.12711997808157244
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.02623182030999624,0.2505133110474445,-0.17443823231941033
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2618027017358318,-0.145088914067495,-0.3684733727633266
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15644219988031954,-0.03112444815327764,-0.2806545271012866
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1720278243842446,1.6267776802511387,0.7410011421904761
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6444600576944398,0.8940507667731957,0.4034435907541237
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0030590205717296,1.3588923475887804,0.6642113582154874
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6226720335090626,0.9608992581449398,0.31966259525332597
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2879895793846606,0.470436303148023,0.12864301837813372
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5300684923265234,0.7831053151956688,0.28706391808412746
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6124304716153147,0.9500193902887297,0.29245273070146893
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.22496471497655463,0.41088580827213034,0.04543060811346284
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4895685243323847,0.7541828559069887,0.23758552872130123
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.093147421925664,0.325858520027813,-0.12705097794088446
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20365752539935958,-0.08341301846295063,-0.3177186158651057
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.011984298783280601,0.15884293777176248,-0.17842663311368662
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8030859830438993,1.216880951994843,0.4285724565951202
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.40648427680492244,0.7023629292936573,0.15560682303124362
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.536887359911018,0.8113015402723935,0.2941873864340267
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.34680177090822656,0.6689088843244113,0.0701408975225264
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1014403778416855,0.28535395142796904,-0.07300165946736761
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1737890467715754,0.36543072435816837,-0.0013685735112639766
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3385421445172531,0.6457277198801142,0.06051761126832494
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.047695627019895576,0.26809679001418396,-0.13918396742083647
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.14290143887738135,0.3469686787833247,-0.03758163108450255
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.015660251220866325,0.21117160158173365,-0.19812618304636487
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24186606658684212,-0.08681148178322723,-0.3788212431452638
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.16657771062497143,-0.02521534763616817,-0.2967435923494588
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7529525363522279,-0.7264975849766233,-0.7794349620200124
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7161453493239953,-0.689323897285929,-0.7407385721620595
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.738195778014504,-0.7145223074198261,-0.7614068785796175
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7743130349960822,-0.7461243797028074,-0.8003076387073624
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7524658366834308,-0.7271557181892956,-0.774737338912258
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7660735465490277,-0.7433108966382916,-0.787070814320604
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7281195431337234,-0.6990053633717765,-0.7572639588794772
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6903119391268594,-0.6610494857843154,-0.7171433737121408
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.713210818765624,-0.6872781000442285,-0.7386370417506243
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6048288187940677,-0.5611024554022714,-0.6476493371373245
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.540172830237205,-0.49635777371763423,-0.5807796752125305
2,DALYs (Disability-Adjusted Life Years),56,Eastern Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5785224497929617,-0.5402740969112809,-0.6158827412200991
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4232161459313848,1.735396805491824,1.162247004157947
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2252476332165991,1.4150223849291517,1.0230318355684171
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.326753003474168,1.5088536075279002,1.1384590313731286
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3267207437554152,1.6096532376898718,1.0681951086574069
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.025637911216922,1.2040287466018504,0.8514018891569901
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1760117805713888,1.35094714579207,0.9864270630100116
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1105428426033697,1.3824420942407991,0.8832471656432046
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9727397987844794,1.1409800431147885,0.7934702442374768
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0449370587039064,1.2049816672574678,0.8794492218320766
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.48409800734672104,0.6398174400543242,0.3517785851048617
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5462885907260656,0.6490464999114336,0.4264691647429678
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5191728940139527,0.6287419374388666,0.4266314294652419
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3302486395164829,-0.2111765052539024,-0.44113720237829523
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.34339799034258733,-0.2775980693628024,-0.413804080342848
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3353930455316337,-0.24450444718700196,-0.41777330292735493
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3570466042526011,-0.24093520260395862,-0.4603816622788409
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.40241665798018106,-0.3414507853871576,-0.4670815455347973
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3785774858977824,-0.29240304750237006,-0.4560694617436566
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.41666823961795274,-0.3129602641064223,-0.5132485892774411
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.41790527171994485,-0.35957193347207544,-0.480322098389949
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.41589013159737787,-0.33600994547917984,-0.4882925056364523
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.27590068610020346,-0.1449929644088777,-0.3976355046579776
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.29031589792974255,-0.21674617160149606,-0.36862977992828716
2,DALYs (Disability-Adjusted Life Years),73,Western Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.28159465762632274,-0.18142089948341045,-0.37151026351398964
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1081059913537308,1.6537431197167942,0.6274891182856386
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9739793636167587,1.4361675312034752,0.6057601329510045
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.046582455457459,1.4403122517363651,0.6982258452199113
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8384198874923962,1.2021159465529312,0.48621903932767474
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6632228926145111,0.9710183931745047,0.3865722656367889
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7573073925345579,1.0467585921289668,0.501333021607087
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7097591293256889,1.152292884907277,0.3199594276947263
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6188848941854571,0.9979311276812695,0.31690374825230705
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6691365590957283,0.990251789817054,0.3850264553470958
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.10532406802078477,0.38896789902358087,-0.13767491487083475
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.06066070373920252,0.31941493864634574,-0.14084209066989986
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.08963176937523791,0.2985653374372979,-0.09614617378635379
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7901543933228904,-0.7319833719110953,-0.8316654479447861
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8145753956887652,-0.7502075842704017,-0.8629451219966175
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8011064139289403,-0.7488030110126668,-0.8433573953006974
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8167347213763436,-0.7653917065854909,-0.8534517107180992
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.843593633888714,-0.7905860041739419,-0.8842602292595203
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8290902017829853,-0.7850843708515697,-0.8649738960220819
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8298067349380849,-0.7826276863850521,-0.8634738773392824
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8479309883058874,-0.7951421499332094,-0.8875995991834579
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8377878423634523,-0.7951306204470487,-0.8722465847792364
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7265806234204892,-0.6514253655803672,-0.7817206516037061
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7535096120049218,-0.6629367636123978,-0.8197377504257731
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.738344398633361,-0.668258157509919,-0.7949874535234852
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9546297808975164,1.326151129581126,0.5908124425960086
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.49683467748408083,0.7404556891126967,0.2896810164332093
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7414724684024557,1.0057564758120563,0.48208936830183596
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4600390228605447,0.755078653767179,0.20950508364637188
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.17237394713128273,0.3319671080569313,0.022624799268279663
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3301258712097653,0.5248816732916939,0.153782509063538
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.451042470111731,0.726845724907922,0.18095837828125969
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4151176868055079,0.05090963173853182,-0.587687303676834
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2275990025274905,0.5841006780348084,-0.521556174690631
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3280087809013991,0.2270790058345761,-0.5406417306214657
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4403359473487222,-0.001965669973664535,-0.606415220959845
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.21033144774283224,0.604191787919359,-0.5099586803222319
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.33673835660013635,0.19950637918887082,-0.543418995135625
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6467561235989646,-0.36529557538687485,-0.7509807839066491
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5521280433945037,-0.08146898767204833,-0.7225772974551964
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6020928187269545,-0.2734078444270216,-0.7279994902194443
2,DALYs (Disability-Adjusted Life Years),159,South Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4227493296505847,0.04237783233579026,-0.5931044626920159
2,DALYs (Disability-Adjusted Life Years),159,South Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.23078703024482503,0.5822046696410497,-0.5237236313143347
2,DALYs (Disability-Adjusted Life Years),159,South Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3338620674477156,0.22047387615403685,-0.5442986069735084
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9040888507723903,1.0489645060838102,0.7456626521251866
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6809616858981242,0.777879072104061,0.575835285709122
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7971099099727394,0.8991477798974521,0.6778589167619438
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7984398125639215,0.9401631544935585,0.6521229508027613
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.510311659652668,0.5901552863894329,0.41941990476821456
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6574938983477353,0.753403268739073,0.5502663800048277
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7408085245137066,0.8732607342193203,0.5959677640631196
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5540570237730259,0.6436576054059062,0.45686716991243387
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6524688633009512,0.7462941780423835,0.5428158297802897
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.18854229301792813,0.27444675816111475,0.10128920897541914
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1564553119074885,0.21341654317943104,0.09541757611744187
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.18757149681398994,0.24965313873010037,0.12179152525244324
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7807806886011531,0.9149041912392971,0.650330928010715
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.4779220474296128,0.5765690086846547,0.39114794190175217
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7212107995863579,0.8340991029470866,0.6102758993337258
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6818697849373017,0.8058597227671958,0.558916337305447
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3279963067080372,0.40897983130052945,0.2478468609205604
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5874666462428446,0.6910643507620298,0.4848005501860888
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.628074342092159,0.750696422797796,0.5088109709713784
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3663459183305841,0.4575455002712967,0.2861228476273741
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.582678520501247,0.6864809675854717,0.4806722561633874
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.13918802490489607,0.21856891609508905,0.06068970692078522
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0579725693822472,0.11797752538744438,0.00031138598076432453
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1770774764745172,0.25109746174067993,0.10695903054763381
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7617114184820101,0.9357712479282063,0.5907618800933088
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5195870916767049,0.6415409357079656,0.3850341850911301
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.632458992006623,0.7666740422811753,0.5020851633836125
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.663780761399808,0.8296590827387151,0.5135434652636857
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3652694002292787,0.4650029701611566,0.25528417520838387
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5055178751817706,0.6174072431105391,0.39154382832876256
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6106403090289447,0.769774077787913,0.454350116180006
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4048654486691999,0.517612353897825,0.2804706505589377
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5010699345303368,0.6244826375232406,0.38118929106311195
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.20682909561078455,0.30001425508124635,0.10698717407117796
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.12260692893563063,0.19943385412286907,0.04305736147661846
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.16569564455530122,0.24464235825259917,0.08723903732157606
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.4989103340583183,3.74255466692889,3.237043170191305
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.482926152847334,2.686816919381001,2.283359827240793
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9440265968327872,3.1355266316897787,2.7505752868828965
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.092711588409477,2.2625528599644658,1.9187549481246475
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3261498870219628,1.4461312756112479,1.1999438466409797
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6752747732041156,1.797039746032005,1.5423054120262178
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.1465280001960725,2.316932311138367,1.9633786813039604
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4223961587046183,1.5642034173060413,1.2835965748659306
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7506231537899357,1.8841781430621212,1.6157073160756386
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.030836440872413,1.1318276070005429,0.9320437949471425
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6534331646212613,0.7467248099439605,0.5631336677862095
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8332632206749563,0.9109661127030497,0.7505756779392365
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37747518381881634,-0.24289144760407094,-0.4975083977225433
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5032349027778523,-0.4068288205680975,-0.5812686515203177
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.43531869612836965,-0.32690678963584974,-0.5355448724880145
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5723638284203935,-0.4920199541649416,-0.6485319519133139
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6682378425172386,-0.6056936184719597,-0.7179097987567898
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6171307774503221,-0.5508744151464446,-0.6790845287578633
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5646075117118298,-0.4704799423835705,-0.6485584777140583
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.654496876913197,-0.587445864927269,-0.7087698200959108
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6061828106866987,-0.530574725187401,-0.6760820455275731
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.34878178725900455,-0.205988033093005,-0.47518016345680014
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47604435305853066,-0.3736761094887536,-0.5589606903549375
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.40695444843903067,-0.29216920865620993,-0.5131733329906432
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6882268336246453,2.2778266328298007,1.1421232272849928
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8645306017685779,1.1766505660566826,0.5628001774728899
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.170897040498474,1.5171655071058021,0.86129009299382
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.007614280425253,1.4450919952813908,0.5880064642977356
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4603184624169104,0.6876234380237979,0.2582231406468279
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6578815301221614,0.9226612251274805,0.42257264681889317
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.995636894006708,1.4333332584932823,0.5902304412736747
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3888961221488678,0.6213955016891118,0.16413595149728
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6143807386014337,0.8718821918935549,0.3841425083839691
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3712967181007916,0.6692121586099082,0.09434975643273556
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09096919767386716,0.07348543556987705,-0.24158299499637143
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.08090265555314986,0.2512398095495693,-0.07567613297373701
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4106702470107027,-0.11512757441140499,-0.6116508290534445
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.40125416696690264,-0.026336049861010187,-0.603917669649361
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4056613465218567,-0.1121033063555825,-0.5948595755197856
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.560381032010499,-0.35674878133417776,-0.7077979411806575
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5307379149809645,-0.2455701620402955,-0.6864144735934186
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5462028723673223,-0.34611854166446465,-0.6883787491650144
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5625041075066058,-0.3431045189691845,-0.7117044128850929
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.553991892187953,-0.27471392352505947,-0.7049567262913882
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5580219344897571,-0.3397184236069014,-0.6987186008787015
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3773819353076315,-0.06411589559151559,-0.5905702841284068
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.359306361763757,0.03892297181252941,-0.5780501314330584
2,DALYs (Disability-Adjusted Life Years),104,Caribbean,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.36803772990865313,-0.053919002679314196,-0.5688212928918652
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3262220584935196,1.7303936286308317,0.9688979562104347
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3058586316066274,1.6918119125016768,0.9243674543951386
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.319925054292583,1.6459353914572192,1.0088589512259225
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2773775193847772,1.6748764380599908,0.9352543984636934
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4194623766953867,1.7827397316805536,1.0456177739284445
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.346392034637541,1.681551450896051,1.039793121786491
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.488463982963496,0.7470785132877387,0.2598254251993352
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4363905095440018,0.6768127202580849,0.19874788093257184
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.46506242795842834,0.6709421374008542,0.26862019402885856
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.08233839374809256,0.2723897358089036,-0.08731616906233548
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.006186167634734369,0.1928107378777031,-0.15876617863132897
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.039742770271117264,0.18996346861520574,-0.0982874952275265
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.102992674985487,1.5743729307754135,0.7295169371491387
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0683197457975209,1.4962004224194159,0.6889379619978597
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.095422753645768,1.489895780046349,0.7623654450729536
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0588583749617448,1.5107993639511843,0.6830144658476683
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1697895505130895,1.5663572359044489,0.8127041970874107
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1191589803674702,1.5117514861383174,0.7611856037286905
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.34562770640182106,0.6472466040739577,0.10665431078363466
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2884202061841083,0.5549602857416857,0.05209158383313049
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.32328634555469254,0.5724011213760896,0.11295638328106991
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.03928823329765991,0.17423798069702082,-0.20767883846192153
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.11971271800461235,0.06152194742205104,-0.28504607592409625
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0795660088787913,0.09211667933590964,-0.22472512956847793
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.808243419337403,2.3539763335356785,1.3285432757730016
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8456095256219978,2.4034088063335393,1.342441231402094
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8268542956282952,2.278835584146954,1.418759727105537
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.7496726691342221,2.200046328166456,1.2896970492481703
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.9860490717894277,2.5689940277836163,1.4600468855480835
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8594364199744797,2.2982421307967487,1.4203688253784166
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7968917325910635,1.146086163164001,0.4899492445723469
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.772618000273289,1.1200883881202115,0.4591789400402973
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7851947459142267,1.0706267268843375,0.5274777915279945
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.17640678200183876,0.3907412932455442,-0.022341881208928396
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0542366600885249,0.26992584850220736,-0.13533895964024417
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.11199220575364828,0.2880744751513942,-0.05031652218180232
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0524930136098156,2.659642644882698,1.5340990578124925
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1374948456069225,2.742966246865681,1.5715433738030242
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.068115308166847,2.5833688624402447,1.5723523342018544
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9878778970634352,2.526586973838698,1.4827979896203367
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.291507637406545,2.900666720275117,1.7468315807205124
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.10275580067326,2.6386285617287646,1.5915778427984295
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9531780693148135,1.3416707994561987,0.6214768332385039
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9544423748271764,1.3316091979131275,0.6018937355399698
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9375541698307132,1.2629433981772187,0.6244734929419833
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3005881333895226,0.5529517167834754,0.07661440815716186
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.20250878612791987,0.442214273580097,-0.010242339441236835
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.24389703021587,0.4564200340288107,0.04856051021273357
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2441306189090393,1.6872698901023067,0.8649708986621576
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1673495540306362,1.591242828397002,0.7695118166941759
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2069053916367123,1.5403352016030532,0.8644773495791012
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1970753440569737,1.591334188105353,0.8201183433573325
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.273637130178146,1.6761629210777977,0.9007665198991762
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2319724183107539,1.57616945889544,0.8866141226944857
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4359366884668325,0.7194852182383344,0.19332632144818068
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3501089301840263,0.6141651338096319,0.10228352475126293
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3936890613613961,0.6042542630428649,0.17744136069981387
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.04174743062457356,0.24331780248832446,-0.1336921898203885
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.029925810676957744,0.1616780222412127,-0.20562348027701116
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.003283711356788081,0.1511014329143249,-0.14533376509383653
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5562445379880776,0.6854799983600461,0.42571969333877563
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.859184818983288,0.9962495518766015,0.7167456656157863
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6344025268446106,0.7491672921867074,0.5219354330190246
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22454520336869854,0.32333443118039407,0.12070387350832587
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.42804987228743246,0.5308139271371104,0.31429574827018747
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2713766719766852,0.3584246951828406,0.17967063945040596
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.23599635210098577,0.33863739191362763,0.132331260974848
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5126104429979209,0.6241246637597517,0.3967236582761692
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3139390593543011,0.4062014643272909,0.22352381277805242
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16583095647111537,-0.09729684924532547,-0.2352863227298373
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.04005558277738021,0.11012270110520576,-0.03090914969302181
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1064213664065,-0.04396492485192393,-0.16876359629671644
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.12850386198471844,0.34422987250974313,-0.06090045325826593
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.30301675461424327,0.4811879929728543,0.15420198588088244
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.1570843449975918,0.35040338824074435,-0.02211309368460711
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.11207373328998806,0.05251226369866473,-0.2631380452746642
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.000766430891108539,0.13362755068739657,-0.11684420727680564
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.09998434610231008,0.04543015136323904,-0.2377501506836444
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10372269736719958,0.06761063460833895,-0.2541508832968751
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.06011878448351463,0.20507676447094003,-0.06095512433933272
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0697895464008479,0.0856247029423505,-0.21385106744815008
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3464223893954908,-0.22633934348894985,-0.4534397598905128
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21443760993607686,-0.10897127106096968,-0.3020639697216993
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.31724173545580103,-0.20363974460005296,-0.4188970664546993
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5511736600696253,0.6533845695155152,0.45010397272164027
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0159604099764372,1.1522689072063228,0.8483381418333857
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7081920323933028,0.8126973993860052,0.6021171085483125
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.220501397388273,0.304377410619004,0.14081679083976054
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5484715669759314,0.6571557024252164,0.41101614098829053
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3287409907470738,0.41011335275832295,0.24405041486059936
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2319689730765673,0.31314664672377324,0.15169767777512516
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6401611812150579,0.7510601377222579,0.5037857167193678
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.37326037825733493,0.4572749838080031,0.2879839647858945
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.21651613496674404,-0.1683111233614602,-0.26528088085830814
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.08087301160289471,0.14332434995915286,0.00899916653871706
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1217720980854615,-0.07243718598705837,-0.17190719972128177
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.108960306252655,1.2617927028079627,0.9394109827196118
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9764230501995438,1.127213138177558,0.8258655854036339
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0869926608672704,1.2266996601798896,0.9329494643103526
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6594447036216946,0.7819576433119584,0.5189312474081995
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5181286073071214,0.6316286833533193,0.3966109154281684
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6234218556353549,0.7370082814589802,0.49476163820508967
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6749727832773402,0.796354918291564,0.5403137754719549
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6079940600787104,0.7306750649186953,0.4855023146662619
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6777881388823768,0.7901022599431368,0.5539487728391256
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.10662691673899921,0.1764957530608835,0.029872582445474825
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.15142410902458475,0.23530763751175243,0.07146809256342498
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.152699907105121,0.2213519558053702,0.07760572465442071
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8561943833715092,1.0280847960264972,0.6970105988060662
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8226685934385989,0.971248835520176,0.6702976741243709
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8406710385626913,0.979347123536108,0.7052682894687092
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.46049544757347677,0.59400426879088,0.3378018506190029
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.39985908748315324,0.5045220435729588,0.2776457000545414
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4317488670849062,0.544891851075403,0.32504535020334213
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.47422171171346933,0.6107400530259222,0.3477951943932043
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.48290128039408214,0.6037843811493129,0.3589341301621141
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.47976372605040174,0.591249068034476,0.3709099046346874
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.049128980904730266,0.13080371699228133,-0.027057020333697404
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.11415638753098557,0.19398176909790887,0.038342447529768835
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07890950006047413,0.14580124932733984,0.0169879328682436
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1267693897468558,1.734339856266312,0.6656899584987279
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9826205232677385,1.5375369754650268,0.5613799186554167
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.061169210664389,1.473699951185092,0.6903273389244526
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.001759102826701,1.4405712364205305,0.6625716890028263
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.927383971375851,1.3225925165061683,0.5581345630532103
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9686327067279406,1.3325841915017995,0.662969332321171
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6738522032211611,1.1520343554086834,0.31096432944632524
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5491405391686932,0.9827301050295508,0.21999994484389868
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6164465656988593,0.9399687177423344,0.32561839550795285
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.026253082962176526,0.2527223861079938,-0.22898088326337668
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.13594579770765633,0.10614340313091275,-0.3197025908271809
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07885062284548928,0.11161520988559326,-0.23866987800966394
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4309254597174699,3.393812841708873,0.6272600389239227
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.324246759928441,1.9244581562808474,0.857280825157385
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3631295740982323,2.235234124307964,0.8641327154077167
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5125907281851774,3.443812358918451,0.6815007369633944
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4564621275143117,2.0725716986272875,0.9468317770325465
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4673401828605959,2.3309306026511294,0.9625819021795763
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.08905689251858885,0.9684322859722249,-0.27098597193673907
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04053636679880098,0.30924354386764374,-0.16851847434914816
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.058310934014438945,0.44887681377280975,-0.1651612942456439
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.066491628006589,0.9333152137961325,-0.28771737645574424
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.017853839211935344,0.26445502151306716,-0.21874651066478745
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.026469977534893642,0.3954424680963273,-0.19935487076712308
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.153363200021642,1.1065456477775237,-0.5637341129234544
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.09756418314642169,0.8243022083168248,-0.4918236400236817
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.11967186187293671,0.8087189610395313,-0.49787862622724155
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.12794066170866517,1.0930766858854695,-0.5292173930544576
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.04765662289019864,0.9033185723930193,-0.4267860738636473
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.08303648764518332,0.8853781826989868,-0.44665013666877473
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6207059172503482,-0.05626556834705094,-0.8045524722314321
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.59599070876328,-0.18328259093992816,-0.7724957640388066
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6057512443193197,-0.18997795380821555,-0.7751284796692359
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5227628407377662,0.19835903700215735,-0.7539946115310622
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48693637225523334,0.05172486369846845,-0.7130631201650992
2,DALYs (Disability-Adjusted Life Years),174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5014281557855143,0.03154210741204222,-0.7162747313476011
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.4410139666092183,3.749375130503887,3.1591021846366107
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.9772229946979887,3.18601315528886,2.7281452613035713
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.190253905956003,3.3897317697574527,2.983005483391226
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.678229770169161,2.943629853350885,2.427710753079606
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2304884828571483,2.3964678398133015,2.0227322717382097
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.437600541072164,2.6236413250469903,2.252341804625567
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.3492075547108766,2.581759297952517,2.136602713329219
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.032682591576396,2.1918877169014026,1.8427576849212939
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.177842644324126,2.3291244702979395,2.020667711736122
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3326798332913645,1.4833113772978563,1.1996846706924034
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3360236204448845,1.4434609579658466,1.2070516047898578
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3395435605384447,1.4435721904087733,1.2348542639308593
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.1745926609271176,3.496873474065832,2.8828882261254707
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.9080912051383003,3.1755461466834394,2.6426210802872183
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.123017347961513,3.397687620873814,2.8682614975610665
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.457549916608221,2.731275034201923,2.1920295920668957
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.1743577199092257,2.394211610125958,1.9466656827790947
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.3824926206069086,2.61498954325614,2.158480366503376
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.1482849148733503,2.3913342144743326,1.9282949071575506
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.9799687319306924,2.1839064910999184,1.777544420471982
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.1268511755377713,2.335158100602187,1.9336471302786338
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2797863413432402,1.4500220652514115,1.1240846252811711
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.356880560917678,1.5079851780760676,1.1997618624439133
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3665573899088286,1.5171501329792578,1.2291169710003464
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7132053273842502,3.0763646437556895,2.343496852215618
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.521110734385065,2.791924544783283,2.255326883207214
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.608514244215726,2.850348228866533,2.3640901212289234
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.0747856469211774,2.39649368999981,1.7761021574392988
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.8595210273510652,2.091580723010305,1.637177129844311
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.9598227851884715,2.1563489752551277,1.7581054235060956
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.8003279044319909,2.0742058825468668,1.521510853329395
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6848912523682238,1.8913901913133133,1.4822277206367303
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.7366576597232555,1.9200619035992172,1.551289083316719
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1433738597677257,1.3361603701314153,0.9616621290328805
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1906359215725852,1.3389474952554277,1.0456304434314498
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1678477538127945,1.294818878272832,1.049336291620345
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.810256658560623,2.073216322497071,1.57728824129243
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1929708072452427,1.3084317942598482,1.0577620237885936
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5386785488412043,1.698973005004154,1.390534496672387
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9997710353392837,1.1808193690511053,0.829631737740024
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4189184299660187,0.507094988527186,0.33009845862297926
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7305133555226471,0.844989947337795,0.6201558036871699
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9067945482576903,1.085215993173871,0.7487225420549793
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.45352573214076825,0.5300545738059814,0.3639078287394188
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7021410882293051,0.8096158136823883,0.6028130034316372
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.19133317295063942,0.29452436425587913,0.09411308277991179
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13936929886828398,-0.09566368844333449,-0.18728879901760076
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.033883440514800064,0.09515115875544673,-0.021905420124886194
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.37995436158325,1.6172865403892769,1.162435457906235
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.897864138604259,1.0346945826308973,0.7624654132875726
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2311569819728778,1.4179104547116586,1.0734380234444698
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6934981956529741,0.8888595852932227,0.5357354322683089
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.22787478904982392,0.324420605839118,0.1362541083725788
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5208077702112696,0.6631295981085048,0.4002014798399926
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6148290185329223,0.775861891916537,0.46723970194475006
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.25792571084598703,0.3486184691243342,0.16818191184207443
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4959530717424767,0.621168120911775,0.3902051739527093
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.059547184592601,0.15532384885130268,-0.030926417918484647
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19312845025946093,-0.14386097793640626,-0.2415518548576694
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.03092445629508108,0.03649303059287265,-0.09438095219732101
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.6544078438604592,3.017215511003159,2.338683286943666
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5502924767197164,1.706922611053444,1.3862147343313045
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0278584090803666,2.215367699753756,1.854264511773724
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.600233538502302,1.8622638935673144,1.3690569529746657
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6498608146093601,0.767866421939915,0.5252141181593453
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0636990738388,1.2142477373899132,0.9322335089453064
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4795617626442363,1.7257313356853405,1.26533867307477
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.690362556195477,0.7941787720477642,0.5816099819043901
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0301279221777917,1.1558497345063317,0.9137361460679826
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.34234985795965067,0.47197472412912034,0.23636316964515697
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12578965473978254,-0.0761999955417742,-0.17656330365391237
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.07053150473188967,0.1330771904546803,0.01163536333451811
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3165870495444247,2.623708054631547,2.032029341228144
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5431998925832235,1.7124478839166228,1.3784324563918
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0438062923510762,2.2665204851478755,1.8507875661026159
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3600933924071386,1.5859181104910598,1.1425966023561116
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6456217617859888,0.7691799812431503,0.5138841164352399
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.074913537553187,1.2352593924112607,0.9211472413044619
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2503460976167475,1.4587315688766904,1.0572701074827733
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6856615116053202,0.7978409850864403,0.5764518004993439
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.040820708547985,1.19014681313271,0.9114049127217853
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2720517850411104,0.39035627880267054,0.16973667576256682
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.07607897339316246,-0.020950295434337997,-0.13088874251490198
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.13341236958548253,0.21269793131413478,0.06510040363839298
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3563470985505481,1.6004107209814824,1.1407308577331492
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0078596276609582,1.1513884922623396,0.8778375090251945
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.151733084076167,1.304684144413612,1.0161388579175417
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6765595180685804,0.8624794897283427,0.5189438305907517
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.29897171242362686,0.4025663560008329,0.20396857740622115
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4665389988789525,0.5799621302985987,0.36860496278353483
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5988111931457228,0.7644114358359004,0.452512857278772
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33083195895248013,0.4259645057760857,0.24465183536846105
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.44270068968763804,0.5452517922710818,0.35178705126082477
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.08363676100104481,0.18241759443350603,-0.00784388777255681
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11954194133174856,-0.07011085075451912,-0.17160118219353004
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.037241186736619365,0.014352195122981585,-0.08591810737386743
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5974451492854717,-0.270752222841236,-0.7715756784954135
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6910244386581234,-0.3815293788455462,-0.8303854938326327
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.644988302165898,-0.3842622643888664,-0.785056284376934
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7101559874888749,-0.48589946806351325,-0.8323782294322943
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.759481675414163,-0.5370380006927644,-0.8630253062441611
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7350937999745082,-0.5389621097631311,-0.8346105765325025
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7705540704778752,-0.5843474900746062,-0.869804001417318
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8210918086031863,-0.6418828085229205,-0.9017869749915575
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7960466854910587,-0.646260242092626,-0.8765153838545413
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6591747439283135,-0.3801161317475001,-0.8067206848888957
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7328802456116743,-0.46351153294069414,-0.8534592345029807
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6963373392533206,-0.47253621126036005,-0.8162328750181431
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.769402123334167,1.192423451334236,0.45901072341501625
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8970561476513098,1.3187765315791102,0.5578770660254089
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8384718827798303,1.2158109249696287,0.5427075425427801
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5680442526039604,0.9294336349390668,0.3016772428441399
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7001233374784959,1.0531788545476906,0.40241124042369136
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6375317966389413,0.9608788618976907,0.39014205917413314
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.26316426331783827,0.5651563413786741,0.04157793263102916
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.39023127676306135,0.6992832088900159,0.1416685927940624
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.330021982329594,0.6030037045981895,0.1160545685284684
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.04879537545848941,0.17312865762252877,-0.21534395616510166
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1546250348930822,0.4279317244868368,-0.03925112673357841
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.06616166107279656,0.29000928471202025,-0.09774795643119971
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6605153587883401,-0.5341667776217168,-0.7723104414234159
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6320291138341196,-0.4602230939630204,-0.7554950522176997
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6480887746795808,-0.5118811139785205,-0.7549492366233097
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6992513638208568,-0.5888408911570866,-0.7894425488245924
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6702572082331064,-0.5181669359959405,-0.7752686572147494
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6866404992438198,-0.5675231547399624,-0.7791111224435762
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7576442002252191,-0.6674447987743768,-0.8374539570560711
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7303376415508943,-0.6044319836415639,-0.8208179414451616
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7454137482935045,-0.6468758350455837,-0.8227207578585105
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.686475414125594,-0.56970480512854,-0.789181749176469
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6465347554161402,-0.4826065820225949,-0.7638628179802867
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6687213392655311,-0.5414453913725802,-0.7682380835240613
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0076275433335293,2.147075356220755,0.5883376591095396
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3237702604383828,2.016191503666387,0.7654373588522547
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1847108741030874,1.8908021629345437,0.7801047316557559
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8572417752280993,1.8904600336606814,0.48789119228103306
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2546038660907421,1.8848426114970953,0.7501118236333474
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.066506700834729,1.7145012559681105,0.7052339147422291
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09393271903478659,0.42031425125245414,-0.2831634588682548
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.036308786453653284,0.3451010240085669,-0.21268540265810443
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.01985511416130241,0.2969244532803288,-0.20137691001975275
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09874262156395913,0.4272576429459529,-0.28780843917153
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.013633066373092726,0.3004231941449662,-0.25767368417680026
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.04467702900738045,0.2762490209302304,-0.23078999033656367
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9994785638096693,1.6416551226433702,0.5210715404223847
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9147854179414051,1.4823166070560783,0.4938979478345562
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.961343154565623,1.3790664126262624,0.6039786281651736
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9040109562421391,1.3508806716450308,0.575018852527934
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8744184778609884,1.2611782293817444,0.5419971735220024
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8914629433327811,1.2253307713031942,0.6096267740393454
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6083220520051784,1.124870085851141,0.22350544057729294
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5257766063692193,0.9780078609121091,0.19039685583123717
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5703870804332938,0.9048452328111265,0.2842563062451743
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07538921631155072,0.22014061666674994,-0.28786925381274564
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.16442336095431012,0.08045451155715252,-0.3435791371056813
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.11804301290846371,0.0754994480389827,-0.27394531681245227
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8224996190564067,-0.7472241320735602,-0.8704422379485461
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8363144748581077,-0.7621070853101082,-0.8879919592809986
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8285944025581035,-0.7611141970779591,-0.8734882973976056
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8303510838932316,-0.7537022915924443,-0.8803689247538317
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8393409305225505,-0.7636860804298599,-0.8899827772514188
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8343328974692518,-0.7732759457107509,-0.8799332987577146
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.857223887228393,-0.796674488059408,-0.8957875270646676
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8695689121492974,-0.8104375348517865,-0.91074757168454
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.862760815153574,-0.8087314921234221,-0.8987059746133925
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.765379905759707,-0.6636319162698748,-0.8310601775731338
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7800188829312824,-0.6786760038777225,-0.851066533721742
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7715540774637561,-0.6804554527574102,-0.8329756573170359
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5042391963147367,1.0843424091046534,0.06074604425076074
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4447224996345576,0.9995934226564585,0.06390294712493938
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.48920828385494786,0.9595940143128165,0.12369321973003292
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5165580303747218,0.8950466014439542,0.20272815504323324
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5141371765585367,0.9024932957584249,0.2094670240023033
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5280950237977667,0.8918441233447472,0.2355560307597867
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.25279773204049505,0.735933652918703,-0.11656321563486798
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.18485995160872765,0.6399261218712662,-0.1274615057454278
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2310241330672861,0.6198590544962579,-0.07112155724048955
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23812552878303916,0.05237413822690916,-0.45751932660449335
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.35971291278866624,-0.11902024553877097,-0.5267684897144157
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.27897109967158185,-0.056056938268904885,-0.454648870759245
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.43615190788273817,0.9929753375704862,0.02036393750020346
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.24925442230718714,0.8001711877048923,-0.09255098427729161
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4080662290446909,0.9109425804953063,0.03974900091746564
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4478791790686038,0.8249859438417831,0.14199134222232607
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.30928115181258253,0.687353732448831,0.023049499728196775
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4444881988587455,0.8381692630620284,0.13273900477217854
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1960915906652624,0.659839066179031,-0.1501952416291768
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.02455075956545142,0.47637400738963664,-0.25577403471700094
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.16394968232656648,0.5796423233734309,-0.14051236060229527
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2560756456525655,0.029029529072413914,-0.46983658213846957
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.4121590160233336,-0.1600873995937237,-0.574087397607027
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2904986809234451,-0.034762512168920755,-0.4738769275970386
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0390639537492818,1.8356205360148135,0.45331631574047965
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9117846845596155,1.686224678317447,0.4258297107040716
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9694474639632006,1.555679723933479,0.5411718225186655
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.056433840825564,1.581366068673156,0.6352344762728721
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0041468150321073,1.522899695953786,0.619904585355721
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0221368766207533,1.438176016362231,0.6766892927777103
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6982237286470347,1.3616317040202455,0.21038687780355536
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.567911560459942,1.203052865284835,0.1693654127034418
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.628004210848859,1.1126013403638035,0.2739787491731124
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1464415072662602,0.1805784146347763,-0.3870193621500656
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.27155689129517996,0.016163302989150957,-0.45291720555684556
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22298879933420226,-0.01033766749367868,-0.3896008511735757
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1508865508059902,2.0731544845731795,0.4963878718481177
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9732360453389763,1.8064908464065033,0.45987178547833885
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.092354452266805,1.8052150446850805,0.5748872453569145
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1693653593692084,1.72657037049057,0.7237452271866159
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0680411489026496,1.6520515656739363,0.6297656314452169
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1476269785227133,1.6672751705840354,0.750900360837254
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7913545926257993,1.5594606083365243,0.24625879760148478
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6183096517042825,1.3016867317458414,0.19728433213599855
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7296028054609525,1.3188747040216615,0.30184892664957264
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.037117175957488605,0.35509258774894914,-0.31606477923539356
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.184973255607548,0.14752782552056914,-0.40073376404400385
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09329636908388293,0.19729317591037882,-0.31284303726372353
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4364778946753891,1.0141949595736464,0.00018073327409001867
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.19567151132437194,0.6896776482438001,-0.13158191311273312
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3201567775558574,0.7151482195220744,0.007061741952364539
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.44779300564676205,0.8250773868231104,0.13067952251438672
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2531935744654416,0.6014340616770354,-0.026201177039210488
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3547541392036077,0.6412006896171984,0.10052032536686037
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.19636308705726288,0.6775117171679454,-0.16700471750358065
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.01939418164659124,0.38575496473468895,-0.28778446195330615
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.09128109897211065,0.41779284530538385,-0.16753262705266556
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24806905309777638,0.0387399616941322,-0.46824601774486374
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.40909963146025863,-0.16798485983954156,-0.5767955471524762
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.32852586294077324,-0.12570680697066025,-0.4830343596968951
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.996487906782138,3.1495934132183447,2.8479647290033836
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.3686554050142448,2.4672995680327885,2.2569808169215024
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.7760233963412753,2.884478133908359,2.6610484440928404
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6547596023109323,1.7655168968054142,1.5551980674748935
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1967349951224844,1.2676252336653282,1.122725882979335
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4864651023222746,1.5599398668448312,1.411729878258075
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.0209555678979503,2.136688417072686,1.9086865128330714
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.574828800978155,1.6502273803669714,1.489470427625227
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.870520743354834,1.9529676832236564,1.7831171574249498
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.0501853418446263,1.1282775991275187,0.9743878123337086
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.923556082246206,0.9779658349986113,0.8656900690257958
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.0431686397290363,1.1012515796052682,0.9835510561518153
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.062280151735746,2.277780756730529,1.8264949753100077
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7634371584195552,1.9225294811124027,1.5994156777047364
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9769155958904054,2.1540809362895352,1.770595517645099
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0342105502985985,1.1706772457009413,0.8832102116247507
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.802069928295223,0.9044630093011763,0.7007791979949901
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.960263542067062,1.077474484367273,0.8330193091322939
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.3147855043300092,1.477682970237404,1.136554878298999
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.1122307656047774,1.2338328427642007,0.9868610908393001
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2630415843026195,1.3977221016722905,1.1061977297471661
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7054391052648478,0.7972321728160476,0.6084856150687089
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6870163210198491,0.7535362831230235,0.6165443168187832
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7229374980049468,0.7969325920410302,0.6353049075991399
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.5497116696277082,3.823134840597365,3.3057372148972384
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.601151151540597,2.732038308625893,2.457233284011695
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.0975265989699365,3.255401186336249,2.9223066905225457
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.0221892767781604,2.203719270631335,1.849188328194868
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3482955820829703,1.4352882099911692,1.2469641099222528
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6980885440309006,1.8225760302136265,1.580194780890056
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.43913884422554,2.645820127892473,2.2547179214968365
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.7525367206929183,1.8525802042857262,1.6425332250141393
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.114926435622208,2.2349421850804023,1.9817248293148082
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2403934279610196,1.3694292081951205,1.1280390907171096
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0176400380453825,1.0884944085782717,0.9455220639393649
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1619782816485893,1.2432350954122002,1.0739827115083835
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.10986115687943,3.3412701957245567,2.8549905247988123
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5508440540887136,2.7539561110626902,2.3502089177491357
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.0158561864442057,3.2255452057159824,2.7785635705537812
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7300694047574676,1.8876280762075606,1.5556511939968336
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3155403752281456,1.4525391504596648,1.1803977525946996
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6444222894498086,1.7884699129281734,1.4910734723266792
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.106654701517465,2.281577393808046,1.913997330086164
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7140845349276692,1.8693330573333888,1.560729244633989
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.052840852810242,2.2122457654113097,1.8724517755554806
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0889946046897137,1.1939651611359592,0.9730845292679802
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0256212788415906,1.1263548170566087,0.9276423841427656
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1546344373890507,1.2550905740171878,1.0459672201417345
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.4043012994878548,2.634490335353358,2.2065977861551804
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.854735337119492,2.0065715651716682,1.6948777469319016
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.1425824520671743,2.3130039276863066,1.9766590026049737
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.261467156178757,1.4142196301056327,1.125407142649077
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8615887663659314,0.9681497823994863,0.7621818703101204
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.069366224515142,1.1901051423980757,0.9618211693121
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5733201764572924,1.7473206653332514,1.4238755782685235
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.182014448329801,1.2980703359218326,1.0598274396327099
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3889809912465998,1.518534844475329,1.2628465229189567
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8249798607380342,0.9240481697111356,0.7418169134800959
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6891479853800594,0.7589992418941098,0.6080815525818937
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7712753418354243,0.8421425993445031,0.7004949523674069
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,-0.1007747119934618,0.03948852679454422,-0.22773952314660845
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.16206620865125115,0.35704511903255576,-0.018349404527638835
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,-0.043071942250686245,0.09555287405111156,-0.1644257156922377
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2220167760851134,-0.10320071462031535,-0.3319698604567748
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.07597966487413492,0.08120848958608874,-0.2154150715087031
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.20437146822174096,-0.09559873731778659,-0.3089992835833669
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.15496563638044722,-0.023155223228923435,-0.2742790385121009
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.08104909515702047,0.2624344354011502,-0.0867882741143976
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.10533560885539806,0.024269418262191637,-0.2187933541372554
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.529059020825007,-0.4551114622050879,-0.5927760860102969
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.4850735871477707,-0.4073717256275404,-0.5470858774148335
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.5125521516623435,-0.44094994822485467,-0.5757151129515798
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.2081736910782726,0.05567323118082017,-0.3958325972203046
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.19343747628367758,0.03024195435632221,-0.34745933987991207
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.2060644990438307,0.02748611086036215,-0.3833604679997913
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3149541072903939,-0.09572612743975656,-0.4781350604802888
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3588041139702306,-0.17962768777631,-0.4845064957491495
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.33995757663356874,-0.14939467510542143,-0.48572887093725275
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25589232200059286,-0.007945874077114586,-0.4322421493957078
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.24966952832824926,-0.04158461518094954,-0.3929532715741383
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25772286033532177,-0.039368499713026694,-0.42348285538808483
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.5150801371057848,-0.3583177965085604,-0.6258400262948826
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.5409597004492537,-0.4209518151291485,-0.6202332878247826
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.5076333412565484,-0.3590853705395748,-0.6150643633928954
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,-0.025987558842115017,0.045892656434892536,-0.09206157371022755
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.35870706211584225,0.5439406892028495,0.14066197514852397
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.0790064722458289,0.1712873182094048,-0.023612874680053735
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.15733441771129655,-0.09510219987420213,-0.21612214512445488
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.08040727795695399,0.22631510678013894,-0.08552686945536381
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.10285539574131619,-0.026746989986865918,-0.1866791498036433
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08468545719390846,-0.01713703214005194,-0.14677758677540964
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2639805108768967,0.4362999910100278,0.061137125349803124
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.008799627845999606,0.09507611038794875,-0.08714266874946165
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.5594085901679132,-0.5293610445331065,-0.5848357422335284
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.46235697348064714,-0.40526811610641017,-0.5238919367194197
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.5320556430008119,-0.4996701405182088,-0.5654764210548424
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,-0.006243731091505026,0.21476760213724472,-0.1865486141303275
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.0844054633897401,0.3244696708504117,-0.1285965422461193
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.0074986387715783205,0.2197933552988164,-0.16241087532197113
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1401449297051411,0.04217087954766705,-0.2920317272505908
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.13780675158125266,0.05357346565380932,-0.30399209833519103
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.16225556295425922,0.01262414228390545,-0.3048288005332137
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06613147173422783,0.1415608316502689,-0.23557045896953932
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.008802713867251658,0.2321300874049078,-0.18934918466057354
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05805546306624892,0.14042604426020283,-0.2169096117613052
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.48581511799940197,-0.3903762900531068,-0.5680227492906661
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.46374576648188315,-0.3635418706039356,-0.5517040852386609
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.4680007049864939,-0.37301066165832214,-0.5491980084124488
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5705339295966413,0.678181238801564,0.4569483157930808
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7910081025400291,0.9094245055640195,0.654078790332434
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6294171382994534,0.7245916126574297,0.5278084889581103
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.28980424377000186,0.3843351896590297,0.1929463267202082
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4154422190117883,0.5092382305253602,0.30439468290072674
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3139636970856997,0.39743257441823454,0.22626072843509779
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.28386043489307283,0.3718586109314576,0.19100788787876655
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4986097863959458,0.5976936376581989,0.38403542627566556
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.34778553965738596,0.42650987443273397,0.2637391251037115
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1261092037836895,-0.066232531004695,-0.18991518544083597
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.041813379919063254,0.1047215582809896,-0.021450098843216345
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.07316194071621365,-0.0169700171299689,-0.1324803095561986
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.14824770396591605,0.381210355364299,-0.04438589133876551
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.29646329446716435,0.47134726657860665,0.15427469932421164
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.17407170807977904,0.37956228556108496,-0.005922928330175844
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0570412980748723,0.12213189858280953,-0.2174032420063163
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.02453015203916937,0.16440144191173683,-0.09444662676469992
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.053298805146198065,0.10318380314936197,-0.20026643135291156
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.06134482751527347,0.129094567203814,-0.21881652983398708
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08480390347547401,0.2311364810435575,-0.03417111394232525
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.028857108792748245,0.14111608122426328,-0.17774112533280534
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3116343812440141,-0.1788585346488351,-0.42657807451312146
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18667286297360453,-0.08313419423187075,-0.27893385881583127
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2820766583341798,-0.16001252760861023,-0.39277197298657773
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5596587707812737,0.6604458132743917,0.4595978854825702
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9055144382126266,1.0216758492732823,0.7526561120234692
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6795390072904213,0.7774756918286052,0.5772822956152548
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2808301593558604,0.3679652631388856,0.19967347734206728
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5059207907005017,0.5977665723849439,0.3789040564246935
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.35435461153969355,0.43385477839470615,0.27142750549150757
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2749703460747945,0.3573604770795026,0.1931738249717021
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5944219242639639,0.6916189314523609,0.4665191061615222
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3892442482095328,0.4702533674337924,0.3046617836648554
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17620434272617463,-0.12418519525544874,-0.22598568274808378
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.06475520455185797,0.11983444344419353,0.0030831677747876836
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09576792166046676,-0.04884560610705735,-0.1454687380563792
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9842018738375793,1.1102055045769692,0.8407659445823873
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8127974060376348,0.9375954556325844,0.6808056441112389
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9559738519568498,1.0726007736251357,0.8268132070883806
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6295344943316552,0.7355369035145602,0.5042504105947689
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.43269226240081354,0.5342173865541451,0.3281181961686199
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5773100152610982,0.6710946089221752,0.4610796554828185
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6220205324153814,0.7250244046085322,0.504766322848474
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5168417884812303,0.6212654246338971,0.4063988787780227
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6178995615369025,0.7143684612830548,0.5110632914653697
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0921230471289928,0.15034393697002288,0.023669151576257937
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.10160040804592078,0.16866275339475867,0.036210522925751616
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.13247779669604917,0.19101402232770018,0.06759176022332479
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8733542323765899,1.0374220578730475,0.7292918758330492
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8454413513534121,0.9777130426048575,0.6997110356938655
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8606591412824616,0.991530791884066,0.7333521909905012
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5384138702014938,0.6702606874241974,0.41531722379973207
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.45833914737647335,0.5682431227389106,0.3364203682060194
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5003547128639523,0.6036986298498521,0.39611360330268236
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5314061887892441,0.6655263028627694,0.4136398952770671
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5441563136625605,0.6548334516897074,0.4222177937238521
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5390592291603586,0.6473107714364038,0.43375625752200986
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.10266547051161842,0.18265269350572327,0.028623232153773416
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.17443993428893179,0.2467455645878485,0.09574062329828188
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.13545066347984328,0.1953842002576912,0.07168964239989731
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.0977366447030965,4.751818130191651,3.5960710153386377
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.748477620486371,4.163736641514828,3.3464736879030514
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.912356242082108,4.310541562625231,3.5528660851568272
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.221799519642438,3.7737190575124835,2.799445012614302
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.857910583534027,3.201377025867324,2.5267469684256234
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.0302806371426736,3.3476726238824694,2.6986163917230175
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.844477457341096,3.337755494533882,2.466144417085177
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.6207739509040677,2.9374141809708476,2.3142408926078826
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.7254771430464784,3.0274565267223057,2.4528437474262015
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7458765587010705,2.070339404635269,1.4909286803329342
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8541925390919312,2.0893044465676054,1.6294783795922374
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.805389050602801,2.014480987213685,1.6204171884485539
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.167167098060865,2.796489969144054,1.589606379298933
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1729799886608294,2.790159519896341,1.6083581295945435
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1698434311228203,2.639044123370174,1.6789128908990483
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.1006959174103397,2.6545771321731597,1.5549973197198796
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.3287941103166365,2.912252598556194,1.7432859471523883
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.205880802798048,2.671140449907479,1.7054968942642452
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0265538005187576,1.4292343717231855,0.6569939278003398
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9765471656473017,1.3610073442549644,0.6248267831714607
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0017967842780025,1.2981030395648991,0.6917678512793468
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.37478042353226915,0.6391501543235981,0.12630774932545036
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.26702983832876587,0.517606506159752,0.05321780272358945
2,DALYs (Disability-Adjusted Life Years),44565,South-East Asia Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.31741806591637756,0.5126050469901458,0.1053433954717596
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.02172517459801,3.604733058126119,2.4365919496008965
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1624308998504453,2.608928047655237,1.780931956242099
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.479078765684477,2.8900186508947674,2.1161648286440196
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6364644430510635,1.9897285295736853,1.2923786080724313
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0402161802639878,1.2886714062045366,0.809357594159622
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2643154438479238,1.5327943101182955,1.0350290912854896
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6471472780905199,2.030889991723609,1.262005639458721
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.029823313602798,1.3164099138394016,0.7849561609678803
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.26080636302764,1.5278470280648646,1.024974353075701
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4884095504214336,0.7063625115324059,0.28214388722142136
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07942989160955223,0.23411393823368987,-0.054768950456207485
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2341950808272297,0.3727287297468261,0.10131288885962192
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2125241503842923,1.4195227035991815,1.0004141099781996
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8923949445497038,1.0304914331643114,0.7602747950716857
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0453806593088133,1.1925131198871455,0.8965554760414722
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0955434804493371,1.295352261906085,0.8943635124193512
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7048604313315708,0.8317136625635859,0.5812145675770788
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8916381647827883,1.021401148129517,0.7565530770583332
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0323953354565227,1.222541460608249,0.8375538659747265
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.75738130655434,0.885625248597766,0.6346873194558469
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8894375249910761,1.0253523684681392,0.7519590147444735
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.42601377362031945,0.5331016692747779,0.31536341064507145
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.34168146548049816,0.4285468471709297,0.25106721537186205
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3925354099985549,0.4796555612501804,0.30820833846927664
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.656865690237845,-0.6050362423402469,-0.7036268996705147
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6493353264298704,-0.5824173695928214,-0.6947022827426437
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6537739503260799,-0.6018426414414468,-0.6966781682558121
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.675021730338606,-0.6273453882041409,-0.7182738430888918
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6841121090318908,-0.6265117939632925,-0.7248935345851442
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6798230873041945,-0.6355501579422693,-0.7175586673903613
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.684801374721912,-0.6371915313997192,-0.7277556014202999
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6743536311085622,-0.6122099613862657,-0.7164838646462055
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6801707851269162,-0.632198803343493,-0.7198039159907939
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5759435715157564,-0.512172428622208,-0.6346271230702119
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5618567738726107,-0.4763503444948036,-0.6203082489420755
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5697728941023524,-0.5035563049711688,-0.6240929732789908
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7185510779707465,0.8281107511885879,0.607221815500585
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5349320111674153,0.6160941299968569,0.44533955253432517
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.655651835939156,0.7398792351018394,0.5653766932773807
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6231254061909522,0.7243910191381262,0.5200316632503617
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3791488178087881,0.44240322924194897,0.30419884304677125
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5270225388860568,0.6019891627693585,0.44420591185402875
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.571181074417889,0.6713457348029294,0.46939857143371333
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.41905189926699044,0.49408666174214255,0.3362232477968916
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5223960939584454,0.5998444201742099,0.43938677908526613
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1167870704381862,0.18794074357054052,0.047432742236911
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.06965187736216676,0.12207344482755945,0.015192118450082441
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.12658429390401088,0.18546826489621288,0.06747136343767754
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4474871065770247,0.5809000212765207,0.319161417218572
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.24290518402427186,0.3368551709832109,0.15349573394210694
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3912007037899137,0.5048887156220321,0.27963139458776687
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.36709519134221175,0.490157471843659,0.25233624194048665
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1167946736224161,0.19534997378990293,0.03580576226504055
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2831370667321299,0.38624315749703897,0.18630986109194947
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3233615086978788,0.4453339361373304,0.2060400644497952
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14907171729189045,0.2359289242953389,0.06641225809211823
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2792294076493458,0.38376719837691475,0.17663979499769905
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.02009536567694426,0.10693083483802451,-0.06584159024342495
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.06531884600142157,0.0001546409340227767,-0.1287969069544023
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.016786992044017957,0.09401611233337183,-0.05773328082679459
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,-0.19588368464784872,-0.02878786612324047,-0.3235303742969519
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,-0.05815033291622517,0.17290362114784147,-0.2568492908541278
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,-0.14144217195879474,0.03698904486165995,-0.2750727533251803
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.3043322238309276,-0.16235851972687354,-0.4114963932700414
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.25126738273733706,-0.06658143609115197,-0.40709240640900657
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2862184439629159,-0.14355314359327553,-0.39647290353863507
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24434296067665448,-0.0873170067208254,-0.36429714856976325
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12381435515914929,0.09113094323595382,-0.3086603881031118
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1973052621181018,-0.0304838854585811,-0.32224101015923357
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.5509590494339549,-0.4609797856626754,-0.6170429923051781
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.5136380935016865,-0.4169719356856557,-0.5960513867032753
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.5349862390279825,-0.4580510076376887,-0.5980095265659819
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9238823001703197,2.350962373850896,0.365879851664456
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2900492992557635,2.706954351222862,0.385655898512755
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.127967003841652,2.2245774092932544,0.4476603811638049
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5045588630292357,1.5738218029106241,0.07581584989495865
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7947889927983272,1.8185024478005396,0.11415899493244255
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.665618920345263,1.4875288669748286,0.1532841917525114
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.22744087208132371,0.3456210751569158,-0.45151377142449656
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.11270303079544366,0.4362875776904154,-0.4631171130200761
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.16085751297400544,0.27157982335121245,-0.4291296197611582
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.11822114034090608,0.5221567496846126,-0.38046316795611523
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.05323759736734801,0.5294700084546322,-0.4344545876074021
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07299438692768283,0.4055791216540229,-0.37733197405095825
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4576746583629412,1.6848919443768768,1.2379673060757497
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3643444654470902,1.592602330948301,1.130893463599917
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4144224333000843,1.6048844237723032,1.2176691146796923
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.933815611977426,1.1204710365107315,0.7573917797817807
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8161981731535222,0.9914916721997891,0.6386764762631956
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8781888841217418,1.030225228797562,0.7228858057875747
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9519277582909639,1.1323876601843916,0.7774323757672092
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9236022652311419,1.1093101236044483,0.7336693334877202
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9410175209523884,1.0941349106366518,0.782842367557328
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2871631714504936,0.38872486754958996,0.18225755972496877
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.35090462411591733,0.4622485576601001,0.23868030923180858
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.31893930113501395,0.4097162117385541,0.2175894263212622
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4016427774130972,-0.3255619817834058,-0.46901322322829075
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.40619794076235843,-0.3336371011734733,-0.47310151920605537
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.403463859484613,-0.3421039438929817,-0.4586443156926402
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5292660983841039,-0.4699376097825214,-0.5833989117871669
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5439641823670485,-0.48851253653615295,-0.5972661418338691
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5360471790796068,-0.4876321271278222,-0.5779563085317352
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5247743357051033,-0.46434965078713525,-0.5782811100161948
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5168897751823772,-0.45785514742822786,-0.571321723203128
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5204289503560248,-0.4711001048297162,-0.5647899664055374
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3142925289544302,-0.22642412255358582,-0.39233034232042263
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.31859241502402635,-0.23585733866672437,-0.39580875349614436
2,DALYs (Disability-Adjusted Life Years),44635,High SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.31607548289452886,-0.2460548348489494,-0.3786062626479638
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6500408982670256,3.9568646202649362,0.6950870773757485
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7666051944817587,2.881919649564953,0.988290186413878
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.71379436257349,3.0330543517477935,0.9741351109972196
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.120854864922864,4.637327890522807,1.0939535371369622
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.317248957991432,3.475791182624806,1.4469064661906412
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.2229057982525697,3.6323241093021665,1.4320119824371402
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.46374478719370843,1.7379142538828205,-0.06372204482930185
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4579821545814843,1.0457453003680572,0.047815429430634486
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.46390883001128796,1.1755605210411968,0.06491260372565641
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.049190333657652595,0.9536771077753108,-0.329295948673212
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.004456197809975464,0.41568586311864586,-0.301174524918232
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.027288446845884645,0.5294554205248139,-0.2598025970918711
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4069695771641912,0.6118291427433673,-0.6929786439893222
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.22565984637906314,0.621478517850101,-0.553960608326192
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3156044224872553,0.46931039756943466,-0.594134361861964
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3009794091524472,0.8833812358350293,-0.6266618932044308
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.06940745969408367,0.9047862035352662,-0.4448304373358319
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1858643930292593,0.7440641349759184,-0.5051255240982123
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6724408326524892,-0.10970939841707382,-0.8304173683841425
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5919279961567872,-0.14549182956134643,-0.764940268818294
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6308147946068069,-0.2074062446686053,-0.7810628912556938
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5248488114766938,0.30487879675877017,-0.7538103421280782
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.38037148029562956,0.31409987509656345,-0.6457355007700233
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.45198077225887184,0.18654136584223352,-0.6767457761769431
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.7270415520689695,5.290159854715627,2.2203545751987446
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.413763872091404,4.0139979593536586,1.201019655967129
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.962649586603188,4.350756436031299,1.7182389521201267
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.5610753111390254,3.675382627218424,1.4140454164178542
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7394552189535577,2.9150396319333467,0.8059885012760535
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.073466883705408,3.08263191891212,1.1552403615704048
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3493829251234721,2.126267031119681,0.6005457046392364
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7104753826752963,1.5122768883849038,0.10282669785528063
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9771765646189499,1.6697768745618031,0.35627393634199306
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9436711376927551,1.5827993184140898,0.308221378353283
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.34779687733912307,1.0360006077232584,-0.14588165394849573
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6003163317510064,1.1849120936830104,0.08440100567492484
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05919670138234569,0.44878539535989415,-0.336847404126052
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.046386270343401384,0.7108522083503683,-0.40315844235219556
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05238904151467489,0.4865726839512489,-0.34707283515489906
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.29236639340624554,0.08590005666044771,-0.4834759855044418
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2343915720472888,0.3553523736046874,-0.5122398844605712
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.26556400057231444,0.14982368013020636,-0.4724122916486011
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5324121479946102,-0.2799403955869584,-0.6704070890141338
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5221893281800164,-0.142772993263251,-0.70095096498613
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5271865103017245,-0.2582698499892807,-0.6742199226751616
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.33021239129643676,0.030045230388333344,-0.5284964210918983
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3161166598655614,0.2270334516997905,-0.5720476962247258
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3229615036485442,0.06255179036953787,-0.5338897289016007
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5372009127010318,2.0463701238723417,1.1787976647789304
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.388397991552824,1.8062012148237463,1.0060831080011137
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4639691743895842,1.7888567416500427,1.143588300703203
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2541806111904157,1.6401087860889167,0.9591569329719462
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1713818313582591,1.5222237835455656,0.8331765867536227
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.212545204452433,1.5106421448219902,0.9180906995111292
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7210396400330163,1.0664204065002965,0.4779267695848253
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6084063091989519,0.88976533842662,0.3509460061087457
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6653523429686984,0.8849379924006358,0.44881268647395023
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.22816480765438926,0.47587193106598735,0.06349924550181564
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1635152132966637,0.3678426671735384,-0.022009548093778218
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1945256645162222,0.352524684020069,0.04667575358033256
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.43291632156429466,0.8667826795253994,0.08814036951132953
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.43880064859377615,0.872236078989801,0.1298078245826661
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4343589686855005,0.8083471428230584,0.1480255335209428
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.36437174098269165,0.6615504040206037,0.13569236827456277
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.40874579725140403,0.7018202341216997,0.17690667814064498
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.38317402884458823,0.6545066471314027,0.16525928147556962
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.15259596194869157,0.5015853653671916,-0.12473172574171117
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1464931528533385,0.4918716134752223,-0.09972452668120227
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.14844706694183143,0.44788788408457714,-0.08081129931182232
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.28527641344658033,-0.07004497277267724,-0.454369983013751
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3523217194138426,-0.16342444194713995,-0.48966375505710735
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.30653982730587515,-0.12611656386535516,-0.4433456288794968
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.38821329792963744,0.8463286764449485,0.01316023269334095
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.23725618942215956,0.6890420726215961,-0.05924825586563784
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3654338668862788,0.7864703129760451,0.03697078903960382
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.321382350914125,0.647486803202419,0.06628953449468954
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.21116787802307552,0.5208587959201296,-0.03587004250317258
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3162992225728698,0.643696781168487,0.05186391817633604
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.11663815774701106,0.48513276377320796,-0.1850435538800274
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.01410542809783272,0.34589539769425676,-0.2503718744921132
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.09326085991269024,0.4303717799430784,-0.16972941420076898
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28269026564697536,-0.04476069235288542,-0.47420689631691604
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.40134453894610145,-0.18577282074329055,-0.5428737458719461
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30536813026683046,-0.0922376184754165,-0.47072293562313167
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.45308089994455325,0.7632448101215541,0.2037993184032204
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7732581037703681,1.2522842166099468,0.4266252189427471
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5850682897455458,0.8324085178539664,0.36742497696921905
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3845817645624686,0.5994171298629043,0.2399421512861586
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.736582780851866,1.0316407381267017,0.46605420851118995
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5292484245564362,0.7215524921711225,0.3646824761690395
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.16881575878240226,0.4183025327357899,-0.03169905143279335
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4130020557062035,0.7947089717722307,0.13679128988740769
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2691153804608842,0.4671530862997225,0.09485508045624713
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.36594458407486796,-0.23526213235536472,-0.46702565066362656
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.30106792079515654,-0.11813484501419974,-0.43546308736552597
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.34695012795457225,-0.2433758465977145,-0.4351545733550089
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9848298554270895,1.529187597465135,0.5333502909573038
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9607312737365556,1.5857686116812992,0.5297915465244531
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9786719845594785,1.4518068482336255,0.6331443202649807
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8914945134850917,1.3100628743281473,0.6097422976967103
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9198797720587547,1.352350931858389,0.5887825806838962
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9088023612406777,1.2666692464434508,0.639788519782828
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5965390596032937,1.034404499396461,0.23338210823146083
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5623880779602378,1.0604425019220987,0.21899829215214267
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5842617411106101,0.9630862601586292,0.3076083779919341
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.11101123258316842,0.13685293770437695,-0.30122053462690745
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1588184723925338,0.10205218879565249,-0.3445197143568852
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12474776021043023,0.0805917851405753,-0.2750694208665838
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.38234139700362624,0.850508392557254,0.015655300262314226
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.20081384423089277,0.6071973931296191,-0.09609317934487627
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.29714737765239707,0.6252122145153126,0.030322390557804686
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3155536528716397,0.6363490944645029,0.045350011373584215
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1755549124187217,0.48470772516155863,-0.05896616873887575
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.25072665759206025,0.48642513861448133,0.03850061939109667
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.11191497245389248,0.4884948051154937,-0.18303659453319815
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.043144127292568446,0.28067832629055844,-0.2797313639583142
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.038585970303800066,0.30125738512211797,-0.17505258218240752
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.28227431392459434,-0.03557812988598223,-0.4650921492573228
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.39921066119797,-0.18578644238485562,-0.5500507396687271
2,DALYs (Disability-Adjusted Life Years),44568,Western Pacific Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.33853230140382146,-0.16796890460183705,-0.4705302696635708
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2101400814882795,1.6929258364508277,0.8851372046431261
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.099751604151235,1.5385854755534825,0.6565058576774385
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1687238545534233,1.5867308752523486,0.8448404609398174
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.139385927971483,1.5774324847496581,0.8436050662710539
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.148985844800976,1.5672317144901924,0.696458676406638
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1549900179497752,1.544375920033635,0.8305218027976338
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.35312366484547586,0.6487016852441695,0.15414574146158705
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.253099015872951,0.5149882275771869,-0.011423134079497382
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.31110409262091715,0.5638106391145863,0.1153000754302666
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.09405925775645499,0.33490850122121396,-0.08933348079753517
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.032229090736718966,0.21318024097341526,-0.27493134736804126
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.032163928512902056,0.24154270839628855,-0.14904694190328466
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9999051196038719,1.6589882970343672,0.6435755747655865
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0108904031459693,1.485099363259157,0.5323213846481425
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.002765962501089,1.5592201935082124,0.6514609484668059
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9358552755931144,1.5465626657582168,0.5965710550660128
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0577032828746897,1.5084628888610272,0.5883647328423505
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9899260787825684,1.5321804642132855,0.6508790382341634
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22441060068887514,0.6279239580332701,0.006253415249468529
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2000680367281608,0.48306854977035363,-0.08553449117147811
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21077408932625427,0.5471790300004071,-0.0016076948697981786
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0496029954881114,0.2557605194226102,-0.22012685986153724
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10789474723326312,0.11124944826261063,-0.32692922115878464
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.08390815369328813,0.16492470340607304,-0.24545470372073486
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6498985165503655,2.3483446061971867,1.0063249965399497
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3229082047562417,2.0441120344077888,0.6399319486786899
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4927600461058488,2.1185878514075314,0.8566580621028584
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.565239623579911,2.168444693318385,0.9290452239178066
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3773557394869256,2.124182133593254,0.6964747804005059
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4770668494871693,2.061243042498396,0.8727883476337557
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6223588822336991,1.0499715663507572,0.22834106983893454
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3862753954270075,0.8166785952119027,-0.02131418453253178
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5070004839524737,0.8853452857050049,0.12244441758212402
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1929188395613821,0.49780938143946374,-0.09516400270800533
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.07004532054410213,0.23700800632266278,-0.3490836281603158
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.056748462890645786,0.32509133158483355,-0.21680063646605602
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.793471812394716,2.377170419517001,1.3627685964249787
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8977224637404893,2.552358971007054,1.2469839132438443
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8176503949320935,2.3441225415234883,1.4004961448416284
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7038560629760904,2.2505712313537867,1.300345523624856
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9659028601299342,2.602011434213231,1.308183981273951
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.799906197593345,2.3287600536293356,1.3893651723744336
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7102593849547923,1.0676197192837573,0.44656808369516143
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7293155820942582,1.1199924418658846,0.3409649621419751
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7034132568856303,1.021692499582961,0.45122225368368607
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2754882540327568,0.5457675337841584,0.07609095258445714
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1891733488323503,0.4650014619429714,-0.0866021412344476
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.22102421138151604,0.4472687835976987,0.03967080170214544
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4004699896465063,1.9491428215839737,0.9487874175405824
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1763694455908023,1.795474914262724,0.6237900553088762
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2712448989620866,1.781569321612996,0.8016873133579913
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3237251724776182,1.8424887853353624,0.9020421506187988
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2270739275077582,1.82510206638128,0.6953478777996349
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.256712046891468,1.7122823509375458,0.8208593429241603
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4696501714745643,0.8055665232799389,0.19311458785525282
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2988233489399737,0.6682958389147801,-0.03094741479464925
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3730832886452319,0.6816004092999413,0.08921179854558364
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.16662797684785857,0.4309528934872354,-0.06039275268800895
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.002622070279593099,0.2992203472023614,-0.27684153380209164
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07165509297970954,0.32900972111566484,-0.15140752261426554
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4764002762319258,0.9181777296360356,0.13921261254936507
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.481340198504165,0.8926681842168827,0.18000661762328535
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.47763786796951235,0.8318492960026793,0.1907406543587104
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.38934298649080173,0.6939979529013213,0.15119756995787964
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.44018945481989613,0.731738688026546,0.19731909742636644
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4111944787170779,0.6913835144599354,0.1952223802753181
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1619858114947225,0.5096822600513387,-0.10339430751349209
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.15746010236024577,0.47885537194614547,-0.07798992979520136
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.15881929764320057,0.4366052471970201,-0.06617630837027401
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2753546143661176,-0.06196774595544556,-0.43594230598201483
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3335406115283149,-0.14916625699057537,-0.46894802847369016
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.29471870564550556,-0.1286481259984341,-0.4293746248629956
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.40870474726316003,0.8577757267365436,0.05029864094300832
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2706263187389568,0.6959808057145473,-0.032828651978410686
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3872066049764645,0.791903934668129,0.06820933880018482
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3252644444491692,0.6486321668363977,0.06351173166905874
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.23511227401935847,0.5450089709780874,-0.00749334706010393
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.32449780982927945,0.6614083734010126,0.058581874498697485
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.10870673438421719,0.46214347840453296,-0.1733731439533745
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.007183312493439367,0.3251717053014633,-0.24429091399032982
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08789969349784237,0.4052785895840721,-0.16226998335841247
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2870542999960807,-0.06233759908501882,-0.46324802595357656
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.39095742481383844,-0.1965482172372312,-0.5330727860027182
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3078054608661983,-0.10868223699082925,-0.4623616134939562
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5366757809917038,0.8535195388949133,0.2829372400427875
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8250007789217323,1.2775341331826442,0.47678676230504835
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6581130637796019,0.9124988460482292,0.4359993986519662
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.44689425357622814,0.6868899397511827,0.2921252986233747
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7746156270015796,1.108967150551124,0.4929558753068237
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5841707277815278,0.7958841579824775,0.40608276675051164
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.20942503406808777,0.4587936890806966,0.009722697812431165
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4259827624412778,0.7795742622690498,0.1539022290679109
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3003547470142031,0.4998536634462931,0.12616484094888275
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3301840630811265,-0.19512446212841605,-0.43253830265058446
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2777378394658812,-0.10456395380679015,-0.415048033906817
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.31534104305158833,-0.20569746625476346,-0.40597506296342667
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0632957185361804,1.6035961967535217,0.6410081231478237
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9656168946232608,1.5511270937688777,0.5365552616110107
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.039231667788416,1.4944413667829242,0.7130486549461683
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9426885762397111,1.3445380470756394,0.665167096822685
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9108768513699743,1.3585347923080606,0.5585859951775036
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9478793882705437,1.306273687514826,0.6751157184341923
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6238958962916283,1.049133888819436,0.29153874213026437
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5358545824578705,0.9933488810129119,0.20060294872329743
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.599242317906746,0.9562349174494615,0.343437307735747
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08544609899467127,0.15615284272384716,-0.2570873450326212
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16237181112153598,0.08760671171988677,-0.34740193395597224
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10626415287037316,0.09542858710005805,-0.2498777903162685
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4142025816582927,0.8669685188865095,0.04939921697741311
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.2289187905137342,0.6371070521312208,-0.06845668236870986
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3270369873453211,0.64427205263432,0.06392401671753653
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3302143559584516,0.6641149881062014,0.056220419056943374
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1946422012117344,0.5285866551061749,-0.03850700121370121
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2672496599885611,0.5197910534604446,0.052230610842567714
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.11303374899125566,0.4693785719074568,-0.17408102643170034
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.03977191026288244,0.27917010423933053,-0.27212923481905726
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.04071241198982818,0.2895001045055531,-0.1656306944187031
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2784328082698862,-0.04608896003032903,-0.45254049891140036
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.39079798395158166,-0.19097138775539263,-0.5365268385657649
2,DALYs (Disability-Adjusted Life Years),239,East Asia & Pacific - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3326650703915688,-0.16917168607870461,-0.4594645008376769
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7162997741989593,0.8255125320977971,0.6064297050378558
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5364161468831234,0.6157228513747741,0.4479534124273629
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6548012206413162,0.7398642096193004,0.56531349263679
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6255883854563947,0.7270103165757065,0.5219257482505455
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3840749262004762,0.44735325537668014,0.3088712923716277
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5303984628600065,0.6049077642916156,0.4471904788032339
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5765702058986261,0.676891596599554,0.4756450177914015
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4267999517738805,0.5004484892313797,0.3446486247969256
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5286364953393633,0.6072141442632637,0.44597145665894233
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.11924428615551604,0.18999257906774908,0.05041282489322824
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.07477204406667166,0.1285768427756957,0.02137210594325961
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.13010697301188362,0.18857569314366962,0.07253061295429955
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.44563371869455815,0.5800054700712702,0.31826098608230624
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2456552542201665,0.3394109096244308,0.1553385761719025
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.39077115589280836,0.5034930521271246,0.2800160715646137
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3692098574103019,0.491151801323109,0.2548735847956396
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.12217955409386257,0.2011760564604461,0.04042875676063555
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.28623801382195685,0.3902290882906163,0.18983151159758446
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.32793995769183854,0.4513720660680194,0.21093705511085203
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.156783505727767,0.24385012819246343,0.07291050546995406
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2847365103701912,0.38886430666275934,0.1824255730584251
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.02289633585736686,0.10967479616695497,-0.06315598095761221
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.059355071428410164,0.007133471327724308,-0.12273969839033678
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.020533348840960773,0.09834525459200413,-0.05404378653660934
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9005350906225078,1.0461593177161344,0.7427637135706162
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6809104881156685,0.776963801725123,0.5762138790473296
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7954047636413409,0.8961066688453478,0.6775478369316656
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8001640542431986,0.9421712306068496,0.6543449585076689
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5141946282406588,0.5933692216006937,0.4234550003097094
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6604340300529036,0.7570694073193547,0.5538005171007085
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7458063236876922,0.8795748069935714,0.6008796295618293
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.560985289203734,0.6501856425739583,0.46375829958074877
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6585201964890157,0.7515444253359032,0.5496488727616087
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.19023749438415602,0.27626501400936765,0.10337772847996059
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.16060005500193375,0.21748767533168284,0.0994768956233165
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.19057571995106937,0.2532167081898769,0.1243318162213344
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7787046068717447,0.9097137399402679,0.6477934694108651
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.48036485606979185,0.5790006048834717,0.3960530909970925
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7201743818194614,0.832589879592544,0.6078187573797473
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6846654383268105,0.8076047933353578,0.5619972162234624
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.33365364160959726,0.4150752909208382,0.2531669236689668
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.590835730391271,0.6954981771932419,0.4883650262076238
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6338944573930504,0.7542377091963904,0.5136412230549807
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3747476616495078,0.46634620540084887,0.29645115156417934
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5890255008260058,0.6928702589722925,0.4852360511731793
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.14176979760666694,0.22066508768560872,0.06276002639754713
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.06390572929328733,0.12373982543835998,0.0068122237240147345
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.18065305519574956,0.2526103239609791,0.11049722251459954
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7584379692913911,0.9328863911740828,0.5881808335748161
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.521066184194194,0.6435342106166737,0.38686155137672673
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6319194999749043,0.7653673395594291,0.5011721849657538
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6653923595023067,0.8324873573096853,0.5129749142453085
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.37015536183623793,0.4714505316719149,0.259000303476844
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5091239968040837,0.6219429159994847,0.39324149603240754
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6152777929482602,0.7755237992350397,0.4588818465363509
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.41254513801868187,0.5262756364568293,0.2879153858384218
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5074993141175084,0.6307728742699735,0.3867203861728218
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.20907846733738222,0.30290191112342313,0.10882576024884502
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.12808746981381255,0.20418006244648193,0.048524285963427165
2,DALYs (Disability-Adjusted Life Years),240,Europe & Central Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1697040270119787,0.24626678021343584,0.09186562433682485
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1218085073339576,2.7822904399449206,1.5660686690764232
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.059716542543288,2.8463303245717912,1.317224258171088
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0904507507312378,2.6722284850977545,1.4951826927507725
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8111997890310307,2.4227921975783815,1.313689192656092
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.902816600215139,2.543972871301749,1.192261824287169
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.851738062579923,2.388818764760252,1.313987903673731
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8355591712884609,1.2239089582873217,0.5087955807070663
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7615916844236567,1.2144742563898294,0.33411148627053316
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7983747084772882,1.1369189687902572,0.45198024806300685
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.37768844996694506,0.6657845495096819,0.13530478738406
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2777383990574097,0.6149482221801126,-0.0526857962177324
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3232995357767177,0.5901437261711231,0.05747997264276822
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.39775399147185314,-0.046463412145195004,-0.5481906132281715
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.27896589469464667,0.15882170661128087,-0.4923201259336655
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3424234437464158,0.02203600930592756,-0.5086915125772982
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.458393856081621,-0.16640520747307272,-0.5893081676913745
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.31613827118303917,0.08327270134066314,-0.5155788590505186
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.39379788001266014,-0.08158262966132714,-0.535567802119775
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6458917381611683,-0.4393401052998174,-0.7343453765293596
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5848740671134282,-0.332823595351993,-0.7077099685315537
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6173473894142365,-0.4052635493854914,-0.7141010069058181
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48097531779101843,-0.1759666320703252,-0.6098343115112925
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.37247850169956687,0.011250306599200592,-0.5583434568098088
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4306105277824286,-0.11275729193638587,-0.575217675928419
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.8632570995577744,3.216759127791218,2.534624322146888
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8703797642085633,2.0693182570493915,1.6857428908275471
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2496382944380673,2.4561350065251846,2.0521282192715002
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7489770068478792,2.0264012158646505,1.494186832345468
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8571617360190981,1.0129605527257801,0.7296352195427389
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2150393294141137,1.369160283085131,1.0621177846453238
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6212686138523666,1.861124193655109,1.3982871340515817
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.902520012810516,1.0343786848466856,0.7801406151118973
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1788275894052267,1.3172801470904791,1.0464004199891854
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5339149500307985,0.6633085776945029,0.41255954378799914
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07911044291132797,0.14046797695855445,0.0188872208468292
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2512837230946572,0.31942712757835034,0.18521104180983833
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.40044384339636097,0.6872673886071086,0.16806862702640768
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5723700852749292,0.8777183030218756,0.31760604705790063
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4632850279335653,0.7490737383049428,0.24099476802532363
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.24131788179495403,0.48539576952614005,0.0559009842139927
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4091304593454312,0.6517745034511321,0.19611150795984425
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.30348227246601495,0.5456810738566205,0.11370672312541522
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.00023256871175648334,0.20452882916971432,-0.16612367120809832
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1522896008650982,0.3760598056327479,-0.03441068977325448
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.058597235995089356,0.26534789161067873,-0.10221617372031348
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23903068888223097,-0.08205844931617037,-0.3623267473874039
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.038497761512137706,0.14999893429392142,-0.19544971439992687
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14978109701447867,0.013199265454904404,-0.27999620411408266
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.26000932995865494,0.5206552456449655,0.03860245364848307
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3520377514175524,0.6458139433456824,0.10456062480709252
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.28451813238428686,0.5357230989420618,0.07142866916487292
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.11640610322444209,0.3423170916060862,-0.07688703893676019
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.21119354459925344,0.4527249884239851,-0.002266956667839043
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.14378646404643936,0.35739763591154994,-0.04792833069115619
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10048782237714068,0.08558554202817704,-0.25854870074934533
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.009177892962094656,0.2061119132423676,-0.19053807153312552
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.07072968111492396,0.11100175069083562,-0.2248868770662188
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32736283756249235,-0.18360192298463401,-0.44423633993576866
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21801256376894151,-0.04999021329766999,-0.36176232700220934
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28300512864544836,-0.14845225218478078,-0.4023265682003829
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5152181718334136,-0.3624962856804414,-0.6383578485850516
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5949652894828312,-0.48629337144447415,-0.683160847820391
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5517254180906459,-0.40687185879134774,-0.6569171969947125
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6827743860772258,-0.6004308827603517,-0.7503978386521304
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7388197220246315,-0.6786606702289151,-0.789570369509913
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.708591641402643,-0.6388123178078793,-0.7659219185688935
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6809108426889969,-0.5803874832639959,-0.7619628405223962
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7400262885538494,-0.6702746323900353,-0.7966350829083001
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7086981653993011,-0.6145681181577222,-0.7770548365474816
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4545245476019898,-0.2813374958548678,-0.5941030653201642
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5413356496396033,-0.4163737761859771,-0.6424521757336521
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4940078179253452,-0.32773012629569154,-0.6144121927648315
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.556404189439116,1.47596409936151,0.21609681741482434
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6354794955225244,0.9968308698407085,0.3696041745966774
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5869718480537951,1.1882614926266728,0.307458983482365
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4699027873914562,1.324716987755013,0.1676514198156897
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.602914053503647,0.9032532647750648,0.3940257184882051
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5246570812305715,1.0690286413541357,0.2845285956273843
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2961171642987954,0.11975323838019905,-0.4500209636176633
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.25478986726696995,-0.09013925174036878,-0.37593659135615454
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.27957227094834836,-0.006608554753158526,-0.40646098577392603
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.29195216023015347,0.15449183377108183,-0.44903556380726717
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.22330773255444097,-0.005511355122517402,-0.375784892738535
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2672557591047335,0.04158823475392898,-0.4053061878456437
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5596012933728587,1.6133863721454214,0.18557976756111416
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6871800139381221,1.202464055905636,0.32311488922134735
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5918078780895728,1.4141625182470356,0.24895096416743379
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4725893205088285,1.4652203525920395,0.14516681900395512
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6531505448487056,1.129106665503678,0.31640404229285335
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5289099752609514,1.326396302346722,0.22992663291553667
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29467127601464355,0.18190237657450237,-0.46382228061103736
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23123240274581097,0.0035579999226986883,-0.3971195451137893
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27737688850311276,0.09594232734201022,-0.4330215070195034
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3339362334184962,0.12349864548969101,-0.4948911686723705
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27850729965957927,-0.04695305006121596,-0.4420107762859643
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32343389434104003,0.03435953533874096,-0.47087621124474865
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6208278976209959,1.4562957427811787,0.29199358494265804
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8125011492315561,1.3229099659248515,0.4642349835953513
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7310279759352252,1.2572305852567038,0.44096115718311746
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5312584589140384,1.2969806657265917,0.2486070294164064
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7768117382242528,1.2275027407615484,0.4491097528813327
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6635600679071362,1.1264009346080446,0.40049558849857403
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.26698158196796873,0.11085823623532884,-0.41569669726671077
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17412952856001265,0.058439466084946955,-0.3328178375426099
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.21417600749675247,0.02470091481250564,-0.34585583519066754
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.25275973485821046,0.1275766090702397,-0.3987772167188447
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.20056940205797383,0.03135433737244276,-0.36134845415227346
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.21753890826133482,0.021293741451803974,-0.3511394655489468
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7094142467698105,1.8163596699480715,0.3130361477562318
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9265804003892968,1.526373200130367,0.5128565664697531
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7596628792030553,1.6677747180237392,0.39527024204378447
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6156976824395557,1.6295774711619058,0.2626996531042046
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8892634162075596,1.4417561885283015,0.49628562791152175
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6917945544874335,1.5475022558364735,0.37367056551933264
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.22691846014756337,0.27369692544451046,-0.4061802111995686
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12214904569239804,0.1511479740079652,-0.3106632973440202
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2011767987469845,0.2110730786335296,-0.3665978554555448
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.23215986258718457,0.2834476586375241,-0.4078188403414723
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1488802620269757,0.12385989272953685,-0.3386139401239445
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.22160548934466834,0.1801804649404534,-0.38121040269977274
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7738484882612718,1.8364520421032349,0.38043644666819565
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9171551772818983,1.4376473596930663,0.5143494934213009
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8584133446702947,1.4794722769566326,0.5107960723623458
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6761529638300415,1.640197861421409,0.32242596435321436
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8793074025667489,1.3360770337275314,0.4860121603238228
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7860701819763913,1.3488996196759002,0.4883710282449908
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.19777811413396792,0.28278368837184314,-0.37569846754507574
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12644367108032314,0.11071983320268683,-0.3099830416179353
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.15634766477929304,0.12559059187157187,-0.31415331355313136
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2330593337940444,0.2332676463522767,-0.40053543025470334
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.17497435705772757,0.06018897373678716,-0.36102067998729015
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.19748524764921596,0.08802596095804391,-0.3526698429593334
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9583082900928598,1.9949759126026663,0.5262493267011343
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8144458654108159,1.386455262508476,0.3493385313009977
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8994859696797636,1.6172595295385843,0.5189809986205388
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6899779725673548,1.5441853996389479,0.36278988679827096
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5975614030216639,1.0260138006611785,0.21599639609705218
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6545262679578346,1.2242292578380183,0.34855900115188654
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1027450721447752,0.37223383569653257,-0.30070523806372906
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.17604735214150463,0.08370614413150171,-0.38725586862784367
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.13359649640699273,0.19379814455103203,-0.3071544196149464
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.10992298000972317,0.37823145115514734,-0.32264082413013984
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18175890658087396,0.12452444668879317,-0.4252543350769987
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1464021611160712,0.20718833200021336,-0.34606988120210236
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8109914964643804,2.033882961894621,0.36348388099763607
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8267255846589074,1.5059528713320844,0.2993558731888228
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8154194299321382,1.7535987296314413,0.40809396813175103
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5626525862194639,1.5662983167115865,0.22031429558563123
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6080194617048293,1.1455369302349867,0.17095372887454993
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5810123442797848,1.3793597577547612,0.2446638573839352
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.17024247268568657,0.3900602126169189,-0.37528088020385947
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.17047104513653616,0.13797085000117937,-0.4099533457384148
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.17194136745890282,0.25598589561793467,-0.35773279358140836
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2450616457810039,0.2616797751507294,-0.4328767122521805
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25583908464898714,0.036588547723494354,-0.4811729809870292
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2591538372507898,0.13217932204363383,-0.42807197538786
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4105297736973736,2.313997310392648,0.7078367572961133
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9079509013474372,1.6915813001167836,0.2939699594028897
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1457473594664511,1.9636673183936533,0.5036011669518841
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0799498503762504,1.886883375468126,0.4849053418178488
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.679972903020902,1.340539545225087,0.16317556772043368
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8690037704732629,1.4988908585877903,0.33963086777517815
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.10445312882230165,0.5184026093806544,-0.21750576545659026
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13358605670316454,0.22226602701950016,-0.4123991271252584
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.021270459617762895,0.3518034821669439,-0.3141695491052893
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.08446893371784105,0.5017162052356553,-0.23187723220564732
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19660948850592297,0.14762098704101906,-0.45794008348479615
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.06954794488952444,0.29170696618353575,-0.35030557369968307
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0934289100087835,2.3761548045522676,0.5995462633615909
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1998010267904429,2.0358949631501146,0.5466037143062743
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.120594611472871,2.173123073569151,0.6652279370169825
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8076566861871138,1.8960383699598315,0.43737078180482436
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9383112516157613,1.6001119824550278,0.393214757225554
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8483433722142487,1.7448782342031413,0.4873651230873984
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04083569725841859,0.5468818423083802,-0.2671221510962687
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.001054859040703426,0.37862128663808237,-0.29767635955238947
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0327432629627165,0.44734153984597247,-0.240447498985366
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08262341316894374,0.49089082420233054,-0.30099962785234957
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08180336895678231,0.2843687444158436,-0.36269499236193764
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0984431449011524,0.35068231721066423,-0.2917060484805179
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2681264925000635,2.401049430259431,0.7172454072781951
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0741149499769842,1.8284705621241533,0.5013775508068518
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1504214942505637,1.886916115165951,0.6499924893870033
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9578042145459891,1.860930884184127,0.5418489054366454
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.826217844962085,1.4125556759775595,0.3332631390654356
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8732579348225018,1.4439083641681045,0.4466378049352211
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.03920699447080898,0.5582880267717083,-0.21319492348977842
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.058129791814157464,0.28442840510115774,-0.31821387895608544
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.01913846874346521,0.31679532077859135,-0.24739677127067114
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.013075017473725994,0.481687780019014,-0.25988451548092967
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12509350027825353,0.21341645782311602,-0.38806505257223645
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.07739651731965702,0.2609821838135283,-0.30657008510211947
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2157619103919959,1.4217694311922005,1.0028620519575666
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8895250479279518,1.0294006591963984,0.7577964108575462
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0451250076966936,1.192927914567938,0.8956834523202019
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.09268288254494,1.292150737724557,0.891036915750506
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6978570424569565,0.8246854644090771,0.5750391117289847
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8862582846815259,1.0164327630187966,0.7496295185426777
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0257548487500872,1.2140967153481006,0.8311116795092884
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7468748377560965,0.8761905015037382,0.6250910901616722
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8805223754111805,1.016429311405875,0.7431086781339402
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.42304325276837,0.5292412331419636,0.31117712293181155
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.33440986945075235,0.42083555611073087,0.2454465622854483
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.38725639362672537,0.4744904739496593,0.3034386013351302
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6572335356178651,-0.6057204904134368,-0.7035168988240805
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6500598584722208,-0.5838965392796971,-0.6957804517153283
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6542842393097915,-0.6021080153171603,-0.6966952807172178
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.676287343612871,-0.6284394140818368,-0.7190576983925933
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6855838428008368,-0.6274711175643861,-0.7263250869264088
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6811647113170916,-0.6372254850792856,-0.7185520220313062
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.686626607328856,-0.6395309331017041,-0.7289410577180069
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6764786851457535,-0.615310383827606,-0.7187475896999689
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6821092984225777,-0.6341324968513558,-0.7211068716912057
2,DALYs (Disability-Adjusted Life Years),44566,European Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5801045034430864,-0.517175977395201,-0.6378167785927866
2,DALYs (Disability-Adjusted Life Years),44566,European Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5666858705017166,-0.4821370314483876,-0.6250843201575523
2,DALYs (Disability-Adjusted Life Years),44566,European Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5742116102311594,-0.5085898753058489,-0.6274031549670883
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.26850610106288203,1.1257185144062327,-0.18064517176763467
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.29964711454630855,0.29575743378735375,-0.5784092472268891
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.05584391772885475,0.4604538052356245,-0.38225937724834913
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.037498655777002315,0.5659953443978403,-0.35807646622787254
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.42982392875389214,0.04399566676488144,-0.651386207471248
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.25963766975731734,0.1183702705967491,-0.5021958792473596
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5027945219730291,-0.16680031004932552,-0.6788445016514867
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7146118641596784,-0.471989326794508,-0.828205178388757
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6226238473971438,-0.4162613063422048,-0.7530910578262189
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3883308881224186,0.046132439678962994,-0.6049520650974843
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6507802809724762,-0.3436333248790433,-0.7921920105535281
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5360679762526983,-0.27075712546537967,-0.6985344839642758
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7979044310981427,2.559611614978672,1.0064000598649017
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1363155105209648,1.9243104994823335,0.5126588612898155
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.50679420638497,2.1767812663862074,0.8633512122980131
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1065329103489074,1.6167790464115277,0.5348773225528427
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7146690234909572,1.2637704280728363,0.2561941649454396
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9440677716142748,1.422321689026178,0.456753548280568
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3905841156975242,0.769159559141539,-0.002800802639415174
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.07040651529740007,0.4652334807208062,-0.24207829200654368
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2507729106159892,0.5850650766734781,-0.07027500966391628
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.20193852110115715,0.5469140833619002,-0.16292124213902623
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0963286681939724,0.31062511194285997,-0.4035531277802359
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.06956763082323197,0.394936042983774,-0.2434666968781259
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7494009621139721,2.362521456214551,0.9868485143703392
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2938029641045845,2.0477817353996364,0.6465824738509061
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5898616075546428,2.223584078399842,0.9206920204221084
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.071448968652851,1.4955830212705836,0.5111741443104765
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8415160112633524,1.3847788669380308,0.3635276104786024
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0095221206099363,1.438731631755664,0.5025607950012386
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.36647744758694345,0.6712039459721071,-0.012518099735015087
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1493160188624362,0.5270990687984182,-0.1749755130717047
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.29221965358103247,0.6084174879955573,-0.041664631798923976
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08320202290605813,0.33029819466955856,-0.22030154515733136
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.10806849184661735,0.2084140349716369,-0.36978181890720385
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.014179035051138461,0.2702506673313759,-0.2569567257225892
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.964877674547122,3.0856776972111604,0.9266324622594981
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.147154788469959,2.3499080520468225,0.3281948599072775
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6011083493144407,2.5910383245500697,0.7203881638502856
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2313008162668033,2.0431060977079714,0.4766465093167993
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7229893930267366,1.590790386124227,0.08078296346311581
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0166252655250607,1.7443824797596488,0.34368944229497633
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4735713462497517,1.030619217887855,-0.04244602888250367
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.07583756407300501,0.6784802557950378,-0.33450446592387206
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2978312510109366,0.7917599481803175,-0.1416068755833631
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2008025232059546,0.6386152487657717,-0.21578717810632211
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17667110077189885,0.2900423319810074,-0.49886321139457723
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.026002519295498194,0.4175004842659067,-0.3249043271543889
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2619743522232145,3.1971669525911715,1.2956940347350403
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6434378163864294,2.8969370063477595,0.741685799685007
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0983809982772548,2.989689238754174,1.1905392323649533
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4551168409074349,2.076578707004727,0.7546210484976776
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.120739485649573,2.010367902686412,0.4305295330085779
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4023786044344837,2.0586549977048967,0.7199424392537566
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6212311148290305,1.0860303984411306,0.14098095121538695
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.32450148281400076,0.9525705546560215,-0.12732374108487476
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5459470145342173,0.9906680847193161,0.09297648945613654
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3037222777436006,0.6709895568953463,-0.09432732415191769
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.011703941749674871,0.495974658354125,-0.3371421080938597
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.21329738654203131,0.5705977481751934,-0.14922776758305328
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.107510016920807,3.124405214941591,1.0582884687833722
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3797409622335122,2.313857570583849,0.6398689642061093
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6496045626206033,2.4956598258711558,0.850994422179316
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3395864363429477,2.022111178890448,0.5828735210430016
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9100102499967777,1.5815976098327278,0.33794053705915805
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.054532692636982,1.680796393179741,0.4725659261554658
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5444609261385613,1.049867148731295,0.022988211605979605
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1923754792538399,0.6604170670724299,-0.17833933476794375
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.32202859027249253,0.7441705441123843,-0.07644046923904514
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3019820366889469,0.7484807937056432,-0.14729420243570301
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.022461620347633316,0.3974923892122805,-0.3434321424031494
2,DALYs (Disability-Adjusted Life Years),44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.10276978291388583,0.48948812276605536,-0.24312112204760566
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.016441468931173507,0.7067613693162018,-0.3057134009781521
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.03108891558917145,0.5264213905413904,-0.35329721939834635
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0244535512082258,0.5422709298457247,-0.3132877877566278
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.09271129906551837,0.5098494899950337,-0.33352013071300557
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.06148229882570496,0.4642094438219501,-0.3429668673073908
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.07926761210323607,0.43644036606501985,-0.31943032057654
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5561078015317816,-0.22971736551042082,-0.6866598223982416
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5679043289426331,-0.3192769845714335,-0.7115963719945922
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5623325383621262,-0.30807825310679987,-0.6919146277652669
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4622306401340663,-0.05352584695175063,-0.6215383497687959
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4620929882733739,-0.13956389165209326,-0.6437538972869008
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4623021863005326,-0.13509597023169145,-0.6233712123919499
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2902711903268613,3.05788794962029,0.7152954574220483
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.329609093932061,2.2253509209089968,0.6439277247731808
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3131921310287167,2.30009051255444,0.7639034104504896
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9895364255095022,2.4090082085974505,0.5407078259663625
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0491827677616599,1.7608626407134245,0.48624647767304163
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0208811880901016,1.840064359963944,0.564642631238431
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0022639887712548267,0.7758049699751051,-0.24935576435746054
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.008620361200741474,0.39643797722110474,-0.2882501275138846
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.006826298224593764,0.4363778390875227,-0.23225385503113852
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.03297924885507608,0.8321230680389469,-0.228888666036418
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.012647209714994837,0.3926836133881233,-0.3183300014041415
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.01237437925033687,0.4468418321142228,-0.23547190422211772
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.011987534116342183,0.6807002292789152,-0.3111415200120744
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.06458279377165956,0.36853889692411557,-0.35261444857372937
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.029622763273984488,0.4165935811894031,-0.3144551328303975
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.12341909761388208,0.4258000995203681,-0.3762997342701164
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.17827266329809785,0.18055706229652413,-0.40652307418365485
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.15391897631658708,0.2122865404117808,-0.36892595616792917
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5571359990842505,-0.2644952602816264,-0.6985431023331925
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5950046542671451,-0.4074816242226082,-0.7197099503017527
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5776393547129284,-0.38342187304460384,-0.7016138038770316
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47273290609870366,-0.1060260315819157,-0.640929502848521
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5011741038564367,-0.2615014678004074,-0.657407009628276
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4880454605626448,-0.24315900143997474,-0.6393907904240507
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.027801958456845,6.768033635630294,0.561147641280444
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3139628253909976,2.367747682533757,0.4791917811693514
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6991324148029352,3.7946373833760347,0.5982287697733453
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7213188569203475,3.4616573873677963,-0.09906132925663758
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3293725957386978,0.9015120116570998,-0.139493213584245
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.541833911328405,1.7352902862111765,-0.07326769014336132
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9635242272793362,4.037556105437819,0.012401490610183242
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5198129223425118,1.2119397904497395,-0.028465471019764953
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7618526452064588,2.1296888253344903,0.043240253878326224
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.521539910931778,2.8727212351473477,-0.22700260995260366
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1601771486647568,0.6967113567845395,-0.27163616561090587
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.34380794233815853,1.3967724388896516,-0.2108980029046092
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9020870437236657,6.397832683787283,0.5205524137310016
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0564932580049464,2.0411758373447872,0.3161018919284207
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5982274066680149,3.9527209703173947,0.5067611039809946
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6496203853549157,3.2917541808292046,-0.11792403397333034
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.18119716535896957,0.6952251357078639,-0.23429123284376094
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4840203940676495,1.7957093455952302,-0.12315864160506279
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8819983269081128,3.7974814414145173,-0.013924442822356315
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3507066725231631,0.9974471007032788,-0.1355830610052015
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.695987126893212,2.2328775330425166,-0.016465060334233103
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4104777469802541,2.5639941001651883,-0.2619422539022241
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.04288030736853743,0.5538515653591523,-0.33875147070564143
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2750651587363127,1.4256484575876258,-0.2648644341779417
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.280809235847282,7.639498008637686,0.610534754142987
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.707080437789218,3.0858049512151218,0.6514416846155849
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8897245954908992,3.7236678253051148,0.7790536517024498
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8656937613423257,3.941683917331855,-0.07496281284955317
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.555263133548306,1.3113968923667172,-0.035296723616039874
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6506549020501126,1.6761407826898322,0.015809654163786182
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1275990002170262,4.602699213569936,0.04442894615433829
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7780129334953686,1.6835604681671976,0.08466842476164227
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8862612647536661,2.0833636050782944,0.16127329101229682
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6284848419053569,3.250812243406604,-0.20542967676136525
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2575785198716391,0.9032482895682102,-0.2389313178124859
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3748546832424888,1.249181534005023,-0.15684032258037325
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.054413547751915,6.7085608913872505,0.5605537828859948
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3338651727143038,2.4325881426490277,0.504564151683718
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8213256938908184,4.492897801373641,0.5964457907329872
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7366668856551731,3.3713988935228087,-0.10819306835478743
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3413192320136742,0.9238071657571487,-0.12487196892797832
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6121039718241635,2.1311065796800377,-0.07541021688686297
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9807817959790763,3.99898813574025,0.012016374489289942
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5328848024587345,1.254527064580719,-0.01180087461611233
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8416140347576855,2.5854767510194447,0.04207641829865088
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4861351065453684,2.751345014546219,-0.25180829278846706
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.098638661583621,0.6171298965226615,-0.2974050061482207
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.33430445637863404,1.5941178991239577,-0.25433011717834597
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9787973768639477,6.894160670586912,0.4734335482938139
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1370143561400237,2.2539921189247867,0.3131453995392336
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.422217878312468,2.9080766023886078,0.4828336918804287
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6933535169024949,3.5221778127208663,-0.15796019572349115
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.22748883437840514,0.8252027269875785,-0.23424192888975726
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3832967879194237,1.259064047140277,-0.14497515560101712
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9317448425885376,4.119349265046727,-0.04448094391365828
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.40359300419801014,1.1372250311354641,-0.1375248879388882
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5810973010313694,1.5509882589774877,-0.03208362505196487
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5147461326744355,2.978156709350431,-0.2521907878398868
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.12674156789259616,0.6956863379668125,-0.3083144099752996
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2617581874716781,1.0481245071438159,-0.22835062085898142
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.053785360134419,3.077064254973381,1.0473502258464402
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0354388815516218,1.9148693529201841,0.3429016957184541
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6167228422370572,2.487514898039315,0.7880577712578949
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.3731147786718625,2.1078586141003743,0.6057339940468243
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7270292871287297,1.4259163142980977,0.15603813702258018
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.116341839441293,1.7881532496397563,0.4568050876741938
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6253704630412087,1.1700083779506834,0.08969760220642033
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.12153814186915712,0.6061092216993413,-0.2600536984039053
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.41614414978546954,0.88740807411067,-0.03232107299504464
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.16586345468097993,0.5698797748717914,-0.2297394038194087
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18978693963867846,0.22921481145466693,-0.49543467218638304
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.016427020554561217,0.3891818232384998,-0.33173545021979794
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.883085627334995,2.616113097846304,1.0176635584792613
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1602810817902107,1.946859842818263,0.4888712807711503
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6410901548969499,2.347326951067003,0.8871082231472514
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2417303932417396,1.7617740200867946,0.565495828717647
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8330203450164237,1.4772468452085556,0.27366118302572773
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1369235793409813,1.6590197852667394,0.5446728186415593
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5345159100777943,0.9246681502190134,0.07389693955519251
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.19032688839035286,0.6237361595175012,-0.17962364537051945
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.42933149493043854,0.8115397636534756,0.02128403783771044
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.04423322183596938,0.3051486604575355,-0.273342102885205
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.18141025551575565,0.12981559405853343,-0.4423007677759133
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.025385905243096203,0.2336601781153794,-0.30682861707635617
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.177578203297425,3.693658691792514,0.8898737082453079
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0071596009959662,2.256869018215382,0.1481566804485291
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6655939043902264,2.956055539063766,0.6228451177551061
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4681957631436011,2.6267272740404035,0.4729184606893805
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7027950563210896,1.7246395182867431,-0.03049960103057494
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.155137245245461,2.1665713035521224,0.32978576100615276
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6912589283668058,1.498189394981046,0.005881076109706481
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.10595610103499188,0.7945529389789561,-0.36735928470459267
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4425926783208205,1.1409775683702383,-0.12173250356462276
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.13222601600480113,0.6441202000734498,-0.3201027820284813
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2852120283065161,0.17085786690820134,-0.595554616094518
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.05264960125249412,0.4088548952417503,-0.4182205153714786
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.9489183420693053,4.446746810405912,1.557436252989319
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.68566922629468,3.088691520032963,0.6283261885272735
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.6340349233588944,3.9769437878686995,1.380525272457028
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.0675325220283884,3.119365883698431,1.0044591931253646
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2785746927537875,2.4661536766946655,0.3761545568379434
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.938582587099616,3.0131759766356456,0.9437925954965707
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1018030009412887,1.899018870438224,0.36118975517540847
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.47981867745279316,1.252891762860651,-0.10278321575265252
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9667032418424433,1.6934720464991782,0.28831639468719716
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4031914822452791,0.9158057019283197,-0.08798186766476623
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03095874504152091,0.48227123283025286,-0.4208470892688785
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.29848535860295017,0.765660858438421,-0.15307736511153922
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.312501447737636,3.5720827695504846,1.0790367273030985
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2558244401785643,2.331428198437327,0.45282889958401445
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.65790210420457,2.6787221969827435,0.7421601050378492
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.57427079227287,2.470286534891597,0.6278399637107952
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9142540278162458,1.8154570421266267,0.2549078163880132
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1495969256644856,1.9305956568083902,0.4526108409916892
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7630715250062623,1.4334808808828279,0.10656267210199988
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24297181013476454,0.8356354618703647,-0.1994831978196431
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.438429953228801,0.9908875459998396,-0.0571604294821675
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.27257423929248586,0.7630173432640381,-0.21533015625733315
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09567003211639052,0.36029188431986625,-0.4288179818013234
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.04542400963726975,0.45881040151452157,-0.3209113069511395
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3835265778081274,1.6507494871821597,1.1448661646070413
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0314692064212654,1.2431027657342928,0.8260017682192744
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.15986067898658,1.3613283144464274,0.9614878661844082
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6743211814819353,0.8523496206628134,0.5173405175972379
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.37877486692777185,0.5091653409801888,0.2540018813321701
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.49363533297286066,0.6216560709863235,0.36559892448842596
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5963074730341914,0.775273351229674,0.4364706142144063
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33890168480883226,0.47838523111642184,0.20348210851772486
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4347830288076474,0.5686168205073162,0.3030051100027462
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.13333069597476027,0.24670839632722505,0.03173137890219346
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09237325215402706,-0.007548829408167628,-0.16856393493128624
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.009152452172986528,0.07529837446950158,-0.08781206229237021
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.7960000665357803,4.081980948261744,3.5321299109634037
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.882841767905134,3.073199102562911,2.6914835307728175
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.357868712988088,3.5634613863113165,3.159870229941709
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.185766640572039,2.3814682567876817,2.0042269733531675
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5320198730978265,1.6616063316870213,1.4072777697044183
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8694812998915407,2.008669037639031,1.7420083158817432
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.625308881844196,2.8414825716222314,2.4258487472781116
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9678466959729901,2.1133461575755943,1.8215821954428102
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.3128376666230674,2.4691285503151335,2.1623198617577355
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4176485385506563,1.5544085474916483,1.2938082500554913
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2543442676196535,1.3556413956498727,1.147718732068914
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3691292984951944,1.4639520712046772,1.2806048814040265
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.24489987226317705,0.40269560967160056,0.08530165180969576
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1253201310502028,0.22323442138175464,0.02204618597213355
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1959512004081588,0.32775758524925,0.06842324985071999
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1729026979541914,-0.07304400397726107,-0.2753321812538462
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2660838950855904,-0.2023469539514624,-0.33231777834781473
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.21235473619933856,-0.12870663286385198,-0.2973723488849068
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.05897695969335022,0.06030124723067848,-0.179617668223294
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.13986254591798433,-0.0650218440766065,-0.21879989515882292
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.09084177493759706,0.009357011478703953,-0.18778810948291919
2,DALYs (Disability-Adjusted Life Years),44638,North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.30380536814044456,0.47189303297754315,0.1361047111600745
2,DALYs (Disability-Adjusted Life Years),44638,North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.18272268607412165,0.28688627759556595,0.07318693979359617
2,DALYs (Disability-Adjusted Life Years),44638,North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2539161593165752,0.39375059287446723,0.1191760218067859
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7908063096640309,1.3081222956875806,0.38163861342692595
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6304468518699672,1.059071706947524,0.3066058004319986
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7448767267985098,1.1536356991822543,0.4283217358225901
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5073297585838761,0.8810637415062246,0.206950901185254
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.39933777867794557,0.7211059950951826,0.16384576000578083
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4816527420121233,0.8053210364578216,0.2352160187311047
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.27363964724500056,0.6415600339432368,-0.01736457665526355
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1347416029732793,0.43305151388332763,-0.09064195577063883
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2277746424081648,0.5153960505235665,0.005032150128444813
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16804796112250253,0.07082091453673592,-0.3569210845376958
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.29623924003146074,-0.10990011330330503,-0.43682735296569586
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2172179869919269,-0.03549085895803164,-0.3559562853350601
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6075723471690806,1.1468752105290867,0.1912850157889927
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.38210657244124124,0.8268192348895591,0.0713365728402795
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5670965987736971,1.018104380527837,0.21060787848430923
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3528413844077552,0.7406133462755649,0.04313158501697568
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1861152876846817,0.5222581500481218,-0.0556132137228378
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3305194750213687,0.6826075371712303,0.05123627194872677
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14332179092744352,0.5268794682381284,-0.1527459898427555
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.03809570628251373,0.2714108310635845,-0.2543822090279125
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.10268045680719601,0.4200300491663545,-0.14816122407126547
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2483453280522885,-0.00418977791435711,-0.4409842179776079
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3948664232492718,-0.208935615909983,-0.5266247437089514
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28909687281527435,-0.08760209238296376,-0.445965866726891
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5106383061020066,2.1080801621486636,1.02406352333422
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.117030235948655,1.6681855433895623,0.6929402155699462
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2921470860099131,1.744764230367454,0.9237972523248087
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1135924355569737,1.5682160271596808,0.7851144344160234
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8169403931705246,1.2342193340321557,0.48247927404815566
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9464782731020042,1.3025509315147017,0.6769901804254315
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7855914787029364,1.2104981984739962,0.4395345481804261
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4733888938042278,0.856976286631803,0.178235090429664
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6128589634158829,0.9313409765154533,0.3536712635698149
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0010275700177173497,0.2460620366133499,-0.18998088148763276
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.20887759650083007,-0.004923369454994412,-0.3700116053032074
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12031323336625609,0.0528352312596007,-0.2582146313272452
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8349912070696064,2.548440551083667,1.3158253540877562
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2625244159173332,1.876107649485363,0.8157501762681785
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6775706461610043,2.2218979021407894,1.2344102426798593
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3870494219687692,1.931037079652853,1.0111809633224895
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9419357912382018,1.3983680825271136,0.5802619256214276
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2739606140804784,1.714509675491037,0.9247184815959038
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.016274558241991,1.5236869824296821,0.6470385273629677
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5746484342863891,1.0016837720025353,0.263707101678585
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8840605139164881,1.2670739336036299,0.5722326939008993
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1716511710033572,0.44583136913508326,-0.03148038451306869
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.11207503117998036,0.11812244489025567,-0.2879201901837814
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.08051849932799843,0.2917326699212606,-0.09515056023904805
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6967319424676275,1.2218042900773085,0.266423749643941
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3624126212523609,0.7849253752217287,0.05493703466320669
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5254542626477687,0.8721045125452309,0.2421065684810701
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4278336809453389,0.810892925985998,0.117810010545203
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.16929834533990124,0.4922476041953988,-0.06449187433694639
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2952180931977516,0.5746374916655191,0.07165719975569283
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.20673300122513985,0.5801697911106749,-0.09930655869656618
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.05180209954232414,0.2422539742057917,-0.2657957906590648
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07337901472775443,0.3172979002695784,-0.12599731286015298
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.19115268257582285,0.06408647219058883,-0.387534123000345
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3743905343381863,-0.18725632377048274,-0.5107695311295164
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.28746193679053295,-0.12695677081805953,-0.4131162236644117
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6399536928860956,1.895362292142773,1.388428448601983
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2316239113413823,1.4294487432106509,1.0539139846959458
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4457621434129804,1.6401901447005072,1.2541827208981275
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8545630585957842,1.0119358687457176,0.7036755819304044
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5148347824320426,0.6218877589961116,0.4042975544825704
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6915321754546429,0.7920878747654627,0.5815110485114714
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7680431372800601,0.939096675959521,0.5995903787307051
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.470819742337286,0.6012022260340921,0.35369459988337115
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.624705727554458,0.7538631307547554,0.4974406188521455
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.17495389366658484,0.2877071597646395,0.06567863528919463
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.07240796428977676,0.005005981863445459,-0.14615065690097273
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.050723547105803096,0.13352085882513254,-0.03226569797667537
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2090598446758554,1.4590709798506083,0.9650496522001051
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8390235979765709,1.0675419409822555,0.6542921754300524
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0695110439900168,1.2960829202113335,0.8586683421742685
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5515890584991071,0.7090692192831797,0.4036852464206825
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.24803034619600522,0.36636178447393203,0.1346780475112017
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4310321166704702,0.557651594510421,0.3020331937652896
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.47946273025351205,0.6469014519933881,0.31604299020439863
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21206454222935828,0.3626765197542536,0.09031166893802031
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.37476428583351296,0.5252746803095044,0.23470269146478387
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0003892806049316839,0.10953454198564497,-0.10599757127538864
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21068054945290476,-0.1206891349375887,-0.28509719124687144
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.08744476587613392,0.013895461848064353,-0.17752344498745656
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.459001926566407,2.813466006405397,2.1389643108789187
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6936733672256377,1.9014727409417165,1.4540491184908817
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9881311711694418,2.2079423026794096,1.7532436056526874
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.430433092808746,1.6789118451769423,1.2231911975519738
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8286147512892089,0.9676074296988926,0.678481307901458
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0668865771446974,1.2192961050484203,0.9209107118621438
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3165802622160199,1.5539737382684322,1.1022430518276347
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7753475161243456,0.9123040255763433,0.6174158530019629
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9849983538089461,1.1310176244507395,0.82896389475323
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3390552936676653,0.47320684868633445,0.21893187019023808
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.009408276347354347,0.06624375834736006,-0.09724212789097197
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.12563456152915892,0.20884716726194852,0.04481740934168583
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1530150631035645,2.474754053717694,1.8570637899490587
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5771433665205576,1.8008005458983964,1.3505539910967483
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9653181584597992,2.2238621793402937,1.7114471111265905
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2149452471817215,1.4215712434510208,1.023643520062654
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.749388412834164,0.881767707774832,0.623514201692125
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0508566984630936,1.222731376663083,0.8980692169479012
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1116531926613002,1.3271298564693055,0.913447209397221
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6985448681779033,0.8459529476811692,0.5492042355186632
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9698438006517858,1.141593106969577,0.8011987237895948
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.25968661989617103,0.38453365974183557,0.14260896612467466
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.017604159107885122,0.06752099897152956,-0.09832914493860619
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.15502392239782745,0.2550111396211947,0.0613577249932461
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.8964895699990985,3.332494102709915,2.484075399384823
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0412427039178036,2.347692851220792,1.7501164640188387
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3533399116816285,2.653298958893621,2.064158189718665
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.736955934895013,2.0118086786865956,1.4690475155116762
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0640852840157486,1.2489910496255923,0.8772731048207594
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.318867488583422,1.5052200870907106,1.134374428274148
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6095766991233598,1.9015798596180504,1.333372595226956
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0044236788414926,1.2063989867796807,0.8125480590384928
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2276044200043668,1.4268654901577493,1.035502665039082
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6072491511933764,0.7831480987424757,0.43904027857727423
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1897251810616082,0.30907630165907524,0.08040326807961967
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.34409128297092545,0.45999142355443223,0.2338695139767336
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5005891478084548,-0.36179827379304064,-0.6178674537051686
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6008230827565574,-0.49766062119628984,-0.6779692557792166
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5475871641027791,-0.43671317720267955,-0.647665652023071
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6496326148282131,-0.5685029168827352,-0.7229336217529445
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7291371455412771,-0.66528707990541,-0.7780777541072228
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6873958367368083,-0.6214513227867406,-0.7464751516956463
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6655320385808964,-0.5725803125785409,-0.7440762586750866
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7369102886990989,-0.668917924770829,-0.7877558248805481
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6994647547060117,-0.6258118027873047,-0.7659463187317708
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4758167567065746,-0.3290622387620019,-0.5993826437095272
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5765439253224961,-0.4658411519776264,-0.6592571004834806
2,DALYs (Disability-Adjusted Life Years),241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5226514143651652,-0.4047688829425379,-0.6289233908044914
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5240762245326915,3.7100195727603484,1.60773696826428
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.201449196925074,3.2204063631232724,1.3931970626053396
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2811727908967097,3.2317764412835297,1.4652889260541184
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5403606861530124,2.3860169847658956,0.9168637196316818
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4914953591917228,2.201631000027264,0.9307880042926614
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.450138843794981,2.096259508096906,0.9098375325476579
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.008632969170536,1.684590229185372,0.4863431196284703
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8537565986873964,1.4437702001632382,0.3857489448918974
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.885025395677695,1.4311447671337043,0.41630219724728057
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.33666133669755566,0.7774891690583527,-0.005546083567623968
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.14377388301729385,0.4976230175681423,-0.1390143867712637
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.19780235554252318,0.5466159656022597,-0.09088479546868947
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.240281618119587,3.0942131355550644,1.6331649512151718
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.254969978707998,3.147891556934053,1.4815329366693502
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2478249145369595,2.8992780447842152,1.6277688756751176
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7514414312194058,2.467277840933659,1.253390489178022
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9155764977011531,2.634542179976639,1.2003826689467703
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8287061964103042,2.4072972729785764,1.309767724001028
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8445306968408032,1.3306313147937734,0.49892946193371457
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7812815019760094,1.269932611022686,0.35801827529846597
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8135751644969349,1.1773445329016539,0.46733783266203854
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4459390045060091,0.8161146605783018,0.18068398781849693
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.28083743206500356,0.6537533330896923,-0.04759560556329172
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3565745323620208,0.6447649699011129,0.08500899915464638
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.24083632101565947,0.2490574465269547,-0.4596847550698585
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.09044676414903462,0.4508509402272075,-0.3759367843342025
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.166452782482367,0.319518778687794,-0.3878118660307469
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3557737403594543,0.04955606121973341,-0.5339947953618831
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.18520690123518588,0.27335700770196647,-0.4245553919084182
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.27450152627083013,0.1176317670107863,-0.4575332351121434
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5678459853665923,-0.2889738998755361,-0.6924254825038727
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5022472205022159,-0.20602218795976482,-0.658481562226146
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5345498689417418,-0.26318488555079983,-0.6581560813832696
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.37071580188650266,0.043092864717271834,-0.5527322681438063
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.23893765279815848,0.22049484790338622,-0.47927042730003955
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.30593580068725085,0.10350967254916518,-0.4911171794944974
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3298781490842255,2.042522260711915,0.758301600943813
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0442307392753698,1.6582940451565014,0.6043773040728513
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1911866757037604,1.6642621441490921,0.7745250191531241
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0441647083143806,1.5005467017876626,0.6253949335362511
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7932056562186317,1.199989216645432,0.47346918894289935
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.922737401757282,1.251272874777368,0.6036938355155657
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8423537206879461,1.405877839363289,0.3903789337067601
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5954434789041576,1.0746962746769424,0.25215478776736167
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7214524524293259,1.0931126739747157,0.3941123684211978
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1023053759016553,0.44212687392117667,-0.1549056765684335
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.06141267195307806,0.22029244469578607,-0.2609254604879109
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.021308771169591546,0.2485176838434832,-0.1710979193543198
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7131833586281969,1.872413819831673,0.3184927446862265
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7855846589396169,1.3028493304899622,0.378807711235538
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.742321211953584,1.4927622324785932,0.4085082686674914
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4868189829917061,1.443810115976279,0.1664940968244413
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5702820463694797,0.9619066533029288,0.25248079897731546
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5213563924573209,1.166550852807553,0.2763642984018574
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2502800568913529,0.2570201051410411,-0.4230037896662451
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.22691877862891802,-0.002965463364812267,-0.4030356700808306
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.24164759484579323,0.08498491639099351,-0.3869410382567063
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2193970709972184,0.3348501043151696,-0.3991996913595818
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.18836771796656798,0.09508826122680153,-0.4094991735283686
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2148422878731196,0.15844514703312423,-0.37575378609622484
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7173642111198301,2.0034231832679787,0.30522514606424334
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8068816322522674,1.5039157224442037,0.29416429593901955
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7418260799214572,1.7611324534032091,0.3637576711650472
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4900831969780608,1.5708088547634227,0.15379336721443393
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5886313321180657,1.1148972659740108,0.179965361196562
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5205296619042329,1.380462156682238,0.21426255436772113
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2484504404195437,0.3143521659549028,-0.4288099301671816
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21769810681275967,0.08408762095154343,-0.43968262185141316
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2418631030797832,0.20179414830165363,-0.4064189181190623
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2742356785344021,0.28363006953722947,-0.450343510569637
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.26956078988822113,0.02929338953945038,-0.4835235302803119
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28884520194681995,0.13227164340404649,-0.44791219261769777
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7290295884231565,1.8063066758814839,0.32271517027150676
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9400141104294172,1.6420849627136822,0.4233358848181502
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.853717438027594,1.5552000582138896,0.4573541928508854
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5012413422853723,1.4049268864774143,0.18827076045260066
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.706334397770267,1.2728160007834752,0.28098282867322366
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6190734612329641,1.232270068633375,0.2959757748822083
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2433454608712987,0.22809042639311253,-0.4211559800586899
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1600574800757034,0.14390894865430087,-0.38375688951653497
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19316193365499365,0.11216123439372876,-0.3656806507734345
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1920182946388361,0.3006708974480423,-0.38061183416722744
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16765964986282814,0.14568113773807656,-0.39703904221338693
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16900226451631983,0.14663112939413467,-0.34975133319242
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8919838997354442,2.2544429503802412,0.45226561777411994
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1564783723851864,1.974467662166389,0.555081745634229
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9593475099954208,2.054801823063816,0.5563062114134606
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6430702130422321,1.8050266342165044,0.2786078774073746
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8979684031727659,1.535883404275426,0.38999643094408204
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7120745209177781,1.641966192145814,0.37280652860159375
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.17203371458852978,0.4242029443731833,-0.3644623671758684
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06633778150070806,0.2878163360576588,-0.3267166083512816
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.14718601452834712,0.32961493776017875,-0.32261138159564995
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.14155116330779555,0.47752550212556516,-0.3430451365921277
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08960552561903178,0.27176211342854273,-0.35623355554802905
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1495719093039843,0.3432420560008607,-0.3326235725736621
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9360507109086562,2.281902626027102,0.4885036774520314
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0283827284717515,1.7120279376642342,0.5075011273186949
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.991436090239139,1.7619087028938851,0.5739716246082516
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6809234379119967,1.8249006030665245,0.3076272270666285
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7837794402846894,1.3344428989987391,0.3614585130558863
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7391427742589647,1.391893529842474,0.3975990023649364
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1527492830655585,0.43621979380150777,-0.3486039385358387
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12179767602496058,0.1741912431567697,-0.3473169659634536
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1332193292588025,0.20213201405465903,-0.31492243853945445
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.16626670675889327,0.42745013462886466,-0.3572229194149544
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1607141312939133,0.14570710293040462,-0.39191585987911626
2,DALYs (Disability-Adjusted Life Years),242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1575195515268361,0.18073187641983962,-0.3443164018470027
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8011753717550978,-0.7463843338323174,-0.8449865185766381
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8245041310696987,-0.7561816973935314,-0.8727397680948061
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8118377455880643,-0.7556693342303966,-0.854910297725968
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8252195401592252,-0.768739891801292,-0.8627039361674305
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8458373985451363,-0.7861354785976703,-0.887616021426051
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8346985375623642,-0.7883075839523571,-0.8705312387709004
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8427792055325416,-0.7994531317560802,-0.8774229182889348
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8630322231830249,-0.8097091911117322,-0.9006782829276189
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8521749069106477,-0.8080475623293554,-0.8860138086036626
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7488477658393692,-0.677811735396104,-0.8042994309659542
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7750381325411784,-0.6862103588528765,-0.837257475441719
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7605891152541371,-0.687367442845942,-0.8155618929841646
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4229796199747546,-0.3525875234267939,-0.4901890135604516
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.42939489072121517,-0.3664924086116764,-0.4893173334694152
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4255416619344957,-0.37145329881638345,-0.4786502411838527
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5261923906399696,-0.469850982142516,-0.5840257676854754
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5491065004997413,-0.49883726270647294,-0.5982337411343683
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5368198186437938,-0.49513668104238584,-0.5801863721837315
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5283045962390369,-0.47076134551136317,-0.5832460907535779
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5225513498682751,-0.4699182684521386,-0.5726909103760411
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5248321482684623,-0.48009252207893294,-0.5687613383214984
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3348419381213416,-0.25338343685339604,-0.41316882640644176
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3420664797617096,-0.27013697357909744,-0.410283042621295
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3378295179278803,-0.2753737219098791,-0.40100398720812913
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.191608409135264,5.680065005385108,3.0518163903466102
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.6847140059701537,4.507635006783369,2.872178679540758
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.9263506800158487,4.693790056447071,3.1678139465477386
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.2295647056747487,4.414258921926331,2.2961413050775947
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.4415571345111293,3.0798115082039725,1.8246004873606059
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.8223699000668017,3.4306524313620055,2.2186100357553604
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.8080764149378084,3.899868401572212,1.9720320212493474
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.4205919055647223,3.0214561014822703,1.8273109161536751
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.6050766235114984,3.1666845835695705,2.0499835691348074
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8360316301780641,2.6030393154040845,1.235672264146392
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.545357423721941,2.018652604729904,1.1158580038102102
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6757009246223837,2.102768970695673,1.2716968378563718
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.018871314541155784,0.36843997855714283,-0.32271405699604405
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.19158472980659552,0.026957193311235837,-0.38464084744400767
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.09593826412918527,0.16642854051692213,-0.3023570088855493
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.20064598912120699,0.12420853468665488,-0.4440880912356491
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.40629564885870023,-0.25128870678891363,-0.5466349966021352
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.29857776508492395,-0.10917131495885644,-0.4585572287646633
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2803361284837187,0.0037590659634221917,-0.5032066322290524
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4097273118413512,-0.2501566886846872,-0.5506892131375057
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3384125406621256,-0.1464139405519029,-0.48946865495672554
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.11397299932895234,0.5576920572377031,-0.23375535182230647
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.06008407205891891,0.18385117288101804,-0.28253518494660523
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.0374749693430813,0.34171199633990246,-0.20432228715926126
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.288038768011392,1.8193020993503666,0.9396700985893196
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2039276376022632,1.6492987907159646,0.7538908234975321
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2589141680323273,1.666210747654595,0.9067798556865352
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0599974808367791,1.5064871061123153,0.747316413774425
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0911153126555293,1.4708176691707116,0.6759565326482178
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0843085767522531,1.456768140231961,0.76006877882223
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.34531971932946637,0.6576916274454156,0.14048610937388986
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.26888244237307113,0.525299044662358,0.0097796469381604
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3144924271804536,0.5515037652413098,0.10958075170402676
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.07118129452699155,0.31849154326759643,-0.09826005482439618
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0010016459069860017,0.23618318935072583,-0.23733607223335657
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.03472978786600925,0.23876350038800942,-0.14676162625889141
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3706200490649452,2.1214121915438424,0.9104330604215688
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4889120343407478,2.097305183598417,1.0214519149015961
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4463227362975262,2.003845731388615,1.0486961861616453
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5147805481487544,2.2986375151035103,1.015920801701519
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6776898912748552,2.2770713741059323,1.15500938511233
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6115171444923135,2.156341185618028,1.169214023146069
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07356829854560258,0.4135749745544385,-0.134833787062997
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1251365166867595,0.4001664652293865,-0.08618330627960627
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.10686492315696788,0.3591221735857142,-0.07304546819533393
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.028582968632104095,0.3557920431211381,-0.16846048798086993
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0383050126191438,0.26826029378647365,-0.14776081903749783
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.046231075257527565,0.27640700662279294,-0.11942041168765197
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0988607367851179,0.8451288799429556,-0.4568441502080822
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.035645469319755464,1.0170646925962465,-0.45385657499736987
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.06109797046137289,0.8321348201565806,-0.4211849252916364
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.047125711559536654,0.979274155053453,-0.41294033729031254
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.03573801572817547,1.1040922599673333,-0.3827657139361996
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.00017042330232060548,0.9057281953577256,-0.3516831763479946
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5919065368810037,-0.16440769451054135,-0.7540243103334081
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.564054300622133,-0.08816659213079907,-0.7531106353537327
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.575183720709695,-0.17103097770531495,-0.7381089201015184
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47793646523312916,0.07975459209790793,-0.6849034714412772
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4385650556444426,0.19155721577838208,-0.6846544350348747
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4544691270414777,0.07478507401546791,-0.6647582805523105
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5725790414893421,1.09344847465059,0.17438110581744504
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.48646346784547845,0.9435518176488353,0.1502689804116818
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5491260996584834,0.9659361317881652,0.20005952995879928
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.37922814255855863,0.7098935674348097,0.09943815224495843
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3039183649286351,0.6200677648874213,0.07534974666424436
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.35913986889016836,0.6671577905865074,0.09724954732261895
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.24351861461191002,0.6553966943966527,-0.07135684299248815
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1601275730957819,0.5168674522912856,-0.10225929562428711
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.21703319618939906,0.5444898478579908,-0.057202453896241186
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.20265054309325298,0.05505997880354459,-0.40221355339525366
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.29652892701410755,-0.08422461881116952,-0.4537219208969969
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23251044289547068,-0.02694990587384711,-0.40371640859566094
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4662878745705856,0.9826287788468415,0.061156269114721856
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2621782658912052,0.7233135962760858,-0.053571691192408066
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4334465356810748,0.9182426098273841,0.06824159848596903
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.28570947652696377,0.635941737866006,-0.00448274842457984
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.10703979302966495,0.44231537481279526,-0.1471898180483937
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2573816471884012,0.5992414330722232,-0.024108293167407806
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1594687569290061,0.5677658974943375,-0.16088950771812568
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.014918401899923831,0.3449799900084522,-0.2613491008981629
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12615236375602895,0.5070205937525601,-0.16076200175410826
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.24131931800005194,0.023927274908744564,-0.44579407344384475
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.37733719231112123,-0.14959227037152079,-0.5324541012501899
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.26797735989651145,-0.022126836550490435,-0.4506991194350251
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1172556312797604,1.7699924109735383,0.6135163388341414
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.909114092155221,1.500211749510981,0.5147897897570652
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.001267649486103,1.4567060981911188,0.634133628571538
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.857467395676929,1.2829143722305418,0.5118042805179417
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6747640766506485,1.0604021532798333,0.38888472039438826
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7562382548505607,1.0655298070964259,0.4851720414679578
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6742222298058725,1.190374559562422,0.27588982771923054
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4899901318834358,0.9513191221509765,0.1822351780284826
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5722471943513586,0.9300513208309311,0.28381729119368904
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.07599067081704948,0.20355796432631795,-0.28979664710279013
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1903815524293158,0.05492048124447732,-0.3565019522373759
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1436523471971492,0.040524227139204685,-0.3031049533111931
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1894062585335747,1.7526886687403895,0.7281396054190387
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9199354916502248,1.465381481455593,0.5220926537744768
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1088948160984966,1.551217210961386,0.7258637341824001
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9216419917789463,1.261966534568217,0.6443997484753545
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.684375504762558,1.072353614993884,0.39211292123644986
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8508643013666488,1.1629916638046376,0.6004769275237778
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7312754180265865,1.1766916062725268,0.3665283024193329
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.49843581804068665,0.9241354373693109,0.18793478255455148
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6568018568852684,1.0043016750632772,0.3558828148737755
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.010919587519697875,0.23199564410013165,-0.20645030134593723
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1479762783667274,0.09949437606644748,-0.3283854248292472
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04963038602606659,0.14256588703297257,-0.22600501283168467
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.49527391987487285,1.013612536276945,0.07977224078929351
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.25018003336198963,0.6965185366332676,-0.05287164994156732
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.37364556239787117,0.7385056267984789,0.08619260712788915
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3111261256930238,0.6537218864713388,0.01944488205707998
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.09664198303597436,0.4299309044591987,-0.13022563272596965
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2051430702217224,0.4645689802093985,-0.018375882092371718
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.18238950428026526,0.5922663379163744,-0.1461689075475334
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02428256098398916,0.3240674763901821,-0.2608027456227237
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07917118535735584,0.3658146099547707,-0.14665922895393668
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.214943721858885,0.04757050171631244,-0.4239464065468723
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.35746730684954486,-0.13449044938396254,-0.5152244822734445
2,DALYs (Disability-Adjusted Life Years),44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.28637611944064606,-0.10000132963158176,-0.43284788715772854
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.916141915983997,2.5068650734725475,0.18753796226561065
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9803223016294604,1.5356538353920954,0.5386714533405617
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9409572046499126,2.0238250325779426,0.3591306907498142
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2550641999127319,3.022020935781274,0.49418150296228924
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.37514873955202,1.9173871737879273,0.9255395630275502
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.3047388905637176,2.4351642616222238,0.7161510329217975
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.05837715292585732,0.9370099057882133,-0.3440657829101264
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.04361640824444481,0.33627235630571584,-0.1891305903679102
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.04701536334040881,0.6311494439845,-0.26684075743999425
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.146647592191169,0.6076698033047383,-0.46383897738398894
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14178831615406393,0.16537278550705992,-0.34921528651447
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.15589254710610728,0.32728589463454605,-0.40306841385769887
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.006053320933529,3.239711099471793,0.19086714563202611
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.084864041117376,1.9180750545587988,0.5211395066423371
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0269594199153778,2.6595214473323416,0.31071337638382457
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.3594653572492077,3.741430387379893,0.4750376568314281
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4982083952427228,2.3447613025308733,0.894642415548726
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4051505032142824,3.1995768744551953,0.6534483686937349
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.10803953752913303,1.3417959417597731,-0.34222691513967446
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.09870919520454678,0.5378057424897869,-0.19836980725077774
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.09340775182199465,0.9740647391150399,-0.2929586295246685
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19104139714941798,0.7098401113730886,-0.5212847580118223
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22682248897800428,0.104424809583646,-0.4488755740445761
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22255903633570964,0.40811134227590073,-0.4989173660222591
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3016409786150038,2.7039644582112556,0.5238688128192038
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5471600475509077,2.5044154693377134,0.8822615921662742
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4241352452735745,2.346556656331561,0.7859508302024512
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.7101406672426285,3.1898342731267397,0.8863474799203597
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.0553398089208463,3.037720238606965,1.2838822082153187
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8793904973300772,2.815898358491749,1.2507199052423772
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2713067887526875,1.0458773565354964,-0.15829411063435667
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3423360519959575,0.8468031603225463,-0.008060919893333537
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.30765729328596586,0.8052413649688077,-0.036600110031897164
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08295967152726133,0.47920851726521796,-0.38555207038205974
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.09904499148687783,0.256094412909897,-0.34677491279291717
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08688532834275577,0.2629737575670815,-0.32851508314094946
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2886540283640544,3.232581227556704,0.4739642621792344
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5518010582678312,2.5468260159833176,0.8613374747676812
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3475067200250945,2.930638397499294,0.6053905078226689
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6940460962063917,3.8072857153509867,0.8301504807175542
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.0605559517467698,3.1284683521839076,1.3057380089640813
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7880126163217567,3.4800074787295037,1.0204536741080625
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.26413347276959925,1.3378577712749726,-0.18585878931696445
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3447818331352356,0.8691532304730216,-0.01908778770532398
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.26632137768047504,1.1203140285928024,-0.13400021297513923
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10095388721931967,0.6561634017389623,-0.41644813864646174
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09887991418311441,0.2766260894163858,-0.35368408110820027
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12657921580641782,0.46726180802687806,-0.4021738721750661
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2958088893872088,3.3319931956967475,0.46113586951972874
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.38494331559575,2.3097072867062534,0.7592920147124119
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3478499864303553,2.4363420106323175,0.7014845112303476
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7017591801061378,3.9408355028700246,0.814720630002745
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.8588685652626389,2.7802270528466524,1.1819404645450864
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7869938527548033,2.92325451611544,1.1621325857557663
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.26808544593823447,1.392767772945065,-0.19294452633170436
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.25684893557006244,0.7441932699797221,-0.07286505235204563
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.26650654672962465,0.8536745015318621,-0.08216398616308421
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.060093216773809695,0.7881234392001344,-0.4025972194115474
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09027161918344315,0.2927279089490843,-0.3459487060115519
2,DALYs (Disability-Adjusted Life Years),44537,Commonwealth Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.07049846806421223,0.3890240303778303,-0.33502679910526056
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6988147068313004,1.0560218860476969,0.4180034145651711
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7238585104492112,1.022317524204241,0.48796763577526625
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.706145214044823,0.9835547299860383,0.4902667128109183
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5090553320580575,0.7748619428500074,0.2947742877940993
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5673361951291901,0.8126168835355642,0.36894920080141613
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5320097621188435,0.7570610265108777,0.34024232852959035
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.15234368586728345,0.3946452363902664,-0.03813684050318013
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.16088897837757765,0.3618786637058557,0.002034226175515315
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.15315279070335175,0.34064888121307396,0.007244403714086476
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13489990847206867,0.044524054356838205,-0.2753754731220551
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.12996575979295621,0.01909800177433577,-0.2506681341508983
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13635413279797517,0.004791520314820939,-0.24614212976551375
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5198068593106128,0.9288576026580031,0.18678460671209404
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.477937598432908,0.8176956095813805,0.21749282511153306
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5122539953117633,0.8681215049161887,0.23899014227807436
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3498142246241707,0.6895378448771678,0.08796184595763942
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3435222773768054,0.63774755874839,0.12396751337620349
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.35773432690915763,0.6600486854576606,0.11198866374170864
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.030918693499562163,0.3083868831733476,-0.19497768501189933
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.004720249167373573,0.22408120296280615,-0.18011020431284835
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.022105211555715622,0.2626296454918594,-0.16258890013545568
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2144203608720532,-0.003156255840281597,-0.3865924595110786
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2442921477133385,-0.07421610053991395,-0.3742568115019078
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2233836609803702,-0.04458976805052629,-0.3599525753853615
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9323529949493715,1.1770506238795486,0.7309263395835652
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0172464672360626,1.3436290217851687,0.7149772803199159
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9710338246207939,1.1873054894303583,0.7558711321056041
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7167519290705237,0.9254461529294278,0.5428289188279749
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8342344719881543,1.1128029597624294,0.5741646804886684
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7700270325341102,0.9607207705706982,0.5803277571890921
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3107578852728651,0.4767417130031634,0.17412571841983693
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3584636884585254,0.5782577771346562,0.1549081382395764
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.33218622701154166,0.47836034617339007,0.18676164223019986
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08889114937850301,0.024099509030915615,-0.18127461380185722
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.06524963890624874,0.08209915218512977,-0.20423561406773244
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08247091667394643,0.01745971961829994,-0.18285494039690203
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2561153144721335,1.6143862019208712,1.0115116935082087
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1080051438661775,1.4562805010039268,0.8075407573277411
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.222427513580446,1.5043123860228549,0.9982266957579979
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.004378463556981,1.276781008335821,0.8017742962571885
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.916801888237562,1.215020276314154,0.6442725929018102
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9957762952828031,1.2496268343874841,0.7912862953899142
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5303730458454328,0.7733961332495267,0.36445298580321683
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4195828271543007,0.6541200708381627,0.21724267417007403
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5020986890942769,0.6926195923785858,0.35056539836282385
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.06226768062506798,0.2194684394798343,-0.045871980601518064
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0006538830154064304,0.16074209520172372,-0.1407205546390845
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.05399611462205382,0.1851572862579959,-0.04922131453714745
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7183832562661807,1.1037424345215197,0.4191349594743632
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5837611990988391,0.9316598830555256,0.32129869241189357
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6508370158023994,0.9050597291001456,0.40661301854760556
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5264398402878668,0.823615767536094,0.27875322661551005
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.439939981149187,0.7164195034202652,0.23812549750170037
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4823323471548217,0.7142885742214629,0.29083034836215127
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.16561746687011117,0.42701514259534273,-0.03736928849992785
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.06654398216057562,0.3008275648034121,-0.11020476456274275
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.11577097664262168,0.2875955252720297,-0.049295620076555344
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10870695465171439,0.07814579599522825,-0.25918115885722154
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.17334131488468035,0.0032495003452905876,-0.30498865535309894
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1425223487673497,-0.009853373049027139,-0.26100605407553906
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6036811930552701,0.9503929261620416,0.3198737492879222
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7831547015645128,1.1369650798520972,0.49023591189688576
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6937439369529209,1.0215623770201583,0.43514500513016785
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4214578095254172,0.7195071876493535,0.18285338856188127
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5979751482234653,0.887750870216287,0.34799254927162837
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5087741575463576,0.7939481842592706,0.2792271008141892
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1448572069107644,0.39237237893294474,-0.057751016456216456
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.30676018234423963,0.5660452090672241,0.09209871149020757
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.22532016381924327,0.4624767586990993,0.03823965029452111
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1672622868717332,0.006496272121304885,-0.3131254779680541
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0650975249132568,0.28115643768530607,-0.10631402154017283
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04138103935818791,0.147380920141368,-0.19300205538134318
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5727041587688915,0.9207285949910329,0.29625091590860214
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7748712064335349,1.1776593426983453,0.473811992419202
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.617242493704393,0.9643417663377856,0.343588549526721
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.39455986834511364,0.7033573376986069,0.152360951658915
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5912889251055036,0.923732347922128,0.33394155521296487
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4412127228834982,0.7588721502329334,0.20748705377106647
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.12274291068713819,0.37119521262558475,-0.07461519816457841
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.30068973786832986,0.5958674349743036,0.08006266997758132
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.16997604778814437,0.4210811459825171,-0.027995846542473828
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.18864784286405992,-0.012499133081282055,-0.33296057767090814
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.036029929595678245,0.26379131117149957,-0.14394691941237947
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10446447877490267,0.08885558396238995,-0.2585429997943013
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.2942897618748425,0.5610572501111506,0.04556413129015821
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.47197903244557504,0.8227881203047606,0.18639474866031305
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3947557287680057,0.6889348430203093,0.14928385276429826
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.14748510052582395,0.37433482022603726,-0.05875810474902633
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.31906454045550947,0.6005106618476093,0.07431447853492698
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.24248822616420834,0.4655339614829746,0.0233001889966193
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.07601525282577452,0.1144282610093921,-0.25357880595056864
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.07871941069263856,0.335804983367108,-0.13056706928941095
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.009020478701406482,0.22184107844112472,-0.16856341267416486
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.27627481863530295,-0.12277558912664673,-0.40522195612827416
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09911897333103722,0.11918275706512158,-0.2654739702581834
2,DALYs (Disability-Adjusted Life Years),32,Central Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.17525170616923927,-0.0012426492581616624,-0.3158420512520289
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5211470962701268,-0.3565044881883816,-0.6200436233850588
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4749636570199329,-0.2411775090001628,-0.6127570060666011
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.49930675228164145,-0.3066417245434929,-0.6074291178666631
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5749880434172718,-0.4323587763365912,-0.6547663663006321
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.522927176351848,-0.3160217118020948,-0.6470214910117854
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5507710742584139,-0.39361135984744167,-0.6433864863007508
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6751834571166524,-0.5635027252011603,-0.7422671644314196
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6464275344416748,-0.4889901572506782,-0.7392209854310641
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.661590460683037,-0.5313716419223101,-0.7346684182832746
2,DALYs (Disability-Adjusted Life Years),1,Global,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5478223197493304,-0.3898671348645373,-0.6417511722181641
2,DALYs (Disability-Adjusted Life Years),1,Global,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4999946613013822,-0.2767692134322574,-0.6319758364071582
2,DALYs (Disability-Adjusted Life Years),1,Global,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5252049999230182,-0.34251694883275396,-0.6279967327526772
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.0055007860571314,3.3753208259398475,0.8160023254907318
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9076409358729886,2.1494130764014887,0.08240697472227876
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5404971853250136,2.7619019863875733,0.5375557258276276
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4769500032887077,2.4945450310760684,0.5131164133645896
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7075726743933799,1.744941973636911,-0.012516908006958352
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.176191238730616,2.1292901200747227,0.38957103298302076
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7138846006134745,1.4950234653437857,0.0355739831364201
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.10235270862195588,0.8199253172095581,-0.37451842326377716
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4581677992147775,1.1592168541020036,-0.11748996934498666
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.23443862652443426,0.7946500679091157,-0.26626420541739637
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1798788264708354,0.4232919465344033,-0.5548597261887299
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.06863779417889505,0.6200882027960992,-0.3655494367237887
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4482096224142116,2.6030552022607196,0.47957655986221615
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.900607141000538,2.1480904085376626,0.05414842342839037
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2710656795519362,2.333016848856693,0.3681754851114369
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0187860572421412,1.8630413226485674,0.2543123879092165
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7007810632861627,1.7679102902671588,-0.036403953358562016
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9459597493232181,1.7837709791914327,0.18724453769463117
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.396089726675484,1.0546395645486062,-0.15627256091880087
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.09828814768508,0.8191609980576267,-0.39084795885654056
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.30352234316717003,0.9130498830375098,-0.21470905475168825
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.009157958284658312,0.4556170521655653,-0.4031510160709666
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1942985535447144,0.34606747641978164,-0.5618701456657669
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.060238539838800745,0.3803143937891446,-0.4386805011883081
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.155424443444557,3.9332213758083183,0.8021274358392168
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8189614139809532,2.2985698431727903,-0.06213375499882093
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5878453305105873,3.13490773505007,0.494591993606061
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5998189764329176,2.9623141352714257,0.5031352061921405
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6282380617378344,1.9069263256851983,-0.15016361639989267
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.21636849268773,2.44289891604779,0.28360494302283024
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7993784553667268,1.8131658413262444,0.027661837573437535
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05110820588630202,0.9061173058420484,-0.4580429806990748
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.48534418856917855,1.3733107624768983,-0.1421498395552188
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.22549382813460736,0.8797585423054526,-0.30458787322494524
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.28063094132176397,0.31083551551036587,-0.6316928778676912
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.016257853221786245,0.614213991809013,-0.413742817209913
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.769792925211413,4.689742426793315,1.1587380726462473
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5326839007444348,3.533561124811304,0.32290232585877077
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.465665412576528,4.1729711532242515,1.0367646709124916
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.105243656924762,3.482945365243901,0.8205735719913785
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2664905497637722,3.07064857428103,0.18983346064159468
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9677161368602014,3.369166654773605,0.7891544224117955
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1497216277549271,2.2445714111860626,0.2310187894910395
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4635411232623747,1.61977151551946,-0.23554536143074495
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9891861076102662,1.9691274627149542,0.16904071961131714
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4611952523021338,1.1617581940525699,-0.16122735332942634
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.016044953641758147,0.8730369963627294,-0.48442115689128573
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.368738034408722,1.0511495320673303,-0.1970988097890924
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.415930404125762,4.2505199534918585,0.9217569899396543
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1988375021307618,2.750838694797915,0.22878914789022653
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6600218820140578,3.0980961215823073,0.5351660375269139
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.814653851687557,3.0997023217408213,0.6395854806076822
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9682977226347379,2.285909700791108,0.14618816883406754
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2781824143040152,2.404955484206651,0.3853079765978184
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9479317867951522,1.9941051206008298,0.09588050233045912
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.27062406279519985,1.1674661709449787,-0.2899297661159841
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5267713249063748,1.3521820205495723,-0.11886157745004158
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.446064662302411,1.219264027437398,-0.19317683418792947
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.025962088931309562,0.7035316833419296,-0.46540858154636777
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1557252115044664,0.8275980945476231,-0.3347394126536899
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5665282212669451,-0.5214996806771243,-0.6112272005889492
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.565890533063277,-0.5121394909760051,-0.6134888561461025
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5662699402853614,-0.5282584089265037,-0.6059268633558749
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6331188826827185,-0.597021529776699,-0.6696051551447026
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6479498927153219,-0.6045045608187543,-0.6868956036098812
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6402613834024465,-0.6093258662188523,-0.6727847723380725
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6298756100610745,-0.5914275220116991,-0.6680422987917787
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6219217880414112,-0.5751084853353707,-0.6633765137592564
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6259029308035089,-0.5931175562173561,-0.66010747430181
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4680225656899774,-0.41184481747876867,-0.5248810108419932
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46510561790113675,-0.39715978109382477,-0.5239745922160568
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4667329193725468,-0.41888282844866404,-0.5167607971564091
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.170888387409649,2.855782565148096,1.5991346947301963
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0255115803957655,2.860603940319632,1.2252354121524935
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.093516580013049,2.7559550933835455,1.4798151013779968
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.0699432961579407,2.7413489949652154,1.523869638909201
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.0958654885004098,2.8524863220921644,1.2959465632853224
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.073963190661398,2.715961560198909,1.469605141644192
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9413267744994972,1.3606425127076949,0.5912795270388842
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8055781342949204,1.3039482330793488,0.3279857958156326
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.870188424464465,1.270666265000146,0.4991746051639846
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.46974849439215793,0.7878282598316232,0.198648529200737
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.27610251649122586,0.6339622582727897,-0.07727536701886739
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.36559267442405163,0.6879517718273086,0.08694838888496997
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37691973442129734,0.0022088278045210878,-0.5486127578166746
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3315280565508191,0.07187044202049916,-0.5456282603581346
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.35524111127218955,0.012569827398155688,-0.5199560010342813
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.39751831247922154,-0.04730370834252473,-0.5505469076832237
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.31597914144252204,0.08895084249304505,-0.5291453439513973
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3598338685804675,-0.015716974166471616,-0.5157912336334697
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6185288618063475,-0.38641333489316493,-0.723645227502367
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6010663676509261,-0.36032443390744495,-0.7288380308127662
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6102103935501652,-0.3878499367363909,-0.7097889386144709
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.43659890419302116,-0.08961708633996926,-0.5922972983755839
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.39217213947759466,-0.020371228727314252,-0.5870636964222309
2,DALYs (Disability-Adjusted Life Years),44636,Low-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.41543370952828873,-0.07935120372670079,-0.5648216298870976
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3471723508296476,1.8781599979112293,0.9216403459002289
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3151659596735075,1.8047389629458293,0.9103330033398951
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3325103695174156,1.6943119036840417,0.9819100014201395
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.189017470644852,1.5958806786305904,0.8367499686120544
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2733416131551223,1.6807623435667605,0.888674487444513
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2276037037314251,1.5614970126866228,0.9067390809549501
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6229461566979534,0.9900961705350431,0.32871316962818553
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5790627635875865,0.9129768384274285,0.3029457776115002
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6020489126045527,0.8505467379369325,0.3612444361017516
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.051245205398784854,0.2909818899322344,-0.1303139604993078
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.019722064902789556,0.17920960092639732,-0.19115564099663343
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.013304197006139652,0.17104818803184363,-0.12813698994095826
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6335611749164654,1.4827386401532223,0.3116772542093019
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.786641734241014,1.1579983497278716,0.5170966191206134
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6941570777468843,1.247985568261635,0.4260405336830082
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.510074791707186,1.2812941123562283,0.22566152237590997
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7330687164772878,1.0203740551496185,0.48588080910866926
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6016956486633532,1.1105066424349226,0.3794856613538719
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.26275352369928806,0.12049082834145058,-0.40802374067255176
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.20322909757461877,-0.037618869193386216,-0.32343546044124694
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.23993631594718495,0.008532334547656527,-0.36022365583642285
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2459174905625854,0.1770616270564805,-0.3900482427753128
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16724380800827685,0.054241065156775306,-0.33380140054644525
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21953683000398974,0.07381025925521933,-0.34906577311800413
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6458766300622736,1.6631729639423751,0.31157867218603275
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.861666613090767,1.396580576231143,0.45150831424624394
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7027201155767072,1.4885448235454604,0.38013134199832954
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5212223434836522,1.447639820381021,0.21948938644820984
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8056552135971525,1.2889031141238299,0.4290337577161858
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6094801525168257,1.3469693442648438,0.33406816385580324
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25719540561365806,0.20192308289050778,-0.4080682319658059
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.16977099610982715,0.06877928118589094,-0.3526852265592999
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23609460955224115,0.11645642033974343,-0.3808202757260912
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29027153964868607,0.1557376778281541,-0.43961885431930847
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22668251005114445,0.012003505292228631,-0.406913093515596
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2831930808617181,0.05752334211307293,-0.42215258143809636
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7251479767259653,1.5196040023187778,0.4018283875801483
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9714717955240406,1.508559555149009,0.5879867007853126
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8682787576668992,1.3911727574978119,0.564454915888095
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5952789697225539,1.2832962538262445,0.3130168272816133
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9129302281125923,1.4206303378830951,0.5397522257692211
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7669971124727634,1.2583130886241736,0.4764264906344158
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2214192608957181,0.13712862481423654,-0.36733741289203825
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12080226744889577,0.11871743631521958,-0.29182131348694107
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16181866838555684,0.07277158602530273,-0.2981256682020019
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.20915749782063112,0.1484807615767077,-0.353888671404203
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15283664988636952,0.09510831487838133,-0.3308221762471282
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.16829280706924812,0.07120575855395836,-0.30679666876351486
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2731813173582602,2.931919627480523,1.6914132774451165
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.819255330358903,3.558765656033133,2.1839458071821922
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.522912387734174,3.0573840268018624,2.052043797368313
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.1001614909681647,2.691968775361552,1.6133699679419573
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.8637299968995924,3.547128484553168,2.232554134724628
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.442843921307557,2.928176213780154,2.0177317679546687
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9675756045237982,1.3635565487777108,0.6178630491104052
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2066830599713314,1.6339561190327854,0.8396149691085075
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0773444142747348,1.3925045862594878,0.7996888474035235
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4428117489555143,0.7356606148217903,0.1839960047557276
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5132793278984211,0.7952502805841389,0.2650645178262714
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.46956266016943576,0.6981878033424074,0.26768122783097775
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.39376792553603607,0.09540062393215133,-0.573600796771262
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.20519251669507169,0.6297408723098111,-0.5023284484447108
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3056653616703651,0.27852127313475983,-0.5222154514884108
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4257694590362266,0.033248341978360435,-0.5954544792730061
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.19520796988123304,0.6426563054860415,-0.4890447648691555
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.321452974970098,0.2416301210025198,-0.5295965910844656
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.635581617776724,-0.3415324921356492,-0.7436828000905331
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5407774401973237,-0.05837100062880327,-0.7124561498894324
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5905739275284043,-0.24609847394299705,-0.7182663223380117
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4144521855855538,0.05962199928923227,-0.5891416994754939
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.22498318452721194,0.591929714989144,-0.5137442280602623
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3262461282591881,0.2418638792795802,-0.5377269082604763
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4106100670475639,1.6178423569016558,1.1973530867169353
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.280620514017115,1.4884770106540484,1.067188180678592
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3501902944561157,1.5255195676388582,1.1678565828310732
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9797251548871844,1.1507092757326185,0.8047060793552598
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8025670246500163,0.9697303156709661,0.6301820056702669
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.895287745437174,1.0427918338500524,0.7472412531242449
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9705953693290554,1.1400010298895327,0.7962647201455751
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9082885311988816,1.082210569622002,0.7297009619853121
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9439788743212286,1.0890038980060555,0.7931600728344801
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.31918677465386475,0.41211451907618696,0.2170096642761944
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3546395062052798,0.4537757281181849,0.24715370838608636
2,DALYs (Disability-Adjusted Life Years),44575,World Bank High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.33883995936865924,0.41915113669873494,0.24689790651144705
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8335554599190782,1.8695622581301181,0.4469676314004153
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2097695411405853,1.8642754826555294,0.7265566982889102
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9210399377680633,1.7680685077761695,0.5569937252585282
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6961778844490342,1.6308668189592905,0.35791348949066076
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1451071522769591,1.7259586236344158,0.6960993584107052
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8174890623050093,1.6025649755880016,0.49928956117181567
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1724936153698689,0.2950691384056221,-0.3469655107188171
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.014530984190481697,0.2773525421311336,-0.2300246254078243
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1381479843330488,0.24186143974854638,-0.30147304378589457
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1658940527093722,0.3029727701100345,-0.3347449999742331
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05110688528375747,0.2529519544373027,-0.26729072741853277
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.15302417891047962,0.22789706817173405,-0.31113163246086983
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8128877380305907,1.8458100507079525,0.42977761646446344
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0942973479971188,1.675391747280844,0.6613746800341153
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9794169484546194,1.5789912204207655,0.6410718887384024
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.676236713108766,1.6296236682480134,0.3449446820840295
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0312902373072397,1.5382326867882323,0.6323742583980329
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8715689963395359,1.4536964996322008,0.5751661112105733
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1818212153210826,0.28434947176855807,-0.35472357826699763
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06602697343817834,0.19311793515667058,-0.2590932039098502
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11195782381651433,0.15703413448521902,-0.26375236279219527
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.21371304420856088,0.24420156667962367,-0.374757833604596
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12666092467796472,0.1317183338170645,-0.3211563112959278
2,DALYs (Disability-Adjusted Life Years),44637,Low SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1582869166439974,0.11545695420291405,-0.313072585348791
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6882070412106948,-0.5621554213441619,-0.7599085815980919
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6307733023313428,-0.4449959636532137,-0.7356612759315769
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6623271673456901,-0.5248914593233178,-0.741158264670861
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7091937118048429,-0.5923805180403858,-0.7746115095877778
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.637359458495275,-0.4584909403430647,-0.7397421360188421
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.677545552194173,-0.5615202982650647,-0.7513023312195899
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7844115776271294,-0.6972535161683572,-0.8339894193906101
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7481683215084892,-0.6214585810687999,-0.8197073370024992
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7680746026085793,-0.6736789979983273,-0.822218530712677
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6586501382032395,-0.5211210880887623,-0.7371560506260544
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5906812770941366,-0.3842929876040506,-0.707660175985384
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6280658402943644,-0.4760849836075215,-0.7142133897307466
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.986072128098484,2.2657979011584426,0.5036477681518473
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1382528471468534,1.796477993918876,0.6498803385627816
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0708578736627572,1.8186038092996877,0.6585266507210852
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8773899090477995,2.029686814333538,0.4768219976253198
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.096142343142455,1.6943005453681952,0.6465594831109333
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9905995220936731,1.676906269319092,0.6365910403389182
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10180010377839221,0.4769550885897112,-0.31997622332029035
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.025699990491170218,0.2742218674942629,-0.24822808878984473
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.05990554467541014,0.2795440221074885,-0.24708898269622653
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.11489959458443913,0.4715784931929301,-0.327170344351267
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07206198882035399,0.22815686953798503,-0.29549400066521914
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.08760243760656812,0.2555947333200296,-0.27301365988859005
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.023874925445031198,0.666235321738383,-0.32272117899475516
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1256781553818027,0.4206536854450957,-0.43605658031121663
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0796541133451975,0.45916200284149655,-0.3685547160255892
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0797773873073926,0.5316741380947367,-0.35002368758235597
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.14388367583666714,0.3780148447196249,-0.4260724640254105
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.11692585290114453,0.37214975625168284,-0.36100811873383587
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5585480364683387,-0.2464461023884942,-0.6937010705031972
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6016131662530271,-0.3526757599856263,-0.7430378358207856
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5821963080959004,-0.3375933106092982,-0.7133467159408368
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4611668943845325,-0.0713753785060901,-0.6260415845529115
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5104480769139367,-0.1919774650593103,-0.6859690406160797
2,DALYs (Disability-Adjusted Life Years),44578,World Bank Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48804468770977905,-0.17780440093384042,-0.6498330408823275
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2899157936861273,0.5027079273444343,0.10926103419380648
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.33645520587339034,0.4903459862124384,0.20833597572580065
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3082385410905844,0.47594109461861644,0.15986460613411518
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.06824085663225524,0.23698581771688143,-0.08306408418979551
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.08535434763484073,0.20506125380920753,-0.02194251065414614
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.07315530398788496,0.20222859662429546,-0.053031036558672584
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.02720510369099278,0.13327289232296155,-0.16344657688503905
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.019063915369334942,0.13640757227781014,-0.07862861015229963
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.007846226474064796,0.11933755239096405,-0.12037139282272921
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2644397246019007,0.4754459687665554,0.08475414880820073
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.31668136642379274,0.46978590034612744,0.18864856811229735
2,DALYs (Disability-Adjusted Life Years),44535,Commonwealth High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.28516108939845486,0.45172930061057365,0.1377988676732196
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1865453662968508,1.9029063943036895,0.6104009306093979
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.140203768652451,1.793699069924842,0.6319028538390966
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1626201538845238,1.7893525232520844,0.6309344703439277
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5756743223762072,1.072022156592826,0.21398143189199506
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6655687671734353,1.0655822704891489,0.31958723459450494
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6145888695130645,1.0010032744545145,0.2868780746990713
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.24627472038102882,0.6545821141503667,-0.0821128157538989
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.23925654122068557,0.6176543081158916,-0.05506834635183096
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.24241975996717793,0.6024759069121987,-0.06303230850446476
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.06692773707880788,0.2526045012338516,-0.307626098505022
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.14573069582120798,0.10801175927325467,-0.3593712705697678
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.10808312012840722,0.14529174734959913,-0.3229347339503485
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0796474288459315,1.7549232042634015,0.5203384862249738
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8797804125313636,1.4002275627481016,0.4145574695907981
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9937586080851317,1.5678406715337938,0.5093120866179381
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4983442069563462,0.9474114082512135,0.14044826439986607
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.46218648490348435,0.8203098509983417,0.1496563469608974
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4879828949255162,0.8573219917209816,0.16289862777867287
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1853456405826158,0.5702354952183752,-0.13344609674688598
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08846185882326842,0.3898198625388916,-0.18091930179773108
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1454092327958074,0.47521791334019403,-0.13290405760661844
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1520396693963682,0.12528013987426692,-0.37378211865626093
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2722025618415176,-0.06857225883032764,-0.4549500867319018
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.20607800027425258,0.026179336858474553,-0.39783985419686824
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0033692238419905,3.0371409288157616,1.211344429848755
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8860335755033852,2.762955754842131,1.1787971035515121
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.917298776006126,2.7470154367937383,1.2188062961449972
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1651667823690826,1.8576961714906397,0.6348537743003242
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2471297824199852,1.8393988048435295,0.6924295622921595
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1791485692197972,1.6957302048617278,0.6841262460174966
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7118433476566177,1.3010666779440587,0.2604095499026337
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6711193761129589,1.1788895066044531,0.2616034987495447
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6759807026341142,1.152650807037273,0.2746985553235212
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.06194373080529624,0.41463811814525453,-0.22229667136701925
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.028741478580279683,0.26544304390931667,-0.27273258503318887
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0016091030270319248,0.28637783076703316,-0.23903072123685581
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.20015806174214,3.3206243209183715,1.324856041199209
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9727410866300465,3.0223344858481873,1.1991629326286408
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0965607649536495,3.1442721571930026,1.3625844557966253
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.306451841010827,2.0786163118342937,0.7420673656160977
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3135637008698327,2.0086740159096674,0.7604960666217448
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3121135797265038,1.9553752881811806,0.8111850072850073
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8240079328092564,1.4626449331547864,0.3251082540211657
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7213262077756971,1.3290793127158427,0.2733960613414261
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7789662578548826,1.3808737792116814,0.3572987411592242
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.16437295777075142,0.5835710042705788,-0.16115240887692453
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.028798014910234898,0.3912825866052848,-0.2507341638628813
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.09846650779903578,0.46997006174464784,-0.17004714807860427
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0809321352371164,1.9295370463572952,0.4814155823087857
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0936345257740359,1.7553418575213195,0.5268760780650301
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.090419596603164,1.736101540307412,0.5450720486936603
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4994862839080052,1.021652944467238,0.1172220956767488
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6290683349425203,1.063626583115708,0.2532482753868009
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5606630401191943,0.9788987690810053,0.20410624785216447
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.18607789024142507,0.6697609020928648,-0.15563115265392152
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2122912402049287,0.5954440741791549,-0.11588270467962716
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.20094072404592314,0.5718833530930275,-0.11236005064416099
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.08489331291479407,0.2277088343400563,-0.33744867487274643
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.15719146499822606,0.10447079030148454,-0.37990803923406047
2,DALYs (Disability-Adjusted Life Years),120,Andean Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.13507801593665378,0.1192907091375685,-0.35639279477157937
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7444312364442415,1.312771443725187,0.4047436757322149
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8077843202583589,1.3946951502558864,0.4088529001104699
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7772191267195289,1.2355368274480882,0.44088647789176816
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8490366855097731,1.4705595116930015,0.4867823396828207
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9443897823376739,1.5680274993398824,0.5101214930713281
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8963233491749153,1.3706107001164676,0.549862150772946
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2100100245174557,0.047370752113673115,-0.363842266311984
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1827737883250687,0.08254487210081493,-0.3631145566081844
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.19587817137049357,0.011492581094563668,-0.3480554805931315
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19059155928931096,0.06872310771471712,-0.327076428639357
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.15227432813537872,0.03789752265399347,-0.3057128009247908
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16920850411139435,0.012533329971394776,-0.30457048033963097
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8756763335179077,1.476664642016986,0.5215484217157311
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9052696346451682,1.4421129320526005,0.48892158968481786
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8880721553032044,1.3611479250316665,0.5543950284891395
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9877839140353718,1.6193969347653385,0.6114791117660561
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0487267058554965,1.589622906939216,0.6167407036283947
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.014226115469942,1.4893373146433388,0.6796146190971071
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.15057385480590582,0.12159206906521286,-0.3109456106640087
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13870461852561006,0.10398053439166755,-0.32691873882098915
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14572153130644006,0.06832666754259158,-0.29669732115225145
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23360516501896259,0.017226758187992783,-0.3678989750483115
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22740820377703852,-0.02969335446656051,-0.38139051437358606
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23445205493598067,-0.047379891430969066,-0.36344723735988377
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.1159952724110385,0.3580247062338363,-0.0925634257416639
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.28583358877254794,0.6280099184720691,0.02032053071549811
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.18897320138563722,0.41779875488970064,-0.02231771367948788
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.03443337476037829,0.171375058698916,-0.2143877281590999
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.02282628362647696,0.2870439839317679,-0.19418787259201936
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.011219951921045825,0.17601924310037986,-0.18224654239561572
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04874091888020446,0.27618468777269933,-0.1472491951895325
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.19618764173379172,0.5145080686182056,-0.050814335458274254
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.11161124045920574,0.3255479861175393,-0.08593177894575908
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.44635506573254896,-0.34022236905658154,-0.5443969314630835
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.4238904658138954,-0.29895334288347164,-0.5181036446642682
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.43515404719085765,-0.3354902285939245,-0.5225690614414658
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8427911867938128,-0.7760859633214499,-0.8851132886381777
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7725696621497782,-0.6651887629612312,-0.8391564991050504
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.815327742837753,-0.7485827340899758,-0.8591426598362146
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8641072164086139,-0.8082053420317641,-0.9000198986911424
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8192018139194208,-0.7359681170406558,-0.8727204264912201
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8465598118861903,-0.7916858916584165,-0.8819989464983338
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8522652207462059,-0.7895799217239451,-0.8920368228976286
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7884256859773944,-0.6885311850955056,-0.8503702114303917
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8273436637400341,-0.7649414986768435,-0.8683077108510335
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7476472744709092,-0.6432228975079927,-0.8144170747396835
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6357545920819608,-0.4661722761814875,-0.7417284543148805
2,DALYs (Disability-Adjusted Life Years),65,High-income Asia Pacific,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7037074959480922,-0.5993423130441261,-0.7719745183683191
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5367939868849354,2.175642032456409,1.1078717777992302
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4591059563647686,2.0091118707752873,0.9546421642687639
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.508591853678434,1.9686674821797454,1.11400501986631
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1538149046081534,1.6821992924084967,0.836070945893326
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2029552539171509,1.644948793916812,0.7494206116047064
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1847899771760961,1.609057124226098,0.8635283264680975
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4440702790166357,0.8077346050072798,0.19990626043528736
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3457451159688725,0.6467357142618047,0.06967743265525575
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4007897603492479,0.6576945368061566,0.1804537198083513
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.20442102215947341,0.5139882703816498,-0.011752813719243284
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.06987578831865121,0.3506575213327875,-0.1852348503738121
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.13333921107775865,0.363784086176002,-0.0641463414285473
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4278173900751403,2.149245032698747,0.9692569725708324
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3196036346976157,1.9537231716747467,0.7452138784111424
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4002860618734125,2.0072322458336016,0.9599841726698435
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0611875382230125,1.6500050219481808,0.693994106767474
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0777047500373091,1.6014696497783194,0.5542995562000013
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0902289395119946,1.6244171504745402,0.7185735269273121
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3820353383099796,0.7927081097529068,0.12099976605818252
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.26940250553194095,0.6164242626134946,-0.044932144093222014
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3403121486068189,0.6792289789105579,0.09444896566041608
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.11131253081619003,0.4380577034632751,-0.10191170745180013
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.03775340165166118,0.24759922718971836,-0.2879589199770967
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.04132310437572497,0.30294685791407316,-0.15481400269052603
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8705172418238432,2.5494670351619,1.3134968059605565
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9078328086751548,2.8016303039916224,1.1051517487116524
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8905231191137921,2.519506717160837,1.3110466983897546
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4373389774797918,2.0454922494687064,0.979069607454401
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.604763740848733,2.38623778804437,0.9010427937966857
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5175381066402465,2.0720140851714697,0.999825747736935
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6340422816173426,1.0205345322978676,0.31695833219392244
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5913107730068775,1.0804412274609208,0.15204376487704513
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6140589715182864,0.9652814241783244,0.29048117016179964
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.23098282819668794,0.5144527717488826,-0.0006864425799960681
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.07493757785657672,0.42490323851491346,-0.2301745790776749
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.14750069148389394,0.4018354800875398,-0.09109449687884844
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2213386352692637,3.0762260283257072,1.6278846746018132
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.340563970979999,3.233459717157647,1.4912806665598302
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.248173996624521,3.0056042417667683,1.6654101975502706
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7347414589475154,2.4002304633172766,1.2692758970245817
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9927271090067633,2.7801916837280007,1.2399840649532639
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.828899842571184,2.5013390555157917,1.331804367181403
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8337474015982637,1.3203921518622597,0.495923663842991
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8281227927134764,1.3167597651781624,0.3633527180287375
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.813770090831029,1.2367167451535752,0.4883566277966111
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4214289670686831,0.7835616493854334,0.16433064394630645
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.27811347179450074,0.64044140988976,-0.05269078112041291
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.33917516796723113,0.6561420615172102,0.08563352049510611
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4948441735663953,2.2514963614079746,1.0145846952416746
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4205844192671204,2.0790911768994094,0.8464406410764487
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4534747891269748,1.970765202460465,0.9829752211224559
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1182962611996674,1.7716149877752216,0.7315480354409625
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1682366503190251,1.6989593697878536,0.6753906977106605
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1367712542991215,1.5994218664532485,0.7419782979952891
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4201903427913083,0.8509146907927309,0.14680257758441514
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3246642144832717,0.6850318719331248,0.010464176309154664
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.370012565752613,0.6588658971791086,0.10728709443169807
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.15400612271724498,0.4925952830984256,-0.06924434246987266
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.036110770122534816,0.32838383964253015,-0.2291653509100318
2,DALYs (Disability-Adjusted Life Years),44536,Commonwealth Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.08951391583859844,0.3283624781220993,-0.13344933308028673
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8629243084300531,1.4013487777215237,0.5429929566216447
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0242191092175228,1.5036044777029822,0.646213610915718
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9647449712439427,1.3725694092099823,0.6444882712315283
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9756071159792113,1.5494321872757344,0.6354682208483503
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1779211651575734,1.6880906993395612,0.7672758736408761
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0972697663820625,1.5349650162253576,0.7444444826568677
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15634878693051063,0.08748423119508944,-0.30123415443080753
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.08493236959295009,0.13177837639016193,-0.2558133745379034
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11103009453676703,0.07349444038784736,-0.2559336685379024
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15985795124387578,0.08278129696202617,-0.30340801006726903
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1417642934008194,0.048826793765266135,-0.29514142767022344
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.13634627579537179,0.034631455531205876,-0.27426624654245096
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9095326100159142,1.5801965207583288,0.5364305222129566
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2190804416700458,1.7664843653644522,0.7993997206707584
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.004269128672233,1.5613801991667797,0.6771461965650906
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0253732965821953,1.73520137331439,0.6231588519037383
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3882818389495861,1.9108020140419084,0.9067134766785069
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1401184728646734,1.7360405678349937,0.7519267555955812
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13524156856737807,0.16847792196661449,-0.3042060442303691
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0031565615575032723,0.2506157467067778,-0.18656412685196244
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09314696618841346,0.15892390454474636,-0.2411572404409667
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16776948863756874,0.12459726033309,-0.32533546436223637
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.07089041862972371,0.14739718119854883,-0.23812469332046632
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.147852104836114,0.09092751390226447,-0.2872393723062996
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9484536427840364,1.102483819103942,0.7869113785081159
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6934867291731295,0.7855956447473866,0.5879923899130451
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8265135551009327,0.927532619427165,0.7053738893022204
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8590549122077279,1.0129373122534608,0.7066108295364896
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5302897818542949,0.609110771029669,0.4410500766499965
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6980549218453033,0.7930643285587138,0.5845528509153843
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8342074612412846,0.9792061886724366,0.6821371117423156
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6087089105552272,0.6962067519455986,0.5084957345927003
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7274746608959097,0.8230161768094548,0.6129035412279209
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2246963503011969,0.3150033080179171,0.13520164739602314
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.16980907743062093,0.22476648738449911,0.10560034989326957
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.21543844193485623,0.2822477342026842,0.14542853962268418
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8202332480279094,0.9605230708413683,0.6840317859242029
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.4864268798102723,0.5866226572461208,0.39483226371674296
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7548100130238854,0.874672002901638,0.6421613276935054
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.73660748079184,0.8655770989458356,0.6110596130198953
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.34328140742114444,0.42885326197457296,0.257760215688008
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6313580642111112,0.7371663717052059,0.5288946196290328
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7135051773476055,0.8455692070429648,0.5852897902647307
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.41201470625467745,0.5071945722579735,0.32500541794422755
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6596590940808367,0.7730218171441978,0.5531185491459195
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.17734744470063768,0.2616837309137401,0.0987943439167053
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.07545824795636251,0.13561185503265566,0.01774135286997208
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2156567516820041,0.28995401686595235,0.1424603469153531
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8161711145375202,0.9986750114879261,0.6434846803186322
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5321691373172738,0.6576173123654292,0.4000115937641912
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.664834493059314,0.7905573192354052,0.5304266473233903
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7326594925663783,0.9067823418842675,0.5700541656583669
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3844644183939165,0.4919144913486114,0.27032430607343216
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5476327391907662,0.660738201521918,0.42821672118550125
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7096812241402931,0.8814841360195462,0.5471201351082395
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.45546705576104485,0.5746351564236325,0.3299254650012863
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5745623093317457,0.6934680770490893,0.4474424491555139
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2585210525484881,0.355377489443645,0.15433310843410736
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.14162353674123054,0.22057748874445968,0.06006069756235856
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.20184625121152608,0.279777458722762,0.12134826021634607
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0972904489984847,1.7137376936106503,0.7381876079774949
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1215967907930255,1.642855620647097,0.632056839035454
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.103181808139025,1.6410939797516706,0.7467147397042466
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8882339183918351,1.4284535383900847,0.5613029529121822
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0127162471774107,1.4545514725483848,0.5567918860392627
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9404796315873254,1.411164541743994,0.592054637274713
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.23316363238516755,0.5956219288518166,0.022018550384368202
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22148153673553572,0.5215894739695087,-0.06036467229024781
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22386967991378529,0.536887981396631,0.01643671560381668
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.05240014369386643,0.22105801450558155,-0.21486236974060396
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0838431318746027,0.15281541809766283,-0.30283029244995685
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0753561958525791,0.15770217475090692,-0.23464390441989558
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6611536566995437,2.185949848122009,1.0866580306133586
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4512551328055594,2.1455664418082465,0.7734558940480671
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5615437649961077,2.0932595512179057,0.9525691609581172
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3962266187299954,1.8428887768218556,0.8554310956887667
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3259043698463715,1.9538461680689552,0.6923602931055274
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3637461566955502,1.8571824400581631,0.808788966987859
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5647035970615055,0.8732729599675713,0.22691198913608712
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.41127800510624796,0.8110186383754266,0.02104397979637221
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.49059664533942715,0.8000091871225766,0.13622616208620958
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.13505286803196662,0.35438159489348375,-0.11034969760172697
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.022291944634895377,0.2594207867426823,-0.29634314334177314
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05430586593088125,0.28232934292111794,-0.1987579104915837
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9899856200855948,2.6998229425106457,1.4955969607536321
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0453508865516454,2.740731073710772,1.3236537079946622
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0014720586489454,2.6318509863695927,1.506937606168691
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.691671211587236,2.343174084126418,1.2376107228149174
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.8894980959445817,2.5075165036345255,1.2259826048509943
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7694193284265551,2.336529332347734,1.2960121674744682
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.758050025834462,1.175419766559811,0.46735966616446245
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7533208463298953,1.1536768721839339,0.33781315771203646
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7465968151080705,1.11342276116193,0.4588205897141797
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.29482863083071875,0.6046100285655591,0.07774546094433835
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2325804668269985,0.5199098310077536,-0.06532441535015147
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2573286907442503,0.5275018885854375,0.04880355668815668
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.350411979242812,1.8770441127127904,0.9237995700495618
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2664631895640233,1.8089546397142025,0.7308286815006069
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3050488785146552,1.7622635640615805,0.8457333084555267
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1162006288228603,1.5591678117316463,0.7291709528450312
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1502396052277264,1.6486418934955136,0.6651709610980019
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1267857610536272,1.513731476428157,0.7330114961044358
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.38199388420843705,0.6916427432640389,0.13115456512769058
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3048864665318278,0.6172188065273301,-0.0034980789563473945
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3413388334837104,0.6073981863588325,0.0740569477559673
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.08746183763840114,0.3149388073244428,-0.11638334405155293
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.017860363486905464,0.2778854996636227,-0.24470858226612222
2,DALYs (Disability-Adjusted Life Years),44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.04901784906684002,0.2614364064090259,-0.15900364995682997
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.140286698523237,1.9503443325724068,0.5207572714602264
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.978398380008822,1.7612187576797944,0.4433965365793763
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0656816226672747,1.6542196447265218,0.5724889741929862
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1581357688885645,1.6929864065685498,0.6955176186879573
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0732943175235334,1.5997685692145507,0.6079539204121319
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.120112754280877,1.5431926212332494,0.7302192596894326
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7825265611981346,1.4571788168002773,0.2665547243663465
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6225434361221508,1.2645577433958133,0.18377248981465005
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.707554246310304,1.1940573877695873,0.2998664439354738
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0039721787828588765,0.3756279083888143,-0.2807727441347142
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.15172392646246682,0.18502301397270998,-0.3821598653705284
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.07705905041891463,0.19523069732170265,-0.2882951326102259
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8545334008095709,-0.7920996692857377,-0.8972997360122636
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8711235646332516,-0.8041811503350742,-0.9179144089877045
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8621622412428244,-0.7990287262502034,-0.9045326872167129
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8523499085629127,-0.7811287376976667,-0.9017089789583145
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8643326276142879,-0.7874733167711702,-0.9138927678785759
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8579788765762582,-0.7949295422554375,-0.9017752919864206
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8788489051476074,-0.8268512990172072,-0.9144666233142912
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8943045968960984,-0.8394031291152801,-0.9326791619711023
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8860591837168987,-0.8338711309079931,-0.921083862325093
2,DALYs (Disability-Adjusted Life Years),5,East Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7854931669299205,-0.691146130768343,-0.8480817717838482
2,DALYs (Disability-Adjusted Life Years),5,East Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8054670415718075,-0.7008281551774478,-0.8780509999802886
2,DALYs (Disability-Adjusted Life Years),5,East Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7943456531656028,-0.6995955746245215,-0.8586220414501949
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9137157304724847,2.2629665914842185,0.3500754049863848
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.315375782831168,2.8222647966400194,0.3769965806811886
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1412264130017191,2.287321759653733,0.43779483421516885
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5534213140658091,1.5805557494682554,0.11690344135507198
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8709662596338601,2.047790041832463,0.13999532875962006
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7340890874981165,1.6094162872159852,0.18193352993733114
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.21638134518589297,0.33610308490851193,-0.4471779398020412
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09215494346528144,0.49868726542232455,-0.4600878406406914
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.14232514647520775,0.3167468846731524,-0.4240868381100015
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.09948667350853369,0.5135001794157585,-0.3708191495813984
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0413540898560453,0.5851638116560918,-0.43512663584324385
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.054665992241225765,0.45485693164754104,-0.366549196928724
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0729533967483789,1.738830084647572,0.698394414958492
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1743191809907743,1.7101686563358016,0.7446032214742598
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1401051631030605,1.6249685387918,0.74985421284342
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1983789481899583,1.8915695160403718,0.8093334793263727
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3387098232235235,1.8739652509983098,0.8785478094452647
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2839389088941122,1.7589719327681104,0.8820815801820772
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06123418976850455,0.24031734024200346,-0.2308584401597671
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.017078194925775874,0.22515769121225143,-0.21133540899528963
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.03168649755058231,0.18769512986526649,-0.20825971974318214
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1281488521097377,0.15470887092371785,-0.27714174218822474
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09927296460116478,0.1007984348422312,-0.2730221478112513
2,DALYs (Disability-Adjusted Life Years),248,Eastern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10306319674432544,0.09300591680021783,-0.24844443298853738
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7731996946145947,0.886405353119145,0.6601197159509355
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5500124026482461,0.6297047224464523,0.4633013483702402
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6968544836557622,0.7852268192804344,0.6016846429558276
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6917862896573187,0.8001445973182704,0.5849105081998334
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4006898952391374,0.46512833286897903,0.3218389062129243
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5775241919359018,0.6598820078859502,0.4904183518091234
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6692294025972604,0.7757973285280465,0.5627797873600573
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.47241706749532547,0.5481199016266509,0.39004686449481374
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6048460826128161,0.6884266123545608,0.5148366283541812
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.16176301836494847,0.23458547862501275,0.08633112897323889
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.08497913520401912,0.13996003162348747,0.02996779036213363
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.16510152054728935,0.22552223251077833,0.1041467631843609
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5150028327257955,0.6676711823992716,0.3862171429510779
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.24741464736485236,0.3385607830864021,0.14997256792529629
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.44047168940704107,0.5678916604546445,0.33035803839263644
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.44548520887284854,0.5817617236969052,0.3283467415363098
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.12732000370552937,0.20593007762680876,0.04154954337862396
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.33924751110584767,0.45446552444834637,0.23421010576206883
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4261717284773651,0.5698884789905443,0.30493729523297675
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1849676905072457,0.27155094986914247,0.0924036693330208
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3623651115203913,0.48287599996253094,0.2582221439443261
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0821056359069929,0.1740822554450909,-0.007196825262706291
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.05252149237587719,0.011167580858660781,-0.1171151452691383
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.06823207688373624,0.14668985359922831,-0.008393177254555116
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5086857070667429,0.9799554110504071,0.15405612322719558
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.497869147478888,0.8789656622765645,0.20250489819423753
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5058579775964707,0.8961962909207541,0.20331152342384795
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3153709991529441,0.6294770517496848,0.05641439673067386
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.262115121831538,0.5307989383091548,0.04322356553190271
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.292882488785354,0.5732510526315117,0.06064043648762461
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.22360506137745065,0.6058238312426534,-0.0640138586320121
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.22842101645739482,0.5409629823988704,-0.013810858030519235
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.22813649482322393,0.5464857249986047,-0.01861210117772776
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.17507529488358656,0.07559801188008619,-0.3665657137636086
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19623444647721072,0.007641377670640048,-0.35598994195007694
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1723428539674187,0.04490401222820725,-0.3381349530246657
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4236777462829107,0.9426587584916261,0.031163211242924385
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.32451485259623764,0.7835488866477651,-0.005921453752959424
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4090496991743455,0.904435163209071,0.04720947089453776
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2408810412988569,0.6130515405086996,-0.05350454479314514
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.11594626375721469,0.44405844146507545,-0.13259028196313208
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2095143220409344,0.5591139997719582,-0.07447863911117485
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.15466017074498797,0.5755747391821944,-0.16368497529137832
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08625101483513802,0.4627105044021775,-0.1847438874920206
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14918231620872532,0.5532051234306,-0.14592465686379397
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1935395300814929,0.09884365412702992,-0.4128625717715517
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25121470411785013,0.007981445332440114,-0.43416088162182565
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19314118460487031,0.08940470139937726,-0.4009918521127195
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6772651605430207,1.186977886884559,0.26286588342749145
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5864855060398336,1.043571670255335,0.2371053060399043
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6523117253787519,1.079136704221868,0.3161322839740072
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4438851240102426,0.7960511197502935,0.15980313205569985
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.40363791305360486,0.7322037109892281,0.14289002717984067
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4401548551551592,0.7583685890584999,0.18338361941785988
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2348656501558342,0.6101353165231164,-0.07023067259476937
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.15847327586390597,0.4922438044914173,-0.09664889403617119
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.21156556146560299,0.5245370408764087,-0.034939639352581035
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21440234968831579,0.02423211247037078,-0.4031956941043864
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.30096010054638717,-0.09925357583708863,-0.45770686730517296
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2454959660835064,-0.054862072694687555,-0.3973689591179769
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5163357892819721,1.0413276036170747,0.10331121297625129
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3570491760961113,0.8156867079760639,0.014018187734424698
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4901220398698133,0.9492612997179285,0.1344984527839902
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3050265435962509,0.6652028163634378,0.01137403080041732
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.20052778254939385,0.5435126554159189,-0.05594661801153099
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2985593154705847,0.6547232962666036,0.024325085577235304
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.116383398603488,0.5029021038066168,-0.1877008177436627
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.009064250158359152,0.32583910821985773,-0.2595501394383456
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.09263919038842482,0.429305272583825,-0.1681235242617305
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28050983213144876,-0.035572537086966664,-0.4712394536105937
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3844228161928611,-0.18252830195893247,-0.5334969864669528
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30570701039505277,-0.09317727298700523,-0.46850005551312546
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.337447961822789,1.9017292668792392,0.8382307495910046
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9887774836176395,1.5820390433254046,0.5057827019375335
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1553672972275073,1.594700531930032,0.7542892863223318
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.012977833397102,1.3985342713929718,0.6603765876234204
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7596855502839744,1.2243221625904985,0.39647095596946536
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.878979109057143,1.2427994711251231,0.5621680062678069
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7209170410164818,1.1363621459596485,0.35337456660414435
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4522323447895781,0.8854399977446653,0.0995429916073749
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5804334917683014,0.9025767102647106,0.28634110108309474
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.05033439635658987,0.1851050246690797,-0.24974233146657873
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2295209714379249,-0.0042519606369851495,-0.41566286319233336
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14863984899341814,0.03008201167944423,-0.30604815527983087
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4775546715323367,2.114692541135539,0.9862149091240269
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1112756193409448,1.7450220020789349,0.646257225984457
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3748003648144742,1.9064792524807415,0.9555190063616976
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1337791778504276,1.5605046535784002,0.8101742334529682
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8680216031766989,1.345844181103864,0.5105492921986402
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0702202747652145,1.4946915713660207,0.7697856377562193
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8240688665278716,1.2931537125588617,0.46232606674461546
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5416821481683899,1.0044523690637726,0.20211939802805612
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7413338495226397,1.1311899645406014,0.4338937662360186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.04277611952777208,0.30787575919199034,-0.1597088533042752
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.14289596555212483,0.10821004768630041,-0.3320637979877471
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.01499332260606372,0.20553297143367338,-0.18781786023731722
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5989762763828831,1.114687407373939,0.1889441963000828
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.34689215027487535,0.8052595018429352,0.025642672272756316
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4738611453853756,0.8473421960358674,0.1693922937797101
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.37619581070957525,0.7256446269337427,0.0808517459930116
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.19170824264326827,0.5375089479793935,-0.054354248313685544
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2845769081934884,0.5617651900122508,0.05911042044770877
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.17722643119830078,0.5569123485148512,-0.12465459695843428
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.016481048440703496,0.3182250206021857,-0.2510617828589239
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.08071581088722835,0.35457259703598154,-0.1425374466419157
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22609118721264854,0.014078516342613628,-0.41951470351626996
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.36076801107436984,-0.15140501599314898,-0.5157830807830628
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2946303906960805,-0.12218717444445143,-0.43420108198020435
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.3679045464497435,6.383244352024278,2.48118484247738
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.567135004236403,4.553296143334875,1.1675119343356517
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.345478468994897,5.165502384239058,1.7971670973270384
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.1736385594088623,4.628470533685108,1.6876913658353632
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.025640097949797,3.637399277533865,0.8551538231452916
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.5147303227242337,3.8902299701436585,1.2985879603233914
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8570552508772131,2.929715378119384,0.8528528865239007
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9655112225221874,2.059897054288923,0.19431112835031814
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3517293511394137,2.3367080345674287,0.5137987703220541
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9461709622883685,1.676539162111021,0.24929367542144554
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.32267718678326623,1.1097358065007075,-0.2126463866526847
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5918281580681698,1.2784448933415609,0.020717290227886404
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7502832702408366,2.435696946294625,1.2290866752037184
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.353118435025254,1.9327327263434841,0.8764600463403978
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5555211795549857,2.0197540753425844,1.131454606814283
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3154678966970657,1.8208642364685093,0.9183597851496866
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0194701482283604,1.43406252589156,0.6442278650988232
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1700515385420387,1.5495558741889786,0.8423239771256481
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9560294126898232,1.4435025849000667,0.5853490974228369
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6376991263984442,1.0410931096382732,0.30595933161361133
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7981809569730857,1.1248363411992903,0.49978842487755526
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.18499976895333614,0.48232708880462694,-0.04166332152403631
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.03977056489823041,0.1910455151805457,-0.23399443828537575
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.06855175557592509,0.26447185171278026,-0.1019115846691187
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7483109947476768,-0.663089166160745,-0.8056400767470471
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7567961389125791,-0.6574131538457428,-0.820572666743529
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7520747524782218,-0.6729613434122729,-0.8050605045993147
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7880348856981813,-0.7154815789101678,-0.8372596948113391
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7912078134942284,-0.7077291342538463,-0.8451080295722703
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7894217716244756,-0.7242462232797667,-0.8367262227378522
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8209962215706323,-0.7603855909774238,-0.8617692473191602
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8307374822656034,-0.7615699361700837,-0.8751240130746029
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8255485172992642,-0.7698807236758967,-0.862831702904338
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7172182256722724,-0.6209712181119416,-0.7822268002193381
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7222403585599434,-0.6071407338022895,-0.7963168333140711
2,DALYs (Disability-Adjusted Life Years),44639,Middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7192591472228641,-0.6287266077911342,-0.7796990428938194
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.288100486373349,2.6402708123576484,0.6610485156537524
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2134051324757704,2.244402473611444,0.5144347576026362
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2500322228368959,2.3064056376410202,0.6175343895651946
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.20909256441455143,0.8887488199417575,-0.12644473314813737
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.20539641344144902,0.722219664159991,-0.16769585948063345
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.20487452985091859,0.7187544646876167,-0.10675969943926718
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.07939457374345013,0.7172709787949219,-0.21641258100378863
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.03749368450693069,0.52075506963585,-0.2901360561800722
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.058159111882435624,0.5549569546333195,-0.23929589286345218
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10587894921362496,0.41005143507202435,-0.34430509039709356
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1113348215896,0.2872703013463081,-0.3916538912901696
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10744282175382634,0.29986105716222566,-0.3491457743749736
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3493114469946632,2.104818100459241,-0.37927347413717505
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3437793675487134,1.2813725206577655,-0.23446344364958357
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.34806475546393434,1.7222409258512679,-0.32437572071551546
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2883695156791134,0.6058461238170827,-0.6688820871979193
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.26790661309905783,0.26775960777792673,-0.5734329396058739
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.278821016753317,0.4349738798900646,-0.6210433717189925
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.36347225008267786,0.46467510061501227,-0.7071768273355326
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3701276884439638,0.06935217031082752,-0.6411685638478857
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.36602374404967175,0.28023235009359526,-0.6822632226873204
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.30057216166547407,0.6087025054418993,-0.6787412317925787
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.29609644439637695,0.20298255553050246,-0.6005613707846943
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.29781694425482913,0.4113807507709314,-0.6480027212652449
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.4989103340583183,3.74255466692889,3.237043170191305
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.482926152847334,2.686816919381001,2.283359827240793
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9440265968327872,3.1355266316897787,2.7505752868828965
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.092711588409477,2.2625528599644658,1.9187549481246475
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3261498870219628,1.4461312756112479,1.1999438466409797
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6752747732041156,1.797039746032005,1.5423054120262178
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.1465280001960725,2.316932311138367,1.9633786813039604
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4223961587046183,1.5642034173060413,1.2835965748659306
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7506231537899357,1.8841781430621212,1.6157073160756386
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.030836440872413,1.1318276070005429,0.9320437949471425
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6534331646212613,0.7467248099439605,0.5631336677862095
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8332632206749563,0.9109661127030497,0.7505756779392365
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37747518381881634,-0.24289144760407094,-0.4975083977225433
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5032349027778523,-0.4068288205680975,-0.5812686515203177
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.43531869612836965,-0.32690678963584974,-0.5355448724880145
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5723638284203935,-0.4920199541649416,-0.6485319519133139
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6682378425172386,-0.6056936184719597,-0.7179097987567898
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6171307774503221,-0.5508744151464446,-0.6790845287578633
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5646075117118298,-0.4704799423835705,-0.6485584777140583
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.654496876913197,-0.587445864927269,-0.7087698200959108
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6061828106866987,-0.530574725187401,-0.6760820455275731
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.34878178725900455,-0.205988033093005,-0.47518016345680014
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.47604435305853066,-0.3736761094887536,-0.5589606903549375
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.40695444843903067,-0.29216920865620993,-0.5131733329906432
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.575597117479996,0.9804426368981662,0.25367768734918933
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6385960783072113,1.0118604293382107,0.355912449128696
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5920166647844711,0.9196753485291079,0.3189978544533947
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4691753642379219,0.7917690611037457,0.2167740117869311
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6090604327951994,0.9252064798447673,0.3491000559097942
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5203592342681487,0.806774337408557,0.29005402308920936
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.08944248828369271,0.3693718592835934,-0.1331478560992071
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.11760715943683933,0.3721927260676031,-0.07519767636618335
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.09345218782198651,0.3184995208836353,-0.09406658762593675
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.25066433943741345,-0.06310345547141909,-0.39956308612566005
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.27160893856459783,-0.10446103122250039,-0.39820609033220555
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2657707083325266,-0.11664265171163798,-0.38937521822322474
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.47709686684095054,0.9076183750546459,0.12731817441306204
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.40697156000445117,0.8004107981146122,0.11137881547343244
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4657770309805139,0.8526716232152585,0.15579232806865156
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3771224158865495,0.7402437168914744,0.09423017110438503
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3814102044996593,0.7242780421594519,0.10785317338630529
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.39963647759291204,0.7492819825432133,0.1227842664538041
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.02133474870848896,0.3190177147183124,-0.22051880941221202
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.04037272552889507,0.2279731561294727,-0.24198224476241592
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.006746434781725625,0.272479041539865,-0.20616179607288856
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2915479988816955,-0.08975242422568036,-0.4552144230372251
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3606293639928682,-0.18625132951887674,-0.49235370744764084
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.31359509108749567,-0.135301758758243,-0.45635841970542135
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6732751430983882,0.9741861141837727,0.43280148186159906
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9930707539596986,1.4124269978074648,0.6464240016387311
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8100005394051016,1.0695981798800194,0.5829854513916084
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5605825272756135,0.8019553632531343,0.3832146659531244
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9572952884307664,1.3137610030595477,0.6507183016291906
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7287494447154004,0.9582754382378526,0.5376350895792299
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1569817025280938,0.3650458030866425,-0.009293178885446741
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.35937719696648557,0.6453998151598501,0.12294620746377327
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.24317106318697104,0.4214717143105895,0.08724923765095349
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.266481229491699,-0.14176796963808436,-0.364346422984823
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22439450324122664,-0.06591602611242434,-0.3549669976846995
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2567078540979794,-0.15597951677187522,-0.34660389340201153
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2620708566419698,1.768566198817109,0.8836692792780574
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1969220232597944,1.715463137473281,0.7928274495257426
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2466918581630542,1.6248205332186685,0.9350464180495129
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1096328659498604,1.495175610208982,0.8256062311028842
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1572528597975904,1.6517548630107695,0.7673291386999543
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1456229711915682,1.5000988387257395,0.8637108511162608
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5641029520767297,0.9143178260198396,0.30245817535032904
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.49841429161487155,0.852086114329133,0.2228009207093919
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5431057865231714,0.8028176577388946,0.32905690383573294
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.014620092210847242,0.19042147758965106,-0.16178333581211674
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09739191740744266,0.11075796981500391,-0.26452201105608814
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04563208890452271,0.1148871341080742,-0.17412613067214938
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5039511577235946,0.9467217898562984,0.1630755950765964
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3738181670117163,0.7588619445534128,0.08449110288919262
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4419625800535077,0.737138495629579,0.18214934490751358
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4021244339983066,0.7511283714469983,0.11340538028033845
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3489907328645244,0.7039263419801136,0.0937924156729549
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3769857565072905,0.6548052291881945,0.147776797245655
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.03990307760151852,0.34605566817054867,-0.19579443481790382
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06298505193369108,0.1996346919886574,-0.2603210535041469
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.009610154972589848,0.19312688781000398,-0.18805888398382684
2,DALYs (Disability-Adjusted Life Years),44561,Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2692722146481928,-0.05341992728462998,-0.42517428959445935
2,DALYs (Disability-Adjusted Life Years),44561,Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3525326448277122,-0.17525026261469942,-0.48438329832320165
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3114675034156938,-0.17071116448467039,-0.4340238637830598
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3643386380605858,8.10077231121499,0.8563206317541863
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3769414091119807,2.530924434819654,0.6074564680587433
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.795497821724718,3.8271515001904395,0.8087121775699111
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5615855608612175,5.837419762279033,0.4359128551150452
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8497073509108432,1.6811681797701619,0.2761330750174883
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1499317963557834,2.687677863216668,0.42439296008290406
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7252501481079348,3.6669228240565404,-0.048069237549787674
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.21712456254170498,0.8080272578966292,-0.17689399368839948
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.43246994704599623,1.4735306177397263,-0.0731790892162046
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6280630712433565,3.3487028932099294,-0.11012382501711156
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.09671835018347218,0.6448158699319034,-0.27307546736106014
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.31257642891862064,1.2820071021337542,-0.16672914430404528
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.216320089741285,1.2570111335839904,-0.6146660112795237
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.26819077718274037,0.29071613121468365,-0.5789353465851648
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.24176551273886282,0.5759998858618388,-0.5813776046326464
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4052333619669995,0.7023601919920814,-0.706431673101472
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4308235261717052,-0.016018304300809454,-0.6614025482864241
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.41796651368875404,0.20417736960109284,-0.669850693251093
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5981249134830068,0.1574069115532692,-0.802398749760145
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6252734809655213,-0.33908244412423283,-0.7843917691346167
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6114652254869957,-0.19242560108590379,-0.7854893694196583
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5168787661196602,0.41271415280743334,-0.7651685437618944
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5430047533986795,-0.18778224680811945,-0.7383575773792471
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.529569015718894,-0.005965803042252599,-0.741867123546851
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8473392393415562,3.5252944906369343,1.1322992659990059
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5137918322061146,2.529086018686976,0.7215671950029448
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6526311313100575,2.675101512553753,0.9946956278194667
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.459382208830884,2.862121636682452,0.8904811986337768
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2137048022714836,2.032239041824989,0.5338637105429095
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.31163407518299,2.1562934067438873,0.7386714911185769
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.30458987315711006,1.0733930414641484,-0.02302613242322219
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.14153057734920657,0.6025828188371796,-0.21822421058132047
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2099320250806512,0.676306578391496,-0.0901689677466776
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2528789203598566,0.9953574578678004,-0.07259498971725516
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.05741818026525845,0.5130273894858297,-0.28406010089007494
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.14051814234914103,0.5994075583312468,-0.16185492712007715
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.007859103455456462,0.5744769496102202,-0.2968086519101202
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.11351602797604525,0.3143608450749036,-0.3966303670827459
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.06526173852764086,0.3488077497688234,-0.3292528721292414
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.14532924927400645,0.3128114323756708,-0.38203494515061404
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.22025542837023818,0.13177126725750035,-0.4362678900714999
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.18689157981500717,0.16105505859038002,-0.3851929985711495
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5454222846040844,-0.2786083738810886,-0.6778127808115006
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5974413841947959,-0.4031394823147301,-0.7260055997498613
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5736422813280245,-0.38477473446664706,-0.6940553018614042
2,DALYs (Disability-Adjusted Life Years),44559,Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4532400659356708,-0.11958966187957659,-0.6135300388921374
2,DALYs (Disability-Adjusted Life Years),44559,Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5018376985137044,-0.25294817104229106,-0.6634736322398673
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4794518602013244,-0.24009809404886517,-0.6287504894378526
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5134384356059024,1.4516600688105175,0.11007006025596669
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7688882922064968,1.6926372128268374,0.13174623501864627
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6049787862796391,1.3714217287536665,0.167638774457257
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.22717562015272919,0.9436908182320483,-0.07471487083511129
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.428927955399958,1.1201222388701604,-0.06199984037560007
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.29903899373469534,0.9121743613375111,-0.02714332525433177
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3802848708566253,0.0038933863539036434,-0.5454541165565752
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.30642943424147323,0.055767016668546554,-0.5562490407249909
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3571207897145977,-0.050119701725965415,-0.5322986823011446
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.29111930403128045,0.16946521497632963,-0.4920962189550717
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23766804522778404,0.2310639774611037,-0.5387967884879385
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.29218705954706553,0.07836893069175513,-0.49740060494913396
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5134841689058255,1.5345524520605647,0.0789053946449858
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7842647724891753,1.8922474191671577,0.08776211733007228
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5773663534052627,1.474498120322052,0.137829671359184
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.22697348306885234,1.0161065236152877,-0.09365011870142523
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4409538927700388,1.2931376258179654,-0.10017943248951339
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.27639407889021134,1.0012655935842774,-0.053020058703695735
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.38026614421588295,0.037835740917034254,-0.5582152664781359
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30040040788858374,0.13403298990868767,-0.573494951348098
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.36818103499141364,-0.008832134702006774,-0.5442388106211127
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.323093622777044,0.14220647617205745,-0.518980441101096
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3231058317845765,0.11056688756814223,-0.5944339006090006
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.35899333541312317,0.011651155324176503,-0.5455709648466254
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.49454864860809894,1.4209897487301275,0.059628456395893266
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.809848523449477,1.9844999686682363,0.08147231392367163
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6906205483515745,1.5444451308276566,0.12116740899266824
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.21247853268818673,0.9812945644534915,-0.13394106147025836
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.46233877709258,1.3438347379170539,-0.10401692724481201
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.36881660241725567,1.0817524306264419,-0.07837471268460132
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.38801976546048156,-0.00866534145577957,-0.5661086898216117
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.29036917148663477,0.17020466521008093,-0.5759611458083744
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.32281671738733847,0.01918535640758174,-0.550912931278236
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.26527024259655363,0.18449305226855695,-0.4805500228492833
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.23030456028153434,0.2838602181526533,-0.543734874470295
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22743729906115262,0.17417707754697095,-0.49027324028758423
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6030279722869895,1.6571088622352477,0.12950408117410925
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1869527769824326,2.6637445249169067,0.3023605647115545
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7376300798122498,1.6902939477097831,0.22808192741876673
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.30085484344086544,1.114444982602394,-0.05848443724747253
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7682379002196945,1.8749192651481477,0.08260698968104382
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.40764525158230924,1.2002979247090637,0.006639478749690403
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3436001997210027,0.08801952095850352,-0.5374963717948995
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1425088393078579,0.43653241085768135,-0.48935217804972575
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3039869043582341,0.07760555050596361,-0.5080879906862557
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.23096864035032885,0.28006509432229876,-0.4553639413753339
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10031427416112813,0.520740793281663,-0.47258562435504914
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2354176515886974,0.19945329952630123,-0.46321555432001327
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6726892002404691,1.8290356195897237,0.1881766629946571
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0032576420739046,2.265786752465802,0.24162638306597178
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8578353154172622,1.7888781903244162,0.29745546161065256
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3570538274774411,1.2506990280650732,-0.005504387887638412
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6182911855424986,1.560793450184816,0.02270499831369142
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5039820276698143,1.2646090542357449,0.04905552326026362
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3150756718235763,0.15841922148842658,-0.5134714192334564
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2145346078128178,0.2804955380924592,-0.513165689004826
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.25583832594801326,0.11709377339119556,-0.48030020728547473
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24925549272380154,0.2639614441281871,-0.46701320973886534
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22024829590301767,0.28112033205988773,-0.5225978246957911
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22448868960183907,0.1674572977074494,-0.46596520950547754
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.405513209299785,2.543480216396793,2.2508058922092227
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7307427915386402,1.8632372513351108,1.5966764026929647
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1267998026608823,2.2429073465718856,2.0090997036421347
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.3411817598702092,1.4337110693082047,1.2416250907756723
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8238960409853631,0.8966222868286838,0.7419674568128275
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1211035044591415,1.1915124348962691,1.0412306819786235
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.3818084541447722,1.4783022756925304,1.2736064965784049
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8992480915008007,0.991398787891025,0.8060041089702861
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.180676961299269,1.2616520994658713,1.0985911513748845
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5997952472004221,0.6663246553657474,0.5282787608929196
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.31702341425987096,0.3811493081634133,0.2528303744690816
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4907124090533792,0.5485010374972782,0.43406805347575667
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5714153442088845,1.7774257668275197,1.3799674057319373
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1432552959276188,1.3130232900597603,0.9846255796068961
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4244343697281199,1.6074117145528266,1.2536762418724776
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7675248589989377,0.8956684994401878,0.6511152772693956
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.431287978569986,0.525863427646165,0.33888013468693645
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.644418838773653,0.749961176412032,0.5432154482505331
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7984422404321254,0.9425254772538374,0.6645439730145307
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4906469928264255,0.6087216572922471,0.38031906779775837
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6908368005361597,0.8184479382749417,0.5717475275189019
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2836868666500678,0.36995674130350686,0.20115736576504584
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08244550243499174,0.1607785545669523,0.011415280263315144
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21739154623309423,0.2924072621100787,0.14334493582702346
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.1457491485145574,3.3388387522822756,2.930675379269632
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.144162287376061,2.284238031746798,1.9849396826932222
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.605506187013105,2.751114519918148,2.447172595890093
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8502704473818135,2.008715979473018,1.6950529586036813
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1000882835574213,1.20248705903765,1.0027202327782223
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4459188722280716,1.5611387140920692,1.335536699510152
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.899527843183954,2.034574287697957,1.7491057216507118
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1867838458352526,1.2842073713998061,1.076043563372667
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5145339554999855,1.6160833852616927,1.4041097402790772
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8156654780933174,0.8966914272571169,0.7199094596169153
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.43973862635932126,0.5052402953849859,0.36919255944833623
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6213725508065043,0.683900129544815,0.5562021639282119
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.76550956377176,2.9702950817806597,2.547441522513984
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.998694978118129,2.170040317462205,1.815243854806167
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.585626305111503,2.76439006344916,2.392747691676189
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5886581448734163,1.7358248857335248,1.4283841410763523
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0028040086016226,1.1084230584013333,0.8989478648811406
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4323677623031865,1.5503651095800648,1.297437957927599
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6335891132833567,1.776815654513039,1.4810728044849646
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0856104543536633,1.2047821719336345,0.9580190909658239
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5006694284460724,1.6253419479308373,1.3661529978489475
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6912929995304804,0.7715242396798353,0.6000899780237554
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3952740321662886,0.47237732702974655,0.3108399347474569
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6416984728143342,0.7151979759229872,0.5601074010794904
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.105063470017491,2.302658688141662,1.9201649176845859
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4935163983424042,1.635937267930257,1.3314097601712913
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7770279918617755,1.9354444296454618,1.6158621221631226
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1347310747285246,1.2796016278862092,1.0057757548125312
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6654003346907255,0.7589361142573561,0.5681443842911751
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8838262117326291,0.9916216370013075,0.7823390440798395
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1716745668017527,1.3098722280944848,1.042356925659439
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7342557033756263,0.8333102776814676,0.6215095582168472
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9367408676381231,1.0472228613596282,0.8243413789658613
2,DALYs (Disability-Adjusted Life Years),44560,America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5153880034516237,0.5912556057938341,0.4437171344804625
2,DALYs (Disability-Adjusted Life Years),44560,America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2618611866328718,0.32083838724019315,0.1963118227959374
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3813460839151433,0.4407956162630091,0.3193861655106162
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.11160202734513029,0.6505024532640831,-0.23827823388402739
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.05017417870346314,0.4613399374667991,-0.22727204863021805
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.07969786283577159,0.46602070072345264,-0.21727325994814306
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.10032938833164227,0.30564425118448857,-0.3517702335340037
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.15235820808535525,0.13533698809928998,-0.3615091621527631
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1273535124990325,0.11293287173275038,-0.3189717986314077
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5448268144079258,-0.3241605889528537,-0.688094017203353
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5882329582498419,-0.42701731270430077,-0.6970179718129976
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5675236860820669,-0.4127808800963576,-0.6864763865943508
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4975478085838442,-0.23895978288466022,-0.6575998386234729
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5042654606479102,-0.31155659249274825,-0.6324418929905278
2,DALYs (Disability-Adjusted Life Years),263,Western Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5006026148309808,-0.3170779486841792,-0.6406614523450851
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9852074008994567,2.5405324492920105,0.4785892848526816
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1906942240208627,2.06517601329848,0.6038418529016145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.094804890903737,2.0367946277472164,0.6164710032305256
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5840796221846756,1.7712777314821466,0.19602384709645881
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8531097853396682,1.549748504529652,0.3930196530875717
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7174182866066839,1.4305000208490153,0.36859949071448317
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.21078031752109186,0.40753953172373414,-0.4121864721139781
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.10997542595127599,0.2453047740332958,-0.3483989475490204
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.15804618466946752,0.22056275231626615,-0.35030038623121557
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.06146549412809712,0.7034655655938786,-0.3112944509202605
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.008715490184528999,0.4009227712917464,-0.28331963788710024
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0280103054664174,0.4279931427003814,-0.25314674671752646
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3011537885686577,3.0741434117212383,0.7206358381304502
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.332967286618524,2.2610317716688835,0.6331209785469076
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.319716842983275,2.3090916563247834,0.7623639619169986
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.992391613678017,2.401203861446838,0.5364251809248601
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0412104685247137,1.7649667116618475,0.4659334837738014
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0180102164829323,1.8452726112308628,0.5527319847248224
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.020067169655989207,0.8060070384744212,-0.2372677836094915
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.02268657001398778,0.429515714345296,-0.2841001665356304
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.02250117130159767,0.4586047882400245,-0.22317276749934362
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.017046538331299738,0.7998974323332209,-0.24368410140957836
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.02364688368051653,0.38465850967336446,-0.33098839907449334
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0012836250176738318,0.4295918359725517,-0.2497472320234245
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0078910798151086,0.6759111793476906,-0.31799627106085115
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.07051979850050966,0.3313438893648982,-0.35005783606937635
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.03505885152238658,0.41128126180010105,-0.3174226563674615
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1297798536276771,0.4254762885117701,-0.39327592059372185
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.18785705781395234,0.15383983726609635,-0.4106417445803443
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.16219371350771275,0.1931641820597264,-0.375256871411663
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5532169096147134,-0.2570935581079169,-0.6976779140404544
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5925502579398777,-0.41638808073595457,-0.7150893944590639
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5746664264046201,-0.3779254793137674,-0.6991287382857372
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4668877563182007,-0.09899844646094302,-0.6398333871461828
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4962796978862287,-0.27098427948632464,-0.6507204686012731
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4828733641292996,-0.23461001049200975,-0.6352292995749007
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0445711381866047,2.272736101962011,0.4555188584467525
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1013422974073765,1.9785664412800537,0.5652358685802886
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0775173150972106,1.9197651349586655,0.5799334606947402
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.551073525533506,1.4378600308037086,0.16763307270836747
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.708710516403313,1.3330167502809915,0.34123938906874574
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6277911030804444,1.199029104796169,0.31101108470549643
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.19860695248494853,0.2827863552794069,-0.42949273228965484
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.14372001104696783,0.21374173193102844,-0.36217904436109816
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.16962300401508382,0.16702074352387247,-0.36850567193161476
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.19982672193384327,0.293289706025297,-0.41587352046713333
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1172975659429239,0.2728021250570506,-0.33185054634218236
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.15085095889486178,0.20401410198249859,-0.3434915528161286
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7735638419167067,1.1697829850155024,0.4342463731879574
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.729718446666054,1.126542755889024,0.4177872259989728
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7522471164707856,1.051529095779425,0.48946035424984347
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5469810795672739,0.7908759003566399,0.33111461173407813
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4575549003662242,0.7180775149527019,0.23440463339055206
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5048074174054258,0.7128730955664395,0.3129433346415711
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4384319301762382,0.7597816630194855,0.1632317541518266
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4185634946917596,0.744004019393907,0.16274484204002676
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.42908472359483507,0.6731709033676028,0.21476304263850743
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12167905530396944,0.07085149255461876,-0.28585243999772036
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11279087225330461,0.09020872756939913,-0.27460529182739435
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.11505953762951228,0.03439907340808655,-0.2468220335970508
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7428876756388448,1.057450639711539,0.4919180807277932
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6786693307879804,1.07335200373762,0.3863061838120536
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.727258747607768,0.9950662530527536,0.5037582948094455
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5203295335635402,0.7175868113482052,0.3631047977652472
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4144461014604765,0.691176072809943,0.1956793781858851
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4832007432479727,0.6593882864302424,0.3328745678309718
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.41355231996621744,0.6686755925990491,0.2100058389817438
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.37669748328366287,0.7003816255860515,0.13692684992270232
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.40870489481724925,0.6271213563414149,0.22642405108904393
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.12160887482863499,0.03458476008430145,-0.24539793187357187
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10976547525206168,0.10405392947075273,-0.26373351899651654
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.09713858544591485,0.03683987811364721,-0.21251445682720901
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.40760392121548183,0.877550644137135,0.045633636610426104
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.28147569503018155,0.7124167147790362,-0.02876852734949569
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.35004279821621503,0.703833678760464,0.07270354580890168
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2270361298191462,0.5422453561033989,-0.036219474902260004
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.07977528332509985,0.37313498628009634,-0.149626877650483
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.15909183769522842,0.4131662209976345,-0.04486369353402789
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1416236492109972,0.5227694279846828,-0.1519488756935471
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.05095406932173901,0.40437413034915776,-0.20348105516636142
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.10105790501506756,0.3896000506864381,-0.12513238809083674
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.199375656104196,0.07110813141302105,-0.40506730066359464
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.26053877106661816,-0.012894514612959602,-0.43525482531468657
2,DALYs (Disability-Adjusted Life Years),44634,High-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2245399825840802,-0.028394579362148904,-0.3841130562357383
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.405513209299785,2.543480216396793,2.2508058922092227
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7307427915386402,1.8632372513351108,1.5966764026929647
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1267998026608823,2.2429073465718856,2.0090997036421347
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.3411817598702092,1.4337110693082047,1.2416250907756723
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8238960409853631,0.8966222868286838,0.7419674568128275
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1211035044591415,1.1915124348962691,1.0412306819786235
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.3818084541447722,1.4783022756925304,1.2736064965784049
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8992480915008007,0.991398787891025,0.8060041089702861
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.180676961299269,1.2616520994658713,1.0985911513748845
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5997952472004221,0.6663246553657474,0.5282787608929196
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.31702341425987096,0.3811493081634133,0.2528303744690816
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4907124090533792,0.5485010374972782,0.43406805347575667
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5714153442088845,1.7774257668275197,1.3799674057319373
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1432552959276188,1.3130232900597603,0.9846255796068961
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4244343697281199,1.6074117145528266,1.2536762418724776
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7675248589989377,0.8956684994401878,0.6511152772693956
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.431287978569986,0.525863427646165,0.33888013468693645
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.644418838773653,0.749961176412032,0.5432154482505331
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7984422404321254,0.9425254772538374,0.6645439730145307
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4906469928264255,0.6087216572922471,0.38031906779775837
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6908368005361597,0.8184479382749417,0.5717475275189019
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2836868666500678,0.36995674130350686,0.20115736576504584
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08244550243499174,0.1607785545669523,0.011415280263315144
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21739154623309423,0.2924072621100787,0.14334493582702346
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.1457491485145574,3.3388387522822756,2.930675379269632
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.144162287376061,2.284238031746798,1.9849396826932222
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.605506187013105,2.751114519918148,2.447172595890093
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8502704473818135,2.008715979473018,1.6950529586036813
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1000882835574213,1.20248705903765,1.0027202327782223
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4459188722280716,1.5611387140920692,1.335536699510152
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.899527843183954,2.034574287697957,1.7491057216507118
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1867838458352526,1.2842073713998061,1.076043563372667
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5145339554999855,1.6160833852616927,1.4041097402790772
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8156654780933174,0.8966914272571169,0.7199094596169153
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.43973862635932126,0.5052402953849859,0.36919255944833623
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6213725508065043,0.683900129544815,0.5562021639282119
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.76550956377176,2.9702950817806597,2.547441522513984
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.998694978118129,2.170040317462205,1.815243854806167
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.585626305111503,2.76439006344916,2.392747691676189
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5886581448734163,1.7358248857335248,1.4283841410763523
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0028040086016226,1.1084230584013333,0.8989478648811406
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4323677623031865,1.5503651095800648,1.297437957927599
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6335891132833567,1.776815654513039,1.4810728044849646
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0856104543536633,1.2047821719336345,0.9580190909658239
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5006694284460724,1.6253419479308373,1.3661529978489475
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6912929995304804,0.7715242396798353,0.6000899780237554
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3952740321662886,0.47237732702974655,0.3108399347474569
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6416984728143342,0.7151979759229872,0.5601074010794904
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.105063470017491,2.302658688141662,1.9201649176845859
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4935163983424042,1.635937267930257,1.3314097601712913
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7770279918617755,1.9354444296454618,1.6158621221631226
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1347310747285246,1.2796016278862092,1.0057757548125312
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6654003346907255,0.7589361142573561,0.5681443842911751
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8838262117326291,0.9916216370013075,0.7823390440798395
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1716745668017527,1.3098722280944848,1.042356925659439
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7342557033756263,0.8333102776814676,0.6215095582168472
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9367408676381231,1.0472228613596282,0.8243413789658613
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5153880034516237,0.5912556057938341,0.4437171344804625
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2618611866328718,0.32083838724019315,0.1963118227959374
2,DALYs (Disability-Adjusted Life Years),44564,Region of the Americas,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3813460839151433,0.4407956162630091,0.3193861655106162
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7079414492442235,1.5563388752591545,0.2507202250117375
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6404808941915777,1.1886429834682661,0.28805896905832573
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6806407730558572,1.3012225029736815,0.2971205563645515
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2954146454569019,0.8870575084103534,0.0005300658770874217
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.33455847195361366,0.7098234923017823,0.07953278741438957
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.31687000785600716,0.7153268981141832,0.06695893886659984
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.33055281011103677,0.001986266685798782,-0.509765899561776
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.33151730506298305,-0.10814568763091109,-0.47512638890060116
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3282532827435969,-0.08020875916369499,-0.4815450811422583
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.34531623784734305,-0.019699570522341947,-0.5102596457412388
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.25589194328149883,-0.009830920627530387,-0.4038676924931165
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3035495758694768,-0.05926712384413312,-0.45363415634696935
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7777173228491817,1.7771064371340728,0.23872455910084683
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7218677493925354,1.352647185003143,0.2993881541230474
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7631190863846097,1.5522727509264262,0.2833503786440478
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.34763068066678926,1.0890917317801256,-0.010039263530044671
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3995966339641659,0.8586759896311488,0.12513327509546285
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3805378553881932,0.9510226992868891,0.06462924888211637
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3032033582152724,0.08851863814455149,-0.5144677380460203
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29835281988682744,-0.041315302095055684,-0.47050983762571574
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2952869659008283,0.02013521834318508,-0.4870489769349128
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.36734220184913613,-0.006724573274265161,-0.5530190297703661
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30349012176113854,-0.04507402476003802,-0.4660857479003551
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.33957857030178373,-0.03093649692629754,-0.5163595270183041
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.47721829642206637,1.0186170723184786,0.09156875823804975
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7346827440343894,1.3117098753981604,0.3296958649189582
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6203421209500591,1.1337870947068545,0.24781214956960257
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.12152119386339673,0.46120272393231987,-0.14411379817317482
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.41194478519945155,0.8070967132906095,0.11138787124965963
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.27067539397498086,0.5937556772049146,-0.004283849464426307
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.4209873893335653,-0.20877994551658913,-0.5721471376572026
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.293130813227608,-0.05799692462726777,-0.45815969062799267
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3523544602566281,-0.14713215389439532,-0.5012534929151229
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3912871326532532,-0.1784632944590835,-0.5394434056489131
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.24703136142981444,-0.003674909684053016,-0.41817523785259225
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.309335440799766,-0.09727710004046476,-0.45857100323461
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8321437171477084,1.8828684361902548,0.3181387818343658
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.919828857410845,1.5630781019487638,0.48798847457118766
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8534051828611471,1.7493738286657776,0.3945727250812703
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.390158946745335,1.1217131367837068,0.06265588550601561
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5620171687119133,1.0105020271580318,0.24545722026599312
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.45259862628988173,1.098630036421673,0.1477563420084287
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2818703103317746,0.12997326359235623,-0.48334042494656027
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.21768526962802848,0.04443359443640763,-0.3936567325846556
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.25919990321953246,0.09891588584916619,-0.44259376241044907
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2771080775315529,0.12403428065252069,-0.464456125861898
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.17868110960927291,0.12280249564766582,-0.3673153129506394
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2473306608484765,0.11171355054039955,-0.42244128312438145
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8952442670243382,1.8743448290671876,0.37448122041793963
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9059540363088324,1.6286160818814306,0.4440673226816611
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9017369392614218,1.6029166172379419,0.467144668205586
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4378620685986219,1.1076725439151167,0.08962532348726865
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5504496911237712,1.0466373475002941,0.21879317037689583
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.49049484938453497,0.9654709382310106,0.19986594943849517
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2571373279370622,0.12663233827036716,-0.4612563615859834
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22333914699708715,0.07113979113838571,-0.41155424671225377
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.23988185547153643,0.04037740899412086,-0.41358698991019793
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3102879903729704,0.04468190007108119,-0.49133200594189186
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.21763151554488125,0.08921611036690591,-0.40160883762049654
2,DALYs (Disability-Adjusted Life Years),94365,Central Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.25650348708223103,0.0017861695200215035,-0.4150969760313888
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.247499159914635,10.083454781799926,1.0809960702378607
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6397285092430822,2.943033252427843,0.6694583065424309
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.29330610651131,4.4873433106532,1.0123440111981403
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4155506508740707,5.269803041644284,0.19231834789047172
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5167546717389091,1.2224947544233156,-0.02784730768314398
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8815915642905933,2.1480406834541084,0.15502893092826342
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7544957101790228,6.187600868423621,0.3495222794781639
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7337761245778314,1.5897878844503293,0.09650175869463366
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1496981931711454,2.5818510696283,0.3135530512509798
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1581306622159342,4.599935246297614,0.04261816295610127
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3106600644730139,0.9543100723605317,-0.1773725511163869
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6413944648283453,1.757785258798358,-0.006227368865600021
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.33323816148660473,2.4846329834116565,-0.28131271026777455
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.06358917009748805,0.5458251682761042,-0.29786156805649233
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1965073015169337,0.9660662055141145,-0.22942026452741085
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.24330045441402007,0.9690968428105671,-0.5911591819789581
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.389159141459661,-0.13000156280581565,-0.5898792428982733
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.31719276703750554,0.09445734560448862,-0.5516001095920677
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.13539740487303006,1.2597783408504857,-0.5339325607853946
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3014336500827019,0.015299399216290725,-0.5388348289645766
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2189825357862772,0.28334531712441824,-0.49700580162755836
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2237903313688598,2.1861738968535884,-0.3399847045230263
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.013819931217645444,0.4318110949936531,-0.3463966068618326
2,DALYs (Disability-Adjusted Life Years),192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1036151561308001,0.8110079691400728,-0.2871524660759607
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2815527099030894,1.5060133434378202,1.0526186187496993
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9078715959955519,1.0524193958931112,0.75971880192451
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0861026705079448,1.2367025923998658,0.9325005855023369
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1767809701864078,1.3880528056611754,0.9732199035296388
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7241819571405785,0.8512406662265617,0.5926202401253626
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9394363668572422,1.0789855382669473,0.8036634406144298
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1477755035218746,1.3590750488351944,0.9322647985681503
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8123614338400268,0.9496730110083327,0.6716253324935996
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9729880970582915,1.1154220517774625,0.8277147652689179
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4768541629592044,0.5956769108274094,0.36406695725552884
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3539307702145346,0.4489284222341216,0.2623559633035373
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.42595528357880214,0.5110963598383532,0.3405616125209804
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6694759205966283,-0.627541184003704,-0.7081641745756752
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6721983527434194,-0.6178193779470282,-0.712000449451319
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6705903663562689,-0.6290640256199664,-0.7051299121747704
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6846533220414951,-0.6449742741593586,-0.7215178045583606
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7037754468972118,-0.6554409108793602,-0.740211519871033
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.693762085879647,-0.658038981065018,-0.7259748693776522
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6888559628776516,-0.6493800394812773,-0.7252757588392184
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.688608465745803,-0.636951762569554,-0.7264180254723454
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6884519178161232,-0.6491772564366031,-0.721118628683767
2,DALYs (Disability-Adjusted Life Years),44562,Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5655220242300208,-0.5088057566395433,-0.6175212434477859
2,DALYs (Disability-Adjusted Life Years),44562,Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5659321325531614,-0.4905668902834553,-0.6195813861063647
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5654067485379975,-0.5089715234180687,-0.6115134940024947
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7191776133493485,1.8823364027592295,0.3124663792342055
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7870415637582061,1.3151250643401045,0.36541980634347926
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7464806868491694,1.500093889816963,0.40380820539183115
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4871308198329594,1.4460932798530113,0.1639215161813059
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5632162978937484,0.9670079420110241,0.2322427265683219
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5185483798001703,1.1630499152243767,0.2664328516072869
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.23791419291623642,0.27769675845431085,-0.41820321988699877
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2166270749722908,0.014865199689591602,-0.4014504590835663
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.23017390964739748,0.10200903978186329,-0.3812195058902317
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.23026998849852534,0.3112120636827059,-0.4141894565964721
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19695400376201289,0.09115275945060461,-0.41887928938071567
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.22430322181609383,0.14365417202747666,-0.38497898087093174
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7174727255470392,2.005248006850658,0.30539113622414715
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8015100321459157,1.5137971274269866,0.2804407034370424
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7403663705265527,1.7623600134368966,0.35322853116850106
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.48529960482760826,1.563973962294133,0.1473030829797909
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5754994028271312,1.1128913021914484,0.16080631147093638
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5128298792642662,1.3653770737556417,0.20101866530662138
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23866994426311255,0.3321816402237329,-0.42133956963804586
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.210284633570023,0.10195568395026897,-0.4387021547128759
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23286902117383018,0.2176125538078406,-0.40351437187520967
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28451591451916153,0.2620909231310866,-0.4590547612722139
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27784920099685395,0.023773759783245613,-0.4936435820683216
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2974473592156732,0.11669010775972748,-0.4571375896569937
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7413793088163786,1.8152072114905917,0.3198792830711519
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9455688448405561,1.6649981262425304,0.42129349415190975
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8623408704012934,1.5755078098568656,0.46230165245097077
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.506942628889444,1.3983916172122277,0.1869997739109026
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7021577564126718,1.2790150473328326,0.2613987840660338
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6197465922703536,1.2333860109665422,0.2884494555840931
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22807251229101244,0.24793938870403098,-0.4149171901251246
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1471345783249237,0.16823660942586133,-0.37695750092397784
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17910423976609052,0.1352505200110095,-0.355436351229631
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.20446993980983402,0.2743445851511709,-0.3927161759017147
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.17794339910510004,0.13791222291315142,-0.4087088258573497
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.18094145421708133,0.13150457448591996,-0.3624804369393795
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9072571721945422,2.2762988193730873,0.4566849834004817
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1673155489155025,2.0046620950978253,0.55308824561854
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9736731277512352,2.076162239288605,0.5552567838939484
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6508868004939219,1.8215460360319147,0.2728875916910851
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8974018557059305,1.5490390390647817,0.3803708614965461
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7172857306311888,1.6450598341370268,0.37392664184994934
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.154541328306132,0.45233442468178087,-0.35427326262189285
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.04992902490672331,0.31713273036952383,-0.31918355651577524
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.13003042117124444,0.35593251491040945,-0.3144629319666559
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.15231552070030926,0.45660776702231326,-0.3531676372718263
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.097514541036153,0.2636556055840442,-0.36573335315294786
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.15770643829113112,0.32604454078866685,-0.3404756118284805
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9330675077058006,2.2864073944913192,0.4766692536481526
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0243552722655527,1.716714794357776,0.49566617122782014
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9878593399236809,1.7459528449178616,0.5546801086559305
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6727294180938622,1.807290651407048,0.2896269486414304
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7707484484181226,1.3326783664703084,0.34353667055865067
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7286516256124037,1.3760384964553687,0.3781583763624504
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1430999913456751,0.45681540533650006,-0.345414533539791
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11259752258090192,0.19090728390582484,-0.34435527008354283
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12377732239044631,0.2103804862047614,-0.31471712295040355
2,DALYs (Disability-Adjusted Life Years),44563,African Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1786238899490298,0.4059147620969997,-0.3696302864395883
2,DALYs (Disability-Adjusted Life Years),44563,African Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1671996195206116,0.14290366911555566,-0.3993076289282134
2,DALYs (Disability-Adjusted Life Years),44563,African Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.16681666362949812,0.1628887081746513,-0.35638350540142
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6712105475145068,-0.4940061170791208,-0.7762501180386369
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5866688104644594,-0.4269758662994583,-0.6974124671975974
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6388688758013535,-0.48860226016613467,-0.7315842614779282
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7196994090978565,-0.5482302812617578,-0.8094698133172764
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.630404970975149,-0.4864987120717167,-0.7359432577405591
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6855931788987522,-0.552790847819278,-0.7664955403237146
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7825845179869007,-0.6654062254147985,-0.8520430382749264
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7222414055571476,-0.6149277335268453,-0.7966611522794382
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7592611584499143,-0.6590897565749104,-0.8210675025892535
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6626284483480418,-0.4798404188399519,-0.7709302206922141
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.570114663565158,-0.40163421077961226,-0.6857489888057586
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6270757647694317,-0.47171466299478493,-0.7232004131450915
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.45459873243112614,-0.2710785991757477,-0.6031665809430692
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6131177712921708,-0.51238391921945,-0.7066647118483727
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5284321984891089,-0.4006957165488675,-0.6454038953996823
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6119794622490907,-0.4931492305918614,-0.7142447270179838
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7495842831442278,-0.6910549457247399,-0.8075384926016103
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6785658483055423,-0.5948422762746115,-0.7551341186490665
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6299383686378935,-0.505417646119221,-0.7307435256067402
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7435701045919517,-0.6768025737148353,-0.8055740696298122
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6838217539577676,-0.5981766003105716,-0.7622493010618602
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.45702009074569544,-0.2740480796269335,-0.6061674055437287
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6120748523369822,-0.5101092745255292,-0.7067372782882204
2,DALYs (Disability-Adjusted Life Years),134,Tropical Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.528820452738549,-0.40117513485095235,-0.6457148526468206
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8773651681476753,1.9805546091350013,0.3395896071191692
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8717812852456758,1.7079037577212577,0.30708490348230977
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8755872666521716,1.8198226063911556,0.40167357421722094
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.007151560210244107,0.5649203013856869,-0.2874954549862919
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.019761096477171416,0.41182701323258974,-0.27539934456099213
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.004990110537010687,0.47774510832173805,-0.23977352710339578
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.11436679136175512,0.40605471263441445,-0.36805845653248404
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.12263632458080309,0.26928098506121345,-0.38732755581875267
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.11793718499002298,0.3261236681680957,-0.3408122562028352
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.25723726740226777,0.1756175291934884,-0.4651112501805664
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.24710158145598654,0.08435006530604558,-0.48055332122203964
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2540565638363234,0.11860367042575676,-0.4389964433194984
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8362740472529463,1.9324822355191693,0.29822514189647265
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7450177384598625,1.561281905797595,0.19182489259110336
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.813102532700176,1.7669313757434009,0.33824708605903014
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.028444570597731717,0.5639864722253525,-0.3144452484518452
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.04914198711538179,0.3514268172356501,-0.32794068707749147
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.02816026961169657,0.46131282487091974,-0.2769195472151606
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13375122538768816,0.3833769239896764,-0.387571838734481
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1820544479448134,0.2005546397801036,-0.44135360447170335
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1473228932984529,0.3012496521071025,-0.3706408585215488
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2854188929738008,0.14399201703649983,-0.4890211993138034
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.30715425941698216,0.013931174316137194,-0.5204187659836039
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29171352170639203,0.08006861516287586,-0.4704267882247751
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.971836720023573,2.1953727734129407,0.3853522124908376
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9945748939784939,1.8983529606491631,0.3322050394060573
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9833066337256322,1.979227742586878,0.4343967858734481
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.04319864344852506,0.6586992250954262,-0.2582040917096641
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.08683870970842548,0.54959301197378,-0.25367908613497914
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.06289273544096792,0.5298189043230163,-0.21032665661303812
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0698005316737512,0.5073936014830668,-0.3464702840668445
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.06507903798699664,0.3585506096581661,-0.37555294574287723
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.06727825280314274,0.4010897044916526,-0.3254229812259478
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2366900294979131,0.2148782224819596,-0.4501587446944091
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22209125193078927,0.12341442405899335,-0.47400428324980004
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.22824638456935795,0.14358170952601645,-0.4402314318128955
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0448611054748116,2.2978102195502386,0.44803371552081483
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0120798822200796,1.977123393563878,0.3503717587284888
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.037884437810211,2.1266964137998547,0.5066190391126504
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.07946413894877198,0.6963805950790363,-0.2341993634491915
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0945586863082341,0.5898457702604201,-0.2640384932262901
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0902226396383463,0.6569465484453075,-0.190917804636799
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.03535181498650727,0.5557177131937333,-0.31690074608213853
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.05687389086704737,0.39547282759098645,-0.3670376241288215
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.041611064523585324,0.47044218601498844,-0.29145785194020496
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20148124369144133,0.28680618658341617,-0.4224515071210195
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20835446677513436,0.17607926999592483,-0.4762592272646159
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.20065096406839417,0.22377931748279783,-0.40497523088892107
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8961900135049996,2.0951584112480535,0.3036380364547404
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8659755737217546,1.8317998324246478,0.26103073276424327
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8786969803111581,1.7757648031659237,0.3532502237403949
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0031734253389714097,0.6066418534005344,-0.30484589010081453
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0169031536026364,0.48653579691246795,-0.2955620241300169
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.006997240942163429,0.4433756503905446,-0.2603205054067871
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10548630903536216,0.4601182132839274,-0.3850183455425362
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.12535764701371874,0.32735503266956434,-0.4089146166618588
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.11647472955929582,0.3054038911537368,-0.3635850898604466
2,DALYs (Disability-Adjusted Life Years),21,Oceania,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.24828915534252,0.20067696592591638,-0.4680418099147431
2,DALYs (Disability-Adjusted Life Years),21,Oceania,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.23761031575472388,0.1315740403070364,-0.47924358977285525
2,DALYs (Disability-Adjusted Life Years),21,Oceania,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2421405896561632,0.12177191901523975,-0.4493872493132255
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.9614004578811692,5.568071799221298,2.3022738816818613
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4115345387658644,4.178853387357211,1.1155047518133814
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.085762380530251,4.609019815971379,1.7541247851060344
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.0345069558105258,4.30753906986542,1.6935899932999439
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.980966683025406,3.4064718324695127,0.8927809060641758
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.4327298493589504,3.6348491266269845,1.3490195477186586
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.665586677415273,2.528794910416924,0.7741960841328294
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8838578486692384,1.8597757079749564,0.16818698017415185
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2244897698340034,2.0538259539717094,0.499480840713878
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8753470963502252,1.4923941074314633,0.25044480184434026
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.30405457559304067,1.0183862220981634,-0.19191831722702618
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5525444437196433,1.1404127915315865,0.04496399079116384
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.31492969099902907,0.03405202166687707,-0.5049495877615284
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.47812044973691215,-0.029782546297413295,-0.6619179270654696
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3986073328099691,-0.020485800905989483,-0.5671015091063558
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4435080662278387,-0.16569735056880278,-0.587850121819558
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5436866227354267,-0.15707768288253166,-0.7004375839020115
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4948651843934077,-0.18981915441614222,-0.6281862352520807
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6319357197089431,-0.4444400696720424,-0.734026754196866
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.711816815673,-0.4642435114449405,-0.8133102393204901
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6725722860946732,-0.4667043473514507,-0.7643087936395085
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4290931207928884,-0.14090495559424482,-0.5869675687458982
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5598066009030171,-0.18373965621752478,-0.7142454297439496
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.49590470353445554,-0.17960485412634292,-0.6361783442427416
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2139565601549063,1.0666630049043961,-0.18253908234781682
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.010349779442171969,0.5243025580659677,-0.3004904844944186
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.10678166877754733,0.6554820862328783,-0.2204780583948971
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.034161879688202654,0.6194317303150255,-0.31024019825587335
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.14621037235160828,0.2502563978666367,-0.3868213084263703
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.09428478418242377,0.32669282639582553,-0.3285725006065018
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5173912758361893,-0.1783976224436003,-0.6750182144313657
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5895200150581679,-0.38071378465864636,-0.7158066827609642
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.555157116153604,-0.3346208686223766,-0.6866908819440775
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4558022961354128,-0.05326999225421358,-0.6361593823475882
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5363850500523518,-0.2887372080894918,-0.682174456345918
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.49764357894045336,-0.23655452278721495,-0.6491205552561059
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3646908685365622,1.5651421070750664,1.1816275307267636
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1689958989077633,1.3605486694968811,0.9805598108560413
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2714479587417584,1.4383749467335702,1.1151472230909714
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0015941173295129,1.163913430790798,0.8353711387900242
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.759299605007625,0.9171352936686903,0.6059881548102946
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8841928713366924,1.0254095094968692,0.7538787545073373
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0191159103122145,1.1902732866780077,0.862805373960633
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8890398704990525,1.0558685957767793,0.7249255521871428
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9591494874870016,1.103125897650092,0.8243383398375097
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.35635825222999046,0.4395690657724697,0.2606996530857066
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3514068620189001,0.44580507911626827,0.2541308333270574
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.361308596756906,0.4378992012485604,0.2741486382652635
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4573989426834964,1.0231758525505286,-0.009771591181901313
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6873949846776709,1.3977177252011561,0.10611188359044674
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.549172820794845,1.14401907522957,0.056042949599708486
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.24461021186876086,0.661024258776664,-0.10833181557997267
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5031553457116076,1.0362741093510441,-0.00035365437218642503
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3488825729987633,0.7733902518376989,-0.03754852647037489
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.41922209857982273,-0.19375828303763787,-0.6053909740451131
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.31781488286042897,-0.030643469912630988,-0.552817762451297
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3781658749628771,-0.13939606491144566,-0.5761069812540172
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3802693353028084,-0.13145704633901917,-0.5681541345408871
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2621028697466467,0.0007763682419483699,-0.48355012106997275
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3341904992285736,-0.10228236479440439,-0.5223256647877177
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5453419757093193,1.1696812880045009,0.03710230299033042
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7803798480345893,1.4868020402075253,0.23680055597352254
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6140062527136314,1.2736870105457854,0.13771742797466235
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.31963222059286117,0.803559893158371,-0.09065001738018108
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5857773798088269,1.0738854114426264,0.14491883339592623
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4051536351994061,0.8562797066157913,0.033466390902381335
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.38417653303877963,-0.1353754224099658,-0.586711584969522
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2802226827665886,0.005371804768019422,-0.4999825530972205
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.35214189631491405,-0.08734767752664861,-0.5433230483600132
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.42661835739749643,-0.19133966286449303,-0.6093011144204399
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3049312508904222,-0.05422140675976947,-0.5155018765835
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.38925943012951925,-0.14137717135177952,-0.5731697002640399
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.47671602790760975,1.1425539600889036,-0.008380072577890524
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8842425941934472,1.572681137360107,0.3081179116842085
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6628006966952402,1.2849443261491453,0.1811949005052983
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.26117491171340235,0.7225585123124185,-0.12700448569950834
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6782779098801354,1.1764104503811832,0.18961761273783073
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.44782198044995164,0.8770264075643996,0.06418964925910961
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.4115241814965575,-0.1461857449074887,-0.6048364496585809
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.23823273951192603,0.040091264339049124,-0.47115015813258077
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3325559276142686,-0.08282901898544681,-0.5258712988024383
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.37807672593148567,-0.10966841642105526,-0.5796699523477123
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.24057199694667836,0.049659211417693486,-0.4655222173021304
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.31587813217222316,-0.058840266882774675,-0.5057130685799602
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7951841361082979,1.544425456701087,0.22275860125152228
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0843455931602513,1.8749647087109924,0.4596178296692376
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8566833777000398,1.620468783981274,0.300837586165002
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5341914878952235,1.0611794827021812,0.058263664150505046
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8568204852937183,1.4306766017097767,0.32096139348499075
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6174496870761307,1.1128815096039852,0.19002411091941349
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.28461367392511266,0.013961266049755311,-0.5127269867022584
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.15733449752964168,0.16229937530529254,-0.4099013158427035
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.25473190069865626,0.0518496655770333,-0.47784702174591126
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.27816667117124694,0.01637949948721015,-0.5088812355464681
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.16851517491490317,0.1636821457518617,-0.422661804377743
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.26331063248785663,0.03883306451127809,-0.48068689286977107
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.37970610026155743,-0.05837925789284726,-0.5563450713227069
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.561538805101501,-0.16897361896883456,-0.7296526675465274
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.47504939090498466,-0.16218173468278171,-0.6301000387908355
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5182617451309587,-0.2863913580106545,-0.6484995924124337
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6278858773742725,-0.29918741499843726,-0.7691849704862017
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5755740287369484,-0.3303078295057801,-0.6942110142202027
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6698499520624034,-0.4988244551868114,-0.7638656513753853
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7584054435310147,-0.5420998430984797,-0.8510371165416587
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7159019969571243,-0.5465811602737166,-0.799813852037764
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4646218604753839,-0.18733993069949295,-0.6192125549565828
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6170150349946305,-0.27471421868976353,-0.7636398037388329
2,DALYs (Disability-Adjusted Life Years),243,Middle East & North Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5442793419665495,-0.27418689674399505,-0.6788032105937843
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2034551292032645,0.7642009310833324,-0.16284136500257562
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.032402605967825425,0.4408688917117778,-0.23804020931657421
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1145351713591266,0.5205699639345414,-0.1869314704176927
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.061156629729185966,0.3381829187484846,-0.3077444049273288
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.19160783525431763,0.07715636184444231,-0.3850498148876336
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1290358613353627,0.1260221320971312,-0.33262064805954356
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.516737461005685,-0.2915629336210456,-0.6638284239498731
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5999877803627017,-0.44172442005834556,-0.7047729002389329
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.560494211665965,-0.40037845562007357,-0.6793745641710922
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4638828014633366,-0.20087424051144376,-0.6275634644573236
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5203815149819253,-0.33298872148510095,-0.6437594866188361
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4922473565098102,-0.30666865746969657,-0.6281414479014391
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6148092294459306,2.077642876798553,1.2183774668357918
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7819469096053837,2.4456415828244085,1.300192480412799
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6696560333344306,2.0569026739066762,1.3456720938585067
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.476418572085479,1.853030375442085,1.1566102381998626
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.8148955392953345,2.404629096368248,1.3925613175272562
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.6089647344796663,1.9599185489591944,1.306527572895527
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5718148038599352,0.850033486294177,0.33351163964671304
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6073487075787907,0.9908171237236765,0.32900142623441275
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5742074847478686,0.8025539655006304,0.38316491743102876
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2481317762899057,0.4764494357935588,0.058037098037871195
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.26218240453239194,0.4987804216978558,0.06744979301057234
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.22743588190822076,0.40302123703282133,0.07517399120457374
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5631004084801894,2.0615247934103786,1.1192023494771068
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7974090321165554,2.3686887827963945,1.354192272485196
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6148100935668077,2.04047206414729,1.2449177332499402
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4272504139960145,1.847035982498364,1.0459354251358803
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.829880388517489,2.286782365471858,1.4054124361208387
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.5549855055721797,1.9318670629766643,1.205510165435833
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5407315839566176,0.8403445798171452,0.2738954673143401
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6162823872794915,0.946355461553732,0.360201337238251
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5418666558874566,0.7928653807019771,0.3237534177432251
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.16896656101137394,0.3989679552187111,-0.03411477124407658
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.18169523819147063,0.3989810407857748,-0.00013304767937610774
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.13537199883358483,0.321240023092556,-0.025518807396375437
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9332471801765239,2.542169267961084,1.3982990467361107
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.461551076625195,3.183260820882134,1.8557140785868884
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1770883246675727,2.6836112761083895,1.7059666761023933
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.7782210491047543,2.3392297881998623,1.298320258205051
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.5017927867324357,3.16857423103024,1.9144923256428825
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.1047753320465414,2.598409715502024,1.6594738532932267
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7632343075975893,1.1292697113275474,0.4416661465363473
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.000009284871911,1.416997553293959,0.6499697810848253
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8734234515410426,1.1721032108053056,0.595618664655543
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.24106628608343295,0.49493268690634173,0.01579740646026323
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2725093984819197,0.5364891514560713,0.04935149278853183
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2547535619538376,0.46527716309820105,0.07182835862510362
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4540664173853557,3.143991430907216,1.830343131609275
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.0559462672992024,3.845984841723274,2.370346002801437
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.565610759772717,3.170979854596065,2.0027764305735083
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.270777041970338,2.8505808324836197,1.7661733979275538
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.1032257324239794,3.8538476214000923,2.404455416040916
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.4841113623967077,3.04264892022319,1.9756853896403892
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0763093028825534,1.4910372063926387,0.7013765991675919
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3434379600282018,1.799905147505211,0.9473129674011946
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1025222259517171,1.459488272590948,0.7706375177214255
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5008375701600231,0.7971293067072874,0.2402131951174527
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5397104035514185,0.8429805827761351,0.27986028407558283
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4520724674426579,0.6940324833610279,0.22454865030465757
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6200531800434494,2.132816773288291,1.1933176268198467
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9072408386555284,2.4565267088755194,1.4612051465322633
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.767463044566701,2.15513780540865,1.40488958879584
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4813856236202705,1.9118623771460355,1.1249158794104008
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.9411763808585083,2.464090576164134,1.522593150889842
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7045122918657107,2.0841977532342115,1.3771830367176374
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5749670488065536,0.8831996332974066,0.31844766210072184
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6797408277270458,0.9971063139413896,0.42203105950935116
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6318810304107326,0.8604799594656465,0.41808350716482856
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.21019034081476476,0.44738414663701515,0.007415093842156025
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.28573611686600164,0.5098799615491878,0.07703125119870873
2,DALYs (Disability-Adjusted Life Years),244,South Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.24593090956854605,0.43367294554909,0.0889559016215802
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8885973178351947,1.6853188898670162,0.32720419794562683
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1527120164678195,1.9723044274345114,0.4778002605391577
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0354768884530818,1.8044375779555737,0.4617909568775166
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6123633670921544,1.2010276494772074,0.13908809115096987
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9171358171027638,1.5356408393326422,0.37388300361620097
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7717969028518933,1.2942178007952014,0.3141862554732048
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2473882375264614,0.07010772673492863,-0.471105099459162
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.12969511438817988,0.20165216941853392,-0.402550468029648
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.18296462926899945,0.12569428284604028,-0.41324073824718577
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.23385840217338846,0.08744492627252803,-0.4610440230170001
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.15119465134407697,0.18918522563059736,-0.3981769249629614
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1833523141302916,0.13144546090676418,-0.41309358042036914
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3813515038984591,0.7873915424890815,-0.6985842650070149
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.34591024869275394,0.6673591192831051,-0.7055050876003524
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3645252487974194,0.6505194515373589,-0.6899743140883359
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.47211403996514084,0.4700809335610209,-0.7302103936090969
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.41652405781474505,0.4434715712384411,-0.7367096218434321
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4464525484370873,0.4382365510496814,-0.7170771895863739
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7534666968942424,-0.2877190461305135,-0.879884914900571
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7355626289830637,-0.32591504275499905,-0.8809407114892323
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7449220121906789,-0.3374855889371412,-0.8755564591954306
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7033541882695289,-0.11857512872572515,-0.8554081831744133
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6761017794784221,-0.15435127647766683,-0.8559012270377198
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6904385420779103,-0.17683071161218483,-0.8503057230870925
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5757001753974775,1.8932075125200933,1.2659657756914098
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2656923311749506,1.5250061556703334,1.007734379787639
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4187921870282254,1.6707739839247782,1.190096326334811
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6887358257305805,0.8682230190837573,0.50308155952391
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.46208864496905766,0.6058677526468741,0.3064690773651518
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5745959259338531,0.7090197358446656,0.4459153496904218
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6953564484082942,0.9043435489060081,0.49148558764146577
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4542468312864866,0.6206888068329344,0.2886751302004837
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5718013691475283,0.7355464546022933,0.42318816091737965
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.05568851781328803,0.18664547037500373,-0.0716716904081283
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.16619549501953504,-0.07032101599347824,-0.2613120715877946
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.06256188769442246,0.04052193849657081,-0.15300655213232645
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0373246067817679,1.29731967872941,0.7609399626537355
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7781085806802851,1.0090943314049836,0.5463034223532357
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9252476531317111,1.1668313620813096,0.6834404113771592
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.33519631082618084,0.47629085655479875,0.1874137321952885
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.14704051682015495,0.2800287235182324,0.007842920970123
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2528254964080759,0.3640894854963964,0.12303570084037846
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.34099125457230256,0.5121230990280694,0.1590715990397314
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14128857372115528,0.28954802247407874,-0.007496816216655844
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2510818057744873,0.4080699118743521,0.09394844156986658
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1612089198557572,-0.04953551642039443,-0.2705736513584005
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32931439170650795,-0.24465440502889407,-0.4141333009367076
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.24077267450300563,-0.14619699750682608,-0.3270732743024751
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3891688779027858,2.9052632789783215,1.9443091951563884
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.762992044455078,2.0822545576784455,1.413715687067537
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.987164795427942,2.3281931920435923,1.6698684008792999
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.222909815724357,1.5484027530483944,0.9464265583327401
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7832125168668508,0.9907225997446718,0.5777094574034793
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9450118565657786,1.1427953610968964,0.7523431957384388
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.230791210397966,1.5704906751137304,0.9379792833790966
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7734413319194456,0.9783616963551882,0.5492564198794614
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9411463872353518,1.1627565377862512,0.7349579804545789
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1613999805133669,0.34199218688351474,0.014039104041680708
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1225811315142649,-0.022854347775533107,-0.2305985332230702
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.015522902772224035,0.09580947781313598,-0.11537896318651591
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1550804791666724,2.655000637491521,1.7393028642519155
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6127380881105102,1.99197318117954,1.2748484346980853
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9903894662820247,2.3984831158568696,1.6444512153412132
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0682303117639238,1.3661544909500432,0.8137006282722874
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.685794295301105,0.9159725151224833,0.48799753220104863
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9463521073322232,1.183020027634695,0.7538474061632319
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0767114459573703,1.4057648319845453,0.8030416814084838
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6770000204069336,0.9204141083745947,0.46012372566982435
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9432418719531661,1.208432970461819,0.7184411555520951
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.11299342334423036,0.28055009488154825,-0.02889860381903512
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.14432773054443304,-0.02125743604209633,-0.25836450728491006
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.01287145838325443,0.14280835288100735,-0.09943793593537291
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3537362404886968,1.726342135878272,1.0418685758442388
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0016968613255137,1.279735617887717,0.7320919067922378
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.128096476952276,1.3990195357300357,0.8867038969432541
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5430986071441569,0.745033846818927,0.36009637038320363
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.29152361839594654,0.44234601304721877,0.12395503391441105
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.38519469409802637,0.5304084161054287,0.2530257827077846
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5492571500675592,0.7945107760514836,0.34398214898035906
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2847999164428301,0.4632605905343282,0.11175252362854089
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3828988592282857,0.5589525264280732,0.22603495426156583
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.04257653509505571,0.1949981147398145,-0.09496900416586311
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2002966115801456,-0.0853855979206112,-0.2977503568344081
2,DALYs (Disability-Adjusted Life Years),124,Central Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1108663944513354,0.0027413822861197,-0.20552807492682507
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.2920289866295045,7.186069427551152,2.08691304932247
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.34983160181201,5.215220831807132,0.7521511162134791
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.176195607880103,5.697847208391218,1.3786344390508551
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.3634556241405047,5.452360670979315,1.5766795226784875
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9969028137879365,4.352787613877475,0.6090576655765426
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.577249465050226,4.569588480505056,1.0532090147832498
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.0177756160507085,3.6681000372781103,0.7603098835343302
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9357395148343308,2.591538318237454,0.012501091034204303
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3970087405760658,2.8443597496397937,0.36526352603832346
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1060548210122036,2.203812526063736,0.237761013730722
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.37387002207990927,1.5569913814925855,-0.298395542493507
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6895932419790909,1.7217377597288293,-0.053606528092015396
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.15727505964382388,0.3907416534860032,-0.4756830197668863
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5107506093623916,-0.06549412101179398,-0.7155853790362787
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.34736615084568484,0.027803217638882077,-0.5631693839433878
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3054219967036708,0.1293592916093949,-0.5539042234362017
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5616449890050954,-0.1784250386294779,-0.7411628513195965
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4407101050185874,-0.12787901835975535,-0.6161563426679237
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5194367259759863,-0.20693060058441998,-0.7010086297662967
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7172814963135613,-0.4599848076470621,-0.8356476725282856
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6254081016064309,-0.4100723415292342,-0.7492725669115763
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3413763421759732,0.09288867935429004,-0.5913212323221
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6136274162206947,-0.2590852751886987,-0.7752185945224244
2,DALYs (Disability-Adjusted Life Years),254,Northern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48732180695239474,-0.1897576433059509,-0.6569901992367515
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8307736264606493,2.647469700627366,1.0055794858638718
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9874322846083284,1.7611818981723337,0.36965809636424807
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4720075377301072,2.1894604176552646,0.7779947773912492
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.300870869895129,1.8902774345861963,0.6271410036554564
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7372278015085004,1.3424157517560946,0.21212035885123254
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.076901773078844,1.6365969930365207,0.504890951241827
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5208755127769923,0.9596577060865539,0.07752760604597769
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.09746504557226451,0.524731504655119,-0.24367139610945504
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3458823510728737,0.7364989467262735,-0.03197229188550704
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.13382443470827565,0.46623886054525054,-0.21665511451887615
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1832368297441474,0.19231622087964315,-0.4654795972361694
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-3.539988892422991e-06,0.31751944252065656,-0.3099646841940511
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6075690922626937,2.2188874829579186,0.9268914323463825
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.06686447508204,1.7705528965946944,0.488601639847548
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4347140785033523,2.0163515011252464,0.8130066864477177
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1204045700225025,1.5793965434572677,0.5584791414914712
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8066610438092864,1.3839349000567294,0.31056738353507674
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.046250569316895,1.4948059513881757,0.5424569372083348
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4009555349909527,0.7293954929684738,0.03525127118678026
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.14132769851056054,0.529906193267305,-0.17799047586861688
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.32557795967533315,0.642249947880164,-0.012910088491200948
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.012676162088172616,0.2139520533856677,-0.275184796633927
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.19467937088088083,0.08131941561512646,-0.43049815961996746
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.06784402959771361,0.15165469569919926,-0.31207638074600597
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.103754824227984,3.4934793538050837,0.8805697481777934
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9980138554016909,2.127671829472943,0.20086065616377796
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5995873066231512,2.781097893327697,0.62643565388635
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5215877577224441,2.6023567341153173,0.5456578022163832
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7463140426905283,1.674823134565378,0.049607983864357094
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1833786867483316,2.1256437700383413,0.39497176692358127
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6675387483151767,1.4141890585987271,0.010364252845196873
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.10330821525552973,0.7271081553070758,-0.33688176198544195
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4153430451388699,1.0586154551055333,-0.11448852468656916
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1543176643080139,0.6557074441884294,-0.29501381368621704
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2660913526041952,0.17227258419059666,-0.5642823303965725
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04117204205825952,0.4034574870966132,-0.3991786668229499
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4505641506505285,3.5133652141715745,1.3566834506520462
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4652457780779402,2.6449502656796033,0.5753403469508486
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2117905779668114,3.2490997353065216,1.2294542257713106
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.8040138687996727,2.623200632818985,0.9276893718252159
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.154705107405107,2.122945854119297,0.36885869082841605
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6982332674751779,2.5071601118273863,0.8815420164686143
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8538672513181544,1.424873034809044,0.2661634678096393
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3613148438505574,1.0127505930201026,-0.1300931462935549
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7486565830608023,1.3134186503932277,0.21382441161392982
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.284078749363947,0.679628791842105,-0.13469349437442363
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08368262476292754,0.35898783294771963,-0.41897352542519894
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.19315619381063326,0.5919570572356933,-0.17287321086121976
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0950890800398927,3.0958872827774644,1.064317726167292
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2052689207065315,2.1298084624069658,0.48322631434562413
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5404565668094659,2.3754417772847987,0.7359136911169605
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5161668657710496,2.2597695132361375,0.67653115063643
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9279142218484595,1.687862219226786,0.3192871477454014
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1345352479940287,1.7861788439513593,0.5051033267366593
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.662882947507772,1.2005767657442652,0.10908560507000324
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.21775497726668894,0.7282880093219615,-0.18095874396641376
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3831493653436219,0.8377563360074447,-0.05488330265958655
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.23445825733820222,0.6264110413409323,-0.1816710689362565
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.09416324550483643,0.3105190976340959,-0.3993739081937454
2,DALYs (Disability-Adjusted Life Years),138,North Africa and Middle East,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.030555134568849087,0.3826455524873884,-0.3014556122278553
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3622188155706338,5.5542298388890075,0.3968957966717751
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.934707605833122,1.7117758548703303,0.3982902539262291
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.186199359312779,3.207255179954588,0.44089078904639223
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7970597425787841,3.989474544060996,0.08965602430442432
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5054587512159404,1.0578715589253118,0.12100488427142873
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6806811427832351,2.1998983074543537,0.13365460938455137
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2113579517001006,2.3610427536495413,-0.2836646546708506
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.00932343583702986,0.3885781906182074,-0.2839985844446571
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.12025302117196562,1.1558831339458002,-0.26165825054697484
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.16409547624401055,2.275321658356259,-0.3245882490924936
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0525967349149893,0.3780687055655694,-0.34513561735869225
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.061597394740538575,1.075516697341854,-0.32278512130080433
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4953033543777465,6.175915879956229,0.3736557476100777
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8644451507547982,1.7189174635072306,0.2688909522788555
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2990351799282054,3.997851015102492,0.39833332325483783
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8977613154864907,4.398551486771934,0.07341720144589471
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4504417268509686,1.047980114546335,0.023601928838519574
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7670342370254851,2.805314031519684,0.09923256850844604
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2796043873265122,2.679846551309503,-0.2955822712960433
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0453016722262336,0.39223508651589734,-0.35025813455683313
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.17807239084765078,1.5610005213778493,-0.2834655616795688
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12900569238880485,2.2355112609808145,-0.3818185879823237
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14594695359472093,0.2642397912610098,-0.42109139109574123
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.03034483658679843,1.2558365508595268,-0.37990084022685144
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.184611068708727,5.458796828305635,0.32613309769982646
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3091020156169586,2.5013874595997736,0.5459288973668798
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2513127796205257,3.032345082647726,0.5071384377581712
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6628093940173907,3.9018587038263752,0.013404693673690387
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7969404619594297,1.6738927903817507,0.23494039208559397
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7310479706046114,2.052674510938864,0.1979390614023395
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.12027978610995183,2.312104215245374,-0.3199521304620059
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1823870667775263,0.7929027041716248,-0.20839948948039116
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.15361846220911257,1.0662556422411602,-0.22771160780427524
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0761786392038548,2.16777454351572,-0.34995419657084287
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.034552523678142134,0.581703011083146,-0.3104752559505795
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.05010298658378449,0.8740642077796575,-0.31152631084050314
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6751201829651299,6.097006651028078,0.5554216768163438
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1977620786178387,2.2443518039663957,0.5100527192281961
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.544397727659157,4.365614105864829,0.5819586976834931
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0358673943347454,4.455987740791153,0.19860633975712783
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7111149298883723,1.437816534741662,0.18937629049517146
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9570923708791278,3.123727888073234,0.2599810217282803
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.371815381381353,2.6393814930792607,-0.20237176842441185
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.12537490333337037,0.6612863299854082,-0.2267700633007309
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3038011512222087,1.7494498097499553,-0.18937218470035433
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.26565455335961774,2.381946762352549,-0.2733048881543435
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.015156503218560935,0.46844182176340354,-0.33458118275742943
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.15373747815555106,1.4314659666642338,-0.28430867876198673
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6044938622527682,6.123900799724545,0.4498439528342514
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.004251029766262,1.9669267227061145,0.3594947097392749
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2328021220309544,2.7839487250809265,0.48816926099078783
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.981525016990426,4.382107167718763,0.13294837869852372
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5592247082332938,1.1952273868891556,0.0990249262262945
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7161951286594358,1.8822700266264794,0.16546561170770546
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.33559784106277374,2.653172950781201,-0.2565125680087263
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.026286617110760104,0.5192294499240837,-0.3038640340371882
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.14413322473510495,0.9389722959960168,-0.23743179983172438
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.22055614677989135,2.3601614319707327,-0.32850307540695667
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.05808817798193821,0.39783810662693225,-0.3646581536332154
2,DALYs (Disability-Adjusted Life Years),261,Southern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.05285284582256369,0.8139866626325947,-0.31308327386682644
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1013100115787187,1.7834160980810618,0.6184682132199755
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8761275076589929,1.4347370785452938,0.332095360262183
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0386062491013164,1.6027774992245079,0.5699952712245102
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7916506801854609,1.4002051285077095,0.38594084668231987
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6768720782275905,1.1503256983651204,0.20971108561189566
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7753075394802452,1.2715505453151743,0.38033598156058235
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.38951333618737916,0.8405631568549666,0.07022912091630096
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.26075784435359234,0.6361435233923679,-0.1048318048632173
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.35898479499501257,0.7350751513493761,0.046597253760377114
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.10839610783645957,0.1760190097251058,-0.31443380315924796
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.19029890001551597,0.05847545991556084,-0.4334394206711618
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.13136099722451985,0.10357492071660244,-0.33775032077088996
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.858868476056306,1.5274355997515128,0.40352980174271913
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6716595360823949,1.2352715768435747,0.13673737542771053
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8202571874815445,1.384573923264992,0.3689196535875712
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5856198251115242,1.181322671693033,0.19752708973783012
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4938391281116008,0.9699724335674442,0.02444349373569167
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5855137535779904,1.096246169169253,0.20005712145690407
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.22919632204007415,0.6712933612165922,-0.07190116331634036
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12335535010312386,0.5021026893223224,-0.23611238724991235
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.21342796916191883,0.5896153098163466,-0.08744467176265736
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.21977779179898,0.06309305956580316,-0.4075425482313833
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.28193872803321174,-0.039207736056270356,-0.5120435978518162
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.22955606819763788,0.008095414882025424,-0.4175304778937346
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.402940478100812,2.1009984202701464,0.8544538276933017
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1817755343562646,1.8769708554677762,0.5159356583918049
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3014686942891445,1.8467464135448817,0.7600277499991785
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0492182099878273,1.6199694995700573,0.5870404091879668
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9505093415949375,1.5558912123611628,0.3632605749262582
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0048014545315131,1.485514194717843,0.5335002386206158
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5889696532102928,1.050567806139225,0.22627708939892588
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4661533442312164,0.9333246590118969,0.018708891080436017
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5342153312218783,0.8977107977175688,0.17327755277536944
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.06427490676976051,0.21147366243117552,-0.2783480753016041
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15413087238903,0.12249083872598723,-0.4180426052563391
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.10525238872760012,0.10647567942498129,-0.3175398835383977
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.849302541854308,2.8250708977821106,1.1583854119431194
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4890253456146316,2.327855327004606,0.7141398600314944
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7873976624595544,2.7005994235913624,1.094916353857051
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.427411417282148,2.2898463146322534,0.8106971609740187
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2235790727378666,1.9431192960956505,0.5663737058828084
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.425683885999103,2.1846367027657863,0.8284527575055456
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8841312604629166,1.5293683440537706,0.4272550447109037
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.672625243469824,1.2363190621463591,0.15190213140176467
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8581474684270509,1.4669101015681387,0.39652248830943015
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.12185755567620904,0.4999782021738007,-0.15412824413355336
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.020665413165754952,0.3098119913176899,-0.33059815535074777
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.09442325741015944,0.4473608997307549,-0.17641586039121937
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9741088450963199,1.619789918180806,0.4709552155351996
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7122455253729999,1.2976614703529077,0.17786182540409495
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8573768416907782,1.3594158991827954,0.41521518062262064
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6828481603579969,1.2176675171573599,0.2890758094211258
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5305200084814453,0.9841562478087418,0.0675295652505519
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6175239288325145,1.0490925775598337,0.23927314838709307
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.30540022758752416,0.7323636251971013,-0.0273153996040095
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.15062913835050457,0.5440287030549529,-0.20847675337599253
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2381728386962189,0.5728443555357465,-0.05658294093815532
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.14192185282543246,0.13448592916959312,-0.3467800391150878
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22259957276864048,0.0475664348254954,-0.4629287000350656
2,DALYs (Disability-Adjusted Life Years),9,Southeast Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.17640792607318248,0.03670964159669382,-0.37416150416893756
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7065675395030969,1.4922162226561781,0.1711030381093404
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9785592957547253,1.8007886711689194,0.3605347838467092
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8663883831077501,1.6545255209848277,0.2847164912775173
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4578392084002143,0.9839953314454969,0.012714881943827656
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7630731889273545,1.3519539082532548,0.25536969841387935
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6256420638236202,1.168063736801324,0.1641364070525249
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.31992765659659994,-0.006844272156225191,-0.5333118853732799
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.20010209986498517,0.13231126385594238,-0.44995890747641265
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2508363356169732,0.06551995527741572,-0.4843179892192859
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3478350850305084,-0.06967290581845641,-0.5587978488627919
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2163419117594519,0.08717863459830713,-0.46056404185256994
2,DALYs (Disability-Adjusted Life Years),167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2699103104060328,0.013331656943716103,-0.48601497139351846
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5648202270769977,0.6651814550173819,0.45946930974541556
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7025030575699405,0.8046341137902739,0.5743551356638477
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6034327359439564,0.6905696651469775,0.5085052186051804
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3245461756271363,0.40904835285576824,0.23239021648423794
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.38079004498839697,0.4631605398888977,0.2824061756005306
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3300108946949603,0.4063972465371532,0.24850650305175814
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3361380378759099,0.42183251693410223,0.2461830605972848
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.48275806192887727,0.5717068871956953,0.371150412544151
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3829788222771393,0.4581354066630108,0.3011027677424378
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.083383449657564,-0.025366038812957105,-0.14494651469638908
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.04100071626378321,0.10039798589775668,-0.01961815693647122
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.03644140073336939,0.015679486988254058,-0.09489766048717344
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.17607478241699556,0.3739492924220774,-0.004503160933753671
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.24367462644461432,0.3879143496175871,0.11874830210408599
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.18876173561560639,0.3595680225370198,0.023292060441709055
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.00451509486075601,0.1641295492000258,-0.15942623527477795
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.008652511085768538,0.1331348007224485,-0.09697482437426654
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.013969473543809001,0.13079399583603812,-0.15143292949094062
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.004203693806587043,0.17316090369497866,-0.14998466261760707
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.08315140497266442,0.20877385917864066,-0.0256504639810722
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.02532040679707005,0.17264275604737692,-0.11739905462134315
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2592616834863701,-0.1388473642355051,-0.36936179128368535
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1766756484119463,-0.08323229533777536,-0.25430059232703994
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.23333091164227537,-0.11973571735594014,-0.3405615289628042
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5679589167738848,0.6659768919551918,0.4731828395710724
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8463588147299087,0.9596368733844182,0.7035713156852317
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.66932364311108,0.7649573327236787,0.5720764309452729
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3271582540612875,0.41021674384844414,0.24232938056975334
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4974416745866998,0.5879765991341988,0.3805919343537929
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3846307645578059,0.46339067450178684,0.30167933640339784
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.33881804074175476,0.4225117090425303,0.2578925007722962
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6080461092750478,0.7067031742141103,0.4836884381332708
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4398104729912626,0.5222956090781156,0.3559336555009275
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12417525339413575,-0.07367572254231308,-0.17265015711113293
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.09024510041371946,0.14466920978705616,0.025275296610385124
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.04627984937781371,0.0014756897260705271,-0.09516932774014542
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9365390829906093,1.0517547035751815,0.8072491429304716
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6945474898848838,0.7988194997284976,0.5840114748027037
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8931181581479906,0.9978435878722871,0.7737803648616866
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6391548919567452,0.7393678819889784,0.5286628975323395
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3743557915817843,0.4661749194206921,0.27671927622023756
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5702712970986829,0.6568148298207008,0.4651009647517404
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6535340519277242,0.7519121087528757,0.543138490929812
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4758293330377387,0.5666427753641372,0.3795603913945238
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6328357667249778,0.7231626312175545,0.5299055738253753
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.11342385080508313,0.16758082665910984,0.0512654677451961
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.07763602331098539,0.13742206939723936,0.017613303358414056
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1520620074298337,0.20499332960872096,0.09362475236117689
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.840505570964834,0.993008276011492,0.7016615477012624
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7536325975603332,0.8818340883857677,0.6139205593855948
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7998695293401019,0.9261953640892756,0.6790977967620696
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5578725117135955,0.6839860085476552,0.4396687791139345
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4221137108075869,0.5233792690876995,0.30857199397186613
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.49287838195675326,0.5892698256434112,0.39298114450210636
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5715348381470257,0.7017508601321385,0.45298142376490147
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5272882243191217,0.638942528390701,0.4056090590271648
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5524077724868669,0.6613652299768071,0.4482407907725985
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.13330990444928498,0.21008581529703851,0.0612260975977917
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.16575706186682074,0.23364547762549642,0.09256896511487668
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1507545327369832,0.211941780782325,0.08859112998960667
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.110815822366507,1.676554670313561,0.7851709845353942
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1843015407851096,1.5577531294863984,0.8508574123177636
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1382543151190894,1.5412733608940141,0.8831828399050636
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9981583500652509,1.5478675519513305,0.717608022157471
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1543746376215829,1.4663757224368998,0.8204847318162032
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.063706497451994,1.4568444308984254,0.8218757463100521
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.17266517243512675,0.4869617759811876,-0.00824703973490653
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.16979373670516149,0.3697942042543171,-0.008780899506471464
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.16666078442057916,0.38655348509496895,0.027490300698235798
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0007499015412712975,0.2710735318019138,-0.16196939311278527
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.03709437744199419,0.1711029468423786,-0.23229786640334532
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.028333408395935337,0.17926111649054807,-0.16861109874086333
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0054948069593512,1.6789360867623666,0.6505674938219639
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.109317571581398,1.599914392954056,0.6491931820968341
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0321797467744127,1.6025424130436319,0.6976988403724196
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8982125455947696,1.5417447378559044,0.569693081854584
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0800161687734326,1.504934294943428,0.6550906881680276
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9610002288970823,1.4940950165813214,0.6457854732470878
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1141540103598819,0.4882847735165425,-0.08302610097525165
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.12963637935775835,0.39237349608520355,-0.11678135137866076
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.10878504988467601,0.4199827175001878,-0.07371230502650394
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.09756059093693896,0.20161397302915596,-0.2560707102527805
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13808440750574882,0.07938297275496273,-0.33718387634637015
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13162717438025257,0.11410079562520926,-0.27752633094870727
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.412107942229718,2.0375116622090688,0.9962673604069693
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6019817001606311,2.236146746710487,1.0073791733190387
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5135613548665947,2.0353599698894254,1.073757367071217
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2839065031103385,1.857029768298094,0.8817350894800612
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5663965627416268,2.1777212646625,1.0070097640710618
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4262588456409269,1.9256366605375885,0.996957385735874
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3400482154978908,0.687491679470472,0.10902769612259672
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.39348063398578287,0.7331051252200459,0.07504368801432597
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3714334357812761,0.6561338931626526,0.13147036788770033
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.03279055303055633,0.29955915422365353,-0.14685056084092435
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.02937929985507217,0.21618125481487993,-0.2594995156233945
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0028713918689624437,0.21790356419756673,-0.17975549309751457
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8275079206328184,2.5513292170037722,1.3536435470958361
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.093341095460874,2.8080452649075305,1.4278339240709368
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8880197821018632,2.5051430219955497,1.4279121214078512
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6768002857960307,2.3207750293317675,1.2545494264696477
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.051652695300704,2.7063977054647133,1.3922128597633092
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7878541046680059,2.3813075313287695,1.3485030007515704
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5708239573423345,0.9729433731279522,0.30756828083256926
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6566261440543552,1.0393830324257531,0.30021650633350166
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5757430725547004,0.9124539483601559,0.3247020431749512
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.23336721195608218,0.55246119325433,0.03195023652207894
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.18468393610571754,0.4725016147914605,-0.08630918889468503
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.183609771357428,0.4431208358140082,-0.005321155699987891
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5423363581971333,1.5681400990867715,0.12102442355033996
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7579594583581665,1.654294552680267,0.1536296567825366
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6178129464963921,1.4117702589668446,0.18624304393544366
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2049342008997691,0.9593413221699694,-0.08885006451412637
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3773979368316585,0.9963005800140845,-0.08544688425447819
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.26557376638064717,0.872650882129161,-0.04929035264644203
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3806554425182042,0.03126894776661447,-0.5498385473181409
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.31886527513070767,0.028426555155280482,-0.5530174401134945
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.36203165884857313,-0.04894254018453746,-0.5322169299109369
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3007422860556726,0.18227840026545822,-0.5045781545051231
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.24519548024109733,0.1892997449291564,-0.5298721539891202
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.30001055611999305,0.0683085870928025,-0.5006045681569431
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5324862212532926,1.6098843833622758,0.0978205711555182
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.76976759959129,1.8063679905647179,0.10300781585303667
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5867935650204121,1.4978002731776496,0.1436532732969098
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.19696701417479132,1.0113707273718942,-0.11628288002623044
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3862015485276077,1.1566546412756804,-0.1224448530608965
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.24095243044550255,0.9540726620680193,-0.07702863285694421
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3846108888604986,0.048031889996821384,-0.5591563460051553
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3142901212545479,0.08734856202004207,-0.5726312563081493
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.37426384142977337,-0.015017465240514201,-0.5490117796388538
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.33440090208884055,0.1463639794155655,-0.5290077262685045
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.32936333656505723,0.08446794208396419,-0.5888125970058915
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.36528263553619544,-0.003175104558868469,-0.5461128275635402
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.48554129738578317,1.4380432999582005,0.05344468430765451
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7864384075722648,1.833949278919657,0.08503386753577105
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6706051021086841,1.4681272752089427,0.12547092261709222
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1611656842313273,0.8864588503489563,-0.16444255626090032
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4000209616929172,1.1885985867151196,-0.12583477677403382
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3073816427897733,0.930905003647063,-0.09639872544292617
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.40346221331006676,-0.020973057719314844,-0.5769760413372285
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3078308902674604,0.09803514137536334,-0.5795953989018185
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.34121360073207596,-0.02671871496291407,-0.5561818076242013
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.28725078531624787,0.1556888648477761,-0.4919392890904105
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.24024972627688226,0.21258435040674528,-0.5411107894619964
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2450077742141471,0.12752396678588443,-0.4907141429240385
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6399767813833221,1.8043204556661148,0.14675478380402934
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1739926147113573,2.5121346358007743,0.31855179837950365
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.759954649715501,1.7723036866376503,0.25598199179135195
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2821472424798025,1.13733291209231,-0.07684892716878106
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7048963687849779,1.7086952704380978,0.06355193868447101
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3778706600115815,1.1649218180408893,-0.012520567864300978
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3414467028881077,0.1261101396078752,-0.5395061976328905
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1576700734200922,0.36080320139707917,-0.48911710554808985
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.30597950102184907,0.09323020807965457,-0.5047160739104755
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2345324834358087,0.303851185919058,-0.4633045483688866
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.10636194463575377,0.46701733861363187,-0.461923982614563
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.23691246716712427,0.21512278009653163,-0.4513898705568535
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.693229078567975,1.9652889552349182,0.18779299663976562
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9862917336640675,2.1382220956284996,0.2391883387957502
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8555952304497543,1.792875786796412,0.29995047400729646
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.32347293563811136,1.212672984241622,-0.027504643162513522
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5562223680072891,1.3985307122600863,-0.0059614722258146185
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4518228561025297,1.1246555578856203,0.03635407229158121
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.32006257337613003,0.19074906457654067,-0.5230267872672404
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2303962033441968,0.21592795187722896,-0.5198670798727204
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2682645953710269,0.10134260985064344,-0.48737754307290254
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.26230221459976044,0.2708961895810206,-0.4811140676966015
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22814910360237028,0.2399259043711039,-0.5264541958583772
2,DALYs (Disability-Adjusted Life Years),199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2371154186357113,0.1413344206622657,-0.47113512986852707
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.705547580102602,3.6020968449009,1.9268974942869797
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.6800607779780203,3.1148838446059646,2.1877053505091286
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.6964372845410622,3.3041786076304365,2.1142561245667393
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.01912815398021,2.757904568788084,1.3993598188574068
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.703303107057568,2.030361438654907,1.3415875458730269
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.8680306557929036,2.3513779327134676,1.4185991758048333
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.7180417381612538,2.3756660890465535,1.1468971537457167
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.6870340629323037,2.004524577863398,1.3275357055694652
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.7050326926243946,2.149774486159155,1.2789956873851542
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.0678772864959842,1.5586865815103714,0.6340468487330562
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.0280772608959285,1.2611357284655846,0.7625814456607831
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.049839576634399,1.386849179410888,0.7284896751848027
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.201031625316225,3.0079803298445085,1.4665682450464805
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.08948108821768,2.5001457332703882,1.6805089053156448
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.171589427291289,2.7760235223449867,1.5852012975322127
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.608006164775503,2.261875494514403,1.002142931507088
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2696220576088908,1.5630041378805357,0.959463216221477
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4607862483198906,1.932073304223303,1.002777732120565
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.3479762099135573,1.9398780036566285,0.8092428433677975
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.255816254585688,1.5556672506078026,0.9572010271346489
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.320951886370223,1.7632734684230065,0.8918362435324991
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8369139390133166,1.2943525389423371,0.42317462991936394
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7750661941463151,1.00313576799384,0.5546756267415431
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8188675055879682,1.1601383563882113,0.48394540018524085
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.357230177976889,4.491931740546562,2.436825180655203
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.9816999938567923,3.5047975983069355,2.452146567099844
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.1648527192030356,3.7827328041315527,2.5923513304976784
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.5505218081677916,3.4785611162259187,1.8134443878654576
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.9249302982087009,2.330716850760791,1.5267191956110098
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2318444753390185,2.7363726036453153,1.769462765631717
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.196054896207555,3.0283654092291608,1.5209322200973558
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.9072790253613647,2.289224098064248,1.5206201678899283
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.0478165590759,2.4999778433598543,1.628863157783952
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3537970925424865,1.9231945537074149,0.8740253136348362
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1348446642265684,1.4076361528905799,0.8503251300913649
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2345815987552846,1.5582840334877481,0.9186198620298833
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5745654668001756,3.4725199500703656,1.7888054000609144
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3674522733463412,2.8966600181443924,1.8967807006824597
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5336253709308987,3.2367285692962504,1.8730143516342932
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.912346994638502,2.6795532980824324,1.2620044419957592
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.473830968849619,1.8710823045106033,1.100337541221785
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7414954696720235,2.3165982733529322,1.2424895643785479
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6219655596174416,2.2806206468177503,1.045605760853617
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.4587797619886151,1.845186216237792,1.1151140932665229
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.585887820099142,2.1004149150998037,1.102456270542334
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9659142835173841,1.4629892788891516,0.5383669714884373
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8549997038220737,1.1325755883628479,0.5980203496847487
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9461799255730725,1.3367603766974683,0.5942781562987796
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7315319591948133,3.8264819641458088,1.8478877155012245
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.5349114361783696,3.1254396157659388,2.0291839525673083
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.6257708421285058,3.2240074667528917,2.0555847527734494
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.0403716996312307,2.9102201798362914,1.3156622545280527
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5959069739102452,2.0229330163011126,1.2109618681287628
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.8130252146469021,2.301103538148689,1.3491693473351498
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.7371014386201202,2.5402539418121806,1.0889429993811346
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.581051784606412,2.0122319822728856,1.2117896835139939
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6533193745608428,2.091105681473705,1.2360602967359728
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1389095046521271,1.7620556020581322,0.6527321134060394
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0259505184493012,1.3490421273289965,0.7291926014814525
2,DALYs (Disability-Adjusted Life Years),96,Southern Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0730274100932327,1.4311982544784825,0.7604340834981207
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5723332798806113,2.2476478456028732,0.9999017717328162
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2463784752292393,1.904746034102636,0.7204572089491215
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.415399550968015,1.918206558936363,0.9377812949952533
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2151603259610595,1.6972770384349367,0.7995976809399619
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9873610328614105,1.4515156787423318,0.5746637109160402
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1053847448592138,1.4835464153573514,0.7463246691900133
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8938484401887067,1.391040404749837,0.4724028494093937
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.640336089501999,1.1210850277979665,0.256301233920582
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.771103399064437,1.139789068700034,0.4208875036157647
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.13081205555026823,0.4493827033504825,-0.12032081160912264
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.050808154584826654,0.22982823295178853,-0.27150850612864075
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.03893656470151881,0.2577316471196254,-0.15840311995001485
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7466668223007698,-0.6697352653641724,-0.8043009267877772
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7730974631864254,-0.6888042532833537,-0.830026291753739
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7586044749619761,-0.6914329008262204,-0.8116415354605317
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7816618504851038,-0.7154065362990527,-0.830012672949206
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7991303494633616,-0.7261270958605824,-0.8474705753980798
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7894838986667204,-0.7327060948733158,-0.8351929378207199
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8134865932084806,-0.7568466895672132,-0.8559189870736559
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8343126841540447,-0.7727606367904025,-0.8758828884013531
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.8229955641324658,-0.7737416826267468,-0.861885245174152
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7056948966263614,-0.6134863135828734,-0.7735146482945094
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7330396549717796,-0.6320281467791355,-0.8010804928496631
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7178239558728566,-0.6383932873674018,-0.780652670219968
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1511536265407054,1.8402509846934318,0.8042058443669847
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2764425198870903,1.7831710261501779,0.825103559315324
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2229028537741737,1.6898724290839882,0.8813805357487513
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0365065774943996,1.6634910214717218,0.7172109919455127
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2449040343087734,1.6680444189571315,0.8366650025020884
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.145285352049622,1.5830917831049849,0.8229208880653263
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1950748671068997,0.5779033752885361,0.0023277896510439273
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.21913946037691898,0.4905158348235843,-0.022573269916763214
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2128461842624562,0.4676311680594606,0.026506938912923203
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02279119943728583,0.2828647014778653,-0.18527954506046868
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.04117323978398561,0.18772124622850675,-0.25741039548934447
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.02912633483968341,0.18420292953225192,-0.19640851405540366
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.827364580489448,2.558196697016764,1.3348525872389163
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0205270382967133,2.7326545516161955,1.3656059639780382
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9294283286695852,2.5048624223927636,1.4427582972813222
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.677203332806044,2.4042424995635034,1.2241142448164564
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.979208671965057,2.598251595960144,1.3146265932281147
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8277811297084037,2.3547783957899315,1.35053190233887
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5707443246277374,0.9767586063417152,0.2971289502442037
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6176308742052483,0.9990078449494674,0.2668905773784511
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5983361416198882,0.9123008493810589,0.3328023196798179
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2464543668242981,0.5710046483667877,0.0323229340614508
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.18464808903052163,0.47744648761197966,-0.09101992231849332
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2151948315531212,0.46143773726754356,-0.007322408025435207
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.31933863760940057,0.19368062806400704,-0.5157380138928205
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.19300817172559548,0.34953361835693475,-0.4539971932309904
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2558368794385592,0.23737849091229643,-0.4641771467337877
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.35646985023069383,0.10804818812577179,-0.5302084694341046
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.20455669317209738,0.3103670699144593,-0.4535058345731794
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2825981859469973,0.15852594655483745,-0.47281177466976987
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6218581150283282,-0.3368499114376552,-0.7309679227221796
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5678188342309471,-0.2772628024336009,-0.7075904349029333
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5939744286578361,-0.32486938030451723,-0.7076477265206802
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.46037737484536606,-0.04709961676536104,-0.6157997461491562
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3559963613501297,0.08272288874721137,-0.5647782007808366
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.40815646649765197,-0.01135657869126283,-0.5740813872098509
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.859754899474143,2.197626034418397,0.3849900364492733
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0918208788741908,1.874894096849381,0.5982326185820643
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9908416494270964,1.7664711661550254,0.5636760631879829
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.48354184458641525,1.5428076621575002,0.1312605816599794
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.769688941180753,1.3542227992814646,0.3461782246812448
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.63209711896288,1.2474908903860413,0.31293845359129824
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.26065398981155824,0.2712170035365446,-0.4493968759598097
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.15014520680614124,0.16799796426504593,-0.35067783993448265
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1998315787152214,0.11191307766197792,-0.371519976366786
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1945675264510244,0.42741289370825386,-0.4031880972831636
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10102003299475594,0.23690963971822818,-0.32583292803725905
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.13923450390116893,0.22203158848215504,-0.3269313299636847
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6406520955151515,1.7125924517684736,0.25662024904399927
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7546103115136638,1.2608555843235476,0.42606558278231266
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6815332082022476,1.4038407594182951,0.3476745397409658
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3080173756280683,1.134889582462486,0.02845101473409778
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4839861237041052,0.8568975810414976,0.22888723609740494
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3779157361819067,0.9544754809092808,0.14388244555517815
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3477583625296984,0.07839178541719716,-0.5004303159973458
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2871454728811243,-0.0814706103848831,-0.42062502426660603
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3241502793894635,-0.03383703769847179,-0.45833632263995366
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.24720298799910898,0.2968011247927862,-0.4306467577564742
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1547959729052568,0.14114132708235816,-0.34464842520143635
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.21622563474640166,0.1802124594774665,-0.38299862414684505
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6564861915143799,1.8963675418556765,0.23859124034115786
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8377274624065705,1.533611641494979,0.3931187514896447
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6983626985697082,1.6759050635296182,0.3048365391115052
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3204551610697812,1.2734706382123275,0.021100987701972072
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5540674363864668,1.0925814356726826,0.18209263815228058
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.39147841967388786,1.1770446078006462,0.1057971976092009
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3414635138347005,0.1514516169393047,-0.5075977527686469
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.25337704184750043,0.029343391378286104,-0.43401050233377825
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.31738609161881154,0.07551232455308977,-0.47555397294606205
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.29370066064387435,0.25198485514575064,-0.4727991832345153
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2107165413003255,0.10319524676444072,-0.40672042897744076
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.27799979332023383,0.15688598688632038,-0.44768077062372114
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6045146783433694,1.5068279986792927,0.23409096859757905
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8615880673894499,1.4719603502321896,0.4695715041352261
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7471926005888093,1.3367146918553423,0.4178087616348849
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.27946300636636323,1.0071470161366196,0.001997989491907865
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5747170854024984,1.0249411934471149,0.2517141364502607
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.43200316355065244,0.8700254761639823,0.17624174555152336
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3621248014685205,-0.003409922685901893,-0.5093868368889897
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.24368307152815086,0.0042960051917257025,-0.4029496505443648
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.29776014817857865,-0.060816661881218856,-0.43014764694741775
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2002429155149792,0.26168024949867763,-0.3782957079366867
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.12635974710160372,0.17922980853867115,-0.31855186519689305
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.15203484389524127,0.1456927637903721,-0.30841336606773784
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7140824699394456,2.0698480995619835,0.26012060473506476
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9721193925652367,1.7946588072447138,0.48238455646660994
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7665881114273674,1.855393996173345,0.34056041873759246
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3676601230816008,1.3630426554566344,0.034908340390562335
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6687369315594691,1.266613560035765,0.2644934367167383
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4486128838274951,1.2973146283403787,0.13602989669120147
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3185660994134157,0.22041885462298577,-0.4990387487455743
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.19877694335656979,0.13540036179225573,-0.3977440260813702
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.28996461341459234,0.14765335893066106,-0.4611956635492301
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.18210033202590084,0.47860178860189106,-0.39979066476245484
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.08502101064591573,0.29992781725764184,-0.3221173068887049
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.17602905727075602,0.344617167698328,-0.3758939284069833
5,Prevalence,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6633035176493725,1.9512210707777613,1.3995726796559036
5,Prevalence,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6488461340329528,2.028302231184228,1.2803953763413791
5,Prevalence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6570211026232686,1.9196071624964024,1.3976964326032169
5,Prevalence,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8297334369953879,1.028538411684577,0.6470826871289193
5,Prevalence,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7903505758978623,1.0474746305177305,0.541270920787996
5,Prevalence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8105452638274903,0.9885943481465724,0.6357210109803355
5,Prevalence,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8065778332210638,1.00187869391158,0.6276833577328456
5,Prevalence,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7837985332193063,1.0393336588058566,0.5356746755556281
5,Prevalence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7958326607990716,0.9733098445990596,0.620559791602376
5,Prevalence,1,Global,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3003860487640478,0.4338299927734009,0.1718237868494265
5,Prevalence,1,Global,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2289772447852018,0.4045092949417493,0.064622186906383
5,Prevalence,1,Global,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2552959049244114,0.3751415875831863,0.1326193178010304
5,Prevalence,1,Global,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2741936999703749,0.4041212363371099,0.1477364915359313
5,Prevalence,1,Global,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2169162570258343,0.3905339834989495,0.0544278139536385
5,Prevalence,1,Global,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2363256985307071,0.3554416306067736,0.1153187593767163
5,Prevalence,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.021526621106343,2.4183400616628408,1.7220045614316095
5,Prevalence,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6700180005320402,2.0793111777441866,1.3098722430357783
5,Prevalence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.944017172974566,2.2606024067460937,1.6742692749948622
5,Prevalence,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0758593446626,1.3466872390361742,0.8669631712367615
5,Prevalence,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8046695289946127,1.080995685184448,0.5616512473858792
5,Prevalence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0061217156807878,1.2232570802540697,0.8228508250212
5,Prevalence,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0495685076839587,1.3187358635196431,0.8463960528799079
5,Prevalence,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7980561920245294,1.0736843456523526,0.5555251270023166
5,Prevalence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9898081306020802,1.203782382508586,0.8074903895440266
5,Prevalence,1,Global,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4468675345165596,0.6324157753806954,0.3126869012900511
5,Prevalence,1,Global,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2717614224987205,0.4684470932980702,0.1032905134565471
5,Prevalence,1,Global,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4096418193360162,0.5586154950486757,0.2870984480978863
5,Prevalence,1,Global,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4177143497887525,0.5991626049857128,0.2864203008771729
5,Prevalence,1,Global,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2592751921773895,0.4531603207648341,0.092297414538615
5,Prevalence,1,Global,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3883328558832039,0.5338703728543313,0.2691665605819193
5,Prevalence,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.419826868135701,1.8839999135832524,0.9898603023274296
5,Prevalence,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1332360275329658,1.5738319464779646,0.7862912666395943
5,Prevalence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.278134254940671,1.626365248963331,0.9524935366801108
5,Prevalence,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6624616437511677,0.97946930490703,0.3700796207166672
5,Prevalence,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4418556685114846,0.7408208359418138,0.2076258167719269
5,Prevalence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5523695542410693,0.7888985537578528,0.3315393349872215
5,Prevalence,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6414222229034914,0.9562810923966568,0.3497663670583445
5,Prevalence,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4365739285619606,0.7332821230692376,0.2029327413150984
5,Prevalence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5397498712631374,0.7751129219935207,0.3196551806485184
5,Prevalence,1,Global,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.260575605955368,0.4992092731778651,0.0522249910849603
5,Prevalence,1,Global,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0930074252561781,0.314395723999063,-0.0827664120397934
5,Prevalence,1,Global,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1739219648210862,0.3470122381272595,0.0131858227821848
5,Prevalence,1,Global,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.235185052244525,0.4689619742369427,0.0301270872566181
5,Prevalence,1,Global,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0822772190613203,0.3011990765944686,-0.0914839195031671
5,Prevalence,1,Global,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.156178255288623,0.3266981608775959,-0.0024616455416029
5,Prevalence,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4079596420714043,0.0221426802151331,-0.5529971382989005
5,Prevalence,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3867150647612378,-0.0265959363468187,-0.5608339231530766
5,Prevalence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3978760266806675,-0.0138821117341986,-0.547062296637262
5,Prevalence,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5932459121362527,-0.2977042969295177,-0.6926173053068714
5,Prevalence,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5854781002159976,-0.3419540134612275,-0.703150985108981
5,Prevalence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5896933983734443,-0.3279830683190431,-0.6912813425002237
5,Prevalence,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5984058970679899,-0.3066579545933177,-0.6967880468808427
5,Prevalence,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5869987486744722,-0.3444856163349148,-0.7042546965434752
5,Prevalence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5930352619068815,-0.3335006976807486,-0.6938675721457164
5,Prevalence,1,Global,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4244257880969903,-0.0046063670376166,-0.5673882477049177
5,Prevalence,1,Global,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4058065730467065,-0.0564031608086997,-0.5759896800237714
5,Prevalence,1,Global,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.415594233263265,-0.0381113478305121,-0.5611280462732099
5,Prevalence,1,Global,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4360348513899747,-0.0248778212584669,-0.5763133810295076
5,Prevalence,1,Global,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4116430394574434,-0.0655840219345886,-0.5804296004374021
5,Prevalence,1,Global,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4244361436185163,-0.0526100826845233,-0.5679158625140872
5,Prevalence,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.042161435097919,3.1950527364346213,1.1613393182659797
5,Prevalence,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8047713887930488,2.940921110400442,1.1001731283736675
5,Prevalence,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9110868857184784,2.7585968370114964,1.2738018774522528
5,Prevalence,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.58720117977867,2.566966296736532,0.8390758813961133
5,Prevalence,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3173065171700309,2.261880014068936,0.7349849485963859
5,Prevalence,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4407879147937814,2.1439614255338983,0.9060542822459592
5,Prevalence,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5336482094928086,2.4938276883565123,0.8000601252295971
5,Prevalence,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.300276553344668,2.232066779152408,0.7224145341989328
5,Prevalence,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4063915361111272,2.1069686241969485,0.8795926770644105
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3078855893740085,0.7953955378688837,-0.061630407466948
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0841003425771213,0.5119639000124252,-0.1816432116153481
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1722363889106244,0.4926223736241268,-0.078749686411443
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2440989324674046,0.7054498247744866,-0.1095098028674566
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0541407507304321,0.4683206850449776,-0.2064835549892499
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1265727589054802,0.4282085606870573,-0.1148387481723115
5,Prevalence,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.180253319627058,3.5067931866321462,1.2376890259912714
5,Prevalence,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.870522045916183,3.0896001294087174,1.1214643444786438
5,Prevalence,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0777416323265645,3.1264104456418256,1.3293782329914503
5,Prevalence,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7047497390265665,2.827987166482163,0.911366544756978
5,Prevalence,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3716729824860263,2.378560697667835,0.7539742970321668
5,Prevalence,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.580583345499725,2.460873644594986,0.9540238730986452
5,Prevalence,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.648657311885,2.75345908870132,0.8636475792159957
5,Prevalence,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3542006255709065,2.354002870901475,0.7398760946648454
5,Prevalence,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5441533369209488,2.4110143601784992,0.9255337557156644
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4704413585689395,1.0452433874852458,0.0503468876971946
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2118844377541356,0.7056944540311741,-0.1093986046291208
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3685527244829913,0.812894048968539,0.0390970546858824
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3986765008107776,0.944895306020518,-0.0043529294139867
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1783693903965494,0.6598549272156868,-0.1353215992003174
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3152100462225513,0.7434519414286578,-0.0017843136187257
5,Prevalence,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.115194023619107,1.9407028428337665,0.4759703414316635
5,Prevalence,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.813519377842132,1.5773785820321908,0.3190131329814349
5,Prevalence,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9699084453562288,1.550896942176899,0.5074622505724651
5,Prevalence,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7988756870061493,1.4951734711698386,0.2562299854750477
5,Prevalence,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4983447808891957,1.132006179764634,0.085531021553448
5,Prevalence,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6516703730049396,1.1426576844318768,0.2599614551847491
5,Prevalence,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7616282583964702,1.4491489525954004,0.2292541643873869
5,Prevalence,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4873212556840871,1.1137849398458872,0.0817619558849406
5,Prevalence,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6283852718635338,1.108647749835618,0.2461134082191113
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1309457352601524,0.5551535829737714,-0.1940612983794382
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1030320634937058,0.2771031788057044,-0.3567372928873454
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0126784277267992,0.3204947983230312,-0.2171511314741361
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.075777070722696,0.4783242681692334,-0.2359589216947101
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1278318180465621,0.2388143675493069,-0.3731858796303852
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0267789954295982,0.2688664560423102,-0.2477091829866528
5,Prevalence,1,Global,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2044059625858303,1.6207553294412649,0.8776399061644474
5,Prevalence,1,Global,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9927470704877646,1.377196996089263,0.727831168791637
5,Prevalence,1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1372428673981454,1.502516380089239,0.8695350953007044
5,Prevalence,1,Global,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5144750352518737,0.7977679621080727,0.2903789543109812
5,Prevalence,1,Global,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3469002645044527,0.6053407364387595,0.1672296482510029
5,Prevalence,1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4563667027272739,0.7049862415896291,0.2760593590124527
5,Prevalence,1,Global,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4952974458362855,0.7777164536782915,0.2736447839192725
5,Prevalence,1,Global,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3419651884426604,0.6008632816815058,0.1635642648100959
5,Prevalence,1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4445239225025642,0.6914057043475904,0.2635850657476482
5,Prevalence,1,Global,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1806692586204451,0.3838947691339604,0.0088176501887319
5,Prevalence,1,Global,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.066929436840126,0.2340970551463652,-0.0647660207691115
5,Prevalence,1,Global,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1358463758208857,0.2976372038416585,0.002118934539478
5,Prevalence,1,Global,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1568808260123308,0.3562621109293441,-0.0115107815960145
5,Prevalence,1,Global,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.056454081810162,0.2230961913534801,-0.0739678745546328
5,Prevalence,1,Global,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1186754000120185,0.2781128436375871,-0.0139538522760663
5,Prevalence,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1012251609190855,1.6520268986238205,0.6377168438756247
5,Prevalence,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9621833750874578,1.4329885380949436,0.6052639607928606
5,Prevalence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0758445340734732,1.550640729026043,0.6923941419608604
5,Prevalence,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4435827909138796,0.822417203547728,0.1244173679557536
5,Prevalence,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3262458593472387,0.644205558047969,0.0854651770142397
5,Prevalence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4145262825096054,0.738414731482641,0.1528150421261047
5,Prevalence,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4253076200917425,0.7989286524835956,0.1108996506150301
5,Prevalence,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3213828396514832,0.6384346866480346,0.0810244739781824
5,Prevalence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4030258959365665,0.7239320841776484,0.1438586889948623
5,Prevalence,1,Global,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1006283228456214,0.3841806627918623,-0.1338905395785472
5,Prevalence,1,Global,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0018340148932767,0.2223051911886132,-0.1740510943808218
5,Prevalence,1,Global,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0718515123474317,0.3167139382055608,-0.1261748020925949
5,Prevalence,1,Global,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.078453771319525,0.3565423636554515,-0.1509249999404648
5,Prevalence,1,Global,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0116383472071199,0.2102861616122665,-0.1829193651336844
5,Prevalence,1,Global,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0556477705803744,0.2962330721788882,-0.1393671632349839
5,Prevalence,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9609097132350136,1.3303028888237678,0.684374282734989
5,Prevalence,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.4586489892529249,0.6961167757540059,0.2584586028182636
5,Prevalence,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.6562801399521186,0.9209290254030492,0.4477976800070413
5,Prevalence,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.152906618627606,1.55840683057018,0.849538775987009
5,Prevalence,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5755655160305142,0.8333362097582091,0.3586114463626395
5,Prevalence,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.803252060258077,1.090722112639709,0.574791942166159
5,Prevalence,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1388515553965757,1.5417651433238122,0.8372220455547057
5,Prevalence,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5754302995045144,0.8319100617821275,0.3592124137880782
5,Prevalence,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7975058682901403,1.0847205206666677,0.5712467734985589
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3978136266035091,0.6211194132868041,0.2179803472950294
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0010263529293927,0.1373203878470995,-0.1262257777927778
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1585114029269484,0.3126318711598987,0.0271905753473404
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3596246911753145,0.5786227290093909,0.1841456992926768
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0154984514856726,0.1195168154553754,-0.1407354763322348
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1329348988265617,0.2839484089438947,0.0049461449221305
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6286188413448204,-0.1729528180041827,-0.7573941268249509
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5338439907938269,-0.070872664711099,-0.6779240424939093
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5925114845517271,-0.1634915294125458,-0.710765389539306
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.74720371467224,-0.4355606560360494,-0.8342989947635404
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6820793615974976,-0.3665211203760008,-0.7803600335207994
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7223555515945858,-0.4289827339737082,-0.8029489303315177
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7544203045164231,-0.4531063561744575,-0.8395743158522109
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6867431222558082,-0.3756263518408219,-0.783564929224787
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7283581874266234,-0.4423629904430919,-0.8071891332739392
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6029975125337237,-0.1060489689500108,-0.7401212032000897
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5024042343908715,-0.0042307954806427,-0.6565954086819539
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5647965743991803,-0.0981564900365951,-0.6912082601282272
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.617010321272973,-0.1404987364524074,-0.7502596292782593
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5128953778629736,-0.0246978366130636,-0.6641437440740461
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5771547395450507,-0.1258762809450603,-0.7000197769635484
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.175506620895941,3.168727877097208,1.4217580886068093
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.828244101961388,2.8342727643745667,0.9719360624937156
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0147763782131807,2.8086086445391407,1.2880955290931968
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1615572291521543,1.8382849562540984,0.6456792917571148
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.928880525963096,1.613982389653262,0.3428260812995832
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0541426919409305,1.5950579793853512,0.5588869600821584
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0998371371062827,1.756615134484964,0.6014129959865546
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9005802765206893,1.5766316230331696,0.3251412013327662
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.009723682593417,1.538911690424248,0.525300452161611
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3322945643937109,0.7493446571651019,0.0090014653177936
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1631077399882075,0.5787287592316056,-0.1998084263807322
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2517232404780972,0.5895358762227232,-0.0633113743425621
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2852620090118254,0.688366827573355,-0.0279335883029043
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1385834630919833,0.54389173373104,-0.2156149436260664
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2161748862225966,0.5442987922738545,-0.0899809386535468
5,Prevalence,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7711788549565847,-0.6783479081918309,-0.836028398378162
5,Prevalence,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.799520159760599,-0.7057036862161916,-0.8544006009757312
5,Prevalence,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7827762192697553,-0.6958149240877158,-0.8411306199850921
5,Prevalence,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.748777501234256,-0.6472444553064722,-0.8199012551563045
5,Prevalence,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.783449795938387,-0.6821141824069556,-0.8427859667695985
5,Prevalence,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7635009783865951,-0.6685973872674161,-0.827036846869339
5,Prevalence,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7504145863114104,-0.6491597383514962,-0.8211488714637707
5,Prevalence,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7834694864357051,-0.6821419456061438,-0.8427437262134168
5,Prevalence,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7642542398618191,-0.6698780322183786,-0.8275843343284495
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6170083339013106,-0.4684799483534307,-0.7267862865818954
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6662463715086174,-0.5131152009799262,-0.7581902169167918
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6368782099519051,-0.4947533398422354,-0.7333493773579484
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6274618269709364,-0.4836698667177219,-0.7340763077235488
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6717561272306662,-0.521538270136079,-0.761912893690815
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6448910499235603,-0.5056930145855706,-0.7393993390842304
5,Prevalence,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9026252599638944,2.5624686863010195,1.2992615846082582
5,Prevalence,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.983807958390288,1.3209398343169192,0.6621479726341026
5,Prevalence,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.324280543346521,1.6919545642134768,0.9910458603642912
5,Prevalence,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.169343999379501,1.6597336497524524,0.7201769750651883
5,Prevalence,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.481233986207735,0.7350106197448122,0.2416249871423487
5,Prevalence,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.736265159677468,1.008989225490908,0.4875183644434426
5,Prevalence,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1547980943443648,1.6446406438626489,0.7068839540708407
5,Prevalence,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4777462906121392,0.7288771407484284,0.238140511847518
5,Prevalence,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7284438968248375,1.0018635230432555,0.4806349756256394
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4883158749958557,0.8180950875165365,0.1886368975155749
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0373819792060299,0.1257101719647574,-0.1974340380529495
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.157378439491941,0.3405388074073046,-0.0075626427996401
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.468596294737706,0.794020536198129,0.17127493914193
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0457987738673401,0.1161849113063989,-0.2045525115126835
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1445867441959686,0.3256834701039431,-0.0185098483039365
5,Prevalence,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.118195428451673,3.6720738241514095,2.621090076415374
5,Prevalence,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1795622546075606,2.477808675630732,1.8860571592507087
5,Prevalence,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.652904854902368,2.939324753349356,2.3559105052169427
5,Prevalence,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.57414091728304,3.054301438280733,2.1405014050846702
5,Prevalence,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.81383631290389,2.078171213030048,1.5535625356084404
5,Prevalence,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.2025875075774337,2.455308149819672,1.94160872724819
5,Prevalence,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.586814944491831,3.069225102446357,2.1538522702699727
5,Prevalence,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.818764486589037,2.083167681907556,1.5585645995681303
5,Prevalence,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.2104656139072625,2.462194380909998,1.9494431714775984
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5295966992858914,1.795435874049148,1.286761961431588
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.255006223543246,1.4322208824809215,1.078416748364601
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4129303547280478,1.5796840074726697,1.2471985275473847
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.492832469756121,1.7567264546959966,1.2558603687194514
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2386640651004786,1.414374160846797,1.0646364087900242
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.386539039473356,1.5515953272169334,1.22515686097034
5,Prevalence,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0337395531925933,2.3005135314025216,0.4354755443193204
5,Prevalence,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0803567018815274,1.9909490655590427,0.3959460440397299
5,Prevalence,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0572494359581397,2.0678286345665304,0.4835724285497766
5,Prevalence,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0257276131135601,0.5762991539176952,-0.3125133570536834
5,Prevalence,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0178985498286259,0.413978095359481,-0.3412927229466854
5,Prevalence,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0214409096088606,0.4582222264169713,-0.2943262573107534
5,Prevalence,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0405983254682458,0.556992980675152,-0.3228249709716316
5,Prevalence,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.024870364645105,0.4019533616642966,-0.3456755009040315
5,Prevalence,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0325039730633633,0.4427574816095169,-0.3022963549258924
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2010549146205338,0.2729705868813603,-0.4162535292908472
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1837427033541559,0.1840507592128922,-0.4534571696111891
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1908802386029918,0.1887514556740714,-0.4143178035117901
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2116676600051384,0.2599592959693924,-0.4235627371628906
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1890997197477836,0.1767820637118576,-0.456326245427661
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1990196358429044,0.1776756465786492,-0.4206107341721318
5,Prevalence,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.105983087629245,2.37251063128464,0.5151176025515275
5,Prevalence,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1021799738331004,2.145025667141512,0.4017010525164689
5,Prevalence,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1051774875585996,2.184042248079964,0.555526382904373
5,Prevalence,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0089399248648999,0.6130084301450922,-0.2759891142064931
5,Prevalence,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0075792644444363,0.4882345087089137,-0.3388186405251661
5,Prevalence,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0013933521253263,0.5130191405475035,-0.2599852987611991
5,Prevalence,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0065179695033887,0.5909570829516213,-0.2852544158279372
5,Prevalence,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0146411000189255,0.4741739862244741,-0.3429779446088484
5,Prevalence,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0099640716339293,0.4974111407064415,-0.2684574029040003
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1640978334744315,0.3313372009850593,-0.3935374391918945
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1651776151464206,0.2399997550099614,-0.4469449550481442
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1629771695302447,0.2639354138845192,-0.3772531860785948
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1752390971340167,0.3112688771327054,-0.4015460588330801
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1706680342590705,0.2319151291169684,-0.4504566693344388
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1714200100885934,0.2518551415696776,-0.3836795648572605
5,Prevalence,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9592437639706728,2.1522870091963795,0.3639112783301783
5,Prevalence,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9521575578257232,1.9170389782319135,0.3212428832927821
5,Prevalence,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.955211219905539,1.8528385168117183,0.4223497437375167
5,Prevalence,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0613914071908844,0.5056469407128622,-0.3467292646617986
5,Prevalence,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0784383227320398,0.3753744544854236,-0.3754843479316354
5,Prevalence,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0699855157564747,0.3555562348555781,-0.3212716324292269
5,Prevalence,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0757411660610256,0.4870682091421652,-0.3565848870429087
5,Prevalence,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0849613983043233,0.3673093429538667,-0.3806912584580829
5,Prevalence,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0804911383050032,0.3416505953356384,-0.3310885389357368
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2155288475843875,0.2455340276379833,-0.4366051491786227
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2054032518578902,0.1669516763365934,-0.4536904273421038
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2090643828153168,0.158904889822427,-0.4227144951866695
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2259687478542772,0.2297380794375945,-0.4446118489368486
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.210606798117952,0.1610956871012739,-0.45691252841865
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2170188502808973,0.1476118551101761,-0.4285493947170032
5,Prevalence,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8203726594864859,1.2619420934267436,0.5013741067864249
5,Prevalence,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.942412092945608,1.382651885434306,0.591876289428212
5,Prevalence,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8870925388968844,1.2693075548244823,0.5879438342007498
5,Prevalence,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3171810054997164,0.6354314325663972,0.087841568550023
5,Prevalence,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4298796145654456,0.7532662634288243,0.1726903142018907
5,Prevalence,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3775401414179589,0.6552043950882223,0.1577623409797116
5,Prevalence,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.299551785916964,0.6147852319330541,0.0718208668076661
5,Prevalence,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4234697519728508,0.746093375712829,0.1665844519365297
5,Prevalence,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3651960538161786,0.6417052449121604,0.1487802592870353
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0009147649391819,0.229638244236022,-0.1695790651122435
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2096882524073089,0.4840537415978901,0.0062144018672677
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.119886484009255,0.3520122443635983,-0.0513929442567012
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0214822567917055,0.2044942226286145,-0.1864978792707108
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1964162276620224,0.4694464213655857,-0.0045499765369326
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1019894140450076,0.3287588501654311,-0.0649752197764585
5,Prevalence,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.174892881190549,3.355137843641142,1.2606721477532243
5,Prevalence,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9507939223146329,3.104553487416964,1.157308516098829
5,Prevalence,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0711930549579955,2.916378110429809,1.356684479340721
5,Prevalence,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7001525535479702,2.7078379993818253,0.9199403235313606
5,Prevalence,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4379779351588424,2.395032413883681,0.7786293397875318
5,Prevalence,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5750720379104777,2.282333101365654,0.9762477624879576
5,Prevalence,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6441928988232677,2.6271537310052686,0.8827889517378168
5,Prevalence,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4200339822252552,2.3662665651753017,0.7692729673944458
5,Prevalence,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.53874008689719,2.237395346523017,0.948105916107103
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5152241819704303,1.051342312071028,0.0970977939705656
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.279028255261852,0.777318891459588,-0.0644727934265655
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3965107551019912,0.7989680235976133,0.0929790421409363
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4412789451925334,0.9541938817269762,0.04137978692325
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2436621951029029,0.7279403878736428,-0.090437894554568
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3420799460146737,0.7253264764960956,0.0477093045699767
5,Prevalence,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6369139877282882,0.9814219995462644,0.3462058854584265
5,Prevalence,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8095052704123137,1.1774597263273077,0.513674410066967
5,Prevalence,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7246754381166243,1.0564024200417337,0.4576588320796653
5,Prevalence,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1844063018115855,0.4374047166767837,-0.0243903870089254
5,Prevalence,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3320311338472602,0.6015765197829648,0.1131225622920788
5,Prevalence,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2589651558500276,0.5043314679894222,0.065500306511923
5,Prevalence,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1685818752874668,0.4145238255181678,-0.0389526817256558
5,Prevalence,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3260708311186924,0.5957211488864014,0.1092752896725366
5,Prevalence,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2476972134110876,0.487681399312879,0.0545270273437258
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1282225091276913,0.0507046407904125,-0.2820496028646621
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.111703109978667,0.3392743605408684,-0.0709248150973679
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.003608949945421,0.1954633871530298,-0.1548272068993416
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.146146391524146,0.0293879841854704,-0.2977059223737388
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.099517315256219,0.3257827379877246,-0.0796876566562564
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.012414743738457,0.1781783885713543,-0.170184563696838
5,Prevalence,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6073999201467073,0.955676842374541,0.3231775756445655
5,Prevalence,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.799671603688732,1.199399845245145,0.4988830568663346
5,Prevalence,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6505258972195124,1.000048839278306,0.372121915716937
5,Prevalence,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1630656113689488,0.4195733435328548,-0.0416476828800385
5,Prevalence,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3247988890905108,0.615232412333852,0.1031143212781737
5,Prevalence,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2048468018384678,0.4606350671818388,0.0015914586294507
5,Prevalence,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1475119811449504,0.3961445311429908,-0.0553924370632768
5,Prevalence,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3188643648992741,0.6117996606232532,0.098435651704716
5,Prevalence,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1940545549094611,0.4469130297226866,-0.0073537009549841
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1509120535242277,0.0392903085883002,-0.2949026448180802
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0786995745800941,0.3093980181631627,-0.1098981693465336
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0629919505210873,0.1394903671959775,-0.2228397989569811
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.168379193865307,0.0153100598680041,-0.3109808030527399
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0668660100025998,0.2945575597364855,-0.1195996865183252
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0779618457936682,0.1190545743191573,-0.2353315081935835
5,Prevalence,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3464663391604582,0.6243228940459795,0.0916027823329452
5,Prevalence,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5318191193027914,0.8888232766317097,0.2414556448525685
5,Prevalence,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4515167899143636,0.7463410040233196,0.1978791379739941
5,Prevalence,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0257288040095294,0.177904441561991,-0.209686777789509
5,Prevalence,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1276188790129866,0.3899958749523331,-0.0862450824612497
5,Prevalence,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0595757550542445,0.2753682107718098,-0.1265477120958135
5,Prevalence,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0387667455812855,0.1595931782774237,-0.220712122927138
5,Prevalence,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1225723880840116,0.3841979314647818,-0.0902164554671216
5,Prevalence,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.050083635430712,0.2633709254680534,-0.133407695487593
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2410912781253751,-0.0827386017880443,-0.3776274981955798
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0553196413657161,0.1659454191798842,-0.2311136086484996
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1338367250864215,0.0469910049277171,-0.2815642899576571
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2567146057642059,-0.1026408891591308,-0.3916685865547887
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0656746312623308,0.1546080016129489,-0.2382837918562301
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1476750984459094,0.0306555683222146,-0.2909891070218641
5,Prevalence,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,5.495022850008074,5.893294629768056,5.115622292008903
5,Prevalence,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.756470052460389,3.9998652223486095,3.5005308813723643
5,Prevalence,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.698545698980837,4.964479271942461,4.436452194928831
5,Prevalence,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.839345553072611,4.137181568635896,3.5604248008278505
5,Prevalence,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.590123449219783,2.7770088035637164,2.394976913121134
5,Prevalence,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.2743727704851437,3.474812897168162,3.0724364288617108
5,Prevalence,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.9097164782098206,4.210778008715606,3.622920078186645
5,Prevalence,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.635622874053957,2.8216627391892697,2.439994962070638
5,Prevalence,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.33207557896603,3.5342402009432257,3.132830205095923
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.299216866052548,2.488271810595164,2.1236918898778665
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8144876977870863,1.942391660497805,1.6811514225350557
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.137512897665043,2.262863907503059,2.0121367939773167
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.2911980704158714,2.4804603185242646,2.115093360949471
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.821871096208757,1.948834776534028,1.6912035487466373
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.137778740035498,2.264137286204881,2.01307153348392
5,Prevalence,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3700447974979892,2.759600101845698,0.7376790021075258
5,Prevalence,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.329210003413185,2.395273428608337,0.6037787121740166
5,Prevalence,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3494532083303656,2.435373433004925,0.7193134590827233
5,Prevalence,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1354163009929752,0.7987061451995354,-0.1696033886612152
5,Prevalence,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.099575862815855,0.5996047165769252,-0.2421169091063056
5,Prevalence,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1175610457072334,0.6352200416335672,-0.1818752625878941
5,Prevalence,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1180511997543414,0.7735636933540694,-0.1802627126941905
5,Prevalence,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0917751264670491,0.5914731052490251,-0.2482576909153273
5,Prevalence,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1049154297006782,0.6156087294917447,-0.1914306006619476
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0612122546481495,0.4715302971322542,-0.3011573901088795
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0626158304885374,0.3481145326186458,-0.3582408058261185
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0603975446334501,0.3611625231895017,-0.3141409137728134
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0737104603997659,0.4573882424995864,-0.3106668473281521
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0687647794100135,0.3380271996885836,-0.3631274146867549
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.069859847151652,0.3472908983189176,-0.3205123654139622
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1622716745992836,1.4104915184786764,0.9257880630813972
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8165056783351967,1.0386305916882024,0.605403027314593
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9720287126186284,1.1612014416560852,0.8123427719951192
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3829905674451537,1.653393874184582,1.1223296379419536
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9757600492354952,1.219250058952044,0.7464346109385679
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1579501695873724,1.366470292142076,0.9827230939111532
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3796213168058706,1.6527920005309291,1.1193665811711822
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.981824570247321,1.2241649142370463,0.751509616858125
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1602268121325745,1.3674530045181577,0.9853014430199452
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7110376114326412,0.8873265714925154,0.5366401933981324
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5471026545628977,0.7304032799675109,0.3729395649748883
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6575124115823178,0.8134319770522087,0.5260375551640784
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6758778390711261,0.8492699173820347,0.5067792955788379
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5315074565999415,0.7115317776851042,0.359539080859888
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6318971590172564,0.7841160700671703,0.5044593344395634
5,Prevalence,5,East Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0734953297535714,1.84760082467084,0.4889024545723187
5,Prevalence,5,East Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8397421124954828,1.5599555800258051,0.3692157264573379
5,Prevalence,5,East Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.008412974855261,1.629710091742754,0.5322959306518571
5,Prevalence,5,East Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7634455426746444,1.4210366109928354,0.2649215605306575
5,Prevalence,5,East Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.52001730220769,1.114742887028758,0.1305503428619366
5,Prevalence,5,East Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6839687834481749,1.2024684330290971,0.2841454334325808
5,Prevalence,5,East Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7268997197227133,1.3716094246475443,0.2400246070488969
5,Prevalence,5,East Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5088273013920164,1.099495816973234,0.1229345980300842
5,Prevalence,5,East Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6602142682232751,1.1737970578071408,0.2666416713385376
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1103939390040553,0.5085412309727089,-0.1927951354461179
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1139219864329312,0.2140565904711752,-0.3318172083474147
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0289645681830819,0.3372392475863955,-0.2154653869241861
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0562064068407184,0.435730148336968,-0.2342636965256841
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1384240033531797,0.180690988531944,-0.348868625591204
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.011137063255391,0.2850296322703893,-0.2434004130045707
5,Prevalence,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0926501929744157,1.8857760989678656,0.4883885410197888
5,Prevalence,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8644579300847909,1.6829067726173297,0.3538688351329331
5,Prevalence,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0581694360310074,1.775849743682175,0.525551191799376
5,Prevalence,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7797320837573678,1.455653962587529,0.2644188021288265
5,Prevalence,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5404374806020853,1.2188259566767652,0.1209291053792192
5,Prevalence,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7256827107286974,1.3310807738559085,0.2789771516476436
5,Prevalence,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7428527471796545,1.4034035017973134,0.239596596839715
5,Prevalence,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5290974795336625,1.200331751999565,0.1103481553626666
5,Prevalence,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.70134444802916,1.2946004674348313,0.2610662683618983
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1133320659222892,0.5273184311332165,-0.2047578308332443
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1111972428821634,0.2752809464571509,-0.3548165641026476
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0553624424666459,0.4293089789741755,-0.2125535136960413
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0590009315225496,0.4533208684773013,-0.2437560544461611
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1357749407502975,0.2383960361129611,-0.3721246369390359
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0142330757107771,0.3707536642600781,-0.2451801006034306
5,Prevalence,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.3249649141620776,3.9507151520153942,2.69152590716989
5,Prevalence,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.418209645783598,2.89226690396448,2.0244578544675376
5,Prevalence,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7522696086954515,3.178015774304306,2.35812319153734
5,Prevalence,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8979463824928973,2.3189751954220945,1.4700405915203367
5,Prevalence,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.203944612155633,1.5065050881136473,0.9459287663124872
5,Prevalence,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.464865239127551,1.7457315808598253,1.2037078976895224
5,Prevalence,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.846743276411351,2.2586195153349777,1.429806198316913
5,Prevalence,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1939962799255566,1.4982724855127478,0.9412645709658458
5,Prevalence,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4383337022451512,1.7149959180411576,1.1822059201826185
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6172813536294722,0.8534328891266152,0.3992927289483763
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1586019667756893,0.3236635863935936,0.0182034724309358
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3333403659510979,0.478998419470819,0.19119673535602
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5639749981944641,0.7887486318896596,0.3526245207125178
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1387810164269309,0.3019715449452957,-0.0010951850025068
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2998798727337233,0.4431600412436166,0.1591665536073353
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.952175134741155,6.627876167225432,3.6707284520584498
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.2327048699892,5.178460149133611,3.3276986252467804
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.570086856620497,5.47285729674724,3.703562201392634
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.3890725509422626,4.632981759933576,2.435669300316984
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.814259645401294,3.505674101663109,2.150268348964265
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.082968121263281,3.737727285984512,2.448304499254735
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.3659567444075527,4.5950936664184345,2.426007791258927
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.820713046662813,3.511265948795959,2.159913469291309
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.076159255001834,3.7368017511400926,2.442041227040354
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.298203717196784,3.191110744146846,1.600477657302028
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8551846528599352,2.3853389225388826,1.3579711719152805
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.0527078066816067,2.536785886185005,1.5858425476645284
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.2257183576862567,3.108563825199973,1.5526484186668328
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8180220284617865,2.348223414105036,1.3291472929028263
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9989920554343288,2.4764952093746806,1.541667068309342
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.8845629382878384,4.175797155880379,1.8724494392056448
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4915179513722303,3.587997577346264,1.6075701332063623
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5874221144615897,3.616954592262813,1.7180555600251368
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2236070825479126,1.96554236252846,0.6432028556072094
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0235253704415654,1.6583233508629864,0.5137164653958332
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0663916498836452,1.6595596983071204,0.5664063909089385
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2141011407032145,1.9500714929680592,0.6372224317108662
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0217170548913876,1.6566190061476898,0.509878821633098
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0609648505977594,1.652428631997675,0.5615159834694694
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.453364505424244,0.926816682069474,0.0780991264517318
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2301341136213685,0.6093911376255814,-0.072398384460786
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2928524748615845,0.6694011256484111,-0.0165347594881188
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4354760671707239,0.9041198485075652,0.0627917923955986
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2203149956158503,0.5982647647730062,-0.0792691885887117
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2795183229468049,0.6522586506373498,-0.0288839587251711
5,Prevalence,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.51165098018403,3.2464879618267544,1.8756667179262232
5,Prevalence,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1801739458905223,4.012189341754317,2.462359981435456
5,Prevalence,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.809512899212141,3.3872650762597054,2.2895043906323918
5,Prevalence,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1692056112663685,1.6245481409893574,0.7782166954135368
5,Prevalence,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4454418310248192,1.9321598770409123,1.024876183273413
5,Prevalence,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.291554616958682,1.63983569462692,0.9754683403982009
5,Prevalence,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1208868465051478,1.564696922587916,0.736779580715262
5,Prevalence,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4238480921484566,1.9062870901440256,1.0076280901142414
5,Prevalence,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2557326593971294,1.5978379335579076,0.9478192313548406
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5666510910567776,0.8920574750916448,0.2851380888814878
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6363739389282883,0.9610538544775232,0.3661675117061359
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5910153672806382,0.8400946175802161,0.3741042752995568
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5305177579024326,0.8486313125719231,0.2547340784941299
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6174911159502664,0.938629127981848,0.3515610838260505
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5632323157626686,0.8083704346224779,0.3488812871861668
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3592248357267818,1.8477099640221493,0.9447796798481244
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7206757060208429,2.3890795647431604,1.128035176804735
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5220796460961117,2.0167142162150222,1.0647952864555243
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2066133961461447,1.66162751839133,0.818130620250106
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5150872702091425,2.1352691789228477,0.9684443918965108
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.344802483254763,1.8012976604847657,0.9195142128116534
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.217048479712383,1.6760955339181018,0.8275794520680204
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5309952120741903,2.152799186143689,0.9796724878672384
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3579775226779798,1.8204281039216064,0.9304469158734976
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1340014879183378,0.3311210538215531,-0.0510075539716464
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1994152350608634,0.4433876224692928,-0.0130536679306536
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1586023141549916,0.3398862716520092,-0.0157334612077203
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0919507858458938,0.2854266093977977,-0.0823947958567545
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1758951330927261,0.4152831604048949,-0.0306367204339016
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.12551731526227,0.3047510910284869,-0.0448006829767505
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.368146197127476,6.109992055252223,2.599203818254657
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7002910311248423,4.604516924360944,1.3045102646620932
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.4304081595700726,5.043748845266099,1.9989753904665652
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.912549811019066,2.867839762466895,0.94940016835218
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0433154418989157,2.0936930203673523,0.2730156625389253
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4245781772450965,2.306899252600238,0.6410387993769651
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8841169155677144,2.819949681526536,0.933726138151534
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.043309901199669,2.0948281707200294,0.2725562939758545
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4121318640839997,2.290513795370471,0.6327895395647095
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0615630643474447,1.742043597889725,0.3737215921007483
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4105547002494331,1.1687035636020842,-0.1270788827264947
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6939224762951811,1.323540721035958,0.1413301975165867
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0179303522082987,1.6822119118601038,0.3443367185624613
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3982127175635071,1.149652615353132,-0.1341624374202251
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6682077092776049,1.2917620353488328,0.1243276245054212
5,Prevalence,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,10.919986021021083,13.565172264624644,8.751206425361804
5,Prevalence,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,8.361836964840935,10.132620140674469,6.823564254353415
5,Prevalence,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,9.793641558739962,11.484551645076714,8.301818980599707
5,Prevalence,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,6.761961395157031,8.521505753374287,5.353729828229421
5,Prevalence,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.995987698249955,6.131497004083848,4.006094609356749
5,Prevalence,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,5.969537468735353,7.087531502582623,4.999997960121709
5,Prevalence,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,6.832733474074883,8.570909911437944,5.407608267815968
5,Prevalence,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,5.1105615226897445,6.266368826311012,4.106516048344268
5,Prevalence,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,6.068620144788893,7.175975899958333,5.091644295544173
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,4.467283923002694,5.738932921421716,3.492277875848406
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,3.387908449573908,4.146360040636059,2.69570993536378
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,4.034781385531781,4.792989109115927,3.327772819058333
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,4.436517869100366,5.688736961800434,3.4921737237533623
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,3.440664139279256,4.2141924649925855,2.739915647939023
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,4.049878935522531,4.8182991533615045,3.348259487243069
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9740494854272166,1.1889004069333626,0.7470880428035241
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.524417801216521,1.9419615460637747,1.012627491919643
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1362713990433466,1.3627803211183398,0.8672769995604228
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8463275390567969,1.0512502394146028,0.6314565979484703
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.333652516688291,1.715636326666747,0.8620341450838889
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9860872831864292,1.1961330683734666,0.7368100924467135
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8550853417051197,1.056988484498742,0.641801506395215
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.348420046540053,1.7368534113476413,0.8723108139880887
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.997272349856667,1.2090431984758117,0.745780392142803
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1269823106073137,-0.0410958448289133,-0.2109788609693359
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0005047559842487,0.1379578729761396,-0.1518410949628296
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0958136924788274,-0.01708093565155,-0.1915930705298116
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1593335385398886,-0.0776574195980048,-0.2386226711330059
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0191098523233017,0.1165192374302904,-0.1678195625817808
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1216161469489569,-0.0433632854328287,-0.2147992136959366
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9917965361372424,1.4065851882825942,0.6691423993665624
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2212424899725272,1.7033556260653342,0.7951468337986323
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.029264872641707,1.4096742834346778,0.7115570969490934
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8629397245476819,1.2520527353311914,0.5624672228083845
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.053385759278591,1.500055578639824,0.6609877414630487
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8866085370744718,1.2396391040410988,0.5932668049570684
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8717628839216174,1.2615547073692133,0.5685531802224856
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0663815590130248,1.514882656159083,0.6699925063688106
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8972283308561229,1.252885949144844,0.6001925909171452
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0081018796951377,0.1887351299757654,-0.1332845603779862
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0770051858329903,0.2610650820282827,-0.0910050127665049
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0376277202102267,0.2113015245580078,-0.1090469520552429
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0292390427030022,0.1446230575697871,-0.166504326641562
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0559125820198309,0.2359014950370674,-0.109188128650207
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0080346648610075,0.1785929785579494,-0.1368888771039032
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6839140189071351,1.001004330275213,0.4263991022306566
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9934962679862868,1.4444639242171262,0.5735210763517324
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8139915957333508,1.1790268248929432,0.5313062080660894
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5749959725839194,0.8709282526211688,0.3361126919093438
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8428491733182704,1.2621058489777663,0.4539942763172315
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6864809761480277,1.0241283483491892,0.421018918157937
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5824346026920106,0.8804157794345624,0.3404385682848144
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8545133837139554,1.2740404064291797,0.4638180881060694
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6959620667360148,1.0372458428753828,0.4316699413304272
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0898368835508515,0.0579858870134097,-0.209413387294121
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0005428022420168,0.1774640605059655,-0.1579462075848818
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.055335096753311,0.0841601561028788,-0.1797869164037385
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1235843787407278,0.0195065201597928,-0.2372006725968762
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0190699904797489,0.1550012065489713,-0.174730998907526
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0823016180627825,0.0505963557493124,-0.2007809899376485
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9650602609570031,1.183320352488337,0.7383605664131947
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5613845280965422,0.7485668898292899,0.3975014638829424
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.716430870234817,0.8825957954178679,0.5721701520169855
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.165672386419037,1.4129975112963988,0.9161620664706778
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6982807449603001,0.9027245615914274,0.5201746889098738
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8782688805175287,1.059939288542865,0.7208875531913527
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1625863857500556,1.4027857892372275,0.9130990377969804
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7034850252831115,0.9077027208417948,0.5246870797663108
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8802363085929182,1.062258976072127,0.7222082487388395
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5033452438192061,0.6580181256495585,0.3421439705845
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3050594477224592,0.4630057667483193,0.1668629565225047
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4062643362039947,0.5458955047566825,0.2890160173611287
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4724443269899591,0.6256532801863872,0.3151305360690695
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2918984225204554,0.4472893281633884,0.1564115895995624
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.384524381187475,0.5198209878026518,0.2701757537587388
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9140926891899276,1.1283506578754028,0.6975408635788978
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.4933984687943037,0.6680075231797961,0.3358711667765151
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7935068040869345,0.969996444004797,0.6233397500262978
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1095025769153064,1.3430400118862744,0.8707601966789509
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6243351300653559,0.8147871901205143,0.4526193431850641
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9626185441557262,1.1534222964899914,0.7760847256130705
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.106495598608215,1.342290589389832,0.8681761744254411
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6293116029996431,0.8198117034375163,0.4574478530829678
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9646678880177426,1.1580005964994222,0.7782611534853325
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5023206294933553,0.6533154662503367,0.3357874949995165
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2788415474367597,0.4287397933407468,0.1445060387878906
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5150164988285484,0.6563133588494183,0.3791593799711026
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4714434427356407,0.6212948582887636,0.3081813583425986
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2659465011719203,0.4137575166471741,0.1325252668343305
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4915912736357603,0.6334960912577894,0.3580734412894935
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.598546930479064,0.7885184664110924,0.412545186190027
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.286181754418235,0.4448205441515791,0.1515767503229526
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4180071149655852,0.5583545362665852,0.3044977203903264
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.761746822002537,0.9697589433038254,0.5573009879558171
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.398946659392159,0.5692899657635984,0.252495539437385
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5517088101015509,0.7039529131501858,0.4283986869966529
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7592314584556111,0.968298765677305,0.5545329828326149
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.403236242589659,0.576312635929634,0.2563809326526398
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5533328546093076,0.7070741569382664,0.4289908325984808
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3587571601928873,0.5104991109035505,0.2119717037661942
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1576791372353459,0.3002620377356728,0.0398700364646072
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2544176353430233,0.3718869995466105,0.1579273186932113
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3308166380046407,0.4761638537044675,0.185843947290785
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1460070675394449,0.2867632150766058,0.0295314670228884
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2350207387925771,0.3511763135345574,0.1402360076696187
5,Prevalence,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.347998481675422,2.9444641933986557,1.8898237115005967
5,Prevalence,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.019591019919054,2.506130232868294,1.5617094072282698
5,Prevalence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.186551971617142,2.599684134997355,1.7772956130775732
5,Prevalence,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.300152354770157,1.7105785476435176,0.986660746950904
5,Prevalence,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0409462835457564,1.3702285594847488,0.7300016515676893
5,Prevalence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.171395200364468,1.4549625431511235,0.8930754913811003
5,Prevalence,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2710216100307372,1.675617528571284,0.960231503663308
5,Prevalence,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.033467313578127,1.3611148591496536,0.7251185051623057
5,Prevalence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1537330284332032,1.4329616094528554,0.8771240340298727
5,Prevalence,1,Global,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6401899055745748,0.9260772789690864,0.424425741995749
5,Prevalence,1,Global,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4596993377263494,0.6915072847609061,0.2412280048112414
5,Prevalence,1,Global,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5464911575626007,0.7328579159685031,0.3574365583836678
5,Prevalence,1,Global,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6071380301935881,0.8870997272431335,0.396236317910705
5,Prevalence,1,Global,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4453667749387436,0.67488566101398,0.228740310581567
5,Prevalence,1,Global,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5231079847245493,0.7067720952663079,0.3380933068195106
5,Prevalence,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.239212847692012,5.619560185265897,4.854124626574261
5,Prevalence,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.4378765284842863,3.605541803375461,3.2310454970077664
5,Prevalence,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.429710126076522,4.670833425716152,4.1645619233531255
5,Prevalence,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.648766203454486,3.933575687173995,3.357408792936934
5,Prevalence,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.3496419626003178,2.4752352454419477,2.1907483553472
5,Prevalence,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.072726121104743,3.251554202190637,2.8723490863247205
5,Prevalence,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.716344628307772,4.003856717772929,3.4252488110260897
5,Prevalence,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.3921049099928093,2.520260391233273,2.234012959280068
5,Prevalence,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.1277048356824597,3.3110085087714287,2.92613725783006
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.096762690788207,2.2756327399137914,1.914809118043304
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5294356098908086,1.6228803274935846,1.4218939499335843
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.898504737337627,2.020465763869085,1.7666465883672071
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.089232452206016,2.2689901314386285,1.90718052236693
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5360952627132427,1.626711088956741,1.4299563534590043
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.8987614118648992,2.0203478994376,1.7663457074106907
5,Prevalence,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.616435052273876,4.938859332509037,4.2650866768368765
5,Prevalence,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.3973633417475075,3.6734087605914807,3.152217082863888
5,Prevalence,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.42644899601987,4.714638226697058,4.121906646350773
5,Prevalence,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.184758361559187,3.418922664003909,2.9218524910495534
5,Prevalence,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.3190760460878725,2.529136597809683,2.1332328847718203
5,Prevalence,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.070302358211877,3.285345217941727,2.838793363849884
5,Prevalence,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.2455745517369468,3.4893014543518515,2.9799833523968013
5,Prevalence,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.3611385280380115,2.5721347138560704,2.1737602125107207
5,Prevalence,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.125225701070835,3.3443092347101167,2.893710408318443
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.884099780049296,2.033732965583627,1.7161065746347517
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5514768813038955,1.6921061785542355,1.419250585420644
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9472441272135148,2.0869274448709905,1.793901336736106
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8770818432782177,2.027815785383412,1.7154232186933085
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5581816421813162,1.6946692520941018,1.4268395474308646
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.947484620289016,2.087457275291876,1.7960419319280136
5,Prevalence,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.734315716958108,4.044092971989572,3.447442775046496
5,Prevalence,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.6342770846192254,2.8267646977316563,2.438932271094592
5,Prevalence,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.243588844527657,3.473470566592675,3.030697654362804
5,Prevalence,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.527464330434548,2.753080125539228,2.313438441205416
5,Prevalence,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.743101613526984,1.8887726960101172,1.5958447498321844
5,Prevalence,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.1830310459455267,2.3546643908811022,2.0247117135442245
5,Prevalence,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.578763066024938,2.812929831673914,2.361910124536948
5,Prevalence,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.777871142625432,1.924999656309991,1.6285587188016797
5,Prevalence,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.226006874673093,2.4007646193353143,2.0641654550184003
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.560890501271369,1.6895688831385844,1.4318379010043258
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1932286639330922,1.284606667713529,1.0909002032122224
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4207299791187906,1.5133289501982137,1.330206688409386
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5546745708943073,1.6832153408082058,1.428095603071899
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1989900993098372,1.2899158238865498,1.0979861878353407
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.4209436659639834,1.5130332018677162,1.3290209248691618
5,Prevalence,21,Oceania,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8804405269278669,2.0489962772322245,0.3450385755432338
5,Prevalence,21,Oceania,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9208594945448564,1.7175662894457953,0.3598897246910278
5,Prevalence,21,Oceania,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8929173060789637,1.8909920890131933,0.4327432532719107
5,Prevalence,21,Oceania,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0991174572845912,0.4615996091130207,-0.3544926794563512
5,Prevalence,21,Oceania,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0931897366311242,0.2845617073169404,-0.3567824070017793
5,Prevalence,21,Oceania,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0995851472497447,0.3721719165619809,-0.3191944318996941
5,Prevalence,21,Oceania,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.112916013478783,0.4383415661192392,-0.3654879457597001
5,Prevalence,21,Oceania,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0996318002631728,0.2738101223137971,-0.3625762494664969
5,Prevalence,21,Oceania,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1097871065410943,0.3595936939571117,-0.3262006147955263
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2248312289730433,0.2350848978056599,-0.4331744451118163
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2100446652248999,0.1270204527532044,-0.455231164906798
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2204818275368749,0.1662153987447846,-0.4130097592030285
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2351616726154992,0.2178804491547403,-0.4414760840936554
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2152308822483319,0.1202486629041909,-0.4583017927823831
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2283379644704034,0.1547869300517399,-0.419575728885056
5,Prevalence,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8867929347656791,2.015298425633732,0.3427600452125348
5,Prevalence,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8185422042986831,1.6609026519941714,0.2401934503115508
5,Prevalence,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8695873275845376,1.836640026671892,0.3897746113713982
5,Prevalence,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0960510208807561,0.4417046685686375,-0.3553880482951278
5,Prevalence,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1414814068436645,0.2559866701764776,-0.4146804674363435
5,Prevalence,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1106668849257199,0.349253587429256,-0.3390854119265007
5,Prevalence,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1099193118080382,0.4224448525007405,-0.3665628256828999
5,Prevalence,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1475911823431847,0.2472500655330968,-0.4186817165161789
5,Prevalence,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1207588735555105,0.3340326689049743,-0.3464081742654586
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2554436687313952,0.1862792114082832,-0.4631343918902214
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2744736993055622,0.0553301946204634,-0.5034699172125043
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.261731480311703,0.1269323482752402,-0.4509501030755608
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2653784373717648,0.1722869906870764,-0.4701326026359881
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.279240603912828,0.0483477916053675,-0.5064112428029747
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2691793093085929,0.1160777058348311,-0.4571727346839785
5,Prevalence,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.608488193757426,7.591518205827672,2.302447533394556
5,Prevalence,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.54098892270321,5.589796948346367,0.84701052695826
5,Prevalence,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.422395174899372,6.129496644204664,1.499534381061003
5,Prevalence,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.2675441553206785,4.015561900765579,0.9209900544849547
5,Prevalence,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0591550745084302,2.829054619751216,0.076352224076534
5,Prevalence,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5741646935082043,3.154073340976665,0.452839654932075
5,Prevalence,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.198236244886679,3.899306903251783,0.8832182636838262
5,Prevalence,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0462020167101944,2.807991524334731,0.0673167150892304
5,Prevalence,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.538319773267565,3.092113343498576,0.4346564005451211
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.278788355181108,2.441508435742586,0.3444715820505989
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4495705817482307,1.749779469413911,-0.2643179348414988
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.806456677813554,1.936455099161951,0.0093670627772811
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.215904602697488,2.33798530854845,0.3108775780820534
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4319870028023481,1.7158624386862846,-0.2732794447212817
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7701905606641176,1.8798994833210976,-0.0099583869904236
5,Prevalence,32,Central Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.2980633850280485,0.5579397319790851,0.0831549158106617
5,Prevalence,32,Central Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4113405078321511,0.7304963302915666,0.1867867723588119
5,Prevalence,32,Central Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.3411591414475898,0.6066847959709587,0.1330858698237801
5,Prevalence,32,Central Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0607538852281002,0.1296964950819125,-0.2162044189070668
5,Prevalence,32,Central Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0389380232793106,0.2726576943358525,-0.126369268142188
5,Prevalence,32,Central Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0209805182357971,0.1751259478858353,-0.1721415319929116
5,Prevalence,32,Central Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0733212886626847,0.1122026858036555,-0.2267429979619886
5,Prevalence,32,Central Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0342813092696951,0.2681702255748075,-0.1302797801611686
5,Prevalence,32,Central Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0297533747263736,0.1623381990944624,-0.1802816628046557
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2305692711313194,-0.0736816074397083,-0.3586877284982587
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0596805006446269,0.1303225080889857,-0.2073143378358692
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1506159528687832,0.0091840967168985,-0.2748487559558655
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2464006679960383,-0.0943909875352137,-0.3709742204450905
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0699939678726273,0.1183358048096759,-0.2155589828533499
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1641856837205828,-0.0072145164216908,-0.2859601662671257
5,Prevalence,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2887449370696993,0.5608952274056191,0.0653101520142042
5,Prevalence,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3866154416626612,0.6825451980846327,0.1351088505038038
5,Prevalence,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3148358167580415,0.5738419962692243,0.1027771681985107
5,Prevalence,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0674872943858761,0.1311141217932633,-0.229139539433582
5,Prevalence,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0207382276228952,0.2387634775187365,-0.165258160536415
5,Prevalence,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0401912468218931,0.1498622924679891,-0.1962848237423929
5,Prevalence,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0799736659235366,0.114312594090734,-0.2394822546960985
5,Prevalence,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0161618875797138,0.2330299036434752,-0.1681512281780858
5,Prevalence,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.048796690434941,0.138578441888654,-0.2022081550154177
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2984397583615064,-0.1481815413352347,-0.420899884875793
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1826278608053736,-0.0111465690775121,-0.3316360771032882
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2513934646201626,-0.1098469616835112,-0.3714126650989751
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3128837465434571,-0.1669902383898971,-0.4318614156704213
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1915982700006258,-0.020175117653459,-0.3386506932645153
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2633601323451653,-0.1252244592923141,-0.3821258052086084
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4720257093672573,3.1636666738575725,1.845111680436008
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.0873038387525757,3.861727670458502,2.419603780276631
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7497043641310004,3.327320071382534,2.2394828433701983
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1349436862505504,1.5614636524725305,0.7515536880042363
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3833271335264776,1.8341989681305184,0.9940112754094752
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2466801684499165,1.5931406599530835,0.939467640454978
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0871049971481634,1.5028643935505577,0.7102542730781682
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3615556860618514,1.809001013186124,0.9757730450143172
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2110761093945412,1.5516769052684567,0.9102154266578648
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5560036951130466,0.8729743653945201,0.280365906758358
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6025408362036792,0.9002200048572893,0.332350706969055
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5707309311211138,0.8148447945811534,0.3550759345781978
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5200691837712955,0.8286877719076969,0.2491716521450486
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5836445047463,0.8789101883107728,0.3178249436943704
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5430866224614216,0.7816134434542656,0.3299557262830441
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9139293777914734,1.1663683389100448,0.6921492513088188
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3194733866700312,1.6976499944767776,0.8917549301737147
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0161394345834942,1.263031381620647,0.7841360035864304
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7901174917129591,1.0278175133253558,0.5857462740106987
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1441961764952742,1.4945446237465645,0.7453585936231805
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8744117287426786,1.105274227467623,0.6575924027231987
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7985883130135265,1.0358142893142106,0.5901735469417237
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1577639787071317,1.509574810685057,0.7598652643869108
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8849569150963288,1.115784542822095,0.6680490643383111
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0337423059201264,0.0927917849666716,-0.1365243785627062
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0220577530223833,0.1670813878930246,-0.1060551507666238
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0153568515327169,0.1025685926668815,-0.1186003191015125
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.069562502761095,0.0510269183832519,-0.168179333184566
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0020207658265575,0.1446250877539986,-0.1230678744203535
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.043463438399175,0.0712304604815916,-0.1446109458448885
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8301913823090302,1.341884903067565,0.44344163317791
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9003272220984229,1.369402222903327,0.5408625636876587
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8417511518927511,1.320092647848623,0.4628287526151029
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7118268940242422,1.1907313743084282,0.3505475058320301
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7567300903468492,1.1927259165253672,0.4248840475232739
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7123011021204226,1.15951285926286,0.3616859832342016
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7198967051739069,1.2007535209792146,0.3564540479266348
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7678399119238902,1.2042118685351038,0.4334364667304266
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7219154142302934,1.1691330496344703,0.3676480532772314
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1082303875507376,0.41093573890153,-0.1198075641725975
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0600073326044607,0.2974816045558077,-0.109609207683477
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1153982843149062,0.3961704574993976,-0.1007968663300631
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0671169631705559,0.3551272900770276,-0.1528346228536938
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0392195998072099,0.2703777028657727,-0.1277669029567099
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0835382880652796,0.3559310581887919,-0.1273913457766997
5,Prevalence,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7143160861652219,-0.179680850292088,-0.8223501736816279
5,Prevalence,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7560616639154488,-0.3805004420019414,-0.8570993661209599
5,Prevalence,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7339927584475389,-0.3141724501893143,-0.8292789001101093
5,Prevalence,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7570241678801579,-0.3024250653601247,-0.8489848488279013
5,Prevalence,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7984505839401024,-0.4897254319001442,-0.8818199821715421
5,Prevalence,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7769571895302618,-0.4246948627767282,-0.8571589212193698
5,Prevalence,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7620696494217817,-0.3168014948545235,-0.8520452730827006
5,Prevalence,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.799938905110313,-0.4919299612923047,-0.8828029339990173
5,Prevalence,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7801104536740329,-0.4330744234420393,-0.8588768298788783
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5268045916943886,0.3879919189895618,-0.7045686458618108
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5983505696890793,0.0262531677404843,-0.7682473262278293
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5603177985677473,0.1454677579113648,-0.7170608847078226
5,Prevalence,5,East Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5499175129737937,0.3246386233603806,-0.7184283999008239
5,Prevalence,5,East Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.60946991054995,0.0007557007562459,-0.774513641070322
5,Prevalence,5,East Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.577469837730449,0.0989382953818568,-0.728576804277568
5,Prevalence,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9382567942301512,3.648821922685251,1.2037343867364108
5,Prevalence,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.581163588883835,2.6289235690813357,0.7662847107853012
5,Prevalence,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7293951632119382,2.797681608394618,1.0394512058059848
5,Prevalence,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3733550592049886,1.173102696908023,0.0297433404777664
5,Prevalence,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1838728905329832,0.6631318600236763,-0.1901428327321048
5,Prevalence,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2636153987900818,0.7586954758607929,-0.0562127730305907
5,Prevalence,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.346246350109709,1.1299906658991643,0.0097039103528977
5,Prevalence,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1721245666016301,0.6479197536949819,-0.1979176716886956
5,Prevalence,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2449460379511586,0.7322184546583141,-0.0697548187654212
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3194812027471619,1.094034334516428,-0.0172032874580077
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0976073446860083,0.5791075953966807,-0.263994995458376
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.191325959067628,0.6812819017001638,-0.129451202800201
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2992819423388768,1.0637146614634625,-0.0316611962650684
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0886023708626872,0.5669108461585568,-0.2694729065056795
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1773209999417658,0.6617622847106406,-0.1394833120513261
5,Prevalence,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1598269028270652,0.395432376147362,-0.0445426700779107
5,Prevalence,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1278065021721821,0.2821257244054261,-0.0127544241409748
5,Prevalence,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1471702137667836,0.3306193923557419,-0.0166126863349462
5,Prevalence,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.0066267321125674,0.2114490605520619,-0.1715403130283959
5,Prevalence,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0019128241196057,0.1345509676109267,-0.1264956120227882
5,Prevalence,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.0057619072331821,0.1662553277778055,-0.1374356775376321
5,Prevalence,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.0101716978613299,0.2153764404218439,-0.1678275862985727
5,Prevalence,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0001702556820918,0.1366377412674117,-0.1247811661051963
5,Prevalence,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.0082251443407337,0.1694549883014861,-0.1357203975796748
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2867823089055719,0.5468439244437384,0.0578537185514314
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2410785862886736,0.4095256711782006,0.0892242704570044
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2675750867526186,0.4734497725556792,0.0862414775933964
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2680570099722786,0.5259313035112242,0.0441143866065944
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2320743217188073,0.399729299780191,0.0816530413122304
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2537003031650663,0.4570642292341775,0.0744136034983915
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.9618182851877504,5.217500691675729,2.9342948062701493
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.4162279467952783,4.007053712754699,2.813990436213261
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.6783658345309047,4.361062105788863,3.040844006963612
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.658831417752433,3.5818550910942166,1.8945622360512449
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2190239994118883,2.6466536951683723,1.7833364584058295
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.429305622373234,2.9425561525748423,1.95926436991278
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.639523958275175,3.5605746577819364,1.8858292229450264
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.2245540600099765,2.65595154341331,1.784824174407773
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.423602662863612,2.9231960796405474,1.95706765818672
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.7232617782107449,2.3763212343145748,1.1714117374276736
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3800793423539115,1.694949705395555,1.0615861454244546
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.536237999147017,1.9017182860425208,1.1808774366172714
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6634689552572606,2.3021508390610115,1.1338249435690608
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3492452346092267,1.665168151151347,1.0323922580621605
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4916986887402537,1.8517304898115712,1.144576686590001
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.091526588519462,4.147074986603388,2.193274144357692
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.758912665881152,3.35465310800082,2.2240219663745293
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.0244576761101127,3.827348020950399,2.280196517301222
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.017199421957072,2.787635457970993,1.3515389349229934
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7398959491174677,2.185948804947661,1.3393051118609869
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9500050031489944,2.5416045879347573,1.4077486239214756
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.001159693673259,2.775410878045298,1.3422860503426737
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7446085763724355,2.1795945609032312,1.354052654546154
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.945076230425664,2.53262701627785,1.4004299639116229
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2890224440993328,1.8664341121101224,0.7929200802077616
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0868013885623136,1.4136528554898975,0.7938239152514888
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.245657783092966,1.6921063833630947,0.8389343053905285
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2386889233227278,1.8104876323137669,0.7561819697921233
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.059766806629849,1.3748306492938838,0.7706107965943052
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2062160219847828,1.646141053506794,0.8077221527885544
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.3214619710421305,4.59672268123221,2.303938790351201
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.992050116240467,3.659369888066914,2.38658085946951
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.1421391423684604,3.822511147584924,2.5025306111503536
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.1865405291242466,3.1218376799673107,1.441681059399469
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.9097954573378384,2.3907472391296523,1.4720770813111974
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.036193767322623,2.5339587923559908,1.5694846076741924
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.169818698386236,3.10523020300328,1.4234592427648498
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.9148362732108817,2.402086638339658,1.472746695033926
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.0311948871322416,2.5290874186662755,1.5631328440773795
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4979836340569497,2.2371162323524216,0.9294299302611218
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2859683022702653,1.6820412282610075,0.9453653202739118
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3766826350351518,1.783863943615354,1.0266291545404005
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.4432259063926869,2.1583861984764448,0.8930332330446613
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.256354389881159,1.647446604958274,0.922640046884824
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3349725182681214,1.7297365951574823,0.9909614238973884
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.254860920156996,3.35387544381147,1.4035368795851304
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0957182199413555,3.0672424591316494,1.322536924469932
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1380028272522287,3.061391339912219,1.3921341589828988
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8631038648771123,1.5010283786367542,0.3755042599846718
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7941107367641325,1.3577883544906737,0.343235388866192
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8074783687417586,1.335950031053823,0.378411970181719
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8551871576384564,1.4815972194986706,0.3699543118117844
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7925344820105197,1.3550826776568994,0.344834131232357
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8027746168961407,1.3332589611739811,0.3742749702366453
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1512597061778712,0.5404119345237934,-0.1537631790284833
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0392670541471433,0.368537234185983,-0.2299281240991516
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0764870632080327,0.3815978122571825,-0.1787693393008462
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1371226565205006,0.5158528883654573,-0.1655377409395957
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0309939163175261,0.3584711100998644,-0.2364976113182017
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0654156062229509,0.3674228048606801,-0.187823683576678
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.482731064996686,3.77337324251426,1.544544140976328
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1943659847659247,3.3105705138899064,1.359492504155622
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3511042133572344,3.485952190733405,1.5407591345006324
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9935559662232172,1.7249081261790802,0.4547674680511352
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8512763904526828,1.4968084275902318,0.3691086988986932
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9302268706625376,1.5823480425315448,0.4617917951156411
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9850672897503456,1.72070019437278,0.4503248305171123
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8496551588480422,1.4959785530583052,0.3662327683765806
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9252008194346164,1.5771680866028035,0.4596596394196232
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2689104439252958,0.737318676641503,-0.0782121106979834
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1027404045863991,0.4933197176425765,-0.1956627707046258
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.18810982623115,0.5801872289250769,-0.1076607404050828
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2533110399538758,0.720420007393189,-0.0908975741504505
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0939581552795577,0.4814370010336056,-0.2028754202723852
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1758816841442849,0.5647738977031443,-0.1161965392780472
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3774519022131515,2.3347965277274367,0.7012406797755762
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.365470603481283,2.109465626924097,0.7333632270773958
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3684219707241416,2.1321670954856,0.7520174502348919
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3608896355635337,0.9102203579766864,-0.0280852071471912
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3708917846128946,0.8017431955173216,0.0051216863917647
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.364217858652679,0.8028761387239687,0.0099075674091404
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3550865444279018,0.900748401648712,-0.0303364909922056
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3696943073206288,0.8004947352713152,0.0036809339979658
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3606523785892751,0.7994220038874686,0.0065295544708837
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0067982794388287,0.3689623293746488,-0.2744229084462828
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.082396708099952,0.2129777235907991,-0.3266842683575668
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.054854231419137,0.2313104272898755,-0.2935773461959989
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0055771715059046,0.3529126887839313,-0.282012715481669
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0897030156451081,0.2045803309991766,-0.3317310098864134
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0645875734250131,0.2188529405454142,-0.3010616887452298
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.275745373123837,10.129552634668585,1.0932754199300612
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6581023561302866,2.955163376887148,0.6864150291860616
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3124558755895377,4.513410466244008,1.0275004649437285
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8392129821341063,6.393204397309273,0.3907062170861202
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7642000094846773,1.622978300419782,0.1203078568247099
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1990002592715736,2.6657616312738632,0.3465585524589297
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.772813329602659,6.217495244665885,0.3574854160857373
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7458440841949433,1.597754961406183,0.1076389497988223
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.162198162094689,2.598866347122209,0.3234463925250734
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.232496200694349,4.7761474555596735,0.0816495645009972
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3246097906671126,0.9806643133611432,-0.1660026341487177
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6732991685583807,1.8026738496262256,0.0125922055993299
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1771849845620224,4.639486550847127,0.0552253554960571
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3074807018569103,0.9539353864652728,-0.1758277967928279
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6416221860784608,1.748505723389703,-0.0069645198354343
5,Prevalence,100,High-income North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,4.258715645036543,4.4739434271948415,4.053605188704331
5,Prevalence,100,High-income North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.952102897728802,3.076116817432013,2.796465376646114
5,Prevalence,100,High-income North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.820869430804385,3.971387740346269,3.6523580287766406
5,Prevalence,100,High-income North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.9182025208265703,3.080045186387345,2.7572767429770924
5,Prevalence,100,High-income North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.982990304708898,2.079220569010935,1.8689157239974
5,Prevalence,100,High-income North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.616047013722938,2.727214409365404,2.4866797601694683
5,Prevalence,100,High-income North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.975167363210051,3.137862308714343,2.820120304783443
5,Prevalence,100,High-income North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.020802304466403,2.115592734806832,1.9018402747535097
5,Prevalence,100,High-income North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.664859743830186,2.779284849356722,2.5367561595012487
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.7638349619808955,1.874081551553764,1.6564162811327343
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.325557217538428,1.4018663902668442,1.244618084690971
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.6697813470581693,1.7576643155962717,1.5824567749678795
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.75712137466763,1.867907593339659,1.6513747996705486
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3316739472037364,1.4085773594537423,1.250782536109263
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.6700150710699373,1.7592138788819676,1.5844167459433265
5,Prevalence,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.324655013219758,3.612882006713232,3.013390387509077
5,Prevalence,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.5320300405455574,2.7040957812781343,2.332746366074052
5,Prevalence,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.11648374537776,3.351652236671179,2.8453058936102105
5,Prevalence,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.222223680498356,2.434155115258633,1.9954232150592768
5,Prevalence,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6659245799254188,1.796211000950804,1.5167485795459663
5,Prevalence,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.087689695175145,2.265133491670304,1.8853184982128648
5,Prevalence,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.2690924222000777,2.486968918110789,2.033801323580823
5,Prevalence,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.6997182922681933,1.8312372834420807,1.5473951876668406
5,Prevalence,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.129380660709793,2.3081574455053806,1.923229300125151
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4406415837371631,1.5680994887037496,1.2983633904742518
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.202278631016738,1.301047246941458,1.1096752848482496
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4177237493793118,1.5227469178076776,1.3005960557693144
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4347141663790537,1.5643578752963814,1.296540596647298
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2080660799355252,1.30534150598129,1.1156301815107117
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4179323584144574,1.522697382407722,1.30277226510539
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4780359966984875,0.630397340728102,0.3210683149460495
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.2505256688722915,0.3874350782209434,0.1279149503392681
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.3856926710796028,0.4960557051835727,0.2764761641394681
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6289194182205825,0.7956540681534027,0.4558244265699777
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3601673444067311,0.5093203539282617,0.2262975282351916
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5163458092762497,0.6364266015269219,0.3951682763061881
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6266068718686483,0.7942834438596553,0.4538609371484318
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3643351220170244,0.513704559493201,0.2305656890543258
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5179345220926591,0.6388299146466138,0.3982950740917982
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2278189207928129,0.3445098737948779,0.1036683423724657
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0602624022845146,0.1656638482918952,-0.0401471181687548
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1731377819387658,0.2699769968860431,0.0803415397874148
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2025835934444415,0.3183307534422813,0.080905234850255
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0495655997487142,0.1542087269504768,-0.0499066228299175
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1549983594139866,0.2503729671629467,0.063487513334054
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4336615688181927,0.5963161201694122,0.2761795435718555
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.1152559520201447,0.2518137664460229,-0.0050193683104224
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.336333242250545,0.4703917017787927,0.217067016091754
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5800102708654609,0.7589185075786986,0.407053152013604
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2130386239783974,0.3623913354289348,0.0818975593827892
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.462331829636964,0.6089266432359668,0.3325797670081482
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5777719656237665,0.7567764090605936,0.4044599860551549
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2167546042871416,0.3657404484362839,0.0855331124589727
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4638645377634284,0.6107166991001477,0.3332162881302042
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.240428036532077,0.3784054193631433,0.1052880679866431
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0232003432925072,0.1538551537656183,-0.0908923971090813
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2076825037977582,0.3239422126492002,0.1026975740807956
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2149240343524348,0.3505667316897879,0.0839055285989536
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0128726227034606,0.1417733448778059,-0.1006481454166248
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1889997061091622,0.3038074900429609,0.0847098374850669
5,Prevalence,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3781790693363732,-0.0325956761869868,-0.5847780634021152
5,Prevalence,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3779471742970209,0.0167254401911288,-0.5903310585684698
5,Prevalence,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3780566964029883,-0.0573939123596462,-0.5745579507120211
5,Prevalence,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5352537297704558,-0.2779396712009312,-0.6891388513263084
5,Prevalence,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.53553581126831,-0.2411987978529059,-0.6941214428455915
5,Prevalence,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5353940083457615,-0.295064166008525,-0.6822623606101128
5,Prevalence,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5383838985697763,-0.281835990968153,-0.6917550983752456
5,Prevalence,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5366304223856078,-0.2426372515248048,-0.6948360066713962
5,Prevalence,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5374938234755655,-0.299033955278861,-0.683621361608228
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3277240403976217,0.050834205270765,-0.5512406732545987
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3227466746391417,0.1156664338600896,-0.5561731509464721
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3251793374082516,0.0270360931893944,-0.5390476406885132
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3366562240029215,0.0391555376518643,-0.5563428066057712
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3286701952530672,0.1065372984831912,-0.560115189607657
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3326502831001783,0.0161342983740057,-0.5441569530874438
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.197221183755945,3.2079190330713425,1.4050366490076724
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7785803005546248,2.629100505031037,1.168595519077564
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9927443919261487,2.6389753345962426,1.4253424539265531
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5761271227122993,2.389684499409175,0.9389077298632746
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1835978780250496,1.8546468461502983,0.7026964502076882
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3813975022817022,1.8915600446804453,0.9338439162420544
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5327128077577048,2.3333478719627894,0.9051753926241296
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1726271081349906,1.837665743834353,0.6956678957190939
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3554735988961195,1.8640970310728524,0.9088934337052106
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5309251554147695,1.0190901863177593,0.1776757878872392
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2750832827267489,0.6700015838431335,0.0010321351500799
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.402423043461115,0.7127101294377319,0.1459452874257099
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4744127487085721,0.9445288784918195,0.1320730515765865
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2499963802399049,0.6370598939564851,-0.0190517042142894
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3621822790832369,0.6625966830610346,0.1102564955373406
5,Prevalence,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6427220288718396,-0.349692609857555,-0.766750451283338
5,Prevalence,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.611054370127315,-0.2906879904896671,-0.7470962306149491
5,Prevalence,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6288339754304064,-0.3340316330378806,-0.7560563932914455
5,Prevalence,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.741484945387701,-0.5304661044805625,-0.8311562974357802
5,Prevalence,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7136809636284388,-0.4777847786404124,-0.8140550868339737
5,Prevalence,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7290572745824372,-0.5141608333535572,-0.8218766483995024
5,Prevalence,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.744941661791731,-0.5357499323830694,-0.8334847175277992
5,Prevalence,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7149665916431781,-0.4801905353060877,-0.8146629815645312
5,Prevalence,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7314840784918522,-0.5182126113038654,-0.8235217180038876
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6613715878738335,-0.3821510301201191,-0.7785010751354797
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6204970853470829,-0.3058412638045198,-0.7531968439223526
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6431759049509558,-0.3573871161989075,-0.7644366495742005
5,Prevalence,32,Central Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6683350825571069,-0.3933338837861798,-0.7831811656487702
5,Prevalence,32,Central Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6246612388413625,-0.3137174413245772,-0.7557958922986392
5,Prevalence,32,Central Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6488739348057041,-0.3671183648638696,-0.7683625939425514
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9421942591238064,2.763595963684733,1.2917585058425054
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8788768307665031,2.6615738150219426,1.276019824316704
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.913355454931224,2.4364146664859527,1.39659569972066
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4119338406584976,2.092646292204962,0.8797400004074132
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.309359494104556,1.938765394939916,0.8261156594653231
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3627729834950877,1.79048329784312,0.9474288953592184
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3666149734637938,2.0273264704067206,0.8434234852681284
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.294002701213543,1.9176865549043656,0.8136224409461614
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3326340199489992,1.7514314273354077,0.91888039331742
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3878677485450235,0.765066699122152,0.0996491735914668
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2419781720318148,0.5681277576467041,-0.0184636203119208
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3126866301332001,0.5515715394799706,0.0937006143174783
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3288702799250142,0.6864797026713266,0.0536181816388354
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2124279070993567,0.527379409973424,-0.041001305125174
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2684186403961779,0.5048529652606315,0.0563293368063565
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9263796698346528,1.7188408876961292,0.3633737443471286
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1853489383134903,1.99792396097324,0.5234174443028238
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0706406871297576,1.8285720625372115,0.5089671346553413
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.2205705273074929,0.1005112419303619,-0.4478289876021414
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1090057354526941,0.2220542540380995,-0.3791940550889796
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1589757460882519,0.1480308987125347,-0.3878943867626115
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.232331855596774,0.0834663445988584,-0.4566914254546338
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1165005615096093,0.2120097114563379,-0.3841082158409358
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.168849967760881,0.135381805052468,-0.3943043375840125
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1941249752892513,0.1310459405103424,-0.4315918510401741
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1315241346500084,0.2037067460410123,-0.3789400450396794
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1522829504093269,0.1662290472843124,-0.3881207415250759
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2026935807929831,0.1210561442655584,-0.4381150402921577
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1367117518205825,0.1967201545760614,-0.3828186814055881
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1593354832845101,0.156012195201903,-0.3921040833410276
5,Prevalence,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0415038115567177,2.18098772658378,0.6152774224080777
5,Prevalence,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3773344775326766,2.095022186594627,0.8013356376944005
5,Prevalence,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.229137873210112,1.9565514475207049,0.8043814976370112
5,Prevalence,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0582403626732721,0.4677151505087007,-0.2549745983870984
5,Prevalence,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0739218818455801,0.3968406597237964,-0.186157425038929
5,Prevalence,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0176065299142118,0.3498340664757153,-0.1774667647971454
5,Prevalence,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0786439378362272,0.4356193257957582,-0.2710052086177013
5,Prevalence,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0601962893446897,0.3802563621895735,-0.1966762031188778
5,Prevalence,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,7.65374288818e-05,0.326422097933714,-0.1904854239639611
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0624946559244359,0.4764192064903562,-0.2570200903186993
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0220304821600142,0.3600308814342,-0.2341271139831285
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0075232454221876,0.3290541262437846,-0.2045844881994845
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.077477739850234,0.4525191268369706,-0.2686369094426876
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0123094825240898,0.3471691219227755,-0.2413915401391027
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0201821678390943,0.3119095613183054,-0.2143832539021293
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1918023260172275,3.5736695179975992,2.8461049120590047
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.105550954415726,2.3145771787683955,1.9055978176411457
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5178756550351604,2.7478861351218806,2.3044741487542613
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.862115559091682,2.1331938952998373,1.6275317340077566
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0570084983980048,1.1950325495638536,0.9267832504927642
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3648849333803268,1.5203540472080896,1.2192344399116406
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8441906892295885,2.1032923899972262,1.609630638540143
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0583941244470911,1.1969390584630972,0.9258629349921702
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3586762091049975,1.5128943510819162,1.2155941035361173
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6577316536731397,0.8023742470943465,0.5287013659875848
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1432877003051234,0.2110190870824779,0.0788423110704753
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.337002451932792,0.4127859727586803,0.266258912065741
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.627048641441226,0.7634566169241814,0.4984610220866865
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1341484158685356,0.2006208702444688,0.0713415318070932
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3191299325568958,0.3926812625466859,0.2512332708449741
5,Prevalence,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4361182897961067,0.3428231366421363,-0.599172691496845
5,Prevalence,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.53367474049431,0.0744632081114343,-0.6495820278636526
5,Prevalence,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4807931615597464,0.2053930640277017,-0.6175370346434703
5,Prevalence,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6221745902587764,-0.102021531057588,-0.7313416934598265
5,Prevalence,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6993357571529903,-0.3068531078818655,-0.7738612942647315
5,Prevalence,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6589381096357286,-0.2087789797572573,-0.7485970608422602
5,Prevalence,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6288463608206479,-0.1161378620371517,-0.736170704703975
5,Prevalence,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.700686619425807,-0.3103500002051631,-0.7750823363819866
5,Prevalence,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6626043262799627,-0.2167006001753856,-0.7514644640330972
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3330841790133184,0.615024115928255,-0.5299600804127365
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4531356950939997,0.2841606461116321,-0.5897310854006312
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3886022233926351,0.4420876757540151,-0.5518044427286953
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3550605589580303,0.5641449945355701,-0.5462476389252222
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4624816484736646,0.261250779677215,-0.596870629890218
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4039384689733117,0.4082233797183534,-0.5629384182064097
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.1265962637940587,4.123660966303214,2.25779555645253
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.931057607862315,3.4323439814569405,2.399272057030924
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.054392516721406,3.713530548284168,2.4228287816187857
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.043012931148108,2.7800916054011786,1.39999946457984
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.8653824898265088,2.237980765651169,1.4730287825076378
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.971940719322932,2.4542813405979347,1.506849081618569
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.02688351426376,2.7582365514287,1.3896128994217554
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.870301968620996,2.236321347755446,1.4820133028983915
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9669823839104452,2.449336009058106,1.5048074788814068
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.380221816325138,1.959089796684346,0.8703244464994686
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.218293097546877,1.495863430441146,0.9194865407480024
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.313456588417347,1.6960926668904517,0.953218601597283
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3279110879446565,1.879760830429415,0.8340615033321439
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1895382041995903,1.46235125374219,0.9022992591197916
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.27281485923566,1.6508022005762355,0.9191603657031072
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.695831022163304,3.606465204321896,1.8501048036798216
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.48180603116357,2.941918904716971,2.037830839695264
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.6382349182773077,3.326383787980024,1.9781232326498173
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.7253771120015975,2.39949704550178,1.1046254093797852
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.5378774645729425,1.879383886207837,1.210007534222831
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6668897418357227,2.17268396241533,1.1792722695930142
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.710914583682904,2.3788703073103568,1.0905692470749893
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.542276329305647,1.878232455745208,1.218103296699457
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.6624405176698769,2.166024116321273,1.179374377775272
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1508896360812029,1.665024541551692,0.6703483783266465
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0118141287754747,1.2745906754177136,0.7519837024840259
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.107456591850866,1.502002232624665,0.722950647786341
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.103617035685473,1.6168624308635915,0.6298111700521953
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9857802375960382,1.238161064545297,0.7371784490898134
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0704411148514497,1.4503436918535062,0.6964350434441169
5,Prevalence,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.941462779332889,3.320466794560965,2.585386443603731
5,Prevalence,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.519096111414381,2.9033588603094245,2.1420000420332697
5,Prevalence,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7436384611225555,3.0691743260227997,2.437861191791397
5,Prevalence,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.1045336682220053,2.4015072170153777,1.8239423024401185
5,Prevalence,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.842953763228499,2.15365616141782,1.5391743717390325
5,Prevalence,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.987154364646026,2.2441724482525025,1.7428508925324775
5,Prevalence,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.130377969708629,2.4313895195124493,1.8475759798621567
5,Prevalence,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.863094337737612,2.175725895880162,1.5562935039876489
5,Prevalence,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.009609149140548,2.2713159692706517,1.7637867822279223
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0567762074189917,1.2194493378803886,0.8926896647173324
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9921041203769528,1.1723162124650943,0.8099294707611207
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0333476513223507,1.1716533321652762,0.8920413833841168
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.02616746698872,1.1856998591181205,0.8683427304367866
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.980007587282412,1.159956231934416,0.7996540852095813
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.011720149988943,1.150042906357175,0.8695022846647713
5,Prevalence,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.4124746709615329,2.309653965427966,-0.3375930919462084
5,Prevalence,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3983193853396868,1.6440803453976187,-0.1793740971467409
5,Prevalence,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.4093336876965311,1.934323470683888,-0.2825713689739905
5,Prevalence,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3233553224639365,0.5916586371995283,-0.6812013081692473
5,Prevalence,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3398880500156147,0.2469285391995799,-0.6122865348899615
5,Prevalence,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3296409307873933,0.3953178435146982,-0.6581174869134632
5,Prevalence,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3336754637894121,0.5613049131918757,-0.6875144136275615
5,Prevalence,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3445630400292657,0.2393649131058767,-0.6153464275196919
5,Prevalence,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3372098105160951,0.3799718449364296,-0.6626032128160575
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2584463181582492,0.7427110268347675,-0.6507922334117611
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2640014475109035,0.4027081118689668,-0.5694127527334659
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2590861140015049,0.5337819597528787,-0.6217403413022597
5,Prevalence,21,Oceania,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2682920340842922,0.7136434425963767,-0.6572903281628748
5,Prevalence,21,Oceania,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2688232429676641,0.3949693105113894,-0.5724639767779176
5,Prevalence,21,Oceania,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.266531927612347,0.5187050226175556,-0.6261576738362715
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.826478740859599,3.1736336663447924,2.479985628813342
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3650487203943515,2.7128122924226186,2.006965897675106
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.6098322819228508,2.912769074004098,2.322770571849988
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.128477149039567,2.411383458475197,1.8446785365717884
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.815486020295108,2.106181018383702,1.517566376469666
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9865043577049184,2.235701251945021,1.7499809799999229
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.1494073695868345,2.435135412196013,1.8642240366867784
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8325502548326933,2.125282359601377,1.5311318579466788
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.005045247765843,2.257228367734021,1.766077517328651
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.104771719488145,1.2589579175414047,0.944276570893274
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9849092479408508,1.1459304069831089,0.822050506541286
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0560042240805076,1.1843894970824098,0.924436765600442
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0717524294784508,1.2249402102805882,0.913703278924957
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9719643969700424,1.1321573415408408,0.8108875198970094
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0328522022957471,1.1604816802581333,0.9023658656477171
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.307316399643486,3.005484765232404,1.707810496325305
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.256972520141943,3.1085559346937868,1.4401407735877256
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.28187808093273,2.90361717361211,1.6351452226993193
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.991228865722314,1.4110737267702405,0.6331397673908744
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8931969460447846,1.3883775354248549,0.4188865079053988
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9417489026727834,1.3087963107182503,0.5591577386972126
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9480443690743754,1.3592729268857655,0.5949290459345267
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8763102178251507,1.3668991473210732,0.4057413865484172
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9120201610620192,1.2742449758807084,0.5352339937306256
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4801594026202823,0.7939721164667448,0.2195819965591498
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3522742214993545,0.7262353797914485,-0.0021110082945559
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4107537707129421,0.6991485850156747,0.1210769763024539
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4463392841753395,0.7528909083067772,0.1904670179588082
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3365380321854815,0.7045971469490555,-0.0134335729288458
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3862756806176576,0.6690743288260796,0.1028046931344296
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.321189080873458,3.110944380517953,0.744450708299148
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3693999247962696,2.2930089234918887,0.6616429031646116
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.349355446612395,2.3479629865951264,0.79078190037735
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.037725945746261,0.8377338149072829,-0.2193493619784
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0379618029938456,0.4422160296208487,-0.2721317717369134
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0395432036191139,0.4823662673829654,-0.2070538578762944
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0157942154249823,0.7990234212598495,-0.2365969006206563
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0258480764870869,0.425730977141574,-0.2805802185688857
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0225665286500055,0.4572145284306604,-0.220554882796224
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.074452956016421,0.8946003245397303,-0.1968277804878112
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0217567916269973,0.444725679060036,-0.2979979188682313
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.050386970515688,0.5086575730179446,-0.2089674857530025
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0579996852847101,0.8668288496180958,-0.2097671749521261
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0128032856409454,0.4320329132278788,-0.3038029311150025
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0377622755235513,0.4897919187013165,-0.2178325839132949
5,Prevalence,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,5.495428250895032,5.894094584521881,5.116136973329228
5,Prevalence,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.756082208080493,3.999454483965076,3.5002053266884987
5,Prevalence,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.698529725462163,4.96440119721343,4.43653088817328
5,Prevalence,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.8395508075124,4.137666346992312,3.560794467009329
5,Prevalence,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.5898213410502176,2.776783385079651,2.394675603320417
5,Prevalence,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.2743141433452587,3.474628610089428,3.072292288624471
5,Prevalence,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.909911051431748,4.211263966389823,3.623203791571648
5,Prevalence,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.6353072596731377,2.8213286450527364,2.4397279900536035
5,Prevalence,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.332003821642861,3.53411845246527,3.1328331549829844
5,Prevalence,44638,North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.299425694757204,2.4886012828612847,2.1238032218166847
5,Prevalence,44638,North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8142503798186609,1.942052702751798,1.681056258623976
5,Prevalence,44638,North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.137515484405539,2.2627400916534985,2.012036840320488
5,Prevalence,44638,North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.291395508079867,2.480621877813817,2.115237037980922
5,Prevalence,44638,North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.821627930679287,1.9484879866639009,1.6910553775898354
5,Prevalence,44638,North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.1377729209387506,2.2641207177710774,2.0129818720041
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3339141013367946,2.706407521727892,1.9900617737293065
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5113680157618998,1.7109400172855316,1.29790856144469
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.901501299169558,2.132144569132038,1.6708618107308864
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.068372050134583,2.411867066280232,1.7520746234607372
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3293358314532546,1.5128483680674192,1.131460682321726
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6812306063057023,1.8945966391131976,1.4675438143510782
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.0624892691872816,2.404656784041138,1.7466310822409723
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3321935082787923,1.5175269693511702,1.133963400021124
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6802861406315963,1.893344794124982,1.4672309803525114
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1532041337269208,1.3462485535303197,0.97117667056025
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7851220291869777,0.9000470353208284,0.6606512145849399
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9778562547755784,1.1053932382673666,0.8503265586309022
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.108225153245137,1.296846046382604,0.9290860725045867
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7669259822748844,0.8805112120092153,0.6427866050346103
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.94682292258397,1.074733328394859,0.8232369628745895
5,Prevalence,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0140625100728131,1.500732826611832,-0.3854624095121948
5,Prevalence,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4164413921624804,0.5005000397661162,-0.6712101937757704
5,Prevalence,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2198859963099126,0.957886858714066,-0.5138864036340907
5,Prevalence,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4092301425516065,0.4563152911182319,-0.6418976510719793
5,Prevalence,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6606574784161784,-0.1245269867934521,-0.8090739807314891
5,Prevalence,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5459406327521108,0.1385693596607544,-0.7168253837369782
5,Prevalence,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4217316035530712,0.4260410450270814,-0.6495603934887347
5,Prevalence,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6627838080571701,-0.1329184376269541,-0.8100049508044846
5,Prevalence,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5522383860654139,0.1237672642874371,-0.7209856412847884
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1761332879976308,1.058130934923808,-0.5038491934035948
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5292489792619083,0.2207651629816378,-0.734579140335436
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3684174470413018,0.6013904439525068,-0.6072396296511897
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1988319428850988,1.000791348551641,-0.519094958459372
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5349486755292112,0.2024284463036963,-0.7381810801742885
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3810674888898761,0.5692184084705412,-0.6153958081221367
5,Prevalence,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3556470027690061,0.4149872665926483,-0.5732178954230936
5,Prevalence,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1577482502033298,0.9274731129046015,-0.484266452140259
5,Prevalence,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2634096770068047,0.6151135989535403,-0.5147973458855273
5,Prevalence,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6019616823979962,-0.1265913471616483,-0.7366446205562873
5,Prevalence,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.507266558927284,0.1279108071613006,-0.6981484455633489
5,Prevalence,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5569064781750585,-0.0296653947254025,-0.708361001896432
5,Prevalence,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6108383765798495,-0.1454082713164873,-0.7422418808051618
5,Prevalence,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5116255152826055,0.1176334018286865,-0.7009550817219683
5,Prevalence,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5638416532162782,-0.043640331405777,-0.7126962154299201
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3442264796565473,0.45441274636669,-0.5677242802207496
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1444855769837782,0.9858485332337362,-0.4745450184998665
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2510566281730606,0.6575583142388567,-0.509355372450584
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.359367004405477,0.4218063367946148,-0.5773758160981655
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1543682235191343,0.9624487467976822,-0.480438841908888
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2641476913214166,0.6300900202059267,-0.51735670178381
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3336644995468474,0.4568141187350549,-0.5558912583281247
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1346656849586306,1.0119905562095646,-0.4638757734227323
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2403749701728055,0.6814780165617502,-0.4978946468536918
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5902592946150588,-0.1040204775420167,-0.7272789834248778
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4954112468783437,0.17185091207422,-0.687363012791754
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5448522395546946,0.0062111964058658,-0.6991250371899485
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5994522307190969,-0.1242795181715282,-0.7330372377370805
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5000285634125845,0.1624845927210438,-0.6902390265913134
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5520743524167736,-0.0084882673801314,-0.7039251517104064
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3364938070913546,0.4636352911621759,-0.5592028826052503
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.139474817055092,1.0233626744385051,-0.4702562149266968
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2440845197909525,0.6880620947327887,-0.5023778025304947
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3518340188992189,0.4294229620419814,-0.5692119770472963
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.149631950766395,1.0012476294402686,-0.4764904384378831
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2574015753811383,0.6586252530073743,-0.5107110213065282
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9344873663291814,1.8772831127673408,0.3851419072722615
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8695712612588264,1.6460231773027862,0.3867151758001422
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9008694768135748,1.7464074451910752,0.4184629824300269
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1073486068463223,0.6459788815508998,-0.2053910176300779
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0834949982952893,0.5346943987668467,-0.1968199636772331
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0949050690670565,0.5839533086573325,-0.1833303859889885
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1026081318567163,0.6399775015389939,-0.2105046756485088
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0825503854952999,0.5321445456376603,-0.1970410118928324
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.092044663909004,0.5778040691507254,-0.185096636139485
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0562472579737227,0.2724347481765874,-0.3082696019405573
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1518840535484447,0.1096717337817755,-0.3505930382925031
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1062432507310864,0.1775430049705635,-0.3116778304958186
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0678563468861071,0.2552253512734306,-0.3183820039582885
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1586371541674037,0.1016677567566778,-0.3550217212077891
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.115445125237081,0.1650001590049987,-0.3182895431116737
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3090615609943632,2.080772539952552,0.6925212036089685
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0705185805804018,1.6574017729936374,0.5500664646944906
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.205953383681304,1.856772035787232,0.6703834806740159
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3217389999463057,0.7637806791584623,-0.0324721797067533
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1999432591321583,0.5392980008462134,-0.1018653605589479
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2706216960945669,0.6442755133758271,-0.0372336413937385
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3161058058194177,0.7559612505499963,-0.0353063685391839
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1989062594347357,0.5387331702099234,-0.1024546195856127
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2673145899103915,0.6412082448267256,-0.0403689527333579
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0730428082679302,0.2288014065966662,-0.3123645036631878
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2104298747665429,0.0148219630627084,-0.4091380471739377
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1355293374238077,0.1266816887043795,-0.3475738140576975
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0844401412213722,0.2164338030640598,-0.3199241194613629
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2167135880145067,0.0068036374623246,-0.4140352174365437
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1444269016518363,0.1172394230883068,-0.3546806359090181
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0196485001815423,2.2965587199667983,0.5383778356575327
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2001564741464643,1.8726085738679408,0.6862291477138952
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1199853402162447,1.873595829151125,0.6968296682550936
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0849103930231447,0.4959041420097088,-0.3037853353297506
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0033526584886001,0.3094520727544714,-0.2318331121112671
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.036303227480994,0.306833042527557,-0.2287335459036338
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1011971660910704,0.4670653429975654,-0.3153767310562268
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0069552939945419,0.2965572086467639,-0.2389173461405787
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0498260978372017,0.2879408694141045,-0.2394837659457158
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0682905457313747,0.5380688880189834,-0.2844692577212859
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0115116442475472,0.3098185369627603,-0.2522298266656697
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0319746381641572,0.3294187079239135,-0.2331523607145174
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0803821519147512,0.5167632771631891,-0.2938646676301717
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0191485301673236,0.30013335353296,-0.2582877309338813
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0420253853659224,0.3147012739266441,-0.2412407217319304
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.2715630584905555,7.617148333913505,0.6017723371571555
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.686538632095847,3.0775588199902257,0.6405190073316654
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8703438889385855,3.669707507238901,0.7658265442570693
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1723910506980877,4.731154735399291,0.0634767401065146
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7830721670940956,1.7082498370526826,0.0889183499245758
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.905481263440764,2.1063459095127994,0.174228179499816
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1216028705167562,4.5882054889489545,0.0387465342009578
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7645210565306807,1.6781444015573932,0.0774944002265364
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8736105519105717,2.04814112818174,0.1526393262192893
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6767163579048276,3.398653059450381,-0.1887142421277638
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2633278976267978,0.9102869807381496,-0.232591291904465
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3935470357951525,1.2810491620273452,-0.1434139227574602
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6351893102165329,3.276498943165447,-0.2091107988321583
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2469917718733782,0.8843014832062621,-0.2426139030456054
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3671799754530703,1.238333597808424,-0.1594337186268809
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.061619270879537,6.758686470614381,0.5623498961270523
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.330257477785817,2.424216653593668,0.5012747735216927
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.822706609329856,4.498796990587149,0.5948026026449407
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.03296824464393,4.140140559026673,0.0377752718058307
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.546598821932798,1.2730011123295577,-0.0025171151626205
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8738825585410609,2.6549588898992766,0.0567823980442906
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9854546947123048,4.0314944854187615,0.0131811507567413
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5305152650953768,1.2490286628320066,-0.0139613412330608
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8425154242211021,2.5893274335807703,0.0410038309503537
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5329293309867775,2.8596846491574808,-0.230725384630226
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.109522790517287,0.6269688547458341,-0.2937977039877841
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3609190846084157,1.6463577638404612,-0.240433517930238
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4949716233912193,2.7728310433439614,-0.2494824324927417
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0951821133218855,0.6052658859525821,-0.3038245197095478
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3351543702930205,1.5931714646568231,-0.2544910263713535
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0000001356819705,6.893182293456555,0.4941243168537232
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1540036114922776,2.271209569755315,0.3370205626322932
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.44223956426957,2.9085726659271165,0.4986213460111686
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.992069104803998,4.231458674828495,-0.0076416995267628
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4296170377320725,1.1699326216966417,-0.1124390285164572
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6212835369204524,1.6001791628659985,-0.0054984953633498
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9454947942681976,4.118714789204111,-0.0310630170129445
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4147515628152907,1.148533468753779,-0.1218436587533088
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5941664117469243,1.551312063342445,-0.0217782691385982
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5563886785399782,3.0719506108335173,-0.2307836704579932
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1298353413294967,0.6956375062362056,-0.3008420077443173
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2797014438127777,1.064268575025319,-0.2087308043113512
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5178388864619258,2.971464331160063,-0.2509094548459757
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1152316382102915,0.675990387111449,-0.3105357362423028
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2554881905212565,1.0210095711708829,-0.2230894619094708
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4584967007954224,3.340164318332242,1.742676436285754
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9942309561090297,2.7844655789531094,1.405382366775901
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.229727824197886,2.8310477244145424,1.683601157190052
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5060748727931796,2.1408832777260547,0.9936262439772352
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.096377360015992,1.650680245052162,0.6834435084275983
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3006243585749222,1.7321411864443914,0.913241634928544
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.459718002012998,2.086768971918058,0.9506193550733628
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0838940140309143,1.633873365778958,0.6740732391911382
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2725834229595765,1.6956994598248398,0.8883038558148111
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5125324339819203,0.8949457781577375,0.2161571567635143
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.215464209751773,0.5303177281300788,-0.027740165904017
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3564723883511914,0.6176626835196766,0.1359433275038775
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4661343754283398,0.8378291259214157,0.1782312557673152
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1961966078175498,0.504741761324897,-0.0425532425687053
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3245576607634258,0.580745102277602,0.1072214523404039
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.2992201067346265,3.7362382027497536,1.0158429221347856
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.127837888992122,2.3386904312903534,0.2897169434241139
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7657845966073396,3.0101746766048603,0.7390172605519831
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7900547485369032,1.5654517013806726,0.0944804869969424
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1750059470268612,0.8441886401333139,-0.2887026415474516
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5136120367419721,1.2008522132362869,-0.0486340733878753
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7725553978217216,1.5446148847470016,0.0830417908453102
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1749973691673997,0.8436331515314275,-0.2878150993862858
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5058290149313591,1.183336110260324,-0.0531935669835531
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2528814387006393,0.7662045500175436,-0.2288094990129723
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2142896919370042,0.2613404938900544,-0.5344960139320496
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0332208441481872,0.5072006685844448,-0.352441434138569
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2263533865665101,0.7249299570655876,-0.2449780172617301
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2211701058665854,0.2497131363922177,-0.5384781908794978
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0175274858301231,0.4829339899761975,-0.3611109264585745
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.7164010853907263,3.821425548825282,1.537283748972098
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6484576502040271,2.9285631873686446,0.6896356597607265
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.459688436709207,3.5607515485720125,1.401027729623049
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.016352811523194,1.6199251925848317,0.3746855876173079
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4624911527876403,1.168322995789367,-0.068285010597763
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.89332889353109,1.4976176301189748,0.3130388522083014
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.996692124582065,1.5903830618395378,0.3631936820054002
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4624848948502409,1.1693623530467785,-0.0669789905796614
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8836243563615703,1.483097208711474,0.3072374563645238
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4144944560032199,0.8387202131732586,-0.045831646546478
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.009784118876835,0.4657447676168668,-0.3743381347289634
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3044915147791957,0.7288952755782936,-0.0972513053923868
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3845765610105301,0.7986980525308998,-0.0639578653366276
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0184485734704939,0.4534296627601652,-0.3796783037857048
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2847000813565336,0.7018850293533961,-0.1110827053349049
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.4263563769840686,3.4902539607878675,1.2719964160868764
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4561392027727869,2.502550366162452,0.6406762938882129
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.826656554226744,2.7393015760554578,0.9312612019346488
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8589908152196443,1.436296116943105,0.2278248348709773
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3562948805713489,0.9356913125100668,-0.0952199833753973
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5469093385254952,1.0428201982536942,0.0565861851624755
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8408612624803279,1.412456167910078,0.2206640905666404
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3562861703406847,0.934117014697269,-0.0940144740598225
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5389706992445273,1.0358594865666175,0.0514734794790969
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3634232874964258,0.783844141769648,-0.0994849114940279
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0140826490286131,0.4354723442268505,-0.3510868637613786
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1313712206978413,0.5219989127138125,-0.2373624416973582
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3345877767795625,0.74553966081637,-0.1178745101925378
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0227097546594322,0.4207911049983497,-0.3560450688072935
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1142034551808993,0.4985036228481795,-0.2473432529391666
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,7.043408530786984,7.953946783243482,6.287056632987934
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,5.17280152400155,5.719079305180321,4.630221361908619
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,6.055790146426935,6.60144569151674,5.578565878707847
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,5.033532210040488,5.721149818610311,4.469486352811419
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.6808953431230176,4.098573959223007,3.2660398366405907
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.322441402317547,4.7319562829677455,3.964715133696849
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,5.065967101091106,5.752652983394007,4.495561443920298
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.706838854158157,4.123382537867714,3.293114651540529
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,4.351033927764305,4.76485311371712,3.989112272680718
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,3.357998464804889,3.803910666183614,2.981952964127988
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.749981777700908,3.076224877454916,2.440297240806066
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,3.0695949612333555,3.361317906825714,2.7952293242646906
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,3.301506316914365,3.749996079508197,2.929824433399553
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.7351897711200555,3.0551099610121275,2.425296071410496
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,3.035192541201937,3.3187774842188182,2.7634488309067926
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.965890333022844,5.28651405345556,4.644951169391194
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1973583628610505,3.408182359682715,2.965305908431004
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.054874157397974,4.264504649279359,3.833717619761287
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.1743587490892406,3.401406908828569,2.949945831994251
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9063833352562047,2.0530046729459737,1.7467871239379251
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.517967823910575,2.6654533408315184,2.3635632207187536
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.1725305874282776,3.396774112850692,2.9480664417257865
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.919288072355224,2.065917434463881,1.7578941898665674
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.5253448615176164,2.6715443027618337,2.3711069835266274
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7078385310869044,1.8500732767010368,1.574827045611639
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0082361703486888,1.105042669385316,0.9102741217677974
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3642221298674715,1.4519540019471089,1.265686693741292
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6610090478086428,1.7973633054051557,1.534077624397616
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9915608854066822,1.0876379012210946,0.8946586107850012
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.333727306848464,1.422043176888216,1.2369900224516706
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.708070586909719,3.9773694874964463,0.755375522542967
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8389639338400896,2.9652358610624834,1.0303012175992985
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7795705813033893,3.1260376022493555,1.027290344948908
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5361989255140118,1.832519168462628,-0.0059425787090643
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5144511299748769,1.1161755650637537,0.0818527833631995
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5284498857191361,1.2720685023314615,0.1148107010547961
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4957973695930082,1.749240076266109,-0.0304218427836511
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4961147189686555,1.0896523781806149,0.0699549576459649
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4993906589705523,1.2257187066906452,0.0935862635343533
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0949755852090602,1.0101352457572397,-0.2936900094814944
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0262563637652101,0.4587236677860034,-0.2807666216938816
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0664012176263146,0.5841719579176212,-0.2240445049305544
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0705565416081282,0.9657377906318112,-0.3078872651281605
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0143767894987567,0.4419391001961405,-0.2888585175882786
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0484382959770085,0.5555491179136376,-0.2370619852156451
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4523376545319977,3.404308633337916,0.657921178156974
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.387433463267436,2.008516148893791,0.9132078141498448
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.411184849577758,2.267696315886642,0.8987372513019983
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1259525201979595,1.021356484463022,-0.2391431247361549
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0836371368032945,0.3643892938560888,-0.1321570168380234
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1006507420625417,0.4933011868458113,-0.133748206810299
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0986495759361325,0.9731344104945358,-0.2572497527200019
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0688242680044279,0.3468752616963333,-0.143480656964387
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0798321506394149,0.4634147776095559,-0.1496638965977013
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1050825886876932,0.9991216797003404,-0.2549305813530684
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0230846438860826,0.3298669930952714,-0.1914755451119698
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0696587560312592,0.4555296888148654,-0.1673738593476054
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0857696682576242,0.9637428676104628,-0.2680442318902662
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0127319565611829,0.3163930519795883,-0.1997968456399602
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0548998721119565,0.4337725009630204,-0.1787718665016292
5,Prevalence,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3317691681960677,2.702377722066108,1.988130440641248
5,Prevalence,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.505481509038246,1.705805479681748,1.2921159363523516
5,Prevalence,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8967029934298785,2.1260817623954797,1.667114574601909
5,Prevalence,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.052438128373085,2.3926564362955416,1.7377491609715716
5,Prevalence,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3136985308390423,1.4972134055449955,1.1168337410072655
5,Prevalence,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6648492746300836,1.8760898043034069,1.4529098883367089
5,Prevalence,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.0460617251946496,2.38488967934866,1.731890868074298
5,Prevalence,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3163294974055155,1.5015299551079753,1.119072016972991
5,Prevalence,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.663560796315533,1.874477931385872,1.452450885128484
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1447973889837162,1.3349078541146424,0.9631139514905248
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7741332803144044,0.8896166370653344,0.6510631318236946
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9677071394709388,1.0932452730310191,0.8397704532716881
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.099891545806288,1.286618320143439,0.9211585174195788
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7560598924849965,0.8697543719648013,0.6332513441520853
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9367925483970896,1.062318788948176,0.8125645627751603
5,Prevalence,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2166327841089628,5.498626961836189,0.3446443789504299
5,Prevalence,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3282038072904083,2.513008297872881,0.5625909874701784
5,Prevalence,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2772659662911656,3.030743114663679,0.5179249798529384
5,Prevalence,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1636739223836827,2.416959850599839,-0.2934708902741807
5,Prevalence,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2060919459055433,0.8198572303992537,-0.1896409923870885
5,Prevalence,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1873386464751488,1.1023256619200297,-0.2081408511960207
5,Prevalence,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1367006863760386,2.3325293124681554,-0.3104594502787525
5,Prevalence,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1921682333410705,0.798853211679005,-0.1998675841291422
5,Prevalence,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1669174029726657,1.065434761260519,-0.2221843642259678
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1251992251222875,2.27501189228572,-0.3146997607323049
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0546906155494965,0.6115267136303313,-0.2964443262926187
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0829546241986941,0.9061487340346578,-0.28592214000046
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1046268636008125,2.211944009360369,-0.3263265321856466
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0443940928495658,0.5953982235372672,-0.3041169323189837
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0677941123644126,0.8781971773113415,-0.2956247712223003
5,Prevalence,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6797811906577538,6.091169038653394,0.5557436204920245
5,Prevalence,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2092999892350482,2.2600833610436624,0.5152385022615728
5,Prevalence,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5493894442592535,4.328383506031361,0.5924087645716061
5,Prevalence,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4068152052351552,2.7247125349096777,-0.1821369326464648
5,Prevalence,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1444857814323858,0.6908760003947081,-0.2157808453347096
5,Prevalence,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3292284737293284,1.7810634469014426,-0.1703643521249121
5,Prevalence,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3742055700862205,2.636387935445054,-0.2022066740525592
5,Prevalence,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1312829473258653,0.6693417513148394,-0.2241146575419945
5,Prevalence,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3063590083445582,1.7303720930880142,-0.1840173578621755
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3020836540735668,2.497618306102348,-0.2509285954579613
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0008479781921547,0.4907600853684317,-0.322698677666082
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1770002683971075,1.471309760530829,-0.2659756893581714
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2782743327931836,2.432593605146839,-0.2640825281974258
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0089166540414348,0.4770953772591428,-0.3294473853299436
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1605172303508678,1.4342104526714117,-0.2758040779298479
5,Prevalence,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6216820653179995,6.137070630431319,0.4682017402930719
5,Prevalence,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.034164187713221,2.008741501110918,0.3874356402193514
5,Prevalence,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2596093070835148,2.8323461005113915,0.4926319881308702
5,Prevalence,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3763291888013487,2.7497560810363346,-0.230430967140009
5,Prevalence,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0537669686544786,0.5578638066340833,-0.2809448377531761
5,Prevalence,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1781357686593118,0.9974200731369564,-0.220972393517768
5,Prevalence,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3444120399512349,2.659926507667649,-0.24709860023094
5,Prevalence,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0416037970550638,0.5406409132772081,-0.2895567428868033
5,Prevalence,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1578697716407305,0.963772095617134,-0.2351450076688565
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2549466468126302,2.451797564378733,-0.3067124298044449
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0401886772400667,0.4380415514119584,-0.3516672380199629
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.077833850380796,0.8520883249746198,-0.2967684254130647
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2319916492725626,2.388648998975842,-0.3190647250977009
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0495580642363694,0.4249555037994164,-0.3581110244571651
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0627423249112431,0.8256762883398854,-0.3073525326772061
5,Prevalence,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4602235004621824,2.8675765437603022,2.101074232541737
5,Prevalence,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5620862340139356,1.7747330375908108,1.3450045973692346
5,Prevalence,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9875453437562076,2.2300721347544004,1.7566506781328384
5,Prevalence,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.260499021879994,2.6456649796269645,1.9223364015215512
5,Prevalence,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4293878815398755,1.6301679574005576,1.2228463394985742
5,Prevalence,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8243451038495613,2.053054703191777,1.604460171908348
5,Prevalence,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.257335777843617,2.640803967679102,1.9192449695974576
5,Prevalence,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4338253635335925,1.6358268329411725,1.227611073706382
5,Prevalence,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.825551918409511,2.0549281991755306,1.6071770352412509
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2495090754991325,1.4520658425891564,1.059277968759535
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8323341485509997,0.9576053958107196,0.6979471705152593
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0517937171802654,1.183695023138384,0.9209566024844398
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.198329766541601,1.396224685401162,1.010247994575468
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8121193534093936,0.9361899791624474,0.6792437931858499
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.016840443475576,1.1462129991051275,0.8899983738432315
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.416410891377437,-0.2492099533662767,-0.513645577356278
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4229514961903109,-0.257532377482683,-0.5102416622648632
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4190945926964816,-0.2625180719210045,-0.5065917820953605
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.462887547643836,-0.3098607758824182,-0.5522529961984708
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4647749421625794,-0.311418898361092,-0.5455672806658691
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4631913266293231,-0.3186515055927408,-0.5440255668883897
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4639227861166105,-0.3103342223764966,-0.5532412788407013
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4641212414506827,-0.3105040127634382,-0.5451836573841311
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4633837618273002,-0.3187448885988302,-0.544210023789393
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2502337412566162,-0.0369387920800517,-0.3761540212712805
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2588213933932892,-0.0477774799242095,-0.3719872282754438
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2536827570351814,-0.0515506295488836,-0.3671820784168121
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.265898162041699,-0.0555896940133887,-0.3893176214756173
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.266380866886592,-0.0573581179838313,-0.3786249831874875
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2653947845267554,-0.0657892162786219,-0.3774447881252187
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8977837353221396,2.677830197999954,1.2472513275553836
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6119272077414393,2.2160396508270206,1.123562174557918
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.765106260323139,2.297616106868089,1.3113792701515026
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3724278199383222,2.0154703741222466,0.8442910424274421
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1448150107250945,1.6428327893360772,0.7428345253775245
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2672479232415066,1.705594020290421,0.8964628459353259
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3502196837346745,1.9828688799001728,0.8226116186453114
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1420738125535688,1.6375138999863132,0.7415596077745388
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.255144881449788,1.6894453175629065,0.8850975837587366
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5508063016105238,0.9692589891826876,0.2207559884909113
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4172381337723586,0.7615402105914908,0.1457757606749359
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4940409402698966,0.7817730715344997,0.245181416364049
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4989401496707161,0.9012266662010248,0.1833082754737995
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3923335502016375,0.7293262043032718,0.1255018145259534
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4552260451239149,0.7349644523283976,0.215570129728746
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9209353380245806,1.48507306513145,0.5941683099229473
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.100310257723869,1.5989454479635152,0.7084039272886022
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0342921701051944,1.447245166694641,0.7031577459408496
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1080745262121366,0.1531222473006143,-0.2616608240720622
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0376047274707124,0.1900357328178365,-0.2176365479766918
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0616959900786414,0.1291697615090021,-0.2136745295888093
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1300776844131588,0.1253999405543648,-0.2780586831051431
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0505346373308671,0.1748781748950479,-0.2276996465435074
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0795627195329904,0.1072822866697503,-0.2293880363315498
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1099843492433951,0.1518199995393695,-0.2622842098584685
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.09665367324948,0.0962498255007728,-0.2516918213663015
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0871827058859219,0.0917604177559355,-0.2322073202802206
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1262168299896503,0.1304520160433549,-0.2756331559704612
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1060632983898776,0.0849345391277286,-0.2597671585387874
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1002916991006912,0.0763099842079119,-0.2435106904210895
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9496489926672396,1.6158698807430587,0.5745521502114678
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2863737546133258,1.8379811421679684,0.8667356704426669
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0528643292199338,1.6048750805983245,0.7256500030774586
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0947493861642619,0.2157546453737991,-0.2683308138141662
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0476406273868418,0.3014972635006904,-0.1448831858345527
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0531436265472419,0.2028973230071728,-0.204716112206276
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1170743060894565,0.1846330997637977,-0.2869421341726217
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0335771480132107,0.2829365492490606,-0.1561242660096216
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0711595472260909,0.1786036294964556,-0.2192111736887983
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1251427399932814,0.164869018164554,-0.2889881016448135
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0265066880587412,0.206402498058499,-0.202199196509455
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1063992046842903,0.1320986451205532,-0.2485549787377924
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1410945335009779,0.1454739025916024,-0.302613960058183
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0366396509186678,0.1936783830324461,-0.210291644408888
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1192233494195774,0.1154316902210178,-0.260169016807967
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1273990967124357,1.8184748452758777,0.7558201839435961
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.240529286575362,1.7779609760946329,0.8070917851537929
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2013898673269658,1.6938752759743396,0.8173413162559688
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0122090351553869,0.3093452971208886,-0.1866678560127463
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.026641728891913,0.2729696033638715,-0.1727441084331337
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0153726017997874,0.2432554195299014,-0.162455277941375
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0365776964191826,0.2763855790934922,-0.2048523810587619
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0128527172716255,0.2558038584769656,-0.1830868554501775
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0039575767401751,0.2188727211229034,-0.1777244569896368
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0804246659680607,0.2192207312399428,-0.23594168793985
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0602928828745852,0.1575066943769595,-0.2340094003844308
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0584803074752146,0.1496311739961976,-0.2052777499013582
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0971971252439522,0.1961416304854851,-0.248967608418216
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0700768398878455,0.1442533917352149,-0.2423150029929817
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.071997486550988,0.1316280150003172,-0.2164808677125786
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6744713481175115,-0.5643477903705357,-0.76031811779309
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4993065490421541,-0.3250156098917503,-0.6329153721119876
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6055612870378875,-0.4932347501562212,-0.6995054095399317
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6955236481130689,-0.5934446673483091,-0.7762868183457025
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5371440794281673,-0.3758544230005581,-0.6604976086696894
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6332859628358616,-0.5285586197279459,-0.7211531941276161
5,Prevalence,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6940890110049381,-0.5906019407663616,-0.7747623098424472
5,Prevalence,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5342139732836266,-0.3720742770598659,-0.6585078355518358
5,Prevalence,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.631225912838104,-0.5262080361912637,-0.7190574488446733
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4500620251286231,-0.2694666824627072,-0.5903832663762316
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1798795115367222,0.1013001538572677,-0.3909726423131209
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3432120853486943,-0.1566738507536239,-0.4988380407744884
5,Prevalence,65,High-income Asia Pacific,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4704662842304161,-0.294999220960264,-0.6052537037231216
5,Prevalence,65,High-income Asia Pacific,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1959580032213703,0.0799669063525951,-0.4039318198820376
5,Prevalence,65,High-income Asia Pacific,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3619700005899383,-0.1795978106221774,-0.5118442661614209
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.63934059157332,-0.5633685932522845,-0.6901737415211031
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5818738548100792,-0.4893668339053985,-0.6335643719937197
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6163232355686559,-0.5336769254930855,-0.6622591641796736
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6025251649805294,-0.5203403812961545,-0.6579583486452685
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5452103818557265,-0.4446880730760233,-0.6010879287340009
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5801470852115023,-0.4903628842702401,-0.6303825735914214
5,Prevalence,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6030874258398782,-0.5194787892338513,-0.6590302791996667
5,Prevalence,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5438204912413857,-0.4428944720520043,-0.6002153256892563
5,Prevalence,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5797075223026171,-0.4891739647501031,-0.6300272889423026
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3888025282519033,-0.2588986774355613,-0.4750172257537588
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2892280083970105,-0.1336002812611448,-0.3787960587387741
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3486570384471252,-0.2081121038414002,-0.4266515149723041
5,Prevalence,56,Eastern Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4013610825499319,-0.2725484591893424,-0.4856277969648407
5,Prevalence,56,Eastern Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2964065362359994,-0.1424912927191885,-0.3862269975168659
5,Prevalence,56,Eastern Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3587290757251088,-0.2197029293576029,-0.4352497947861172
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2256548757997981,0.8987760261449725,-0.1663843410837768
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.006437412502383,0.4833792947836417,-0.246250349968947
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1272760367449168,0.6328707503115302,-0.1499531207315704
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0961758122797533,0.4058393750620617,-0.3867957251187333
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2663874325059729,0.0809755070877403,-0.4499438057483969
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.17367615905396,0.1936448850425743,-0.376557227713035
5,Prevalence,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1009746772938588,0.3927637896742649,-0.3885378326578244
5,Prevalence,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.265139416776364,0.0831045827243535,-0.4496419742095796
5,Prevalence,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1750655297846761,0.1949259306779249,-0.3779403188305605
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.4720748573388515,1.346792973245098,0.0076322231889435
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2335764341616803,0.8286497422791654,-0.081237789902098
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.3654194656799275,1.0273977451315646,0.0252500503712015
5,Prevalence,96,Southern Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.4397066198109157,1.2817720038905644,-0.0157632654834347
5,Prevalence,96,Southern Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2175671762862323,0.8138411473981784,-0.0928733349329837
5,Prevalence,96,Southern Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.3414147076183761,0.99877375414715,0.0060851205230362
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6436731622072598,2.5088984071454443,0.954749393951408
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7516129982805191,1.4846671322281333,0.3080752673012814
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2465313000118283,1.9832230039839884,0.7411081481345353
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4343596655566059,0.9080535900657,0.0615203395411985
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.032751290103859,0.3759090013882554,-0.2773669675226459
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2294338851495143,0.6329465614479038,-0.0479124920700964
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4203529871139401,0.885208203992672,0.0502183781447249
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.032754950258972,0.3720393638669553,-0.2776775873278779
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2231220098119431,0.6242131664628514,-0.0520551850601637
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.20845268939213,0.5385891418928614,-0.1419845011030474
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1592273129065096,0.1668532180635084,-0.417779202282143
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0476225867025926,0.3587354063295846,-0.2412940352579297
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1828720301976401,0.5036113556187967,-0.1603172451015234
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1665875985634026,0.156403653178032,-0.4230632372868738
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0317152430116744,0.3387124321427164,-0.2532094923321504
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8826556917032344,2.536781290291451,1.1310233902779747
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2809456491910558,2.0462496251717064,0.6485601851975993
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6928452795177649,2.3252280980983686,0.9971715121959184
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.564027618777602,0.9194435940261398,0.1555054741112415
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2595638224531444,0.6816049457635016,-0.0899176006557093
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4736950659107664,0.8161453105866145,0.0929252784271723
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5487499290998576,0.9001887004216302,0.1449242218216757
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2595438547636627,0.6821466117887964,-0.0896609696903151
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.466117267263997,0.810417542104936,0.0873582905002779
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1100716602365616,0.3625059066895151,-0.186071160418895
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1134427699758369,0.1860225702416632,-0.3704497591786769
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0394491275158381,0.2748478213945887,-0.2330272410353982
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0865662397165155,0.3331217267765849,-0.2019031109773197
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1212147750401129,0.1747110996798661,-0.375962194316467
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.023656574164173,0.2582615646582378,-0.2456202449146102
5,Prevalence,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6966143110854468,0.929433872696128,0.4669145299661161
5,Prevalence,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.5499382672106792,0.7080775500042585,0.3970286130219502
5,Prevalence,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6358038799613557,0.8332397847820069,0.4424096516448788
5,Prevalence,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.2641083974619482,0.4391246122520202,0.0907261718517135
5,Prevalence,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.1698679840380798,0.2889354301113197,0.0558022009734716
5,Prevalence,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.2269755048724145,0.3747658325409465,0.081180000959996
5,Prevalence,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2825043779934415,0.4584972981858837,0.1088697616962333
5,Prevalence,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.1847001989906098,0.3055744581512312,0.0678232229346679
5,Prevalence,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2435499186443037,0.3936421188064565,0.0965302301380545
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.8166148735365802,1.0659765269650985,0.5664340489789041
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.6543724696386781,0.8244494063409227,0.4915657053743822
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.7480258233072998,0.9569711847789624,0.5405171469783817
5,Prevalence,100,High-income North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.812243900411304,1.061488235399793,0.5646686692929095
5,Prevalence,100,High-income North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.6587312936633177,0.8318829688751117,0.4938569059887233
5,Prevalence,100,High-income North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7482062915428533,0.9601222271748446,0.5438796443016609
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0738749054706225,1.121524499842783,-0.2656332489997821
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0100955277488086,0.7778748782458249,-0.3324792764869317
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0282936434499464,0.8325947471853417,-0.2963335007438793
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5199099268139219,-0.0509891385706037,-0.6726409967627187
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.566352844459363,-0.2219684403077282,-0.7073425112826681
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5450029287231846,-0.1895626736392109,-0.6886900436244766
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5300529689478692,-0.0715826071300732,-0.6786278619810866
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5714140157862286,-0.2302567814760066,-0.7109922883575565
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5524310027536842,-0.2023556708910717,-0.6937262896897242
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4300014099642738,0.136122595569025,-0.6140000811726263
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4655900589223795,-0.018869387056733,-0.6437535903854286
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4490598012299808,0.0032305030382844,-0.6247983187146576
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4387266526434944,0.1193841445950613,-0.6191436862089207
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4702730274410759,-0.0267689765502487,-0.6470856993883844
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4556793064235525,-0.0084350170442333,-0.6292549453149321
5,Prevalence,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.381212337503629,8.04060371471649,0.8650737094835239
5,Prevalence,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.410387282759887,2.5601750713987963,0.6214323612808006
5,Prevalence,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8201409598541496,3.87239248577227,0.8240467210811575
5,Prevalence,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7750835910614079,3.742695241325225,-0.019158628750374
5,Prevalence,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2486673383786402,0.84396707852079,-0.1600995530366953
5,Prevalence,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4704014597205247,1.5426528221131282,-0.0489436001152622
5,Prevalence,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7339030679222189,3.636068058473154,-0.0435806142946551
5,Prevalence,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2342506869705526,0.8230051905095144,-0.1697375686882641
5,Prevalence,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4450975922893534,1.4967130189983076,-0.0653213572012403
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6822481658739687,3.4494879161305265,-0.0797678851989049
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1208963951248601,0.6699113950116162,-0.2572619378187353
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3455558802128025,1.3370474717521406,-0.1457757503349023
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6514655689715748,3.371226701210584,-0.09712740426141
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1099533384224208,0.6530384568388083,-0.2640498770882116
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3267098210228932,1.3036917694681187,-0.1574270926309726
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.003590301462499,2.7495900927757866,1.3849258411884435
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.905899082719386,2.5919620581030944,1.315496099394931
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9586758127788984,2.466887815801983,1.458616487951364
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.410824361394927,2.008654678010961,0.9140326908325384
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2874396931000034,1.8285757071557376,0.8206222373011391
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3519104715225188,1.7590104418864057,0.9511960058449556
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.363945178031328,1.9510767214474676,0.8770316109672389
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2705535522017823,1.8066157764734672,0.8092362273883649
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3203050636687592,1.718864067307675,0.928139697486814
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4077747989573029,0.7597077450238706,0.1361426800056722
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2533717407758174,0.5472769949196006,0.0059671250284593
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3282384299909059,0.5642766106063195,0.1137453613815569
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3514249082690776,0.6843384980085734,0.0931421569351905
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2251877537720994,0.509343018778138,-0.0174698650820472
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2860991066544918,0.513059785086896,0.0794804994649198
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9503377210978284,2.381468490268833,0.3830739939234319
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.319597734899996,2.76695778166956,0.4052514169225802
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1575890657173191,2.2761320657802937,0.4633305696247282
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.2007259513726174,0.3855627067829058,-0.4329351137740196
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0907549168845436,0.4755884722863589,-0.4496536036418598
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.135572473935016,0.3150246798188151,-0.4143969678895237
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2168173651658192,0.3578711897787616,-0.4446092474067185
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1012542653036326,0.4595363618954255,-0.4555246807957215
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1491763493900268,0.291909886075025,-0.4229502378001004
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0837876391180934,0.5833145632325372,-0.3563595205523625
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0148784573962234,0.5933615170433139,-0.4147984650190956
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0361651339428468,0.4631918228451813,-0.3541862751902785
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0966589548557145,0.5612424960663018,-0.3655240731505206
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0229479944016194,0.5802370370952702,-0.4194535341058357
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0468118360295475,0.4459621256785604,-0.3614640839329079
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5319248524334694,0.4112218860995843,-0.747460132400168
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6353289709257235,0.0597544024710194,-0.8121497868178034
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5847103169053343,0.1373171452186277,-0.760514336318456
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7320599840621005,-0.1889510936074667,-0.8550791592601328
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.78866016737154,-0.3856497488612779,-0.8910757086269168
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7607940792094722,-0.3448710874616124,-0.8620543418768656
5,Prevalence,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.733209183471572,-0.1956397573067449,-0.8560587592970557
5,Prevalence,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7888420884061327,-0.386363301202607,-0.8912278312628554
5,Prevalence,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7614171367724748,-0.3466142022069884,-0.8624160973195609
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5962556800592492,0.2273933293141641,-0.7818705045771192
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6809453302706934,-0.0690121521973764,-0.8362800808182851
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6392557134735706,-0.0085980103711302,-0.7931402253553875
5,Prevalence,120,Andean Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6012252830319078,0.210212626647634,-0.7850318882905677
5,Prevalence,120,Andean Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6834820811186221,-0.0763155544039426,-0.8378787774366155
5,Prevalence,120,Andean Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6429668016377744,-0.0188329576161211,-0.7951365262995873
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6038492565818223,2.3469802623042257,1.0028668721826772
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.486746843013926,2.2724662447699995,0.7384859086286154
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.549405178801349,2.154962925029075,0.9439784649743216
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7723859313291104,1.282068948058491,0.3620173403324869
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6959660456781255,1.2327751213014244,0.1852517461592774
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7370314343107282,1.145981990049845,0.3247957337423542
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7218226951309089,1.2132258851865425,0.3244167753309521
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6710940895287979,1.1990975941844282,0.1682626781250171
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6994958569365172,1.1031754640100777,0.2959035992666341
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0502005652346241,0.3573786949305724,-0.1934927926418269
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0229726161907724,0.2950181176036272,-0.325285297589549
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0161095467933767,0.2551930989939631,-0.2276706573398787
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0131580779265759,0.3075175855058927,-0.221360541900514
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0435649219322342,0.2661747234375003,-0.3386740484305968
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0127288429127954,0.2226961586195315,-0.2489322093441154
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1650240667417258,3.292069097924613,1.3826196986367405
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.936389618837876,2.970437368093732,1.0455158852432207
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.124892435059696,3.14459801282921,1.3317888047916229
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.154429962050826,1.9175191043312605,0.6243186303133655
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0026573325158707,1.7054011580891453,0.3944821478816369
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1291840352336586,1.8236122890104909,0.5890767158493997
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0929054379689274,1.8381758134409212,0.5755323241577204
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9732540730388324,1.6681342482872727,0.3745868484643613
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.083129739798036,1.7628904224562276,0.5544274585876251
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2892740732037067,0.7420408242812973,-0.0311150969919381
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1705816912312321,0.583669361925581,-0.1954279703507587
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2574710289475995,0.6574839915720126,-0.0581186112718525
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2437584527442488,0.6784691844561761,-0.0665648110883767
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1458885904553447,0.5503324380662923,-0.2125123732841502
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2217539566806662,0.6135534805672691,-0.0830754166672743
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.197695211876262,1.9119438707379697,0.6356390390211006
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0609648642675718,1.743665783286187,0.4337933493951475
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1368346260956714,1.70578997096751,0.6300228015589824
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4959850873027519,0.9820059152780376,0.113487788933111
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4056008761330162,0.8694660299826833,-0.0230252952532668
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4559643928471244,0.846170879012063,0.1096979655701776
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4532490631798475,0.9255534977343012,0.0815835099938499
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3849685636797127,0.8437436391937023,-0.0364907475358513
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4244662340081662,0.8037457849527545,0.0866130739029922
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0259156126549493,0.2875255254352592,-0.2603461773598137
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0768922880915988,0.2360727563774334,-0.3563944296336409
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0481641981658092,0.193404695335155,-0.2794932602582847
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.06031452485885,0.2399980102732079,-0.2866671204994804
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0963611049150954,0.2092509770770882,-0.3700552670864678
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0752038116585921,0.1602957119248124,-0.2998783168988547
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.915805806027482,3.293363948977652,2.588311577804213
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7240523120601978,1.8963609193002648,1.5456430751776111
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.236124022513902,2.436961200770525,2.058000062260122
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6736496275095418,1.930357868004482,1.4447059612590958
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8043133994827628,0.9175993447171664,0.6856394736843248
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1754706053327189,1.309002353545493,1.0550429573803457
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.65692357323453,1.9131015299470049,1.4347146134017197
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8055325306636693,0.9197406148138618,0.6872808805260245
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.169766498338727,1.3044244341812443,1.0503373915364995
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4466836675893893,0.5806063583667487,0.3309830846268019
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0753739284251803,-0.0208426711812511,-0.1310061603560229
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.141364091677443,0.2064583667156589,0.0789369557198046
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4199167846301764,0.5507581400489694,0.3055579247903098
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0827639262665178,-0.0288377448164628,-0.1369338759444351
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1261110335927965,0.1904996010045348,0.0639924592668488
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.558885209604951,2.89036592847621,2.254529960744085
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7137865405861867,1.8909866026339264,1.5373540211178505
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.259639805882031,2.498036146340976,2.060786590828639
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.429941358495657,1.6591578190986491,1.219336802756216
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7975040029572716,0.917566264868314,0.6811629417858027
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1912671844538845,1.350405307090792,1.0572551916082809
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.414748451846174,1.6396622958080236,1.2082395810305226
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7987282617931251,0.9161784572414096,0.6817868022048896
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.185533433900955,1.34537415361866,1.0522057118766863
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3754277177413417,0.5041878724322061,0.2636501228134009
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0210859372036079,0.0390419080182441,-0.0802898171503307
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2145501384207155,0.2990764779883855,0.1418475327894086
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3499866902462759,0.4733217303376739,0.2410858434107474
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0289055060977582,0.0309241025765765,-0.0868190781686158
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1983262521638863,0.2838881396755671,0.1256061099182643
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6401796275727532,1.9072271341534015,1.3981575525070051
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2252882849960214,1.3813380635942665,1.0778016689012273
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3953015909615731,1.558952475510445,1.2463450574210897
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8026977350003409,0.9874902194117968,0.6363854085363956
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4739475954682258,0.5783327928397881,0.3772767411874157
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6102403169330387,0.7222016650704762,0.5109276626295587
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7913951399923879,0.9725902376439334,0.6271801129102197
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4749461201155902,0.578377669654704,0.3771903310590789
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6060092596353962,0.7157344136305162,0.5061364198009898
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1788296529295647,0.2861798881007131,0.0748698744004435
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0657024875748449,-0.0112739282560098,-0.1216537250095157
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0332716278304469,0.0870532356691653,-0.0187957193288427
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1570063001641896,0.2620504697824626,0.0565632624948498
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0731676591943953,-0.0181270866564301,-0.1297175919902877
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0194585777584891,0.072772931390409,-0.0317948833530843
5,Prevalence,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,8.770144563745328,10.651707532443048,7.215249422401612
5,Prevalence,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,7.0356115270541935,8.490468018027261,5.854966038333828
5,Prevalence,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,8.05190421449997,9.32596259545581,6.991600942578121
5,Prevalence,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,5.362258256795471,6.580121443607246,4.354498485044585
5,Prevalence,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,4.146611519958488,5.08468305191032,3.381767705149187
5,Prevalence,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,4.844991077660557,5.668341708570541,4.167790682061351
5,Prevalence,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,5.420052694360731,6.656445188656285,4.398316662053206
5,Prevalence,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,4.244921353886633,5.194520255059822,3.474302625702617
5,Prevalence,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,4.927978257486574,5.762343072016594,4.23359897624914
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.342877666782657,4.157684510368196,2.667780768240119
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.653676980129349,3.247012945731332,2.161232275253412
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.1041458945499936,3.6695373073237487,2.648818217549798
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.318298794948446,4.124332468693785,2.648040083307482
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.6975813137450797,3.30002015699531,2.1967453595217377
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.116368560618385,3.675873380161717,2.655194720333948
5,Prevalence,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,7.151374497758564,8.582454720893757,5.827236543717566
5,Prevalence,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,5.7011274437503,6.818030307586179,4.706417081202278
5,Prevalence,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,6.946662585607281,8.160870199840296,5.810825204052179
5,Prevalence,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,4.307731698383595,5.232405509233091,3.460745016553634
5,Prevalence,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.2918861768542573,4.011170288154919,2.649023110948614
5,Prevalence,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,4.13112174808396,4.907947400877184,3.409621368960408
5,Prevalence,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,4.356343856084871,5.296719956196886,3.486240513797433
5,Prevalence,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.3738906872874157,4.102903987772023,2.7246336140833014
5,Prevalence,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,4.204169411293777,4.999338711220535,3.460323791372905
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.8252788380262293,3.4932460513406323,2.2349748415509185
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.175979665872928,2.663716251428035,1.7259796739993187
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.779177561115701,3.347484789268166,2.2627728435318604
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.804022771126582,3.463480017599037,2.195982119148097
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.214163017786384,2.7112132338088344,1.7641458350856611
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.790656286799132,3.3549809094405525,2.2598744314489494
5,Prevalence,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,7.308419032304199,9.225766713156291,5.646567815435235
5,Prevalence,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,5.534712671022725,6.880859729545591,4.451183420944279
5,Prevalence,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,6.471911431514955,7.754282811458532,5.474115609403959
5,Prevalence,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,4.410196026196639,5.683169248605899,3.328189648576473
5,Prevalence,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.185347730974129,4.040945762605569,2.4896256992934616
5,Prevalence,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.82475135903411,4.656372941691104,3.185584081890165
5,Prevalence,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,4.459539277663952,5.719446238524936,3.3675214151978263
5,Prevalence,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,3.2652701557768484,4.143913359090908,2.558040135738713
5,Prevalence,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,3.893260849682216,4.733069742727203,3.2398169113990294
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,3.136650675029043,4.104492473347539,2.3687136313406763
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,2.283207711343604,2.890598758230622,1.744613010128201
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,2.736798900734104,3.3814580933151115,2.2838460088403325
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,3.113414256682692,4.043029387431747,2.356141565728143
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,2.3226271122979174,2.9382853939533176,1.7814673331430224
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,2.747927089727653,3.388945794591442,2.289442551601456
5,Prevalence,104,Caribbean,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.965129179053306,1.4040162721698315,0.6167953290184013
5,Prevalence,104,Caribbean,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4738563942981295,0.7538487293495431,0.2259039460930771
5,Prevalence,104,Caribbean,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7324960906718524,1.0361018933628714,0.4542503175676243
5,Prevalence,104,Caribbean,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.468685095913203,0.7959787134157211,0.2071097471584218
5,Prevalence,104,Caribbean,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1004752806397814,0.3098988352914191,-0.084054026034601
5,Prevalence,104,Caribbean,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2941969823509456,0.5212231607090141,0.0864445327501242
5,Prevalence,104,Caribbean,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4588368221591383,0.7846498318245969,0.200247080450562
5,Prevalence,104,Caribbean,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0978813802805349,0.3064487634146329,-0.0868193660964112
5,Prevalence,104,Caribbean,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2883652546878536,0.5141407524882752,0.0814486629209813
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0830801180350154,0.2954741155537673,-0.1138299685967243
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2119410837450996,-0.0793369359074574,-0.3243196277108674
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0614110967812273,0.0843508567099698,-0.2008625874043469
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0687265004396684,0.2790796716567273,-0.1268613244800325
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2188333856517465,-0.0887398729556875,-0.3305086887269841
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0717868481718538,0.0740257408953321,-0.2092466522002053
5,Prevalence,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8742791837356421,1.26009432792475,0.5089709421290386
5,Prevalence,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3941161801907161,0.6552828636165462,0.1718455309993813
5,Prevalence,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7010500754940475,0.995429334109984,0.4313282019462985
5,Prevalence,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4007833918376363,0.6885277400355772,0.1271505964536146
5,Prevalence,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0409453318636138,0.2362781147565583,-0.1247954850621307
5,Prevalence,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2707104073514497,0.490744334888889,0.0690627242845786
5,Prevalence,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.391393256680027,0.6778076791460615,0.1202023751977944
5,Prevalence,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0384825835817553,0.2330266653471877,-0.1270876904789288
5,Prevalence,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2649805246606939,0.4838947320540632,0.0644027039202881
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0070639330639456,0.2105974969287141,-0.184179926452129
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2669888826395003,-0.1291424774698883,-0.3788001809357285
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0974939889576781,0.0587058542452345,-0.2405163766911701
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0062814555126881,0.1935980647868128,-0.1952765681998445
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2734078517995697,-0.1366727979357104,-0.3835297781877793
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1074748649088634,0.0471778421058027,-0.2492122595176074
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9734781408963449,2.7458026445099497,1.449391489132125
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.172689635646593,2.938887188133088,1.4650226045047916
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.078432529940282,2.6896167411863106,1.5389096643471445
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6904467023016959,1.1318347442694807,0.3892417038527042
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7164557900827312,1.13139164901024,0.333986801606202
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7077252691337711,1.0483884626420243,0.407837457930896
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6519178129511147,1.080983218662606,0.360761115455351
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6991209295007728,1.1094548880875408,0.3201327517032762
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6796348707314216,1.013105331319758,0.3852638199470933
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3333534842019485,0.6871377501260181,0.1064304507973174
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2392827260109894,0.5537899429698125,-0.0569669215100316
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2850177589754286,0.5616735429035327,0.0442013192065322
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3051240859555149,0.6473378347982585,0.0838778172855766
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2257624236141394,0.5378305314953571,-0.0667024008046463
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2643155362500388,0.5344271210973741,0.0279965651639675
5,Prevalence,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.965890333022844,5.28651405345556,4.644951169391194
5,Prevalence,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.1973583628610505,3.408182359682715,2.965305908431004
5,Prevalence,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.054874157397974,4.264504649279359,3.833717619761287
5,Prevalence,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.1743587490892406,3.401406908828569,2.949945831994251
5,Prevalence,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9063833352562047,2.0530046729459737,1.7467871239379251
5,Prevalence,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.517967823910575,2.6654533408315184,2.3635632207187536
5,Prevalence,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.1725305874282776,3.396774112850692,2.9480664417257865
5,Prevalence,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.919288072355224,2.065917434463881,1.7578941898665674
5,Prevalence,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.5253448615176164,2.6715443027618337,2.3711069835266274
5,Prevalence,44560,America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7078385310869044,1.8500732767010368,1.574827045611639
5,Prevalence,44560,America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0082361703486888,1.105042669385316,0.9102741217677974
5,Prevalence,44560,America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3642221298674715,1.4519540019471089,1.265686693741292
5,Prevalence,44560,America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6610090478086428,1.7973633054051557,1.534077624397616
5,Prevalence,44560,America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9915608854066822,1.0876379012210946,0.8946586107850012
5,Prevalence,44560,America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.333727306848464,1.422043176888216,1.2369900224516706
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9890992699340608,2.515180626553668,0.488704726523588
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2111906266735066,2.106703017576511,0.6093285720903119
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1074254802520798,2.0598030222664527,0.6300984912243879
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1965039027395961,0.4201984908708308,-0.3987970397715503
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0919528617254052,0.2742415841122211,-0.3388629601692277
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1416000294476355,0.2447992709346627,-0.3361083306486702
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2092331040448829,0.3974609084611215,-0.4081650758306328
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1016482473608441,0.2621761629696472,-0.3461698300139029
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1529736581541321,0.2298103942490397,-0.3448231622856226
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0305105347812485,0.7574258499719553,-0.2800126337543767
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0169827695615617,0.4510210964735093,-0.2672979991603658
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0014434202269915,0.471643676323344,-0.2279175680241911
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0408189214644229,0.7391192025500442,-0.287668441060952
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0098342464851576,0.4408768032948154,-0.272916262595484
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0074020142599351,0.4591899011431527,-0.2354366955602786
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3265361946662693,3.0351620535456503,1.7146944988732535
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1784350694756216,3.0740021420344905,1.3188504960469984
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2478097427575485,2.9658540454605307,1.584222004942497
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0889160515257184,1.538963476723636,0.7039288294071103
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9168945639960436,1.456029384184737,0.3970208657149561
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9989453506658792,1.4407061176176854,0.5894690761613732
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0366197078046189,1.4704647962686348,0.6620292080209074
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8968404880376053,1.431300952338748,0.3838538181412952
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9634665044343969,1.3975608784047855,0.5622938991551879
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5726633602324223,0.918744600204108,0.2810644981953166
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3345330231265013,0.7227556583553335,-0.0396630714071308
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4442741010832004,0.7811986566392405,0.1381989567882905
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5331420709017352,0.8692104099300089,0.2498702759300469
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3175178003962152,0.700148045668977,-0.0515844284237627
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4167554500368676,0.7493296787987984,0.1165193210759831
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.347210061673114,3.2989481816190533,1.571832181274508
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9308857523749563,2.796856092270561,1.2560464202628947
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.145777410126533,2.8186433075040918,1.52051245141412
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5126891807316083,2.226707092956687,0.9315462996837583
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1548508090393113,1.7930340603558264,0.6576123138734714
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3371100984081874,1.8352430833422837,0.8774907881330962
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.46434185020449,2.165047224591825,0.8934795125614141
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1401726053029644,1.7725159154943255,0.64739575434695
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3066564956271325,1.8000386681469256,0.8481779415313389
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5022804456752951,0.9353225859904692,0.1629022454529776
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2381845856419826,0.6001382470640588,-0.0445679742756912
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3664281530832518,0.6588924628810056,0.1015578800006206
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4494141209133908,0.8671975094259172,0.1217596665751074
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2147474079536044,0.5677284777454499,-0.0621837128843125
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3289766947189582,0.6138022233117615,0.0670685908499122
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.684768156577058,3.0042206002513074,2.3697890278855693
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.173293982429182,2.5020959313903126,1.8619780749089896
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.440146193417889,2.7219166405292032,2.174243310058255
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.133344485429039,2.4044190290246306,1.865491310331984
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7497796691210326,2.0338792143633087,1.4796909202643267
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.9539420837970056,2.196192206153879,1.7251338462465204
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.146277642354539,2.419045436315689,1.8773294349506475
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.7637114743472166,2.050074390661694,1.4925776460525753
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9671648983974277,2.2101950875429024,1.737820661981852
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1137774150447668,1.2566553152450362,0.9641574240696604
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9572788091100108,1.109937816448213,0.7952264263463663
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0518167978557995,1.1783422783677702,0.9245302289411008
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0747033618313535,1.2174450967336023,0.9272197745559267
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9413490867787628,1.093547962558732,0.7811956882086241
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0241744812654316,1.1499619690250833,0.9002391921068257
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4296525975406025,2.2089994409012936,0.9538902790515336
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.564686972226401,2.169520295267916,1.083882237293269
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5157596735396492,2.08137069194942,1.1200744754115646
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1281497505915763,0.4903542197627088,-0.0948151323969186
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.17518566477506,0.4511165003417382,-0.0450046848746339
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1603883753583265,0.4212670335084549,-0.0226053552997431
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1003020101122525,0.4532400800208573,-0.1151535804932021
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1593913029100107,0.4328119979259594,-0.057961081266337
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.138282409110225,0.3941991723155522,-0.0407495967334752
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0862225281047689,0.4352401030271853,-0.1213364316516085
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0874223226494683,0.3150987412329774,-0.1111069107767437
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1012999668266,0.3353051242678843,-0.07075705163085
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0663983174149066,0.4093713519269394,-0.1373776361219477
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0760932251556696,0.2997568905729617,-0.1203977582360644
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0854772844208918,0.3169512569240468,-0.0839112869348318
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.434576904882737,3.11894134355107,1.7950276446044993
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5190779612163494,3.2254185555801715,1.890704879159117
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4734378039507505,2.991306897715376,1.9205973194608432
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2464539038755709,1.6948367839090253,0.8289934458876287
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2090568813190057,1.6529353139964296,0.814130984591229
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2263479138317783,1.5586894826171862,0.8739794848767655
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.197659505880076,1.635559152846079,0.7884354441533137
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1921422747042685,1.6321436313975604,0.800709287812507
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1935205247267824,1.5205614998098238,0.8443946678453924
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5138591126637332,0.8064488483323352,0.2371441324128227
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3888559788176747,0.6691676520120311,0.1443369649710779
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4470907796324662,0.6650886436716034,0.2119962511826685
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4765865470303737,0.764728646188106,0.2081621990522548
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3730692804754931,0.650400912008686,0.1325107849565869
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.420760336159006,0.6340803018230865,0.1907891895376984
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5108895716616904,1.1598047479698008,0.0174162754437986
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.922078383743641,1.6102436145038166,0.3448061280584054
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6995618221595917,1.325277501381595,0.2315361028655821
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3886832720407481,-0.1273274882236079,-0.587415529456605
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2163481561778819,0.0637833129041866,-0.4514373623938767
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3096978851087837,-0.0551841398957978,-0.5000907098876755
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3979059206042865,-0.1393112535860771,-0.5945565266878978
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2229363727686661,0.0552771355209695,-0.4563177357228067
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3178001030983337,-0.0666393825588466,-0.505664465127831
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.344801888961577,-0.068197742180444,-0.5559428716502555
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2198759927789378,0.0727193535607441,-0.4456450737351739
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2875255913123585,-0.021203814942447,-0.4841874973597853
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3517680662850111,-0.0783267738702659,-0.560804291165031
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2245351059055682,0.0658760146690661,-0.4487608806095018
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2934530050772337,-0.0291834150690693,-0.4886326661492928
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8296038227404542,1.563724151210368,0.2509511831342976
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1054774974855668,1.8958473973590748,0.500816821143378
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8888245136304742,1.628361404516678,0.3378667057887481
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2597332393886361,0.0373322063261908,-0.4938830914292202
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1415751312923368,0.1802833567367384,-0.388574829850799
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2328322094333043,0.0683389768105745,-0.4565434316294547
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2708973243489602,0.0216518543773489,-0.5014921572660943
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1487912277211784,0.1707418914505581,-0.3932452637149989
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2418305285142769,0.0550177438695279,-0.4629836250395883
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.243069948179507,0.0644257775425398,-0.4803070638281925
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1519924236013659,0.1886087685915445,-0.3986632292018136
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2363521507778659,0.0560617325040647,-0.458931779352892
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2511175295858555,0.0549459941447795,-0.4858645830590015
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1570544652899472,0.1807782715239896,-0.4021503413692748
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2427003972014059,0.0470144551513701,-0.4631802220553022
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7422404698827981,1.5062060217520448,0.1784594540383056
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0187798438625202,1.8147529078139504,0.412710179224703
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9034607967468308,1.6528082758106004,0.3320102142740974
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2950842703117742,0.0128082772214922,-0.5248046523454553
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1769259174591451,0.1479843143008655,-0.4241637126559363
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2268870506606167,0.0770732706017166,-0.4579959704286222
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3057118855838371,-0.0012692947617535,-0.5303803313011111
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1838416157628744,0.1379567674268061,-0.428865281780625
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2359555608003552,0.0648306573268863,-0.4653344061970653
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.3172206500697201,-0.0295229526308794,-0.5347415772629607
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.194592060256632,0.1028709851592361,-0.4423602557067083
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2424316347252949,0.0449422305776606,-0.4601611168759701
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3244745591350687,-0.0397051432795204,-0.5400586129800393
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1993974979610657,0.096064006608376,-0.4454272120456773
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2487284255610155,0.0350647440074892,-0.4646592865654783
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.04427626187752,5.674340267112956,2.441731310688299
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.616628973004441,4.322659727850337,1.3261194712781026
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.219060079805432,4.708305888328246,1.8758673787821083
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5515708794505256,2.3698977949537525,0.739094675685328
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8260027536775186,1.6885868526639949,0.1732368768618251
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1322170983915538,1.8825229215232104,0.4519531194936459
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5070514800263803,2.317208213064258,0.7105719687728981
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8121214759954851,1.6669326807502798,0.1655082899290622
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.105113392491845,1.8481773064758087,0.4349231391802848
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.12626787421745,1.807547508502808,0.4266492834339442
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4387409261042824,1.1721695477234273,-0.0831746867044087
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7310109733130381,1.3602810688698113,0.1669083701359005
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.081115460008173,1.7484349671685235,0.3986848890428544
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4218195598490343,1.14626714047461,-0.0941467746293592
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7021727219422303,1.3231455052273795,0.1473645987931241
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.894104756550928,6.41237802840859,0.5032508906828459
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1971708807297128,2.2215081481693426,0.4367923105013215
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5671957157623373,3.4792481957291272,0.549284301974723
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.921760856086071,3.9243830391736663,-0.0010724036336372
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4582767270386634,1.139557619911356,-0.0453114181998467
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7042609052116753,1.9763521629568288,0.0291830530919929
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8768218277619207,3.806914071735101,-0.0251444499892713
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.443103865146772,1.1158895291207425,-0.0563134825412401
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6757312600792874,1.923819238693336,0.0112918620223746
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5580476902769071,2.948527442114748,-0.2048743669211953
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.162531907680747,0.702973666617617,-0.2611669287114698
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3578365602228986,1.3917022247543271,-0.1935899687687223
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5194498376171918,2.850532446224725,-0.2232717424122328
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1474993316317534,0.6810479199671423,-0.271812312518262
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3321280958254802,1.3460421673331115,-0.2093097515791766
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.900552479471908,6.380633404086793,0.5359298178878911
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0508045101326111,2.0145701400189417,0.3215475077945925
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5945773357696331,3.9252283263991687,0.5104138581436972
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9260722360607188,3.899506156915348,0.0216543301382883
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3611442451907574,0.9996928364591384,-0.1225531767592887
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7224687549166598,2.271839158981953,0.0025013839310655
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8810031646987003,3.786327738878147,-0.0039522233611774
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3469702976629225,0.9799724541099736,-0.1320063754713174
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6936045512803101,2.21493177123202,-0.0140807332265479
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4458726047545596,2.638647586630584,-0.2448610860710496
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0474776654136157,0.5559225942751173,-0.3294221821345086
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2935957279586816,1.449254846230975,-0.2512244431979042
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4100350063329946,2.5530249108385177,-0.2637566501970635
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0339258871485207,0.5370213609329899,-0.3381170470547213
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2690841633144403,1.4027822655896924,-0.2654222663697002
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.6997655562537184,3.075870903848319,2.3610402519099982
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8737340286025963,2.098534555326682,1.623005054492333
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.191269893224531,2.4237246678072317,1.941032735836283
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5036497180934656,1.7595662220429982,1.2743768747733388
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8968686826450513,1.044819804158597,0.7315985696269571
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.132168921855413,1.289395889876625,0.9669798036935447
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4778256978168005,1.7297128731490283,1.2509728740790864
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8940219819362624,1.0421836193489311,0.7287714111643768
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1199422387242803,1.274360608752227,0.9537111340559032
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4528944990583654,0.5963215904394252,0.3253003604486347
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0574101138746252,0.1399761138388133,-0.032369032871468
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2108329139554322,0.2985207095182233,0.1265080728834263
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4189331911706885,0.5597331328243754,0.2915317612313493
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0446231418053899,0.1257208617984852,-0.0440610591769284
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1892285575839928,0.2754593550303446,0.1055528159744256
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.390756659836285,2.7325612406450537,2.0841857935015327
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7527612562904265,1.9901344760602704,1.518417436640046
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1830702141345832,2.4597147142940523,1.9267085737866776
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2945356137662138,1.523313008464597,1.0879142629972565
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8170091134440775,0.9733524712602398,0.6605220385593498
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1266806448117743,1.3136539615329257,0.9558876205699764
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2708746970694969,1.499789789413085,1.0655565061581225
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8142911899790006,0.9707392438671631,0.6598397545535157
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1144952390569445,1.2982685896732546,0.9441956755772076
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3753969832982529,0.5088529106569601,0.24595965479897
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0511743274800759,0.1433626146507333,-0.0364362723717937
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2505883366907284,0.3586738672994389,0.1496481136694591
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3432521829108355,0.4727637229618378,0.2189490598817896
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0384684497196547,0.1293328020508243,-0.0474105018538543
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2282814195999816,0.3344606769329732,0.1291515253215061
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6878999986638532,1.988848223358416,1.4281705377731575
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2674723692596357,1.5018861299815405,1.0480382344895247
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.419025081439654,1.6392404641594371,1.2063985175390126
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8189198787294144,1.0223426288015298,0.6415039059319221
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4966873510911029,0.6505366330330957,0.3513583373342772
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6162144535683783,0.7642617433301722,0.4752196469954318
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.800153979647006,1.0017065465657569,0.6262066516636786
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4944467609269992,0.6489442931469622,0.3498220076599565
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6069444510366088,0.7532322634324449,0.465697847342957
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2444999332811402,0.373455339615516,0.1302807012613958
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.021704354354759,0.0724201581883086,-0.1096221125974152
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.076718115814264,0.1697245452727577,-0.0066276939475335
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2154093557379545,0.3433919377833361,0.1044650595356883
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0335294428276926,0.0598595476177065,-0.1199203693309498
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0575073261066668,0.148441886067318,-0.0237490586207342
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5131576655334156,1.4799459930329404,0.0844721758319253
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8111113019942092,1.8711266372184163,0.0987466943579997
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6977208171060792,1.5001547941181108,0.1412914873347192
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3798813870248116,0.0161884167135046,-0.555727337446966
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2900712662574446,0.1247412337485689,-0.5697292149152836
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3198139076750256,-4.6300556254e-06,-0.543025133892787
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.392372513440939,-0.0041465044439928,-0.5645165619858292
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2982711901993402,0.1124397908089984,-0.5742822601486288
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3305207899510238,-0.014088983476386,-0.5499431262915782
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2584971852130263,0.1979771971593368,-0.4695752131136843
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2093685407638244,0.2676916206193569,-0.5247372583338568
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2152416643710018,0.1700086457939625,-0.4725294405390104
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2689163968777841,0.182799057874882,-0.4767138905403748
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2158459289971496,0.2567379305107276,-0.5286578080782538
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2239108876677456,0.1586837265123108,-0.4783783821970603
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6610653577265715,1.8162033400178603,0.1632848127690927
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.198621288175673,2.563720910947356,0.3271917349256262
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.783885272529567,1.81271075867504,0.2708783951424902
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.3192848552446998,0.1521724196421378,-0.5228440350607553
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1381803431890867,0.3966170158965608,-0.48029944322393
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2853011745801772,0.1274878244257226,-0.4905240162582801
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3329783198964108,0.1308818612309341,-0.5328683566586327
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1481275070973854,0.3807906949436112,-0.4857694966062276
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2965426994605338,0.109164332463012,-0.4988418263618762
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2069978304704648,0.3519397326062015,-0.440488518067566
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0733312949433587,0.5234663224542355,-0.4466898683011185
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2077188993165044,0.2569094798114866,-0.4313853710630492
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2181291717466597,0.3307683908386313,-0.447896828656526
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0809193553275788,0.5118771324543934,-0.4510112604635879
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2164663890985661,0.2442998230604305,-0.4377153470093609
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.711297683733187,1.9725991840731825,0.217934465812185
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0179023102996323,2.2276157461199952,0.2518969398010934
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8802335954715153,1.8186489624096145,0.3142249674270977
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2986972333885493,0.2167781462410412,-0.501707943807478
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2090211964873489,0.263715220938015,-0.5093932048618365
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2467030197936064,0.1289552654289455,-0.4731433892632742
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3128068977831351,0.1936845788830423,-0.5109231013317908
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2181484456855919,0.2505641997401082,-0.5149430360285395
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2585487027546034,0.1115060036643522,-0.4817485394804109
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2354030124751246,0.3180657195423118,-0.4589117053203078
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1971372572494041,0.3038492790345239,-0.5081288678788703
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2075748276710139,0.1849258741252563,-0.4526253409113499
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2461366094072982,0.2990291435723585,-0.4667215324847336
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2037091496940467,0.2940734046354329,-0.5119986992748047
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.216320948560883,0.1712587829728709,-0.4585180931886382
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.189039496076975,0.5997605873453083,-0.4497441688670303
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3960965396388776,0.1983704243918909,-0.6266822161869483
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2965453189087778,0.3329852619764659,-0.5209055834407185
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5600115862317805,-0.1332436489317244,-0.7013600811363274
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6665275362085881,-0.3375829452166656,-0.7936202006097297
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6150374353730681,-0.2704426926306872,-0.7384482723149298
5,Prevalence,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.564299327676047,-0.1405046730489448,-0.7043668163677095
5,Prevalence,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6665230087187198,-0.3382568741571546,-0.7938529922260621
5,Prevalence,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6170047115108587,-0.2742573349991741,-0.7391574621423778
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3013010935305744,0.3913334252105825,-0.5292486938366021
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.480660784112125,0.0412052950567642,-0.6784417588503575
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3944952965412435,0.1620945209928069,-0.588460286266128
5,Prevalence,138,North Africa and Middle East,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3160798602307832,0.3631714399087916,-0.5388540022985193
5,Prevalence,138,North Africa and Middle East,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48519746039078,0.0308665985560434,-0.6808715254731658
5,Prevalence,138,North Africa and Middle East,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4036755588931977,0.1437352197397745,-0.594480932700437
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3135932832487501,2.5112383225170705,-0.3054246923482545
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0565298148684405,0.5993770728853235,-0.3013904858874868
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1822441371697282,1.0572266045613063,-0.2484307582406357
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1277879147476739,1.3252410255756115,-0.5390366967163701
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2987841834860862,0.0599256614209304,-0.5362992230108388
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2151791557487911,0.3663014125235198,-0.5015778384973881
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1481370737454418,1.2770318563132632,-0.5495691386172148
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3060702411215815,0.050472339657714,-0.5411526254574931
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2282927844040633,0.3428500636564987,-0.509414858868187
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2494769005157039,2.363315103426024,-0.3367182749620456
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.0018628842364718,0.5249035013022307,-0.3329879249347064
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.1226283518647738,0.9408952470789772,-0.2796004232732789
5,Prevalence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2185842963130873,2.2889508650271067,-0.353341108450239
5,Prevalence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0110787296794254,0.5049040752623128,-0.3421534218200268
5,Prevalence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1014045935535034,0.9014718762494264,-0.2936110835478684
5,Prevalence,73,Western Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1483059680247614,2.3953222671967573,1.914518042576788
5,Prevalence,73,Western Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5547819047920406,1.693575253585827,1.3933526094132065
5,Prevalence,73,Western Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.958031196340636,2.134549389787707,1.779981192894306
5,Prevalence,73,Western Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.7324249431952568,1.9457173215583548,1.5259446859732584
5,Prevalence,73,Western Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.26092988271562,1.3829781452637897,1.1170455715477734
5,Prevalence,73,Western Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.5933957359105166,1.7473631137874237,1.4393003888252711
5,Prevalence,73,Western Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.74207261217558,1.9572158147739855,1.5384508949920948
5,Prevalence,73,Western Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.264880485913598,1.3879243929758818,1.1217692245286175
5,Prevalence,73,Western Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.5997549396808528,1.7548932782910938,1.4432703236489353
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.97105890630137,1.1159094927237154,0.8249502185548632
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.7758475435815602,0.8630607612548535,0.6853090925375982
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.9553129226924147,1.0705372753406373,0.8386798684296661
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.942389691952247,1.087638150550834,0.799604211778921
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.7629679065449186,0.8499172366649398,0.6744430288107721
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.9339137231983504,1.0487779047004755,0.8197654838810887
5,Prevalence,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8273161115514696,2.113956264425442,1.5810151680606128
5,Prevalence,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3787729658671208,1.543821657974028,1.217734940549199
5,Prevalence,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7073701946706916,1.9310336753458568,1.498617118798324
5,Prevalence,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.453833576553677,1.7039712567073768,1.2398701545016446
5,Prevalence,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1051663166156116,1.251057376071466,0.961512835037308
5,Prevalence,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.3736321879744966,1.5703947026984697,1.1912178554135018
5,Prevalence,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4625008351116775,1.7121551319711013,1.247980684161099
5,Prevalence,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.1088439920079185,1.2551639425592085,0.966079601690106
5,Prevalence,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.379453957702382,1.5760273540312646,1.1959850203753708
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9407586741797732,1.114120324596484,0.7971341066509742
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7941713669897694,0.9041864272411562,0.6875713023718492
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9379272834521616,1.0852715137394329,0.8183143729978366
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.912527320437098,1.086185204037107,0.7694105942200242
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7811546626925349,0.8892401869230531,0.6761293288653718
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9167148902733682,1.0603101963215738,0.7960930107181174
5,Prevalence,70,Australasia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,6.797592424851395,8.174167586010181,5.660033861871642
5,Prevalence,70,Australasia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,5.824943331086264,6.787529063378208,4.9959576668763575
5,Prevalence,70,Australasia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,6.541618745762153,7.561905395181667,5.6559924022176205
5,Prevalence,70,Australasia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,4.077473384491298,4.976559900346118,3.3378180217938613
5,Prevalence,70,Australasia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.371184044002212,3.983662798531872,2.83963812618338
5,Prevalence,70,Australasia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.869642464425709,4.53998561135415,3.2910934401666587
5,Prevalence,70,Australasia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,4.123870371627702,5.028430689515115,3.376370079323764
5,Prevalence,70,Australasia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.4547065143408178,4.082995530708377,2.9136195544197605
5,Prevalence,70,Australasia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.938911293329553,4.607084191632449,3.3589257362155465
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.6779380750025137,3.305208199542816,2.151285664547075
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.2097522282552853,2.619931952078195,1.860535420563836
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.5678163858578107,3.036083913041888,2.1588710880308413
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,2.6573694906131538,3.2994280864560546,2.1384327203034648
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,2.2483443711092423,2.662768842919659,1.8958522847512569
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,2.578572836661796,3.056013196611353,2.17981482439632
5,Prevalence,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,5.464396790865543,6.7535137667280445,4.392135483378096
5,Prevalence,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,4.210264494636079,5.079141548018756,3.484682091891388
5,Prevalence,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,5.231095957835423,6.316161444178594,4.33239266521875
5,Prevalence,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,3.209247732570854,4.065378895857747,2.509952150174731
5,Prevalence,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.336933892002949,2.895340353215515,1.8752166465972409
5,Prevalence,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,3.0233291492094447,3.712403015902081,2.444267834946209
5,Prevalence,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,3.247815143761164,4.094905876168872,2.543222284230884
5,Prevalence,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.400790022676991,2.967914478089729,1.9271953714986385
5,Prevalence,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,3.0806663971533563,3.791262141271792,2.492116910512824
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.326184921671272,2.97767437911188,1.7750441676396855
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6768121630037731,2.0820592835437965,1.3264122983486015
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.1899426177216506,2.698150163972774,1.7219131762557205
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.3076610073534374,2.9599104404516106,1.7597148426377038
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.7091030242559748,2.121210956749268,1.3578277300596204
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.1996551372471647,2.7181551357500653,1.740170615662602
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0875291493702928,1.7684975237717868,0.6116790705310545
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8875836535868584,1.5209137917253874,0.3828960501539833
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.028117954995141,1.561148941322545,0.593931073870752
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4209540323511874,0.8876158904114285,0.0968783803695613
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2873415028462404,0.7170455632660628,-0.0580557201205019
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3818633694239796,0.7440252800997076,0.0870049472675073
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.380400596174123,0.8306980927542796,0.0657397289391279
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2684563753892757,0.6940542819622808,-0.0706937369450197
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3519930415742588,0.7073245363145816,0.0625534453332144
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0188759717350664,0.296746259305878,-0.2402936503079087
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.092864882244824,0.17444994596542,-0.3452618146912933
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0452533187010663,0.1968776576888903,-0.2616781445516286
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0534981480039084,0.2504282368718554,-0.2670906810636517
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1119904449408125,0.149274604303713,-0.3587825004677326
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0723603762670957,0.1623246733964774,-0.2809080197770963
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0616117214415703,1.8134485349292109,0.5525498325670616
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9738003999267848,1.626575729994447,0.3489705517325787
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0432772779882509,1.69201172330652,0.5298544189046583
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4033004072727327,0.909594873190477,0.0576566056180054
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3461439209872765,0.7903172005803266,-0.0806603624910595
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3921854776392955,0.832155901286027,0.0429335824013525
5,Prevalence,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3632624244868437,0.8604224214512246,0.0266398987109183
5,Prevalence,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3263940362459944,0.7650591134454803,-0.0934916747630955
5,Prevalence,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3620986171159477,0.7945608680119688,0.0198383796595707
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1084564304921775,0.2206472588267072,-0.3269680334030047
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1492419876812131,0.1335829024017788,-0.4148234742108588
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1180132159461791,0.1580340104279607,-0.3379220176162468
5,Prevalence,9,Southeast Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1399114367849879,0.1785925590846631,-0.3506882261795842
5,Prevalence,9,Southeast Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1671804669825624,0.108775606999606,-0.4272666404192674
5,Prevalence,9,Southeast Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1430510943935957,0.1272975663570311,-0.3575306871792766
5,Prevalence,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1852052103276442,1.681760240309286,-0.6058359722700613
5,Prevalence,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.233434945968062,0.6005318670148186,-0.5743091616404918
5,Prevalence,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2090010730296915,0.8596754859432417,-0.5635184303977019
5,Prevalence,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5722589385568538,0.4103070110397857,-0.7932238723722813
5,Prevalence,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6028857841216303,-0.1706007817402954,-0.7795330446085839
5,Prevalence,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5875833686103735,-0.0308976026842449,-0.7721594827760312
5,Prevalence,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5821690433724731,0.3752204369209054,-0.797870660364942
5,Prevalence,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6074765863088947,-0.180439769778653,-0.7820229083350037
5,Prevalence,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5946760601188632,-0.0470644533615456,-0.7763379652683817
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4857983361562826,0.7295595689431833,-0.7531124772759712
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.514286427636502,0.0262602049875955,-0.7328292040136877
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4998381626103193,0.2010965589355601,-0.7257942750975093
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4951962828329194,0.6968188430210234,-0.7575887646409109
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5190343633584898,0.0159998136370737,-0.7350777733616394
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5068401257990547,0.1851531745559529,-0.7298778392889844
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0496023535047606,1.2256194658705877,-0.4548124504599158
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0311743540131384,1.4140780468130951,-0.4107400586009354
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0012817861996086,1.0964920289337898,-0.4037525028184331
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5587183502221513,0.0330591765027866,-0.746893787551048
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5275101740374041,0.1056231009803918,-0.7301469493333268
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5393566410277307,-0.0332358607781441,-0.7250298477066122
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5695991921218724,0.0079027654081902,-0.7531042268123669
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5338477596785086,0.091307096082529,-0.7336194012720905
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5481192474846097,-0.0514197272200114,-0.730221433845128
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4365072560683345,0.3451466424990373,-0.6782920249668134
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3912290673029394,0.4508763008424407,-0.6544701165745022
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4089024642402504,0.2675081239859659,-0.6482858600174424
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4467811476226697,0.3210903021925959,-0.6840498373691575
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.397560473510586,0.4364487897223303,-0.6580218895090864
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4173835818860787,0.2498005319068646,-0.6530235878062391
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.2395837851308227,3.7167359775947695,2.7762610301145694
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.298966629161823,2.641946908944776,1.989643192399423
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.6409903303216478,2.954495143150616,2.3440012403773847
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.868937552765962,2.1900588045506937,1.5569228524933814
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1775529040153403,1.4030776266646665,0.971451479774894
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4326365672932733,1.6445421642634035,1.2333544371393006
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.83935549188733,2.158916271153017,1.5290566334037057
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.174284485313001,1.400336090233258,0.970415448399751
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4186889389779536,1.626948383335991,1.2214007943588316
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7545662488706554,0.940864549449977,0.5743297812912729
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2776858871204303,0.4052843082521685,0.1616355754813522
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.454171947332663,0.5787747433128929,0.3321603723228554
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7135538098189076,0.8957863703735951,0.5345243424265046
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2622334182158028,0.3879719914530072,0.1468550168840131
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4282234766165608,0.5493272730904246,0.3095538244334704
5,Prevalence,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5252608180106785,1.4611280518689242,0.0841892243029903
5,Prevalence,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8346847609531778,2.0357498354921697,0.0906924387900439
5,Prevalence,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7191505336388665,1.5696948763045355,0.1373691255646432
5,Prevalence,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3630229294645869,0.0267529357188547,-0.5476924862165066
5,Prevalence,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2725675837094518,0.2045989806352831,-0.5677694886952014
5,Prevalence,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3007775503082415,0.0445839442342434,-0.53731086760164
5,Prevalence,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3754439014016474,0.0077702882520763,-0.5560516705882436
5,Prevalence,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2806310306596249,0.1902994328020952,-0.5723459897535184
5,Prevalence,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3113889436574024,0.029299219949486,-0.5444232836616447
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2351438674673647,0.2199434684134295,-0.4590054556602509
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1987883887996047,0.3400436322964784,-0.526665096986582
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1969975091867073,0.2150413331693684,-0.4711534731884169
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2456134291174196,0.2030233395229911,-0.4655929139846404
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2051414758358342,0.3295541952951099,-0.5304852341085637
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2056091511257421,0.2024119172438896,-0.4767194990439105
5,Prevalence,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6264118156063806,1.68294039943283,0.1557487851243375
5,Prevalence,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2109978438044038,2.7193535640753264,0.3129339352627381
5,Prevalence,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.763635477334107,1.718588023265864,0.2477584787664561
5,Prevalence,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.3208000164388659,0.1225422517250062,-0.517222847298809
5,Prevalence,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1233716723866364,0.4763334692757011,-0.4795160443206162
5,Prevalence,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2826943026935275,0.1055596624863283,-0.4925659246352921
5,Prevalence,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3340251016254241,0.0985968883847266,-0.5267498229329141
5,Prevalence,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1330809117937834,0.4583363839634579,-0.485206422420346
5,Prevalence,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2935703620556608,0.088938829864386,-0.5002064872672198
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.202698932574928,0.3209441816119582,-0.4353177774914351
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0671823564519349,0.5741621818731684,-0.4550299251118666
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.205481268599921,0.2451057896936801,-0.441949308369807
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2135995458306027,0.3015775546231175,-0.442890237770828
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0745743497439004,0.5612172073303012,-0.459146009465016
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2139958721983693,0.2319863547695531,-0.4479045478244681
5,Prevalence,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6935113182501195,1.854633757761753,0.2108893875631612
5,Prevalence,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0340865086644098,2.329541452462002,0.2572575054620002
5,Prevalence,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8832993983467224,1.8166742582444484,0.3123330901812977
5,Prevalence,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2927746894044524,0.1909468287957196,-0.4941697627046404
5,Prevalence,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1935144644621956,0.3181855786691817,-0.5015503470061982
5,Prevalence,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2340251981814068,0.1451215237784243,-0.4662550179603913
5,Prevalence,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3065495360734815,0.1689010178601162,-0.5041711274554607
5,Prevalence,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.202446792806593,0.3054933763058446,-0.5070368189956685
5,Prevalence,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2456386088774345,0.1282275742527583,-0.4743409272076446
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2210744792150555,0.3093265239652796,-0.443749729034633
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1890539771080915,0.3338249071197028,-0.507023856433074
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1942582578145686,0.2100558991807505,-0.4470006819593228
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2317264274172202,0.2919891898639563,-0.4508273160923697
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1954795229504602,0.3225703950233256,-0.5109369430652604
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2028919633128999,0.1967891809549755,-0.4527319582953553
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.776132146446513,6.926933672287045,2.7650395065838147
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.857378122818009,5.024831668148462,1.3618670682253682
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.6902974819893135,5.603689548420696,2.039718346154624
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.099086092076913,3.24375706040514,1.0172493076944356
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1202175295178922,2.306104698184375,0.2982959102233748
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.546223253702691,2.592924549554068,0.6485180522549071
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.074333482639957,3.219092809081708,1.0039338998976672
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1254367947683934,2.3197157504521733,0.3014018878425607
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5383419415539843,2.573850531682793,0.6450650727771872
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1296420126346964,1.909654517881445,0.3657501502610823
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4254826857393843,1.2580781342459617,-0.14419865488134
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7289804090399006,1.4524868766994812,0.1195329079253349
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.082218621398316,1.846882822169,0.3386173233651657
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4137650768265967,1.2434683069375227,-0.1513740897598667
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7021966861074084,1.4160070896477637,0.1040173195509236
5,Prevalence,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0531632630643186,2.2832710188011616,0.4758989031120613
5,Prevalence,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1335005774295337,2.059479685322278,0.5920884917352303
5,Prevalence,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0998014539469347,1.9764091835552435,0.602806876111187
5,Prevalence,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1819100920075795,0.3084628777972067,-0.4115757352815564
5,Prevalence,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.121831870663948,0.2581689671688122,-0.344120095912667
5,Prevalence,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.149521664846219,0.2030496357630494,-0.3498408575798756
5,Prevalence,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.195239170845184,0.2869156364540067,-0.4215045406352864
5,Prevalence,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1306157720583492,0.2467132243909254,-0.3512368176297166
5,Prevalence,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1607161053136039,0.1896611877561502,-0.3593632412797019
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1707237770351504,0.3355454772451115,-0.3894885072497198
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0939901968320879,0.3176742231643084,-0.3244025093109897
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1231929389696377,0.2373751697868796,-0.3273526550199209
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1802695436013123,0.3180292242003668,-0.3966348500449722
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1003632797951055,0.3091367935816606,-0.3290006043919208
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1313451321257568,0.2270289791630209,-0.3333540242774643
5,Prevalence,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.04501730671641,1.920448201703071,0.4217576445107071
5,Prevalence,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.3374495046286148,2.061305065435758,0.7722313961190439
5,Prevalence,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.1355123005976466,1.846265880232184,0.6112954692993529
5,Prevalence,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.3316783534093189,0.9110245008863518,-0.0747143175721323
5,Prevalence,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.4970801217323672,0.9617166750177336,0.1363545340335516
5,Prevalence,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.3789300601674632,0.8433193485073648,0.0421572847473249
5,Prevalence,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.3437998572424454,0.9190536254355364,-0.0657498528486598
5,Prevalence,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.5256758964992827,0.9981434212451892,0.1567525710069603
5,Prevalence,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.3985201551580146,0.8639837379205322,0.0552171434925894
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.7452283861765452,1.5123242682968163,0.2088892012323291
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.9760402399521864,1.597363143976248,0.4943112565304668
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.8131037109207635,1.416902425386259,0.3655963408705941
5,Prevalence,70,Australasia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7353898616568723,1.477064020593807,0.2014482089430169
5,Prevalence,70,Australasia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.9997903948009904,1.6304197345855165,0.5115424894956221
5,Prevalence,70,Australasia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.8185311760729878,1.4257733168181637,0.3686997618532206
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3706944908129037,0.4444308272729483,-0.5518935159140409
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5634988611220435,0.0514912205170187,-0.6791998343459743
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4615576702525836,0.243906088470125,-0.6071351590914196
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5703275660836844,-0.0148734446431449,-0.6941704709482175
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.710881563829643,-0.3043429386966277,-0.787383628709396
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6380400928388542,-0.1645031254484945,-0.7358510931703904
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.573008283620226,-0.0199354858249528,-0.695954105013431
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7106821324881831,-0.303059784885375,-0.7873700397138929
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6389835122988163,-0.1659819774937403,-0.7365907597334831
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3679322709555184,0.4343644570350468,-0.5483072313862626
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5624308169503401,0.0451477616009723,-0.6802791569169921
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4596872482997283,0.2370047399186187,-0.6067098830979742
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3796175192557578,0.4099212446885257,-0.5569799616519127
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5659232051951258,0.0379471019560359,-0.682950187552821
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4669010331598289,0.2209074063233149,-0.612455640540964
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3431242700851858,0.998648048936588,-0.6819728169828331
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3066373282366501,0.9479611274154912,-0.6967228073215757
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3257507312966269,0.8158965978036183,-0.6746899463926843
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7342138971709571,-0.1898778299983018,-0.8714649434744781
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7173010743564231,-0.2050107785246683,-0.8763258121773452
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7261352402613704,-0.2628452546938807,-0.8679912307952763
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7382330282116697,-0.2035326872121881,-0.8732652024522618
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7196852546367856,-0.2124724193469673,-0.8773901848163832
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.729358017108792,-0.271103612911476,-0.869421351940002
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6795595567887757,0.0203123566075895,-0.8458492428900782
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6522738390957129,0.0163775910557088,-0.8497969391472178
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6665917702603354,-0.0668304346541975,-0.8402665081957348
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6829751835382154,0.0090687318663379,-0.8473158144736759
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6543557020601976,0.0096385910358446,-0.8506790627709748
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6693718959122466,-0.0753054043212623,-0.8415007162556993
5,Prevalence,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3272966525434478,4.166521702639216,0.9038543076563296
5,Prevalence,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9054408429262424,2.4798892062265265,-0.01817434517367
5,Prevalence,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7238893233213473,3.322162524330816,0.5857632449914412
5,Prevalence,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.938557625068674,2.0113615382946683,0.1071128688115308
5,Prevalence,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1080674925371204,1.0208413027944725,-0.4285841736717
5,Prevalence,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5855311525069212,1.5065371014976197,-0.0757669842927446
5,Prevalence,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8973884555019987,1.946205180170712,0.0856715109978305
5,Prevalence,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1010813590857512,1.01089482829358,-0.4326405196913895
5,Prevalence,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5634292857458846,1.4807892928823565,-0.0898203255718095
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3289338338966251,1.0330623624142796,-0.2480803751354831
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2425031604377721,0.3905778956239951,-0.6152539184199541
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0881560786729129,0.722465913384408,-0.3708109611648475
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2922329417080903,0.975828338285941,-0.2660997962936488
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2517037467697895,0.3729797741378319,-0.6200452006446299
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0662946142389008,0.691567825426952,-0.3835466646505966
5,Prevalence,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.97708354923028,4.9978421457804965,1.3011895923525807
5,Prevalence,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6564138194963227,3.804817134352098,0.3813495800059391
5,Prevalence,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.653532385925808,4.489435353697342,1.1626223211778384
5,Prevalence,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.317107371535665,2.5063349097154357,0.3375376234411892
5,Prevalence,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5447706060871861,1.8003985822267583,-0.1962838516041651
5,Prevalence,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.126648927805175,2.190886791373228,0.2634955279905483
5,Prevalence,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2679289528056006,2.420265048091813,0.3122516632574649
5,Prevalence,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5350399092806698,1.7765199849112845,-0.2017709295085435
5,Prevalence,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0970160129753517,2.1507682491719065,0.2412791672513548
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5840049845047381,1.3550931429894328,-0.0846050358182199
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0729509937242881,0.982216844573393,-0.4500359937714093
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4692068126011799,1.2041546607943985,-0.1336567727907252
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5402832917121443,1.2936651725344,-0.1073226233869363
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0599292552926977,0.955384751034522,-0.4574337595833099
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4397043316247691,1.1581667936234048,-0.1502393112160513
5,Prevalence,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7210256524820324,4.714521589547296,1.0890035237443838
5,Prevalence,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4086459958254856,3.148883539736429,0.3420811850581685
5,Prevalence,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.908441447102896,3.5201557612370573,0.6925172560095352
5,Prevalence,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.167923293012166,2.331653733334693,0.2145090975417058
5,Prevalence,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.400682904659446,1.4178495060726652,-0.2205048326405952
5,Prevalence,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6929449344438898,1.6193370179712665,-0.0176445243534318
5,Prevalence,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1219121265455017,2.2587017104217697,0.1912527145500229
5,Prevalence,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3918643638219954,1.3974810572475618,-0.2244626325014351
5,Prevalence,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6693565686924815,1.5944313642795138,-0.0285467834467512
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.578341578223078,1.424019894927372,-0.1150573284439901
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.046807480077819,0.8468886725437379,-0.4359679125974141
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2529845609306416,0.9791049183619208,-0.2787169751780077
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5347797049453351,1.353841977253529,-0.142285607339181
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0341074214095283,0.8281700834120418,-0.4418032928896531
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2278261199654259,0.942437493586212,-0.295106212835012
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4206604663585804,0.3580875089175155,-0.5701126893658349
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5431132464455823,0.0344228801402462,-0.648965191196254
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4782656343808317,0.2025916530665158,-0.6003244048587295
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6079593210284715,-0.0804056085460172,-0.7091604157789694
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6984247797176982,-0.3167416680777382,-0.7682667986725231
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6514180429352254,-0.1960883004496171,-0.7329471421342031
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6120017978459531,-0.0904547657643384,-0.7120936964088975
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6988748625048107,-0.3182320792031856,-0.7686398122854845
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6534148611440329,-0.2011252803513386,-0.7344978004755582
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3729785839981668,0.4836930590942249,-0.5363881756805557
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5058578563147479,0.1271309877665246,-0.6212551241321613
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4355352191408503,0.3125223944655043,-0.5673300510012951
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.387633996875359,0.4474824464940423,-0.5468838538896108
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5118306872925157,0.1124635868022516,-0.6257707839435871
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4456046273806007,0.2880162017308304,-0.5751174405890623
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.281766326133503,1.3245117605478538,-0.1292542807376658
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0883970650612913,0.9412793274380536,-0.1984255935855905
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1817659664693097,1.1420241638261492,-0.166743174575443
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4747068097533004,-0.0472879910463849,-0.6430551454277763
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5733607007794937,-0.2396865116344377,-0.6859836026538629
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5265265550779223,-0.141870654112762,-0.6663117122877151
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4852906152182172,-0.0665630748790742,-0.6503411079499637
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.578292302513369,-0.2478366015198734,-0.6894239169285176
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5339824205941835,-0.1553142126462204,-0.6714135117904404
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4200366172713675,0.0523698732645469,-0.6064526227776688
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4887106547593194,-0.0910811564243995,-0.6250950599966798
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.454364407676826,-0.0102248914070128,-0.6164961677596499
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4281892189743616,0.0374383912185793,-0.6118274077033087
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4929025905837299,-0.0980050105768839,-0.6283343848125473
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4603947663846583,-0.0210794844620131,-0.6206209129944797
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3100781390525902,1.6513447779311197,1.001218700511258
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6751329434802025,2.2094583758121216,1.225803217382284
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4547267402049142,1.7842082478584715,1.1511532313675503
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8541434556266426,1.124121469560865,0.6130980286934633
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.105766594313774,1.5262126456531262,0.7516405385717386
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9512804955176748,1.2155539988181228,0.712909047626561
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8181234887560884,1.086713923678937,0.5750388110376492
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.090242102195382,1.507742667038683,0.7391537895390611
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9250892107273346,1.183481024825992,0.6870154255871321
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0621925222140438,0.2123645902588261,-0.0651282923956178
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0589388596415681,0.2591231152333261,-0.1165261044891302
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0375569570432582,0.1732194409207024,-0.0827446788944637
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0196979151206429,0.1638053193923865,-0.1063100733882296
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0351393149277103,0.2290522599763419,-0.1348826972403298
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0046582918378752,0.1354146459193727,-0.1152319366834829
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7956213859564956,2.451393184092904,1.2827619617779409
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7656101133815367,2.507744065777873,1.2159897544536429
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.788451920993387,2.3336426452168597,1.3858865323434189
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2439201060856475,1.7760545202666158,0.8338866305864165
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.177024723151273,1.7586095089679552,0.7439999104943972
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.216608822408065,1.6515924933534256,0.8951133287474017
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2002653596648112,1.716383879337306,0.7966245694396925
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1609373512954877,1.7408111988917898,0.7314859413179948
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1868090732120231,1.6143681834792645,0.8711021256282675
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2776977477237095,0.5535379232907163,0.0654345447809504
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.186044533961453,0.5044414567252226,-0.0493410112024801
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2420314976208558,0.4719615236570559,0.0667613594033308
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2265517753499692,0.4938131345917519,0.0172644928710323
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1593675084706576,0.4739502973835501,-0.0724652131131656
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2026256660991763,0.4257934650733938,0.033395548542922
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0567676606016927,1.6703843033598818,0.5580653998004439
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8769568162139991,1.4474721760373075,0.4503408782574009
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9725810737743626,1.428947076765949,0.6067298687371564
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6508401230121554,1.148482205436983,0.2472017931307448
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4774859280189507,0.9280201727245014,0.1412581209521755
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5680353867351049,0.9274061872287056,0.27484425057434
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6187580547329383,1.101698788394811,0.2262595158608379
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4665791361191552,0.9123570657574585,0.1332384708794091
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5469724104977013,0.9048718272077344,0.2600581091975386
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0636862703012348,0.3807143948886691,-0.1786101090326746
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0868866182492531,0.2029700289525754,-0.2935480251097735
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0117810438026654,0.2122592377330036,-0.1907430520807592
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0211234644746933,0.3238851311427648,-0.2092173774913557
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.10741949972978,0.1742393501204531,-0.308583889633329
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0431262716839188,0.1724991955271939,-0.2176866346724266
5,Prevalence,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.335644237224214,3.13065844871831,0.7508155897989226
5,Prevalence,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.376077721585025,2.332268350000449,0.649902864171134
5,Prevalence,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3593036626133554,2.374496851975209,0.7911881832901564
5,Prevalence,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0564721129028986,0.8692690141355977,-0.2078231562043188
5,Prevalence,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0531187115508166,0.4769499468665681,-0.2694135364579788
5,Prevalence,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0562091737768344,0.511274132749568,-0.1975999073691553
5,Prevalence,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0353562713731404,0.8310593118683106,-0.2238895496043109
5,Prevalence,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0415845901965187,0.4607431954897217,-0.2767436085822254
5,Prevalence,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0399505292102161,0.4874345522537066,-0.2104674236531493
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0576080598715183,0.8631915929643468,-0.2151492114533216
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0100510266516205,0.4404360239347023,-0.3109797069912191
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0358728805801948,0.4899740164074027,-0.224353332770439
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0420267099818439,0.8368164618323652,-0.2273436798657734
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0015241952866725,0.4282223920178447,-0.3166535226738829
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0238919591396992,0.4717703134741894,-0.23305168241848
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4163814181365626,3.3128809148511182,1.769276343612797
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4282391186019283,3.364270645252235,1.5949115596458427
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4224547597124517,3.1327286422772787,1.7538369484704623
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9869360845700528,1.5010096170269769,0.6109134589797789
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8933066957211667,1.414072894206798,0.4328986447464391
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.940561714354918,1.3454872281231354,0.5610381610533204
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9447755289635532,1.4551079741884738,0.576410888258893
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8761029951926279,1.3883460126690514,0.4200646981990246
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.911087917962395,1.3077026085033827,0.5377338459552072
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5470201719104865,0.9430376884732492,0.2633330710585524
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3389467672911315,0.7371572759604776,-0.009960449467289
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4341701669629578,0.7481746656469426,0.1412078675907287
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5148971323454141,0.8980662687542551,0.2355004509387693
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3247474006929732,0.7169283520080112,-0.0201924643906112
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4115256206139802,0.7203797834076071,0.1245664519936263
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.2851419038386192,0.9633180366109144,-0.1989002379742778
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4068042188296733,1.2203586409892808,-0.2004453795801134
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.3364051706321562,1.053981558125967,-0.1709430071832773
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.480019530893196,-0.2054873113444085,-0.6754684555485241
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.4264259780714907,-0.0946391442696925,-0.6737062075759654
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.4571962649476044,-0.1670563835805086,-0.6633056509958317
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.4878670513070247,-0.217611804339769,-0.6807593137395717
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.4312529612039306,-0.1023467336638606,-0.6767536543941921
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.463570281623742,-0.1755369007930791,-0.6672185809007514
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3744341797565862,-0.1386519902885147,-0.5642232678596937
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2886259064104914,-0.0228074212101419,-0.5366586700730673
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3406556980692484,-0.1177307456560431,-0.539809641043673
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3810864089802606,-0.1462584668098247,-0.5690988237664716
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2928756898056417,-0.0282198689927413,-0.53896416876049
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3461412024153478,-0.1250750438462912,-0.5435516572947301
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5729607753855763,1.1905663883545536,0.0628130963606205
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8051660058670604,1.4825292669790442,0.2702850439054302
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6407286331402142,1.280359899166835,0.1725245274987716
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3635661251233422,-0.1131256129566564,-0.5695402268249218
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2640097356277259,0.01243353716826,-0.4825187505771051
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3335921677159378,-0.0734371454340969,-0.5237081822063963
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3731703575531656,-0.127052646540567,-0.5764657557870538
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2702020603646483,0.0036443951621772,-0.4864453436533092
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3414155991397871,-0.0846691965970568,-0.5293515650063683
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.4016196376118831,-0.1666893316392957,-0.5909705821290174
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2890228053537335,-0.0314267096135867,-0.4952627610353675
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3684943489034301,-0.127898924607237,-0.5542845815574382
5,Prevalence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.4079832939547069,-0.1751707237325758,-0.5957542375305422
5,Prevalence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2932719817681541,-0.0371183702563136,-0.4978386576092511
5,Prevalence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.37374825937284,-0.1351684064675388,-0.5577511263886176
5,Prevalence,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0558426650756327,4.614769654002373,0.2041719035275104
5,Prevalence,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6524862864537208,1.4524266672149084,0.2675332360555202
5,Prevalence,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8810893214637854,2.5878005069146406,0.2798990567530379
5,Prevalence,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0792721532130473,1.94680213281676,-0.3670224237306924
5,Prevalence,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1439497861067008,0.2717938514527414,-0.3440772722246912
5,Prevalence,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0192133382227545,0.8705331762472008,-0.3325730947790029
5,Prevalence,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0542466867880335,1.879282741508936,-0.3824944577797173
5,Prevalence,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1538362532639965,0.2557771609585904,-0.350953359840068
5,Prevalence,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0360915684621983,0.8384619591585963,-0.3441536889053648
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1485842112842139,2.1266669246520182,-0.319100820856804
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0877421530300621,0.3204000080069643,-0.3339512327149558
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0327513344387168,0.94765038930264,-0.3129468111496952
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1275751311478525,2.0669878959576917,-0.3317809311355427
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0966498391826857,0.306975764894375,-0.3402457637839804
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0182855948308714,0.9186568174143872,-0.3224009457395489
5,Prevalence,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.491546112476879,6.084639805627572,0.3697386200014719
5,Prevalence,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8732648070515862,1.7493708103018326,0.2770124272694872
5,Prevalence,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2990369707567353,3.980059405106102,0.3955234664953619
5,Prevalence,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3080276442776835,2.719500372516233,-0.281558834250327
5,Prevalence,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0295740537288203,0.4244536045594385,-0.3391554128378728
5,Prevalence,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.198720793134984,1.5951531097535596,-0.2721182033569039
5,Prevalence,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2776776543655023,2.6330397111856425,-0.2975909944698796
5,Prevalence,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0407855237545679,0.4078288728217861,-0.3460994932637525
5,Prevalence,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1780733085046175,1.5518837385167312,-0.2849053894383936
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1535844039147225,2.280062260868815,-0.3693631996665324
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1338968913960378,0.2793582144792588,-0.4133143434327274
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0459678093041712,1.2822614328479962,-0.3701822471393389
5,Prevalence,261,Southern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1324739662715469,2.222852240225442,-0.3807784238192398
5,Prevalence,261,Southern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1423572311258629,0.2667484325668972,-0.4194424833617748
5,Prevalence,261,Southern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0313059875716179,1.2491186237537164,-0.3791257660033551
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9349035062329684,2.3133727769016303,0.3340973791350269
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0248603299626386,1.5469853970354452,0.6390400979215848
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9915166005444996,1.642908462716055,0.5943034421192427
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1116377313792233,0.5181761564321421,-0.3878508010314908
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0809332143214626,0.1578911769227365,-0.2560796365052146
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0909259534642895,0.2076464565206343,-0.2725804003519199
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1331614092081997,0.4843941206603542,-0.4023231192753853
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0934952143036557,0.1402536843387773,-0.2662221335821548
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1081133185717158,0.1836079385359262,-0.2860024336263876
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0952216580162537,0.5594756963449165,-0.374896099783528
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.121164161688749,0.1199176529985818,-0.2870069811648245
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0943348978757095,0.1992280826330624,-0.272263531040943
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1110185986649299,0.5341037180594318,-0.3855571541246426
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1300568684180601,0.1088009098637286,-0.2943627665726524
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.106824953960699,0.1827090191862431,-0.2824778432196931
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1141318846788093,2.769679011770416,0.3951297969876503
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1796954622286435,1.7950411290725357,0.7549510417899288
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1340203779724776,2.3350872040498727,0.5561713372609158
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0293464332953049,0.7315120773420984,-0.3593899839944585
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.01066339535179,0.2682629654565605,-0.2034522567580374
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0258813145752124,0.5232803738288524,-0.2893649637948309
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0528669270795479,0.6888197430900991,-0.3749805386693969
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0241774513369394,0.2513051503997383,-0.2143302456447913
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0442940056388067,0.4935953121760141,-0.3030796281868899
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0322863705777333,0.7459350765680606,-0.3609501841896418
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0609926635610423,0.2323183059468829,-0.244061026441947
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0579337381899543,0.4774335720011129,-0.3077437585486161
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.049185608900528,0.7162502465783942,-0.3721792033565958
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0704893530927051,0.2200070409995115,-0.2515470629681191
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0709238746219946,0.4568989634606835,-0.3171432714009657
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1985864638858656,2.7692209810741506,0.4823265417213239
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1200637754192395,1.6381798668901917,0.6940087276009518
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1474432504876044,1.9028160212743304,0.6803935264729901
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0094265037330252,0.7305482556991187,-0.3200004647021871
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0377243758247747,0.1971794244842611,-0.2316170163560499
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0197526855168087,0.3230348177898621,-0.2332667613709931
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0150311961555326,0.6886145449073415,-0.3359163150101373
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0508738158574835,0.181080314269294,-0.241613361742353
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0382826667328292,0.3000057078627244,-0.2474475957620425
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0420184120750649,0.6927339979711966,-0.3543458284692055
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0997886959858282,0.1300836284941164,-0.2820634549627872
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.068200149898223,0.2688170366834324,-0.2775781271902539
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0587459665050385,0.6623397012409402,-0.3654693283382827
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1088951723441199,0.1189358539960124,-0.2892117704104273
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0810484819422416,0.2514966582124853,-0.2871127457255239
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7620231159479621,1.848706569329508,0.3475920981487653
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.976705462814156,1.6926110442697462,0.4413097009313138
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8897749563385129,1.5914634055667172,0.489254185992872
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2122705877662555,0.2747117192412422,-0.3974455683779127
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1340664814142196,0.1792460858194644,-0.3682519639022157
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1638171299016034,0.1465107928746894,-0.3407253520804975
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2289068980319661,0.2466453846487886,-0.4102693876464274
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1441717054229369,0.165784564937683,-0.3759750015820163
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1774677519235324,0.1279450040541599,-0.3517960488081612
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1562784272694775,0.3566971125032886,-0.3505255893580844
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1370316964085574,0.1892373777731271,-0.3782457455500183
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1353260444581741,0.1896607875254412,-0.3264044940408248
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1691878187965684,0.3361612549246568,-0.3600550945176766
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1445934515347916,0.1786903900550082,-0.3840081622050643
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1457145337783787,0.1750699560005179,-0.3344848914832143
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.913693603744237,2.2763037684571783,0.4769211671842278
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1882961847149154,2.0205118741620165,0.5683625844509193
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9843878917517028,2.0762886985115934,0.5801370219595156
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1444670208059466,0.4628246134280087,-0.3398895789115202
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0413832284986568,0.3235639475677004,-0.31255743478939
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.121958346576711,0.3613219100596939,-0.3015849840570336
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1625331564769841,0.4337696327270052,-0.3536726539744396
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0525620397042755,0.3077514959328494,-0.3209665773786047
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1362870863625321,0.3389671878293839,-0.3122389242264882
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1095828377648264,0.528104523775595,-0.3150666694418091
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0598455553108306,0.3067972449842572,-0.3383537926256717
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1198912132226739,0.3826097872112091,-0.303235618426407
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.123206817684915,0.5045024975971996,-0.3257696720027717
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0680787993757225,0.2953472324913273,-0.3438604508621311
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1304622700077982,0.3658926468531728,-0.311799651785724
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9596537910332692,2.319261730147584,0.5110609040604311
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0664992996375469,1.7893376231347573,0.5292941997203517
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.023146047054759,1.801565885876423,0.5876789313490127
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.123918274593732,0.4842515056353063,-0.3244773889374862
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0947364721905626,0.2223879916106571,-0.3301726193257908
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1048088101076484,0.239802988681735,-0.2970746479471221
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1424201494097285,0.4525688117129504,-0.3387324892456237
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1052948430487693,0.2076630059030172,-0.3378815046173046
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1194174413787271,0.2193929644983072,-0.3089562774414172
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.134332412005606,0.479386892734866,-0.3295156892537021
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1321715627135889,0.1915796516552674,-0.3736556975970154
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1264873568049908,0.2261240178544918,-0.3226941804381744
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1475785006069476,0.4570991137141448,-0.3397290642003761
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1397716093960269,0.1814648050212077,-0.3790403578015475
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1369783773592233,0.2110645593993304,-0.3311110241510666
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3756357779407864,3.9252062258262463,1.022757707626652
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1378149119111172,2.453213933390093,0.2275744870236899
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.8338873537669225,3.191465331726736,0.7390651836394779
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8111725285068409,1.6485570784661348,0.0855323996316392
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1750643180280827,0.8989117779526536,-0.3259048005808548
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5384511415296723,1.2786508978486664,-0.0551208770792682
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7966746317784998,1.6214300547607137,0.0766082891040459
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1779479038629922,0.902740079023484,-0.3235996316759881
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5336714047090823,1.2683789863961803,-0.0588353698929763
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2307266998999521,0.7632620105682866,-0.2545466555457147
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2345076709828915,0.2546588766908506,-0.5671530407539015
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.021307256909169,0.5166882303194534,-0.373421486809105
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2033033140266483,0.7232177273228255,-0.2704685843745867
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2408078388545057,0.2441105620497017,-0.5707351022215841
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0054745722514127,0.4935709181752344,-0.3819580750015358
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.2292570544504646,4.760644616002693,1.7557720977929576
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.876100999909038,3.3594297204118795,0.7512638413974659
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.89423832206044,4.306017881673109,1.5722643395351206
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2691315399741452,2.0995126370353465,0.4751719510039951
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5808588704270217,1.3972857906152898,-0.0387318969926924
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1140617561222192,1.8787099278108188,0.3958924479188238
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2510126568325264,2.0660902790220943,0.4667535672607373
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5847476436173237,1.4020700167193474,-0.0350438854217486
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1075227107130796,1.8715636446099928,0.3920836541558502
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5402659719945017,1.080853574257632,0.0048867801313014
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.044600422586703,0.5906834599597472,-0.3698981690754879
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4142482623163834,0.9053873552142996,-0.0659478053339971
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5059739533130342,1.033050686453121,-0.0158460131155469
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0360124992737951,0.5784428998304285,-0.3746180504830059
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3923451863265719,0.8786686880629186,-0.0788369390584642
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.67096170585202,4.035406310498559,1.2830396919969895
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5341326183101305,2.7821344849255407,0.6113225201947681
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9713740088832512,3.108065586177473,0.958228975880235
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.969598653317675,1.7063189910999006,0.2202664131939351
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3929034433608581,1.0816709731813634,-0.1159958583850853
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6130834736893397,1.2326560779794042,0.062909841642076
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9538611997879862,1.6800838046245008,0.2151427961391696
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3963211638283143,1.0839771318945743,-0.1121523315533983
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6080778031146952,1.223243880818008,0.0597738756934652
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4046024334312185,0.9312105225493316,-0.1333703021028033
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0106044095745667,0.4977409813889542,-0.374920534039865
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1501748013381299,0.5959441866375803,-0.256999959479624
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3733283049644148,0.886728303828713,-0.1522286290449496
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0187407747670992,0.4849165971786098,-0.3806105644109379
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1323554023122879,0.5716313292716113,-0.2665617260478472
5,Prevalence,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1847663902073213,1.1619300042043732,-0.2095903829158819
5,Prevalence,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1086498723236492,0.9323071380034356,-0.1990139210258616
5,Prevalence,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1454531564871205,1.0113447061503555,-0.1989006336808347
5,Prevalence,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.505214995306486,-0.0954735498124901,-0.669831214477406
5,Prevalence,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5604287747442339,-0.2346282843553797,-0.6826074059461504
5,Prevalence,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5341110561948552,-0.1818961000013218,-0.6738508856902783
5,Prevalence,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.514867840515682,-0.1147438176313594,-0.6763470608361104
5,Prevalence,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5653049870003496,-0.242353877953175,-0.6859381282546559
5,Prevalence,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5411852001057806,-0.1943496653317294,-0.6791171743938116
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4563162545378165,0.009949701186407,-0.6383455463144423
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4710293531852509,-0.085354161597742,-0.6176521841323594
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4633206030741035,-0.0625633857490831,-0.6282241205796166
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4637630370589024,-0.003740143279963,-0.6431858142939502
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4752268021625292,-0.091961509322856,-0.6205293739608756
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4690795787768652,-0.0726016474768011,-0.6324768194489034
5,Prevalence,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6884128477231809,1.041742652471576,0.4380210739534148
5,Prevalence,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.2913394060524275,0.4777749544181103,0.1408806490901353
5,Prevalence,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4514349611280903,0.6785602162821818,0.2896859880189512
5,Prevalence,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8537087496759586,1.2407129181678602,0.5779194660171629
5,Prevalence,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3948636233638655,0.5958673971650357,0.2321452386698073
5,Prevalence,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5802375382331284,0.8271315623555977,0.4044848966379983
5,Prevalence,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8416270882490534,1.2270196422016406,0.5685136291380561
5,Prevalence,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3947256963315885,0.5960875139889477,0.2322210181734931
5,Prevalence,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5751941939873972,0.8216856957137781,0.3996534014968324
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1772737040484307,0.4026370201629152,0.0186174523443332
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1260043244039481,0.0040182908627158,-0.2258558560780814
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0033095794395577,0.1519936076648951,-0.1165234197881664
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1451444419717207,0.3642691709381951,-0.0077824364144687
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1404380552459984,-0.0125098300612753,-0.2388346813680613
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0253060473084773,0.12697192460667,-0.1349335823584083
5,Prevalence,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7269839668366347,0.9860758263990635,0.4854913979467675
5,Prevalence,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.2449274629102887,0.4348828677869232,0.072296557001862
5,Prevalence,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6009343712663323,0.8320565221873755,0.3938283734674404
5,Prevalence,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8960728611210065,1.180516767688045,0.630821068103496
5,Prevalence,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3447397381694816,0.548558458455958,0.1583156300842153
5,Prevalence,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7430151615366095,0.9947324055489788,0.5176068636660183
5,Prevalence,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8836983256713516,1.166301355823855,0.6202916256582831
5,Prevalence,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.344597953451889,0.5497614318501917,0.1581459956451374
5,Prevalence,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.737440942316562,0.9882701423723128,0.5126756762110632
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2392863055603402,0.4192287209154829,0.0862346779193733
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1114685020281789,0.0138291809681031,-0.2223111729818601
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1644708929660251,0.3310099988286981,0.0291664170862495
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2054541650534824,0.3813694674462601,0.0553371368295303
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1261525443951012,-0.0033407211229479,-0.235831958804641
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1387625503678487,0.3025302120048642,0.0063362162986145
5,Prevalence,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3945523708672094,0.65306408203623,0.182107165201051
5,Prevalence,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.0327944151215005,0.2210728777469647,-0.1140722163601592
5,Prevalence,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.1774075232262154,0.3733387975377101,0.0197606719586914
5,Prevalence,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5310919628913482,0.815113615450188,0.2966662027655734
5,Prevalence,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1155909923468741,0.3191790454409708,-0.0436777008672512
5,Prevalence,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2818930458482444,0.4959602621269159,0.1094642053045695
5,Prevalence,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5211003787576407,0.8030706152199356,0.2893769314674633
5,Prevalence,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1154812615849416,0.318833539583095,-0.0431437009160595
5,Prevalence,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2778013098854572,0.4904390194498882,0.1067124140909132
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0734043567692268,0.2557655476227528,-0.0847355280687527
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2323758831133735,-0.1112613924742435,-0.3295687343585833
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1088723625995161,0.0255568989937836,-0.2220071522566394
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0440899787016769,0.2220265392487646,-0.1085207450350123
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2450549214128013,-0.1248156188035168,-0.3418679373320594
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1285460440666474,0.0031740033526878,-0.2382899440888044
5,Prevalence,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3645486971412617,2.668596713578104,2.069382728881242
5,Prevalence,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6619281182989545,1.8417671973581744,1.4727187584099934
5,Prevalence,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.053627466178526,2.248491108880865,1.8426530412959543
5,Prevalence,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.9200904949819824,2.1849356199620784,1.663751139905732
5,Prevalence,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3557516521160358,1.5131604706044135,1.1877658190459417
5,Prevalence,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6772017902119898,1.849776346024888,1.4946169875420363
5,Prevalence,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.9304130311547705,2.1952290138214305,1.673333025007886
5,Prevalence,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3598683859203025,1.5193003984932356,1.1921293761203309
5,Prevalence,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6837726048878774,1.855034394927936,1.4983513679809473
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.043306005765758,1.2271104460395432,0.8793106897662241
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.828558445134699,0.937762056472092,0.7160799033540073
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9793988152649352,1.1001392025470658,0.8483995754612181
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0135973197557255,1.1928714400747171,0.8536551899736072
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8152976845696538,0.923093198505898,0.7021746764407826
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9577431212974242,1.0736021356713066,0.828115833374662
5,Prevalence,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1573157303454527,2.451212546835939,1.8504958093699355
5,Prevalence,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.400769001939201,1.5819950957149127,1.2087633613077116
5,Prevalence,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0378405156139,2.271524988691389,1.7740695470536283
5,Prevalence,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7402609045457011,1.9970800722102755,1.4772579316513768
5,Prevalence,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1246398420343011,1.2850464100308616,0.954327298787149
5,Prevalence,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6633787432942062,1.869196570562584,1.433801069163467
5,Prevalence,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7499198235815594,2.0058944396096736,1.4826896017665288
5,Prevalence,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.128344049047489,1.2890056861763033,0.9581260637721498
5,Prevalence,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.669897767204064,1.875278414967856,1.4380746953895174
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9740200729084572,1.1454508772856529,0.7957560616728334
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7377228874155272,0.8553508262000433,0.6140610456864863
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.034525411141789,1.1844280218015644,0.8688425926372794
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9452990761953948,1.112525401542269,0.7705336943650832
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7251116231807483,0.8420418419403817,0.6019387417671458
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0122509682842535,1.1584679085798948,0.8494071543619486
5,Prevalence,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.417985318639372,2.859413963973789,2.033395994453398
5,Prevalence,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6970101144279075,1.971685130120497,1.4538900247430449
5,Prevalence,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.051681617703283,2.293734020394252,1.804055173818899
5,Prevalence,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.966414457497637,2.352356977975812,1.633241141912141
5,Prevalence,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.386792019544894,1.6292327464823029,1.1708185940735432
5,Prevalence,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.6754814216360503,1.8871540330951837,1.4581817139516118
5,Prevalence,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.976954599155256,2.3614246636581373,1.6419897439296056
5,Prevalence,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3909694862883324,1.6344760188198444,1.1754372148924983
5,Prevalence,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6820624372629964,1.8947974923685509,1.4644284679254111
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.258308874010306,1.4911155266554983,1.0431474056228534
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0010558478570517,1.1763141067349785,0.8400020940082211
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1346036264487342,1.2803218283101572,0.978954618425802
5,Prevalence,73,Western Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.225507634534696,1.455488719461853,1.0140031010804311
5,Prevalence,73,Western Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.986555205163402,1.1605310606544623,0.8261578850543911
5,Prevalence,73,Western Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1112600874844574,1.2551279325679368,0.9600905763985595
5,Prevalence,263,Western Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4705212033190085,1.2514403771752267,0.1156919926547913
5,Prevalence,263,Western Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5863944667783687,1.5314666334493228,0.1050153106651396
5,Prevalence,263,Western Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5167999278070629,1.2319812926395532,0.1606951649115354
5,Prevalence,263,Western Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3858896498505886,-0.0602295561379762,-0.5340714601912802
5,Prevalence,263,Western Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3710110688843889,0.0034894432715312,-0.5622581007791604
5,Prevalence,263,Western Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3830790061378521,-0.0924931319646565,-0.5277725105367421
5,Prevalence,263,Western Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3978584024410145,-0.0780915620520985,-0.5431520760634789
5,Prevalence,263,Western Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3779841764528854,-0.0074270077449764,-0.5667300769830712
5,Prevalence,263,Western Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3924411038416904,-0.1059729991135824,-0.5350799665520294
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2777884357777554,0.1531795734719525,-0.4731803721945917
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2361589825856089,0.1859611232375038,-0.5227287716816554
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2804857925232962,0.0615764821178065,-0.4788279877134074
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2876683027221416,0.136931948213634,-0.4804816300227279
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.242215358773044,0.176049795265244,-0.5264572930794637
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2882009747869918,0.0495326362769179,-0.4844111119191546
5,Prevalence,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5316015212070756,1.577381655531684,0.0962007834320031
5,Prevalence,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8037384755624357,1.9032826012951505,0.095873942726544
5,Prevalence,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5959911226593895,1.5006349398890977,0.1481110604295801
5,Prevalence,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3603847687786676,0.0748444382195078,-0.5421260764380256
5,Prevalence,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2848376946234387,0.1534334519967474,-0.565519851180761
5,Prevalence,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3508705803098281,0.018059976566044,-0.5333865367787187
5,Prevalence,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3728475422714918,0.0553732269064041,-0.5511332380033929
5,Prevalence,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2927648848782033,0.1383598191072758,-0.5703143529155383
5,Prevalence,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3607208261386855,0.0016370491066987,-0.5401205684719221
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3009252293467266,0.1824760814937467,-0.5034059458110601
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.299733231104005,0.142448147331086,-0.5830664689047789
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.337359844342807,0.0437674345146315,-0.5322954942837845
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3104874240683733,0.1670586559546921,-0.510066495713578
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3052855718469801,0.1328718256665754,-0.5864107619451809
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3444651263467431,0.031865499213446,-0.5370188005275309
5,Prevalence,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0880541652376268,2.744403713389969,1.5548405440856534
5,Prevalence,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0785406681657266,2.6875142916805794,1.5532546488530656
5,Prevalence,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.083669504221507,2.5310390737302404,1.6327497081236075
5,Prevalence,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1753148169687908,1.6382543536146332,0.8001560767050742
5,Prevalence,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.113339049796389,1.5319441615910798,0.7547727895375045
5,Prevalence,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1447566532125613,1.4556683828554635,0.8322372525517487
5,Prevalence,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.13522694120695,1.5890581122531482,0.7665377834458187
5,Prevalence,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.099723743336351,1.515075208263264,0.7414515469678692
5,Prevalence,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1179710241082417,1.4252399399210836,0.8082636897052771
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.418105584999039,0.7116563518020674,0.1762832014439216
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2869577923364504,0.5365847957287283,0.0802016257456311
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.346692148877081,0.5409143962997471,0.1608243261553674
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3783433285724931,0.6653735217498566,0.1427812770708774
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2681316543630237,0.513654766547969,0.0628264184615154
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3175929652384198,0.5077600690737335,0.1368223457122865
5,Prevalence,42,Central Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4723725205395579,0.6778570095268985,0.2841199132764386
5,Prevalence,42,Central Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.1178323086371768,0.256651000568587,-0.0100763599963399
5,Prevalence,42,Central Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.3340935028745466,0.5142483218728819,0.188037868667606
5,Prevalence,42,Central Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6165210549176632,0.8403280275847151,0.4112304735808625
5,Prevalence,42,Central Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.207443574169688,0.3580295737009329,0.0699210455192262
5,Prevalence,42,Central Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.45248146586728,0.6479027835086351,0.2939317816715662
5,Prevalence,42,Central Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6059822818072709,0.8301133654130423,0.4006467790380391
5,Prevalence,42,Central Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2073273980013875,0.3572600925822399,0.0691781971866451
5,Prevalence,42,Central Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4478474036005016,0.6433634497927925,0.289338070999673
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0719258082245481,0.2252204710937948,-0.0656092423978075
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2273941278274994,-0.1280568590596189,-0.3180429444366299
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0417294679813712,0.0915923224866077,-0.1503971823275446
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0426643088202311,0.1935863945469055,-0.091855764563892
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.240154273476854,-0.1427899982389747,-0.3292967472678312
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0628813651300212,0.0682971921566465,-0.1706252914610789
5,Prevalence,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2244655656833425,0.4426427698916902,0.0586309137233524
5,Prevalence,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.1243041193610246,0.0102629313076689,-0.2402334998840491
5,Prevalence,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.1165406522963508,0.3032739116012474,-0.0276889342139982
5,Prevalence,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3443328833320971,0.5834729081214911,0.1637646437736526
5,Prevalence,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0541089118672406,0.0914764060412196,-0.1799881184337261
5,Prevalence,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2156137199875394,0.4189060489725131,0.0592781487799452
5,Prevalence,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3355791253492998,0.5735547187300101,0.1546958848363466
5,Prevalence,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0541947832037921,0.0911458782578778,-0.1794056187265353
5,Prevalence,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2117445148773037,0.414399924013103,0.0552169312398471
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0390812462861635,0.1108249288125826,-0.1636903469007819
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3181877690655548,-0.2298145811628535,-0.4036494457456675
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1182360160178334,0.0101085887291969,-0.2273709224753291
5,Prevalence,42,Central Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0653126288369104,0.0810783649265432,-0.1881918352033341
5,Prevalence,42,Central Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3294475888481825,-0.2415950699704532,-0.412787261671054
5,Prevalence,42,Central Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1376981689716922,-0.0119567395902224,-0.2453283220412964
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5930875104420696,2.162399117320992,1.28364543197522
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9656847892219476,1.3895330250043836,0.7785457549796442
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.310931649690127,1.8152498810412017,1.0831275809502483
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7705219969410251,1.159421173125144,0.5576800973085878
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3019910632104803,0.5814264458691931,0.1766443928517906
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5535094646220868,0.889639198664565,0.3986221127987148
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7594425452223841,1.14572764304422,0.5494821964319175
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3028780013724486,0.5838093823086765,0.1788401432940484
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5494406390374216,0.8875774951264395,0.3967018586018448
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2169384563417997,0.3827654391855946,0.0931617928317552
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1543226766473797,-0.0494450454394502,-0.2208468218867908
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0366780859686208,0.1655821376338694,-0.0464848729928873
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1944186845609979,0.3528463167754515,0.0730969159313915
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1610791953711553,-0.0587203626754265,-0.2263584078250072
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0228246282977353,0.1491368570467827,-0.0584418528039379
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5899066184361377,1.8519349850684212,1.355620773026864
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0527803043867443,1.203456274870048,0.9071610601610254
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.423352009480778,1.626319124940104,1.2520220528708197
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7683850844392202,0.943974958711719,0.6075580632101772
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3596864232789686,0.4579165468611473,0.2633007069212151
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6291031441816276,0.7644493278001712,0.5108012342760815
5,Prevalence,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7572842699214287,0.9350738178836496,0.5983183721271853
5,Prevalence,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3606058890524121,0.4604756180926631,0.2640878150873235
5,Prevalence,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.624816591475562,0.7609026142374435,0.5099427493644891
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1508101295239181,0.2558001917459219,0.0536400287772851
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1410768774094466,-0.0889979961189785,-0.193173089902669
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0432290094031475,0.1159413742941539,-0.0221968754523842
5,Prevalence,134,Tropical Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1294883527709966,0.2328034357976891,0.0346999643197647
5,Prevalence,134,Tropical Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.14794434033929,-0.0955356561954172,-0.1992843552345184
5,Prevalence,134,Tropical Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0292731942908721,0.1002414352928603,-0.036980019397076
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6874866768733315,-0.167418543570543,-0.7915381645209043
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7051575591942297,-0.3356046863127752,-0.7996964991779205
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6954231624036528,-0.2697342390194668,-0.7861568233314591
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7491535805128635,-0.3316489459975027,-0.8328182847043768
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7679055867562778,-0.4780159730472185,-0.8423513459614539
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7578808087918865,-0.4186436043782694,-0.8300083434997745
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7540395696057088,-0.3447252382302684,-0.835932233985301
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7696218856007554,-0.4808680216977715,-0.843490839714772
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7611393666387352,-0.4272980717561035,-0.8322961226397436
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.570571501941463,0.1639178648990621,-0.7138129796619499
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5979730683606549,-0.0882479419131648,-0.7273458624126146
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5829490907538505,0.0070994334996076,-0.7078258206829636
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.587774535675727,0.1164002128065374,-0.7253665954556016
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6070203739151083,-0.1071185866848611,-0.733401597248198
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5961899567819864,-0.0262509366819856,-0.7164155660129521
5,Prevalence,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9432570612396548,2.2993859573336115,0.3743915133530444
5,Prevalence,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.343870236696176,2.8644523960555963,0.3906626693683054
5,Prevalence,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1719235668361734,2.306277022286064,0.4558742527687286
5,Prevalence,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1884689977967689,0.3759573657464122,-0.4267556243386612
5,Prevalence,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0706845920821545,0.5324340077848069,-0.4485660733443697
5,Prevalence,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1166270069640908,0.3450343658401961,-0.4071570359423844
5,Prevalence,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2042849102198331,0.3510159029523068,-0.4372211025219862
5,Prevalence,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0809824377874474,0.5152287719287398,-0.4547294486471491
5,Prevalence,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1300293066897793,0.3243394736693425,-0.4168450711648608
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0639182080527344,0.5707769710720616,-0.3444169368888882
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0028034063510914,0.639666969744632,-0.4136232411372029
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0173653946043576,0.5032804875737145,-0.3421715781422176
5,Prevalence,263,Western Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.076727824109628,0.5501322778294513,-0.3531719842578361
5,Prevalence,263,Western Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0107087731944857,0.6261047741911906,-0.4183040431011174
5,Prevalence,263,Western Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0279019933025608,0.4880649446745145,-0.3495729850908528
5,Prevalence,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2140724423857996,1.6886032728813964,0.7734726918068615
5,Prevalence,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6557547679597729,0.9144946846252664,0.421299485264523
5,Prevalence,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8571978043870289,1.131709915338802,0.5913449896661049
5,Prevalence,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.654744270317933,1.0123611034112283,0.3246866427700772
5,Prevalence,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.236297314187088,0.4300173014855849,0.0612317872492108
5,Prevalence,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3873581214812964,0.5902812132822609,0.1886427356069545
5,Prevalence,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6436427896492004,0.9959163481285604,0.3165583685179972
5,Prevalence,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2333781887342057,0.4261145624686758,0.058731533622258
5,Prevalence,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3810992908658839,0.5852393565465701,0.1833986835216116
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1022034865447291,0.3347062113144079,-0.1119122468089034
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.226509861299721,-0.1061959644137288,-0.3353613144903757
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1064560132643835,0.0262562758465577,-0.2388827779464579
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0875987568989417,0.3152822867759659,-0.1234012151895674
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2332758948390913,-0.1142844545404299,-0.3409929908585905
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1163351319541687,0.0150719388756037,-0.2477750422749332
5,Prevalence,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3127852356119056,1.784304546117868,0.8678064404430311
5,Prevalence,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7220892258328259,0.9726774502379903,0.4827644877818573
5,Prevalence,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.123503210488439,1.4815887928650835,0.7643221263965063
5,Prevalence,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.728513824433802,1.0847913090578367,0.3964144869313979
5,Prevalence,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2858131958564509,0.4733963172293419,0.108192614442739
5,Prevalence,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5862768406858335,0.8529961408204578,0.3191996714131277
5,Prevalence,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7169233958869011,1.066961316985079,0.3865881393593449
5,Prevalence,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2827909852940162,0.469455131649336,0.1045170538830791
5,Prevalence,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5791364663630865,0.8454256805337375,0.3120325857963439
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1767228528042305,0.4159641477724081,-0.0545098612119351
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1638706555330912,-0.040807486934869,-0.2810978176717542
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0547586369864938,0.2281514080175425,-0.1187428661821318
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1611293017480448,0.3950525385825599,-0.0685757894589265
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.171175618593013,-0.0495814587076072,-0.2871562239377121
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.04310575975075,0.2133517626663478,-0.1294879584097807
5,Prevalence,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9643131378009095,1.4073782674534443,0.5653655460204497
5,Prevalence,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4995608183407453,0.795149389840598,0.2430067016412243
5,Prevalence,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6528809069182674,0.9278292310386672,0.4010670235243362
5,Prevalence,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4680714829498978,0.8000521780224996,0.1696746170350374
5,Prevalence,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1196670459756604,0.3400730021769467,-0.0718022375097235
5,Prevalence,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2347215690707342,0.4390555830215784,0.0469356208059997
5,Prevalence,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4582310243112986,0.787145648673657,0.1620675744960426
5,Prevalence,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1170287060691258,0.3372137866026691,-0.0740794567399489
5,Prevalence,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2291596743428322,0.4336241285708382,0.0418990740104238
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0621400983604135,0.3048506066459708,-0.1425596377983179
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.209834568155414,-0.0562492348784989,-0.3426831524104662
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.118391250082631,0.0301937728409961,-0.2494895976192846
5,Prevalence,104,Caribbean,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0480705272118015,0.2903540899976436,-0.153932044044998
5,Prevalence,104,Caribbean,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2167408546545369,-0.0644960710913809,-0.3488142190843867
5,Prevalence,104,Caribbean,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1281316075019619,0.0198464668646341,-0.2580597963404163
5,Prevalence,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.129047304155644,2.776512700548366,1.54957680688788
5,Prevalence,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.7865087612111923,3.577682343068702,2.1205825053583407
5,Prevalence,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.4249861083050672,2.977839745318661,1.9237258535826431
5,Prevalence,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9328444405557588,1.3338752647030565,0.5763783536153411
5,Prevalence,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.215136022641686,1.6780834135358524,0.824459393236338
5,Prevalence,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.060233808438654,1.394061901280098,0.7583888847801203
5,Prevalence,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.889810606727301,1.2808519859889156,0.5398352354480642
5,Prevalence,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1955837617207008,1.6543408856506348,0.8094505276366708
5,Prevalence,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0280422266277232,1.355404290459023,0.7312302306192711
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3408277230999936,0.6123105312509529,0.0978708619956196
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3853038734937892,0.6791518478594423,0.1481360719999722
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3589431646325285,0.5849453283455183,0.162498371049154
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3099155427721942,0.5764605801378759,0.0682438018806355
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3693222087920514,0.6595321782724202,0.1343541176393134
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.335220913867854,0.5580611998845559,0.1440837723364457
5,Prevalence,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.67911025557095,3.4040394676495023,2.015224597563707
5,Prevalence,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.3451455212811703,4.2329377883139685,2.6063597342100207
5,Prevalence,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.801342795527588,3.434629382327686,2.191127037061648
5,Prevalence,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2726248943628875,1.7171325715519667,0.8592956397610712
5,Prevalence,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5419396531373668,2.0610075570850435,1.1094411864045988
5,Prevalence,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2866226455895409,1.6656516292152717,0.9180389476512576
5,Prevalence,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2220250793470666,1.659851286797834,0.8210665650766111
5,Prevalence,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5195058431045951,2.034286715988391,1.091125459015746
5,Prevalence,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.250894883492572,1.6258838320530464,0.8895668995565996
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6190998887180869,0.9285944733062086,0.339305881850107
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6439607246931451,0.971025245617497,0.3674401732890313
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5576541967910064,0.8114683712325761,0.3153072844111133
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.581769871462253,0.8855525310271087,0.307783092303205
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6249961850208647,0.9479973628870854,0.3518684743053821
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5304627268336913,0.7792981913836134,0.2897825107461427
5,Prevalence,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8411128586754495,2.4064362904156944,1.3580081721924473
5,Prevalence,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.246944185184283,2.906385109162498,1.7029520254887096
5,Prevalence,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0348445057038465,2.5078554453475266,1.6207412572078874
5,Prevalence,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7549917131261019,1.1057495336534269,0.4588781640518549
5,Prevalence,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8994936439201822,1.2870147695870826,0.5834801171183304
5,Prevalence,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8255599500014625,1.1086774354737612,0.5760598585610772
5,Prevalence,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.715910529094105,1.057341678477918,0.42413598178613
5,Prevalence,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.882720568675963,1.2650933230539412,0.567290068536589
5,Prevalence,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7970270868813483,1.0771117730434654,0.5518235013552379
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3190335071451306,0.5850735009680088,0.0947105062938181
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3965764245873432,0.6717694279907993,0.1594712609539474
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3511727738918018,0.5536967584320216,0.173486590236014
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2886177226465951,0.548628625242437,0.0693078692226861
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3804601854291222,0.6528884295786498,0.1473486674566791
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3275803966648914,0.5273313976758716,0.1529975376626337
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1165822282546117,1.355388917176906,-0.5596095178222719
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0402906247005816,1.2141991234395522,-0.4709229979862813
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0704124684658997,1.08280770404405,-0.4873160137763515
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5944087840008626,0.0816650865297712,-0.7976414510202758
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5644050904724853,0.0056711623991808,-0.7597511821744595
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5756769817353415,-0.0492329180865717,-0.7659886545330705
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.604228007301981,0.0552164504096057,-0.8027046497464461
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5703500489820839,-0.0087305913491638,-0.7631388065486181
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5836907719622424,-0.067229240918595,-0.7703980880855243
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4911324821702466,0.3753267812502623,-0.7475164708254974
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4470664862158204,0.2871382470019872,-0.6969420254536426
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4643057348649941,0.2233072575297823,-0.705777831772513
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.500012232763955,0.3510693113615005,-0.7519282221679982
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4526541915044715,0.27355444743332,-0.7000646360193419
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4716870381833922,0.20636194618168,-0.7098162253695981
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2377730451245746,0.6049391942306266,-0.4824807477077911
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4689081527020619,0.1494058802570138,-0.6753442118474505
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3605880358499788,0.26022187425121,-0.5698270000866934
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5910568700022715,-0.140789965031503,-0.722479219290824
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7080952938862686,-0.3673168606196229,-0.8213828056722914
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6528980993867343,-0.3152841943511617,-0.7665059647717769
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5943063992769194,-0.1457746849749815,-0.7245515294847373
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7073654389827079,-0.3666709686638951,-0.8211128554672635
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6539566599419561,-0.3179805649088866,-0.7671946881840586
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3187674415307766,0.4513295498249038,-0.5368001935129836
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5268387986543893,0.0336260482952778,-0.7130832909039255
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4294078043012327,0.1306945061386947,-0.6171657874076802
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3339154635461518,0.4214761713935674,-0.5469208601777176
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5307128782883554,0.0261420500203736,-0.7157103901818798
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.438225501153499,0.1123889462237452,-0.6233530983888882
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.006518399436667,2.257806639140984,1.7432325524692187
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2723818484551896,1.4150587499982497,1.1203097274795937
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6535913907914308,1.806536659325368,1.4768754262123631
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.76705410282498,1.998760379413235,1.525543233511661
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1076807989843551,1.2412427124214784,0.967011547383088
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4521441404267548,1.5937363756124023,1.290555651191844
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.7617479203189643,1.9925779639781116,1.519897033775904
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1102579000911403,1.2427554637582898,0.9690354224998275
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4512772852017055,1.592561758740982,1.288034431984589
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9036580402889391,1.0420249476934071,0.7607740736448735
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5827346254805849,0.6673321513262047,0.4930182203620188
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7775102160342695,0.8721599340329858,0.667740782644747
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8639046585799587,1.001462563777344,0.7233013581689682
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5665988419903861,0.6503501522184348,0.4769056062294489
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7496276409555989,0.8424525387934765,0.642040147181575
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.731080067969509,1.9589369233672111,1.4882505086629765
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9456139595774268,1.078698259024924,0.8223477446531575
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5793832318436156,1.7606675355981118,1.3853780356848318
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5135908169329038,1.723899474718226,1.2917986387207157
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8046057069186887,0.9283471916251128,0.6899468276784706
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3835921460069391,1.5522694309013043,1.2061738518068648
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5087339227169267,1.71804020756884,1.285673910666957
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8068033906876378,0.9303927401088572,0.6923316508103283
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.382726876485177,1.550189771299767,1.203512950706917
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7690295153260771,0.9033232289437166,0.633206108179869
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4080451926596728,0.4910739253696681,0.3292870703053343
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7812228676688167,0.8954451601846052,0.6558872210043116
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7320612037564502,0.8616973995056177,0.5966949299205179
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3936803077370846,0.4750976611120861,0.3162045310888405
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7532611698649353,0.8648970248632646,0.6285495295218184
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.824147959521144,2.145303499054708,1.5430633976100108
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1568207896391272,1.3405221507205547,0.9704034178774644
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4682180750033735,1.6622272402816152,1.2661987068412943
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5992043129938844,1.897385630624408,1.3417611753739205
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0004970905176345,1.1697574477538475,0.8273321656304573
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.280848123386801,1.4606597325888342,1.093633025113924
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.594224853352623,1.8892340718466536,1.3360243033618795
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0029415890251618,1.1735367065416655,0.8298242356447416
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.28003713125387,1.4592547235394908,1.0934200469261972
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9414199121507366,1.1153714507450685,0.7684225706963992
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6067804489776352,0.7206163852116236,0.4887812074081172
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7703615376472708,0.8928841543503048,0.649095954877719
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9008690718669488,1.075173960681345,0.7297936175323885
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5903983039927045,0.7027362934199651,0.4720035886484677
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7425812203094314,0.8627439528742529,0.6226113167989737
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6097444760529823,1.8856255646591944,-0.0182217276478916
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4711925961677318,1.1921255595409908,0.0371011179107479
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5354551226656242,1.3795454975820174,0.0464980161525855
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2609205108209915,0.3200732915644609,-0.5488167532916686
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3322436905244801,-0.0040530520741752,-0.52956307266508
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2991080501481248,0.0857349832617316,-0.5220291650139404
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2788329605783232,0.2927629672302617,-0.5601624105108001
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3413653725283446,-0.0186126513684787,-0.5357027283681995
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3123572389695961,0.0656626897138534,-0.5313332349364179
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.126281739440545,0.6048832029330229,-0.4340470094324448
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1871771815676273,0.0264406998191823,-0.3574649368873885
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1552562974895242,0.209151530300143,-0.371363137791474
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1415446014256337,0.5778772117027957,-0.4444426663083743
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1953999915412752,0.0161527566078737,-0.3641630810443438
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.166907628947176,0.1907889639142727,-0.3798806404813923
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0748191645869234,3.3072694619577843,0.2784839866660036
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8420465740810457,1.321341945522506,0.4724080047638533
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9861053998631276,2.2959304413981494,0.3894795830480572
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0473722010003854,0.9765843716008524,-0.4133208752962515
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1639098217488641,0.0539782047155861,-0.3321533368337528
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0933849065446575,0.5054772407187398,-0.3660146685593751
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0704790626588473,0.9296607704397284,-0.4272379714123036
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1753386590813254,0.0392359175176483,-0.3408212492164018
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1105366866806879,0.4760592318403684,-0.3777313561442254
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1178330823719683,0.8503567136952879,-0.4638987268108078
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2287226056041582,-0.0265417296684565,-0.3836843777448749
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1665625927229536,0.4063379554308243,-0.4214506205114844
5,Prevalence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1332536319303275,0.8175775902733513,-0.4731284416104171
5,Prevalence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2365281262821228,-0.0362019444594366,-0.3895620475579001
5,Prevalence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.178064711961275,0.3871290991367039,-0.4291772051839789
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5147602128885511,1.412199691414731,0.1304999861631203
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5785403293681742,1.5255933913348785,0.0950328365810796
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5397034864474607,1.2937323501032991,0.164603418063038
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3792311370944573,-0.0119935404953971,-0.5370860188746388
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3812346749438798,-0.01004948086777,-0.5709669775143285
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3831233767500357,-0.0809487958900018,-0.5337486328979059
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3917289904005626,-0.0313508836792744,-0.5460335160082628
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3883825774096945,-0.0214396859042384,-0.5757212225109627
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3928333425435671,-0.0954896079860049,-0.5407502997611744
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2841349510124175,0.1761769483285932,-0.48503128260522
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2438688067947176,0.1646575573495249,-0.5207279681097805
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2864699757150679,0.0665251529579763,-0.4845871117942285
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2941887302951281,0.1590900994144235,-0.4917912950327842
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2500632929632866,0.1546221043547678,-0.5244991481736409
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2943515874099299,0.0554432786181242,-0.4902460640686124
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5487656266547866,1.613798261712741,0.1110459053520753
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7899906764053192,1.8462539246487728,0.1080463657871348
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6040935064921862,1.5096023192885848,0.1531373808962586
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.365297144854722,0.0706393836701147,-0.5442627123855045
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2983498523280142,0.1162151018438972,-0.5660327814736994
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3573254631598964,0.0073430607902107,-0.5380711919240904
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3780736889294535,0.0496035570603147,-0.5538455467673741
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3064545367669519,0.1028026696840894,-0.5706790319227774
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3674417826827048,-0.010363446495089,-0.5452718167429198
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3130155867823421,0.1679919811984167,-0.5128718092610003
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3060658529408855,0.1323101705231116,-0.5765887647861103
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3442394096283193,0.0215721252671192,-0.53273457368598
5,Prevalence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3226631096899899,0.1519540639024006,-0.5196309131843543
5,Prevalence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3117510674217767,0.1237775609468776,-0.5798960033886005
5,Prevalence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3514832199764042,0.0100977902801093,-0.5379772761359338
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.055817912142234,2.6737426908423947,1.4980014554846852
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.623861154603245,3.376443051433625,1.986309762972672
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3172643925964227,2.8478963655656404,1.8338501941391463
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8789992692766286,1.2600816189324178,0.5371461079755991
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.113085078842537,1.5547221822708386,0.7425506978293666
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9875659830904572,1.3080284245403273,0.697834490601247
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8369140578654315,1.2083611614993024,0.5015992844061073
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0937885346355414,1.528614064569572,0.7254251407065627
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9560806225626246,1.2689766709915078,0.6710273273280525
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3144770553613706,0.5773945364104682,0.0791228397870074
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3294169580261763,0.6041274208125549,0.1010373471643551
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3199859496579254,0.5424589639481509,0.1265444375194064
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2841323111873644,0.5389984520321491,0.0529804238555942
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3137443227716477,0.5838970871533985,0.08770728591869
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2967619122846779,0.5133041347261614,0.1073703604073698
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.643986598711223,3.357290282441864,1.995912309961383
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.272739364171216,4.107718836379839,2.544278769658968
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.7603155182697137,3.387838160898328,2.1623377845170664
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2406607062323562,1.681801706846166,0.8388743895030983
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4914447235892918,1.976952876853224,1.0676420517404817
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.253021577065803,1.630494101596586,0.8948535697939143
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1904741716607714,1.6192554674852555,0.8009035867069139
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.468696318793458,1.9511293842395987,1.0478075552198072
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2173331545188644,1.5873624124232548,0.8647255479837825
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.612265721823992,0.9275937012154468,0.3343254661755737
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6228389862390298,0.9416337791445522,0.350224991978252
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5475497564932811,0.8051233268472764,0.3105171946344154
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5750440013526492,0.8800807005392459,0.30401391299281
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6037084156625051,0.9189573486852548,0.3339847316099302
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5203219595228114,0.7725690683388607,0.2869022924213746
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7879439218059168,2.3325012867359,1.325631597585576
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.147261314505833,2.6824541399126547,1.6591685579253783
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9655407830920744,2.3975761783253184,1.5763363108965829
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7142929209460791,1.051032171432127,0.4294743425647038
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8351833900896973,1.1469605364726043,0.5521646879682083
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7768351063758339,1.037067241208958,0.5467369305341524
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6758895751467193,1.0032340399393886,0.3979842706093022
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8184194632963961,1.1276422932694947,0.536410033583931
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.748680893260148,1.003437814886006,0.5191799442325575
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2954995558731541,0.5527449350165549,0.0793310035008587
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3457320815354462,0.5919227786312355,0.1276214936198128
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3177493662320794,0.5196249770746393,0.1503509917553324
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2655868426554078,0.5161363737260951,0.0528474902735726
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3298636400996904,0.5735916031796158,0.1140066459532507
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2945595430449711,0.4911095714929879,0.1304511376111067
5,Prevalence,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0662915515460019,0.9715797736014804,-0.269114480272755
5,Prevalence,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0559494338274316,0.6533659482854618,-0.3739826866025916
5,Prevalence,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0001396709546531,0.7509148316597105,-0.3151590420258852
5,Prevalence,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5016120162359047,-0.0779438151681588,-0.6586518049611098
5,Prevalence,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5670039077068527,-0.2416397592079292,-0.7124563982163781
5,Prevalence,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5371027200250079,-0.1897473827033692,-0.6831411191600945
5,Prevalence,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5114480421723195,-0.0966643625658481,-0.6651239043459284
5,Prevalence,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5712999883112617,-0.2491948771034638,-0.7157211285208169
5,Prevalence,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5439384622911458,-0.2013635431596851,-0.6876267501503057
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4007286356063372,0.1276301139103361,-0.5901685962715699
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4628668400427752,-0.0482284276964671,-0.6472025793952976
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4341929824969704,0.0003975618520062,-0.6154426031599121
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4099005885572745,0.1100105519287714,-0.5962194003650929
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4672724621573575,-0.0557257478602674,-0.6503072485084715
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4408411983230333,-0.0112915942958447,-0.6197332604304654
5,Prevalence,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.5787598263933558,3.1234503453248155,2.125346896109192
5,Prevalence,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9321629951680328,2.265080650867381,1.5708818076974016
5,Prevalence,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1649084425526683,2.515559508585704,1.839377845779638
5,Prevalence,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3979539783811377,1.7657062573226727,1.09949156801353
5,Prevalence,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8905562929829262,1.1040165338552417,0.6569078917513875
5,Prevalence,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0790272478759333,1.311136560021236,0.86644776702779
5,Prevalence,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3555822245670444,1.7141039937068907,1.0571404484273477
5,Prevalence,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8820246182001784,1.095709609413896,0.6501343412841931
5,Prevalence,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0566493681884872,1.2845126086270664,0.8451101378026382
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2569725997519096,0.4483433762324659,0.0983998186961907
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0634821219874173,0.0413809779983542,-0.1741708527684389
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0587000150199329,0.176349958155121,-0.0464420056498185
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2155419353990521,0.4012453172602627,0.0624437510804673
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0795030254374289,0.0235663636946683,-0.1884906813972039
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0321325894110111,0.1480765287495467,-0.0704861518007897
5,Prevalence,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.349071678072733,2.863136058462402,1.92433305673742
5,Prevalence,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.777176799916465,2.171007167330303,1.4234534599768194
5,Prevalence,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1764203390250034,2.605612811038981,1.829255467460409
5,Prevalence,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.24402906410822,1.5897943302398168,0.9558705451160894
5,Prevalence,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.790618631395661,1.0470245296377336,0.5634558847839715
5,Prevalence,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0865750190457364,1.365921534219361,0.8588879845612033
5,Prevalence,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2043987572140422,1.5427620382027358,0.9248307518045052
5,Prevalence,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.78254589364588,1.035328037097352,0.5555066618925805
5,Prevalence,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0641301326517347,1.3430318583796568,0.8385323225663728
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2108820243580921,0.3925234898903046,0.0586855753691785
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0849225264785631,0.045935318641929,-0.2014676701121228
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.092496329104756,0.2317116673736425,-0.0263452829516385
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1709859395369257,0.3449644077492937,0.0258134258169217
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1005685864745508,0.0280960304379761,-0.216017361900893
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0650924580072859,0.2006298044095699,-0.0518137598180267
5,Prevalence,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6385813105277112,2.067612588762729,1.2916786122889097
5,Prevalence,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2330344241139457,1.540614014438614,0.9285144493497546
5,Prevalence,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3762768025240624,1.6847464706922053,1.1022406739990045
5,Prevalence,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7679825659210052,1.0490863833189206,0.5386018079327062
5,Prevalence,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4397845791244398,0.6399274826263768,0.244899194531136
5,Prevalence,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.560979805532715,0.7657383671389671,0.3817116100022686
5,Prevalence,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.736745558423719,1.019139041590813,0.5084100820949841
5,Prevalence,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4332851776645788,0.6307067950851909,0.2378273909779716
5,Prevalence,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5441736382776081,0.7446261820585078,0.3660970079984377
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1312366731552619,0.3033065454668159,-0.0169929507556069
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1428032430651755,-0.0215734684027375,-0.2455463843870277
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0410512495045955,0.0826414085894199,-0.1426712674651513
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0939528460594479,0.2596445589710849,-0.0500175170029059
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1574659295874852,-0.0383038062538615,-0.2584761823593508
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0651161721102761,0.0553515431676397,-0.1643009417884631
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6707614275525505,-0.157593946054205,-0.7695108718227196
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7167523374589165,-0.3524392972963877,-0.8108487284795072
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6922189407937842,-0.2808710231593396,-0.7828102959072072
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7347116659216016,-0.3208800522926548,-0.8141146511192168
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.77740157051827,-0.4918476752123879,-0.8513864384048719
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7550867969364434,-0.4267466684122823,-0.8273457442223715
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7391901587909747,-0.3326790736277034,-0.8174155826473882
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7785230285301483,-0.4936594286744267,-0.8520988650349263
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7577574078306342,-0.4340013387982141,-0.8290583668545866
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5457506375970181,0.1788862000342677,-0.6824759507938366
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6120762534834321,-0.1088020049944668,-0.7428082800676352
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.57677540508307,-0.0035728304638472,-0.701520060559494
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.56253176645528,0.1338511871038648,-0.6935543071064117
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6197155010808677,-0.1246624576670221,-0.7479320181234752
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5889278104100036,-0.0337572712650026,-0.7099340121985952
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5241187568308114,1.225998427805949,0.0950249328900311
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5424008628520617,1.435757077763383,0.0652776193742934
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5341009887996669,1.217825778380659,0.1204724367450317
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.292323156989503,0.0343009367425691,-0.4923843320945685
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2932531433279128,0.1159315175543855,-0.5121903354426025
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2924104404779535,0.0230687600758534,-0.4831874879660092
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3097815986169164,0.0080743835974147,-0.504102711638057
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3027429213167483,0.1011073096023338,-0.5184310520300766
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3058795767672356,0.0034790272514104,-0.4930302452756777
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1784000009298605,0.0743410969159956,-0.341713144555293
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.153667426665146,0.0880334684947508,-0.3379863287372819
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1629685819337928,0.0451855810609324,-0.3209957395562635
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1933870772287499,0.0548040697872701,-0.3538863339167634
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1624807247401917,0.0771859689141176,-0.3448103578490594
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1749875689203809,0.030441293999587,-0.3307158155295576
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.916901272551008,1.5314301590089987,0.5562400423560678
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9573377932915724,1.503015174530489,0.5476853006724536
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.933676483775842,1.4143594405778934,0.5931023413832511
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1099371547262343,0.1752300728515562,-0.2774533330443897
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1031142563213746,0.1465352885839546,-0.2904632697571532
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1081015495800023,0.1135037687275209,-0.2654090579050433
5,Prevalence,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1319045671345767,0.1463933960088856,-0.2952350271990094
5,Prevalence,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1151667088520644,0.131511976248404,-0.3003540406010584
5,Prevalence,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.125087364447947,0.0924027876686225,-0.2791837828621251
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1944156455744211,0.0647860882079057,-0.3344813759164785
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1927784240633172,0.0074465987115966,-0.3471863941774749
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1978903482526374,-0.0043806326693378,-0.3286776658778257
5,Prevalence,248,Eastern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2091166541560069,0.0447826650418966,-0.3467225712587418
5,Prevalence,248,Eastern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2011889479131303,-0.0026384947946321,-0.3544347725736049
5,Prevalence,248,Eastern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2094121551317809,-0.0191676959144256,-0.3382110788237525
5,Prevalence,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0735367648748655,0.2541818060757104,-0.0726517751603193
5,Prevalence,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0786604555561373,0.2370844690878569,-0.0489564683508245
5,Prevalence,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0756021712313506,0.2373119007224265,-0.048184184792187
5,Prevalence,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1544063352284054,-0.0121294420400282,-0.2702824295726402
5,Prevalence,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.128587180825864,-0.0007400326170131,-0.231586770340052
5,Prevalence,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1417435732405168,-0.013003966674335,-0.2399374940137091
5,Prevalence,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1473785174230835,-0.0039070985688002,-0.2634839865777257
5,Prevalence,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1224148062830251,0.0064770687166694,-0.2262424031060799
5,Prevalence,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1352952030515715,-0.0052925101004341,-0.2348103013966977
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2668414249895495,0.4827613552397453,0.093220361264885
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2616350087526815,0.4442797074167242,0.112321719629374
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.26365329896463,0.4519953754298623,0.1199979806064089
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2479812393040702,0.4598305912685525,0.0787303966708247
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2539734732208541,0.4361888516110697,0.1052844641826457
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2502126463214443,0.4365919571419193,0.1078908685738402
5,Prevalence,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.415120771415942,-0.2475533302274715,-0.5120087070073946
5,Prevalence,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4213034544943337,-0.2572158771436795,-0.5093027831344263
5,Prevalence,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.417661656798613,-0.2601617753753285,-0.5051269435815194
5,Prevalence,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4641509956430975,-0.3110258246208847,-0.5527293833681478
5,Prevalence,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4655970784595856,-0.3141266247171135,-0.5467477475776672
5,Prevalence,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4642690879683256,-0.3195366851081741,-0.5447346758051479
5,Prevalence,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4652756112105209,-0.3120774923656417,-0.5538551667978129
5,Prevalence,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4649923084381523,-0.3132925676082841,-0.5463481036997078
5,Prevalence,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4645313707823503,-0.3197079247697937,-0.5449569820520779
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2553455815293621,-0.0430051948180331,-0.3790793411504732
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2635864806148467,-0.0548544935661139,-0.376237391000193
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2586725506310888,-0.0573514988695518,-0.3713557722905812
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2709384566740918,-0.0628410343745767,-0.3921965419760477
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2710928544984077,-0.0644049854889526,-0.3825234094381873
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2703213643357983,-0.0715083852821348,-0.3815891431401982
5,Prevalence,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0454075202791037,1.0835674090574727,-0.2874676633119467
5,Prevalence,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0274936299935911,1.0204031015498711,-0.3337094663319689
5,Prevalence,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0356137129148697,0.9694102372994756,-0.2960397055171899
5,Prevalence,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5177462247393687,-0.0390955180362643,-0.6715782271899821
5,Prevalence,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5358449399756735,-0.0877706289972715,-0.6989611011915666
5,Prevalence,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5272404760305074,-0.1012656954877855,-0.6791259104424102
5,Prevalence,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5281945834300049,-0.0596601131015639,-0.6784252940509301
5,Prevalence,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5417788518445718,-0.0989808579789008,-0.7028610159419065
5,Prevalence,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.535384065484339,-0.1164472173005845,-0.6841764781556757
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4174719752764701,0.1619267263925663,-0.6045130982484124
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4222929419444058,0.1613828709642165,-0.6281331467234095
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4201038362205698,0.1239972574842586,-0.6085667042261756
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4267818370970129,0.1433541456804759,-0.610436472327462
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.427789439905446,0.1507608016774239,-0.6317128333005662
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4274999760452597,0.1099315287403667,-0.6132850666233469
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6947826464787829,-0.1740213680807169,-0.8014545673589704
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7220561361276969,-0.3451666874878963,-0.8226049770627646
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7070410930258628,-0.2890820551384824,-0.8026366891268778
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7497797434045289,-0.322542953899584,-0.8374208704298124
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7770374414813399,-0.4744520868996443,-0.8579337025916272
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.762399826516817,-0.4223128205817915,-0.8400114637373108
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7544920914843269,-0.3356069566108621,-0.840295863420983
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7785233575487736,-0.4782029673192307,-0.8586446431292765
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.765436822445314,-0.4307898884191088,-0.8419772731634347
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5585787513816756,0.2132487152045996,-0.7142578823056206
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.600917033142254,-0.0527324761517388,-0.7457597148360169
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5776118912807726,0.0327298113390618,-0.7161792820886033
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5773627795617308,0.1598464919449621,-0.7266378673881231
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.61042051726992,-0.0765635659874897,-0.7514652346761748
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5918687692235722,-0.0039646809056322,-0.7251580017046861
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3695724455306808,0.8162725749278892,-0.6801448429915038
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1733252484946714,0.9605095046445232,-0.5300018131708938
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2700659173525704,0.7742346135699447,-0.5792260377907116
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6423804123646634,0.030350464704017,-0.8185910900110933
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5590152931981834,0.045941116744493,-0.7493869806354156
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5986234862057537,-0.0243207354167282,-0.7686985140390923
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6517846018296578,0.0032145222408219,-0.823328644084558
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5643480183793883,0.0331751987455281,-0.7523141464314165
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6062498457324349,-0.0429202178555373,-0.7730208569919481
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.479637374056767,0.5257931487854308,-0.7368830095688894
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3262249768882118,0.6158146704303253,-0.6165253145637882
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4013480921538093,0.4667155095019128,-0.6536546007886501
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4912406726546998,0.4924784377443129,-0.7426970368897279
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3340166698946436,0.597161284500765,-0.621035672232046
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4114269927022216,0.4419317618216898,-0.6597030145858428
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0497082474190382,1.5696222315133783,0.633228397757631
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9701869697585472,1.4503711272107211,0.5979841626723501
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0278711292795613,1.4492095608484188,0.6663771309194348
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6451875683387004,1.0643708150101334,0.3098509806946219
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5508727635834693,0.9269668243485244,0.2581289335482241
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6119887272730888,0.9513950643301246,0.3278987760923145
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6132020154339873,1.022395025243756,0.2854157884392769
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5394254567507729,0.9146221904906594,0.2486010400342145
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5903329555108237,0.920762430773018,0.306835739878721
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0534727167613269,0.3132977547490069,-0.1543825030409215
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.076451870926824,0.1366746738297819,-0.2443739780834551
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0021163494284967,0.2088384425763097,-0.1658242921892845
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0113101005486292,0.2609706881632354,-0.1875527661573408
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0972183649125998,0.1128271585972457,-0.2619373496875024
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0296716431805095,0.1701970978926059,-0.1949758643748272
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0571422260945331,1.6690479720494844,0.5559672943979417
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8905358254254271,1.4725040391788222,0.459338143507466
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.030635712932352,1.5940000728267876,0.5866100332736623
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6511512104235763,1.1425448733578365,0.246863457615013
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4881784860414438,0.944715727243862,0.1501738753920066
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6141850701549595,1.0621810900420885,0.261258246685619
5,Prevalence,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6190528526919723,1.100647042437339,0.2246082233570529
5,Prevalence,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4771892319011233,0.9319159644515616,0.1402685748135483
5,Prevalence,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5925010461886863,1.0343126063831865,0.24427937605466
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0639182860410728,0.3808601475647664,-0.1917828282188466
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0955644427716932,0.1785687454106339,-0.2969391244327265
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0232778624151117,0.3074445764414958,-0.1927467709077434
5,Prevalence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0213368713408042,0.3232949146263795,-0.2230065104263753
5,Prevalence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1159049954627996,0.1512653750276367,-0.314003265469491
5,Prevalence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0091823352987267,0.26676485463414,-0.2181069372455576
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.844953624438714,2.8197640549336302,0.9862232959538196
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7866536809779542,1.538643327561516,0.2830037855298362
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3683499826632153,2.1687649986708424,0.7196035072666073
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5264172534233176,1.0509575660502428,0.0643486647461937
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0179646126227889,0.4002619353225669,-0.2948727786991396
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2857045094454399,0.7170073861661921,-0.0635381641294131
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5142202363826802,1.0330609189908313,0.0571629297828539
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0155438870263722,0.3988065897077959,-0.2930577799824091
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2817272500001311,0.7149038264504681,-0.0693678338955059
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2404250498744993,0.6358963467456227,-0.158278264306071
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1661444832613642,0.2119856701456338,-0.4548269624180266
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0628277483659782,0.4432948136982917,-0.2746679311345184
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2127935044121498,0.5965157279477588,-0.1794994396602495
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1730024203956302,0.1998806693495448,-0.4586103839956579
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0463580803140161,0.4209283357777454,-0.286205728328629
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.169401376336522,2.9436357136123767,1.225527880849444
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3993581382092193,2.276839283401292,0.6587214299265507
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.914021248559873,2.675192782927092,1.085595301200573
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7005040418415504,1.1188783515861838,0.1918126482659138
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3188325150606018,0.8013281974045878,-0.0882550776969525
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5819513084012357,0.997258755568056,0.132037255300113
5,Prevalence,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6869068304108892,1.0989913336993145,0.1845322626237723
5,Prevalence,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3220596758741611,0.8055566661418011,-0.0860352687277714
5,Prevalence,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5770390646227876,0.9889774625219856,0.1287032531463217
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1674114001832023,0.4524926919917659,-0.1855729358306341
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0946995312760427,0.2517130762804738,-0.3822076108800114
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0831841727654692,0.3643543013083498,-0.2267268089888848
5,Prevalence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1413970629463952,0.4193385753937668,-0.2028742422405805
5,Prevalence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1021582169847324,0.2419233070943364,-0.38734379946352
5,Prevalence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0663879375922603,0.3425054521176138,-0.2393087396326653
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3796610025258107,1.975780294262885,1.0882043037277067
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0018847934279536,1.4695165730918722,0.7863065418947248
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.199771323278196,1.713485757038361,0.9683844714536728
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6103304341613458,1.0146375129307952,0.4104695844267223
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3213807608040362,0.630202132533511,0.1783587801960906
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4697206334022142,0.8119986066578027,0.3147877868439962
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5937186004081427,0.9929546270081996,0.3985227462108188
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3194031759091546,0.6276101502915843,0.177319759988487
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4612954403050695,0.8025529845455843,0.3075864852243042
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.208711983764938,0.3778571728000255,0.0777746594255326
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0684389140368168,0.0561130486897047,-0.1538544722334021
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0684155600441836,0.2112799917873467,-0.0289732607713735
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1804557295258029,0.3440457674130854,0.0543652819575085
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.079702517382182,0.0435890991108919,-0.16499186186692
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0493521362862683,0.1896439773183021,-0.0461329331528038
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4266421560489049,1.707703105522452,1.1601902595227818
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0055867346315497,1.2512261919458665,0.8033603079516141
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2673851193525312,1.5110379852597706,1.0386796203085242
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6421443281312006,0.8317501002505421,0.4628500868256792
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3238316723920811,0.4859623510941268,0.1907751449663034
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5149099637695556,0.6796259381126715,0.3612645765651653
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6251830561263839,0.8134166165154131,0.4467335445543637
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3218430530674672,0.48373922270375,0.1885595641822848
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5062108962252282,0.6680680939256327,0.3542831483774901
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0999365984647764,0.2196326032364476,-0.011461229077228
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1472020787997939,-0.0513582478050975,-0.2292474676390405
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.004503100298212,0.1064151476886762,-0.0981446759536476
5,Prevalence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0742070137820649,0.1904534854234778,-0.0355512165161249
5,Prevalence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1575198920173334,-0.0630918499565782,-0.2386668273158803
5,Prevalence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0222771099031613,0.0867485234229312,-0.1154086384516848
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2619078531836675,0.4616595195004413,-0.494730055904361
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1303336484770841,0.7827458671563297,-0.4285804834464252
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1956625953288616,0.5929057062744965,-0.4435244956164375
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5803840241050736,-0.1703237974677226,-0.7124941874778421
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.529496874482043,-0.0357201428240363,-0.6910197475746014
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5537981350532544,-0.1166122937595374,-0.6919492819262705
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5899524034981857,-0.1879740551902994,-0.7192969373069636
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5342537502083734,-0.0452577583281328,-0.6939786201610225
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5611425166607577,-0.1308888715200761,-0.696379357747815
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3989612035839601,0.1940044142211339,-0.5901604129869089
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2943166852320797,0.4616286662353347,-0.5400942166474132
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3462130689914489,0.3130989786858839,-0.5508680434319682
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4116910961047436,0.17021049986946,-0.5991334317364126
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3020212826744387,0.446014325232728,-0.5448686138568533
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3567512933300592,0.2920871754201533,-0.5571779171953299
5,Prevalence,44559,Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8290003172406188,1.777152663422965,0.4156707338711258
5,Prevalence,44559,Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5902019553502652,1.2998043699527195,0.2644437907719085
5,Prevalence,44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7231349947539325,1.3672445489414544,0.3997901936408489
5,Prevalence,44559,Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1451182221357632,0.302184306212357,-0.337445113464975
5,Prevalence,44559,Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2706406237575175,0.0553686067033325,-0.4200750120541706
5,Prevalence,44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2022497270976004,0.0955788771084832,-0.3530002581104476
5,Prevalence,44559,Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1619912166050744,0.2724318868835312,-0.3513699816252838
5,Prevalence,44559,Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2778780912022696,0.0443573634808028,-0.4258071682734604
5,Prevalence,44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2140346280787622,0.0797600002331715,-0.3615203547568019
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.08553525505348,0.3948558181751083,-0.2872049828468053
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.186282656477707,0.1021868358530537,-0.4040795902589653
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1355269049807555,0.1888173771749637,-0.3180911389336192
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.099531782498113,0.3738720018663084,-0.2982409419111893
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1929584684470889,0.0929348121602385,-0.4086555460020468
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1456884203527852,0.1749638384071518,-0.3260555982622067
5,Prevalence,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8420362115684574,2.062562278494495,0.3938096361624689
5,Prevalence,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.864204452414636,1.57534708188732,0.3222425759090205
5,Prevalence,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8482524694504058,1.7990392633239736,0.4387140923157687
5,Prevalence,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1390215609650287,0.4315524669803737,-0.3490876183991635
5,Prevalence,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1449621327793657,0.1815925532332671,-0.3940852118247929
5,Prevalence,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1443187205504724,0.2959856240996631,-0.3342568486887716
5,Prevalence,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1560184489444223,0.4032004614107062,-0.3613862685126189
5,Prevalence,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1534516272995226,0.1694832498049015,-0.3995603328265703
5,Prevalence,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1569653892593722,0.2767124701885185,-0.3437661819312267
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2160548070651597,0.3017947079723079,-0.4075132850732953
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2316423973657163,0.0717881217406003,-0.4681969040840414
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2332069424104394,0.1712065962656375,-0.4087092792812901
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2280567928283494,0.2811663985851207,-0.4165957908549618
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2379499228853605,0.0632580513537017,-0.472419321894214
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2422241685665907,0.1574717290779839,-0.4158337094185021
5,Prevalence,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1741208914203505,1.8158945871308252,0.838315780893299
5,Prevalence,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9776778232600066,1.5283190603559516,0.7131309594561491
5,Prevalence,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0770747057478447,1.6946511465602694,0.8051923410090391
5,Prevalence,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.456763459203837,0.8840589230338957,0.2313343159242881
5,Prevalence,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2751291185033648,0.6295219660812738,0.1053232939694346
5,Prevalence,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3644208356855264,0.7705063024542658,0.1878730684332579
5,Prevalence,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4310321939236881,0.8534552631280342,0.2100012816387818
5,Prevalence,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2693831674356079,0.6228152125567493,0.0995823374111574
5,Prevalence,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3497434313806384,0.7510625279231408,0.1730663793232802
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0933674496811591,0.2857049429680495,-0.054211539357491
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1427420215348318,-0.0128513168466764,-0.2463409541905051
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0318225322828672,0.103998635290989,-0.1390366615488539
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0573331324809334,0.2440607825367076,-0.0851704404878395
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.157404707912455,-0.0311177144774495,-0.2599244341717115
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0561159490519136,0.0758380329535988,-0.1603712153669056
5,Prevalence,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2218529583291855,1.5075891225680684,0.9240537284949346
5,Prevalence,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9351746658314648,1.1910961430851503,0.6883816834252917
5,Prevalence,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0976774621713132,1.36612705055992,0.8392187229218444
5,Prevalence,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4887775598067769,0.6754558157262143,0.2914562126509897
5,Prevalence,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2477417993284836,0.4140544960657,0.0889233651749481
5,Prevalence,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3779791177420155,0.5554191629972438,0.209068074816065
5,Prevalence,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4624500073022453,0.6505249444447564,0.2664350171054086
5,Prevalence,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2421022868148596,0.4063668660048006,0.0836968812310394
5,Prevalence,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3631317005044994,0.5375780348523529,0.1951777099140217
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0795460312530834,0.0451669755869192,-0.1984826971564937
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2756322933048,-0.1840430824306062,-0.3624698309271317
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1740070421088931,-0.0721403517231294,-0.2605102954476781
5,Prevalence,124,Central Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1098996007049045,0.0094469175573751,-0.2257056305061853
5,Prevalence,124,Central Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2880319374204182,-0.1985480909953936,-0.3741732426856542
5,Prevalence,124,Central Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.194746735892758,-0.0976037294258272,-0.2788661754928737
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,5.227710095870008,5.601700123849185,4.84854248700232
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,3.939598597771577,4.196327384916327,3.638118415919916
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,4.778390953158454,5.048592366963706,4.509646567819277
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.6715942696603463,3.9532145487168,3.385847413200648
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.745756236742909,2.939152151420143,2.5149801603440864
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.358887612351745,3.562373964694121,3.1549445085278878
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.696651228404566,3.978697228825217,3.410700535686765
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.7665061015706445,2.962265033008066,2.5366236684192605
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.38226837768061,3.587186168969229,3.178455580814151
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.441157466771996,2.6439929996608527,2.249650383713927
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.966275444857225,2.093464143670189,1.818024022449036
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.3282208207630544,2.4827571694931683,2.18122763396431
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,2.396509644459984,2.596091737777466,2.2010629081134976
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.954559784432118,2.0843331402663265,1.80810963307805
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,2.300053024465128,2.4552548384847235,2.152382106846225
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,4.1901845885557085,4.5494191143181295,3.829598753986288
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.4384744826798173,3.7025575485983735,3.1587711873538344
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.9910561765452335,4.284447344819075,3.7074702137352498
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.8932847828161825,3.166645340736089,2.622130584795765
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.365731420154299,2.564717399930325,2.152267515122996
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.764940005736617,2.9855025235116037,2.553079263195906
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.914197425415187,3.1851155077816644,2.642260248378189
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.38439265656545,2.5857593181303167,2.1711153734781226
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.7851623109278214,3.007666957885721,2.570093824345583
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.0807873875145924,2.281531425122597,1.8896477364080968
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.785020949437181,1.9291642272152,1.6313710048730423
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.0328626668159617,2.188338313762128,1.8922541452145865
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.0408286225716,2.241897481389062,1.8539743675943137
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.7740432468551834,1.918535452533182,1.625295179030494
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.0072166662926723,2.161364893088513,1.8673383590584147
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2854868598013281,1.556479877678251,-0.1457199555154291
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.05850011980181,0.9102621995155368,-0.2943794065239947
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1661012527110147,1.1333148418613417,-0.1824815068357321
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4807280156035851,0.0324134863140491,-0.655163009176988
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5653162290596642,-0.2152162264609827,-0.7101718689380669
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5250219668878275,-0.1305277479448475,-0.6671614352938855
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4889543879075061,0.0163291938216652,-0.6603807616520531
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5699577294141998,-0.2239079823177534,-0.7133239037825166
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5313151105169566,-0.1425680844045004,-0.6714191295753685
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4166685098481403,0.1782573010191752,-0.6097212516680584
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5100379194675493,-0.1138447907283992,-0.6764544806207136
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.465127438872239,-0.0022140113490028,-0.6287518789614488
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4228705804678368,0.165934329021717,-0.6135933354309806
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5134820767205643,-0.1209678648348197,-0.6789627854309225
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4698515425410796,-0.0113836421269963,-0.6319852712701823
5,Prevalence,159,South Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3001551714882398,2.066340929870876,0.850833819942381
5,Prevalence,159,South Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2330325606119052,2.3731313222933457,0.6568108950441163
5,Prevalence,159,South Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.275972673197646,2.143151508032764,0.8138506313309881
5,Prevalence,159,South Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4208480581224474,0.8956765810410957,0.14515937806716
5,Prevalence,159,South Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3063535463157399,0.97412049558247,-0.0317541171997678
5,Prevalence,159,South Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3690819951824026,0.8911210420183849,0.0920276984435968
5,Prevalence,159,South Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3891952462412825,0.8519386413289556,0.1178243868577626
5,Prevalence,159,South Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2948101638367345,0.9558894021969152,-0.0393084165907973
5,Prevalence,159,South Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3476751560256138,0.8611590766812154,0.0740381294436896
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2720824466025108,0.5429554609261014,0.0809059062169615
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2642121736265561,0.6374592308419813,0.0070570790094462
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2434726965652856,0.4697287257158645,0.0682624427153922
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2427425783801578,0.509641536177065,0.0578894562344481
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2496206661259404,0.6187402928885979,-0.0039089274790602
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.221756957303948,0.4455376008706366,0.0497763624860515
5,Prevalence,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7544370165826493,2.3026052675916397,1.263903931068464
5,Prevalence,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.066746826742828,2.731062602719885,1.553526741407275
5,Prevalence,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.819321038666618,2.300852565640068,1.410042632062656
5,Prevalence,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7014614463135189,1.040074142751363,0.396678542168275
5,Prevalence,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.794079185612189,1.1814838474287417,0.4954638457669899
5,Prevalence,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6959203702375649,0.9856194276364734,0.4531062516961138
5,Prevalence,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6635620313528073,0.9946321860456226,0.3673010490646139
5,Prevalence,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7782342412833243,1.1634336485398262,0.4806467387546823
5,Prevalence,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6694088489793479,0.9545388434592292,0.4270622044113512
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2723053329132833,0.5242905203219517,0.0441257709196629
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2842570453322431,0.5479743580219356,0.076174130627034
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2292279091692068,0.431824104131887,0.049740407156972
5,Prevalence,159,South Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2429584106738178,0.4891225990743315,0.0227607619327843
5,Prevalence,159,South Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.269434237804072,0.5299882541346148,0.0626670487954886
5,Prevalence,159,South Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2077597088503494,0.4063936566808077,0.0309838206240776
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,6.29060132147914,6.785356018204936,5.76626496975932
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.256017605572127,4.530495239337416,3.890788861377975
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.214247646125207,5.526733148140963,4.871676144774984
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,4.4689324103378105,4.841217184292347,4.073432577684716
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.9856998842246973,3.1939784873222985,2.70644430453721
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.687682604888991,3.923050856546484,3.4301247809435984
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,4.4982346842125125,4.871355818363757,4.102804432564294
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.007779577531089,3.2170722279071846,2.7292880632414813
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.7128173173892822,3.9498028978160864,3.4530148447578446
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.833234070124523,3.070934047500436,2.6007172125282496
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.1173914362535218,2.2615100425103734,1.9311083647053704
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.495374557611078,2.6572274174621544,2.3324386353928355
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.783469819438839,3.0159561312655296,2.561940211124414
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.1050785756177395,2.2468777301875145,1.9200542009994812
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.465781252545914,2.624307088955403,2.302180184063535
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,5.542112189632408,6.001716223452089,5.105288584697364
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.036832039516935,4.371662495180339,3.692897735901504
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,5.25936034235455,5.651263927692649,4.899967187878416
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.9074588362993232,4.254643427937417,3.5779076977965176
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.8195111955277743,3.0717956749575315,2.5562394297463387
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.721725587878946,4.016166644196693,3.450185131668356
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.9337587618559726,4.28037089003618,3.604326580663905
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.840647824700914,3.0959602613869244,2.5783935893686314
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.747030291852309,4.044245676385608,3.474470461826469
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.607910645480811,2.851066148746764,2.387270657167817
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.071447367385774,2.2716134772989847,1.855825135909628
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.632438643079754,2.8498832973901225,2.4342991958193734
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.561083362261931,2.798965033329192,2.338171742560338
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.0592946600338773,2.255818285674536,1.8448055453728427
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.601674404710921,2.821020671940058,2.405446082820288
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,5.05508278325712,5.626467843954053,4.540626102921964
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.686465445053988,4.034714764285699,3.312586183925293
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,4.321598795840157,4.675121708161323,3.957170576863893
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.5420619803114146,3.967933416991936,3.150979696417142
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.55379692502359,2.8142173790327725,2.2695874873226867
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.0142979437411253,3.2783995429471675,2.7367873188934952
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,3.566463684771613,3.997375899036993,3.178484224831842
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.573488886639306,2.8390333756886443,2.288401244309981
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,3.035842211224306,3.303950113927532,2.759463843457201
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,2.523687764687922,2.810226298662326,2.238382533707152
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.9418535618614263,2.143969134644885,1.743587761006335
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,2.2244303204082585,2.4015528626627787,2.047399281750565
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,2.4779857899518567,2.760099462058678,2.200556046053012
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.93024163597432,2.130522563062488,1.7341836106014497
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,2.197144064139512,2.374874458933357,2.0190168062599336
5,Prevalence,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.893254298731912,3.2050768216613923,0.8720018443405465
5,Prevalence,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7187153239125946,1.7584726931622852,0.0781453597881457
5,Prevalence,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3721692946571415,2.436678576587833,0.5579064384166617
5,Prevalence,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6856580491464004,1.45223408793331,0.0914433113927854
5,Prevalence,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0005227358831471,0.6027058488439105,-0.3722194582200306
5,Prevalence,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3807895297655603,1.0035207415292902,-0.0913430750250236
5,Prevalence,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6498761242250763,1.3979419478032769,0.06750766734762
5,Prevalence,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0068201740501658,0.594015827499313,-0.3769810474806325
5,Prevalence,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3615527305977118,0.9725485489922134,-0.1058092818166484
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3148078309851455,0.86927785120271,-0.1903652645892828
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1685925276267194,0.4022807292978013,-0.5229051671890386
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1121915228765656,0.6541186945085212,-0.3168970593654528
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2785031105677794,0.8274190934855328,-0.2114145646690968
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1786884514366794,0.3850215720475329,-0.5288308523929457
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0898504336259976,0.6219882015269496,-0.3300530613044871
5,Prevalence,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.620416669911564,2.8674472177168253,0.5941234692828221
5,Prevalence,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0410698603701585,2.351143660263296,0.1280125330769781
5,Prevalence,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4340883786593015,2.579348588810664,0.4730159014795151
5,Prevalence,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5267312584294076,1.2513359471133718,-0.0740534779492062
5,Prevalence,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1869838899716819,0.955836414048,-0.3445178704174116
5,Prevalence,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4168834374791058,1.079597893633715,-0.1440410781493579
5,Prevalence,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4942906681598484,1.2054089158385932,-0.0909522705317228
5,Prevalence,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.179456178966943,0.9364977032126848,-0.3481647160041282
5,Prevalence,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3970923938456632,1.054436778957048,-0.1545338575157802
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0826459825453675,0.5811332544869808,-0.3410487036969293
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1347219219521525,0.4380985898929801,-0.5275155178537244
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0188224766012301,0.4971500074722462,-0.3898865294819577
5,Prevalence,254,Northern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0527243517160353,0.5365154958094989,-0.3604830860982734
5,Prevalence,254,Northern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1452618775706269,0.4199567648873948,-0.5332154513358216
5,Prevalence,254,Northern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.001676738403141,0.4688932836963314,-0.400036070389444
5,Prevalence,44638,North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,4.258992106030888,4.473971745923056,4.053851545389692
5,Prevalence,44638,North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.951882689928257,3.075927413798682,2.7963408499493823
5,Prevalence,44638,North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.8209490020033834,3.971329530769679,3.6524510957437215
5,Prevalence,44638,North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.9183301240202333,3.080064143161124,2.7573671123263246
5,Prevalence,44638,North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.9828163193521589,2.07906829515318,1.8687955385403037
5,Prevalence,44638,North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.61606723686785,2.7272294389188865,2.486667896779976
5,Prevalence,44638,North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.9752857646045707,3.1377894316405235,2.820219483077972
5,Prevalence,44638,North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.0206180641000526,2.115431539873065,1.9017297952855543
5,Prevalence,44638,North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.664869800943307,2.7791885913508434,2.536778238905081
5,Prevalence,44638,North America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.7639923281011607,1.874159296424403,1.656571853888162
5,Prevalence,44638,North America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.3254503183151445,1.4017374526731163,1.2444747221870305
5,Prevalence,44638,North America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.6698524133941963,1.7576980186166682,1.5825978437008046
5,Prevalence,44638,North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.7572692469441638,1.8679230857667852,1.6514340753591867
5,Prevalence,44638,North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3315624389855036,1.408448215938388,1.2506841026588784
5,Prevalence,44638,North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.670078988918365,1.7592309273805136,1.5845360195397902
5,Prevalence,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.3245354587283824,3.612751581236066,3.013515747730059
5,Prevalence,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.5313924319069576,2.703207683050935,2.332345595334413
5,Prevalence,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.1162068780032395,3.351373170107784,2.8451861795710145
5,Prevalence,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.2220701729819474,2.4338551072176147,1.9952573820426247
5,Prevalence,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.665436380270106,1.795535208738784,1.5163090278244902
5,Prevalence,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.0874483465816853,2.264798111562049,1.8852170450620729
5,Prevalence,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.268927562735087,2.486790876813927,2.0338269570077694
5,Prevalence,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.6992167045925133,1.8305435409422088,1.5470754298311675
5,Prevalence,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.129127123178516,2.3078997759851725,1.9230980669279567
5,Prevalence,44638,North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4405501396644436,1.567915719936484,1.2983778996983832
5,Prevalence,44638,North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.201901948932282,1.3005485530141554,1.1093605134183258
5,Prevalence,44638,North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4175739232310982,1.5224980599788978,1.300618796851898
5,Prevalence,44638,North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4346148799081655,1.5641656841325275,1.2965490664455368
5,Prevalence,44638,North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.207684301989808,1.304928384347655,1.11528796336068
5,Prevalence,44638,North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4177760252729583,1.5225107696414577,1.302716680503195
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.554188855231812,4.830305140808429,4.272640473718502
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.785383947578598,2.941444386832252,2.6055887952813555
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.656656219090888,3.833204645811581,3.4629301221271693
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.8863023105450107,3.076946338298733,2.691078502971658
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6211131457998122,1.728897865456852,1.4952087672584442
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.240827055550742,2.3634520627388733,2.1049006581700382
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.884587478674872,3.077702601974787,2.6876731594151675
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6327573802677893,1.7412983575907637,1.5077087667844096
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.247621713747366,2.370749227819685,2.112514235458637
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4656326146354943,1.5859306911644049,1.3430771197469418
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7583188961763013,0.8275117516488567,0.679762540715259
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.122584380595942,1.2018324255165385,1.0383730249689205
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4229876185974268,1.5386598152588755,1.3023052612299888
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7437254013643935,0.812364139693234,0.6663609964250239
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0952085896966437,1.1736261480576546,1.01081155875344
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.032223741597386,4.282250912460999,3.753427195585481
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.611623008003409,2.796312007602709,2.42356152812149
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.7354019109902783,3.953664486191365,3.4985454063806545
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.5210768321802464,2.697506945873466,2.324237667643496
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5007960593610417,1.6292409510453851,1.3685203222874671
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.295631121856736,2.4472050363598896,2.131546368947084
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.519526225343612,2.6943946791504043,2.324536533785774
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5119055981489713,1.6403579119652094,1.3811077039433035
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.302540137363885,2.4547597226567506,2.137352867524433
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.292565701001018,1.3988019343407396,1.1682485836887226
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7009543174852872,0.7867590925932167,0.6112141319136846
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1973809428954425,1.2899726949753236,1.0934625572132086
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2529236642981216,1.3560097537102087,1.1301686883016862
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6868391415721447,0.7712254941313946,0.5985792603633324
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1690439612626262,1.260323878103886,1.0654156683066072
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.3518964019233595,3.620103269805864,3.1177913471938834
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.177857901524247,2.331208796149146,1.9974348912196105
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.768289541566913,2.9647565761251515,2.5752865780061795
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.0450472884704096,2.234501708978687,1.882031893486588
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.200444141678462,1.306942434699442,1.0746290560778289
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.6225634755622436,1.7603101381763748,1.4908222696168996
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.043706779159585,2.231290073107105,1.8799742183843071
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.210219348827775,1.3168758215093923,1.084734056311138
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6280615023088416,1.7650805514821697,1.493458348073893
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1110819806723475,1.2207532663079277,1.0132956109870304
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5975586290924857,0.6681413200661956,0.5214154933373832
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8599431942297288,0.9354470351306714,0.7836171857457219
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.074573893902404,1.1822362804630644,0.981226511950645
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.584299681454231,0.6547774013163622,0.5089247644834086
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8359560233598949,0.9110487047148852,0.7603745841274965
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0330466196421084,1.6388835156961847,0.5756284337838316
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8344112022754915,1.298867671749783,0.4750681326414544
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9767850584997536,1.4525821055405272,0.5975559027625634
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.664457049954193,1.1626516438764876,0.292019387310932
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5063475368722564,0.8868840053275837,0.2100640642252222
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6208565613900826,1.0114853770997791,0.3107143168618809
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6488829463672698,1.1402411456984307,0.2778983173218536
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5044233186142543,0.8853298145469128,0.2097216221411404
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6122117151046387,1.0002587462945094,0.3029228093837751
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1579954833464435,0.4961884230140386,-0.0912477738599326
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0233362552257076,0.2931299501320893,-0.1701325009320656
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1272304113697002,0.3958167606886311,-0.0837548050567513
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1192732134125036,0.4436770182885649,-0.1229988086503527
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0053538643744413,0.2709541935535531,-0.1838902890404324
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0979516355698469,0.3595536574957617,-0.1083629983677739
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0240602675773585,1.7850354703061186,0.4631836039393294
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8432613023028197,1.4776730730266163,0.3916359314148225
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9969672639207362,1.6989193498144546,0.4823980240709272
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6570939046281838,1.2820931749779216,0.1979827369130188
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5136183783923927,1.0346907918827783,0.1411963383438233
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6373997531813513,1.2113897327609695,0.2157558143731252
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.641594651781963,1.2587762856240394,0.186701017394512
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5116813951222162,1.0319703359531105,0.1412978418605993
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6286717687035102,1.2011646512523435,0.2090031997049377
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1746951840798728,0.6028820108750583,-0.145548869129894
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0563635559866254,0.4204042317362438,-0.2033538675542498
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1645192913090739,0.5768506778474634,-0.1358544681655958
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1354171455439788,0.5500986491333393,-0.1740070224882019
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0377973377233901,0.3938935957348696,-0.2172528776352663
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1342745205976266,0.5363097745541108,-0.1581349623944856
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.988747283663278,1.5845665283779988,0.6713419903875169
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7926745571545161,1.5246349992973762,0.4863502417544558
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9101264492009252,1.5452186703100546,0.6406062892681657
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2488406699166114,0.6225827362242421,0.0502172961370389
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0811509187961554,0.5233964525438017,-0.1039454502973932
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1756322780635465,0.5661019399594204,0.0104980969954248
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2175793903116951,0.5823603952563909,0.0232529685269552
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0698402224861458,0.5066628008777027,-0.1129693524211351
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1547687824397919,0.5387143956812482,-0.0081698895307101
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1211543774942459,0.3565293167880595,-0.0426655262597273
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0330413312942785,0.2136573147490721,-0.2373695989209604
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0450928244532161,0.2697426908130793,-0.1128118122794036
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0929851894076676,0.3232546534213415,-0.0671774150674946
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0453690281743398,0.1987146928212275,-0.246471621512326
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0251831806008231,0.2449280035510689,-0.1292535246312512
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0902999169632843,1.772990291341752,0.711320416468731
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.117440519992725,1.6424075340840998,0.6027608209020892
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0973437822157306,1.6941579066325336,0.7234728775533948
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3126151386450336,0.745241492398487,0.0742308136407662
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2770185170091724,0.5926076049256117,-0.0334852851117873
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2908639875107467,0.6575554772130995,0.0595635343876136
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2797534002292407,0.6977198943311291,0.0477291340274419
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2636554850233984,0.5769476132080456,-0.0434973339791895
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2679512012202737,0.6287557542821783,0.0419271861362463
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0142439268152105,0.3421289671103988,-0.1662732695126627
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.062481244004264,0.1766927284313608,-0.2983438796159861
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0298832836240734,0.2408124970173986,-0.2034520774584716
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0112450824043691,0.307587282619973,-0.1858269307187344
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.074437950293226,0.1622237884961535,-0.3072380590472335
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0483699005214266,0.2160174655220887,-0.2182990137793344
5,Prevalence,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.106865436832339,2.362525009465004,1.8471103353894185
5,Prevalence,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3189017655911444,1.4641423255820074,1.1664079363151068
5,Prevalence,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7285815576129622,1.8932936263069813,1.5428676225186655
5,Prevalence,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.927544620854672,2.166198681245673,1.6805512751521678
5,Prevalence,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.19880917739572,1.3364677330982653,1.0539510011255462
5,Prevalence,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.57953477843719,1.73667862516914,1.4049889409043144
5,Prevalence,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.924696610779035,2.1653657677780997,1.68017206336341
5,Prevalence,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.202814978556206,1.3407846354813686,1.0579551590282257
5,Prevalence,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.580629904333678,1.7364108040801038,1.404985920660677
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9801257973605934,1.1271756973147855,0.8332679357411061
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6237526055742236,0.7072371854263902,0.5323913920947332
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8408932283355179,0.9408494130827488,0.7227392116065419
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9350845889727414,1.075625972993942,0.7910554998568806
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6058335170286397,0.6888991923353631,0.5144295731042091
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8095367909490833,0.9074329943559292,0.695223855050061
5,Prevalence,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8041133755038696,2.032960122486628,1.5668530723203775
5,Prevalence,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9724688036134312,1.110894551955024,0.8399462018712083
5,Prevalence,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.643904392655129,1.826303775891979,1.4529421745179116
5,Prevalence,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6423034117315838,1.857385070592409,1.4211962276035106
5,Prevalence,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8703263125744708,1.0018778833769977,0.7448644699928881
5,Prevalence,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4995055537812425,1.6741613218304747,1.3196783769965978
5,Prevalence,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6396961993751469,1.8551246815210227,1.4163474838605588
5,Prevalence,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8737248338016017,1.0052208360856731,0.7478364600693959
5,Prevalence,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5005441823237664,1.673053338811948,1.319936492827424
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8333410144326038,0.9684167814628166,0.6941586575817524
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4409806097091974,0.525283744050919,0.3561592171937563
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8456312392447608,0.9619622594304325,0.71504535719639
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7916120840007671,0.9223794580417196,0.6545514538629436
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4250681652491923,0.5082301472601918,0.3406456756812674
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8141731128697496,0.9276239156768658,0.6868898355267425
5,Prevalence,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.930582985831224,2.2643033102765555,1.6385087683264363
5,Prevalence,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2021463988733991,1.3913319608276984,1.0075698227473526
5,Prevalence,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5422025403909505,1.7347026755041273,1.3353267078691191
5,Prevalence,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7614225599494209,2.074217453266246,1.4886989501919845
5,Prevalence,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0881020122531682,1.2661546883204269,0.903100533453534
5,Prevalence,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.403338193806144,1.5847988707830425,1.208364484261293
5,Prevalence,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.758750354829042,2.072903227458264,1.4838016995364094
5,Prevalence,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0919045146249722,1.2716192381131683,0.9070686570967972
5,Prevalence,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.4043569012264432,1.5864191173531026,1.2086984799488332
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0378246194269332,1.213918977905886,0.8563476515709758
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6613805966724539,0.7798291942086889,0.5352212636467958
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8467742011010304,0.970785150682392,0.7207107282877179
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9914694992035032,1.1617535157158947,0.8130364482541197
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.643045178633664,0.7610385719385879,0.5179788401710392
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8153103065202969,0.9378409599193784,0.691790426504515
5,Prevalence,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6622438852691229,1.512394387009171,0.2262975003548412
5,Prevalence,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4091613534003711,1.008377100804979,0.0174021358631368
5,Prevalence,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5505362218455747,1.1329928900932047,0.1585838395391446
5,Prevalence,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3376698308252233,0.0007862274368473,-0.5108694363354327
5,Prevalence,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.4199749215380358,-0.1731622778413339,-0.5811991873017819
5,Prevalence,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3719895611072355,-0.1367720685764755,-0.5312461636141639
5,Prevalence,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3484644930914106,-0.0152382782089211,-0.5193386658871239
5,Prevalence,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.4257781468485874,-0.1816025766898588,-0.585416859151155
5,Prevalence,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3802556538491807,-0.1474495949267694,-0.5369177617524852
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3227279105969757,0.0202939337181645,-0.4907525577750913
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2734512513662624,-0.0276188652738468,-0.4206055070420796
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2962954953320705,-0.0610150518649344,-0.4463095824764415
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3305240388319704,0.0087092891548223,-0.4963544427416611
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2785624967204244,-0.0347981005188474,-0.4247096967743602
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3028369017218474,-0.0694348678591045,-0.4515638000476621
5,Prevalence,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.78482034791795,1.8035793496174004,0.2533148352217415
5,Prevalence,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.745188071694502,1.3875787997877471,0.3262475352902686
5,Prevalence,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7745313076734227,1.5568989911775009,0.3037205841271502
5,Prevalence,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2888264204132248,0.115979191135219,-0.5010513969376628
5,Prevalence,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2816660438614783,-0.016778606084153,-0.4541353585116104
5,Prevalence,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.281265906535584,0.0352050065305821,-0.4718636007935336
5,Prevalence,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3004192462809324,0.0988949990426269,-0.5087489124076127
5,Prevalence,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2888499771811222,-0.0270809516235611,-0.4595648570589944
5,Prevalence,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2907255377180384,0.0219843117078832,-0.4789070712507896
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3491354697222028,0.0391809475421529,-0.5373576921850477
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2864596810829166,-0.0161331350576051,-0.455652161515525
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3242207964119887,-0.0077885062667191,-0.497416562224248
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3566296334763498,0.0272503473684683,-0.5426634453008587
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2914784274814582,-0.0236148874652266,-0.4594936417611077
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3305023032418854,-0.0166054096469244,-0.5023987493713773
5,Prevalence,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.554188855231812,4.830305140808429,4.272640473718502
5,Prevalence,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.785383947578598,2.941444386832252,2.6055887952813555
5,Prevalence,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.656656219090888,3.833204645811581,3.4629301221271693
5,Prevalence,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.8863023105450107,3.076946338298733,2.691078502971658
5,Prevalence,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6211131457998122,1.728897865456852,1.4952087672584442
5,Prevalence,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.240827055550742,2.3634520627388733,2.1049006581700382
5,Prevalence,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.884587478674872,3.077702601974787,2.6876731594151675
5,Prevalence,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6327573802677893,1.7412983575907637,1.5077087667844096
5,Prevalence,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.247621713747366,2.370749227819685,2.112514235458637
5,Prevalence,44560,America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4656326146354943,1.5859306911644049,1.3430771197469418
5,Prevalence,44560,America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7583188961763013,0.8275117516488567,0.679762540715259
5,Prevalence,44560,America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.122584380595942,1.2018324255165385,1.0383730249689205
5,Prevalence,44560,America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4229876185974268,1.5386598152588755,1.3023052612299888
5,Prevalence,44560,America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7437254013643935,0.812364139693234,0.6663609964250239
5,Prevalence,44560,America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0952085896966437,1.1736261480576546,1.01081155875344
5,Prevalence,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.032223741597386,4.282250912460999,3.753427195585481
5,Prevalence,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.611623008003409,2.796312007602709,2.42356152812149
5,Prevalence,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.7354019109902783,3.953664486191365,3.4985454063806545
5,Prevalence,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.5210768321802464,2.697506945873466,2.324237667643496
5,Prevalence,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5007960593610417,1.6292409510453851,1.3685203222874671
5,Prevalence,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.295631121856736,2.4472050363598896,2.131546368947084
5,Prevalence,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.519526225343612,2.6943946791504043,2.324536533785774
5,Prevalence,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5119055981489713,1.6403579119652094,1.3811077039433035
5,Prevalence,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.302540137363885,2.4547597226567506,2.137352867524433
5,Prevalence,44560,America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.292565701001018,1.3988019343407396,1.1682485836887226
5,Prevalence,44560,America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7009543174852872,0.7867590925932167,0.6112141319136846
5,Prevalence,44560,America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1973809428954425,1.2899726949753236,1.0934625572132086
5,Prevalence,44560,America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2529236642981216,1.3560097537102087,1.1301686883016862
5,Prevalence,44560,America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6868391415721447,0.7712254941313946,0.5985792603633324
5,Prevalence,44560,America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1690439612626262,1.260323878103886,1.0654156683066072
5,Prevalence,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.3518964019233595,3.620103269805864,3.1177913471938834
5,Prevalence,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.177857901524247,2.331208796149146,1.9974348912196105
5,Prevalence,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.768289541566913,2.9647565761251515,2.5752865780061795
5,Prevalence,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.0450472884704096,2.234501708978687,1.882031893486588
5,Prevalence,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.200444141678462,1.306942434699442,1.0746290560778289
5,Prevalence,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.6225634755622436,1.7603101381763748,1.4908222696168996
5,Prevalence,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.043706779159585,2.231290073107105,1.8799742183843071
5,Prevalence,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.210219348827775,1.3168758215093923,1.084734056311138
5,Prevalence,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6280615023088416,1.7650805514821697,1.493458348073893
5,Prevalence,44560,America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1110819806723475,1.2207532663079277,1.0132956109870304
5,Prevalence,44560,America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5975586290924857,0.6681413200661956,0.5214154933373832
5,Prevalence,44560,America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8599431942297288,0.9354470351306714,0.7836171857457219
5,Prevalence,44560,America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.074573893902404,1.1822362804630644,0.981226511950645
5,Prevalence,44560,America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.584299681454231,0.6547774013163622,0.5089247644834086
5,Prevalence,44560,America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8359560233598949,0.9110487047148852,0.7603745841274965
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.966647179782936,1.3648996578630328,0.6476173911685994
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.0177026025341316,1.3180256975039577,0.7780400504296467
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.9870292916097264,1.3001785303358884,0.7240152408333016
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.4752222312682493,0.7746262585101181,0.2351621086002223
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.5300538059807319,0.7583203089169674,0.3490866104353642
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.4988962648708481,0.7340216040681691,0.299981107453687
5,Prevalence,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.4831544420944251,0.7834980614338127,0.2425569149894235
5,Prevalence,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.538523629638301,0.767523769478962,0.35577791721811
5,Prevalence,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.5069412403442192,0.7444301914187943,0.3074742664155679
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.9920465539582148,1.3917626392035305,0.6690240128595517
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,1.036257643018082,1.3416443676354208,0.7978355667506541
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,1.0081646607209251,1.3273068597579385,0.7460951128234179
5,Prevalence,44535,Commonwealth High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.9662507366814748,1.3623511351621265,0.6458565471519653
5,Prevalence,44535,Commonwealth High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,1.0282032635333616,1.3334580626446535,0.7911144736435454
5,Prevalence,44535,Commonwealth High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.9911843837189088,1.303812177850769,0.7298659599275685
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1010477689474656,3.259991049722715,1.0271469285549095
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2284630230250135,2.4538425527458223,0.36314978867615
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7138569637258612,2.736795905863678,0.7896578260780964
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5686230846373426,1.1565903582367936,0.0275263998301777
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1251311261833433,0.7437056142907945,-0.3129026464480393
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3715240649836306,0.8882164024604591,-0.0945764619360899
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5412491297371018,1.11725454983928,0.0075105810269182
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.116577269227247,0.73055691121625,-0.3169902067651988
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3540875293508554,0.864486155126071,-0.1070445581735868
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2919559467032901,0.7540363709442474,-0.1516122972105671
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1337029377855429,0.3538376571743242,-0.4717738134092314
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0930288845262419,0.5025851417955741,-0.2839771896993358
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2645174621975479,0.7158154994950071,-0.1703824661300534
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1438959150503753,0.3380704221043474,-0.4779227961300879
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.074815111267316,0.4738231396004224,-0.2965365896702694
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4087068132883207,3.3982657445597377,1.393872992815496
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.735909761910918,2.99144125220362,0.7934199004231093
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.232132861209382,3.164827901380651,1.2792413329073606
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7241932654036317,1.228131978599864,0.2104351116116031
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3813244229284289,1.0176413269110405,-0.0948205660659841
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6334149466939157,1.1106181272326925,0.1518440797448972
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.694158491242044,1.185978339010241,0.1897767921615447
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3708347947635529,0.9999221560413012,-0.1014022336013606
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6126829302602892,1.078054075263236,0.13723468352352
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.404035652620194,0.8082126466714934,-0.0216148585920478
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0624584567732225,0.5742936748827785,-0.3041152923525739
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2948870454103746,0.673324360147929,-0.087197034961001
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.374249341570343,0.7689281899915021,-0.0424323759811804
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0499660485338069,0.5537111732178361,-0.3124222785289099
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2733310248792552,0.6476506411250283,-0.1029052160137171
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.383573556763673,3.483558159839693,1.2282758355756829
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5708696365566155,2.6209719293583467,0.7364667019109358
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.877678437720342,2.833128608557305,0.9940647327362522
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7115032722517456,1.27300172679214,0.1259518935608986
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2980029001255443,0.8302644336877225,-0.1239654021826573
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4543015299536859,0.9386224363018592,0.0064206898085922
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6816670326666686,1.228369450214576,0.1074734890526646
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2881410051080784,0.8142975257194011,-0.1299387837758197
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.435826772774819,0.9125516623099932,-0.00505508455041
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4299486744838249,0.8991838153123703,-0.0731580468002028
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0457096745185773,0.5080756287002565,-0.3087343559744477
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1964986012871402,0.619322743492464,-0.1864703115015616
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3996043644480056,0.8615659772330583,-0.0906373377593094
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0334142911757639,0.4904351284575315,-0.3154360969426756
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1765744528872564,0.5935544798294123,-0.1994039817227612
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0870191899343464,1.6707386089867384,0.7674947654798572
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9079880743082472,1.6585615566370375,0.5881231980967636
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0199522693463647,1.6004119890658095,0.7363298234087023
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2565256576039061,0.6108773640993702,0.0611776265465022
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1090666256175491,0.5445446129514955,-0.077267793456365
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1951195270473769,0.5386735964691995,0.0273352990029027
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.22927639506762,0.5730933118666766,0.0410731267297636
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0991733879158101,0.5315714770654028,-0.0850976588453819
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1768229556765138,0.5149984330765036,0.0115846922830097
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0999332297699065,0.3376281368305862,-0.0590926306915523
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.006069316592801,0.2526834990386708,-0.1909343366128195
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.05221396570049,0.264552844382924,-0.1079189696782152
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.074803518521753,0.3059104345144679,-0.0806988625681778
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0056380408613386,0.2378434502377056,-0.1999077272300768
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0339585429542044,0.2435816758057964,-0.1227755966579001
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.222518338799752,1.8779614724556135,0.8317347484426134
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2770841133819035,1.8586677155777,0.73136827160246
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2357014579139116,1.8203814304993424,0.8478468004711808
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3381051910345133,0.7319013806345414,0.1031546254314015
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.323614942711711,0.6612358100337383,0.0056306821745118
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3227698314899219,0.6698648801816136,0.0928723693336234
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3090868280791349,0.6951497720128923,0.078911156708849
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3118060291769361,0.6468506906136171,-0.0025755640442442
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3025183008724809,0.6431524950089118,0.0765544148583074
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0201141467461811,0.3113993279745394,-0.1579415821089176
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0203838148474917,0.2387973436820348,-0.2637259998037728
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.00932412096718,0.2457618989557662,-0.1861585571696669
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.003194686212855,0.2806685635312885,-0.176180893899797
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0317861526537633,0.2247372504971968,-0.271758959375062
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0265144334497653,0.2230536688749685,-0.1996144604102263
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.219256836394122,3.5994660225793904,2.995556661919151
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.9701134132649771,2.3177313227533114,1.7899007462057792
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.7264806303072446,3.0916114107930257,2.5453936807794806
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.9522356993695549,2.2183170532237657,1.7954239915227015
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.05659326875429,1.2971363207040552,0.9314146236429685
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.5934628474771173,1.8468359274051749,1.4655299017684844
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9509389585359893,2.2168564277522544,1.7944835481434644
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0657318035090428,1.3075021574262702,0.9403928059890309
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.5989033421083156,1.8535510110089524,1.4726105943311445
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.0906656308325422,1.233121059241879,0.9901894552345436
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5218911173485506,0.674612898857534,0.4359807010357291
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.8755835937016584,1.0221032910115144,0.7937897798990836
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.054510535019847,1.19537763431237,0.954734298216954
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5092601820426534,0.6600411536174837,0.4239816590266438
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.8513947249908038,0.9974040478170788,0.7700252081911636
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.481359352947805,2.7239793552650653,2.249230421453381
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6534067908395509,1.8184229018116211,1.4936474011220748
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.216233567154909,2.4218184598235046,2.014220086916937
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.435932982257942,1.6079770757526872,1.272935068682369
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8373013847517388,0.9516235894865708,0.7264448276321427
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.238360553616534,1.3830459617074884,1.098866331787467
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.434855080321941,1.6045429767264558,1.2725046157942477
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.845460436293149,0.9602301373436112,0.7343468165994838
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2430494066436797,1.3864273864721572,1.1021621832749386
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7380685146247439,0.8363916079208953,0.6372813653134678
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3420545102600522,0.4170975443543008,0.2650059346082414
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6142268774609456,0.6930060350590279,0.532384066485381
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7079954984224873,0.8040623972911134,0.6080149185522072
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3309076977623527,0.4047545461534337,0.2538848557660449
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5933961955260888,0.6716506287464938,0.5118989131972886
5,Prevalence,44562,Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6275657257922935,1.7964813943212254,1.4461454555051276
5,Prevalence,44562,Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0183852103062323,1.1366907784515,0.8918201447465455
5,Prevalence,44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.415721572032561,1.5504026831750335,1.2700704964353702
5,Prevalence,44562,Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.4759248717127165,1.6347802088213563,1.3056350296148498
5,Prevalence,44562,Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9138561262942664,1.0262164703196588,0.7932664073290486
5,Prevalence,44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2837719620195118,1.4117431626818178,1.144573842521789
5,Prevalence,44562,Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.473500294450819,1.6325117139340353,1.3027174715627892
5,Prevalence,44562,Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9173426143929212,1.029725674953731,0.7971135359930636
5,Prevalence,44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.284734100007964,1.4121124083430912,1.1469806506981013
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.7384833022838008,0.8556499722046367,0.6208272550212814
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4150981843706542,0.5001808378951552,0.3349299993575276
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.6603477978683606,0.758406105789402,0.5649086927312998
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.6989224676520994,0.8126797079664323,0.5840758853361584
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3994790450723124,0.4834192293380847,0.3207693954581276
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.6320562561867612,0.7278437946730701,0.5386202717088293
5,Prevalence,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.175663677898804,1.3859752869527455,0.977782275304022
5,Prevalence,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6925187567958516,0.8210983718522427,0.5689773647026393
5,Prevalence,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0402920660017951,1.2110898216280763,0.8834878264707142
5,Prevalence,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0501010727999698,1.2485076617270443,0.8636787086448228
5,Prevalence,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.60486519098224,0.7259306782987682,0.487105635362652
5,Prevalence,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9288471729671626,1.090186596051867,0.7799055590104366
5,Prevalence,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0480951989453868,1.2460753376779763,0.8618164304335378
5,Prevalence,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6077893959457141,0.7299321732664257,0.4904326225744868
5,Prevalence,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9296614771907888,1.0911980801677057,0.7813596210372912
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5695657040975308,0.6961841593493433,0.4406874313231439
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2980510199499776,0.3830143858977135,0.216990523100405
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.525604670098126,0.6367718538871536,0.4153312843353969
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5338397907095005,0.6584832901880967,0.4101645673357439
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2837204767004499,0.3669076367873944,0.2035267279894221
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4996032218787667,0.6088036720641254,0.390708247100632
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6463692760149622,1.8164539043896049,1.4616546395471626
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.660898695153885,1.8799190917708857,1.3966477651704552
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6504900193049772,1.808919143085746,1.4716258279686714
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.163646885837864,1.3001531176325654,1.0129113384284572
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2263368574053053,1.4071760759147582,1.0046646339709917
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1928199652839884,1.3226416579351676,1.0450044081254015
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1781108598704493,1.3181000819028736,1.0260803177560178
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.239827682542096,1.4241894353128963,1.017392852838762
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.2064300540080972,1.3383161496334317,1.057532557893861
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4906992883721717,0.583896731615591,0.3944114401524469
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5460113106466357,0.6499928690134584,0.433507213263981
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5175795936074135,0.6009298338584206,0.4262487352955921
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4673144055379166,0.5573741355970689,0.3736962623599545
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5359288733865967,0.6393080499276143,0.4241315368648766
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5004928762178154,0.5820672110164529,0.4098519733344202
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.196088078756629,1.6002224583804336,0.8545663984351947
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2406971036970875,1.5572702285816336,0.9734389092803984
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2045642357529345,1.573378169926602,0.8956556081080576
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7955144212540597,1.1287636251153157,0.5158007593042819
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8747608285638445,1.139297904423948,0.6499354991605186
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8239025272328208,1.130898980789914,0.5681803525781066
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8075040913318093,1.1401294316740116,0.5264125265485776
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8861204337440514,1.152597789667691,0.661154220888627
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8352141492055809,1.1422374327383094,0.5780597079461547
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3209212951504571,0.5487034350334856,0.1168051106246042
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3953866573651035,0.5638668542058753,0.2575952858901183
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3446522622855504,0.5566315474655203,0.1545905210935041
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3001832369608842,0.5237337389941413,0.099850168482383
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.386282348524319,0.5526220746443826,0.2495057989285627
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.329500142207578,0.5383913870088521,0.1410870004731554
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9772031835067467,2.7783501927543512,1.3298110126413718
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5956122332903389,2.3852045553069563,0.9776148893369748
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7759601376023508,2.3687801125875563,1.2488404861213307
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.234889776701464,1.8425462446356724,0.7480882404107373
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9083361112316388,1.4893452827733031,0.4539445757157202
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0623345956650614,1.503959753753498,0.6747333816123076
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.191928880020864,1.7817634188391929,0.7152944319991528
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8953513255082892,1.4719223691145416,0.4440812667531036
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0354861925036496,1.4701743054118457,0.6489731594621605
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2437501014540896,0.5776097586607898,-0.0343521312316506
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0145662947509979,0.3185959402840294,-0.2248255810018433
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1163738873166071,0.3590285571257844,-0.0889357267804346
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.200005412453027,0.5176732472195343,-0.0700763454754795
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0046288903485623,0.2933316310723034,-0.237987164143006
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0857912082255998,0.3213625164210428,-0.1141307206165945
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1341573138760666,2.928760871544681,1.5087667337110724
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.787657491523026,2.6414098028568773,1.1640805568623884
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0360788533976173,2.6768315313218487,1.4940179557344075
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3527669400361049,1.955164341512909,0.8801038232939284
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0495551874209237,1.6779695427805328,0.5901398414742722
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2556149477566276,1.7329286077303778,0.855406163743696
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.307484409821774,1.8925014136561051,0.8470483597897336
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0355853828456971,1.6590069225458342,0.5802410311328814
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2262194985194763,1.6960544976095595,0.8287507244748353
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3533408848525145,0.681490950522958,0.0864693951798223
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1441751126108806,0.4929930259191805,-0.1111084676223592
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2824732305985757,0.5546603567514179,0.0590190195579052
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3057158730729546,0.6200429802394024,0.0489404614734939
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1225146632587542,0.4643338013579242,-0.1271642482755568
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2473258246976166,0.512118805731313,0.0293864712898879
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1970872415382796,1.9349408411512696,0.607838309537549
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8698322686039668,1.5437564563157748,0.4186278990603806
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0352615977858866,1.542868254140244,0.5957048211859046
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6492932880756979,1.2055538298521855,0.2077591627526919
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3747398447291843,0.869506196254493,0.0416604165404341
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.512059279078502,0.8901896337288651,0.1857614934512345
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6175782033729685,1.1608137551750048,0.1837509930807485
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3653769323949262,0.8574855324736306,0.0359013701667859
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4923654069486233,0.8645704419692825,0.1700582752750916
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0791432455638521,0.4384636989564682,-0.1954792067839813
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1224095395645369,0.1807010764906516,-0.3400406158804776
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0244461973236202,0.2234059652623805,-0.2262846076667289
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0411802878584223,0.3877124012419908,-0.22548261444418
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1390200301518483,0.1576789343896065,-0.3533498143515461
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0511777736457272,0.188810493212005,-0.2489104091785828
5,Prevalence,44560,America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.219256836394122,3.5994660225793904,2.995556661919151
5,Prevalence,44560,America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.9701134132649771,2.3177313227533114,1.7899007462057792
5,Prevalence,44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.7264806303072446,3.0916114107930257,2.5453936807794806
5,Prevalence,44560,America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.9522356993695549,2.2183170532237657,1.7954239915227015
5,Prevalence,44560,America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.05659326875429,1.2971363207040552,0.9314146236429685
5,Prevalence,44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.5934628474771173,1.8468359274051749,1.4655299017684844
5,Prevalence,44560,America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9509389585359893,2.2168564277522544,1.7944835481434644
5,Prevalence,44560,America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0657318035090428,1.3075021574262702,0.9403928059890309
5,Prevalence,44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.5989033421083156,1.8535510110089524,1.4726105943311445
5,Prevalence,44560,America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.0906656308325422,1.233121059241879,0.9901894552345436
5,Prevalence,44560,America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5218911173485506,0.674612898857534,0.4359807010357291
5,Prevalence,44560,America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.8755835937016584,1.0221032910115144,0.7937897798990836
5,Prevalence,44560,America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.054510535019847,1.19537763431237,0.954734298216954
5,Prevalence,44560,America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5092601820426534,0.6600411536174837,0.4239816590266438
5,Prevalence,44560,America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.8513947249908038,0.9974040478170788,0.7700252081911636
5,Prevalence,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.481359352947805,2.7239793552650653,2.249230421453381
5,Prevalence,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6534067908395509,1.8184229018116211,1.4936474011220748
5,Prevalence,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.216233567154909,2.4218184598235046,2.014220086916937
5,Prevalence,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.435932982257942,1.6079770757526872,1.272935068682369
5,Prevalence,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8373013847517388,0.9516235894865708,0.7264448276321427
5,Prevalence,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.238360553616534,1.3830459617074884,1.098866331787467
5,Prevalence,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.434855080321941,1.6045429767264558,1.2725046157942477
5,Prevalence,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.845460436293149,0.9602301373436112,0.7343468165994838
5,Prevalence,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2430494066436797,1.3864273864721572,1.1021621832749386
5,Prevalence,44560,America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7380685146247439,0.8363916079208953,0.6372813653134678
5,Prevalence,44560,America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3420545102600522,0.4170975443543008,0.2650059346082414
5,Prevalence,44560,America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6142268774609456,0.6930060350590279,0.532384066485381
5,Prevalence,44560,America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7079954984224873,0.8040623972911134,0.6080149185522072
5,Prevalence,44560,America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3309076977623527,0.4047545461534337,0.2538848557660449
5,Prevalence,44560,America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5933961955260888,0.6716506287464938,0.5118989131972886
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9777752471906669,2.6749314408194094,1.40808185976259
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.008785746442965,2.941295785366628,1.170868682942979
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9944699543500763,2.6493939729344964,1.3925806573608617
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7318334442610565,1.1338590499420689,0.4011973129665936
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6616535089127178,1.1782389710923544,0.2001992506090124
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6978831319016631,1.0715352498070012,0.3546504764651478
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.695098913940505,1.0919551601538071,0.3708008853302255
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.646557242802986,1.1568731270069263,0.1880073406023428
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6721025556932848,1.0378100571724933,0.3360094750871262
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2951943278091896,0.5953274628006932,0.0514126349782701
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1109332739252568,0.4695851040611011,-0.2058821303226591
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1957136728484005,0.4584398598755944,-0.0568690768721199
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2683097283101309,0.5615862194113531,0.030293979468359
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0991531171915439,0.4551191854056864,-0.2148558118061084
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1768388384278395,0.4334402303394369,-0.0720632481470338
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3812393615369776,3.276305067269028,1.7559025783926336
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.475331667054072,3.416593490472125,1.5830374625846169
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.402565300891112,3.195152242752572,1.7825017469921434
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.966477876963704,1.4856539512483589,0.6028147676350475
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9193059773699406,1.4398421760796167,0.4287778469057369
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9292713103664214,1.3795659976049328,0.5770751900564686
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9247709090608972,1.4342871685983456,0.5687978708152893
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9018743804857096,1.4169796765524698,0.413566601569505
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8999817070357484,1.3425597496607629,0.5537401788278773
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5159792274645592,0.9087924116733902,0.2342482191242804
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3308409537654548,0.7161369829055743,-0.0169674316683485
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4157138393521295,0.7478778067402341,0.1434427710302895
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4845133364908079,0.8685025687325544,0.2106552168886112
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.316732191504228,0.6984789791421944,-0.0272305414903679
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.393368417315631,0.7202495861266833,0.1258144056415626
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6261672248299897,2.4054004555635053,1.120132914576444
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5560221773149834,2.295947959098874,0.9152712946514728
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5877617029933064,2.14265881652502,1.0783461656113484
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5273459716841735,0.9837276156603568,0.233244978441295
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4116084053508372,0.8182907326215498,0.0583503200378076
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4672794694430207,0.7831396227186807,0.1768695441581393
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4949460053559336,0.9385246147116576,0.2068859140052937
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3987824935020935,0.8037066914358459,0.0481317341619542
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4449979539165045,0.7548507478426303,0.160541928325455
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2258902509468736,0.5753742503927506,-0.0120823988080166
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0716032925617228,0.3863572045799592,-0.210865599992236
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1418548039930297,0.4039866676043957,-0.0959034788267631
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2004401356724673,0.5473494435352446,-0.0314912015577989
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.060239404425501,0.3723473287067877,-0.2198040370241205
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.123827735864415,0.3814517519610187,-0.1101931652548996
5,Prevalence,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0728434823516336,0.6056640384860106,-0.2673941188783914
5,Prevalence,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2536316395815063,0.3603013933227096,-0.3885709354933693
5,Prevalence,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1549719613846408,0.5001135255567217,-0.3134967892718171
5,Prevalence,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3512689876004409,0.1235386220595294,-0.4874772155118438
5,Prevalence,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4831948285034169,-0.05849484969014,-0.5766901551136663
5,Prevalence,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4119020130522862,0.0441667164768816,-0.5224153696818482
5,Prevalence,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3515487692075765,0.1229978996817801,-0.4876170568222797
5,Prevalence,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4808963010087484,-0.0539021715485954,-0.5747473956717737
5,Prevalence,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4106648037100828,0.0462016153804112,-0.521222390311348
5,Prevalence,44560,America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.001747493692842,0.7324884381162864,-0.2121407783858814
5,Prevalence,44560,America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1968548091868977,0.4675444734189017,-0.3423321245864252
5,Prevalence,44560,America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0905473700855949,0.6182897798540079,-0.262196024637282
5,Prevalence,44560,America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0190008998981689,0.7037149332178345,-0.2267313313672669
5,Prevalence,44560,America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2035172732647668,0.4559164999450878,-0.3476799501769022
5,Prevalence,44560,America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1022698037733002,0.5983938589904525,-0.2719767598469031
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0728434823516336,0.6056640384860106,-0.2673941188783914
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2536316395815063,0.3603013933227096,-0.3885709354933693
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1549719613846408,0.5001135255567217,-0.3134967892718171
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3512689876004409,0.1235386220595294,-0.4874772155118438
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4831948285034169,-0.05849484969014,-0.5766901551136663
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4119020130522862,0.0441667164768816,-0.5224153696818482
5,Prevalence,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3515487692075765,0.1229978996817801,-0.4876170568222797
5,Prevalence,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4808963010087484,-0.0539021715485954,-0.5747473956717737
5,Prevalence,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4106648037100828,0.0462016153804112,-0.521222390311348
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.001747493692842,0.7324884381162864,-0.2121407783858814
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1968548091868977,0.4675444734189017,-0.3423321245864252
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0905473700855949,0.6182897798540079,-0.262196024637282
5,Prevalence,44564,Region of the Americas,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0190008998981689,0.7037149332178345,-0.2267313313672669
5,Prevalence,44564,Region of the Americas,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2035172732647668,0.4559164999450878,-0.3476799501769022
5,Prevalence,44564,Region of the Americas,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1022698037733002,0.5983938589904525,-0.2719767598469031
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.543458790050702,2.32179090003439,0.93336976696249
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8807849848800257,1.6384384516643198,0.4176879676568661
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2365266840764209,1.9944669128296184,0.7747116546375101
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2865645371439814,0.6795004453456988,-0.0226639110866194
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0504087523278868,0.3328217201309981,-0.2852529312823421
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1302857194986052,0.5188375805180736,-0.102394677060574
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2641223027719929,0.6509604866823175,-0.039097526768399
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0576277278452398,0.3219965379476903,-0.2896637084900549
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.115922074172448,0.4940987524079159,-0.1145019977622424
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2577321597816512,0.589272500386371,-0.1023134049403722
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0685940254471109,0.2825725057037125,-0.3475943929542075
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1083427846872873,0.4162056321169459,-0.1844550483317428
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2310271682982508,0.556447870724456,-0.121747049834027
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0795499987979517,0.2694889792561223,-0.3555046621520276
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0898788944227589,0.3931807422822577,-0.198899197505143
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.961143038223065,2.624495182673252,1.1410652729709845
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.454312670496286,2.276396454639671,0.764055931287631
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.786222605354593,2.438565297721163,1.0585396507885292
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4978371275118871,0.835490518369437,0.0830892006573565
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2391659416281518,0.6548966072902913,-0.1092307462818193
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4080897378303511,0.7383927191400081,0.0377249913873769
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4717151978079368,0.8014072862629605,0.064129041068235
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2297398301599793,0.6416470762262831,-0.1161151277046959
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.390194595490557,0.7156830484206671,0.0271148800635855
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1958952108983606,0.4642299700867616,-0.1412082872645541
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0391846672044711,0.3026817950875585,-0.3184099165686591
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1092254255857533,0.3787056497455195,-0.1914856338914892
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1705045100915793,0.4358728089370717,-0.1595205999099351
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0504925628528125,0.2877123267519949,-0.3261465619768889
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0907445856710603,0.3555412798291881,-0.2036121016811412
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1719457290244552,0.6176090981558455,-0.432556782527362
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0197833957599889,0.8624693190940818,-0.34233150117543
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0965090349174556,0.6630217696466991,-0.3673129180836146
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.518405505814054,-0.0606799710468767,-0.6701426587455872
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4586487180082434,0.0282335277538654,-0.6368467052158251
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4877053600324507,-0.0578768731369127,-0.6410458229609682
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.528630007674797,-0.0791758283130485,-0.6769828809047167
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4635767099285109,0.0192358663218756,-0.6400910794717862
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4954935014239596,-0.0713739013610004,-0.6467095336556394
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2956923042340809,0.3836570760488849,-0.5191259601188155
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1664756645817675,0.5932201924824765,-0.4438221808527177
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2316999897682253,0.4216869238364863,-0.462970158507286
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3103237391715598,0.356841511067651,-0.5287648422154301
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1753258435014445,0.57691972544624,-0.4499449325536142
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2438397676190439,0.3994224721762101,-0.4719785740826119
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5770164300674112,1.7766539708763491,1.3710259542752885
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7344077061635377,1.9752470454279771,1.4129477611439352
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6334479645168285,1.8172867593680373,1.422106617772851
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1913615252439893,1.363584451893042,1.0145682570877184
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3694716284736843,1.5765605955336404,1.0912320493993797
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2612525801246135,1.4198303901832048,1.0772582940725963
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2004123009555354,1.3708748930458023,1.0245251892071574
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3814730040494332,1.591226795877385,1.1015044466094452
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.27137857600963,1.429941610362612,1.0890942804065609
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4423714048082093,0.5485973071497054,0.3331785772323405
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5884592519576558,0.7085707860890786,0.4366535911823967
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.492078868372724,0.5837766864432397,0.3901893596686109
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4157211335755347,0.5194659175655509,0.3092341190924814
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5755319839331446,0.6956133960973454,0.4245223105327136
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4719861757827382,0.5623724460189192,0.3704840085843485
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0438210427609755,2.2457119334942544,1.8313517684703269
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4231214220378925,1.605377779460834,1.2441994864530894
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.933934912014074,2.113605523478874,1.7517636225864022
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.588336106087622,1.7606984138903925,1.404326588911183
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.099736045899524,1.2589687231585125,0.9446433439474012
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5192864856584312,1.6731946903311463,1.361210825299347
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5989982781069614,1.7713849164834805,1.4175791768278871
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1103649756068985,1.2690971917430507,0.954536801751538
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5305519578694866,1.68551988703249,1.373427165754605
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7653427541055283,0.8654296337996772,0.6577804302806433
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5380625709855474,0.630961741693516,0.4459009118728889
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.793003513413462,0.8831331432132548,0.6925673064248441
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.732712439856623,0.829449199386964,0.6281809164077043
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5255421154948278,0.6178322217629073,0.4336900237838284
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7688495810336726,0.8568583240775649,0.6712877879500934
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.930921490099572,2.1634231470807435,1.7274926196796403
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5811672976562043,1.7828532485946764,1.3643002227518777
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7688254266191716,1.9628625449982469,1.584780324839155
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.492318532317888,1.6894760203049066,1.3187619700724351
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2366815790908066,1.412117537566628,1.0498036706766176
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3775037336883256,1.544603130853369,1.2192709154071468
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5025978199841448,1.701121779724878,1.3288979616445524
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2480115984342013,1.4236655970582373,1.05913592960556
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3881431641985755,1.555502367636545,1.2294021877922543
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8050293326954089,0.9210684832034568,0.7030501026757703
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7013823185154661,0.8033243154952102,0.5997576962250097
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7627753730332626,0.8606380894561685,0.675361987591918
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7716627467341267,0.8854826341951846,0.6729618761753107
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6875379632077553,0.7890890381567401,0.5871690253480566
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7390298746721453,0.8349703498915553,0.6532588438053601
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3917569343754137,2.819142951401352,0.5938160681043431
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6318184906983593,2.5791831618020318,0.9378189999537268
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.512211344559595,2.4582183246035108,0.8490289653031113
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3567327441400759,1.1666079540695875,-0.0945817078739202
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4039530102534351,0.908367321502905,0.0339427100454341
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3814229374897209,0.90347530303292,0.0159051246693639
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3210821565870245,1.109495966766787,-0.1196588841481978
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3869504767754043,0.8862052266418181,0.0212174568228229
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3551684021731857,0.8654752958854033,-0.0025737150227576
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0242875463902594,0.558330553227641,-0.3403211194913755
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0609456679609195,0.2893330700459989,-0.3218326933616688
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0379135165974368,0.3281054237963217,-0.2944532551723371
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0460254956101091,0.52240273428389,-0.3544454631569316
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0718167748890102,0.2751085082263509,-0.3290501017436302
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0541114951561544,0.3048078199098359,-0.3066165314272144
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3419186377903358,3.229098984434832,0.5237199339539906
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6100643595795532,2.6358034647650346,0.9076856465155312
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4023222476821795,2.975877911725475,0.6555468596027036
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3284432700433236,1.4030812058133284,-0.1350071493719383
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3923199671880398,0.9389516558772764,0.0162974262209073
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3209772565243977,1.1895710185729498,-0.0895125302636585
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2935540731990542,1.3359343612548802,-0.1583763435776374
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3754861973679531,0.91604374189933,0.0053373841408891
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2958906538443618,1.1447176920591549,-0.1069442476210373
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0591491372921559,0.7000736880532241,-0.3839973122100806
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0689644240515256,0.3119429091912599,-0.3296914936775537
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0909974436836509,0.502238468131611,-0.368267056760055
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0801032399516194,0.6608992076500949,-0.3971352997750801
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0797303099378941,0.297299252477785,-0.3377920572469469
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1062947314265753,0.4753780550256963,-0.3784451175774558
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3470370281934387,3.3546617699130925,0.507883522072176
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.45258014046081,2.401984745590326,0.7996063344170491
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4077598795383088,2.5296292096904365,0.7416146330525317
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3313833937126086,1.4737594388898527,-0.14468102060112
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3083381504245898,0.8121277862151548,-0.0404009024654053
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3239938228797375,0.940670205895433,-0.0419408760577529
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2963812058958602,1.4052887145516593,-0.1671235539905097
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.292493083077088,0.7928228643256934,-0.0516196795678513
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2988238890954633,0.903996646905728,-0.0605164949253125
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0287650881090074,0.8285206890154343,-0.3822479126376974
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0754087305978276,0.3275525880404782,-0.3328053012379504
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0468562923072647,0.4105156714816516,-0.3129765212980077
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0504138755971419,0.7876393277180451,-0.3960167649651172
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0861146501427187,0.3125066652268542,-0.3410038572536155
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0629087161477728,0.3881378269010993,-0.324957355094855
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1941288292887091,-0.0456197709091923,-0.2976921342102678
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.188412010731598,-0.0272246038943615,-0.2940698928252536
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1918075263224383,-0.0427509192274549,-0.292915266570059
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3147200445463566,-0.1882989435312932,-0.4027978439113034
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.296726058429447,-0.156904197482448,-0.3878820974903803
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3060283823070642,-0.1776233835765061,-0.3923903089941863
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3118985132073164,-0.1850925079956746,-0.4003271190237888
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2931650673391315,-0.1527823961265114,-0.3851855050024358
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3029248746366427,-0.1743618695839321,-0.3901314411462383
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.0260545470098451,0.2146877995137426,-0.1063358069173255
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.0257586408936296,0.2235355471245612,-0.1061472966675701
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.0252474614427439,0.2095024436984585,-0.1022153400861361
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.0070841147689653,0.1916558848975937,-0.1218098429363643
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.0174068691884917,0.2144513404297144,-0.1136561377128066
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.0114341087140153,0.193449239896476,-0.1146214866243496
5,Prevalence,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3908243731981737,-0.237340343518754,-0.4884320926899274
5,Prevalence,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4064907279141122,-0.2499600299962116,-0.4968269392911054
5,Prevalence,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3972254899609536,-0.2412979767247047,-0.4873973122680625
5,Prevalence,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4259783015494408,-0.2815108417889099,-0.5178921167145811
5,Prevalence,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4372270503122433,-0.2888117983055444,-0.5228755798693948
5,Prevalence,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4301486364464315,-0.2832638852675117,-0.5150926285294669
5,Prevalence,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4265429490589685,-0.2820583453518352,-0.5184275099411608
5,Prevalence,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.436202458481678,-0.2875078604207252,-0.5220163392074667
5,Prevalence,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4299096826199788,-0.2824370141035682,-0.5151921256258467
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1627207383370386,0.0490414178684669,-0.2950726734251341
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1884429759377487,0.0229468861407806,-0.3101277190526825
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1735551593527219,0.0385704235593716,-0.2957830631849755
5,Prevalence,44562,Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1817758500136178,0.0247452314940211,-0.3113643282891326
5,Prevalence,44562,Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.197403102351919,0.0114832196133408,-0.3177129258125816
5,Prevalence,44562,Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1876387195113904,0.0215280283017866,-0.3081031793423364
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0402325076093514,0.8176087474839129,-0.2796032658280803
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0213082853188275,0.9397878865391998,-0.3682482665972207
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.030083107998016,0.7437581012316314,-0.2895535228044474
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4738192772492275,-0.079901908360574,-0.6360395396051363
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4843558201235107,-0.0211007655512867,-0.6804802079698814
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4794274874038801,-0.1187224472574584,-0.6403369662211943
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4829949209001317,-0.0966318131845652,-0.6419562282380534
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.48827079270426,-0.0280641685084307,-0.683459129442985
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4860367700366459,-0.1299463712926928,-0.6455204795609405
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2371149665922929,0.3415929535022094,-0.4764284826162249
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2539148353481395,0.4277357532654774,-0.5348469443497585
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2460259658421439,0.2902218856354411,-0.4783000074437292
5,Prevalence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.253309961803672,0.3126630072194117,-0.4871424050133576
5,Prevalence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2626819458515501,0.4126333181276271,-0.5405385641879098
5,Prevalence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2585771419504307,0.2682946137365936,-0.4878538885596116
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5338983238072086,2.059368480903593,1.0463700979670911
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3138812662644788,1.8173111235141648,0.9118858209870476
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4266455260033304,1.8266380099088984,1.071584028049628
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0744814469837312,1.5095771129204985,0.679173666231258
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9000560471380874,1.3131732944892898,0.5678305137191382
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9897045389321112,1.3161671102216803,0.7001086355115549
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0550939135324953,1.481271440643848,0.6596888255754052
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8976426491262622,1.310511702473515,0.5679612117790109
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9791055828790854,1.3053284899845128,0.6895271564729302
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2852208000824209,0.5492993183040609,0.047924137118247
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2037104232922809,0.4655374542995775,-0.0116350674140094
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2500364864194082,0.4541267641886637,0.0693579138481809
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2422608654047016,0.4967242887861939,0.0130936287460781
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.182573169846221,0.4397334511201621,-0.0269172168874469
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2175806663732248,0.4179010716621161,0.0404602381192869
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.31353091111797,1.7127967408815563,0.9952520018192168
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.175113788087083,1.6786304552398343,0.8070638774149121
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2801877928846332,1.6337793026499448,0.981651572470154
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8941142501835869,1.2224186450414156,0.6323636879954702
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7861273402779861,1.199830516590963,0.4829454472701824
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8696443446611731,1.1609942083472808,0.6267977990755763
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.876367038699532,1.2001877575181925,0.618229984359147
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7838377237221847,1.196777970944776,0.4819954392102574
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8596586697782607,1.14803821410657,0.6161807105202308
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1962002458069225,0.4098597898674239,0.0293338506355892
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1736713647157331,0.4479623891053853,-0.0241310240775959
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.218444537861503,0.4032199950582205,0.0630319212300559
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1561899664594773,0.3625381363397938,-0.0028858440307768
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1530429330441562,0.4234905658206681,-0.0395510095374051
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1867904650482292,0.3657183278103068,0.0352359183397588
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.038565820760162,1.735267938798826,0.5245889510681219
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8126952545829191,1.4252304126043422,0.3644306976868514
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.935380224065438,1.4445199511213025,0.535140164087595
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6689639990537251,1.240474416346176,0.2497629306738798
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4885190666142377,0.9927206294467104,0.1194938535473885
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5869089535577943,1.003762941298182,0.259658509420884
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6533592414572146,1.2184128068959343,0.2365032347751701
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4866138012857546,0.988961461426193,0.118986493152119
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5784430669403114,0.9936834741131616,0.2520182435757641
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1809356196064056,0.5758046465079649,-0.1153435118556226
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0508542524699031,0.3997088073899233,-0.201818274168623
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1242720994325017,0.4136260428476907,-0.1074348067763641
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1414572361651854,0.5229242833611958,-0.147333572875061
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.032387925084431,0.3740583083387037,-0.2159247447289214
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0950715577682984,0.3749268423927027,-0.1286315160757217
5,Prevalence,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,5.239516467365442,5.619860819228421,4.854414563788505
5,Prevalence,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.437696071645874,3.605413998830596,3.230894389235827
5,Prevalence,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.429759954366587,4.670795212529772,4.164658469628934
5,Prevalence,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.648899433298915,3.9337324580298167,3.357445077961556
5,Prevalence,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.349497025696966,2.475149839803392,2.1905406829847456
5,Prevalence,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.0727190538734863,3.251519475585185,2.872333512159119
5,Prevalence,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.71646667092144,4.003969952372416,3.425367143797996
5,Prevalence,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.391949095847961,2.520144146227046,2.2338804114798507
5,Prevalence,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.127685913055706,3.310920134831914,2.926156623864622
5,Prevalence,44638,North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.0969256985095144,2.275872629458588,1.9149566150057575
5,Prevalence,44638,North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5293421856188147,1.6228350030966188,1.421904586158666
5,Prevalence,44638,North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.898546105235648,2.0205077206207043,1.7666711604633116
5,Prevalence,44638,North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.089384850625746,2.2692547807171786,1.907336239252099
5,Prevalence,44638,North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.535996884028446,1.6266261937298103,1.4299184145896982
5,Prevalence,44638,North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.898795012923958,2.020408234010187,1.7663335017083968
5,Prevalence,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.616553481985799,4.9390321358041,4.265137270386301
5,Prevalence,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.3963033327899743,3.67212996399373,3.1513419819316644
5,Prevalence,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.426339228585428,4.714548443748369,4.121819816070016
5,Prevalence,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.184762868063104,3.419029155950449,2.9217597533332182
5,Prevalence,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.318267296057798,2.528143316769785,2.132421616766865
5,Prevalence,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.070175588643392,3.2853858849440645,2.838658901332564
5,Prevalence,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.245567335511646,3.4893297858189354,2.979930910269501
5,Prevalence,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.3603105922483056,2.571138435619602,2.1730745988078253
5,Prevalence,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.125085488407482,3.344181199348484,2.8935908183197165
5,Prevalence,44638,North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.8841794280426964,2.0335998584686337,1.7162440074530112
5,Prevalence,44638,North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5508822255202228,1.6913925431617844,1.418644842337128
5,Prevalence,44638,North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.94722855290852,2.0870067530302245,1.7938911247324276
5,Prevalence,44638,North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8771518020551765,2.02780651844512,1.715514443904108
5,Prevalence,44638,North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5575806945135298,1.6939268835473733,1.4262863047442007
5,Prevalence,44638,North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.947461159129764,2.087346819874072,1.7959427586208618
5,Prevalence,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.734884326296816,4.04462632603,3.4479918624824384
5,Prevalence,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.634359092877109,2.8270334263843573,2.4390601197813258
5,Prevalence,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.2439176462561314,3.473754842543862,3.03120009384821
5,Prevalence,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.527817423617944,2.753308428366989,2.313733892650961
5,Prevalence,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7431563682047777,1.8889687745960704,1.595898575222197
5,Prevalence,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.1832429393850736,2.354760513977591,2.02505523386123
5,Prevalence,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.5791113353815085,2.8132461158516016,2.3622485783399565
5,Prevalence,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.7779191814952835,1.9251896391340413,1.6286425828915851
5,Prevalence,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.226212435143195,2.40093392658779,2.0645052414710725
5,Prevalence,44638,North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5611898366959662,1.689791810956267,1.4321540663124916
5,Prevalence,44638,North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1933076730843413,1.2846957285622076,1.0909205218728628
5,Prevalence,44638,North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4209345665634032,1.513409175029054,1.3304339310928008
5,Prevalence,44638,North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.554964738219489,1.6835130003296424,1.4283911972267893
5,Prevalence,44638,North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1990652296170183,1.2899880511099626,1.0981532964644496
5,Prevalence,44638,North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.4211417834541409,1.513170588742721,1.329184210001363
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6316652043604926,-0.031024379398692,-0.7387766755716758
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6775697216995232,-0.2778073709816731,-0.7787006796594429
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6527734151730658,-0.1720110867893185,-0.7515082227266576
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7234909241706572,-0.2723895706458334,-0.8035717498925656
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7629409692974098,-0.4692465314943362,-0.8372155120865657
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7420300022706017,-0.384113447094582,-0.8155886809773591
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.728818079816826,-0.2866037297694792,-0.8076775706402822
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7645570291575764,-0.4726451281411067,-0.8384042289668768
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7453944278551936,-0.392873126109757,-0.8177922028709494
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5450406222839917,0.2114640822498114,-0.6758517907753551
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6047592777803599,-0.1072587587787466,-0.7286778116332816
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5726468471058477,0.0271456153062879,-0.6963383211169473
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5610618238154521,0.1677882660532476,-0.6872513543801777
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6122435809410133,-0.1244862883750292,-0.7342397406027066
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.584365090077102,-0.0020101877713016,-0.7041395377171901
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3016388443154614,2.0202587131652274,0.8959290693284475
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1007213163478593,2.025937955203234,0.7332159800594491
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2221752134225226,1.951592419002515,0.875913622223186
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3386130406576443,0.7534251079579577,0.1020759347236647
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1601672342537518,0.6705608348913555,-0.0429839708005528
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2599967267998234,0.6748640650634632,0.0630776919388403
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3102081861158684,0.7192826320037957,0.0792578484084313
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1496192118805462,0.6559437847319618,-0.0514979909478043
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2408556139173326,0.6481598755096567,0.0475042360744053
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2267208121049961,0.5312873016385364,0.0296844007929807
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0715427798218097,0.3561064318941245,-0.1467814780812866
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1447804914295148,0.3965682423875831,-0.0305987043734525
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2012495526972452,0.500224110915316,0.0084009875942242
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0601766437560734,0.3430605549825228,-0.1557285222703891
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.126704016576839,0.3744840971575638,-0.0455193127849403
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.548077547284251,2.294519755849448,1.0589094931282688
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.426837164933905,2.1111477991927434,0.8175613769083689
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.517461463797437,2.1552203813069584,1.0450365024942214
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4819410395180361,0.9139520200334595,0.1953351652365033
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3402665113356733,0.718448951732664,0.0045435854016633
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4274261218104692,0.7920176279969678,0.1615698528048509
5,Prevalence,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4504934471171508,0.8754057632000853,0.1720344740578252
5,Prevalence,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3280860279763796,0.702574850418479,-0.0053399937415004
5,Prevalence,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.405742522599019,0.761865085904321,0.1419419177471158
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1839505641987367,0.5283807416737396,-0.0434987349541111
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0015169593948441,0.3041189921685576,-0.2638566652626096
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0994546160543805,0.3818455890503422,-0.1122638298342924
5,Prevalence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1593636117591443,0.4969867081007152,-0.0637817095674791
5,Prevalence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0091061826108763,0.2909228129583967,-0.271299133648505
5,Prevalence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0820915392790556,0.3577583507845354,-0.1263895281146571
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.793959298720955,2.34656086682266,1.2024411701332935
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.571304783100638,2.2957587227118257,0.8538314301937167
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6877032813803454,2.264683380799747,1.0414038142506064
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6821423181403601,1.0142447785823476,0.3248616085636172
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4946311940351858,0.9176794620635114,0.0769083016351691
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5901929082099576,0.929758910395764,0.2070835604406619
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.645671602475966,0.9711597756662432,0.2972611632071945
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4813036977862364,0.8986545722040904,0.067974271531864
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.565854286546575,0.9020025392896888,0.1893206126068963
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.209288406555293,0.435559328997222,-0.051188003910911
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0259434402891419,0.3238527624017099,-0.2651472332484477
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1142686475163825,0.3564187515102688,-0.1557007269735739
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1816654599691907,0.4027408281563152,-0.0729315932973847
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0140069610728512,0.307614509361059,-0.2733298295047044
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0949399269055939,0.3342714038622987,-0.1704436231946289
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1576604780848587,2.900560864467642,1.632772941758363
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2171874092570656,2.963300595326629,1.4319423672555491
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.170138933773945,2.845000784885708,1.6481382021398696
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.90110986177914,1.3500441863399444,0.5855098386811036
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8700637141420814,1.3039576296817952,0.4133505718006937
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8756245197331223,1.2752554857613982,0.565415035140402
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8598954470896663,1.297471638660621,0.5507311319825989
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8533904020732698,1.2832189578927695,0.4010183643319831
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8469210023246051,1.240095103688723,0.5428036955994824
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3897006176755503,0.7175604799276306,0.1589442051352537
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3047958497799914,0.6179322295048428,-0.0206069370110023
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3410400799535296,0.6297705700872107,0.1168274307228564
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3579579436777997,0.6799812073804526,0.1330198884318943
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2896163572060571,0.598954801585798,-0.031482003548191
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.317779779079878,0.6031425202793246,0.0985528717674459
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5137668220895286,2.072624098322424,1.0496144112733696
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.44944337878688,2.089198014902384,0.8454048115648226
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4794311237644184,1.9902814126244304,0.9665632669849028
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5134504548540736,0.8499163743958478,0.2330326715163311
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4237992213749709,0.7958490878577198,0.0726985578223653
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4669712931046422,0.7686304427070002,0.1635108460313048
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4806352677552583,0.8098081192547679,0.2072445844870414
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4111005270015915,0.7796569557774218,0.063119778429042
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4445150550062106,0.7421361205965266,0.1457185555809783
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1702840582142589,0.4184467308315059,-0.053620823780221
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0780950641853815,0.3718568820906802,-0.2058597001132394
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1200056845718194,0.3535854705149831,-0.1122466145607281
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1435485540853588,0.3853714216729385,-0.0758936713364815
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.065550566680741,0.3566031982046018,-0.2152835961915858
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1005746158467177,0.3283808552908309,-0.1262484155789445
5,Prevalence,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.353495791295371,1.680176960622807,1.0617547624487278
5,Prevalence,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7281462843210442,2.223923744511576,1.3058515218076503
5,Prevalence,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5045661131866663,1.817740095219127,1.2242726037527625
5,Prevalence,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6578477129983912,0.8889965348864218,0.4546873562816492
5,Prevalence,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8727887860478538,1.214522460249424,0.5809517508109868
5,Prevalence,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7419574426611161,0.9596566519962936,0.5486898780941161
5,Prevalence,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6273184829982871,0.8532013194411052,0.4255949149141609
5,Prevalence,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8607366755680506,1.1988825104883696,0.572709835869267
5,Prevalence,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7202227568261851,0.9353214950474192,0.5277074660617521
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0965720593888189,0.2369347483662374,-0.0248845563820983
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0633003969473309,0.2469798481674335,-0.1001329994209609
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0578283545774511,0.1862104437133834,-0.0551251081919826
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.065839166910578,0.2054922243087443,-0.0570815331266098
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0477538095782389,0.2273869619177368,-0.1125501366753466
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0349830709821069,0.1608366013912303,-0.0757663390826734
5,Prevalence,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8719723844074028,2.446674062487592,1.4208804230849426
5,Prevalence,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.886619229719792,2.558611442699206,1.3748982483963428
5,Prevalence,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8753597433785985,2.344077827536608,1.4944479702569784
5,Prevalence,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0231022230672555,1.4305933789482266,0.7128940027300357
5,Prevalence,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.98159587131097,1.4446750286162544,0.6304774756610201
5,Prevalence,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9998705776279088,1.3251317434581278,0.7367045286720522
5,Prevalence,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9858177614307329,1.383193727178809,0.6739114096509633
5,Prevalence,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9688234095102264,1.427156807383033,0.6198032696891012
5,Prevalence,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.974896665166658,1.2968284802859988,0.7132732658014407
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2881703909141074,0.5261305652603159,0.1079995219616819
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1877998498869827,0.4534069096341265,-0.0160387153351736
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2399795883140011,0.4334958065386287,0.0889105091988424
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2520547202242266,0.4818511192879895,0.0754218764806817
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1704222914061677,0.4317357334436765,-0.030491230345776
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2131908138073211,0.4036163467540927,0.0641142018489554
5,Prevalence,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1036797993745684,1.682360261868383,0.6362900602734831
5,Prevalence,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9642278835129592,1.50178441527959,0.5576880151275312
5,Prevalence,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0378002877752162,1.4584923923783544,0.6770499017399237
5,Prevalence,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.481875074611976,0.8913367302888369,0.1506780321189154
5,Prevalence,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3483916657949959,0.7183999910828278,0.068741858318234
5,Prevalence,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4173246616659473,0.7100826258711481,0.1648735780232461
5,Prevalence,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4545838715726534,0.8547109573525137,0.1314084641569844
5,Prevalence,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3397048695779802,0.7063461892161109,0.0624236814199786
5,Prevalence,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.399631820634079,0.6885777295263175,0.1518559602467644
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.038817322953683,0.3196430752243302,-0.1776199549197572
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0955260950371865,0.1549819065057534,-0.2788265232491175
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0306980889768455,0.1613977304216144,-0.1953903532794494
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0097017860248105,0.2821700754729596,-0.2024433997001473
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1087568798194582,0.1368607470362448,-0.290100183418566
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.051637016822986,0.13737590875614,-0.2138899369813569
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5597876640952135,1.7159257923475677,1.3947955033308288
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.491278754943661,1.6887889950135824,1.2463629685819029
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5396858351062186,1.6844909363589529,1.3786071389189254
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1767270505361478,1.3084857890481505,1.0370892401715257
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1587911671719224,1.330030144682774,0.9471422958443728
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1807499179408252,1.3059242273578668,1.043091501801015
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.185701339809462,1.3190215057370298,1.0448210660668205
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1697251244161695,1.3417423783500322,0.9564210395237248
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1905076817091342,1.3154037150137885,1.0515754891991111
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5104545812652916,0.5997331329277606,0.4183868872662958
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5110342724594086,0.6094444756749944,0.4038103469482678
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5258099234999062,0.6067440962684345,0.4401469835349144
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4825333356291546,0.5700319357981766,0.3922080605543453
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4987352758869268,0.5968097917386487,0.3926336087788664
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5052549202490532,0.5851005137463237,0.4203455624408642
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1409076162952778,1.4989124424201212,0.8260730786558939
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0852301235979034,1.3461676180853976,0.8515887840468781
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.129809178987115,1.468486680444788,0.8529728681957395
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8205431318177334,1.1234803852964703,0.5525098586418085
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8069352961654898,1.033370909591016,0.6042497403021402
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8288093492755947,1.1208625580591924,0.5912082458987782
5,Prevalence,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8280362512016626,1.133722398179757,0.5592115043725441
5,Prevalence,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8160858877721713,1.0433437313869165,0.6126010374638109
5,Prevalence,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8369844421921481,1.129097607651476,0.5982100012821532
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3476552923658923,0.5615161446594629,0.1565833225884997
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.358751904794094,0.5210222213093826,0.2317666660526336
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3626880874978537,0.5605372621735716,0.1844016591422097
5,Prevalence,95467,Advanced Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3227265072069631,0.5313193470813102,0.1345871569626142
5,Prevalence,95467,Advanced Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3476875407081229,0.5079007864876707,0.2221160722361163
5,Prevalence,95467,Advanced Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3443183186083813,0.539852302063307,0.1685547424245606
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5799840345927628,1.4319288222832969,0.2067487832563889
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.54854986754412,1.1185903091905458,0.2398632658590977
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5674120305900607,1.1353949524572344,0.2623039390283894
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.361768055342042,-0.0173547848818028,-0.5131109340945732
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3640742960860888,-0.1297040087164521,-0.4906403606037827
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.361560617114857,-0.1299291919560276,-0.4860364811715965
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3718769648259021,-0.0331861083813599,-0.5202567292858629
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3708627059213707,-0.1392694531050565,-0.4962743942194303
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3700183988109042,-0.1417320365891994,-0.4926488752309512
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2341859582343503,0.2889774646874846,-0.40908845728108
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1762684673892108,0.070749305690672,-0.3447007313840204
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2149866880298941,0.1439143193167637,-0.3721204941407607
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2423256457899674,0.2763356887522774,-0.4152413487366209
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1820574353996396,0.0633322856408628,-0.3491512511535525
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2219189121585645,0.1343513452904931,-0.3779846284681987
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6575191477917184,1.8981128109239909,0.2422349551222266
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8509327864475918,1.5706413738837883,0.3922648152442543
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7017511566810735,1.6884393686519816,0.3040966436015122
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3304467168754568,0.1701435289751667,-0.4977088589102507
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2398961872553597,0.0553673194737719,-0.4285814527107808
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.30683952758224,0.0950120283647816,-0.4684554841206955
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3410528618167584,0.1521454490796195,-0.506149193075964
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2480120471458601,0.0443876506067593,-0.4343574353903109
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3160241866283554,0.0805501713072748,-0.4758513552227075
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2741918048993837,0.2806656327063151,-0.4566553721298924
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1925497840171902,0.1283182006570397,-0.3951270192083964
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2616496091084985,0.1757933362450326,-0.4338507175821287
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2819076452192379,0.2677409342446509,-0.4629802774810376
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1982270090304661,0.1200798320284604,-0.3994821618129063
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2681716439945452,0.165841936810144,-0.4387505181095424
5,Prevalence,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5900631933137114,-0.1166161229502114,-0.7030545572168796
5,Prevalence,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5449846972922906,-0.1431505560428701,-0.6884480775659642
5,Prevalence,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5694935510768785,-0.1460398393837423,-0.6892035905843987
5,Prevalence,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7112181049003304,-0.3780870423982196,-0.7912036425665459
5,Prevalence,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6876415581183021,-0.4119015502353956,-0.7861868596364656
5,Prevalence,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7005682136107498,-0.4065827924100218,-0.7838560291471635
5,Prevalence,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7165502717917664,-0.3891865385854043,-0.7946778535698531
5,Prevalence,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6896560618619306,-0.4155844226630553,-0.7875054971397848
5,Prevalence,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7043132594907914,-0.4134705831957629,-0.786534261003659
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5309964661129973,0.0136253458236131,-0.6635826881745088
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.481106726209707,-0.0150643022888612,-0.6449179586032825
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5082352216485347,-0.0144603159861749,-0.6458990387131238
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5441631234091322,-0.0138341271607854,-0.6725435617335674
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.488700802163711,-0.0286835986700333,-0.6498027379123288
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5188700981493782,-0.034919524078412,-0.652850129342486
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.108481777614534,1.7836814464459136,0.5961502711463612
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.81535350704737,1.379818487228684,0.4218851743839545
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0204775017962753,1.5461803186892245,0.6144517449024194
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5827965648254411,1.092135611505719,0.1979364168154766
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3346863748826314,0.7512659378151187,0.0448407896887842
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5010796613191296,0.8919770385371459,0.1995649727291511
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.552343530651258,1.0494509038029922,0.1751458199295292
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3255958003737311,0.7377757996309597,0.03827987687241
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4815248970839907,0.8669990293134633,0.183804547730518
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0543996869738435,0.3828679483578961,-0.1971942459338654
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.126054084467136,0.1287264033756594,-0.3130184820156532
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0125214529838646,0.234285414710972,-0.203347535893388
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0172962651527657,0.3344519862647345,-0.224918149494371
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1425959447237881,0.1071005218734,-0.3258118676214397
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0395830167848458,0.2017456392438839,-0.2249559546625137
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1112468638171482,1.8412847732306556,0.536884440461816
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8745171739442439,1.5312012491520544,0.4067603878721304
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0721424884477544,1.729794820179855,0.5657128414960502
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5848696523682692,1.133370560896223,0.1544652523038013
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3781879936911642,0.8618028777973863,0.033538316144309
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.539461152973898,1.0286960122363535,0.1630333764197958
5,Prevalence,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5543792910376595,1.0918606379669984,0.1315120879103162
5,Prevalence,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3687979139393504,0.8483175495852069,0.0272355522250122
5,Prevalence,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5194084983434099,1.001635250296964,0.1480665111580186
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0257801018615447,0.3833017908137147,-0.246745366411658
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1472845812738737,0.1462235579684673,-0.3572566415792596
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0206495512408393,0.2894479398209977,-0.2559569152887463
5,Prevalence,95468,Basic Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0103172187849271,0.3315449304567597,-0.2733563678874681
5,Prevalence,95468,Basic Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1634283763614708,0.1251687437489124,-0.3683957717003198
5,Prevalence,95468,Basic Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0474890439469256,0.254748518915364,-0.2760529665646044
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.767886355165348,2.501170874762189,1.0976500973004435
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.416402132156754,2.177600236107708,0.697657432952119
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5982979118198617,2.265248815532691,0.9335638521515146
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7380907239538556,1.2008126489914874,0.3158705845867728
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4573107672773382,0.9177207430584048,0.0235835845057429
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.599175107291898,1.0107922330642722,0.1896682181663117
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6945950893099456,1.1435370567635117,0.2842534330725846
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4420711134462534,0.8963422725012142,0.013135484366787
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5708035021991709,0.974009312657307,0.1689378869407671
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.271992249455263,0.5953527827445501,-0.0410234144217116
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0304968858809249,0.2891065890380028,-0.3234486274895626
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1139154168187355,0.4088982324409723,-0.1762909898869714
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.240039357329984,0.5548660579142303,-0.0638166073578894
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0428550330455316,0.2724254535641429,-0.3321941657065734
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0926982743428042,0.3814470089735291,-0.1919042979351274
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9051775576859336,2.508080021839643,1.461934744851833
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.00873155657164,2.706801229170736,1.334952947067796
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.929340113156192,2.4758033236009487,1.4944430939616264
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8242859893222491,1.2024777540602452,0.5459184705160369
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8145294461938677,1.2364148312034424,0.4077381990430841
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8029074878963796,1.1398204345358136,0.5344506338638585
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7786494787405882,1.1477670738980388,0.5072810056098656
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7955640777280562,1.2121611733155917,0.3934635098245457
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.770935383485487,1.1013002430671273,0.5080179721528051
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3568353700417917,0.6371744837897724,0.1452969511017681
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2397353365336082,0.5353608362283223,-0.0488260749882668
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2875041663656686,0.5259254919863191,0.0905808551449486
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3227601415863776,0.5957157833963528,0.1154791091153987
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2239391883845016,0.515954946976223,-0.0603789816938469
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2629890735091166,0.4973752362869196,0.0695545766724074
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5452908959833411,2.137115865008845,1.0465922672807622
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3243109323499902,2.0063396168872263,0.7076498341947982
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.419028620824393,1.985344604725908,0.9018278552933672
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5983083524894861,0.9692869793033791,0.2834976705905411
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4017691114525254,0.8130017495227535,0.0303339302059609
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4888383416771913,0.8346038629990704,0.1703044149558195
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.558314504188168,0.9206500763730732,0.2529940759603577
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.387112521382187,0.7941366054219762,0.0190987936166306
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.462426079867637,0.8047929527412729,0.1497518595095846
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2489620036327249,0.5281350046382505,-0.0031802669090986
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0449684682514308,0.3782719295055348,-0.250871738863738
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1351711220682229,0.415232368531429,-0.1078707804236009
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2175883746184141,0.4887907710165479,-0.0268293733199805
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0316505891299692,0.3612423310144631,-0.2596707940493126
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1135502834685378,0.3895435568891999,-0.1238317533619156
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.274813122306274,1.616022721154313,0.9591456895176128
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6580009854435571,2.1976174001653512,1.1964710293265624
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.423397974530839,1.760096585925377,1.1111136471032874
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8647975949284513,1.1405384586944558,0.6047554870465066
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1321553201854906,1.5617897135277483,0.7625293843046798
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9653779123737752,1.2400531905317949,0.7142189436327306
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.829793114573341,1.104252132097162,0.5758794680641542
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1180001086786056,1.547987769061209,0.750234820942606
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9403401496023692,1.2099243618820965,0.6903037028579744
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0384937386282631,0.1883726452541168,-0.0942586707871231
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0459149680451417,0.2502339576381829,-0.1265770387398402
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0178187277808349,0.1531030241926065,-0.1064342044651033
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0056298136148098,0.136794489050005,-0.1352925984248018
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0210435870161702,0.2224074537146325,-0.1484576321534402
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0164859611270893,0.1138194589600026,-0.1355171188836966
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7873103807353434,2.496381160100202,1.256263023445582
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7979534993594992,2.5728664405307287,1.2207449592121236
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7899166082168376,2.3591692451537467,1.3418882895159547
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2849957886798242,1.8711733553005248,0.8496514131784724
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2444605614646091,1.8682305103391084,0.7797874565296612
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.262678419473218,1.7202981631419867,0.8967412012918845
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2420309135888845,1.8123867011058763,0.8148719578255129
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2295197963337858,1.8470010172232607,0.7695772464786508
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2338003356685967,1.6895833966119989,0.8750778542311575
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2835029495565086,0.6080045192254987,0.0462343506790216
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2080296822659396,0.5429632861643232,-0.0405316013594502
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2516017616261742,0.5035537219053567,0.0682098370148558
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2289343654044684,0.5408810058956857,0.0002137209805962
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1792808100274411,0.5056404372822875,-0.0619903130248305
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2093902795900601,0.4534760535911269,0.0282772510261397
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0471081909512263,1.6701667916451368,0.5448602408078483
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.856434853175105,1.459020878675468,0.4136795795710784
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9580788550684988,1.4263903973936616,0.5862025324443162
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6781438590995734,1.191049058949483,0.2661881801167222
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4891802060227713,0.9734490978338688,0.1347451767125587
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5880182967785421,0.968299906384296,0.2841693585701529
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6466339304354171,1.1478040381450043,0.2426403751102181
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4792805729992927,0.9594449049493046,0.1264756934123625
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.567773456323198,0.9427360904615842,0.270023533670116
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0740181239431691,0.4034733854252085,-0.1806620290262944
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.088769396811079,0.2190999560391734,-0.304246227142767
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0070498668384709,0.2229589632364719,-0.1895784371220404
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0283789053593028,0.3424235233534168,-0.2173532670528892
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1104484677432791,0.1887648466442162,-0.3201315250926866
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0405261866132606,0.1838058559829101,-0.2170589823769433
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0147130155371755,2.587641966278971,1.505204992445949
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.102303356743582,2.745199373469336,1.5325255035792615
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.058685717176688,2.555486791321828,1.6144775511889329
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9718035673253048,1.347578457360655,0.6395488825702372
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9474251305234064,1.3484461833129129,0.5885504050313923
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.960489569214231,1.2770277245539288,0.6735690786896453
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.929004037346443,1.295600211973256,0.6029885829605643
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9325205102656908,1.333000281397662,0.5775882999318109
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9315992621731828,1.2453355126407124,0.6510761077821354
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2838254308561824,0.5147915071899417,0.0663233484188184
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.145181863902619,0.3884772061842301,-0.069420109706461
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2107353075150844,0.4110809047683421,0.030647113334657
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2522351580926613,0.4777797910076388,0.0377621605573136
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1321692653952647,0.3742431175720441,-0.0794788913617287
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1887162972404403,0.3868856759413619,0.0121199038315889
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.316222007008271,2.976921707323748,1.7298862345864263
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.441410039123323,3.112117937940697,1.8198099958119176
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.339465046671457,2.9140641684394293,1.804084375220768
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1690211236393515,1.605161427800397,0.7843684366139023
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.160292605975977,1.5812906165335625,0.7715237058605131
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1404571272243316,1.511376002258053,0.7952001701072826
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1219285574737323,1.5446860082870222,0.7467538504906042
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1437605288932882,1.561565179764807,0.7565466768790723
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.108915010123315,1.4717817255297183,0.7708152491218851
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4374444262292333,0.7219912552366266,0.1840385332612494
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3172248830931305,0.5824366486255911,0.0831423901946043
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.366002429629674,0.6025147075178127,0.1396478664789211
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4020643165455893,0.6783281065473589,0.1558545954548832
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3022566101178801,0.5646299693356194,0.0703359555688813
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3411574071962713,0.5735077660958049,0.1192675377848525
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.447003833135493,1.942488019228776,1.0297032395161363
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4497417636939405,1.938634082711825,0.9983610936598256
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4483087969696709,1.8353004336325476,1.0766399651434506
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6005075371564039,0.9204586430667534,0.3279904105211702
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5377953131687901,0.843392392185121,0.2535032452508147
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5692749826257142,0.8166644483914751,0.3306544533907181
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5657478006010154,0.8827899172102339,0.2987324907754569
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5260197533236518,0.8305658679902537,0.2448408025668718
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5461384081539318,0.790528590397041,0.3114247737008419
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1439941038505491,0.3696974779836947,-0.0483231140266285
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0639200830458277,0.2726280786670214,-0.1381971981026206
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1012665934508786,0.2714833089879447,-0.0664411076922376
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.115828103437701,0.3318402054164177,-0.0718128517188837
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0518259848090397,0.258657233971965,-0.1474956866348643
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0812287823313822,0.2483025246477935,-0.0845647330154574
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.596089348918836,1.8007787669661104,1.383177027208616
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.832167426716255,2.1023956634355487,1.4852735386190763
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6780380780801696,1.8637461632492849,1.4608716871819252
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.122524562045378,1.2923408515081296,0.947259200738264
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3696349771773926,1.5948733134903623,1.0796752140837302
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2156040747443242,1.370451297361745,1.0335836603221291
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1367276499631498,1.3051985615589374,0.9614888258427308
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.383994180427157,1.6114604444795029,1.0919941374041802
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2293627435743488,1.3839575156372403,1.0485801531445187
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3766900582320678,0.4794495724730749,0.2719082103973048
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5596992718781314,0.6802682450090896,0.4076976961790465
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4336536757360495,0.5253947551296838,0.3330962298013573
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.355103751144844,0.4558779682672137,0.2526176378930105
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5495285491567143,0.6692110774575109,0.3990574722794255
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4175183669824251,0.5072193925405772,0.3164355622429761
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1805323050861776,2.4124992060662063,1.9385700634993592
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6309252958368778,1.8372850490887005,1.4305222872856809
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.08949038845279,2.293432439114719,1.876821548286457
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6003794197673782,1.7921803077651368,1.4019445404019149
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2012638307040568,1.374538093604443,1.0347000020622918
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5560214811125697,1.7250261328736796,1.380002811150587
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6177570971156587,1.808678912424796,1.4186085539189768
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.214597391117478,1.3883019702274524,1.045906938138119
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.571880820150722,1.7416546606779582,1.394842266118704
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7763752392709082,0.8818192730012041,0.662870807309976
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6017720472740666,0.706277927868632,0.4980431832012322
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8063864016265442,0.9068663249121628,0.6992761646940903
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7485142501318455,0.8523054787662268,0.6370435241298008
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5913256687110022,0.6957210372123397,0.4882418090442083
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7860505425048949,0.8853712042792017,0.6806606152311113
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.006343380493519,2.246014525671279,1.7994153134856732
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7088739207774788,1.928307242703947,1.4811352356201026
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8712024219484584,2.076697224628018,1.6751312661291056
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4579533781193807,1.6521740297861065,1.288494790068842
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2664741866266476,1.4499288225869635,1.0765921353781738
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3754185589301715,1.5452816256771835,1.2127498551424205
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.4743898082935412,1.671652650195699,1.30407636260523
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.280211120898331,1.4649204560632485,1.0885106956509372
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3901645615662928,1.5612310078732796,1.2269429354620858
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.778870264054079,0.8968927668695432,0.6733160342383665
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7160810295507473,0.8231713371710694,0.6131649815854978
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7530713882465441,0.8514691956570395,0.6638482325791989
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7509649956204913,0.8667654282076949,0.6476579064571
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7048945175782121,0.8110359640829834,0.603289480533211
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7333356466928129,0.8284254531055415,0.6461721100418438
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5297624110738641,0.0010883321611628,-0.683119402005884
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4542169050127835,0.2540224709667365,-0.654233675545968
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4962435191133164,0.081029005991044,-0.6612281143747427
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.692423854284418,-0.3459947145322881,-0.7927856502564178
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6573855766210029,-0.212048079149431,-0.7830555707552004
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6771037823511139,-0.3069113399075796,-0.7828451596766748
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6991122528493996,-0.3594403764050459,-0.7972397539211579
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6600148651077707,-0.2188306987421474,-0.7846114847814265
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6818713209626991,-0.317316317059361,-0.7860612090205916
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4773390839570981,0.1185374958777469,-0.6490564470631509
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3926549434282365,0.4085011157995167,-0.6182044235845511
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4397472955403199,0.2096267998760375,-0.6235550206830911
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4902199178906774,0.0928306521750605,-0.6578363184682102
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3995683840385514,0.3908337991854592,-0.6227361757753709
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4499521080522928,0.187058610028267,-0.6305992421897153
5,Prevalence,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.006902518643193,2.25729113372098,1.74376621288889
5,Prevalence,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2706913026667828,1.4148034427379657,1.120480681525323
5,Prevalence,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.652456281752357,1.805178308860512,1.475604949577555
5,Prevalence,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.754808100334667,1.9857553173258844,1.5145509693056876
5,Prevalence,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.096888901445006,1.2300524116050582,0.9587690380061497
5,Prevalence,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.440154966239909,1.58130679340901,1.2792398374690348
5,Prevalence,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.749053193979084,1.9779703663010453,1.5084814769710655
5,Prevalence,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0992648418659443,1.2324971965159095,0.9603944126416912
5,Prevalence,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.438972370326127,1.579402509371021,1.2763549821350015
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8979688515418751,1.0348849968167697,0.7558529455478213
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5758191910666204,0.6604560986316873,0.4856853879409545
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7706865113467769,0.8651098703024028,0.6615304775448461
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8582441199032541,0.9945180493698272,0.7188364219707741
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5597635705432326,0.6443488398136994,0.4696597796361094
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7428747730047686,0.8348734826501308,0.6366780422638162
5,Prevalence,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7291718905304423,1.9541889227854483,1.4864053537341162
5,Prevalence,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.941179119317371,1.0732900085440489,0.8169272615394225
5,Prevalence,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5766283680158526,1.7566205355449145,1.3821854790603232
5,Prevalence,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5003987825602565,1.7073492005946775,1.2794095682480242
5,Prevalence,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7926066274742709,0.9147681874099444,0.6771988267749687
5,Prevalence,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3704186953871984,1.537038190880122,1.1933830052571737
5,Prevalence,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.495138653835065,1.7008599192851477,1.273189947738559
5,Prevalence,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7946292709014924,0.916766412421126,0.6797578411023673
5,Prevalence,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3692474938879675,1.534752926154117,1.190454411780833
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7620461964170109,0.8961601226681051,0.6262015500740268
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3993382635401972,0.4830160313721587,0.3193109081562999
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7730472573705358,0.8871146489254662,0.6488903069331297
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7251402161329182,0.8545417216890291,0.5907464667189319
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3850712114876726,0.4678094550756109,0.3060619273948704
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7451779805329914,0.8565484220741088,0.6217645968620151
5,Prevalence,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8235627781826869,2.1423882009236808,1.5423707876764794
5,Prevalence,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1527620031240644,1.3348874010883067,0.9680238520472446
5,Prevalence,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4652629631141885,1.6594294467250092,1.2647068674641533
5,Prevalence,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5868350192920893,1.8817717785819168,1.3304433843175458
5,Prevalence,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9879875314101744,1.1555242418376288,0.8171021154763151
5,Prevalence,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.267949325744671,1.447112146375114,1.082776463630342
5,Prevalence,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.581435289517155,1.8729206440551405,1.324356207362134
5,Prevalence,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9902386470392136,1.1586144382831218,0.8194473531934052
5,Prevalence,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2668453742247958,1.4453842975722138,1.0824311090939975
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9342777786952916,1.1071102151248908,0.7635917266668284
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5977328228493002,0.7125978988470567,0.479228118656648
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7619445903293238,0.8842255009786749,0.6420206204141092
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.893783933639728,1.065478849964166,0.725058263794407
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5814527486331695,0.6950459579495536,0.4631415766852417
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7342602350185052,0.8542827964068029,0.6156069286322688
5,Prevalence,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7789384918656339,1.865474440490391,0.3522196780695584
5,Prevalence,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9853637469617544,1.7182889984268863,0.4365516734614154
5,Prevalence,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9020797739591532,1.597649941345708,0.4851298837013433
5,Prevalence,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1953494622214207,0.2973346616717819,-0.3886134598497814
5,Prevalence,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1200520698575721,0.2047630881212942,-0.3631597631003713
5,Prevalence,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1484831615803898,0.1622062930481309,-0.3345658204316547
5,Prevalence,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2114230863647778,0.2702221019529217,-0.4005811751419187
5,Prevalence,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.129689965111612,0.1915973567453261,-0.3702688794622881
5,Prevalence,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1615878452298074,0.1450104850907728,-0.3453739622519181
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1681483215940145,0.3305490643577286,-0.363837606084235
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1473991684269232,0.178351701643861,-0.3889296210359272
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.147185777867038,0.1670267150573994,-0.3346320013018405
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1803954944171149,0.3097008279335742,-0.3729647785833095
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1545972949148132,0.1685012818970963,-0.3941338335605125
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1570469198817364,0.1535744698535472,-0.3424706616158476
5,Prevalence,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9305752917004716,2.295213215418857,0.4809838844392338
5,Prevalence,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2000875792281729,2.0443788199789807,0.564403974869502
5,Prevalence,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0001736743571132,2.099055015103982,0.5814420477288991
5,Prevalence,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1267641356119054,0.4884930387398986,-0.3301069692434326
5,Prevalence,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0248892929349726,0.3487334244271922,-0.3062549800683989
5,Prevalence,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1045734803919425,0.3873026484637225,-0.2921154042791062
5,Prevalence,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1442047535477324,0.4607188944794997,-0.3435019220311502
5,Prevalence,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.035562978942388,0.3345430735723085,-0.3142231593420768
5,Prevalence,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1183493230981753,0.3660233542972824,-0.3029208064598008
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1211715080118999,0.5030303632325137,-0.3266373375122099
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0685295015812285,0.2940775614006999,-0.3491965407992159
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1286439475632893,0.3640131144786913,-0.3122253230208226
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1341098326997779,0.4807141375991896,-0.3364989580374727
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0763897008313436,0.2826737980916503,-0.3545609074631624
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1387169256353728,0.3481972189848023,-0.3202915206739671
5,Prevalence,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9606290223356044,2.3279842964420743,0.5042541777368169
5,Prevalence,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.067101148676491,1.7991295178569129,0.5182276828826088
5,Prevalence,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0239435377170525,1.7979862275552772,0.5802988894056924
5,Prevalence,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1131666623858924,0.5065600684152857,-0.3191856588287185
5,Prevalence,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.083829562788921,0.2395138722445299,-0.326698075269481
5,Prevalence,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0939319861299767,0.2532749599060871,-0.2931328496711404
5,Prevalence,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1308823827879524,0.4752458261569841,-0.3331865479179341
5,Prevalence,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0938593113853603,0.2270348504505527,-0.3344651378468368
5,Prevalence,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1078718748696395,0.2333161280502199,-0.3034246958581976
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1473465496256699,0.4543566724932083,-0.3417056182410236
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1389661743469372,0.1886611468566253,-0.3819474870747038
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1363012731946232,0.2071404921919623,-0.334742335649825
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1599009878430416,0.4337201010856521,-0.3509229337897875
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1462318907575442,0.1784077002258541,-0.3874210097415875
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1462851146486402,0.1919524594218642,-0.3420957760841865
5,Prevalence,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0708431219363949,1.0852129426778974,-0.2666019937147454
5,Prevalence,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0143650638412439,0.7467997260769342,-0.3344562095561866
5,Prevalence,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0242213355268587,0.8145803808779026,-0.2990481808873672
5,Prevalence,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5156318359481954,-0.0558395215676624,-0.6691717096440273
5,Prevalence,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5631491660964767,-0.2256768201798913,-0.7048020192577351
5,Prevalence,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.541480082285735,-0.1873550737340973,-0.686339854943141
5,Prevalence,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5253112078099379,-0.0756561881548429,-0.6748955970612984
5,Prevalence,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5679340992358406,-0.234267608204529,-0.7082502184462105
5,Prevalence,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5485364869354213,-0.2001564456106619,-0.6910295072277401
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4233930947693169,0.1370453395506872,-0.6083720382143329
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4594758071961846,-0.0306570950837268,-0.6374124215173701
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4428984449967674,0.0037496461800361,-0.6199196088162434
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4318866865598673,0.1199108530401582,-0.6134456887393022
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4640391207338454,-0.0389689206311594,-0.6406528468808377
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4493403637814812,-0.0079008482926033,-0.6241806372671519
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6159378709374048,1.5225254381488496,0.2505783560581512
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8902029332683373,1.5284732289607528,0.4845998994303484
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7683795344796022,1.3572623065722769,0.4353399262015931
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3472514248008903,0.018773634623852,-0.4945368138251553
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2237732603759589,0.0387376760878785,-0.3903860905003837
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2797061057280648,-0.0399456764801363,-0.4153150601737218
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3575835084893207,0.0028305981726654,-0.502832272015494
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2320575632595531,0.0272557821734438,-0.3968439873374626
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2892445962520157,-0.0525580681181495,-0.4231014389887571
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1717363034815872,0.30107338552321,-0.3555026139034583
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1020797863076111,0.2139428468600116,-0.3025217228972341
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1242245759278154,0.1806335986910461,-0.2859125922521113
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1805330009191962,0.2874614087103577,-0.362344955526262
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1083891022689815,0.2055804843047426,-0.3075069082312141
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1319551059595136,0.1701527437394983,-0.2921701284958002
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7184203917826933,2.055893865119232,0.2785270702814478
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9939194675607198,1.802853178225783,0.4928994403456092
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7747544941106235,1.867555081944221,0.3569811851453838
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.3058481194759618,0.2350261618968575,-0.4837076422198708
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1811846523327105,0.1513632997573031,-0.3868241226968416
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2771074448533757,0.1667648100530214,-0.4471677325756977
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3168415575352244,0.2148713453445319,-0.4917212539148107
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1899201151195055,0.1387295309031496,-0.3934720902982003
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2866823425513386,0.1525411996111042,-0.4545957520311093
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1569286405690894,0.5191053118096891,-0.3754424469134974
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0626331019373225,0.322488705041025,-0.3118762281930736
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1549321869308471,0.3700564334489002,-0.3517281592720986
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1658900052113733,0.5026881901211253,-0.3818259307633505
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0692175187189447,0.3130942434497727,-0.3171840525599646
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.162394154945391,0.3576951098348596,-0.357971851020385
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8612901043462219,2.204708592736272,0.3892870907260155
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.104120474493739,1.8972768716983048,0.5897656134164175
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9966223979865352,1.7832553922483974,0.5627715704726591
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2481454957037045,0.2950580556487955,-0.4379106665031936
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1359331914995464,0.1898216601372682,-0.3475117969974471
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1867448985699941,0.1335270028183273,-0.3642916355124255
5,Prevalence,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2600436687432759,0.2740326763091925,-0.4476885809925691
5,Prevalence,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1451481870339503,0.1770915289590625,-0.3541177735333357
5,Prevalence,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1975081531178185,0.1186590726031046,-0.3718835143248615
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1692413416333067,0.4619591547685291,-0.3810346368114224
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0778109473860013,0.2751781525481773,-0.3132209410027951
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1139917552465562,0.2530427502139697,-0.3089780684114719
5,Prevalence,95470,Minimal Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1780657211508166,0.4463009971423093,-0.3876568631991989
5,Prevalence,95470,Minimal Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0842865450563251,0.2662461513554958,-0.3181719329872252
5,Prevalence,95470,Minimal Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1218095809564554,0.2421822686643387,-0.3154701303123214
5,Prevalence,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6970952995013584,0.9299545091771908,0.4673443460667478
5,Prevalence,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.5501519530482226,0.7082377189433057,0.3973146209635157
5,Prevalence,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6361702944719574,0.8337722622674233,0.4428971673801082
5,Prevalence,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.2644414788973973,0.4394734732075759,0.0911777477173691
5,Prevalence,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.1700262221257778,0.2890657454749258,0.0560283724841996
5,Prevalence,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.2272369524922639,0.3751269581485844,0.0815335344504889
5,Prevalence,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2828387358764865,0.45885761605694,0.1091693946455764
5,Prevalence,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.1848572842030487,0.3056900005579086,0.0680362036227689
5,Prevalence,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2438113531005938,0.3940277283577539,0.0968857485114459
5,Prevalence,44638,North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.8171633878774324,1.0669200008607973,0.5669420511713861
5,Prevalence,44638,North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.6545976540521916,0.8247926485469957,0.4918881436350422
5,Prevalence,44638,North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.7484327952358225,0.9573264026061188,0.5411709344286045
5,Prevalence,44638,North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.8127850999490934,1.0621419293735803,0.5651763457461882
5,Prevalence,44638,North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.6589539897037531,0.8322239719878509,0.4941763901735798
5,Prevalence,44638,North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7486086178031853,0.9604695040550628,0.5445303787444382
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5897690397500414,-0.2325080063665077,-0.7095570709454402
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6440589896901006,-0.3451714952217594,-0.7572320346402353
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6143892725781189,-0.3134091995728955,-0.7201267460078473
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6641342043634239,-0.3706080754269345,-0.7621087832712703
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7077112075706292,-0.4630465345857776,-0.800771258531404
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6838138270994745,-0.4377183056668005,-0.7707469048905579
5,Prevalence,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6672861173507655,-0.3775329854470041,-0.7644390502489666
5,Prevalence,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7080883744620147,-0.4629670430164858,-0.8009029885738137
5,Prevalence,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6855064593156142,-0.4400353608643053,-0.7717430446519836
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4240154706175524,0.0806756295859116,-0.5933465682069039
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5005762826335237,-0.091335334347993,-0.6607351355229483
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4586682125820444,-0.0373429512952453,-0.6058023748945695
5,Prevalence,44634,High-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4432920921584084,0.0426620184829124,-0.6068333498895289
5,Prevalence,44634,High-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5093622232341594,-0.1063224118530297,-0.6663482614121097
5,Prevalence,44634,High-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4727414151626213,-0.0618363978848391,-0.6156341001524991
5,Prevalence,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5189956982640362,2.469444793270533,0.7703771085870623
5,Prevalence,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9602470913881532,1.7841354277711026,0.3264062747639167
5,Prevalence,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2236126432510737,2.064557451019762,0.5492481989377567
5,Prevalence,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1773874858456041,0.6206338723935261,-0.1717266627806944
5,Prevalence,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1009178396893911,0.2774946449612206,-0.3917777250321592
5,Prevalence,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.029452428860697,0.4191606278133303,-0.2831786781560514
5,Prevalence,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1541498930213619,0.589625317643948,-0.1888511155889027
5,Prevalence,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1098379884480639,0.2642955083089533,-0.397669567848801
5,Prevalence,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0142458620377369,0.3978220186449788,-0.2933487854500307
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1543605475552697,0.5901331801716969,-0.1804769195599192
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1642068937731898,0.2023720791412432,-0.4378895957722196
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0214672698001015,0.3575860946999319,-0.3200542926929589
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1366919297415247,0.5654099186734567,-0.1932136864924736
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.171063482479524,0.1923881032294903,-0.442584806816264
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0329689091699686,0.3415195200879792,-0.3277616505442643
5,Prevalence,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1388853147788267,2.417241782268741,0.6359111588089297
5,Prevalence,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2407023383048326,2.095867399854266,0.5694013921811775
5,Prevalence,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1651329394991876,2.214544212981336,0.7050857865514728
5,Prevalence,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0002891258180992,0.5968389255663225,-0.2345287975996683
5,Prevalence,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0277087614737889,0.4194136943835211,-0.2811033948859275
5,Prevalence,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0023717344830456,0.4889426397381303,-0.2101458567367713
5,Prevalence,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0200085458906621,0.5657070157569573,-0.2504605346357075
5,Prevalence,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0175187146137207,0.4058551925720705,-0.2873237734498557
5,Prevalence,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0124282071728161,0.466234767215049,-0.2222673275950045
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0413849032747674,0.55001181222211,-0.2704375518611022
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0512251889255988,0.327085756761426,-0.3429703607657155
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0621731435157692,0.3966326471464343,-0.2625689705349927
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0560496269967607,0.5268601255201771,-0.2815903950405511
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0590048431347708,0.3162585513858424,-0.3482533829846115
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0731917007102447,0.3806721344848743,-0.2716591600457307
5,Prevalence,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3530617465409738,2.5586912444199896,0.7720052386391063
5,Prevalence,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.15218776406116,1.962609838593068,0.5354407040377929
5,Prevalence,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2321365399601936,2.01681174061868,0.6932079632122434
5,Prevalence,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0998135721820744,0.6629327286164509,-0.172235321045616
5,Prevalence,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0128874348028723,0.3581924404950798,-0.2963286918256498
5,Prevalence,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0333900630272763,0.3954477649494068,-0.2157156522501682
5,Prevalence,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0781225092660952,0.6305161306444094,-0.1881051412600514
5,Prevalence,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0226763770186407,0.3453419953797862,-0.3027455611439752
5,Prevalence,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0181338265138811,0.3760439947830762,-0.2276851026775454
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0428503396154494,0.5607292327780684,-0.2235580787615896
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0875165492011127,0.2693776243893289,-0.3665189492312879
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0317609775153663,0.3254780549008828,-0.2775628674062466
5,Prevalence,44559,Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0268999448190332,0.5380852034729472,-0.235566656077425
5,Prevalence,44559,Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0949981275397589,0.2596596329640224,-0.3718273279177532
5,Prevalence,44559,Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0431348511086792,0.3102957261914466,-0.2859836627717773
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3405052188203923,0.200528116893155,-0.5243606761213341
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2206415103160038,0.3998967880528199,-0.4717031560689756
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2846654625478334,0.2411914524209467,-0.4868666959858583
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6029368751377632,-0.2770765439026237,-0.7135658744634805
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5469768194452876,-0.1862939633621375,-0.6929923709409584
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.576765248237204,-0.2654915716479974,-0.6965662312923167
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6115505927859342,-0.2928762309281104,-0.7198434033429466
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5510191478437368,-0.1935330645007564,-0.6956533221627051
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5832465363479331,-0.2768826195724418,-0.7010488511783584
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4165483789674548,0.0690749636664132,-0.5809351840693252
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3113883517728787,0.2473813247667739,-0.5331447942603205
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3676156188036997,0.1054544387861895,-0.5480730790480677
5,Prevalence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4298821290919786,0.0442013736436413,-0.5904494236472428
5,Prevalence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3194028560096756,0.2328535537409195,-0.5385802606431599
5,Prevalence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3785894685418968,0.0859382780605278,-0.5555832409756387
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.513814918780649,2.1697718073008607,1.0877263079743935
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.706351548750701,2.379167839462429,1.0773285817008849
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6171829212723063,2.16700786338958,1.1520758018926034
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4291128806540083,0.8015509101181728,0.1864947360508814
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.464158885732601,0.8279772712184899,0.1245039221428012
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4518448505787315,0.7567911157868126,0.1958364782630514
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.396551595817086,0.7609688934495091,0.1598377769375332
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4493754785856965,0.8096994851992159,0.1125048069502693
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4279707789265613,0.7279627834925915,0.1742019765449339
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0946970198173556,0.3704179866485232,-0.0970890016919227
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0112947624178835,0.2748569768793731,-0.233253964165025
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0534759300728879,0.277609336700417,-0.142299047684543
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0715294301134207,0.3428815254941747,-0.1161858123494651
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0002633779276524,0.2611223240205091,-0.2417741570283346
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0365089491798769,0.2564423260338173,-0.157118301904054
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9621851505846133,2.705592610873522,1.4792185460685787
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.221967051655152,2.9660680086341764,1.5088420119246433
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.021660670614315,2.666363705674869,1.5352284214512395
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6840019384631373,1.107406985419253,0.4081581731743045
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7431025923532849,1.1477256172001524,0.3574981186820775
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6762129075489509,1.0319702433452034,0.4080042373900762
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6456439844669392,1.058644507000393,0.3773315573172112
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7255112476557968,1.124011465092588,0.3436000557310203
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6486593682077373,1.0004181572740338,0.3832552835002302
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3159123986397232,0.6517400999321525,0.1021142177015002
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2384085378963815,0.5411915711866122,-0.0531336366949126
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2528812600368672,0.5251565679903427,0.045382166915293
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2880673719501297,0.6162301707396429,0.078570276017761
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2249047478248365,0.5233510656553539,-0.063687128247971
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2327077653044505,0.5018799106665757,0.027498956759324
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.25710983413765,1.9695358429259389,0.8918268685547677
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.401404389453369,1.971507262527008,0.8986388840350094
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3384038371717153,1.8422783612851048,0.9618476485716728
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2831747519278019,0.6885502642463762,0.0758246998437572
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2991795836718739,0.609878298864855,0.0255361642207843
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2971955891847339,0.5771172733891048,0.0883045725746318
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.253938910637208,0.6497276666198853,0.0510057095099694
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2860622774038518,0.5913785342240753,0.0168082718152219
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2758650997109756,0.550785928068539,0.0704108956603786
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0371512152014317,0.3625615309124632,-0.1360289304026686
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0054906190046766,0.2405377509931596,-0.2399672239285679
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0181913235344826,0.2440316747890931,-0.1632771009752434
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0151993277244205,0.331442906916734,-0.1545060933619165
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0163383182227774,0.2271935650200464,-0.2473302701628799
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0017922280450939,0.2240788362714281,-0.1766394889395527
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3142609617158548,0.4863555404811098,-0.5243563861369263
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2735992723793378,0.4047118741737027,-0.5139388163999252
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2947596336579969,0.3921567323539314,-0.4945274286875291
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5693836431309485,-0.0665483689427914,-0.7011767448266992
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.561910307199838,-0.1529190903498162,-0.7068742769889644
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5659406218288883,-0.1429536050188439,-0.6886930538477689
5,Prevalence,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5801670091491101,-0.0900020894400295,-0.7087946436782624
5,Prevalence,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5664953725425099,-0.1616898572040178,-0.709926264792878
5,Prevalence,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5736462580742557,-0.1583703081760712,-0.6944160707395063
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3600120824599919,0.3956317161700943,-0.5579645240956822
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3265076344656816,0.3146315854350711,-0.5482459821072511
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3439917430780339,0.3051607046441841,-0.5320454574777949
5,Prevalence,44636,Low-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3760974600089367,0.3605269803197833,-0.5689528194033269
5,Prevalence,44636,Low-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3350961419321285,0.2985345292874856,-0.554049275699779
5,Prevalence,44636,Low-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3564923846993648,0.2800398597182869,-0.5411175745412584
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0181469061726708,0.1906715412498383,-0.124903886790244
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0192906085627815,0.1593132049147314,-0.0926391434434432
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.01860758092104,0.1671588388520845,-0.0954757549463154
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1675676028247829,-0.026535528389495,-0.2849825980867977
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1471730397262019,-0.0301205450960568,-0.2410161182514506
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1572777079227556,-0.0345019780414751,-0.2512023529598967
5,Prevalence,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1620077918159547,-0.0200103069363556,-0.2797466457580597
5,Prevalence,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1420059223704998,-0.0241410490997881,-0.2362234728169725
5,Prevalence,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1520487293236414,-0.0283855735779285,-0.2470186779315728
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.216040456837671,0.4192360894065837,0.0440329346470413
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2054941572016182,0.3693259385769118,0.0740861312722227
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2106606701402011,0.3839202025626974,0.0759923253307093
5,Prevalence,44575,World Bank High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1969603667830888,0.3976649929922499,0.0289562257849698
5,Prevalence,44575,World Bank High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1976306830521634,0.360989688975823,0.0673521613117889
5,Prevalence,44575,World Bank High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1970290944367999,0.3683664239903438,0.0639824245358056
5,Prevalence,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4938383619561479,1.0313420873113053,0.1130219869430892
5,Prevalence,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7631117405196624,1.330286714996348,0.3666069645674406
5,Prevalence,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.644131268163452,1.1328884399851893,0.2804871899578431
5,Prevalence,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.4047798182140795,-0.1916359690075521,-0.5560453789114523
5,Prevalence,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2742848990321774,-0.0406072676731076,-0.4377515873864959
5,Prevalence,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3340819860547285,-0.1355686444980701,-0.4813848071213478
5,Prevalence,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.414472964513859,-0.2037922303159233,-0.5637382992412316
5,Prevalence,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2815462271150116,-0.050427012754488,-0.4431187160860333
5,Prevalence,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3428460145476322,-0.1474913432993553,-0.4881933842536441
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3655444540617274,-0.1507653871663902,-0.5193831035137584
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.226139779325966,0.0170761974489341,-0.4008027742159537
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.284049341576181,-0.0706489755056387,-0.4346143488881187
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3728414275152073,-0.1598973067727538,-0.524986434241843
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2315852349965947,0.0096007677442701,-0.4049960304012344
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2907046199075923,-0.0791563763735743,-0.4398788030208177
5,Prevalence,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8433460549805123,1.900609928262384,0.3333218173805937
5,Prevalence,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9452377417236112,1.6428085906291587,0.5035271443948071
5,Prevalence,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8681912913804639,1.7927137770431174,0.4102123461972567
5,Prevalence,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2655140240206086,0.1571003807401861,-0.4692768017734999
5,Prevalence,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1993236173176867,0.0877144164597038,-0.3811786740663249
5,Prevalence,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2433343422519237,0.1318494271763985,-0.4284296893712735
5,Prevalence,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2774794258634132,0.1369272443727747,-0.4773892604702229
5,Prevalence,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2073313547967884,0.0769231236533759,-0.3873248503200052
5,Prevalence,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.253289943150677,0.1162387239685841,-0.4363426560989584
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2503042658450518,0.1742714364070154,-0.4424442612423361
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1573132774491153,0.1610844693804161,-0.3529512473139698
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2251431285812735,0.1466809728097126,-0.398589386334672
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2589348025148514,0.1611732646657576,-0.4479815523208141
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1632405193258873,0.1533853646704675,-0.3569572500092001
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.232345092178853,0.1362454257610904,-0.403777378635981
5,Prevalence,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9096757122343482,1.8747433512931435,0.3861076366201287
5,Prevalence,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9408379648703128,1.7023304834670847,0.4808216977156364
5,Prevalence,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9283808042092556,1.6495627990407449,0.4923481772825963
5,Prevalence,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2390917128354225,0.1438767644451232,-0.4478194591493425
5,Prevalence,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2011481712595327,0.1126984550763502,-0.3902929332650649
5,Prevalence,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2189639349258411,0.0729575146068901,-0.3962768694547222
5,Prevalence,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2514807578912024,0.1267885436159266,-0.4566992547492829
5,Prevalence,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2091242282757932,0.1011778135268945,-0.3965771361829993
5,Prevalence,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2292323882560138,0.0590217379910925,-0.4035132283085203
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2874107651045269,0.0729033417711109,-0.4732419862660483
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1947720165537077,0.1253913629421444,-0.3849716920873099
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2323498068748144,0.0307095756945308,-0.3951199196170804
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2956078421669796,0.0606650119797267,-0.4790640429428121
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2004258810234176,0.1178579793447862,-0.3894137723648506
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2394786538260999,0.0217215684049362,-0.3999027934783315
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.157937996859309,2.9458585676608773,1.545106005816892
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7131297252768465,2.464287559956447,1.1695226812453487
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.908926855357772,2.4981913457397305,1.4366597811427422
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.28824797917272,1.8553156874517245,0.8417683502041756
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.89955596767354,1.4267954881012348,0.5187313712955268
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0720873821101895,1.4957746211481138,0.7376449997165087
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2459575972211323,1.8063347147448343,0.8101052570324567
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8882560753232306,1.4110391666166917,0.5099220451005394
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0468532674978008,1.4614865695821155,0.7145446698415107
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2846889956515652,0.5977908346866934,0.0334085318541298
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0186960828516275,0.2991875156646862,-0.186473094801835
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1299394989721801,0.3659412776112276,-0.0448776899817712
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2453016456569062,0.5491529189589237,0.0011256268048732
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0025545903575665,0.2771213726316077,-0.1991548689246505
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1033673517999815,0.3326542391371,-0.0697077550009442
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4249050572913795,3.250334671207545,1.7997686756860536
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.888185220208583,2.682087752488722,1.299599064090898
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2759961548114296,2.926847646607516,1.729660434353525
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.481738400665435,2.082298499603762,1.030090157951812
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.022140069969133,1.5795519478341662,0.6110609100653326
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3335833503256282,1.7945409362245095,0.9468508330931128
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.435827283763912,2.022881213951923,0.9912239359584202
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0100893952504044,1.5626215008206612,0.6004512659763002
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3051399252049207,1.7631086431824614,0.9207132585424866
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4433273744916737,0.7826687627561278,0.1875723905582225
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1406519970852888,0.4507364058709735,-0.0930064222122742
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3395980123608712,0.5991541710962575,0.1228897282494718
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3990545765763671,0.7296802263878156,0.1495345904358441
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1225666225493397,0.4267949027614162,-0.1085917525251264
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3080834741184984,0.5614370188312345,0.0969289880825175
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2919084076978888,2.024298748600484,0.6938673920977736
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8830032603225249,1.491457180758193,0.4375496554309044
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.083466094479485,1.597052385025688,0.6833225622128909
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6607351436423482,1.1879214440019867,0.2283157545771586
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3183670838277467,0.7441994383849215,0.0056704516118533
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4841068056543324,0.8487330394383361,0.1983902051204805
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6300285520246043,1.1509120056951634,0.2046957038899177
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3105132102721898,0.7339787014770579,0.000490999437649
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4660215245191202,0.8274042024679884,0.1844623320012824
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1034338174872839,0.4523006000714186,-0.1743032986416545
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1488913343096624,0.1237591650961703,-0.3444047896658759
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0300011194863802,0.1969728055433566,-0.2126949874706108
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0695932316002333,0.4094492677360613,-0.20005752516998
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1623856076379857,0.1050878089454242,-0.3550471951907701
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0528205897164217,0.1665840802058701,-0.2313137329616482
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6600435159102578,-0.0355594167911386,-0.7590404748389971
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6790429014318469,-0.2638508342907515,-0.7779528061747145
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6686288991339789,-0.1500393322750134,-0.7629314914605054
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.75365489833767,-0.3011022504211519,-0.8255715553596839
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7752838289288904,-0.4843196932750481,-0.8445321989953123
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7639512249869129,-0.393848048782792,-0.8311691557335197
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7582194935665931,-0.314080055694385,-0.8286271368543713
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7766235850637064,-0.487662487516044,-0.8454618815890613
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.766832218791374,-0.4019290080212323,-0.8331878127388619
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5969333905919892,0.161520366523227,-0.7154819759505494
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6200573857666786,-0.119645515043985,-0.7386234947991808
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.607451575126808,0.015632893433631,-0.7211930063776123
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6093103682405887,0.1241871335770813,-0.7237371726480117
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6260834573902166,-0.1345492411312937,-0.74275755616431
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6166942019666098,-0.0091311725083477,-0.7273938273948997
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5192586429369228,1.691721640821547,1.3414310109704095
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.965360089708004,1.0807616397008872,0.8414489244292782
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3263438861578485,1.4561584461186512,1.1875676290957728
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.3186201682217555,1.4770773994621178,1.1547983416408814
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8229123481853643,0.9303605685623186,0.7072484514070225
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.149747470011018,1.2702487911246672,1.0214790809366776
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.3141575714887557,1.4725797936275162,1.1508074676441251
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8251407256441666,0.9323089081047016,0.7100700496410628
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1489796603560072,1.2688969480079972,1.0207839299047894
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.6562360804375003,0.7701514620924365,0.5381551582317581
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3678888000147358,0.4556935962881349,0.2905279216143078
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5859900600766901,0.6782193946739304,0.49042755975106
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.6216339526077852,0.7320892702778143,0.5062555726371013
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.353940424145828,0.4403652177136438,0.2774164327509139
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5611014669376846,0.6508179913448398,0.4679310192619962
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0527350693945683,1.241211701214216,0.8624955605974016
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6553148927846449,0.7764661591062452,0.5394565451812072
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9428377495240085,1.0991279033098589,0.7866908284340973
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8892495486118172,1.063118346043704,0.7151038932456464
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5353388024238053,0.648337109641982,0.4280551853149721
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.795352376396048,0.9396991339276676,0.6505902174467874
5,Prevalence,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8856152052581737,1.0587473391091298,0.7108637160001927
5,Prevalence,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5372158213691159,0.6497235044572405,0.4296234316975168
5,Prevalence,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7947126527344591,0.9390869920564112,0.6504706258157147
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4620818903529919,0.5747850437368667,0.3432797271910047
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2537202515595284,0.3351919928501911,0.1794009032016155
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4314973822411698,0.5313258041569715,0.3312782631429053
5,Prevalence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4315293545998939,0.5413997219460802,0.3153356239261196
5,Prevalence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2409319249971874,0.3211314934677635,0.1669776886406545
5,Prevalence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4090281860299214,0.5086214426692005,0.3094785005170575
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6629320049014109,1.52207647488264,0.3353492055010282
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8808574745425709,1.405975168478303,0.5102291693009628
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7884919809177042,1.3192495467032646,0.4869623595217059
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2465584227376287,0.1416024946954744,-0.3943617082656669
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1422671266153222,0.0963528203839949,-0.3112983150544384
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1870056841422943,0.0548658561427495,-0.3240739902174767
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2599464716415279,0.1223980226043284,-0.4057304278172776
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1510714897812511,0.0859413554960255,-0.3183552628859505
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1984008699220019,0.0394837879659862,-0.3335459445338314
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.205431659477019,0.2000302926484186,-0.3563818111275808
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1408714494152947,0.115630001034029,-0.3173156438284473
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1616842441852116,0.0907806277429729,-0.3049955666040189
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2157260675359552,0.1848311027960468,-0.3645786702807132
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1475047991951396,0.1074084707551243,-0.3228290879142372
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1703789466392855,0.0785664912163737,-0.3127134207824014
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7306372864029573,1.8609178923064775,0.3383277910916182
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9831998500205767,1.5970987068266906,0.5336104627545584
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7892856165338717,1.6983639658504264,0.4304655911918033
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2158769208426224,0.2958971397844252,-0.3929968242931752
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0956025157958243,0.1839439248313488,-0.3009776293687495
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.186646402400433,0.2269940290976512,-0.3495658290586706
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2298156350733233,0.2731923940996102,-0.4044048698453721
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1048790687590689,0.172205319073219,-0.3078020727122103
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1980451637593215,0.2094022398409873,-0.3588677020975586
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1959804953672992,0.3366242959903517,-0.3759505152560927
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0928783974755099,0.1934903986616649,-0.3009326941464115
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1807430679644849,0.2380261461633963,-0.3455165022638389
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2064022468297951,0.3198011907864383,-0.3846076067091049
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0998772347080368,0.1848598240977004,-0.3056550135928856
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1892390038941613,0.2249541541524448,-0.3522121750794198
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8069071106479156,1.8973923649919116,0.4124010297220306
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9741042011918952,1.5149057994639907,0.5479530735375275
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9042735834969547,1.5477413949783128,0.5351172963275843
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1813232416332681,0.3133415733588373,-0.3601986241246442
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0997451175461847,0.1475189784412252,-0.2937914738891214
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.134376165624293,0.1579347675434456,-0.3019734801460386
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1958733257224912,0.2894246045124888,-0.3714401055352248
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1089844067307702,0.135107397863142,-0.3013285087290624
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1465077482883583,0.1418934541883702,-0.3119629819796767
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1975030601438983,0.2983893577485963,-0.3717254259663315
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1262592422331347,0.1239577505402334,-0.3288705333124312
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1536338509436541,0.1448386264660562,-0.3196811864113209
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2079041337241451,0.2814240563619599,-0.3801084566945991
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1330029234417842,0.1155298486877146,-0.3340948094195258
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1624108961965258,0.1326026105177102,-0.3270128983292961
5,Prevalence,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7598049443679129,1.560932644340962,0.4375284857697282
5,Prevalence,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.023047369629141,1.5816989217463262,0.6198846769093854
5,Prevalence,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9129975038086054,1.4403053377068809,0.6041812492821226
5,Prevalence,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1882011176791016,0.1817842455957545,-0.3371457484558294
5,Prevalence,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0861209466862766,0.1658431444424131,-0.267672609334563
5,Prevalence,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1267159454320735,0.1157595582672534,-0.2687021065414512
5,Prevalence,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2057781403392138,0.1557807550001214,-0.3512255145450399
5,Prevalence,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0978016199574238,0.151334674572738,-0.2775960892940687
5,Prevalence,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.14175612791328,0.0948143413348578,-0.2803029150995967
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1768986953271755,0.1929146312641453,-0.3263607474089373
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1214615139656329,0.1421213720505891,-0.3097715436363253
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1353460150977159,0.107632456915887,-0.2824393706216426
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1900432821944205,0.1730572532563022,-0.3370898376108373
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1298185953682455,0.1314854470402252,-0.3165089337035576
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1463714475633755,0.0931691822714037,-0.2911402253401335
5,Prevalence,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.866312448623588,1.905637951407352,0.4808559296879714
5,Prevalence,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2654643340113787,1.92567125004361,0.7664186168720205
5,Prevalence,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9594408436627894,1.806222126882803,0.5944655339932683
5,Prevalence,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1390700367582758,0.3417352216130672,-0.3171358459508697
5,Prevalence,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0233799246587269,0.3215675734384977,-0.2025914454758358
5,Prevalence,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1055203224843219,0.2826926290729856,-0.2712214319973783
5,Prevalence,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1577099789395694,0.3113505474872906,-0.3316713002025773
5,Prevalence,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.01030667045823,0.3047326038689617,-0.2122478007466876
5,Prevalence,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1209198687180968,0.2589786130490898,-0.2846617567044588
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.132367703598793,0.346983956009891,-0.3081822650940289
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.015759423469746,0.2971655596774935,-0.2431539818032979
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1210894032768671,0.2691538210158499,-0.2814717644493295
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1462250990006224,0.3264626847855298,-0.3192621392812463
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0251178461261918,0.2848965113101455,-0.2498685137990741
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.132293762682348,0.2521247935632463,-0.2910746514690061
5,Prevalence,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8341913237977922,1.8742958853884757,0.4544246733419679
5,Prevalence,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1318322506697287,1.743300444987715,0.6767228868700017
5,Prevalence,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0075762454588566,1.6241903580390016,0.650085661258302
5,Prevalence,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1538871020723397,0.3293635473594323,-0.3291819661556678
5,Prevalence,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0369850499366822,0.2396874558388256,-0.2435136371246252
5,Prevalence,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0835462538115115,0.1981524599305925,-0.2476446106603211
5,Prevalence,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1722066420925972,0.2972054832636734,-0.3436000549406963
5,Prevalence,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0492879049938777,0.2234025038631221,-0.2522485162610219
5,Prevalence,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0993244857969695,0.1773121969537925,-0.2597084395700343
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1856041721334069,0.2866912721851006,-0.3515378408382035
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0995693408538111,0.1712912445379937,-0.307492756694566
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.129905599841893,0.1515223084376601,-0.2919461950941519
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1986124819679866,0.2644007977503425,-0.3617113106080752
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.108130001452598,0.1603110222825355,-0.3140664303803147
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1409974239877454,0.1356028429510511,-0.3010760330695708
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0336350504155458,1.018115756858747,-0.3088729602960356
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0750138596454735,0.7806828143188062,-0.4155154590501722
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0258632384368331,0.7809377279881353,-0.3510694365133117
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5316686824325619,-0.0855542130234492,-0.6871480094535438
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5781757767472703,-0.1880347437663414,-0.7332546271081917
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5571837192847812,-0.190555138458236,-0.7050773738963865
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5400020783529489,-0.1018792818364882,-0.6924281914297585
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5825057896557878,-0.1962855085022131,-0.7361918181944644
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5633935242777237,-0.2017866735159474,-0.7091504011636443
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4286089586942558,0.1379499411001528,-0.6191923301544413
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4848032029868987,0.0095495911789723,-0.6776902129571315
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4591484912898446,-0.0028475655009773,-0.6418938851903679
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4360230715077473,0.1227855610671826,-0.6238865285759552
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4887804797762771,0.0018111747419065,-0.6802430022115349
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4647608238043276,-0.0131044745830664,-0.6455557718411707
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2786747415148692,2.038336110552987,0.8425644702237658
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2104960773132074,2.280001620680707,0.6564204082549381
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2537505384236138,2.087981452683067,0.802249005837731
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4011589882900828,0.8685018214409074,0.1323813021895049
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2889590434179481,0.9140955351060348,-0.0337606073227078
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3503673976408817,0.8483465102092449,0.0805547644167172
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3697575530792058,0.8264053927488082,0.1076028334111944
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2771767860521002,0.8951139389663354,-0.0429561422531326
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3289618295543741,0.820880088999586,0.0627263733394047
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2593578531679101,0.5190720924887349,0.0739985883768594
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2370327290339173,0.5702474796480392,-0.0058343737396446
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2264132594260136,0.4463046322792539,0.0592270312365941
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2302726207586783,0.4863445873188352,0.0515156863752621
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2224429871473305,0.5522248801430212,-0.0187936282417624
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2048266273203737,0.4218382138137397,0.0407398474360311
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7090162403271505,2.2284815451331585,1.2379110560158877
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9805317442185644,2.5613884669898166,1.5107100411855918
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.767441351145473,2.2192034894695567,1.3745214307378637
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6657717402992424,0.9843914252143288,0.3748689221229186
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7379662332886616,1.0762203346026242,0.4642940009171568
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6581473414051493,0.9280612843766018,0.4223744655778915
5,Prevalence,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6284445467348571,0.9407056658218172,0.3452536758534223
5,Prevalence,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7220867265388787,1.0576931679886372,0.4506339160790108
5,Prevalence,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6318682385208283,0.8982573652830563,0.4001764130987956
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2544855245526187,0.4983684577377395,0.0366731217739555
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2467377030411372,0.4773287565915254,0.0548200766450879
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.208569365868246,0.4037964607904538,0.0357509189364243
5,Prevalence,244,South Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2255107652869493,0.4639729437830588,0.0112162824174794
5,Prevalence,244,South Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2320332237501125,0.4601473204168497,0.0411733548319256
5,Prevalence,244,South Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1872954318756301,0.3799488591902769,0.0170602066519553
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5980704796020743,1.5997518541663274,0.2152885413568219
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5591303702470447,1.2315338894718444,0.2626354402986144
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5809217579332072,1.2156651746982718,0.2755357605197568
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2855613790348518,0.1624497735015639,-0.457251252907018
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3169928322336312,-0.0226119319845387,-0.4466783583843652
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3004761342310056,-0.0201128436945601,-0.4361964313697682
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3006555293589587,0.1376983102164153,-0.4681678108196204
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3249637283380725,-0.0338419765387354,-0.4533332578517201
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3118973646971799,-0.0356227068114148,-0.4448178641148699
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2061130937930785,0.3365479706825859,-0.3835071928799325
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1958755070840321,0.0700519524136444,-0.3905812127645908
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2091110754624393,0.1415858854458319,-0.3550560362528815
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2182647219305952,0.3156614864627716,-0.3936125621751641
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2029213999643365,0.0604360075322871,-0.3958527678056836
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2186143395329894,0.1283685386901291,-0.363518593786283
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7324414294503927,2.008200283263638,0.3194344338479886
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8306467121156608,1.5451016632894898,0.3060792221364109
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.759176095262986,1.7698385814769286,0.3767660615705466
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2254852829703504,0.3466847314044515,-0.4107256198083659
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1980485487949647,0.114513500330347,-0.4274458068796198
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2215990064432063,0.2258295322112736,-0.3909558219423226
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.241852377689073,0.3164427110906188,-0.4225916895012355
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2074088512040749,0.1019193587482265,-0.4345239721894611
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2343114382240467,0.2055835260116814,-0.4007569632031062
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2507491576746964,0.3176130644686969,-0.433145832633027
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2479854053809817,0.0598665804011918,-0.4719838659361839
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2675682328357062,0.1608490920235211,-0.4310060501117252
5,Prevalence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2622202015600051,0.2979494722054204,-0.4423308678648998
5,Prevalence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.254576038744803,0.0509488306073478,-0.4763431926118912
5,Prevalence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2763711947218201,0.1469605342288285,-0.4379315846623698
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9204990400503128,2.841780512792542,1.2086161060413816
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5831544259975785,2.39296158829219,1.0211287996963505
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7307434327784963,2.368205358846219,1.2232247903475617
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.353112857032785,2.099258278623893,0.7813062366204514
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.030003443190901,1.6685552540812318,0.588997732516629
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1728902320767174,1.6758632319717508,0.7691595182821194
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3135044148212909,2.043307344133497,0.7495787678410311
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0198197364679298,1.653024036092438,0.5803607397548023
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1492627564925122,1.650984434162284,0.7498144219074563
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.294134911945455,0.690263516341128,-0.0089637092571604
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1019460695041856,0.443592145245619,-0.1295312953982734
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1810299330747401,0.4434636764353955,-0.0343727514183399
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2463919140260096,0.6272271099177857,-0.0463522414233644
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0802763264368382,0.4150211108424997,-0.1451351688301526
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1471592853049398,0.4017227583120294,-0.0625760871464229
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8723521682057027,2.6292462339760614,1.2655188682147416
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.567637314759249,2.362612442109576,1.0195480063316855
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.780526817872011,2.385850902527242,1.2788734265706867
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.31437465181501,1.9242119005303755,0.8283131759184175
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0178331629101198,1.6435516929218117,0.5856948229395438
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2125315823642946,1.691660667275131,0.8127742185678093
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.275364357575993,1.8749460519023176,0.7946548968512726
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0076865990849215,1.6292934360835267,0.5791246860349424
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1884453373931056,1.664872560522473,0.7936133155890457
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3202843477873782,0.6659255212300202,0.0565479923512284
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1495551973692467,0.5011548928107126,-0.0954391051733465
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2695066760522195,0.5396044904858979,0.0446574346038442
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.271552681116882,0.603216090639189,0.0172183639193996
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1269345540165037,0.4738352786460629,-0.1137702390761273
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2330851914803941,0.4956497977178863,0.0102691152991573
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1284408709695404,1.8877948758491645,0.527576890563867
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7937163883166514,1.4679229399270637,0.3496272314735159
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.962796611669516,1.4995702631292138,0.5468587010334517
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7149454516755984,1.3282453755937578,0.2316379578747285
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4096247846317654,0.9395213504805886,0.0611454556240799
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5618343144880373,0.9852447333059762,0.2323484535591662
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6860671015968768,1.2875974628843716,0.2100863009486215
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4025424598255679,0.9297179494878997,0.0553003303130177
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5448414543063281,0.9673152773322355,0.2174727789438788
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1292299160746829,0.5171775847554113,-0.1734760151116173
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0861987866416843,0.2521646457114929,-0.320524391259018
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.020132795716988,0.298985233164708,-0.1944299862453221
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0875617614696989,0.4578817152526178,-0.2054079339798654
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1041774983616575,0.2276562729398537,-0.3326036631018899
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0091311750766381,0.2641513090051322,-0.2176581911414014
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5754114965214256,1.8431044817136053,-0.0318038946592483
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5543018921892885,1.4399663424928626,0.1034443736012474
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5663659120223535,1.5361193571582614,0.063421404154266
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1063269341241257,0.6146224478799838,-0.4507080585954748
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1708579272842601,0.3018120661706983,-0.4113241572294167
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1386783516580826,0.3944198443205974,-0.4157805383446646
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1298246124328608,0.5703830711732767,-0.4652188186602938
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1808934552120982,0.2858456971850034,-0.4184923065665952
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1550513475664601,0.3680651607610486,-0.4263559520080346
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1459365395452026,0.5184414056460794,-0.4582394013268215
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.145172483205597,0.1082840099937306,-0.3344930032472843
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1558246702382452,0.2775964117901985,-0.3991796248643168
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1649736012490101,0.4825668108111657,-0.4707571001482817
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1550661300446319,0.0956735213889696,-0.3423580380917401
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1700413211057475,0.2559297076879889,-0.4087434655331755
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0444533360680424,3.244561688841153,0.2271800667982591
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1414840624090687,1.976667037992101,0.555088053180502
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0698723762866866,2.723417494983849,0.3519224562446681
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1597523986531533,1.4113282756003271,-0.3049910508927712
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1423874746323891,0.5859238653938343,-0.1720865174952656
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1382067074324194,1.0464128165818165,-0.2570574322268272
5,Prevalence,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1292497090468835,1.3444751550914849,-0.3221695457988434
5,Prevalence,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1285475620231926,0.5686833199691026,-0.180479153707096
5,Prevalence,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1165563944089998,1.0085323427219548,-0.2707291132735838
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1605766787201374,0.753533084091575,-0.4962302637602978
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2048917066947857,0.1245358205393779,-0.4312718914579646
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1971603887839589,0.4433519336772767,-0.4743598914817604
5,Prevalence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1792953175547234,0.7181972673678139,-0.5071905050425364
5,Prevalence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2141000085187417,0.1117746887246391,-0.4375642869772934
5,Prevalence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2106892910118309,0.4196307676615511,-0.4835066933113074
5,Prevalence,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3511331163722855,1.684949373872712,-0.1529564404954232
5,Prevalence,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2743460440157778,0.4498162950417869,-0.5668466087894329
5,Prevalence,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0068810341312915,0.867021546664525,-0.3554696476330204
5,Prevalence,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4616256148092371,0.0700419134052366,-0.6622468513000395
5,Prevalence,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7013094586154468,-0.4034606370210172,-0.8217545633820739
5,Prevalence,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5977540266697897,-0.2438050766605564,-0.7388760074900007
5,Prevalence,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4704079180690907,0.0523966229220522,-0.667991586670136
5,Prevalence,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7043018825726167,-0.4092115869775246,-0.8234934967528291
5,Prevalence,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6030535401361435,-0.2537574863553639,-0.7423832889717465
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3368535228524968,0.3421827639199449,-0.5814479601290128
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.63356830755056,-0.2513022803431256,-0.7827030513491364
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5044743834452189,-0.064222970611789,-0.6807791958882219
5,Prevalence,94365,Central Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3444951475537727,0.326493298185524,-0.5863725406368265
5,Prevalence,94365,Central Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6361494584059628,-0.256735227520957,-0.7842797068673212
5,Prevalence,94365,Central Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.509085123269344,-0.0729785674119188,-0.6838407503678168
5,Prevalence,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6179204315030742,1.8421407535745185,1.3894567153345128
5,Prevalence,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9886174470327669,2.2785472863856997,1.6081218062915876
5,Prevalence,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.743902814062233,1.9467337882509803,1.5061952439506627
5,Prevalence,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.062027975584861,1.241060831237024,0.88271872390313
5,Prevalence,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.414399749184137,1.6472327753331777,1.1074457645444138
5,Prevalence,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.189431746510106,1.3513313418599782,0.9978657666235896
5,Prevalence,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0791977253212477,1.2572773865713365,0.8977478870221625
5,Prevalence,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4315032665658738,1.6673867022867952,1.1219365823805807
5,Prevalence,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2058954408428486,1.3689565809574566,1.0147960905030105
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3170421958578373,0.4240936578868759,0.2104168513271869
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.576391103873463,0.7068080751437277,0.4110342017120105
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3957720414991147,0.4899111668339291,0.2880859396304612
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2974524938514861,0.4022917404174908,0.1929362861192254
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5668210424773096,0.696214518309171,0.4029801340945464
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3809350489914571,0.4746262899632627,0.2744038152066897
5,Prevalence,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4156406250260063,2.6839887141853103,2.1345258010465478
5,Prevalence,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.880521227644608,2.1087340430957005,1.6462070053840092
5,Prevalence,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3264313348140853,2.5563296140827587,2.075788726765833
5,Prevalence,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.690385361941665,1.903584260060989,1.467540838774774
5,Prevalence,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3270784043394372,1.5112177301641856,1.1380655390581929
5,Prevalence,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6542614896971126,1.8379037286984188,1.4528623708158688
5,Prevalence,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7127609122907752,1.9258876100544555,1.4894946527289448
5,Prevalence,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.343557480528028,1.5292286867215297,1.1529222430220845
5,Prevalence,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6742053975592326,1.859026654164011,1.472707230954681
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8021415277630181,0.9229849679714008,0.6798536996331506
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.675323386018072,0.7953440238112365,0.5557085438910341
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8421902621720941,0.9552266094652576,0.718808032125074
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7753268698938534,0.8951350706882162,0.6531447084857276
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6651513844626855,0.7869327178911254,0.5463205059899003
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8226009423226958,0.934602055229428,0.701507266868032
5,Prevalence,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.005782281182021,2.2594736546083207,1.7840031623574293
5,Prevalence,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.71772965137037,1.942481379068442,1.485131502602722
5,Prevalence,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8732409591626429,2.0879748574321546,1.6714922952139264
5,Prevalence,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.3675388579153824,1.5690605848333563,1.1916130357028407
5,Prevalence,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1955554625842435,1.375784204641877,1.0077596986669215
5,Prevalence,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.292637665795652,1.4646815550201526,1.1324917830461576
5,Prevalence,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.387244320583254,1.5887304009904963,1.211103505211304
5,Prevalence,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2111122089281996,1.3939675156877764,1.0218731482089316
5,Prevalence,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.309873768042303,1.482503981021989,1.1476827255170925
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6901906950069916,0.8094215246500867,0.5844716161722355
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6451745242677017,0.7634570977396492,0.529558417109623
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6715953284278106,0.7733780637393353,0.5885900779753184
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6650411767230641,0.7808264885412429,0.5607576604978384
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6351912289847442,0.7515168673605713,0.5199025832820495
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6538224224209763,0.7541779262163384,0.5711054231363014
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1494427395921174,1.816495129702404,0.650734011316308
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.794976384272957,1.3218498113043986,0.4229521527174685
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.038589168469277,1.548830165932603,0.6524454027361037
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5575185367377035,1.0404995055171096,0.1959925113929005
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2567353018799581,0.6250948834975738,-0.0034816030230341
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4521431241782919,0.811123940298674,0.1773829537160149
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5287055210013317,1.0031199600443754,0.1740188051172658
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2492491719389855,0.6159371117930112,-0.0096684201162317
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4344440778500621,0.7934728554027022,0.162735757938512
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.070702441124009,0.3913542307260828,-0.1711771817704377
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1443854483523944,0.08566689640523,-0.3161722600632055
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0140861449638396,0.217355598000931,-0.1927895536390172
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0378569625052623,0.3471520118420571,-0.1976043988930038
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1579500228052786,0.0684760766754536,-0.3270750987653609
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0372817327737044,0.1880884686014623,-0.2115544627304204
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1845576098930148,1.9464267250295604,0.6078986945030745
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8715794672850682,1.50200117928497,0.4348653293158014
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.128163083406458,1.7739483459694587,0.6340669680545363
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5829604225691382,1.1319969658073237,0.1639256838884876
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3103717377864798,0.7529409906885677,0.0052863425079592
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5159471954666804,0.9763459072097797,0.1640035831363035
5,Prevalence,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5536795736287664,1.0955286311247816,0.1435538924680191
5,Prevalence,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3025625964827924,0.7413170049466256,-0.0013772101978024
5,Prevalence,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4974723592707667,0.9518762478884594,0.1498038552300698
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0407441998470567,0.4003560032453994,-0.2340164173492336
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1822640589636134,0.0853414510731152,-0.3682071525159109
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0248816405867997,0.2685745485231404,-0.2466708372751135
5,Prevalence,44639,Middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0088168977772998,0.3583779979187752,-0.2581232191992691
5,Prevalence,44639,Middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1952319312292215,0.0675025452345091,-0.3782219093198578
5,Prevalence,44639,Middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0478240029286549,0.2391496068661838,-0.2633257984203191
5,Prevalence,44635,High SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.677969482150626,1.8661201139543049,1.4885733121206848
5,Prevalence,44635,High SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7886406565344664,2.015463816791179,1.4955579841302238
5,Prevalence,44635,High SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7086536680576634,1.8774352871527304,1.5188756381204684
5,Prevalence,44635,High SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1093399283395085,1.258628495586117,0.9619870222263268
5,Prevalence,44635,High SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.252845515185313,1.4333811715742222,1.015495052763726
5,Prevalence,44635,High SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1613125443719334,1.2952679675934626,1.0101647533183733
5,Prevalence,44635,High SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1268897208500863,1.276322209689847,0.97646800398961
5,Prevalence,44635,High SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.268804551206123,1.4533451506209332,1.0303560083749526
5,Prevalence,44635,High SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.177557727835448,1.3132456983247138,1.02499019196459
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4392395383618047,0.5362302116880919,0.3432743611274094
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5576674926079258,0.6652625537281363,0.434000516240122
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4816831087852445,0.5717018608531208,0.3898055637063931
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4178219138742371,0.5130889485142636,0.3225811694771197
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.548210218256521,0.6558583388401802,0.4251961414041185
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4659262213285529,0.5535755684955666,0.3747596181879446
5,Prevalence,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1663183438368134,1.538610322432501,0.8193118197324583
5,Prevalence,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.287292967389234,1.6184896492953271,1.002318544511542
5,Prevalence,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1881084003011158,1.5374241252971588,0.8705587598356229
5,Prevalence,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.706340359549731,1.0015594421751195,0.4331437934871738
5,Prevalence,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8478251907002522,1.1153815065260828,0.6175948241428227
5,Prevalence,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7459614171370997,1.025434900186254,0.4921121820566455
5,Prevalence,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7205275296473078,1.0162082637661347,0.4449289412000799
5,Prevalence,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8609140916719996,1.1303717349478204,0.6290623232890011
5,Prevalence,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7590777339334376,1.039901807306031,0.5037912490935862
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2461884779745632,0.4653087148441767,0.0524876530430941
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3632863615346443,0.5235014316814866,0.2156694112864873
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2766326039584149,0.4705000399114015,0.0942345377197763
5,Prevalence,44635,High SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2276313533895769,0.4441583114662665,0.037782912053276
5,Prevalence,44635,High SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3550051530607513,0.5136509350360593,0.2087659125938885
5,Prevalence,44635,High SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2630462899563517,0.4544676614644255,0.0824052236720953
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0644389586530094,1.7420221243162306,0.5400770901811163
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.773535549112612,1.351057890685617,0.3796848282639934
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9778999220990924,1.503097145098763,0.5487042117634338
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6633986457660718,1.2049972507040108,0.240396021755558
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3937671031697203,0.8469967497100768,0.0844863860977085
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5738580822362965,0.9908268143293646,0.2323072491716111
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6353673052022354,1.172122025430956,0.2199884671894142
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3867626609437936,0.838338847028699,0.0788029620632491
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5567286869977572,0.9700911500021858,0.2189253092076328
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1006538025329396,0.4488806771212497,-0.1716042159997118
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1019921256400546,0.17431844581915,-0.2907128740077517
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0312188880397807,0.3058924788373127,-0.1823811631083384
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0600258689091649,0.3961055411757986,-0.200925974543466
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1196614631321916,0.1512420465872712,-0.3043437442479353
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0016320916491554,0.268529247580114,-0.208116314930323
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0908987056397017,1.8333682067226424,0.5119346243827139
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8010907709910564,1.4934114531355904,0.348179896449877
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0440470939178856,1.7368431770449382,0.5286641657714757
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6847158173265626,1.2843692657748604,0.2190883583851647
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4154234742880683,0.959422894864043,0.0596199204408894
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6264896775671164,1.1779600487610296,0.2165393283497348
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6563276755462438,1.2444827973489712,0.1976951132195258
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4083086360634724,0.9496479240622708,0.0541686303199373
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6087905728310904,1.1540636297706923,0.203152562499939
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1021123739411165,0.4958549259483547,-0.1965093593563144
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1078466036121579,0.2300114197059113,-0.3318063614582872
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0553318805575273,0.4074523121579751,-0.2056473592400841
5,Prevalence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.06142950149938,0.437938361310401,-0.2272810064713505
5,Prevalence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1254034568797373,0.2053294536735212,-0.3453241884323449
5,Prevalence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.025053200392236,0.3681871298045658,-0.2282855274217787
5,Prevalence,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5202423661920004,1.273538576520345,0.1679923483396971
5,Prevalence,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5473786395719142,1.115263859787054,0.2241314419766182
5,Prevalence,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5321545111987733,1.0397351622494022,0.2237072899856038
5,Prevalence,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2987040574340419,0.0500463095252972,-0.4610914362198063
5,Prevalence,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3009960896025554,-0.0453813264629692,-0.4474512393916803
5,Prevalence,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3005694745296308,-0.0692354050216123,-0.4415777746014385
5,Prevalence,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3138957115239822,0.0260762376156945,-0.4728705258291482
5,Prevalence,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3099308879800554,-0.0566767460258103,-0.4540862361947834
5,Prevalence,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3126168655691387,-0.084896765314594,-0.4509980902917749
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2331834737388478,0.1701324793301288,-0.3816294988938644
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1781180752183354,0.0182989473207707,-0.3122479458824408
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2147500056375384,0.0547438916561182,-0.3404577040788381
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2454355996521839,0.1521923732415445,-0.3910868968787178
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1859358717329438,0.0087261450046224,-0.3186762061125021
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2247641399776626,0.042567006302481,-0.3487993442178437
5,Prevalence,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6634331675310121,1.6755360317262402,0.3221100482991257
5,Prevalence,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.89500937368356,1.4439977171932985,0.469247060850503
5,Prevalence,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7236607507957029,1.4983088879044466,0.3946628201701664
5,Prevalence,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2326457112812687,0.2349291485594714,-0.389492858663309
5,Prevalence,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1439597894256507,0.1035094712978691,-0.3364927045498934
5,Prevalence,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2131445461544713,0.1426486364050702,-0.3636100978013171
5,Prevalence,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2492719218876618,0.2075026891518941,-0.403315290937826
5,Prevalence,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1549014557102436,0.0899254334730462,-0.3447744535884811
5,Prevalence,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2266998393977976,0.1208369531873173,-0.3743008986393406
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.267044957341417,0.1885259255554751,-0.4177300334413852
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2028305539227169,0.0421290900262082,-0.3911346481909107
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2616445491586197,0.0850495089250374,-0.4045184326057195
5,Prevalence,44637,Low SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2787592757625756,0.1692305744934388,-0.4278020725398399
5,Prevalence,44637,Low SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2104137590206964,0.0319434330282187,-0.3968423738344832
5,Prevalence,44637,Low SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2710623894903677,0.0710587515151689,-0.4121981879820203
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4715613698722138,1.236792086595396,0.1358445969899882
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4334495461557283,0.9211824564813512,0.1333369878993096
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4551781480995944,0.954660716380328,0.1443144398617778
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3332523387782343,0.0124772861230369,-0.4854757184624624
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3462982273656854,-0.123974800513352,-0.4836715444560696
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3385151732671595,-0.1118741344349858,-0.4798492804570682
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3451120185551282,-0.0045618996987366,-0.4945158315603033
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3530098882225637,-0.1328707343783393,-0.4884662481152879
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3477915752092939,-0.1239243191662918,-0.4871201720131731
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2692777350486073,0.1571311569302642,-0.4232544502916439
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2139946603574516,-0.0233881315217605,-0.3488673654583477
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2473423992090684,0.0370132862944608,-0.3811991326734334
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2787541712981751,0.1427016799258067,-0.4302882752729061
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2200645864172161,-0.0308975256724989,-0.3546410616042617
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2551524135196693,0.0268209164455664,-0.3873423769721742
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5862034395909966,1.6642364467309574,0.207935503310111
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.737029720897317,1.2643625600294166,0.350552501699497
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6239573023152316,1.4664184132780118,0.2768529535885298
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2813064693328367,0.2082285177349953,-0.4522490224895114
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2078505924871435,0.0324394302060441,-0.3839460516198025
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2617889572474448,0.1215099508711403,-0.4194237855384699
5,Prevalence,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2940929342247783,0.18566338068728,-0.4624332632848011
5,Prevalence,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2159884131966563,0.0220242419742037,-0.3904256230160149
5,Prevalence,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2721450391118092,0.1054446290989443,-0.4277166306840808
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3068701948801545,0.1702328642682208,-0.4716250716733191
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2359158653107652,0.0136662727144295,-0.4145899042273345
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2919626392514052,0.0885799546532501,-0.4431454630754506
5,Prevalence,44578,World Bank Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3158622698854222,0.1549819267792972,-0.4787796394738266
5,Prevalence,44578,World Bank Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2418206329865717,0.0060046009082765,-0.4193304301446018
5,Prevalence,44578,World Bank Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2993127826218714,0.0770188450226289,-0.449193514686318
5,Prevalence,44563,African Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6069326921015914,1.6038512693080569,0.2205950431794386
5,Prevalence,44563,African Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5622382955918876,1.2518017654138356,0.2561638197352386
5,Prevalence,44563,African Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.587220345966094,1.2355509425291382,0.2797435961740837
5,Prevalence,44563,African Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2731460442418864,0.1776651432030591,-0.4485106786051537
5,Prevalence,44563,African Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3075887998703115,-0.0018460915712272,-0.4427628046045729
5,Prevalence,44563,African Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2894371618216794,0.0007809866138791,-0.4270519930683869
5,Prevalence,44563,African Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2876706931963299,0.1542484503568738,-0.4589284135735066
5,Prevalence,44563,African Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3151725130363524,-0.0128933924485525,-0.4493442426092784
5,Prevalence,44563,African Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3003738073579351,-0.0145980686587971,-0.4359055804540039
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2159337876877127,0.314061999810943,-0.3921583020805764
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.203075972793295,0.0653785100016205,-0.3996137437695015
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2173404970857501,0.1318080203367005,-0.366343566269705
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2274818165472537,0.2941346966208094,-0.4010809131799459
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2098037508005829,0.0561720899444225,-0.4044999756879714
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2263915773770947,0.1187068270081828,-0.3740115718763227
5,Prevalence,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7347053144775868,2.006412816731372,0.317421688142084
5,Prevalence,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8277606536828811,1.547029906071407,0.299067237641041
5,Prevalence,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7599659260092433,1.77382782407883,0.3660224874805409
5,Prevalence,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2153479670242901,0.3616199985230436,-0.4047373110605072
5,Prevalence,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1899025233810225,0.1298819135848743,-0.4246859888593541
5,Prevalence,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2120991452036063,0.241348491578822,-0.3887570828747705
5,Prevalence,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2310309944877639,0.3326979830792646,-0.4160066053201927
5,Prevalence,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1987773320084648,0.1165237049417496,-0.4305369710493082
5,Prevalence,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2242297907010851,0.2226674163653593,-0.3978749614643173
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2614648151497531,0.2966051343944665,-0.4423986434947348
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2565025590069044,0.0537557158312543,-0.4828872175840313
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2764091880218159,0.1458283730677704,-0.4404522233422274
5,Prevalence,44563,African Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2723449847808841,0.2778659601509368,-0.4511220462181742
5,Prevalence,44563,African Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2627810140748282,0.0449385523349866,-0.487045460638465
5,Prevalence,44563,African Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2847794930915382,0.132704609303553,-0.4468660789362593
5,Prevalence,44561,Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.062838132696971,1.5642451479307815,0.680494997101186
5,Prevalence,44561,Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9858842180445084,1.4641745373418074,0.6400376048895363
5,Prevalence,44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0407717174507238,1.4478755335449451,0.7073866086277443
5,Prevalence,44561,Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4531183987431494,0.8032180265903448,0.1845403638251951
5,Prevalence,44561,Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3632576852805021,0.6931777371734503,0.1256041800266366
5,Prevalence,44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4193941270057005,0.7012799495221753,0.1885062751205941
5,Prevalence,44561,Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4263440084266359,0.7730405720715974,0.1619738516140401
5,Prevalence,44561,Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3544756082853616,0.6806943098998642,0.1185903550213104
5,Prevalence,44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4016727014561939,0.681285703144948,0.1726922613053921
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0455012703173755,0.2747818830968885,-0.1411085087226481
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0507397042737427,0.126766365130144,-0.2030884241847453
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0025190823772269,0.1692680329863524,-0.1496165027044925
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0161903190225295,0.2397293690531066,-0.1666491213521799
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0646249685312766,0.1091659455527926,-0.2146740317843703
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0240684128788465,0.1440606472095597,-0.1684785931404174
5,Prevalence,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0907564317830214,1.671195951609334,0.6020990014281777
5,Prevalence,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9720071976241466,1.527989185389356,0.5684096956974007
5,Prevalence,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0712888339881566,1.59512314136414,0.6445129063988078
5,Prevalence,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4727804056376992,0.8806026981169863,0.1271950539533576
5,Prevalence,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3537352458238315,0.7348971498988804,0.0770886856782453
5,Prevalence,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4406168197056694,0.8059664483859014,0.1434502409897223
5,Prevalence,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4456480429970999,0.8469914243490242,0.1077671463275511
5,Prevalence,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3450107636059644,0.7242191959160456,0.0697364213469898
5,Prevalence,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4226329141109979,0.7824204603889933,0.1295084248673443
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.024006043477317,0.3050903117605413,-0.2114024417212744
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1096950481351495,0.1265670487963029,-0.2885185638483471
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0207228398892483,0.2276536808936057,-0.2153910081669037
5,Prevalence,44561,Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0047017192716182,0.267634426709806,-0.2328415305680438
5,Prevalence,44561,Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1227217276668169,0.1093734470351072,-0.2993951630113206
5,Prevalence,44561,Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0418789572352922,0.2008990992669959,-0.2319887974606147
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.193470921031919,1.7749127880446975,0.864042599406033
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.038305010543153,1.7593143462121907,0.6243448577399549
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1411608661390913,1.7249827991864604,0.8159861350893205
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4346834207734241,0.814263555363593,0.2187712690719413
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.279523250562316,0.7319678657652593,0.0193700951659935
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3724062132843591,0.7463980565429063,0.1649731706697305
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4035214100532444,0.7755646868657952,0.1927323368786044
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2697231012207355,0.7188620696084167,0.011854545592241
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3521705502473001,0.7208615892716539,0.1468185367841878
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1387921888252139,0.350835205648837,-0.020427176242917
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0338905042642309,0.2477101973986847,-0.1485350965893901
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.082962208108365,0.2533546097862216,-0.0561561900105036
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1107542984210239,0.3195712657689707,-0.0458456269706248
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0221372763133612,0.2328092492871679,-0.1573729018329839
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0632577949349337,0.2312041074840656,-0.0722552800554941
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.282501440567824,1.7893666802030714,0.8763359751319839
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2948160271768918,1.7848238767930131,0.8721135608815382
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2851844966685448,1.729701521398763,0.9196714090965992
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4929159733951798,0.8271786715547466,0.2282234696626464
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4405422900642848,0.7473097648307885,0.1758316339304922
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4647186770641708,0.7501898050870928,0.230992290169996
5,Prevalence,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4604887667292178,0.7848132011307276,0.2005984160993326
5,Prevalence,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4295117304262726,0.7347527435322057,0.1661973179011504
5,Prevalence,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.443123320224263,0.7238415228727098,0.2122971172234852
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0589417424064304,0.2897404845929726,-0.1237275605968988
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0336119846426037,0.1740211830779011,-0.2170790178730325
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0093055624465905,0.1987833638163608,-0.154875763272616
5,Prevalence,44565,South-East Asia Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.032864769196746,0.2566642779297877,-0.1459102393816541
5,Prevalence,44565,South-East Asia Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0445982826287964,0.1605648633570044,-0.2265631880112943
5,Prevalence,44565,South-East Asia Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0090615315104662,0.1768119944492203,-0.1690376921322584
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0401164061482708,1.5886599807875377,0.6082917818705489
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.955028650969979,1.4759929817023163,0.5556387802744387
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0171249795139023,1.4581606036010355,0.6581000468105203
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6724330969370822,1.1243213854835157,0.3167312473282427
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5682707118207081,0.9874761905892298,0.2481275087702204
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6359114276550021,0.9954443281009376,0.3446777819146055
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6410099433194714,1.0822423443796445,0.2936628507347801
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5578440030311781,0.9729689466077656,0.2395943883128728
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6150498703269696,0.9681735164696872,0.3275896599306476
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0580919235125332,0.3323564173207387,-0.1596517238216503
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0872837263194698,0.1367694089629694,-0.2630246110128552
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0029068495144933,0.2202249615599042,-0.1682549214667707
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0131158024908584,0.2767880445090623,-0.194757627579239
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1089985874560138,0.1094810317757148,-0.2823247723642429
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0309099736272526,0.1795970840356588,-0.1962572364415942
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0599587670914263,1.7049517212222178,0.531242888849349
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8758294581098297,1.509531887942576,0.4496778356299584
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0315017254400023,1.623288054578917,0.5654647216140666
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6886970250066304,1.2207198627465656,0.2532676500773084
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5047437489643891,1.014644348264105,0.1626378617007607
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6475697378902624,1.127673911552416,0.2687719170420461
5,Prevalence,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6569705578748626,1.175784017690107,0.2316869756383872
5,Prevalence,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4947349598051941,0.9996940710343004,0.1551605248561796
5,Prevalence,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6265608881763792,1.1003859827262494,0.2534194069886195
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0856941388428866,0.4303451021365572,-0.1903632486969327
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0932403175491796,0.2010715889177485,-0.2965364609109483
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0420636196486644,0.3459740752549048,-0.1905916409922466
5,Prevalence,44568,Western Pacific Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0395436048600452,0.3668718226837902,-0.225815141579169
5,Prevalence,44568,Western Pacific Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.114816823777059,0.1703103175485326,-0.3138573535835524
5,Prevalence,44568,Western Pacific Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0069258419164947,0.3016959109591073,-0.2172224551844836
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.88362307667366,1.5445600900704135,0.5298538460945244
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8237365146182887,1.6237304365079597,0.4934565144800269
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8591312754518342,1.5174755921001657,0.5645913992559243
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0708557283703353,0.4480134667454724,-0.1299994830907011
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.013337347495916,0.4190069003705685,-0.192649901491966
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0313336559836453,0.39643512831466,-0.1322149002958376
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0464480873247732,0.4136320967352754,-0.1500886504538068
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0233053851007368,0.405128080588422,-0.2001854853555078
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0143674383459223,0.3735690971238191,-0.14633754448804
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0195965387246943,0.2843626162498918,-0.1341493882303896
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0411736368689778,0.1913996737361298,-0.1955945320380854
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0192395832246997,0.1753999257050667,-0.1353506150342223
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0019880457838138,0.2567809733851532,-0.1521535419298992
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0516352401457178,0.178204617504903,-0.2045350896427787
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0350395036850261,0.1567809644118796,-0.1486462768046386
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0978947192163186,1.7960869834857214,0.724332741356599
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2093071985637551,1.7379283327393362,0.7069779708245869
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1262910656971663,1.7261043047179467,0.7636673902809803
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1926722158685923,0.5929121807411477,-0.0204856422085497
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1952585057832828,0.4818419648303932,-0.0766164026843583
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1795373124296332,0.5115551419292105,-0.0218235826498602
5,Prevalence,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1654868447510537,0.5533680342403524,-0.0420457673036278
5,Prevalence,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1831854142302089,0.4662862958174213,-0.0858349446356338
5,Prevalence,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1601334719974884,0.4873997746977166,-0.0377189624015305
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0395555905440624,0.2752722420759773,-0.2108170857441031
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0995832385484087,0.1309605559842281,-0.3138476606829989
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0830028099699785,0.1731225744812711,-0.2427686390689437
5,Prevalence,95469,Limited Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0598914254705886,0.2483369318427883,-0.2286510601065716
5,Prevalence,95469,Limited Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1094086438406461,0.1184494794847417,-0.3214381976972233
5,Prevalence,95469,Limited Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0977778173184838,0.1550385524030943,-0.2548396073202067
5,Prevalence,44566,European Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5179378785188449,1.6893467427318802,1.3404099687678124
5,Prevalence,44566,European Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.962176532639212,1.077449531521092,0.8369471703397429
5,Prevalence,44566,European Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3240205555733366,1.4540678290655968,1.1863222149317665
5,Prevalence,44566,European Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.306854007657475,1.464075462024955,1.1442555041507778
5,Prevalence,44566,European Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8119888787171061,0.9189633054273696,0.6955999418822
5,Prevalence,44566,European Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.138014915822953,1.2572921355264757,1.011317856838987
5,Prevalence,44566,European Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.3020184805680202,1.458728610916305,1.1397140279641715
5,Prevalence,44566,European Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8140414787629957,0.9206119110736228,0.6982663414134913
5,Prevalence,44566,European Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.136970913378674,1.2565512846239737,1.010355273914613
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.6499547496534342,0.763648790597329,0.5331291116800602
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.36071895334612,0.4471562971641979,0.2836860026109568
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5789725373463782,0.6708557549024966,0.4845717634321315
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.615405505977711,0.7248626724486218,0.500779421121767
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3468520278476651,0.4315147529235233,0.2704474911597412
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5541618602101566,0.6435496905174674,0.4621696330278138
5,Prevalence,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.052179339498379,1.240698646350519,0.8623321525874961
5,Prevalence,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6506348853592672,0.770550473570922,0.5350750211113888
5,Prevalence,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9408545570215282,1.096697785510599,0.7856279397540382
5,Prevalence,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.88013920776953,1.0534884446356363,0.7073435428968098
5,Prevalence,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.524293077674335,0.6350857983449559,0.4171858540727479
5,Prevalence,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7855147268828518,0.9280554101596656,0.642215916354647
5,Prevalence,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8761998877208502,1.048553197951356,0.7026325664294364
5,Prevalence,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5260197533335174,0.6368822814229849,0.4191841126361402
5,Prevalence,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7846441699954178,0.9279442993894996,0.6419110236438091
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4561393756557186,0.5690613899616863,0.3374341258497858
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.245202637791182,0.3267176680574041,0.1705503263488223
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.424634567493982,0.524450169273406,0.3251393029982738
5,Prevalence,44566,European Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.425641940951877,0.5357882836261563,0.3094401696088302
5,Prevalence,44566,European Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2325085758020973,0.3127617893966653,0.1592713985770162
5,Prevalence,44566,European Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4022439084509409,0.5013477483266242,0.3029618970146118
6,Incidence,1,Global,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.156010227080327,1.559220123055303,0.826382540507041
6,Incidence,1,Global,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1778043329563763,1.543307630526624,0.8731631383060681
6,Incidence,1,Global,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.162752224786637,1.476732164426802,0.886644924777868
6,Incidence,1,Global,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5181979223874753,0.8119613403523933,0.2787175207155554
6,Incidence,1,Global,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4988436585896814,0.7476589525427966,0.2879392557728282
6,Incidence,1,Global,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5051365165887414,0.7332493938630809,0.3150054420307918
6,Incidence,1,Global,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4624695452957443,0.7359757586794432,0.2388757761917166
6,Incidence,1,Global,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4665873282913408,0.7127262933734512,0.2614344093680998
6,Incidence,1,Global,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4617652372625486,0.6739786178355658,0.2751492910243904
6,Incidence,1,Global,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0531427527418415,0.249510851979572,-0.1009324666589237
6,Incidence,1,Global,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.027242221109166,0.2029833026582708,-0.1184502924365894
6,Incidence,1,Global,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0402152615742789,0.1955309650620717,-0.0890313897990834
6,Incidence,1,Global,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0499045073330346,0.2411977662056094,-0.1024717787615131
6,Incidence,1,Global,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.033816281514563,0.2077575198512983,-0.1084959347670644
6,Incidence,1,Global,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.042217665120941,0.1920729684315501,-0.0897097719792312
6,Incidence,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9010393657453124,1.3962884484172151,0.4906669407033258
6,Incidence,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8156819361682225,1.228250828854596,0.4853083130982496
6,Incidence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8849855548758205,1.3247606873287632,0.5365569146422522
6,Incidence,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3386128817681362,0.7107902325944623,0.0431681815053525
6,Incidence,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2496876652074068,0.5439224820048452,0.0195613179418615
6,Incidence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3117892465638108,0.6333116710060926,0.0722841823122946
6,Incidence,1,Global,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2895171562223168,0.6254555908577342,0.0111524405475694
6,Incidence,1,Global,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2227251454573811,0.5005592469441937,0.0002433724790053
6,Incidence,1,Global,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2740277528237713,0.5712638363033122,0.038531116582726
6,Incidence,1,Global,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0500485313837207,0.1997806013893201,-0.2529743617448174
6,Incidence,1,Global,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1193611816210649,0.081498537835407,-0.2764339391335109
6,Incidence,1,Global,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0690233970922017,0.1519024426511861,-0.2413759286586959
6,Incidence,1,Global,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0529450060263435,0.1911422478200228,-0.2528777678426421
6,Incidence,1,Global,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1137780522650237,0.0830584671652092,-0.271044667768766
6,Incidence,1,Global,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0672099905911045,0.1473797954978926,-0.2391815583006944
6,Incidence,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7412152545900097,-0.6276242504671288,-0.8177736575718793
6,Incidence,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7724537704252792,-0.6528501097139368,-0.8567077848310882
6,Incidence,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7556205599664297,-0.647088713636399,-0.8304688884366672
6,Incidence,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7589873249529021,-0.6540371034566699,-0.8312528280625904
6,Incidence,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7944438516667891,-0.6845436714964337,-0.8716790021989036
6,Incidence,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.775828133837147,-0.6754870248115608,-0.845389421555163
6,Incidence,5,East Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7844724808856276,-0.6898688083487146,-0.8482337456228483
6,Incidence,5,East Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.813382559882019,-0.7152920354536152,-0.8824817865203247
6,Incidence,5,East Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7979886416371188,-0.708272969566877,-0.8598605098408707
6,Incidence,5,East Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5668430288999046,-0.3791108971622148,-0.694980301505557
6,Incidence,5,East Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6149758123305109,-0.4076418378416494,-0.7601067358221933
6,Incidence,5,East Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5885099825646197,-0.4081467190365696,-0.7139448766273179
6,Incidence,5,East Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6016021955638416,-0.4244139061502177,-0.719011594979686
6,Incidence,5,East Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6425104311425364,-0.4486331038108609,-0.7766100861666569
6,Incidence,5,East Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6198234393218708,-0.4516592847512828,-0.7361062415041877
6,Incidence,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6500267999348667,-0.6118845562521656,-0.6894371366259899
6,Incidence,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5952350820293874,-0.5571266607513705,-0.6328601200114041
6,Incidence,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6281164350591101,-0.5939694606031175,-0.6618792969880161
6,Incidence,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6480629021030262,-0.6078109020290063,-0.6871650133276161
6,Incidence,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6013639350178733,-0.5632851980563892,-0.6409410825839816
6,Incidence,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6303011994739417,-0.5953727921011385,-0.6640351991223399
6,Incidence,56,Eastern Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6148478024436539,-0.5728715340568519,-0.6582196314299782
6,Incidence,56,Eastern Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5583977142623182,-0.5168210726240017,-0.5994469802341089
6,Incidence,56,Eastern Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.592626191071024,-0.555220442716027,-0.6296111695992033
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4730049552120638,-0.4130033049858153,-0.532445660964293
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3847491593144943,-0.3255068336927858,-0.4446321543554367
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4372947747501798,-0.3831297398565287,-0.4886767590568194
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4249809316520487,-0.3597743869570342,-0.4907529495178158
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3254334957390795,-0.2604753173093226,-0.389665752598337
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.384607115937165,-0.3261053006832606,-0.4436232721821447
6,Incidence,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.38153273208007,1.6559279178278228,1.1420567912693496
6,Incidence,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4066574430087229,1.78384501192631,1.063879978888223
6,Incidence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3932664203873508,1.6472024681823574,1.1224750834957158
6,Incidence,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.677028588079627,0.8617137018844989,0.5043755934244888
6,Incidence,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.656303359264846,0.9186152514211644,0.422990600791533
6,Incidence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.665587771488533,0.8512513393319032,0.4862982046058263
6,Incidence,1,Global,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.615446461266861,0.8015748003124921,0.4530046203758719
6,Incidence,1,Global,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6207026756454418,0.8747101181839545,0.3898678491665458
6,Incidence,1,Global,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.617565626212748,0.7891964227970387,0.4345426436058993
6,Incidence,1,Global,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.105698742298871,0.2260848037037129,-0.0006209037067797
6,Incidence,1,Global,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0769827505200611,0.2411132505218991,-0.0729197801119761
6,Incidence,1,Global,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.084499604079877,0.1968135778868854,-0.0310285453480872
6,Incidence,1,Global,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1022634482444418,0.2200535741696812,-0.0035294133887557
6,Incidence,1,Global,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.083894053686106,0.248125036572934,-0.0670853636976075
6,Incidence,1,Global,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0865559177634012,0.1996132996251374,-0.031726906671253
6,Incidence,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6399948974177792,2.008287724318081,1.3702798922515282
6,Incidence,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4213329709577571,1.8049886730506493,1.097754856044277
6,Incidence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5892330185949697,1.8810086343830688,1.351887051450555
6,Incidence,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.859197898719193,1.1219190966723178,0.6688192388932316
6,Incidence,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6666031626727063,0.926187165933161,0.4354483619889803
6,Incidence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8020804321108899,1.0133626336152524,0.633162782206137
6,Incidence,1,Global,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7907670792629404,1.0405882704276803,0.6078134104860111
6,Incidence,1,Global,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6305855393170428,0.888948782791875,0.4126800296883162
6,Incidence,1,Global,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7500159169309764,0.9472217953260376,0.5895980567619101
6,Incidence,1,Global,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2110301814661948,0.3766338179101223,0.0983376356990749
6,Incidence,1,Global,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1173597987409149,0.2883563561610084,-0.0378689897846964
6,Incidence,1,Global,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1972067794350113,0.334937824433036,0.0906637606568256
6,Incidence,1,Global,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2072394155810311,0.3681951700869221,0.0920804670576534
6,Incidence,1,Global,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1244702532097725,0.3014087204771973,-0.0258950251633243
6,Incidence,1,Global,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1994768937511812,0.3322310864326633,0.0941279417960269
6,Incidence,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1961826832880784,1.6340183471002403,0.8222854044181331
6,Incidence,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9999658470032096,1.3954728081059606,0.6706708942579417
6,Incidence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0972888576181907,1.4170784864630608,0.8023730398080651
6,Incidence,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.546485731592278,0.879831375700098,0.278899470031884
6,Incidence,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3765301481733523,0.6520789584425499,0.1551562622174858
6,Incidence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4596753274376027,0.6882343960337345,0.2511153608158919
6,Incidence,1,Global,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.489719413142211,0.7867130526560422,0.2360965979310114
6,Incidence,1,Global,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3468264911791361,0.6131706657344791,0.1250711214894691
6,Incidence,1,Global,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.417519727608552,0.6336597723742674,0.2181914432803665
6,Incidence,1,Global,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0873211077269194,0.3074735454176356,-0.0980354037682731
6,Incidence,1,Global,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0289119514119533,0.168740084167542,-0.1855158201661902
6,Incidence,1,Global,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.026009169470631,0.1837304466060131,-0.1119054209954869
6,Incidence,1,Global,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0839681771804737,0.2957391840618764,-0.0996778000996194
6,Incidence,1,Global,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0227463005818803,0.1667587609192902,-0.1811904514323818
6,Incidence,1,Global,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0279180435849875,0.1821687831314785,-0.1117240663131746
6,Incidence,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8487256277585857,1.9698075632448333,0.3219117360179964
6,Incidence,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7948671106357315,1.6415652089747528,0.222871339993634
6,Incidence,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8356530938468971,1.8149354746343052,0.3606790945756888
6,Incidence,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0921534395160769,0.4610547699682065,-0.3494331368470528
6,Incidence,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1425736798148042,0.2671862684969583,-0.4175297262367368
6,Incidence,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.110611126617578,0.3552727401528542,-0.3434135432915495
6,Incidence,21,Oceania,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1278772838749108,0.4009848727883481,-0.3763978621903999
6,Incidence,21,Oceania,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1586884549549767,0.2381859883278907,-0.4268011429119555
6,Incidence,21,Oceania,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.13671767550945,0.3238253175280498,-0.3600913943988533
6,Incidence,21,Oceania,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2849462844966086,0.1489729881783288,-0.4793974629323939
6,Incidence,21,Oceania,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3032414456745599,0.0154204521025099,-0.528364669736574
6,Incidence,21,Oceania,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2911074456720466,0.0711984777958351,-0.4679895933459161
6,Incidence,21,Oceania,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2863138116866852,0.1369440057888871,-0.4848174154329234
6,Incidence,21,Oceania,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2952835755966637,0.0294637371935194,-0.5178552287767533
6,Incidence,21,Oceania,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2876739087278178,0.0849441029466703,-0.4704367479318432
6,Incidence,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1958772498167298,1.445585855934981,0.9642254712504914
6,Incidence,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8886015365877069,1.1302757723924572,0.6688332083010589
6,Incidence,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0218063861738942,1.21985764734324,0.8540669228766679
6,Incidence,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2080363247266788,1.4641051223539483,0.9634729027924456
6,Incidence,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8598088288377729,1.111230472213896,0.6369463862069915
6,Incidence,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0097784466906632,1.2063989762649436,0.8437504524740166
6,Incidence,56,Eastern Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4166048948133725,1.691413989844866,1.1616676837182962
6,Incidence,56,Eastern Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0604818213652132,1.324150657761341,0.8207125335753587
6,Incidence,56,Eastern Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.214754955851575,1.4317069920045256,1.0310074861779572
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4964022130455026,0.6466291905333793,0.3423409256880472
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4040536651152344,0.5766394103263063,0.2496210159894204
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4818763214411968,0.6225715290666529,0.3719632641821828
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6328686148788182,0.804089277184241,0.466954212332715
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5395554638011859,0.7242894747812885,0.3680962931964479
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6207331394866346,0.7672364839375087,0.4947974341327439
6,Incidence,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9032421210765549,3.036681982285355,1.0558479267869287
6,Incidence,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7074868248223711,2.7641248996389405,0.9795512785236222
6,Incidence,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8101722218413516,2.5589726108714905,1.1605655806704804
6,Incidence,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7033996329938714,2.7600478155780364,0.9167573227387342
6,Incidence,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.445772969388581,2.4224191250047187,0.78561305832124
6,Incidence,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5776308977750195,2.2485623612126355,0.978126225651198
6,Incidence,5,East Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4179499867839709,2.361929435667829,0.7122021726389911
6,Incidence,5,East Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2204905849059329,2.087070941003237,0.623488962532103
6,Incidence,5,East Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.322972455006142,1.9419532649705664,0.785988165466684
6,Incidence,5,East Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3542294492673754,0.848705530522381,-0.0050177472629367
6,Incidence,5,East Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.151668492359229,0.5977814691827414,-0.1593833012059919
6,Incidence,5,East Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2489849341778494,0.5850093090827944,-0.0224367888750005
6,Incidence,5,East Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2459095262297223,0.6999702135505845,-0.0908979209128642
6,Incidence,5,East Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0694614568444967,0.4814520477445477,-0.2138720877804001
6,Incidence,5,East Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1541469203116174,0.4657957562806122,-0.1002659823350081
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2900806018361212,0.6731047524681173,0.003681919856979
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4216841565865128,0.8054480519867764,0.1456872550012351
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3114883225305754,0.6816913185755336,0.0374123801938418
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2571574604712685,0.6481792481198616,-0.0355268634820255
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3868206015731742,0.7729446667457401,0.1171778657987682
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.278561739983245,0.6342620375969108,0.0097176004689536
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2123351677612,0.5722767460254795,-0.0568039803428813
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.322566958435814,0.6795755426178669,0.0658120519566008
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2261547689695328,0.5722700650718004,-0.0300880949452303
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2856220217666866,-0.0786401417803016,-0.4392103324144276
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3019497595476446,-0.1354271477001214,-0.4148729998470022
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2701773642732376,-0.0731938281729232,-0.4176413257073076
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2849329881431424,-0.0781899645798435,-0.4370621653075982
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2996855144664049,-0.1355146968314151,-0.4127354274965775
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2688726149170179,-0.0763696718814715,-0.4180359940860875
6,Incidence,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0520574223251677,2.627357359200559,1.6236071540845156
6,Incidence,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8186407108847904,2.3065632765736046,1.3681230018673924
6,Incidence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9340645194236563,2.323433934875135,1.542066133411805
6,Incidence,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1490088571498829,1.5712509472394485,0.8483843525696035
6,Incidence,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9396720862961998,1.2677608482300875,0.6286636940383584
6,Incidence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0417852637734444,1.321253184154255,0.7768690544326047
6,Incidence,1,Global,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0702782271533693,1.460516931275934,0.7796509095713535
6,Incidence,1,Global,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8981424028935112,1.226721532431387,0.5947526294335516
6,Incidence,1,Global,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9830813114997796,1.2462490796043102,0.718136669590241
6,Incidence,1,Global,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4203641369463285,0.6790842640713581,0.2410075921737806
6,Incidence,1,Global,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3030095408142325,0.5234613436496506,0.1017462066882966
6,Incidence,1,Global,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3580551167824592,0.5354445184316112,0.1905124938811829
6,Incidence,1,Global,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4160810684859378,0.6764625702866891,0.2315003212961423
6,Incidence,1,Global,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3114831583988216,0.5306819053831306,0.1049806294598104
6,Incidence,1,Global,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3607445175454121,0.5343227826909549,0.191402735839732
6,Incidence,21,Oceania,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9122331056131636,2.0463754801840603,0.369868907408578
6,Incidence,21,Oceania,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.949697607112416,1.809270440265222,0.3517958203584357
6,Incidence,21,Oceania,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9240825508101606,1.8902822831007464,0.4388328658084381
6,Incidence,21,Oceania,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0610786412347434,0.4888997796665799,-0.3173424133438566
6,Incidence,21,Oceania,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0686136100674618,0.3512013587863504,-0.362649772489437
6,Incidence,21,Oceania,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0678940871711878,0.3876691893576173,-0.3040550791977839
6,Incidence,21,Oceania,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0979180983423638,0.4371052243897046,-0.3537744193480248
6,Incidence,21,Oceania,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0861144557775396,0.3167947869476078,-0.3663701209565639
6,Incidence,21,Oceania,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0951305219145931,0.3592598820293088,-0.3233367540347966
6,Incidence,21,Oceania,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2502004787682938,0.1925976429510652,-0.4462690380304362
6,Incidence,21,Oceania,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2347421755809876,0.1048684181524958,-0.4759423233014623
6,Incidence,21,Oceania,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2455800539050679,0.1161023550888828,-0.4407238407865116
6,Incidence,21,Oceania,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2515869483784099,0.1866966207846044,-0.454312852072241
6,Incidence,21,Oceania,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.226053343044112,0.1103275235565406,-0.4724866984522051
6,Incidence,21,Oceania,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2418701088320639,0.127915284664962,-0.4323843732096072
6,Incidence,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9999677509123586,2.2162010299874204,0.430004800827352
6,Incidence,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.050921050427586,1.964983839201972,0.3777339224546842
6,Incidence,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0256378804331958,2.0031436876542683,0.4690856588155738
6,Incidence,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.018417996664874,0.6037775127289731,-0.3044266719244647
6,Incidence,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0202262611974454,0.4237168508388925,-0.34160218566577
6,Incidence,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0190506242457195,0.4446963731710058,-0.2854938520938697
6,Incidence,21,Oceania,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0565299247768937,0.5172191783145563,-0.3254057539725271
6,Incidence,21,Oceania,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0386677946929188,0.3897826307090818,-0.3542121040087793
6,Incidence,21,Oceania,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0473704514986438,0.4123370435010605,-0.3091092828655029
6,Incidence,21,Oceania,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2287724339340814,0.2374579458157457,-0.4341930591314785
6,Incidence,21,Oceania,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2136708443090019,0.1389027202181176,-0.4745761793801037
6,Incidence,21,Oceania,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2194984220859021,0.1402024044527133,-0.4329820597258491
6,Incidence,21,Oceania,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2299933947239344,0.2275440815805586,-0.431173189065162
6,Incidence,21,Oceania,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2047879101613522,0.1506955703930581,-0.4664199395697301
6,Incidence,21,Oceania,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2154799767417812,0.1442130144684723,-0.4322366727601304
6,Incidence,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0586826666431766,2.293724503777158,0.4800466300287654
6,Incidence,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0605509066488863,2.1000687935036773,0.3634389707222338
6,Incidence,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0590725281818176,2.1238052663521536,0.5280333536112789
6,Incidence,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0109655840700024,0.6110093941235863,-0.269581691902258
6,Incidence,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0153395549264842,0.4858451735230568,-0.3508729560026471
6,Incidence,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0021885606983622,0.5135209786150956,-0.2686736822941794
6,Incidence,21,Oceania,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0288315951733296,0.5537903068313008,-0.3017988891421209
6,Incidence,21,Oceania,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0341539734924007,0.4531012635719074,-0.3609126044843338
6,Incidence,21,Oceania,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0316465979428178,0.4690825192579839,-0.2813869952735968
6,Incidence,21,Oceania,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1935050660017433,0.2720759468798084,-0.4159449365689424
6,Incidence,21,Oceania,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1955383164460004,0.2104309261180123,-0.4640984076246804
6,Incidence,21,Oceania,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1933133535547527,0.2191649313182652,-0.4074279303294219
6,Incidence,21,Oceania,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1951047741535436,0.2784716528443776,-0.410911266942953
6,Incidence,21,Oceania,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1866093749751078,0.1986691568674191,-0.4573937428911752
6,Incidence,21,Oceania,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1895782089025351,0.225396045893135,-0.394517953199577
6,Incidence,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9334139727564792,2.1082721301688503,0.3638676761889896
6,Incidence,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9330904299235796,1.8784508559341868,0.3214401492678322
6,Incidence,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9332356527329764,1.8453552992179076,0.4094693365000359
6,Incidence,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0509181147020847,0.547231416976466,-0.3306554144170045
6,Incidence,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0768718687475054,0.3748468103865512,-0.3718524347261304
6,Incidence,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0639301406224528,0.3831477091616124,-0.3288626000111326
6,Incidence,21,Oceania,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0879261800687428,0.4663045137235291,-0.356605456032288
6,Incidence,21,Oceania,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0938987701798632,0.3492218574802551,-0.3805987935946561
6,Incidence,21,Oceania,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.090825944360853,0.3381313413433084,-0.3371460167552821
6,Incidence,21,Oceania,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2436312752276939,0.2107593908033873,-0.4487740467154421
6,Incidence,21,Oceania,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2392763587742864,0.1099009075651401,-0.4853439604349598
6,Incidence,21,Oceania,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2404505329642377,0.1105826136234296,-0.4501510659404316
6,Incidence,21,Oceania,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2449159021727417,0.2139114930265544,-0.4547695825270728
6,Incidence,21,Oceania,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2305187144842585,0.1251155635346609,-0.471160557957866
6,Incidence,21,Oceania,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2364993960275437,0.1167476431433363,-0.4390859003484069
6,Incidence,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4409664731218702,-0.2388111657912213,-0.5527648963182016
6,Incidence,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4110485819584073,-0.1534438518491336,-0.563928319371386
6,Incidence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.426869333194204,-0.2124540023343311,-0.5504088721884601
6,Incidence,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6063020846290431,-0.4652823805915354,-0.6863727305735086
6,Incidence,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5946879060946899,-0.4172368861320346,-0.6992255790439328
6,Incidence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6011167503529462,-0.4529437549016981,-0.6857079805261097
6,Incidence,1,Global,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6207951624767164,-0.4836687348385034,-0.6966305119955044
6,Incidence,1,Global,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6033855412958643,-0.4299081415272145,-0.7063385395287285
6,Incidence,1,Global,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6126313150696369,-0.4677118585572152,-0.6961294622265817
6,Incidence,1,Global,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4691939579625256,-0.2745931648509209,-0.5766873506085968
6,Incidence,1,Global,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4419078439545827,-0.1968897787521312,-0.5870558727541193
6,Incidence,1,Global,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4565181943864626,-0.2525683659291156,-0.5718055843689107
6,Incidence,1,Global,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4708842050327968,-0.2780170272402478,-0.5767128520150947
6,Incidence,1,Global,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4383100085118013,-0.1915255078624069,-0.5843877998100998
6,Incidence,1,Global,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.455506412765719,-0.2508689994620334,-0.572998596230635
6,Incidence,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2984745355897881,0.563724868853717,0.0716284034986718
6,Incidence,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4152272589004577,0.7068510070556884,0.162300022431607
6,Incidence,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3294331897414575,0.5881337354341667,0.1154970743656389
6,Incidence,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0837660158507775,0.1046873458443265,-0.2452170608528706
6,Incidence,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0073809628514684,0.202375665827959,-0.187216707408044
6,Incidence,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0648355122429526,0.1188181975044672,-0.2164028826183757
6,Incidence,32,Central Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0730277710447395,0.116332656069921,-0.2349716974990744
6,Incidence,32,Central Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0371296608626823,0.2508420785126403,-0.1482245550995501
6,Incidence,32,Central Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0382363837291069,0.1489176412167139,-0.1930060807417171
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3428072941016295,-0.202093770983726,-0.4590657791383478
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2190120837152376,-0.0520367553838546,-0.3618472805132666
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2919539288856804,-0.1470616631815216,-0.4060046726083343
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3156173110773845,-0.1708143789073727,-0.4331145218204232
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.173655728426784,2.81061325954e-05,-0.3218344116810875
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2566830717937521,-0.1176929430203975,-0.3764436919072014
6,Incidence,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3391604194571405,2.065261648139315,0.7942285324819927
6,Incidence,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2212135309629717,1.923744178641732,0.5510121447638687
6,Incidence,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3046181588616157,1.922427308920387,0.7512857648012652
6,Incidence,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.745588385476799,1.2850566300837012,0.3421979094529963
6,Incidence,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6366944446580702,1.1486950930198452,0.1394071391765914
6,Incidence,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.708918909099429,1.1743948914574582,0.3017908920270142
6,Incidence,9,Southeast Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5467944189136594,1.026936489867728,0.1864524797931
6,Incidence,9,Southeast Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4926556812976023,0.9647563361539436,0.0422802928990268
6,Incidence,9,Southeast Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5363148413495754,0.948161533916508,0.1674499315918903
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0127987718981577,0.3325432611223355,-0.2282398198879299
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0665692021521689,0.2349970449402777,-0.3580543031881282
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0176439483279612,0.2424390983451022,-0.2567292814790535
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0431249798779828,0.2599371326905819,-0.2703332062284376
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1021030376469868,0.1917418513314533,-0.3812278292582339
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0634533571310683,0.1812886257171358,-0.2918971653510441
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6067677629576848,0.7411758144573837,0.4650910003633156
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2289243676027986,1.518203247072177,0.8357003383652757
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7965718178910164,0.9603913227009652,0.609775681513951
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5655419471973903,0.7106411683694301,0.4251947281913222
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1735535663818937,1.4842208692275751,0.7998918743327752
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7512142967572509,0.9150308976036852,0.5493856299223706
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5099374897089025,0.636245572654595,0.3767987373679668
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0735278702984654,1.3426387596525002,0.7077186953680579
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6796757275373886,0.8328361206740683,0.50503370479953
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3482869641458547,-0.3001347158661637,-0.3963189203071563
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2216867345793691,-0.1316149038393296,-0.3247050220446072
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.309530573856341,-0.2562067489436764,-0.3667699405726458
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3475972718916639,-0.2984841692009132,-0.3935301326679701
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2189566367678349,-0.1318647122582764,-0.3211579351651727
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3082262589675921,-0.2572310132894245,-0.3646476999643487
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5371135839029557,0.8350558788377784,0.2815303113675024
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7413111245022521,1.103750122502614,0.3906856667194002
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5716712296139322,0.8500542680303076,0.3194401402778445
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4978044151208874,0.7731480655837342,0.2480729944553824
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.698172788951331,1.0450095593317277,0.3471064912522283
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5320988644574841,0.812151338248883,0.2834261162661717
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4444809510016347,0.7244680476209272,0.2043001521079671
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6199101234643631,0.9570805427752132,0.2937296261284144
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4694085645573161,0.729678278202829,0.2335891922009793
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2835475301199223,-0.1657900419916654,-0.392611426255209
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2363959429695882,-0.1076614700812089,-0.3540948296691991
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2550850505470257,-0.1343164117109397,-0.3645596837845798
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2827720618498798,-0.1632193212412976,-0.3896374677473125
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2337105728816111,-0.1051315397710981,-0.3512355303245582
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2536622937687963,-0.1356334546047445,-0.363155835381227
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3116175829658728,0.568499778653837,0.1156179495755548
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6335798741155652,1.0759686918753686,0.2746437683844195
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4488612984556986,0.7340172871824604,0.2151613177012585
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2780626800661652,0.5253618527185486,0.0879126506414263
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5930000535991479,1.0240100875147828,0.2285352272974075
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4123414697001147,0.6943349906941336,0.1829637051878161
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.232574243981586,0.4739756877061013,0.048386335032956
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5196896972239119,0.931235982268967,0.185777954991764
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3545894081991952,0.6211913820565638,0.1360953957193657
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.3513926040697944,-0.2403758082413809,-0.4373823549110941
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2832099009174933,-0.1426236890653872,-0.4058426299544165
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.3217316593035063,-0.2166113583216313,-0.4082429838820995
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.350745052348295,-0.2382191655653537,-0.4373893128948825
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2807046273892902,-0.1423575623713848,-0.4025958000009513
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3204792846697629,-0.2143586639825707,-0.4104225733404897
6,Incidence,42,Central Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5566691912112284,0.7778045775670194,0.366253182238443
6,Incidence,42,Central Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.2006641919124633,0.3470442906984911,0.0704452547474643
6,Incidence,42,Central Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4130009218092521,0.5988439689813407,0.2563527857677045
6,Incidence,42,Central Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5895957216009149,0.811474648849323,0.3969079021533944
6,Incidence,42,Central Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1997628486276245,0.3520911671192346,0.0664506333032848
6,Incidence,42,Central Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4265379991003766,0.6156837426269138,0.2701227599523698
6,Incidence,42,Central Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6979284147495178,0.9391306291441937,0.4902331933861917
6,Incidence,42,Central Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2967909081661917,0.4548903855394856,0.1561464757561114
6,Incidence,42,Central Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5334830066397633,0.7351722980916391,0.3634779833352343
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-7.46483504652e-05,0.1400402446861495,-0.1200769704771939
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2591250168067892,-0.1658536580261103,-0.3402031251423308
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0978888604491385,0.0221899118355872,-0.1971918699853483
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0661235580872406,0.2196496223525925,-0.0616603570160944
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2059927358936794,-0.1066241552820656,-0.2924952974743418
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0363587632859071,0.091961448120031,-0.1435681518127592
6,Incidence,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.18266519328936,1.4054005133665508,0.9767053911442852
6,Incidence,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9414668252729848,1.0660234605557726,0.8043465854995739
6,Incidence,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.115390550283169,1.286248458038853,0.953178189569714
6,Incidence,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8583047555004515,1.0691735493601549,0.6829136610374051
6,Incidence,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7028671245654171,0.8198490952442204,0.5792428313457829
6,Incidence,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8306861764528798,0.9923832862993432,0.6911988521788992
6,Incidence,73,Western Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9010307476000108,1.0950260031917067,0.7216464252352308
6,Incidence,73,Western Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7211607450176158,0.8315834359384735,0.5996000925391952
6,Incidence,73,Western Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8591747914140505,1.009338417213832,0.7166095654070388
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3799610338579439,0.5000358691673218,0.2736559205404432
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3655454940956041,0.435252039513155,0.2863034590575655
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4136201102995742,0.5153926987057732,0.3203573047873366
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4087085726861857,0.5310441707876317,0.3018177229635845
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3855288841699524,0.4606844742195778,0.3061236758716325
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4376873935613066,0.5418014426537016,0.3446143536837471
6,Incidence,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,4.072480821462873,5.054033170955513,3.276898527710636
6,Incidence,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,3.845008415164059,4.607545341567765,3.1562596059926724
6,Incidence,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,4.027509673387111,4.82781677306048,3.32513836137539
6,Incidence,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.448067565839608,3.099319377347661,1.9239667382903456
6,Incidence,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.255160354203096,2.796620803246565,1.7885717072479488
6,Incidence,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.396417000383658,2.960799485721806,1.923033378116075
6,Incidence,70,Australasia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.333174238359686,2.97816139949138,1.8103897273153864
6,Incidence,70,Australasia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.1623838473150063,2.660099073462584,1.7128308388694484
6,Incidence,70,Australasia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,2.29245287255711,2.816563929606992,1.8324787314677469
6,Incidence,70,Australasia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.509314824507724,1.9807008292899295,1.1281292691552336
6,Incidence,70,Australasia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.4109474881080593,1.7762288460011413,1.0890864967932894
6,Incidence,70,Australasia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.5008226711565238,1.880856872031141,1.1859973653954123
6,Incidence,70,Australasia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.459188148301756,1.9168394841788448,1.0880929702356965
6,Incidence,70,Australasia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.3979461439543823,1.777393083255406,1.0802078809182087
6,Incidence,70,Australasia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4697741257115915,1.8343216804604012,1.151992213060296
6,Incidence,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7867367119412214,2.3434009280853587,1.28108808766921
6,Incidence,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.176255416462314,2.8378784776358703,1.6602324539166102
6,Incidence,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8660265596869376,2.342185728577548,1.4497835850930585
6,Incidence,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8020215748832211,1.1680381956879349,0.4764937547083737
6,Incidence,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9453280029866132,1.327004391096256,0.6392436786919805
6,Incidence,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8032458428793299,1.1094630241778116,0.5316257141750014
6,Incidence,159,South Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6830696644913685,1.0192710183851292,0.3776795439402341
6,Incidence,159,South Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8417321219220891,1.225370175100116,0.5425193883226167
6,Incidence,159,South Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.697064660083566,0.979013512011615,0.4505940752930029
6,Incidence,159,South Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.252804472228595,0.5062907337348713,0.0201729509426493
6,Incidence,159,South Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2742108203085671,0.5130974370064727,0.0724096963077506
6,Incidence,159,South Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.209775513237496,0.4135922034454759,0.0305377206534114
6,Incidence,159,South Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2316724709266529,0.4789752313030689,0.0109800239398538
6,Incidence,159,South Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2588105336822151,0.5125386986459788,0.0526972882562857
6,Incidence,159,South Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1936441659027374,0.3905368766707315,0.0173802634806762
6,Incidence,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.125830367122655,2.780010672475294,1.558261367071028
6,Incidence,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.825941486853249,3.614298407660197,2.169972503044562
6,Incidence,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.4459570548613896,3.004605013316218,1.9580947241234472
6,Incidence,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0212480202453167,1.429514917169716,0.6593164665300192
6,Incidence,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3432049834339563,1.818310506552853,0.9537598512050184
6,Incidence,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1680831164407877,1.51586948811048,0.858324890808185
6,Incidence,159,South Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.887867714487212,1.2829646112729,0.5450803379836117
6,Incidence,159,South Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2184485845852289,1.675572484969445,0.8380890133103719
6,Incidence,159,South Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.040459785065535,1.3712528492530076,0.7515811221365347
6,Incidence,159,South Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3076852516611312,0.5905033274170486,0.0780847572758098
6,Incidence,159,South Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3575486311012357,0.644054010955671,0.1292014965408182
6,Incidence,159,South Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3283358482576113,0.5557824330128613,0.1449694743103957
6,Incidence,159,South Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2856481601556831,0.5530882080231381,0.060264272649159
6,Incidence,159,South Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3411455440700929,0.6244632686107803,0.1179397825588026
6,Incidence,159,South Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3106369631580312,0.5269360222623072,0.1280980830157987
6,Incidence,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.694095546552705,3.3999720006778427,2.0371729658369784
6,Incidence,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.407273702665596,4.301491673231993,2.658351027337881
6,Incidence,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.8275264839296823,3.4569455082909406,2.215233154174688
6,Incidence,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3891350779095204,1.8563855527309303,0.9547086262138756
6,Incidence,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6997414689146522,2.22313596988689,1.2437139983005696
6,Incidence,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4085623144624375,1.7962913290387603,1.020781713052504
6,Incidence,159,South Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2310755535296107,1.6573947108888194,0.8343224398305973
6,Incidence,159,South Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5555304860660093,2.0740372635299047,1.121272289814541
6,Incidence,159,South Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2663990706773198,1.6390979136163204,0.9038408912982686
6,Incidence,159,South Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5918858982988934,0.8933892760278657,0.3210390062630633
6,Incidence,159,South Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6230179912970195,0.945599436624288,0.3593345230412874
6,Incidence,159,South Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5321352715221329,0.7859919886703848,0.2961656575090651
6,Incidence,159,South Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5649252603662915,0.8680041463391094,0.2977352282277157
6,Incidence,159,South Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6032664811160087,0.9325902920534036,0.3321119605860042
6,Incidence,159,South Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5116099593760177,0.7606017378321132,0.2773141447380869
6,Incidence,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8777105434926171,2.478345954704773,1.3919062937402495
6,Incidence,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.39324589359319,3.0651951446608736,1.8219545429260884
6,Incidence,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.117976586461634,2.6072297860348064,1.704851172539612
6,Incidence,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8608609868821858,1.2369954370615277,0.5483286108476819
6,Incidence,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0782517083574596,1.4649174351990957,0.7420800928999803
6,Incidence,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.96180670335617,1.245476295939825,0.6902580749420173
6,Incidence,159,South Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7380139638543561,1.100772037015234,0.4446089959090196
6,Incidence,159,South Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9675527123607062,1.357178343088858,0.6362929446334125
6,Incidence,159,South Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8462522121323347,1.135954452337376,0.6016276332777568
6,Incidence,159,South Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2975769679103297,0.5513993097883232,0.0795143736724674
6,Incidence,159,South Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3804188780534879,0.643194475796049,0.1556258440322913
6,Incidence,159,South Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3311752095869128,0.5303955828154361,0.1516392896295783
6,Incidence,159,South Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2756802035407718,0.5368810426075097,0.0589497874462625
6,Incidence,159,South Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3636939112433563,0.6273023472837512,0.1366806297345939
6,Incidence,159,South Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3133866946600148,0.518199515223276,0.14146165358826
6,Incidence,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5531707254626619,-0.1820628609409954,-0.7466877336008287
6,Incidence,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6575609678238634,-0.3083432430251908,-0.8124709183053931
6,Incidence,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6062167613601404,-0.3041718593165464,-0.7625087086766456
6,Incidence,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7084705808553688,-0.4665575741248944,-0.8345773618216199
6,Incidence,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7766758207001302,-0.5513036847435576,-0.8790515764693431
6,Incidence,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7431268747484625,-0.5468259661182552,-0.8446623670194835
6,Incidence,120,Andean Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7453187856215389,-0.5337968308444295,-0.8556185118123673
6,Incidence,120,Andean Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.801715230666678,-0.5995053494835194,-0.8914137781817499
6,Incidence,120,Andean Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7737725342329544,-0.6002485087482881,-0.8635618591502257
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5952259748464237,-0.2595837295821375,-0.7702188380717083
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6800865818112227,-0.3619053622935497,-0.8248391853816547
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6374749808738878,-0.3651707202969665,-0.7791064702314783
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6213006424889832,-0.3067181448788065,-0.7847806399607717
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7037992960857683,-0.3996774790901676,-0.8377301990231529
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.662914912767583,-0.4043470493493636,-0.7967964653341222
6,Incidence,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.2375292173139993,0.449937667552527,0.0765173538850318
6,Incidence,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,-0.1017340776226499,0.0291353136190838,-0.2187177100556769
6,Incidence,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.1300375066534382,0.3129018912132862,-0.0105640456076721
6,Incidence,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2636249258230154,0.4797893855968638,0.0931390803733334
6,Incidence,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1024561238586203,0.0266617706899595,-0.2216613743135113
6,Incidence,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.140783594804166,0.327820257216825,-0.0053382436887624
6,Incidence,42,Central Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3498282319862876,0.5815115884946048,0.1742054217120665
6,Incidence,42,Central Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.02981775495526,0.1115292077197959,-0.1561672471490461
6,Incidence,42,Central Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2263922029858043,0.4248488507586219,0.0738020045140916
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1498629204672318,-0.0263981018850691,-0.2609554689227408
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3873728524837287,-0.304896050271359,-0.4606210472808371
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2166445416733965,-0.1078281126981823,-0.3124550948358838
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0935570634579578,0.042745797492906,-0.2114507662316904
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3434158115460361,-0.2598786893533633,-0.4218100289549752
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1631805575330017,-0.0458568951842877,-0.2652543955244302
6,Incidence,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.026699353509982,2.4032629754968013,1.6612913241236154
6,Incidence,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6583856144342048,1.952248098530616,1.3666440894447742
6,Incidence,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8370158908411027,2.133510906716963,1.576933492550304
6,Incidence,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.204482008121179,1.4888105151806017,0.9483082108897044
6,Incidence,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8536253492858445,1.0526280953277614,0.6571205889153814
6,Incidence,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0196686427209576,1.222170167048572,0.8311400812233171
6,Incidence,124,Central Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9922094641991904,1.2400681128374438,0.7516935591114597
6,Incidence,124,Central Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7062991311462422,0.8949163500206028,0.5190432613033379
6,Incidence,124,Central Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8435752709272731,1.036246338081528,0.6745661795646537
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1615659122368155,0.3077551721319436,0.0237339985613224
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0871591622800655,0.0108269708763775,-0.182184108351611
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.026757141999915,0.1287831496045238,-0.0663445731672794
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1150417001673273,0.2545998153610674,-0.0172095021565245
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1207773520058072,-0.0243970381944107,-0.2151825713210554
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0124099406682437,0.0920217271837498,-0.102406208302552
6,Incidence,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.056143495697432,4.394409916260687,2.031664028738136
6,Incidence,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.6103286211994376,3.7533325121543895,1.714564302950215
6,Incidence,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.7159959862556406,3.8129214482059743,1.8163403352598413
6,Incidence,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6468857126445748,2.495578196230489,0.9623392670389208
6,Incidence,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.35457789337072,2.092652795998551,0.7716806355018593
6,Incidence,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.424089668210111,2.1520644934934285,0.8422284082120055
6,Incidence,120,Andean Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.311897653185648,2.074675153616601,0.7279706599931088
6,Incidence,120,Andean Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.09051279383305,1.752354002251482,0.5718323732853456
6,Incidence,120,Andean Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.134830211856639,1.7650110906809982,0.6179803360448362
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5381211697880466,1.049206572131176,0.1348267968657716
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3120396860911347,0.7153828649496747,-0.0138981351320645
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3717959029049081,0.7813595683730199,0.0426258278568101
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4388551304650745,0.9329306559533534,0.0789125705583942
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2147583293754099,0.5912071335560543,-0.086992719580212
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2755317564761804,0.6466020658187264,-0.0335504674820271
6,Incidence,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2830659109006843,1.584786052803442,0.983143968076795
6,Incidence,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.98622898342912,1.2418477017415983,0.7500056862014155
6,Incidence,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1527027189986352,1.423738026138032,0.8964508362382975
6,Incidence,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6629504960475747,0.8879997781581189,0.4324789276736235
6,Incidence,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3849660327212995,0.5750608498823104,0.2165062528493247
6,Incidence,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5325527126190343,0.7249296319567118,0.354846314404323
6,Incidence,124,Central Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5027410997436155,0.701336880834701,0.3053289146444102
6,Incidence,124,Central Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2748717756674704,0.438942027399603,0.1232505794694468
6,Incidence,124,Central Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3988887095120143,0.5750153189552327,0.2323687983227085
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0981315097994975,0.0231786687007738,-0.2147615543343011
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2837942325405589,-0.1980158546241903,-0.3688172995029509
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1887589469556417,-0.0923891957046427,-0.276913554748727
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1343630994487086,-0.0159009391432591,-0.2485157733963085
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3102202058561507,-0.2286548271795808,-0.3885123328199679
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2197794479826741,-0.1255139922187411,-0.2997360972469027
6,Incidence,32,Central Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4756421208462969,0.7808019273473095,0.2290253075985834
6,Incidence,32,Central Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6782136195714036,1.0053472561063534,0.4038152422746678
6,Incidence,32,Central Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5525305466514053,0.8545202381915667,0.3135978495330234
6,Incidence,32,Central Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.041420244577992,0.2611073551687046,-0.1362866515708092
6,Incidence,32,Central Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1773037037221623,0.4215427716025732,-0.0142511324768066
6,Incidence,32,Central Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0922884263123332,0.3079554429590834,-0.0775479088197825
6,Incidence,32,Central Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0534509752860497,0.2713025066534429,-0.1226071073395291
6,Incidence,32,Central Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2298555664293112,0.4695909130900797,0.0287665228165289
6,Incidence,32,Central Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1231609113120371,0.3416319860929227,-0.0496922840189922
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2375164896417384,-0.0745797762192654,-0.3648173349297141
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0118728652349681,0.1938497285360874,-0.1747831056466731
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1335587263442451,0.0341227697297073,-0.2673832292705383
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2060618450707978,-0.0415632218257953,-0.3351416335880529
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.045346213716204,0.2549628694403671,-0.1270747370860804
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0905109842228553,0.0790029017351198,-0.2291295568371852
6,Incidence,159,South Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.9773024897555416,2.5392234149700155,1.5106462817984945
6,Incidence,159,South Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.401469876446145,3.082227733608218,1.8415628559047248
6,Incidence,159,South Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.109279508225964,2.54917056530197,1.716517171713032
6,Incidence,159,South Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9253137361992886,1.2775823817733227,0.6274399917892945
6,Incidence,159,South Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0831555253264384,1.4877261504764192,0.7420761996605726
6,Incidence,159,South Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9563107856541556,1.237092883905041,0.6996224154894556
6,Incidence,159,South Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7981632355327756,1.1375394166477126,0.516322865040089
6,Incidence,159,South Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9723213381179144,1.3670545847856792,0.6476627040306842
6,Incidence,159,South Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8411023979863874,1.1015757577769003,0.6085354390881599
6,Incidence,159,South Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3588167321104622,0.6094109712403305,0.1414889309308217
6,Incidence,159,South Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3877802756834413,0.6436497712901879,0.1804618389774244
6,Incidence,159,South Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3355689417731637,0.5298835262175836,0.1557783012632723
6,Incidence,159,South Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3358830262446081,0.5925556633892817,0.1214643629944736
6,Incidence,159,South Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3710249567500573,0.6339704187909687,0.152296878331537
6,Incidence,159,South Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3177563357240465,0.5148992741417022,0.1432625239575517
6,Incidence,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.5882846612635206,3.474609131507665,1.7835976660901387
6,Incidence,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.3885898222828867,2.8541193076846234,1.9392691206481856
6,Incidence,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.534142365092402,3.199574759510853,1.894132674323726
6,Incidence,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.8303518718006528,2.539443136063034,1.2002430999128133
6,Incidence,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6319720458054885,1.9963641376693293,1.266080215602042
6,Incidence,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.7643115691416835,2.300282254687022,1.2596661728284737
6,Incidence,96,Southern Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.6320286723853157,2.282153074137173,1.0417858562409184
6,Incidence,96,Southern Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.474213559805018,1.814124680854796,1.1461374482098086
6,Incidence,96,Southern Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.5862661536135787,2.0732259592515985,1.1179105441823105
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0630003023862975,1.5440153118997255,0.5979526687335324
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9339809834897134,1.1936405741064104,0.6753494724451884
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0252354730538302,1.4069142044566427,0.6543518391608576
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9987864888892826,1.467533141946509,0.564131399609451
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8735762982962154,1.1181556787626212,0.634598113854435
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9614376448000924,1.32404249751712,0.6142660915253046
6,Incidence,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6897079832672857,0.917361844622697,0.4700576981086003
6,Incidence,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.5434074143499472,0.6894771419331367,0.3894499060097732
6,Incidence,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6294786773549986,0.8167069367031277,0.4475938324099757
6,Incidence,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.3820698959132658,0.558522717148269,0.1952020666917838
6,Incidence,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.2512114170559558,0.3689881717705433,0.1199337385446469
6,Incidence,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.3264699338134381,0.4760806674486484,0.1721928215730621
6,Incidence,100,High-income North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2772837479393563,0.4493718129449101,0.1112457447804066
6,Incidence,100,High-income North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.1797083210252975,0.2913571776250713,0.0620304143465067
6,Incidence,100,High-income North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2387414539604291,0.3810737283439429,0.1004712817810093
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.9136030162991554,1.17299370490229,0.6634865319634786
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.7152860376940904,0.8761994651764704,0.5362020351642471
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.8262268912292514,1.0389109431894474,0.6154108604775228
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7970906368687092,1.0401920348102598,0.5621640290190952
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.6451821930915199,0.801806673614244,0.4809245208953063
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7341423548086803,0.9343229580563917,0.5393055142188619
6,Incidence,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0166322708928672,1.7542988347813644,0.5184714383126119
6,Incidence,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9056879439333992,1.5408884550713533,0.2934847992091572
6,Incidence,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9927588498138308,1.621158640346796,0.4916950553431849
6,Incidence,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5050180996605321,1.0527138953858135,0.1322168233632923
6,Incidence,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4043171607840392,0.868800808331307,-0.0470188922016044
6,Incidence,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4777949990023719,0.9406980204469136,0.1090340694501697
6,Incidence,9,Southeast Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3335192899434303,0.8213090603888236,0.0041052022446728
6,Incidence,9,Southeast Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2806224600384698,0.7074772574258048,-0.1307781051673134
6,Incidence,9,Southeast Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.328421797089349,0.7473284696696054,-0.0055995855627912
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1340567640534369,0.1811437513436415,-0.3507750389957741
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1958377631226569,0.0756825039651507,-0.4555392928186165
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1518092714407765,0.1176775150180145,-0.3617400013228051
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1819690533562528,0.1206720333446728,-0.3838059774800822
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2265207818895812,0.0372330422715006,-0.476787462672723
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1914562965882583,0.0625249454256783,-0.3948567438488377
6,Incidence,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3318661554912363,2.67162205469463,0.7227211900424795
6,Incidence,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3126180508224554,2.354516075368246,0.5877601984681813
6,Incidence,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3223673516126242,2.380332338868567,0.6952613490727445
6,Incidence,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1448125956287922,0.8022302806471984,-0.1512222443704957
6,Incidence,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1046806047590092,0.6041889888769068,-0.2533917776597857
6,Incidence,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1247490197905773,0.6209900197946066,-0.1799076823067625
6,Incidence,21,Oceania,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1000407062203366,0.7320606967553822,-0.1873189505098976
6,Incidence,21,Oceania,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0839979483201496,0.5723688319447906,-0.2557660799405226
6,Incidence,21,Oceania,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0921773249757209,0.5897236622926038,-0.2027419761652586
6,Incidence,21,Oceania,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0947388630387245,0.4066869057415382,-0.3275097345092013
6,Incidence,21,Oceania,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0957739662548216,0.3060200248810465,-0.3788952197262465
6,Incidence,21,Oceania,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0936642892739325,0.306706307450978,-0.3392345340784485
6,Incidence,21,Oceania,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0963745517992556,0.4136085110315312,-0.3311545670691806
6,Incidence,21,Oceania,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0854686649977351,0.30681860161175,-0.3735125378118354
6,Incidence,21,Oceania,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.089068319405374,0.3126777211179981,-0.33319969304772
6,Incidence,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.533041747170744,7.41774206595668,2.2906676642815684
6,Incidence,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4886589640475183,5.628318386599932,0.7814438107409547
6,Incidence,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.355403615619931,6.128568905777579,1.4295392252866748
6,Incidence,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.367241534389027,4.167325554002101,0.9522972903591108
6,Incidence,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0710434376872624,2.94059465175129,0.0499216444202506
6,Incidence,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6168504286080163,3.306439879553474,0.4574352669541749
6,Incidence,254,Northern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.1552129645149827,3.800211188001722,0.8765008020336238
6,Incidence,254,Northern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0159625357987685,2.8302515896333382,0.0294282184343201
6,Incidence,254,Northern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.499868664120606,3.091580849973967,0.394481318738018
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.172358007360814,2.2898151657599377,0.252914791954115
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3464914540626251,1.6246042846217872,-0.3278503415734744
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6955739525774637,1.8364207808281192,-0.0737645851249088
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.163222472266713,2.2235250728288976,0.2744364199538154
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3702458582600825,1.6611581007576497,-0.3133455844079994
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7069108113661421,1.803036136553478,-0.0546709489385931
6,Incidence,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,6.549797752347191,8.03679990304026,5.328052597653096
6,Incidence,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,6.296802549688027,7.587870535665168,5.189637249614714
6,Incidence,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,6.439590907151973,7.480694614307239,5.562543071881461
6,Incidence,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,4.132154072596058,5.161870660862245,3.289933609401205
6,Incidence,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.901712559818421,4.77786202645639,3.164005283824011
6,Incidence,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,4.025499837572974,4.759456215100337,3.440861986488356
6,Incidence,70,Australasia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.9610421919135352,4.938165109777258,3.158222108644553
6,Incidence,70,Australasia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.762693589542294,4.605386149551273,3.040036091094805
6,Incidence,70,Australasia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.872094544653546,4.55390027232783,3.297726944747775
6,Incidence,70,Australasia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.222415473501518,2.83278604598752,1.7214114914681162
6,Incidence,70,Australasia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.280662372598277,2.813163442693207,1.8195805342264515
6,Incidence,70,Australasia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2899014860536884,2.722947374827455,1.9237487688408392
6,Incidence,70,Australasia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.1577645518692856,2.7560632687238296,1.6633704147985957
6,Incidence,70,Australasia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.263293901493515,2.7951280200816866,1.7967552918881085
6,Incidence,70,Australasia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.2490564298263704,2.6667237917068283,1.882587346345329
6,Incidence,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,5.210911282029495,6.338491871562548,4.247589464767336
6,Incidence,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,5.062297875317021,6.1387708344267775,4.0774913072342045
6,Incidence,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,5.188466294457674,6.165890450236978,4.327564242703206
6,Incidence,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.221858093986083,4.032970246953839,2.563936734862861
6,Incidence,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.0721612969193783,3.797434540087547,2.4049320211148806
6,Incidence,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,3.180137299902844,3.881736379011575,2.6218920181351586
6,Incidence,70,Australasia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.0812474626622444,3.822191135983439,2.4482397535030698
6,Incidence,70,Australasia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.9569204500268,3.659544760710236,2.31412767924699
6,Incidence,70,Australasia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,3.052748766604148,3.6928515567464,2.488954837316748
6,Incidence,70,Australasia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.8297410831233176,2.3468634293532107,1.3912141965111282
6,Incidence,70,Australasia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.855073890433248,2.3175046711885976,1.44281003203813
6,Incidence,70,Australasia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.9000459373312373,2.369488455352874,1.5085115868492025
6,Incidence,70,Australasia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7730585487299528,2.252262842507694,1.3531876666698508
6,Incidence,70,Australasia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8404059031994295,2.27781864427271,1.4176571749381597
6,Incidence,70,Australasia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8643903440584515,2.3002051379048107,1.46496008038826
6,Incidence,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,5.539865307911163,7.2298863385290595,4.33903887854612
6,Incidence,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,5.117542506134765,6.531970432657635,4.036313765060016
6,Incidence,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,5.333461364038464,6.475130001472712,4.450181118549926
6,Incidence,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.4456662973659866,4.576682621945452,2.6096266880664585
6,Incidence,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.110450268025601,4.03106834096822,2.3902336242194733
6,Incidence,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,3.278803558325831,4.07625687193053,2.7166518455713544
6,Incidence,70,Australasia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,3.297406206926798,4.407934715522942,2.5083320122713606
6,Incidence,70,Australasia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.9929791548171103,3.916189941000167,2.2872506992532653
6,Incidence,70,Australasia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,3.147704214601579,3.8953686506793934,2.5692550876061784
6,Incidence,70,Australasia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,2.123041084858781,2.8982134942346303,1.5418318239108224
6,Incidence,70,Australasia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.977749566748156,2.591950361485236,1.486684321730852
6,Incidence,70,Australasia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,2.0612131385605594,2.5828001372547185,1.6925784553615082
6,Incidence,70,Australasia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,2.060299270964589,2.8090681063905456,1.488492395362703
6,Incidence,70,Australasia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.9613363693486512,2.559487243603769,1.4793489136848097
6,Incidence,70,Australasia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,2.022894841030391,2.5382138479215364,1.6585313002434194
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2391139742788487,0.1465204260947814,-0.4466498651880632
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4243812859699159,0.0762049908257769,-0.6265286028126986
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3342548871034214,0.0835989479664772,-0.5216899318402206
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5607766204835388,-0.3314821090810315,-0.6795899945250031
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6684883640123351,-0.3762019932749098,-0.784812676436877
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.616150218508383,-0.3787807872905487,-0.7259510862690898
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5912025907983393,-0.3840147355313658,-0.7027043553886871
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6821419159195296,-0.4057169301068913,-0.7937681665391307
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.637535653073583,-0.4100354964741038,-0.7395844999454064
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3625020659571437,-0.036147902715622,-0.5372192144667765
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5161428647750964,-0.0907170054659765,-0.6844726995682425
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4409641998757344,-0.0900440451640611,-0.6006547310254726
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3643188529719946,-0.0426615339581494,-0.5382481676295635
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5134135108672736,-0.0925446258389485,-0.6842633744015829
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4406457046978941,-0.0893030894041209,-0.5980385546015348
6,Incidence,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.567198263260866,3.303751959894065,1.930580803622778
6,Incidence,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.34756605774796,4.241608858204395,2.6457178849160083
6,Incidence,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.91433750181609,3.5384236281503183,2.3728412910716963
6,Incidence,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.306505081102208,1.7783708880078957,0.8968970139054073
6,Incidence,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6625096831213773,2.1642516767824245,1.2293356390455066
6,Incidence,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4626422428075476,1.8330648232756848,1.1336800616865732
6,Incidence,159,South Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1544350273185435,1.5992819257572486,0.7699453374202678
6,Incidence,159,South Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5209093762524897,2.0393145824080308,1.1139470400633442
6,Incidence,159,South Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3178026105583298,1.687343676488283,0.9971656367949548
6,Incidence,159,South Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5583887160027432,0.8748225809787599,0.275369125589419
6,Incidence,159,South Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6317708754916611,0.9694970650785124,0.3614423921916053
6,Incidence,159,South Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5844287815474113,0.827914376017866,0.3627144103793808
6,Incidence,159,South Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5322170464426778,0.8502645482744022,0.2627125954230195
6,Incidence,159,South Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6121255780656581,0.9453323027102288,0.3441907142372908
6,Incidence,159,South Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5633866271797627,0.8145752107304274,0.3463455261305577
6,Incidence,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4316709167176398,5.826263283622478,0.4189364876717066
6,Incidence,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1297623938847672,2.122038627213726,0.4801532901223972
6,Incidence,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3064975236033611,3.4998561868712628,0.4826742557222292
6,Incidence,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3692683285341937,2.870327834991916,-0.1989768480470203
6,Incidence,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.1851226907461914,0.7136475968524978,-0.1763041484559214
6,Incidence,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2908543842607367,1.4944173656356452,-0.1666049281606942
6,Incidence,261,Southern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2469733461894505,2.500542902507112,-0.2723620750250772
6,Incidence,261,Southern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.0905553296508053,0.5986552650472967,-0.2420802133242594
6,Incidence,261,Southern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1818962475382618,1.305817841684166,-0.2402475523051831
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2493797642861731,2.5133579963354813,-0.2758931054310432
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0430435393517226,0.5587777054170784,-0.2945567200475976
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1418527043094661,1.21777871779745,-0.2714728570683489
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2107619305331181,2.40667255004833,-0.2988970848147992
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0092642135512364,0.513207503111442,-0.3157508089184093
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1057913438935466,1.1662373580853038,-0.2928788497653355
6,Incidence,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8501300252969016,1.2303865453850449,0.495937664827759
6,Incidence,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3981914417011865,0.6547564069451455,0.1836490197710151
6,Incidence,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6863112089761043,0.963267009989959,0.4206265188160234
6,Incidence,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3933528730093082,0.6790924570441977,0.1119028361680836
6,Incidence,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0509284354797195,0.2396366368655824,-0.1159703838877156
6,Incidence,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2686783600465127,0.4866921754274267,0.0673554142852855
6,Incidence,104,Caribbean,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3734658441057773,0.6557537564138689,0.1105269680829923
6,Incidence,104,Caribbean,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0415182617858409,0.2326345057180056,-0.1182952256262739
6,Incidence,104,Caribbean,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2540200130512083,0.4599773211407836,0.0564444310064492
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0642375563682888,0.1276133913906892,-0.2484422142629351
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.312864958390451,-0.1903598033470497,-0.4112614416530439
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1596810018521088,-0.0165678995435913,-0.2982817002755098
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.04659915557401,0.1441115741190427,-0.22723702344875
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3019269139828496,-0.1821750998736101,-0.4027702775188887
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1454272287910869,-0.005864844242064,-0.2795902872897855
6,Incidence,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5923184348908788,1.8209982748962517,1.3617910008630476
6,Incidence,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.180452778188143,1.3260902549941262,1.01373295934116
6,Incidence,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4015286606408952,1.549292392263503,1.2307162675504406
6,Incidence,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2068850145892789,1.4115947110621332,1.0097910028159325
6,Incidence,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9124215042785724,1.0388815197016896,0.7561397386565939
6,Incidence,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0781524959746556,1.2079457363299686,0.9240582853325792
6,Incidence,73,Western Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2578254637721586,1.4569982038438103,1.057043529099073
6,Incidence,73,Western Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9330279968365424,1.0621394010690768,0.7852265490443426
6,Incidence,73,Western Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1106559004549903,1.240522512973067,0.9605322765916008
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4468972749123725,0.5708302864616639,0.3309453083548069
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3910292743193428,0.4681457466577338,0.3018791842005785
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4442903840983332,0.5282439550110998,0.3503218590676858
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4770694173329193,0.6018454466007259,0.3588931606556362
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4113602460883632,0.4927919236787917,0.3186844284260123
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4689170431820316,0.5542655462674635,0.3760350934468353
6,Incidence,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3758096269698066,1.611827121254331,1.1526370636441343
6,Incidence,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9139167537676928,1.0526422603533248,0.7599863522660532
6,Incidence,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2988463560149957,1.4892777160680302,1.1078070921961327
6,Incidence,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.02257536832696,1.2194016576665705,0.8297055164960081
6,Incidence,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6786049071493414,0.802577840722385,0.5468408729239145
6,Incidence,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9893088998149336,1.1530715048694966,0.823517382272507
6,Incidence,73,Western Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0692532987650707,1.2748168982515415,0.8748772184540832
6,Incidence,73,Western Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6967368913724895,0.8197206545559297,0.5602735940961294
6,Incidence,73,Western Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0204104598392096,1.1877768045824513,0.8525098405352284
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3847683507998606,0.5060217061182513,0.2631628585768825
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.314395171643867,0.3992176045152852,0.2189699826113141
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4623300717975109,0.5723471969715104,0.3443484843031378
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4136711469679121,0.5387575700366372,0.2889168318739166
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3336550222490274,0.4197085436093942,0.2402615152130843
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4872634196531671,0.5991679932359674,0.3677550039147193
6,Incidence,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6283864254796845,1.947677388770353,1.336692485355885
6,Incidence,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1749383058126035,1.3652541741486952,0.9659742674137386
6,Incidence,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3910905808817893,1.5789167754201154,1.189541916795878
6,Incidence,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2376310075348231,1.5048022230107572,0.9878102703794392
6,Incidence,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.907953112550254,1.0729524569081748,0.7338144931037233
6,Incidence,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0693725972215429,1.2300621779866263,0.8961163901967761
6,Incidence,73,Western Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2892395163370112,1.5673316124187011,1.0351835343344495
6,Incidence,73,Western Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9281392739087544,1.096859232174308,0.7428872287382593
6,Incidence,73,Western Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.101482079216026,1.2665587956673394,0.9243449564934396
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5999655047491743,0.7660250265230508,0.4398130752572825
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.503893486100738,0.6193814075702346,0.382640873639105
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5546873050272175,0.6549093198032996,0.448927411323342
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6332803175441586,0.8042015716072028,0.4734832240844802
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5256150253631859,0.6435574984943218,0.4056406701368399
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5810073372987217,0.6833314850937027,0.4727335540626645
6,Incidence,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7325471729334123,2.265402126040244,1.246055090295747
6,Incidence,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.0633957571565986,2.640011725140327,1.585094004360153
6,Incidence,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8023994974429132,2.262014323369823,1.3979927942823067
6,Incidence,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7605495715602856,1.106755280488267,0.452693328673812
6,Incidence,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8714694288915079,1.186192748447742,0.5850884451149394
6,Incidence,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7577913904569251,1.0510111747571569,0.4979498973599688
6,Incidence,244,South Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6425894670612153,0.9628993750161058,0.3501492198571963
6,Incidence,244,South Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7699637595767325,1.1031199847037645,0.4936113599189363
6,Incidence,244,South Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6524818961857842,0.9235014919842488,0.4140166965313961
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.233837575873147,0.4802101487653083,0.0157295505652284
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.230331078314619,0.4437353220554185,0.0417688523128064
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1867829951895235,0.3807220876393736,0.0140018259523254
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2114574951352993,0.45055310205519,-0.0035495852129746
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2138103563495391,0.438225377072636,0.0230929508216682
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1693639468247841,0.3577846969813572,-0.0009480851098929
6,Incidence,73,Western Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4539102055117412,1.6463252414812557,1.26586856641509
6,Incidence,73,Western Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.135201139280687,1.249088461502144,0.9794603281743488
6,Incidence,73,Western Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3464676291177098,1.4844873726814845,1.2055545946909576
6,Incidence,73,Western Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0890744436080306,1.2522904008980191,0.9298120199040784
6,Incidence,73,Western Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8727426318403576,0.9733133432922996,0.7365511402981175
6,Incidence,73,Western Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0305305807942209,1.1469878870868095,0.9068476973043924
6,Incidence,73,Western Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.1372763751718684,1.304863644535588,0.9734981929518453
6,Incidence,73,Western Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8929112441208341,0.993875312015833,0.7548429717280067
6,Incidence,73,Western Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0622638521008694,1.1835666668065734,0.938418181450212
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4255335856201806,0.5360157160629695,0.319913176941054
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.403996327390994,0.4685804884823569,0.3297931282937915
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4650538928145136,0.5486082529338554,0.38282735057379
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4552675485142021,0.5708708059681771,0.3498983422718273
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.424516563096998,0.4897578257205524,0.346893268325236
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.4900232493718227,0.5742855462820453,0.4073422454032531
6,Incidence,70,Australasia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,5.424794265369445,6.49008611175524,4.509982777102516
6,Incidence,70,Australasia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,5.729576013184207,6.722136579704477,4.811455624599969
6,Incidence,70,Australasia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,5.509637697400998,6.36397677726556,4.739474424046943
6,Incidence,70,Australasia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.3673364170151667,4.131076502540169,2.7484886497645773
6,Incidence,70,Australasia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.520971787159359,4.1950914299529884,2.888767541236576
6,Incidence,70,Australasia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,3.397388955304992,4.02340407487515,2.877356628391654
6,Incidence,70,Australasia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.2217919566060678,3.921805118545184,2.620660834977216
6,Incidence,70,Australasia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.392459343675185,4.040313224221896,2.793193287157699
6,Incidence,70,Australasia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,3.2630798801973127,3.822575801712429,2.7587096359956376
6,Incidence,70,Australasia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.9216731237161104,2.438023497614176,1.520349766297454
6,Incidence,70,Australasia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.105707141258101,2.525868925825595,1.710421678637542
6,Incidence,70,Australasia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,2.01384984199013,2.429163159274258,1.6695277153332115
6,Incidence,70,Australasia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.8631094539113933,2.326927021979173,1.4667616524094005
6,Incidence,70,Australasia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,2.0891610453725145,2.512531322137616,1.7011834301352362
6,Incidence,70,Australasia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.9765034426182075,2.350441777080459,1.6378527279776942
6,Incidence,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.92534827538288,2.462421528792905,1.4814470205221628
6,Incidence,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.292238195823056,2.9000622682042456,1.7734934726324476
6,Incidence,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.042207346590135,2.4736999009381826,1.6667009789637248
6,Incidence,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8848244111663762,1.2177748561926005,0.5997584329106989
6,Incidence,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.011182388228078,1.372931595296401,0.6998912035379143
6,Incidence,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9082194411497374,1.190180767454681,0.6619311791809201
6,Incidence,244,South Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7584861158942979,1.081331729624207,0.491648078157251
6,Incidence,244,South Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9021839672160964,1.2533715595471695,0.6024644946751851
6,Incidence,244,South Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7938886191175526,1.0483254455049835,0.5724649873436644
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3409862369141824,0.5838243330652444,0.1276760807412923
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.342216958805296,0.5842325985412398,0.1409810534447264
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.309826939040973,0.4995416085223424,0.1375071007731726
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3166526508029085,0.5562629216233403,0.1083475898788721
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3242062604944219,0.5590105173462043,0.1160046031765873
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2906004108635952,0.4800389647948658,0.1162588937635184
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.48310810614705,0.6773501516899952,0.3146418828666398
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.985110521599488,1.2815547093473958,0.6433429801755604
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6106393980204564,0.8140534288095613,0.4099291046032367
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4451283232613087,0.6385655432076278,0.2845801535004741
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.935886692395142,1.2376351636898075,0.6017371054260892
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5700366620960468,0.7646204044781377,0.3811139749024578
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.393730060055716,0.5762663004537403,0.2354162874340161
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8467122761039241,1.1224889216544285,0.5287721375302382
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5058412225603048,0.6960198765692953,0.3181903840229576
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3140357182060033,-0.2243368771502599,-0.3897277483061838
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.236708855281291,-0.1347574385185682,-0.3329140695066992
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2855079835019976,-0.2030354537262158,-0.3607317827424179
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3133266858487397,-0.2221285190886239,-0.3915717181213811
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2340627636208123,-0.1351001841993393,-0.3347719441945443
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2841752859316966,-0.2014735512194791,-0.3599372117382131
6,Incidence,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0684709939445133,0.5264883753181895,-0.4235903110014511
6,Incidence,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4571042519760314,0.0398154112313548,-0.6809426164443593
6,Incidence,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2778151822554041,0.1391841696240052,-0.5178286568266893
6,Incidence,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4330781242508401,-0.0546389241972339,-0.6466893146055348
6,Incidence,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6775367024347303,-0.38070527897112,-0.8120046063960686
6,Incidence,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5659576473375111,-0.3012492933529376,-0.7118623894692806
6,Incidence,254,Northern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4687962731835642,-0.1295211328473775,-0.6713028011165403
6,Incidence,254,Northern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6862813189423969,-0.3991304582100591,-0.8156289454925957
6,Incidence,254,Northern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5854879696777778,-0.3461430765929237,-0.7232483742234448
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2676575078245704,0.2243416024410137,-0.546223503323604
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.577934009145943,-0.1828635984553831,-0.7537135518349752
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4354478901574851,-0.0940517749662833,-0.6262920803568768
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2708085830982951,0.2037069801141862,-0.549237246413594
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.570684923242457,-0.1772761997761232,-0.74807875510006
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4318502768780252,-0.1026211544912361,-0.6202382034386584
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.237336778999659,6.009843700981508,2.4963761414476955
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.637149576450473,4.6103893096269895,1.2540071611146826
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.3410549047271485,4.990916843980434,1.9175897251385736
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.0223564259435363,3.028816604309009,1.0186805163845494
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.092939185585981,2.231357816665916,0.2929019638545835
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5014103045197804,2.451172160312063,0.6705698717124209
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.813837597217572,2.7661434787869386,0.8784804292648827
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0084430330460383,2.0980709164545783,0.2446683547160154
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3634835623015398,2.261749458281302,0.5884791849547686
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9513454698173864,1.603306951205389,0.2913622137230569
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3389275763518711,1.0925110072976034,-0.1851012712024081
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6049711044942041,1.2195275035430804,0.0643741048724411
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9462972460019532,1.5899327924883966,0.2910562396741366
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3474981924772145,1.0953219460190535,-0.1733004813853062
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6067517188445859,1.2243482902917933,0.0678820766963659
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.736640858327548,1.9975155770625443,1.4914164679285395
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.166841565669576,1.3175042504525298,1.0119904093950174
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.558133190868781,1.7625284016959213,1.376077061620008
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.015018218576616,1.2157905017813475,0.839157461140554
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5171175921950445,0.6294020866611041,0.4059823443431783
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.834662704949501,0.9826332804084924,0.7086790153507376
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.8568453003402644,1.033852083669772,0.6904574619596431
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4362069767491944,0.536067899877726,0.3335698875762796
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7151850971161526,0.8522286337013502,0.5931195374178745
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1649953043709789,0.2703272862141683,0.0642677331062042
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1472752287274388,-0.0911268161976342,-0.1978874059236994
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0462799816542261,0.1188485227543171,-0.0244470337469646
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.124843942648807,0.2234213218932783,0.029725710756479
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1639217344335972,-0.1122477357110726,-0.2144252095895553
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0184450242446168,0.0889161853020105,-0.0482339559672636
6,Incidence,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1258300599412765,1.568130851557952,0.7082770907552924
6,Incidence,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6339978930641402,0.8886107416967712,0.4091746393551576
6,Incidence,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8100883124161531,1.076252671731519,0.5539186852957015
6,Incidence,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6008207028783029,0.9370548860744954,0.2692201540031634
6,Incidence,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2282463985083544,0.4163804723574319,0.0545470654825549
6,Incidence,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3617810704823305,0.5678980855895462,0.1591195000846627
6,Incidence,104,Caribbean,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5781350163397956,0.9064822253468832,0.2681596451818321
6,Incidence,104,Caribbean,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2171714077117018,0.4068335123613676,0.0496996885835139
6,Incidence,104,Caribbean,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3460664657137468,0.543998752213272,0.1555667302942303
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0104672632734914,0.2226324271272172,-0.1942319159599689
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2754181935678157,-0.1692430756521027,-0.3762015096395453
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.171771577161498,-0.0418478485372105,-0.2916053997607536
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0296591139578332,0.2464770790805761,-0.1706260482123556
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2639228680161121,-0.1515496552979104,-0.3626503063658453
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1576868560905088,-0.0331778470494565,-0.2804973586670116
6,Incidence,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2228614982543908,1.6887832842605697,0.7960414970032399
6,Incidence,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6932825281538136,0.9436598891615132,0.4570533292670945
6,Incidence,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0522270656393082,1.4014228675955325,0.7147720374008392
6,Incidence,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6741486989826023,1.0177881469240613,0.3445475283655811
6,Incidence,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2730164098328387,0.4660020777062973,0.0934856848787837
6,Incidence,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5441648730337206,0.8124197064560966,0.2830152182476557
6,Incidence,104,Caribbean,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6501674489284921,0.9960499816988848,0.3333125872246141
6,Incidence,104,Caribbean,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.261332763766118,0.4478398371537086,0.0853647115599032
6,Incidence,104,Caribbean,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5261321860035776,0.7858105429970406,0.2751848183627376
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0857736576745911,0.3033446940858733,-0.1282586689605296
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.212565432296697,-0.0918149203329473,-0.3275224506139409
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0214563945856631,0.1407960555201411,-0.1847904618522929
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1062441544373911,0.3265517843184907,-0.1080513561612784
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.200174903535355,-0.079310460007996,-0.3135016203171776
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0049282291184243,0.1575986329226747,-0.1684021498943763
6,Incidence,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.950336004199531,1.3756963044082895,0.5782892833824116
6,Incidence,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5146992154568615,0.8069950410505786,0.2555470032744075
6,Incidence,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6577977124312072,0.9424352733982756,0.4166223035599989
6,Incidence,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4689806035676417,0.8058216443161295,0.1727727045041348
6,Incidence,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1386039962455343,0.3765087747889536,-0.0498803044475046
6,Incidence,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2473633958483666,0.4674600642541014,0.057830542009072
6,Incidence,104,Caribbean,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4478549343405835,0.7636261697604065,0.171661663345014
6,Incidence,104,Caribbean,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1283053571630696,0.3460376584201999,-0.0647381371110921
6,Incidence,104,Caribbean,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2328160412581968,0.4444858659138188,0.053466708957938
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0130438176778556,0.2161189836394667,-0.2029452978778911
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2606419405730144,-0.1151735843785921,-0.3867320950134276
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1774208740116102,-0.0338479805127742,-0.3005711871498694
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0054691834228006,0.2359707699940629,-0.1854577068963157
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.248921850344034,-0.1063422998682274,-0.3798929824289826
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1635363619745333,-0.01871319141759,-0.2878898332098566
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.2841588523810823,3.7596770221536273,2.8317614029183886
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.391630459442128,2.736824217950829,2.0805613130066325
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.713484030091206,3.041402765539815,2.4057018493918907
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.131911751182939,2.4808816207402837,1.8134011232596297
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3917220852655452,1.6221378716289616,1.1616326319022283
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6638659870484274,1.8929599285457737,1.4265450888005495
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8692085313394968,2.1876749646651463,1.5662266237397866
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2353574063747603,1.462867871899847,1.030337806304989
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.466846086861048,1.6846806171282895,1.262388154118835
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7250060250771823,0.9090509610173814,0.5524936435323256
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.272845303360305,0.3930177028956993,0.1527553574423508
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4384607782545314,0.5580722540063985,0.3179387886474359
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6635551126535469,0.8372752851587638,0.4904058283067583
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2352711404695818,0.3538832887288065,0.1227520719490342
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3918248673791847,0.5083087367051538,0.2715779734754672
6,Incidence,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.173668001061073,4.14725649161291,2.319188813544645
6,Incidence,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,3.058919811492807,3.546129932122969,2.499403419715674
6,Incidence,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.130886263717823,3.789001271675714,2.511849662008874
6,Incidence,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.292554278255164,3.079262850277616,1.6080734033347044
6,Incidence,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.152447073992895,2.545011097661761,1.7039423717498074
6,Incidence,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.2313265810875627,2.778907366348567,1.7409667256333397
6,Incidence,96,Southern Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.061410920487476,2.775544013076194,1.434645227737834
6,Incidence,96,Southern Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9636618659826572,2.3194033248663635,1.5551252427641191
6,Incidence,96,Southern Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.0229600917622697,2.504565073802131,1.5699524747909732
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.3328930841805828,1.8680377752577964,0.8553530575375443
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.2152186278503774,1.4810187626948186,0.9059386371508238
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.2837136451448443,1.653565694276033,0.93781161575256
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.2601517082293745,1.7762258474694057,0.8036433214394958
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.1461920174974978,1.3978848391924783,0.8571331662855174
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.21171537310059,1.5553149589596171,0.88043724479417
6,Incidence,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.38078534648517,8.028081549626505,0.8426653562648141
6,Incidence,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.510956695465965,2.7372665146186703,0.6593996935597866
6,Incidence,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8775412625805263,4.012135959373881,0.8341460408632833
6,Incidence,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9035080848733044,4.018684568277085,0.0416196865950327
6,Incidence,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3968966664974717,1.0856975868213092,-0.0725914517910923
6,Incidence,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6101233623920156,1.7968137352238125,0.0202158775913989
6,Incidence,261,Southern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7336841047329903,3.6296466278443456,-0.0550717330161997
6,Incidence,261,Southern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.285747750371326,0.913685736749564,-0.1502962090847894
6,Incidence,261,Southern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4745106749853516,1.5683204173924226,-0.0601462603147127
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7530217877869906,3.587069943276856,-0.0529643833125281
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1906719410760886,0.8044647340117528,-0.226095958627736
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4088642770853652,1.4510635798623557,-0.1132275110978662
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6990259700637206,3.4620746643282274,-0.0844326150828453
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1523313465646442,0.741852604554555,-0.2487576754526523
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3645553768658404,1.3729932374340006,-0.1410158721194597
6,Incidence,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.568845596772128,3.103309358163336,2.127516978843918
6,Incidence,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9670276784751688,2.2843487333171453,1.6135964089500088
6,Incidence,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1845418603585185,2.5354884719359614,1.8609876169491704
6,Incidence,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5990236942084184,1.9613686213363808,1.2866607290621956
6,Incidence,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0687604673076565,1.3031551674064628,0.8381221625623952
6,Incidence,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2668971988084974,1.5095311797737594,1.0444913468128276
6,Incidence,124,Central Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.349056560873775,1.7008469567319824,1.0585688226585717
6,Incidence,124,Central Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9044027030467302,1.108076931958967,0.6775509382627675
6,Incidence,124,Central Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0694077329433356,1.2974630274549497,0.8591527943373308
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2362891694965644,0.4048775356320321,0.0912126046010554
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0603480738538541,0.0456573496953172,-0.1664140572644665
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0525862475753057,0.1654915233334183,-0.0478716311690782
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1869026029366493,0.3625672390947663,0.0413362358571203
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0949284948147881,0.0015264052504369,-0.1966934435877974
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0125005758842651,0.1204464598370195,-0.0850699237922261
6,Incidence,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.335564488766776,2.830929146807488,1.9151431770494816
6,Incidence,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7893304059479196,2.188626047248227,1.4374593253352166
6,Incidence,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.170391237471426,2.580422036290969,1.8302117603168295
6,Incidence,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4298092103773674,1.7808256585416542,1.1200724617751805
6,Incidence,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9453690108877436,1.212971990150651,0.7016748558926396
6,Incidence,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2574263861367676,1.5506098986492172,1.009247587802342
6,Incidence,124,Central Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1955081647807888,1.5215630664128423,0.9187818638408124
6,Incidence,124,Central Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7903467511660099,1.046636810110752,0.564496402042476
6,Incidence,124,Central Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0602122474661213,1.3266621617801897,0.8391537494211019
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1895991104773013,0.3631255055288365,0.0427133853934635
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0867672225111564,0.0386312005266705,-0.1985687178370515
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0787725822511243,0.2190891072822942,-0.0392237722515909
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1418629316664083,0.3084836839605297,0.0026542553967562
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1205010978830712,0.0027500290462171,-0.2316884376312172
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0375151843674367,0.1708217933997755,-0.0746689127865599
6,Incidence,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7641270824116986,2.1858819444308266,1.408936266103166
6,Incidence,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3399802174987954,1.66431897098405,1.0340478892042944
6,Incidence,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4872774763475318,1.817381714052346,1.2117828370714736
6,Incidence,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.013227279254996,1.3227225887713168,0.7542739344206446
6,Incidence,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6317987541179678,0.8606183725956575,0.4164427421475252
6,Incidence,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7707968506504411,1.0018494558121027,0.5750045876385761
6,Incidence,124,Central Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.819381276651699,1.0969853362396311,0.585590462567082
6,Incidence,124,Central Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.501928911418438,0.7101074880192315,0.3055645980080366
6,Incidence,124,Central Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.616305097948969,0.8308164129633062,0.4372806850501778
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1096382150691382,0.2849402461431299,-0.0393067027123263
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1500681509979866,-0.0300204881252465,-0.2611298594418921
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0545817733680335,0.0648222885247715,-0.1492768230156814
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0651443685392807,0.2329543060718376,-0.0764426087558942
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.181475812260084,-0.066983073735532,-0.2807416079143082
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0907300872875363,0.0243277020693126,-0.1859677435889459
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4709876384786952,1.4938147428753228,0.0420053056067674
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7312082978226797,1.775474551811802,0.0602829375620427
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5315210980650155,1.403529039335199,0.0995409430474064
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3203919986395802,0.1438089549208892,-0.5240707910868279
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2281294939973433,0.2489090707135344,-0.5257981908387178
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3052588789949611,0.0885673363074372,-0.500939145990269
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.409306418037295,0.0014226664364734,-0.581569667689686
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.329230215166522,0.0753786648729906,-0.5891853344363156
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3960599854965183,-0.0521923826517101,-0.5664070355085424
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2821484574115739,0.2056026130959284,-0.4975918555921261
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2498541846338146,0.2143095627244458,-0.547871234529463
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.303752352250877,0.0860355168609569,-0.5044468815686256
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3395391493131253,0.1143931477340886,-0.5343411447141246
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3111399733563725,0.1280987851269464,-0.586235867518563
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3592133943395381,-0.0040979327669072,-0.5440842889296722
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4511959859786174,-0.2924472071158581,-0.5823034842214916
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5636330485014696,-0.448693232602229,-0.6512937895282902
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5038782950715706,-0.3789360811153281,-0.6141653187822587
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5987895600227324,-0.4839211500068925,-0.6948830112918467
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6922841160017121,-0.6101616964686045,-0.754181790962419
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6441019594112878,-0.5507452781902965,-0.721978230310179
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6324522004620935,-0.5261341654995002,-0.7202581771877135
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.712399063343163,-0.6366444751502094,-0.7701745459748515
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6704292043557085,-0.5874308101027135,-0.7436922400030119
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4015153021135618,-0.227369993558918,-0.5443010887237063
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5220712730211718,-0.3974328914830513,-0.618378201736486
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4579251021581308,-0.3195808278132958,-0.5796831389028869
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4228412052008484,-0.2546787046583038,-0.5613299708068066
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5361725302766208,-0.4131639013566338,-0.6298997686318267
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4755008040530303,-0.3421723096073573,-0.5925274067911745
6,Incidence,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6834606451119382,1.0239309225920783,0.436789027822057
6,Incidence,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.2938789555048298,0.4820998068466882,0.1414766697675034
6,Incidence,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4459659783602282,0.670034411068212,0.2784904149647381
6,Incidence,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7189620281345516,1.0716387435025332,0.46075091064348
6,Incidence,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2929661405016786,0.4817203024196457,0.1421273516198747
6,Incidence,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4598394679176033,0.6919520744012793,0.2878960019414136
6,Incidence,42,Central Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8362255003094384,1.2075915951579967,0.5671697815521171
6,Incidence,42,Central Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3974685653726586,0.6007586196538939,0.2328647570312823
6,Incidence,42,Central Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5692588884906529,0.8124329222642022,0.3875032176128426
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0280460668343413,0.215321042922449,-0.1161011076749847
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2330673128866451,-0.1195340968383078,-0.3183941435881461
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1316493033459947,-0.0022307090140376,-0.2300580127453232
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0960954315570534,0.2980246377339439,-0.0518197652878915
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1781293268739763,-0.0591441838013935,-0.2706764046950276
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0724777556536655,0.0672910600880387,-0.1770910947109296
6,Incidence,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7006594549182984,0.9512933610490212,0.4679326658209511
6,Incidence,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.2344468264610435,0.4255586016100856,0.069318702744444
6,Incidence,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5747005940006569,0.7997281889731482,0.3769544475098557
6,Incidence,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7367753413922841,1.0066362990879991,0.5069241859761868
6,Incidence,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2336231533031581,0.4253894914715629,0.0689191456021905
6,Incidence,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5898898978997822,0.82070205170463,0.3887539977485909
6,Incidence,42,Central Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8549850081322675,1.1283625717929813,0.6011395345321001
6,Incidence,42,Central Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3332782237966517,0.5396906529555663,0.1549297305538028
6,Incidence,42,Central Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7089702944804868,0.9531852752276204,0.4943629643707049
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0759418582145675,0.231914434059835,-0.0603337715712772
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.21959384352102,-0.1084412153566041,-0.3166181597345388
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0131529839874387,0.1628161783375727,-0.1070462144273969
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1471301925465428,0.3155658490913445,0.0059833141602998
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1636425348468778,-0.0461969986695761,-0.2686671418356332
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0822371197874564,0.2412161587641156,-0.0440246201028754
6,Incidence,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4251345333872237,0.6793604153755989,0.2168990745773629
6,Incidence,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.0690347153517433,0.2569442982756118,-0.0723972947742643
6,Incidence,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.2070693215529221,0.4027744236064295,0.0520274549169638
6,Incidence,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4550348644981424,0.7213642877864761,0.2394374066865308
6,Incidence,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.068155489112318,0.2553769954886673,-0.0771243257065676
6,Incidence,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2184986546695355,0.4140817007285657,0.0562515897213515
6,Incidence,42,Central Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5544577054269085,0.8317531971279764,0.3273260165183889
6,Incidence,42,Central Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1546230067659492,0.357576872080136,0.0018677683816503
6,Incidence,42,Central Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3099922752120297,0.5223845275309347,0.1417304827855095
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0462084489029582,0.1120585314825212,-0.1848908969389776
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.3079769603972704,-0.1993552334247298,-0.3951664083683983
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2058963974189598,-0.089975414832177,-0.3046084040499626
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0170805675395688,0.1890842115063478,-0.1293365791294692
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2582778772484507,-0.1369182021546146,-0.345910467134823
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1516425880248949,-0.0271557649390064,-0.2570923600191396
6,Incidence,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6249637606638361,0.9695575594903671,0.3332379710848899
6,Incidence,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8049539272244389,1.1768805299982863,0.5005438476640339
6,Incidence,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7183744021980193,1.045611565862547,0.4550286609224749
6,Incidence,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1470190534822054,0.3986901914584252,-0.0581558443543407
6,Incidence,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2663052038755056,0.5326089199795939,0.0449440600536256
6,Incidence,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2091144143906448,0.4519026492726348,0.0182989553053245
6,Incidence,32,Central Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1600506886412634,0.406053881639811,-0.0482103884902155
6,Incidence,32,Central Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3227354424118809,0.5952966928928408,0.0996527391978724
6,Incidence,32,Central Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2431387992402278,0.4798748761885054,0.052624259349764
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1758958735013736,0.0012864744370116,-0.3239832868174567
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0635693602495862,0.2823019019421651,-0.1182325887388712
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0421090969438792,0.1554403831916139,-0.1983268954720078
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1420452834556073,0.0357211626078357,-0.293350359831011
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1250568129760214,0.3536898424606553,-0.058237603998917
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0053629217321959,0.1998375625149637,-0.1570259408636073
6,Incidence,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6052556542041585,0.9624761218504811,0.3247936986671343
6,Incidence,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7972211297609999,1.1928710130576277,0.5014836285780517
6,Incidence,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.649619056286857,0.9957233607923612,0.3691670496438607
6,Incidence,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1329081735308028,0.401511097710903,-0.0734829724841546
6,Incidence,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2609165391586017,0.5430129406745827,0.0450325282147661
6,Incidence,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1606433493595437,0.4172137696752832,-0.0410132890538021
6,Incidence,32,Central Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1459812041248676,0.4009984909845979,-0.0542386977180411
6,Incidence,32,Central Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3170685690808763,0.6070150965400755,0.1003414446015527
6,Incidence,32,Central Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1933985109491443,0.4437838105465404,-0.0094913658650881
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1986558400015558,-0.0088737195614004,-0.3394009713734721
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0285881721521483,0.2554963615703947,-0.1589516926711514
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1088352228352441,0.090550619898279,-0.2609623160871537
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1655670399440292,0.0193638054174531,-0.3095835459900133
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0881246268228308,0.3209096931990515,-0.1005612078510944
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06455037331732,0.1387804339628219,-0.2208601812474483
6,Incidence,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.37422758397822,0.6547872573306049,0.1225543536125224
6,Incidence,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.5775453952083012,0.9340151684498578,0.2856539049168726
6,Incidence,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.48999831712738,0.7971227374033696,0.2307436960036291
6,Incidence,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0299807910134826,0.170046445153474,-0.2070263495379754
6,Incidence,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1067674716651716,0.3552599357273871,-0.098208057144728
6,Incidence,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0483983806037213,0.2663513572025081,-0.1343553376233754
6,Incidence,32,Central Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0189481798089441,0.1813414821244647,-0.1986160045726372
6,Incidence,32,Central Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1560822549440114,0.4173161823607643,-0.0578263738156231
6,Incidence,32,Central Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0779226671756731,0.3001084042018284,-0.1096321974620972
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2814329246138423,-0.1265231041357776,-0.4112675209090111
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0905124798061432,0.1158669066499316,-0.2680315837140853
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1699780831746636,0.0079898145709286,-0.3167849310728674
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2519319319626569,-0.0959960885381324,-0.3900934904973349
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0379126480452647,0.1928106549279251,-0.2209789702512097
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1288219839422913,0.0532706702990056,-0.2769108158267722
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6879355309933385,-0.5847586184065906,-0.7615494651724004
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5240546810531531,-0.3595080404600479,-0.6384836743484985
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6239278891818182,-0.5229111723573076,-0.6990548219922126
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6959775274846928,-0.5950631136300067,-0.7664629877699605
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5357747532124784,-0.3731337953390496,-0.6496275487284595
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6334231803574404,-0.535028045337915,-0.7070401302301282
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7067417881897908,-0.6097827303976585,-0.7759194512873648
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.557236711160472,-0.4041619589647575,-0.6636879260230384
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6483974700846776,-0.5539535265495792,-0.718636179313727
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4912589347666514,-0.3238997848317025,-0.6081580306717986
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2335893029216153,0.026124404418347,-0.4194026233695842
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3899703147746537,-0.2279147290232563,-0.512068169491223
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4907214292922505,-0.322961369097958,-0.6071256562057794
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2310353472270867,0.0322954026235698,-0.41723241045468
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3888430122187192,-0.2282205358265377,-0.5086825882487119
6,Incidence,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4509340882349529,0.6173477268182502,0.2890425850466755
6,Incidence,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.135672302856699,0.2779916422792831,0.0124190942498582
6,Incidence,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.3518372291239323,0.4883124172388662,0.2304066389241879
6,Incidence,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4590671463139147,0.6248795804171805,0.2926078308728937
6,Incidence,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1184736979994092,0.2583801033350041,0.0008096521296227
6,Incidence,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3438924791326896,0.4767868639407747,0.2230832796773242
6,Incidence,56,Eastern Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5967807034627286,0.7799220942657268,0.4186160091173875
6,Incidence,56,Eastern Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2390290327159902,0.3943007541606161,0.1045586371140764
6,Incidence,56,Eastern Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4808481282783847,0.6303476556788901,0.3478289612226232
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0823762208770888,0.2014775616896256,-0.0350471282680244
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0955399344902629,0.0166608990409884,-0.1912692686601325
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0666258618047883,0.1690643994863625,-0.0264378538985601
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1810442384243294,0.3124669254803258,0.0507864622673165
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0083301630246929,0.1156834150425238,-0.1172359930024697
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1665214098538228,0.2820888970776571,0.0632302733357857
6,Incidence,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.042909236071378,2.6502162233216486,1.5102418386794456
6,Incidence,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.6491685112219536,3.3796152568538824,2.006858689208607
6,Incidence,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.326014570815381,2.86779987864643,1.851985466057095
6,Incidence,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.960453985486323,1.3596351665318385,0.6095724771268776
6,Incidence,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2292911879124369,1.6783740451848472,0.8399031614181649
6,Incidence,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0861671460448934,1.4294695618941122,0.7869793721300985
6,Incidence,244,South Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8291543911494433,1.194218925226305,0.5089572267346647
6,Incidence,244,South Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1084105774979924,1.5304468961972422,0.7372978654927258
6,Incidence,244,South Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9612403120031984,1.2807131115191752,0.6817210947777543
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2797348839647736,0.5435647017341905,0.055437115676055
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2998150617455012,0.5671349325666476,0.0753475923973631
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2873970213164097,0.5170134907285793,0.1012937003981701
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2565534573846753,0.5077513006146778,0.0357569865840359
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2823693912415582,0.5525612487351603,0.0651504526353276
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2685249567416428,0.4862488065261228,0.0842361687815207
6,Incidence,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.652977548340106,3.363413383981597,2.008390072674581
6,Incidence,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.3269554107445067,4.206061677929063,2.595783016733989
6,Incidence,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.780021204115528,3.395689841008167,2.1814073484708763
6,Incidence,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3539359116990572,1.808792495058947,0.934953362024566
6,Incidence,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6438779996523258,2.1501351040781014,1.2051383085408072
6,Incidence,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3713530985206628,1.7562790989018364,0.9926819755310288
6,Incidence,244,South Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1958788136393508,1.6229361878748385,0.8084042226733135
6,Incidence,244,South Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.5000211769669594,2.0079497494011305,1.0775655943416236
6,Incidence,244,South Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2289529428973012,1.5919922873743415,0.8759702364126023
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5849794648335769,0.8844304542197929,0.3182042066929419
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6015463792804262,0.9174250520679512,0.3406155143971937
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5215969990965059,0.7719868611281602,0.2884783576738814
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5561208471171935,0.8608209695074244,0.2956681094767198
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5798911879066403,0.893924958837107,0.3141485906198068
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.49916567394988,0.748134146953379,0.2701555663167466
6,Incidence,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8113658850615804,2.3906115046533225,1.3443459768008292
6,Incidence,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.24780167713855,2.8307516369453203,1.7245150886651317
6,Incidence,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.022414090943156,2.4864996431859376,1.6352242611204917
6,Incidence,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8113213530066373,1.1728418076068818,0.5153443415730476
6,Incidence,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9841489165562411,1.3264419958800937,0.6786890561746586
6,Incidence,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8958101518111388,1.1757101553195186,0.6441669584668579
6,Incidence,244,South Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6899689917887246,1.0381652692426775,0.4092338631089496
6,Incidence,244,South Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8765095085733988,1.2133253770730017,0.5741658445832858
6,Incidence,244,South Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7822171937361735,1.0558730283387514,0.5539042123953559
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2707500999148707,0.5183535412975872,0.0590631766993609
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3172401444997862,0.550348002182121,0.1099600201074839
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.290209927454009,0.4887795111625623,0.1226556744792751
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.247701310609744,0.4949437087046497,0.0390462580183518
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.299503916198528,0.5415570778474343,0.0862005805828403
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2712419440996561,0.4664994635007339,0.1007613086386938
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.2673961056969656,2.560859947172188,2.006048986116296
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.576492883802995,1.722162897094026,1.4026573498768045
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.954857029390658,2.140639904287595,1.7826908302871824
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.405674050775748,1.630261527739675,1.2151664675017375
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8039491821737632,0.9173749823225964,0.6808253494350105
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.1191159864227294,1.2575784034609478,0.9935852343558428
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.216969422477037,1.4160883361645582,1.0396421092221284
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7077284808864474,0.8042802051594063,0.5925083325436784
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9811817301031796,1.1057460098131018,0.8657472015244959
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3124343092300479,0.421309238952045,0.2059750052323908
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0759931930463064,-0.0196621506486833,-0.1302149012890319
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1190803336430918,0.1868091357791355,0.0574748542825993
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2673622583258183,0.3742852834094244,0.1678194357569576
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0940092781901818,-0.0463535677142379,-0.144621629633687
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0894017248465326,0.1526981515214547,0.0314468950471886
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8403065099139974,1.408126308825003,0.3860843936043259
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7082613623831128,1.235323697236974,0.3160968110056451
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8185905073491091,1.319676788629044,0.4232972683973408
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5766524151415201,1.06850949963955,0.1877957570550488
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4352324249713309,0.8956483494473059,0.1024360022864912
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5427125240253661,0.9677510284178912,0.2071761200744936
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4483945090955277,0.8952913029001939,0.0909036152533779
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.334767242095096,0.7465927124807699,0.02834551517661
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4262072055061637,0.8191779496367171,0.1162033517509481
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0947809101727083,0.1800411422589248,-0.3125188988831056
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2241659450505304,0.0184341425178835,-0.4009207054306375
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1240724765544213,0.1232676145789245,-0.3167857816894641
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1300260148411552,0.1358916586670154,-0.339676892718323
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.248137739979446,-0.0203972866539639,-0.4186041713539903
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1548056607026787,0.0784495053757079,-0.3365163373266202
6,Incidence,263,Western Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4989802899293344,1.4430895228123228,0.0832296055400682
6,Incidence,263,Western Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8247384787520321,1.888577858896415,0.1199113186985894
6,Incidence,263,Western Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6186862598657035,1.435592712717369,0.1592547043359272
6,Incidence,263,Western Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2920623179722545,0.1494638987026524,-0.494566046504196
6,Incidence,263,Western Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1698733102922829,0.315134908180896,-0.488235418358638
6,Incidence,263,Western Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2501496295421657,0.1291220688964873,-0.4666467820429648
6,Incidence,263,Western Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3862051193479638,0.0003839624519171,-0.556444610434095
6,Incidence,263,Western Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2845309086812251,0.132594177178524,-0.5608894409379221
6,Incidence,263,Western Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3516302188302023,-0.0244158158886638,-0.5356569474848683
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2151348515630401,0.2875253759733385,-0.4428404446985681
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1149740744014889,0.4593559920962189,-0.4711650937781544
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.194809132241676,0.2359448191554251,-0.4380740755777335
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2808014888047931,0.182225823719896,-0.4882242966569327
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1941947798204547,0.3181344318255545,-0.523177536871742
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2634129738952208,0.1314401101237235,-0.4825891452055427
6,Incidence,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.5193548731186657,3.219449033246949,1.902178882105784
6,Incidence,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.235180556276972,4.05169987286057,2.531195844490081
6,Incidence,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.841856249669497,3.4714601837272694,2.3041053147018635
6,Incidence,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2672822374768302,1.7238674142695205,0.8644789016248774
6,Incidence,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5871578304763672,2.05447722176117,1.1725410665857274
6,Incidence,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.409608451348314,1.7694371600799217,1.0789227072974183
6,Incidence,244,South Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1155555163680868,1.5363962999302203,0.7445585241834858
6,Incidence,244,South Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.446995652573493,1.9187628396798495,1.04024852424443
6,Incidence,244,South Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.265415015282406,1.6366715416082074,0.948321151434008
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5467375257732568,0.8629527344782446,0.2650999819179348
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5945523749657373,0.9181888754138836,0.3283783751055643
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5619185887385073,0.8043358708150542,0.3422167616896114
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5187956459487378,0.8311546701348853,0.2534455342234743
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5732012032668362,0.8852782731174822,0.306928566202669
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5390732649029286,0.7857856693573221,0.3249957016289458
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7181028081340315,1.908737644779233,0.3199335513012822
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.892313936709514,1.512213480174596,0.3939091528278143
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7885969704796357,1.6033623342474437,0.4380718067032287
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1518230425330716,0.4463076556405728,-0.3447088112331123
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0929419736316178,0.209732012109196,-0.3316641143288057
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1301829572460751,0.2624854966498336,-0.300956625272897
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2481272170420368,0.2729160662102518,-0.4223732666997278
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1807096000266516,0.0876801925211618,-0.3964973965511094
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2215058824349018,0.1331240612348214,-0.374073387894388
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1586428097696124,0.4514971577472575,-0.3556225480794689
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1116132447981478,0.2298853760268821,-0.370750294240044
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1473494749880789,0.2632184866394014,-0.3311948214684944
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2018567551057548,0.370067223149683,-0.3826865872084995
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1485192688674502,0.1748088213201123,-0.3975892599145183
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1865881874075877,0.2085014786653578,-0.360209807255925
6,Incidence,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3699271732522283,2.1282963441903755,-0.3499411567585321
6,Incidence,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3648709282877546,1.3397484941700346,-0.2022066502458144
6,Incidence,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3687817804492039,1.7706592849943266,-0.3106577070620192
6,Incidence,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3283132920603554,0.5287007296372296,-0.6832342744906001
6,Incidence,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3483503329646165,0.1350865840061658,-0.6172079589659678
6,Incidence,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.337530478718801,0.3065703722271599,-0.6622248966125726
6,Incidence,21,Oceania,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3537469328648705,0.4757507893950014,-0.6933395223734542
6,Incidence,21,Oceania,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3602414002348662,0.0967148536972979,-0.6260487744573993
6,Incidence,21,Oceania,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3562808130210571,0.3030028363957985,-0.6758118301263407
6,Incidence,21,Oceania,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2896007314925133,0.6053118615324125,-0.6631928655998283
6,Incidence,21,Oceania,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2935776581580117,0.2245672570093256,-0.5854652946620318
6,Incidence,21,Oceania,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2912399963796515,0.3944779481576503,-0.6393374052518332
6,Incidence,21,Oceania,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.289976247597584,0.6196436020118186,-0.6635427472286358
6,Incidence,21,Oceania,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2852469121239359,0.229183894825517,-0.5844280611310493
6,Incidence,21,Oceania,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2871354059981403,0.4372226930139342,-0.641144144253691
6,Incidence,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9078849330255956,1.631288709772816,0.3506001713382674
6,Incidence,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7127322121119598,1.4500788272249343,0.2581416052487089
6,Incidence,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8771395893460564,1.5307381322457547,0.3904325421393387
6,Incidence,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7765583034105147,1.4385295799418496,0.2548256570642617
6,Incidence,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5472419285820869,1.2217705615366663,0.1319845335314708
6,Incidence,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7216193691076109,1.319113269180094,0.2733727485566422
6,Incidence,5,East Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5889719686499889,1.1914550132872737,0.1248402751978678
6,Incidence,5,East Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4046626992207895,1.0093826194287263,0.0318394029919173
6,Incidence,5,East Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5516997593105516,1.0919838742795964,0.1493731490297939
6,Incidence,5,East Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0094825184268411,0.3524102203607161,-0.2928981975014667
6,Incidence,5,East Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2062284778748875,0.127384590777963,-0.4172648252087524
6,Incidence,5,East Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0566118785862675,0.2738990601372639,-0.2973809037405341
6,Incidence,5,East Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0887319474902815,0.2470632611919128,-0.3470383509886556
6,Incidence,5,East Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2629335952442174,0.04472720250127,-0.4578028316326569
6,Incidence,5,East Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1281580933430552,0.1742892169772472,-0.3511944148107384
6,Incidence,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7895881442745728,1.3611519799516454,0.4799704764129914
6,Incidence,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9618447206740862,1.448641348227944,0.5921016974815163
6,Incidence,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8773414184520216,1.2891705579541335,0.5599212764581266
6,Incidence,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0921710126591772,0.2035157396887157,-0.2507148868224551
6,Incidence,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.046497366783938,0.2051708997574661,-0.2261886980316411
6,Incidence,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0679934350746491,0.1413060994512863,-0.2278598174684859
6,Incidence,248,Eastern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.189560090026219,0.0692805516110028,-0.3297747621399235
6,Incidence,248,Eastern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1131293091745513,0.1069317674339206,-0.2802751831324123
6,Incidence,248,Eastern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1505767681253458,0.0357597369012596,-0.2941969110703025
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1403197812092382,0.1240666308635843,-0.2822887964642857
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1036851168594645,0.0831639271868614,-0.2611110610126604
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1172857512812614,0.0775733525041446,-0.2516388303953901
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1712595868644467,0.0828655036488494,-0.3087950298580827
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1101912037410322,0.0730499827908789,-0.26635726551055
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1362392785719945,0.0538290271346977,-0.2662621962455795
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0582192398869472,1.4069988876356838,0.7640020580573803
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.402196981308763,1.9462598825775688,0.9761426337783136
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2070179484681296,1.5213903916366018,0.9271207517657432
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.763293121711922,1.0637224544506658,0.5135804495281574
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0179169380650108,1.4630368086089098,0.6412458295961494
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8722328749589958,1.1438299100505898,0.6316630281365825
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6199005054360961,0.8944039775273549,0.3883398668425708
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.876980835788272,1.302089870180844,0.5440789748912371
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7308266418782292,0.9773693582553276,0.5113207129048042
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1002454490773474,0.0454520415628398,-0.2168856128791599
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0820688987715214,0.1173425821960195,-0.2416858778867073
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1054809085779114,0.018996129436783,-0.216070303903012
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1353067467903446,0.0046035177359561,-0.2480652955096055
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.110323813213931,0.0802450999323127,-0.2650734711832964
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1369199049585508,-0.0223120698274827,-0.2426785193027157
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5100216478310695,2.1014038152325,1.0347864864986986
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.465955713211427,2.158875868322963,0.9670894020034316
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4988590275585465,2.001021707355948,1.1140426420023208
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1506928445339395,1.6730894242055885,0.735219009898665
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0719804605606496,1.643303716543584,0.6517266719601786
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1200709395792237,1.5409594955397932,0.7941006245718807
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9754869924354704,1.4409283085569211,0.6014579953663375
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9267993639217412,1.4682195147235302,0.5370051409485499
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9596994134996804,1.353514309909372,0.6579119029747651
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1031309809180394,0.3589313954062492,-0.0916422898605793
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0332409420135767,0.3208227693560804,-0.1813008088068761
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0821709480802093,0.2977110711105524,-0.0791264848198139
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0601358274628639,0.3049813518053719,-0.1254728573254195
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0013532170776754,0.2832201643018528,-0.2065834150907561
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0441594063115085,0.2461543486536537,-0.1099854946370678
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8852001959825863,1.4659331332252228,0.4248629877656206
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7328275553302938,1.2619048800201194,0.3301058091815226
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8126535284044099,1.233547730224813,0.4562197762245861
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6151947995528173,1.1022221473830565,0.2102145864527891
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4558977672974845,0.9115087069658798,0.1212646520930915
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.537925668002662,0.8984482165981871,0.2347575457723248
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4837276278148872,0.9407875757213126,0.1214239131228279
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3539622846869087,0.767362187700644,0.0392915871720835
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4215512028955452,0.7516322964491656,0.1420224230024493
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0735931741229614,0.2100518793422817,-0.2896115387168498
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2032087005108006,0.0462319376491374,-0.3837799834249216
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1382785155513328,0.0632840558080581,-0.2963349360302741
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1096856349622348,0.1621228991338462,-0.3155897847808335
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.227821074810867,0.0147099020750444,-0.4046102943203208
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1686235831226777,0.0255365792045238,-0.3224352430943965
6,Incidence,104,Caribbean,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.081529024361885,1.4817465243140124,0.6954241413366151
6,Incidence,104,Caribbean,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6055019144471636,0.8328077319175867,0.3803958547368106
6,Incidence,104,Caribbean,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8558243419959318,1.128592163474353,0.5842729538664301
6,Incidence,104,Caribbean,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.56761548508505,0.8830494129048055,0.2601719651504418
6,Incidence,104,Caribbean,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2068284972481358,0.3698481307130365,0.0443791409835797
6,Incidence,104,Caribbean,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.396251559282022,0.6112029618878803,0.1820996601626371
6,Incidence,104,Caribbean,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5452476201055525,0.8423538012289257,0.2586181065974078
6,Incidence,104,Caribbean,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1959446420257874,0.365265632588824,0.0282622596034447
6,Incidence,104,Caribbean,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3800779198897348,0.5829208502038881,0.1781395863996801
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0340025649048126,0.2417878687338546,-0.1628936368945336
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.24809354140421,-0.1439640684690382,-0.3517289985994
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1046344162545,0.0353367883616924,-0.2422697540059768
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0535307179678192,0.2541769332551344,-0.1428220945824078
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2361606362295518,-0.1277738219671018,-0.3432396871073521
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0894492623360525,0.0443207772493274,-0.2248306188588961
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4833975291521912,1.0570907171784207,0.0316999303576856
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.809445880593035,1.4516170988422137,0.2251088910878614
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6121069822146509,1.1426404897668805,0.1456322728024207
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.3529842041988046,-0.103676041682629,-0.5536252779135257
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2229174413353326,0.0634686246558695,-0.4731181028449266
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.302339476441417,-0.0603827731556474,-0.5023382847054803
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.4088615829742766,-0.1802431065621638,-0.5888644468581824
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2684717797440489,-0.0088528691019394,-0.5047092945252832
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3529042587789898,-0.1399494256943572,-0.5401460492917309
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3510666673547203,-0.1027765089245098,-0.5465645514881913
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2503870850706736,0.0203969843189824,-0.4675589778868507
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3147064454718056,-0.0618567477400416,-0.5066995160540595
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3503241050068996,-0.0995844606431664,-0.5495505161817436
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2378986491395155,0.0324178919877507,-0.4586682750971035
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3086795520642229,-0.0570955971491405,-0.4993562005153997
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9602164700225668,1.489342886984439,0.5449003126331602
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0755459281779596,1.6148891879909222,0.6960288967891186
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9914380564104008,1.4291987614715134,0.6290374665711702
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6793919155173322,1.1419347658140409,0.3175429305631784
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7436655204508109,1.19581384979455,0.4077837423969844
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.689374015155554,1.0506785825966105,0.3849878988413737
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5427684228275561,0.9592119841671162,0.2158980679921626
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6217487413817022,1.0431700363285346,0.3252092817475436
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5617607668654168,0.9050692078380308,0.2775525680324635
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0674483262429514,0.1769561543736449,-0.2559392494746588
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1245010476044596,0.1009015954500245,-0.2862631134003598
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0916284833401216,0.1039256210150639,-0.250566507778727
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.103764244118524,0.1324287554721068,-0.285147577382113
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1514846738438442,0.0667810296823505,-0.3039522328372553
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1235207316866721,0.0638242285763729,-0.2773284750199406
6,Incidence,5,East Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0454162525515909,1.832929345329052,0.4537602002720301
6,Incidence,5,East Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0430910145467798,1.815781207590038,0.520252152677672
6,Incidence,5,East Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.044783859236065,1.667623198830862,0.5400479684885178
6,Incidence,5,East Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9046468381864848,1.6235457675999276,0.3499218818908041
6,Incidence,5,East Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8456310752362908,1.568313875512562,0.3770866568822823
6,Incidence,5,East Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8754732311982177,1.4456619139158715,0.4113108851067683
6,Incidence,5,East Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7035142074168107,1.3593903599601584,0.2107565647095853
6,Incidence,5,East Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6755997925141032,1.3093060336568554,0.2468040696468461
6,Incidence,5,East Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6902795296774139,1.205137166703265,0.273049737799649
6,Incidence,5,East Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.035215178833993,0.4143847352507643,-0.2578263356951318
6,Incidence,5,East Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1129425893073686,0.2315867422506296,-0.3375118327277177
6,Incidence,5,East Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0212662256163959,0.2659276001043478,-0.2582649379935086
6,Incidence,5,East Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0476222077380855,0.3042434835772798,-0.3140047669123751
6,Incidence,5,East Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1762918279004703,0.1354969042398776,-0.3848367833812912
6,Incidence,5,East Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0955477575102076,0.1708597854254062,-0.3139285969000392
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5060084254616926,1.1096044390565551,0.0213887309626137
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7803804658873051,1.430852461927877,0.2588032329760946
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5841886504126735,1.206055711177279,0.1244101827939062
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3432066824643944,-0.0673206770251378,-0.5581306699883428
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2355093937786947,0.0519240261006578,-0.4626533699592127
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3144779353081784,-0.0419634770959535,-0.5185681313372354
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3998510721777729,-0.1593162290306153,-0.5929734911084604
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.280222432979234,-0.017247658937393,-0.4910872446930349
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3641106078677064,-0.1144947132242934,-0.5486645435454143
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.4182713146125759,-0.1859839680748099,-0.6012346538630583
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3123021602959569,-0.0652037259980519,-0.5155036008834548
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3925724460715011,-0.1622127530181039,-0.5656803015820568
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.4174930330242537,-0.1907489866375892,-0.6026227365943415
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3008198836708581,-0.0543952417840564,-0.5029065206166298
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.387179491583807,-0.1599978404009945,-0.5580818086058961
6,Incidence,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8911135742671129,2.197770378583262,0.3357762909772489
6,Incidence,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2842995451342871,2.768878540626906,0.3466927515443088
6,Incidence,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1198968975324637,2.254039322942611,0.4150072693202012
6,Incidence,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1070823048689087,0.5106111847431458,-0.365998312884061
6,Incidence,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0389363157857047,0.7226865780519034,-0.3848216438276627
6,Incidence,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0182043300357055,0.5013004339296452,-0.3440191128149661
6,Incidence,263,Western Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2256363619888213,0.3094068688305845,-0.4530330688091618
6,Incidence,263,Western Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1043397512092405,0.4777548323512923,-0.4719697915879148
6,Incidence,263,Western Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1508687497787944,0.3034155018460824,-0.4332144676146643
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.00228657763122,0.6796726440962026,-0.306539357360563
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0990706628420467,0.814225237219121,-0.355076391703725
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0678294710804748,0.6424590083415462,-0.2929219626749237
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0814019022197443,0.5395554840442849,-0.362588163163642
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.000926042006422,0.6375507729171969,-0.4140919740593186
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0229485182409595,0.5020084327003005,-0.3533907866005587
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6582093393451695,1.8951456438688723,0.2544965599144963
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7996462645608872,1.538665963332083,0.2669211907133483
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6966291975454374,1.6885237059153884,0.3221788725488683
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.181415654388204,0.4346531752515737,-0.381477893033746
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1373902424508879,0.2110829420315214,-0.39209274637547
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1749205312644238,0.3021641599962686,-0.3630337881422876
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2743376794463169,0.2669679614157899,-0.4510096745965369
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.220830709270958,0.0991329779633442,-0.4514777125833811
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2615352302513817,0.1701908951730963,-0.4245162595952917
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2372650986287704,0.3552914118445871,-0.4234672865065642
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.225036827333674,0.0994235998585862,-0.4655303056193803
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2526319504581272,0.1901427826513322,-0.42887802039299
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2764292754443458,0.2776605454063008,-0.4529899371541859
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2572287492528152,0.0591040935036853,-0.484528406791831
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2870238447990701,0.133560154724892,-0.4501718482229647
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7345315550483201,1.809513759770424,0.3334220652234974
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9655493535960336,1.7067062068779446,0.4209459215826344
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8734956339952705,1.5791517452101198,0.461959390760392
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1435879460297962,0.3923050341040903,-0.3401092528691944
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0577761491592085,0.2989177880681719,-0.3136108076562741
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0888306030873571,0.2493447115283115,-0.2880028877476126
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2409377010221106,0.2294939041578548,-0.4164704496781565
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1490018200282098,0.1718871630251022,-0.3847916406205469
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1845533932901045,0.1225863037302404,-0.3636762196232395
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1223827302238726,0.4275572500444363,-0.3172608647911458
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0988402668011039,0.2558630101199514,-0.3533410748928774
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.098118441606113,0.2454360640916116,-0.3034550769083706
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1675530465501859,0.3487397912399592,-0.3525716826096773
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1363282101319667,0.2003259118861304,-0.3821414500190736
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1396781503647277,0.1891795643431326,-0.3372882250578956
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8674917027286352,2.218382070384357,0.4405993480584305
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1634370751014056,2.0056869503311496,0.5318363529561501
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9452242654288664,2.0307375730223893,0.542346669829669
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0780965850827878,0.5843702115012394,-0.287698670525235
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0370600090673392,0.4467924254948185,-0.2659800339241698
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0539989580605678,0.4721735179788561,-0.2553853600631937
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1827519418314396,0.4084220527582832,-0.3695677372598623
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.063324963056015,0.301332942679426,-0.3367808618006204
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1533332142594591,0.3191408748996995,-0.3286873289366394
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0806933087458383,0.5887921133381928,-0.2940214401869325
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0262415254131084,0.3641061275868407,-0.3191041972246777
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0902369356374616,0.4253368897226777,-0.2845666387297008
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1279157396632901,0.5054280175815953,-0.328021109636192
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0667312835186685,0.3054341166461303,-0.3492436394421326
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1321241140992968,0.3651733074364023,-0.3110308736349927
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8931577984968413,2.217691435692492,0.456800119824376
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0492757630324856,1.798605107181766,0.4914627093502103
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9856402336948528,1.772180375898402,0.5391493158486773
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.065458440654717,0.5911246138096131,-0.2795803373710691
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0177213504574295,0.3480399069680696,-0.2860400522229495
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0344225268733793,0.3494383249691155,-0.2495401661559242
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1715199953137189,0.4081198185582564,-0.3624779872774631
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1127518922837652,0.2116754271848809,-0.3542609098923285
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1357419994301417,0.2066028015733385,-0.3300789902818488
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1086398559144027,0.5280792645989416,-0.3120971297407972
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0972289660081513,0.2624393823201323,-0.3612652790092162
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0938228457637303,0.2795088886654142,-0.3037831193587326
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1543718535918041,0.4487640487230826,-0.3463471042745286
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.134723341508716,0.2066048361822282,-0.3863536428066136
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1354821732624681,0.2268285145066233,-0.3379117227544591
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4579631344442421,1.0777484883696524,-0.0119850280535357
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.922752228935428,1.615598910878918,0.3485241791941403
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6702504616588836,1.27831450011022,0.2069982042057663
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3640647142048649,-0.0840691020658637,-0.5735152690825656
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1742344858820415,0.1273693467051287,-0.4186869434401731
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2771803962802778,-0.0155535492198049,-0.482836565675776
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.4189972664510156,-0.17201092205243,-0.6062730353555645
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.222663948608783,0.0574421908388644,-0.4548145908322542
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3295656104490594,-0.0854902147014602,-0.5155139167439181
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3499977428438798,-0.0904248423135573,-0.5611738410479878
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2409811949083679,0.0471674635846636,-0.450256862105922
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3010046526249555,-0.0459579263023097,-0.4954612408332751
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3493048355882746,-0.0823654673722565,-0.5591964544983694
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2283859110299868,0.0677675345156365,-0.4405128968084948
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2948894192118322,-0.0359001317072159,-0.49054316904396
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7509914404624349,1.436125010215492,0.2000288645785491
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0750464970521572,1.8708610579634075,0.4777599307132185
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8201703828433993,1.5305841340662898,0.2881459490232367
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2361507494683893,0.0712282733746936,-0.4772669131825005
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.108803949327777,0.2312663609215335,-0.3655901348823652
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2121727008829984,0.0882945215061657,-0.4489046205094876
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.302224597251328,-0.029196790533542,-0.5217848557442488
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1610939640596445,0.1606403390444516,-0.4025667726929204
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2693881262045468,0.0157701902054768,-0.4829414133924733
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2590826853679905,0.0504911132384971,-0.4977787424973686
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1826266798814012,0.1325882446200457,-0.4197471343078708
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2660039715566397,0.017446524581872,-0.4859033312942353
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2583188178449465,0.0444721094612468,-0.4904916058892998
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1690385751889244,0.1514402722651512,-0.4094656178359396
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2596323595070995,0.0298612358459266,-0.473617568674632
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6736672013453916,1.4085391437386334,0.1300145028115552
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0051678579056986,1.7674066099378252,0.3789524769633394
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8633912476803085,1.5896434514760975,0.3220147099545027
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2700317324955201,0.0598259261692494,-0.5093639670957413
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1388758238213861,0.1978711612973111,-0.4173070499471547
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1936540427204947,0.1309320565304767,-0.4316293479830455
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3330385411949254,-0.0401898420392523,-0.5496857913806064
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1893447103665545,0.1188154637865566,-0.4425129471349996
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.252039378338304,0.0394764536215719,-0.4693465768209283
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.3316162343366962,-0.0459886142983466,-0.5409222928732416
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2161792141771278,0.0765132503961856,-0.4616406450552633
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2578341133973191,0.0292980638731557,-0.473893322471965
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3308596879356068,-0.0521709396401559,-0.5362848761914257
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2031817183891063,0.085774064636932,-0.4472830858373656
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2513300755001664,0.0385976612942909,-0.463652040147576
6,Incidence,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.0435621028299005,1.893406320950633,0.4343420146659282
6,Incidence,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.33982789343111,2.027383563420541,0.7970245140447687
6,Incidence,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.1344437853148992,1.8235868788706904,0.6218244239713596
6,Incidence,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.389560235192352,0.9623158568443908,-0.0228631462469053
6,Incidence,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.5720800276803121,1.0257563754263217,0.2172060312978757
6,Incidence,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.4421894310180637,0.9154215439261144,0.0964583364040615
6,Incidence,70,Australasia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.3428436292591738,0.9012841545487396,-0.0574805463921656
6,Incidence,70,Australasia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.5272282938714133,0.976002528834385,0.1729352788444726
6,Incidence,70,Australasia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.3978203979341414,0.8491315450794852,0.0621124235232528
6,Incidence,70,Australasia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.7650115431905944,1.4939457639631804,0.242880348500142
6,Incidence,70,Australasia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,1.00681733140906,1.6080816660711292,0.5514429270815955
6,Incidence,70,Australasia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.8354340394134747,1.454891609999276,0.396879101054741
6,Incidence,70,Australasia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7288335840090154,1.4483078758603882,0.2127595915722263
6,Incidence,70,Australasia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.9958749243543892,1.5926213551630553,0.5270494307225475
6,Incidence,70,Australasia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.8120855470819103,1.405627381910498,0.3771667521145043
6,Incidence,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3956708633383661,0.0912245498890111,-0.572997471072284
6,Incidence,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2059470837416651,0.6431905078407395,-0.5069880750594153
6,Incidence,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3074954715808555,0.270050051227956,-0.5265573921765153
6,Incidence,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.609222617657211,-0.2910066367552228,-0.7245886146833631
6,Incidence,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.51389801630492,0.013182834417266,-0.6982662689747763
6,Incidence,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5643751611401626,-0.2047477142099391,-0.7006383915195569
6,Incidence,159,South Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6350110748083789,-0.340947090840497,-0.7421087539343767
6,Incidence,159,South Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.53957331176857,-0.0472061141422791,-0.7141300746949895
6,Incidence,159,South Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5899462417206838,-0.2479633340481933,-0.7196597095028998
6,Incidence,159,South Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3929101468640379,0.1011139491567785,-0.573470170488571
6,Incidence,159,South Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1992869995236997,0.6594843734867819,-0.5020251157767902
6,Incidence,159,South Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.303869326467594,0.2771237460853749,-0.521213470803462
6,Incidence,159,South Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4031554867791274,0.0802070837082863,-0.5783486710187784
6,Incidence,159,South Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.208664802030572,0.638927569764105,-0.5087779971936649
6,Incidence,159,South Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3130538850721079,0.2640732606597588,-0.5297602526788883
6,Incidence,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.527387541859173,2.26951922626146,0.9375296674107304
6,Incidence,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4185318598316556,2.2277835608207,0.6701698326935623
6,Incidence,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4755901445785933,2.069796158601659,0.8773799580799442
6,Incidence,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8858256688757576,1.4290729451779394,0.4504299556480608
6,Incidence,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7820603727918681,1.366827258980674,0.2377303379514747
6,Incidence,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8355505124444041,1.2747302702763137,0.386315057608334
6,Incidence,9,Southeast Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6712615824300541,1.1620039607569104,0.2812118617867498
6,Incidence,9,Southeast Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6252536150416366,1.1690708267787595,0.1223542692994113
6,Incidence,9,Southeast Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6502889494255699,1.046401214120099,0.2515074054068698
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0383747589133338,0.3384883568223378,-0.2094558862086731
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0445937585589482,0.2738427985866356,-0.348567795978429
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0020760956496225,0.2381758356934576,-0.2446200779766439
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0188295710798543,0.2673035740414523,-0.2520522664069186
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0809596598199633,0.2299640689557154,-0.3709072479690044
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0485447047612961,0.1786898867389765,-0.2820812233224961
6,Incidence,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.038380765293978,3.083299823493413,1.286169312735428
6,Incidence,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7779707726772285,2.7031598100444585,0.911708549450528
6,Incidence,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.991319417248324,2.9467911061763585,1.244461931967986
6,Incidence,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2674192693477069,2.0591951252724403,0.6996129102927539
6,Incidence,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0472872492008802,1.750223299922145,0.4073065545719204
6,Incidence,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2182001265031466,1.9167003140403591,0.66476066767862
6,Incidence,9,Southeast Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0091612234880527,1.7001249359360022,0.5117534924994612
6,Incidence,9,Southeast Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8667965949755726,1.4885237065971917,0.2846683074568835
6,Incidence,9,Southeast Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9940866985990376,1.6310274996359304,0.4962132289323877
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2543990336736482,0.672725991625744,-0.0494686546491276
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.112513536929841,0.4876833890156663,-0.2401039674023135
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2121922434584679,0.6009627857160393,-0.0771787889965227
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1851736352735101,0.5842355621329705,-0.1090245362613669
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0701008971965873,0.4338905695740115,-0.2680677360768929
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1557090821531845,0.5229434535641676,-0.1271407072995745
6,Incidence,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1947408969779745,1.9089103992099143,0.6348632615764302
6,Incidence,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0343837620617418,1.732671893918015,0.3890633151911529
6,Incidence,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1225969764822818,1.679836869663172,0.6141509879735689
6,Incidence,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.637848898525106,1.1690640257259417,0.2229331394088699
6,Incidence,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4991798248429952,1.011939439092555,0.0371905389855265
6,Incidence,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5740438607943343,0.9792311985622436,0.1950591420180519
6,Incidence,9,Southeast Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4512954913947032,0.9235475827955476,0.0810705190028285
6,Incidence,9,Southeast Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3671060607417442,0.8363557446053573,-0.0665493343166923
6,Incidence,9,Southeast Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4149750684878052,0.7864448127463224,0.0760325347031928
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0393905779110834,0.2663554973067625,-0.2705610536084163
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1167215753843622,0.1854848192198623,-0.3994428322841522
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0746459357753165,0.1635692177509746,-0.3082308141995807
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0924524930416404,0.1969518912135162,-0.3108902380500569
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1504214346457982,0.1421907144347977,-0.4210024840943041
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1178523755583885,0.106621702382424,-0.3373727512969409
6,Incidence,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4609914178219727,6.043856843391499,0.3408259520545462
6,Incidence,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9543203938469228,1.8846736259973065,0.3151632968519243
6,Incidence,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3071549497909984,4.053618356662803,0.3843186678361883
6,Incidence,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3858534018045351,2.965081963797787,-0.2427225710492057
6,Incidence,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0874344823157122,0.5724869120748699,-0.2689404529690333
6,Incidence,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2912488239801986,1.835762141783208,-0.2226407220729932
6,Incidence,261,Southern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2620090498788989,2.612125998504619,-0.3124175592197302
6,Incidence,261,Southern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0007193889208754,0.4771113463958988,-0.3265641524795398
6,Incidence,261,Southern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1822331260895077,1.5895768415563096,-0.2906469561880557
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1723552561923649,2.349588897460306,-0.3608859124465517
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0844669693955487,0.3372491878960065,-0.3859152947319608
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0704324601275773,1.3518530440577083,-0.3558852440852122
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1360746071954865,2.254427166975816,-0.3795758471713479
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1141066270593824,0.3145370659423085,-0.409527757302648
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0366228834342066,1.2807371286836289,-0.3824737251336655
6,Incidence,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.75990534741737,2.978723461358889,2.5041240015904247
6,Incidence,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.2253002552648247,2.3777336383231766,2.057577410331134
6,Incidence,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.6059037318358222,2.7893166409854167,2.3843724250672884
6,Incidence,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.075020893666583,2.282183828417036,1.8727293013774275
6,Incidence,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.614709048723063,1.7488038485774853,1.4731035624612328
6,Incidence,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.935160330908132,2.101917849496884,1.7582695639785515
6,Incidence,100,High-income North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.8421869586958184,2.007595907141333,1.6488367708017575
6,Incidence,100,High-income North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.4652684142660295,1.5817813509825551,1.3370689291821456
6,Incidence,100,High-income North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.741234048466474,1.8806658660855136,1.5728243497954515
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.146092751987633,1.2665974602832568,1.0283837824853037
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0226629731164651,1.104044727907389,0.932131185548327
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1473515110370576,1.2432473210691026,1.0486089148521986
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.01557341985905,1.1200702941930605,0.906389340454006
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.939910321600518,1.0181607365007996,0.8590770872171123
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0391515994994958,1.1239143606565665,0.946642584983332
6,Incidence,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.207779885311413,5.474378712865358,0.3367381822056398
6,Incidence,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3733730104851076,2.6354812635932703,0.5757452553635111
6,Incidence,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2986551633584238,3.071963611823312,0.5154406187572255
6,Incidence,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2431178724232492,2.656439653877892,-0.2471697633284751
6,Incidence,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3207348474400036,1.0267271757462093,-0.1179868278666244
6,Incidence,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2864382237118729,1.279696076840428,-0.1457085845501594
6,Incidence,261,Southern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1321608743639918,2.3200946857468683,-0.3145137886115854
6,Incidence,261,Southern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2152973464390838,0.861566097345507,-0.1931318764277015
6,Incidence,261,Southern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1778776626273811,1.0865569824708503,-0.2234574013857763
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1746716332424607,2.4146982997959494,-0.2974450133866145
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1078600646282671,0.7082316792831926,-0.2648818938468797
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1321889219710392,0.9877473984193114,-0.2547456873008363
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1384708307038455,2.317949350605417,-0.3192951769373098
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0719572352975789,0.6669807832204535,-0.2935930947724611
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0964499526583455,0.923412342385527,-0.2802997264320024
6,Incidence,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6716707472133352,6.189303360901458,0.534815344011301
6,Incidence,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2709350939244262,2.3930296524173977,0.5327639665555063
6,Incidence,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.560468473879442,4.387691843116874,0.59085892050869
6,Incidence,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5043752010871546,3.020460020609113,-0.1275250578065461
6,Incidence,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.263842095591481,0.845362034533382,-0.1435293340039882
6,Incidence,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4330603851347139,2.012384663186239,-0.1109409278103255
6,Incidence,261,Southern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3700464929958782,2.68671172035707,-0.2129388018144739
6,Incidence,261,Southern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1628435064312328,0.7374175549966188,-0.2151406571815636
6,Incidence,261,Southern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.312036128480378,1.7607628914009448,-0.1848115294853767
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3383728584908159,2.626833166015171,-0.2308288636911109
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0491638968083263,0.5623339092610833,-0.2999316277920955
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2105884998574236,1.538591887389389,-0.2536801593967837
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2969127947966226,2.5209122897477805,-0.2549804170963207
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0150668223062595,0.5378880304475676,-0.3231181561781389
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.172275383024747,1.457750374388259,-0.2729559614875156
6,Incidence,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6168194001357237,6.201009474358903,0.447550722047799
6,Incidence,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1365725419253143,2.202174400264641,0.4403573756282992
6,Incidence,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.32437008479592,2.9740720897105355,0.5151415827540653
6,Incidence,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4735158399679753,3.091190821005647,-0.1882180175717269
6,Incidence,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1889046897754002,0.7527801118176001,-0.2002033896817959
6,Incidence,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3008291779151124,1.2332237195412756,-0.1473639163089788
6,Incidence,261,Southern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.341918440249045,2.692714675513768,-0.2576885485444591
6,Incidence,261,Southern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0940424995166382,0.6396891825618957,-0.262457907462573
6,Incidence,261,Southern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1910545114389214,1.0363953753297557,-0.223610633516484
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2915286576941915,2.5836673307370583,-0.2944577252896825
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.02149357779705,0.5462742694269125,-0.32510514640786
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1298802557156991,0.941916934649915,-0.2736938252172827
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2516090823733183,2.4431765722380407,-0.3155186822776212
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0115935881164239,0.5059297399624636,-0.3493818949777016
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0941663746907181,0.8892903599817589,-0.2967973346697942
6,Incidence,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.819293587721552,4.995392023089028,2.816652928910901
6,Incidence,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.2841237618635906,3.8740664174351016,2.7153708279241258
6,Incidence,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.537582403912656,4.194813613615791,2.924721967736355
6,Incidence,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.8018652334326304,3.747822620967535,1.9933873299149705
6,Incidence,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.3273116337685305,2.796989339145271,1.859825660992017
6,Incidence,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.5495529915377624,3.092723583437265,2.0773525631102694
6,Incidence,96,Southern Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.534981223886311,3.397656595450819,1.799538188784501
6,Incidence,96,Southern Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.1280968365609696,2.558849507871024,1.7128160574952185
6,Incidence,96,Southern Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.320578114335534,2.801536337621278,1.8720901816966944
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6147059825522538,2.238205297491352,1.079600212937022
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2830629657388508,1.5999503214817845,0.9734183644563562
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.4306623717387794,1.7721579278167554,1.0978521605942522
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.533201545835898,2.12228867157998,1.0267156611684674
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2119712475070945,1.5050471337336522,0.9140836388399632
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.3539702197329682,1.6799511117055774,1.0300495628799908
6,Incidence,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.941085352149468,3.9128612799693534,2.0693570491722046
6,Incidence,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.624922818049332,3.1828343911460584,2.0842847949445065
6,Incidence,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.876486595067749,3.642725355794268,2.176013237754491
6,Incidence,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.1094074052153107,2.8827193562241646,1.422948049434933
6,Incidence,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.815782041144732,2.27721514208715,1.373571311044031
6,Incidence,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.0325027323071505,2.6236213039497622,1.4779173900200693
6,Incidence,96,Southern Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.890810129741099,2.6036136965169643,1.2513921056543342
6,Incidence,96,Southern Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6467745168466563,2.054139365271453,1.2520221278393144
6,Incidence,96,Southern Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8367917984249973,2.3975211544428943,1.324189206797378
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1907296139816388,1.736911740600762,0.7105889048504297
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0096158480357096,1.3355584982553863,0.7156470545652258
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.157380387109357,1.5902937276863125,0.7720150057543634
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1223096927298024,1.6402946505125864,0.6608342435465582
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9467984396558028,1.237716688672834,0.6634896193348014
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0893510850308872,1.4989842514084284,0.712413847374304
6,Incidence,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.2212052633582315,4.458821814398556,2.227582540445449
6,Incidence,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.9023030205996347,3.5971808389467324,2.2861423965829872
6,Incidence,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.0464735834857537,3.705472218452962,2.4135544516541003
6,Incidence,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.3302665302446246,3.3464984672344267,1.5399085570907451
6,Incidence,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.0306478287272696,2.5636984040212187,1.5650738249454292
6,Incidence,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.1654485133382906,2.697436279750711,1.6792740103968424
6,Incidence,96,Southern Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.0962797921585383,3.004079076569192,1.3674514680090446
6,Incidence,96,Southern Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.8493065122680057,2.356678667273726,1.3994105228109954
6,Incidence,96,Southern Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.9611873516552747,2.4434389671327565,1.4980205746745971
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.4039785454085965,2.0949289056566904,0.8608647039513647
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1992707366474682,1.5781300253001116,0.859316238531433
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2845483553792585,1.6643651601686202,0.9491854563798794
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.328739861122337,1.981344558873117,0.8003832680852889
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1308160316650575,1.493953897816483,0.8027528166463993
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.21232607470418,1.5812414881875096,0.8858858234836917
6,Incidence,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1479956824246004,0.3688102391616422,-0.0486183915090959
6,Incidence,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1174871198763425,0.2444340336660738,-0.0177461514302471
6,Incidence,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1360046740070667,0.3048333752004455,-0.0186358450631627
6,Incidence,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0226548149782558,0.1638954058593345,-0.1889253909045081
6,Incidence,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0199315045328375,0.0924479822347285,-0.1383314798119541
6,Incidence,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0169490796993721,0.1259886423731067,-0.1483803878641341
6,Incidence,73,Western Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0001329122253959,0.1921894206570754,-0.1713774077659956
6,Incidence,73,Western Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0093186559994271,0.103223078874303,-0.1292064619424922
6,Incidence,73,Western Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0015880270620687,0.1467921693436914,-0.137498511652287
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2277137218909437,0.4633992450557405,0.0135211574752895
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2014629989204325,0.3390131463504022,0.0503448927037295
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2189499615076628,0.4002024170232664,0.0512450052489812
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2532491394774705,0.496566005576139,0.0366308866347497
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2190528275255541,0.3607723562874117,0.069554528393635
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.239684141986445,0.4256910618014181,0.0686404355638883
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.357407537711974,3.260524145557937,0.5865822162472106
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.373892165594884,2.053142302859144,0.8932085173556523
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.36783959308723,2.191319582906199,0.8542295530521594
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.183547388804164,1.1329655638157043,-0.2048899308167304
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1465744128444107,0.468300686024176,-0.0948349930405447
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1657371179958406,0.570228656222028,-0.0977250455454316
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0561207943080621,0.9087188247232468,-0.2892096747580799
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0627619974551648,0.3668538357926319,-0.1524340933995961
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0604202828415642,0.4292099957374705,-0.1695963557492882
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1008743877259655,1.0306219890065087,-0.2580353731537494
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0190216437181438,0.3422264839184304,-0.2055380492061101
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0707612270165117,0.4471380942568728,-0.1695695684098637
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0630945493939571,0.9462453721828888,-0.2857133944546177
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0105137225908386,0.3258930931856536,-0.2123467873347178
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.04806274022221,0.4217693474385273,-0.1897312280534903
6,Incidence,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.467453058138581,4.785548875641645,4.166481367256591
6,Incidence,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.245874848316574,3.4434706692521315,3.030550551426569
6,Incidence,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.869586831031864,4.077486656492339,3.655365219136767
6,Incidence,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.4719337695514167,3.73150686712552,3.212958856451521
6,Incidence,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.44230551650402,2.614536033161448,2.257269362151248
6,Incidence,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.964127576396833,3.151942754326898,2.772987484424262
6,Incidence,100,High-income North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.132956110131055,3.3734110419935988,2.9054456449144164
6,Incidence,100,High-income North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.2453478206859128,2.3963808091179915,2.0807640157888443
6,Incidence,100,High-income North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.701895063180858,2.859942011353924,2.5390422473223464
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.8643798591011784,2.029766881071883,1.7128720427564144
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5870890235029105,1.7016917436594683,1.464037086907472
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7767303740147118,1.8863148239191427,1.6622191236063348
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6900432241980694,1.8366446990017808,1.5494196333349677
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.481224241081239,1.5942563645339485,1.365871954351639
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6367253223575964,1.7397564001882388,1.5352135817962156
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.264868458740973,3.015638616633417,0.6996612016851005
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3487584571502371,2.3247019946277945,0.6225180081337358
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.314279416500711,2.3244812145629066,0.7510031119680363
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1178467169494616,0.9663291470750972,-0.1640844263090725
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1255570401545646,0.5930787026203448,-0.2243431823706373
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1251542141988061,0.6167246022117728,-0.1477398372543185
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0088527048292628,0.757315899693299,-0.2561975967057714
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0169112103806275,0.4394527113758369,-0.2975196123327451
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0072995436555261,0.4469939914965153,-0.2378687624972575
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.114919867981434,0.9590062884288146,-0.1763955160851254
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0633364540495883,0.5383389255402442,-0.2746053835178379
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0919516136597596,0.5866130124755706,-0.1835995990680028
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0578391975457318,0.8678041767093412,-0.2152263525463432
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0193717647230098,0.459288435485756,-0.3052018528642727
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0419173631709279,0.5085107977856531,-0.2203527348521841
6,Incidence,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3253171200330374,2.0726221996959824,0.8815512382880024
6,Incidence,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5308350038816267,2.1047583356853234,1.0838878061846802
6,Incidence,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.455832895917637,1.984208852306199,1.0679587736521974
6,Incidence,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1792136285440336,0.5416215824229788,-0.0434782927446709
6,Incidence,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2297542341666446,0.4996286653898376,0.0100344789576365
6,Incidence,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2188725261149209,0.4900187265074336,0.0195522152407691
6,Incidence,248,Eastern Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0530522363199823,0.3914797473775566,-0.1479133223765786
6,Incidence,248,Eastern Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.144088196484026,0.4035357339948933,-0.057958563795652
6,Incidence,248,Eastern Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.111167896734794,0.3502372573258515,-0.0643299041750267
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0818579212565428,0.407134613596909,-0.1242158403789906
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0766388317661145,0.3215435447583799,-0.1261616773571885
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0978033377766827,0.3300889864452768,-0.081940017397703
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0431679706464308,0.3581516671539609,-0.1606123738027966
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0689986966096143,0.3024084146614783,-0.1315556595350178
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0744307545121716,0.2923039935078921,-0.0986296289369101
6,Incidence,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6432620387940197,-0.5058566821223454,-0.7604999899643321
6,Incidence,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6131525827734512,-0.4253375941210036,-0.7432193569407498
6,Incidence,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6301384485942731,-0.4844896186687049,-0.7419453284248432
6,Incidence,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7482295263306478,-0.6538692031360513,-0.8297112997085853
6,Incidence,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7285723375763663,-0.594247097282147,-0.819964544560418
6,Incidence,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7397637950081843,-0.6355575546068803,-0.8190634269897408
6,Incidence,32,Central Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7453271712395495,-0.6472344121955835,-0.8290225552735001
6,Incidence,32,Central Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7165042376688741,-0.5788666291074189,-0.8118218684827683
6,Incidence,32,Central Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7324277850557396,-0.6270597632132271,-0.813313225482217
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6834328757963634,-0.56378065242893,-0.7865750993098848
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6485149108054453,-0.4774777895660559,-0.766389774371907
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6681175449173684,-0.5374681657651086,-0.7685688354870066
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6703707246203817,-0.542962045349108,-0.778463229827742
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6282169876338819,-0.4493325598109846,-0.7523838182442192
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.651644792583851,-0.5154941577686762,-0.7558555788109932
6,Incidence,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4662135487092823,-0.2916012845968661,-0.6041183910982252
6,Incidence,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5558506811540874,-0.4331199350145667,-0.6552774793270992
6,Incidence,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5072006792000195,-0.3363931885375713,-0.624610737485513
6,Incidence,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6112560576528641,-0.4841188333012312,-0.7131838575848062
6,Incidence,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6902963460717303,-0.6020185168224657,-0.7596347016164968
6,Incidence,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6491882586407437,-0.5324027026501994,-0.7323880781965992
6,Incidence,124,Central Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6486554176947064,-0.5337235514931312,-0.7394260229243095
6,Incidence,124,Central Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7149203664317625,-0.6361449756962221,-0.7787379925933346
6,Incidence,124,Central Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6797646977270717,-0.5687690325667076,-0.7560611614557582
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3720869848800114,-0.1652846228917573,-0.5385796982846396
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4757843574470093,-0.3297357343114738,-0.5953685234114452
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4195440026588079,-0.2229327400151125,-0.5603376004573057
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3971806689594619,-0.1965451563843228,-0.554191734855401
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4950985199408037,-0.3537316816019666,-0.6095579475048817
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4416645124480464,-0.2463462158602755,-0.5761151223798606
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7320512221370334,2.447952317724854,1.1672215246171764
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6364812260978612,2.345467693601932,1.0903314175026966
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6868709910149573,2.193072595757785,1.211330734649294
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3405042682485866,1.9701486146916944,0.851214160343811
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2146842613455324,1.810179089422141,0.7521361543144032
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.279263530318414,1.7134793276671232,0.8778207151071984
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1502331092095748,1.7136757804813991,0.705689644273358
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0600411930436906,1.6140149190506832,0.6333015325666981
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1071454800656826,1.5041278536157123,0.7342088913195024
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2142718439965178,0.5295256008207234,-0.0207532558444436
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0891459533388113,0.3652361543346958,-0.1276726271682069
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1505291212728094,0.3654805489920987,-0.0360371928257465
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1670653750023309,0.4674685345357018,-0.0534535096984226
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.055691235776575,0.3265135866981986,-0.1531996934011104
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1101713963854958,0.3157918887712518,-0.0679914681078072
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1427973253304632,1.1271078750504318,-0.5560624492671147
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0827645791194275,0.8561250776265672,-0.4837357510542424
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1065790415067769,0.8309169735130737,-0.4918816851970571
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5693577413241966,0.0653010557707828,-0.7787580956221873
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5567167670947416,-0.1010036268089522,-0.7467948307636826
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5598770315931184,-0.1025571457385766,-0.7513887507286252
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6159723954502794,-0.0470536711876469,-0.8011155596973094
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5893651101092094,-0.1690358881441838,-0.768874916739619
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.59988771694339,-0.1800367302834313,-0.7724427918709671
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4994524206685019,0.25404667626798,-0.7427182169445509
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4740074067642748,0.0827838860794964,-0.702393610814882
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4829011137350825,0.0612697534221498,-0.7084097161715485
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5169399619346592,0.2097551167211531,-0.7503314029719631
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4787488338633548,0.0712098031049573,-0.7078348032024799
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4942041823302829,0.0444700932287998,-0.7132260955636409
6,Incidence,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.386814677122493,-0.094196795521484,-0.5880457687070298
6,Incidence,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3843103893930158,-0.0035795488907752,-0.5896087622309405
6,Incidence,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3854877875837497,-0.0886727531843376,-0.5790434329329928
6,Incidence,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5382346448536428,-0.3172491453093832,-0.6873709601262994
6,Incidence,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5371802021139662,-0.2490224804544433,-0.691635698004945
6,Incidence,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5376638478097838,-0.3152477456051777,-0.6859759379471941
6,Incidence,104,Caribbean,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5447946438553286,-0.3275663084095114,-0.6941809179465932
6,Incidence,104,Caribbean,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5413704061449747,-0.2577625171382421,-0.6942979653105918
6,Incidence,104,Caribbean,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5430199309994191,-0.3222943666254844,-0.6869569763176262
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3633983809284126,-0.0586752083839265,-0.5727216669082018
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3507917244622827,0.0511694206701326,-0.5657493160753275
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3567527848866851,-0.0468698077820674,-0.5594114332523226
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3513209241382499,-0.0423192341040102,-0.5656937598832332
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3405360656610197,0.0636105397444588,-0.5600159262736666
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3458499145388372,-0.0261139803631606,-0.5513116044907385
6,Incidence,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7823937257874946,-0.71180502089551,-0.8364055068114022
6,Incidence,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.8092489149331817,-0.7449903366254502,-0.8565922646184898
6,Incidence,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7932736781011704,-0.7300634709503475,-0.8437376288985872
6,Incidence,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.777811261832539,-0.7050075455942051,-0.8336417354289758
6,Incidence,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.8093937119703082,-0.7456156305252738,-0.8568881475380263
6,Incidence,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7913032247634353,-0.7276899459453523,-0.8423008149618837
6,Incidence,42,Central Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.762647145392721,-0.6856529012250112,-0.8215602004268256
6,Incidence,42,Central Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7939771382342347,-0.7245739356714763,-0.8451108572604089
6,Incidence,42,Central Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7756467835483888,-0.7070468435088225,-0.8304136345824679
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6662239857298549,-0.5566028190663946,-0.7503823020555418
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.707065767565188,-0.6084414824676687,-0.781033541736977
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.682111824257848,-0.5838282128541634,-0.7599547592979932
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6441061863769019,-0.5284613127287023,-0.7333643414042713
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6860721178344953,-0.5802880570462272,-0.7648668518520814
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6604267566223311,-0.555202729141747,-0.7433889659046937
6,Incidence,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3743183290815213,0.1313380987043352,-0.5610928923171045
6,Incidence,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1835800970223388,0.6771992444457982,-0.4867678554079504
6,Incidence,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2851716331180978,0.3173068547133917,-0.5044057699525507
6,Incidence,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5968898885003765,-0.2639742640675916,-0.7147052612712823
6,Incidence,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5014563300298059,0.0336711314873946,-0.6869918280832036
6,Incidence,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5517135432945821,-0.1678606070384841,-0.6922470833295118
6,Incidence,244,South Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6238900712990537,-0.3199297479567818,-0.736164045312971
6,Incidence,244,South Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5282902519232864,-0.0309505804715428,-0.7034655760505004
6,Incidence,244,South Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5784894565424256,-0.2232279048288474,-0.7077645447214739
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3841172130844923,0.1281796461386858,-0.5648895379597261
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1928461733251871,0.6703082005596781,-0.4924365104489188
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2956801706507476,0.3103196274481259,-0.5110848971071584
6,Incidence,244,South Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3952884604615298,0.0944268633988888,-0.575901540122036
6,Incidence,244,South Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2033941033244909,0.6392922986233598,-0.4986069380953477
6,Incidence,244,South Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3059189548686802,0.2777056470396953,-0.5195587021099519
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1199137739688374,3.022394729521288,1.1577659586880042
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2130292860130554,2.225992343745546,0.447576542586187
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7391972426322904,2.599071378851458,0.8977568236472304
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8009566240950948,1.321822441356149,0.2443230691940462
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2735907359819597,0.8524579083945092,-0.1707820192954129
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5788137094068811,1.0844338617889424,0.0934394693881555
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6762203859930671,1.161091791186788,0.159292067086092
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2220402702704974,0.7814009875774018,-0.2006446365080667
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4913535532142782,0.9595112778238424,0.0332320498991078
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2061680764155352,0.5633974032789192,-0.1840628495308433
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1521862823759534,0.2727283613167622,-0.4620420644276198
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0520926650332826,0.4144262688042052,-0.2899562579789281
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2027998743339406,0.5598002821026455,-0.1844672224615597
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.146757239099066,0.2781422773464863,-0.462845047499273
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0530857111534098,0.4082961895722037,-0.2893184062095192
6,Incidence,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.389693235215269,4.0254559301389286,2.75930703218882
6,Incidence,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.521179431721215,2.987983127721905,2.1073652207481306
6,Incidence,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.839975507655115,3.2733748621152685,2.4272152550662054
6,Incidence,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.19713477191587,2.659447180994647,1.7479215249698403
6,Incidence,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4549525282354685,1.7846887113365608,1.1424054185778385
6,Incidence,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.733462941036376,2.0456306066829044,1.4185918143453464
6,Incidence,124,Central Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.889348226141278,2.307814783231884,1.4744205398768648
6,Incidence,124,Central Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.260087991874977,1.5597084594915092,0.9944791107534858
6,Incidence,124,Central Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4953275410736482,1.776963021120849,1.2271039484771968
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5872815511040871,0.8173697909087824,0.3637713405197856
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1579798175205738,0.3168482102414713,0.0152511093215613
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.320928144440287,0.4689001766233259,0.1837173142750606
6,Incidence,124,Central Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5236865885312139,0.7396749403051502,0.3144177842251885
6,Incidence,124,Central Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1154297300730959,0.2669344046908589,-0.0201455165521948
6,Incidence,124,Central Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2705951586497583,0.4070237500560399,0.131567988986083
6,Incidence,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9607258448958916,1.3173881116252104,0.6886732271012361
6,Incidence,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.4732597728718684,0.7045853620808061,0.2739662397873774
6,Incidence,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.6588183768700651,0.909225441431224,0.4556908507861633
6,Incidence,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.002215755605524,1.372460497038583,0.7237045626841909
6,Incidence,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4720538858480225,0.6983295866939333,0.2718231059093097
6,Incidence,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6746657407941887,0.9386019403608216,0.4609841661118534
6,Incidence,42,Central Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1386510020103255,1.5276784206601952,0.841911095632969
6,Incidence,42,Central Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5912108412128906,0.8410566539996587,0.3759616120769492
6,Incidence,42,Central Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8002605325797533,1.0720190093933444,0.5798129697914747
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2203845906460385,0.4086427704106094,0.0592033629644101
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1156037529570056,0.0013502741508119,-0.227600567970818
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0123853923546341,0.1501036385320079,-0.1016571528412723
6,Incidence,42,Central Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3011198920560197,0.500489285234672,0.1251379180133666
6,Incidence,42,Central Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0521115902489765,0.0711386499011444,-0.1686586295340702
6,Incidence,42,Central Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.081446283963895,0.2212618526141399,-0.035139288167595
6,Incidence,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7444980968820155,0.9170893544697398,0.5548858976470832
6,Incidence,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.4766943631757091,0.6461268328569925,0.3275896993616102
6,Incidence,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6307106594383639,0.7782426569771244,0.4993993579807561
6,Incidence,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7543366049132942,0.941135434997532,0.5638727499739126
6,Incidence,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4542703749948622,0.6194273544422515,0.3080648082569451
6,Incidence,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6211393969053979,0.757512862533871,0.4932171384949693
6,Incidence,56,Eastern Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9198535074169304,1.1097934860397305,0.7111816571002899
6,Incidence,56,Eastern Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6110872685900322,0.7959396670255812,0.4484126951991768
6,Incidence,56,Eastern Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7863354964398009,0.9479470260749404,0.6424926647763247
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2242522513010011,0.3476510786624094,0.0973835953295391
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0988302308263228,0.2156471817784223,-0.0065676487851323
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2113979665128868,0.3114009595449445,0.1196401719108373
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3358107014085194,0.4660870481116237,0.1925642088572527
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2048167756283035,0.3356337158463903,0.08929129768092
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3248411342555701,0.4440564798338269,0.2214533054375648
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8479337807866334,1.5946163625389,0.304805329816735
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1715678827889369,1.983113990701387,0.532802272251158
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0265500501487848,1.7649069100328043,0.4539769049233684
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1942572576964391,0.139776763109344,-0.4303441660765051
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0680611159424423,0.2849720160762853,-0.3431903565809935
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1235152395292023,0.1889990170820359,-0.3711967070945247
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2635927804417309,0.0339624943401981,-0.4800311163822511
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1220720080663981,0.2060222921523347,-0.380314089384828
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.186547840006877,0.1098267708616279,-0.4163772793061808
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.2026762627089762,0.1271067409576572,-0.4307091961060332
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1596591919707928,0.1601363374600688,-0.3987804796056045
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1688827506349314,0.1466192281809906,-0.4072550131335627
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2015981163704215,0.1196378729083966,-0.4324322169521065
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1451908090312096,0.187969796019261,-0.387960891177653
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.161204637612271,0.1469779649617597,-0.3925716765630065
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.3532285420366734,3.514227076762406,1.2229093424938111
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2708742994080189,2.4207510652579773,0.4207626514097911
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8936109439661333,2.942197365078005,0.9163535232972138
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9225353484363982,1.5909615477703491,0.2682336099041443
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3026781476582204,0.979545180929038,-0.1907217140314789
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6595127994452357,1.2600490471979202,0.1079976606120118
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7847484303262381,1.402687317129418,0.1831385514104213
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.251264366255498,0.884852858171693,-0.2171518788692154
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5659932125442939,1.133477663642129,0.0371113008735935
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2359076211065136,0.6674932183795074,-0.1932761573083164
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1628250484557986,0.3062294779444988,-0.4956471115388037
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.063959892099185,0.4726465260519887,-0.3137313529265743
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.236016848942783,0.6491719685721747,-0.1908184228005767
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1524776058077257,0.316997753238227,-0.4922765462952204
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0695399629353922,0.48163387813877,-0.3055835042087051
6,Incidence,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.2414448906924256,3.7048863226004713,0.9424798621293208
6,Incidence,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0554633793666015,2.5637092977053464,0.115758094814008
6,Incidence,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.740576306182178,3.167502694952301,0.6304398802091079
6,Incidence,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.972643652041615,1.909115905657777,0.1608440961894671
6,Incidence,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2200699452738382,1.142982266092463,-0.3415138541887648
6,Incidence,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6467027770889251,1.5032629028993822,-0.0327733388431449
6,Incidence,254,Northern Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8484315517957622,1.68295794609339,0.1076977048715852
6,Incidence,254,Northern Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1877736428847912,1.059331252120024,-0.3552460870094341
6,Incidence,254,Northern Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5730071042982023,1.392019274031518,-0.0641773013527797
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3011341669126885,0.8947152118086203,-0.2472831572083402
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1851216395279032,0.4782291919496456,-0.5726966466247465
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0969529726097036,0.7044865656471776,-0.3654223443413455
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2957063670482202,0.8767234372120978,-0.2377965432281402
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1705834216353364,0.5083010319338727,-0.5647082287114591
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1043059096865474,0.6958942368646482,-0.3561446652259327
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.908202895425505,3.279894002269005,2.592724504283288
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.788574261594229,1.968266225849264,1.5954968175477164
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.2647820887962373,2.4658574136128566,2.0818650102150644
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.877159181101506,2.16218279411519,1.638622910801266
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9523751200961912,1.0928903690084548,0.8075823582805077
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3412072545913905,1.4960061309895625,1.1981014014315563
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.6517649026047172,1.90396200140212,1.4377088396146638
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8482984049861908,0.967400261262932,0.720324502054891
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1889812477407842,1.3237988568294377,1.0663384360567296
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4169718331172332,0.5443236817051391,0.301294748407801
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.086424123578008,-0.0291246644888127,-0.1462161569487827
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1188588041043556,0.1885937849016596,0.055120703861742
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3684068202907699,0.4938780379686024,0.2556996215661949
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1042411756146549,-0.051590773196612,-0.1586752437793069
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0892227816487174,0.1523453157950732,0.0301162946317523
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.553944239222853,2.877207228316576,2.26868536079794
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.758074734349335,1.9484017663506927,1.584531855000673
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2702794940100244,2.5012291144670677,2.0731357124495124
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.616756587122877,1.864614610328931,1.4031015067915809
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.931269676266558,1.0711247963324566,0.8036547349273488
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3454921600035337,1.5184058647005965,1.1913598316865237
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.4113959411923918,1.6307339519679274,1.2178441983059147
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8280829750670498,0.954233873939924,0.7130568014719967
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1926671650843994,1.3475149848173589,1.0604855893444438
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3558353863795191,0.4768866542761725,0.2462238712170507
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0323681398218797,0.0327373527475849,-0.0930250010935288
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1943959057441868,0.277451303156511,0.1252167394022425
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3093193432268921,0.4278043861384499,0.2088182086764927
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0512241615026566,0.0099924068109929,-0.1082404410259737
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1627432345383087,0.2434687590100114,0.0929590486855315
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.7999795477100071,2.064141323377277,1.556694166087111
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.375707185074287,1.5373000061113924,1.213699665376298
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5484762050797112,1.710015905204863,1.4042110780708017
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.061598666916663,1.2654359258114778,0.8795123415125999
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6633469800763443,0.8007067590527108,0.544232765526421
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8276731173596884,0.9533172976907393,0.7128845435423459
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8998213990678849,1.079058491938404,0.7347492025707401
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5746454599981484,0.6817510004506897,0.4672650526058858
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.708710251252927,0.8170198917502562,0.6119829202591852
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1843182509141132,0.2928607489903727,0.0779450084705139
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.07507935943128,-0.0135125775089958,-0.1347149956349692
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.029084512633252,0.087503793511236,-0.0259267275684878
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.143591067476815,0.2465012433610542,0.0443722660896937
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0930919556887189,-0.0404246318835475,-0.1487442755461613
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0017884614620666,0.0533153122192285,-0.0498363320165838
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1573151954780196,1.296953772110321,1.0135697034609894
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8201179248674665,0.9129158498981136,0.6947040581636407
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0352371770873985,1.1349543895777834,0.9164027556758688
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.910954792105402,1.0403959097394766,0.7825813429258671
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6194888849533238,0.70060755839725,0.5121103347350285
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8071959779672707,0.904512762165427,0.6992711109929134
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9816811218252492,1.1099512660168895,0.8496384196393452
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6902609183664244,0.7764381400957373,0.573794751743661
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8800673982833711,0.9721820089840032,0.7702931056334004
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2890080772980677,0.3762433356823156,0.2017975788275478
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1823222893048087,0.2402796130375774,0.1196049475369911
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2882016314265564,0.3569488722490771,0.2160050464350247
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.338896252502658,0.4260236324198245,0.2497977404476719
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2317865174646789,0.2913992036545546,0.1645356494734709
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3393415016017977,0.403764776837155,0.2680382369844916
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0278955255158979,0.7100561042868778,-0.3006177618995952
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0503682898435819,0.3880034444231394,-0.3427113904809488
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0145704867179974,0.4286492933581742,-0.3037651325077584
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4924051709448685,-0.1560247735945124,-0.6532602771723474
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5446865772272624,-0.3326401596475141,-0.6855939846258121
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5206472181454199,-0.3058994849611918,-0.6583502291776285
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.550174375071863,-0.2516485998059506,-0.6939377159373694
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.588850386530309,-0.3990543138295424,-0.7154223528432136
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.571087790023844,-0.3781745752120857,-0.6969609376890096
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4355015269429785,-0.0437298976595617,-0.614975613274345
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4716392015180715,-0.2186745703215485,-0.6386945483956333
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4550514672644053,-0.1962189851998343,-0.6128389389438769
6,Incidence,242,Sub-Saharan Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4646718674724685,-0.0904208805023511,-0.6358367225434312
6,Incidence,242,Sub-Saharan Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4937752547966769,-0.2506252340653844,-0.6532367147132037
6,Incidence,242,Sub-Saharan Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4803139001214831,-0.2319190238531877,-0.6339199160261544
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7117772106365935,-0.5956873488781954,-0.7871371378360619
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7226419334740655,-0.6150379066571426,-0.802360712349111
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7165752706479402,-0.6184851679144434,-0.7869024584492379
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.753045262147325,-0.6542150282775752,-0.818266605602131
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7670006675396647,-0.677775426465838,-0.8336086330014278
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7595488759944261,-0.6757654240240224,-0.8203347750801218
6,Incidence,239,East Asia & Pacific - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7731571869896481,-0.681789842785459,-0.8324684507239972
6,Incidence,239,East Asia & Pacific - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7832834777617456,-0.6992059862985043,-0.8455725495427706
6,Incidence,239,East Asia & Pacific - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7777276469952747,-0.7008016921186736,-0.8328808777967496
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6099364557924917,-0.4499483376333402,-0.7124511627939437
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.623090444683716,-0.4739371808361561,-0.7329780056327058
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6155446995973334,-0.4821202409572928,-0.7131441855730101
6,Incidence,239,East Asia & Pacific - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6251884941168936,-0.4729568766100022,-0.7234364554897315
6,Incidence,239,East Asia & Pacific - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6347094680525615,-0.4896679057549733,-0.7417382073625403
6,Incidence,239,East Asia & Pacific - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6290916146139034,-0.4994548627447306,-0.7221019233133656
6,Incidence,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2071956873231716,1.295625323341009,-0.6112550309495783
6,Incidence,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2589720688106728,0.2945831841450193,-0.5719014457095062
6,Incidence,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2325830635338936,0.6003616558778095,-0.5724363336095303
6,Incidence,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5533870317164509,0.2793078259374342,-0.7817466515725201
6,Incidence,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5873640933532495,-0.2833128821739654,-0.7610134192248041
6,Incidence,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5702674310142962,-0.104558894594686,-0.7628321995532774
6,Incidence,261,Southern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5934458730186616,0.1772084665583764,-0.8006495815126753
6,Incidence,261,Southern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6205529959121079,-0.3371023006137039,-0.7807900255268742
6,Incidence,261,Southern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6067599517342583,-0.1799421345871913,-0.7809076802731059
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4953900544763711,0.4723973616422965,-0.7542488584002602
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5214931476413907,-0.1592410697039714,-0.7240005285948556
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5080649703853499,0.0381897828539537,-0.7301798369558986
6,Incidence,261,Southern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5112441116304588,0.4323549623843502,-0.7626123731469032
6,Incidence,261,Southern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5373042916591902,-0.1866690265558706,-0.7350325200360376
6,Incidence,261,Southern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5238985289484763,0.0075223023037428,-0.7358677198885731
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3718139461730065,0.8037385234349219,-0.688763822975497
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3364454690853733,0.6957602979365869,-0.6998917982383821
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3550475055098746,0.6784227556842726,-0.6831349377375353
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7259924056644138,-0.2083871078658027,-0.8656988773478993
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7147738335663486,-0.2685209165129216,-0.8723863368650451
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7207538825505909,-0.2678736036808046,-0.8633448374303838
6,Incidence,167,Central Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7496659511970735,-0.2812047246155001,-0.875971438948968
6,Incidence,167,Central Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7317361794298822,-0.3144329288678771,-0.878671353991014
6,Incidence,167,Central Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7411176695599365,-0.3262852719118669,-0.8728111505043592
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6990859246049116,-0.1148995710305224,-0.8527332380414464
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6765785318497083,-0.1615569335244731,-0.8569997493942243
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6884350030369623,-0.1614293455207643,-0.8491991741786606
6,Incidence,167,Central Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6987885937662232,-0.1134123268390547,-0.8525751238196274
6,Incidence,167,Central Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6714734090244449,-0.1442755362561458,-0.8534166430623938
6,Incidence,167,Central Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6858577420555154,-0.158943913540635,-0.8472833189099764
6,Incidence,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1958448178112459,0.6789255794398629,-0.167215821182785
6,Incidence,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0063659024677278,0.2430094025624693,-0.2324237559673848
6,Incidence,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1057463642374209,0.4221649344591895,-0.1473313450220854
6,Incidence,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0566443603905466,0.3190183954895956,-0.3447408290803531
6,Incidence,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2281600115138016,-0.0370878704832392,-0.40584986508082
6,Incidence,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1349830990211036,0.1046396321978355,-0.3353500064223274
6,Incidence,96,Southern Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1228405365436404,0.2315021468588896,-0.3891477283789561
6,Incidence,96,Southern Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2744878883149363,-0.0924039556037909,-0.4395463450072417
6,Incidence,96,Southern Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1908208269833674,0.0407325610811128,-0.3760217176313613
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.4242627940704379,0.9866412017066511,-0.009855591681188
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2162180968242009,0.5170428430379244,-0.0666714713936966
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.3335588102229787,0.6973998161450958,0.024375953680707
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.3798805099203992,0.9308115380530908,-0.0374796892304256
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1781336595681806,0.4599271946271729,-0.0902791323701256
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2914080507727288,0.654461000507397,-0.008170549059414
6,Incidence,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8178709632460626,1.3783617804735346,0.4886437121346529
6,Incidence,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9118053129662104,1.404190539819999,0.5432102370312395
6,Incidence,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8563562586136824,1.3125379180378998,0.5468067274268635
6,Incidence,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.077796730452842,0.2067897736806841,-0.2417246222846398
6,Incidence,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0707275301074936,0.1686238572339997,-0.25761434625697
6,Incidence,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0783631674384508,0.1446596097794466,-0.231517009867795
6,Incidence,248,Eastern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1767518216353086,0.0770742494125048,-0.3258469665742605
6,Incidence,248,Eastern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1357501025608566,0.0868373538725056,-0.3023770359692176
6,Incidence,248,Eastern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1600717284538673,0.0463325492451636,-0.3001307292416928
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2045015769653758,0.0455576226607268,-0.3409482354752342
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2062999309069808,-0.0157521450557325,-0.3552394367637491
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2109961637237309,-0.0209278116548712,-0.3357292922327919
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.233186957494166,0.0016652230959328,-0.3655888490661995
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2121881952091422,-0.0225110045338576,-0.3578772300441961
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2280155647861442,-0.0474547018425783,-0.3485824550381201
6,Incidence,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8635959894970904,1.406187634679522,0.5419650485608426
6,Incidence,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.084133586000984,1.5552131060813132,0.7174755633002659
6,Incidence,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0035906940120458,1.4002562960058806,0.6807614191167353
6,Incidence,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0545687407104561,0.214507631878841,-0.212884153312673
6,Incidence,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0128681994042025,0.2523005968109957,-0.1736374389935056
6,Incidence,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.005320845039706,0.190206412485399,-0.1621605065790581
6,Incidence,248,Eastern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1560446068065842,0.0896755749464226,-0.3016996569090861
6,Incidence,248,Eastern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0578474566763293,0.1551085510059785,-0.2235987266226807
6,Incidence,248,Eastern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0934539312167274,0.0860216688565565,-0.2395214942769598
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1075558410902725,0.1529959906947163,-0.2654615868121222
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1027696237241717,0.1004825410047726,-0.2634048519746017
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0865413816610807,0.0984691084483073,-0.2352979941358048
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1396920370227402,0.1125426693889706,-0.2858988264677397
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1092378146291283,0.0928514293818226,-0.2651753574126055
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1061484738648647,0.0710122048252478,-0.2500757307994982
6,Incidence,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8580785137791835,1.4856457151137958,0.5026072776526376
6,Incidence,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.242958763412274,1.7856657992759877,0.8381821129497606
6,Incidence,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.976638223669027,1.5103318208156522,0.6621036741839916
6,Incidence,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0574782350080943,0.267178018220484,-0.2332791217975715
6,Incidence,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0901068392506761,0.351911979921975,-0.1130980776967212
6,Incidence,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0187463270693858,0.251084681010667,-0.1751605928016089
6,Incidence,248,Eastern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1585432725126656,0.1256592730726448,-0.3195233714959662
6,Incidence,248,Eastern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0139509855382154,0.2592868975704918,-0.1690321750772449
6,Incidence,248,Eastern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1056488650954302,0.1358265190107237,-0.2479633908038749
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1343429075246755,0.1533819452333191,-0.2904220810633076
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0402860815616855,0.1952525442672759,-0.2161413722832393
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1200869818027316,0.1172406427476977,-0.2582202323662061
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1654702781954904,0.1090571470841051,-0.3167780937280284
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0472387381617611,0.1884971735936793,-0.2227359297107633
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.138940207656804,0.0875973915092518,-0.2753378272712754
6,Incidence,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0331917798182728,1.687707592922871,0.6837119655000434
6,Incidence,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2048138387763645,1.696121085322543,0.7929111181228456
6,Incidence,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1439848703805977,1.6211462164158577,0.8042360492632319
6,Incidence,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0313380738984623,0.3624395898735129,-0.1480259093681119
6,Incidence,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0714872234640935,0.3148034747818893,-0.1270402626542449
6,Incidence,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0642908004061384,0.2928719151212741,-0.1168714910336765
6,Incidence,248,Eastern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0792407916496928,0.2171658080173663,-0.237507591840487
6,Incidence,248,Eastern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0032927928846297,0.2188073522289157,-0.1894973617627161
6,Incidence,248,Eastern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0299310824396064,0.1859656791676319,-0.1836540754032814
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0859176376807626,0.1985442792149185,-0.2367710567038998
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0731116311384161,0.1482077799129927,-0.245367132605327
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0637154670770099,0.1459828345611354,-0.2139512777474599
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1187525113023865,0.1604322288211545,-0.266834851513112
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0797811332717828,0.1431847175906831,-0.243471385845682
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0837584863420341,0.1169382338728691,-0.2276264270445209
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7507418585316104,0.9144201121145866,0.5984193239404713
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4612860928723912,0.5694132046692398,0.3594701497471035
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6683711067196522,0.805389349974747,0.539515158596681
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5507833157659358,0.6915115917032351,0.4104951858653188
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3002430664764673,0.3975939114889554,0.209248458965908
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4814366710462843,0.6019157530308866,0.3635878103155004
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6082082476930709,0.758560920245791,0.4682867879728816
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3570300800781471,0.4574428219060491,0.262478234189469
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5411717913242816,0.6677435417885762,0.4221400293909696
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1321270830366795,0.2208967117319096,0.0386315348425612
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0130451015508041,0.0795252175187939,-0.0485733467690831
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1288809034126007,0.2066055932483546,0.0466283599904434
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1759782412269096,0.2671245081472214,0.0820926298841785
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0554195616714932,0.1249630600531898,-0.0072539017778099
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1737086118238535,0.2565647301464537,0.0892302257312001
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.097370815669633,2.8507366957566256,1.162933604747025
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.36613382899455,2.2537759609525807,0.6066889950736873
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8597250103078715,2.622313192105588,1.0301837347335183
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.7760248572974094,1.2271302862321534,0.2387855108785357
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3574156315228372,0.8782940546516,-0.0862560511787068
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6402900020777783,1.0821992673861516,0.1691854378638787
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6485687247690793,1.0495460381525348,0.1512165984449905
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3037528967518617,0.7928486472280918,-0.1147054296600039
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5476544852111639,0.9603595584871418,0.0987150692943081
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1112765488770032,0.3942325719812504,-0.2290776052286435
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1376935946304527,0.1890993073345982,-0.4271339069230319
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0324916250357927,0.3072898063495026,-0.267252015480434
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1111637117570361,0.3822934784753783,-0.2271623104522639
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1271369174398305,0.2105494934644551,-0.4169612722125643
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0377019877076357,0.3129133042107048,-0.2608312431078059
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3062467619560727,3.778126257371973,0.9928649118513366
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0744259131082017,2.401315348814128,0.1710434418905376
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7594409444543289,3.096693321453565,0.6899792420465793
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8955242277691381,1.755512545751131,0.1322137701655111
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1898282648873631,0.9586106102229996,-0.3270614885371652
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5824343454269433,1.3217594199306286,-0.0307798847515132
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7597424824161476,1.5431470688143525,0.060697915066238
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1430202130456817,0.8741436703381021,-0.354748551887351
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4933817548773003,1.217089325242376,-0.085400189025318
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1750499499753496,0.6726178051722467,-0.2897715224293066
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2785675943860005,0.200425526167447,-0.5982021547336787
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0328678786032856,0.4179052567604645,-0.4079447886289213
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1752221884445431,0.6630018906361187,-0.2876305694297346
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2695794399450275,0.2158907678206174,-0.5917138092026166
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0277176221598668,0.446898907374795,-0.4022843178559551
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.081580076683589,4.545093355141175,1.659661419450822
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7965095478552184,3.296035795532069,0.6749223844096617
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.7623144061331004,4.137934424891344,1.4827756985473106
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3404017456341188,2.1827039102277173,0.5192188244184631
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.604452800597265,1.476646976124553,-0.0462577096256792
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.158210582755174,1.9658606947215072,0.4380838646373213
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.172411914007919,1.9513636000454877,0.4155988725662534
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.540892310964412,1.3671396116062762,-0.0771084527215624
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0361268109480228,1.780598564107343,0.3436532994535549
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4523430547410138,0.9480159137256852,-0.0561054976031485
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0114225339565998,0.5203949054334134,-0.4141092746110961
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3344949512656792,0.8192075552990441,-0.1098462358901071
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4525241656392949,0.950368939812154,-0.0540825953912336
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0007728115308398,0.5457449826821514,-0.4074380901261346
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3414029923780796,0.8116085658089183,-0.114928431648817
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.665042838010526,4.056107985535494,1.2581203783524662
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5518840889038057,2.88825784552428,0.6051411853686798
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9868949058735623,3.149571032850484,0.9430036416265652
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1011627328014213,1.899142378541508,0.311272280907355
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4640456591670732,1.2185112580859552,-0.0838192270730362
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7129596921596015,1.3827535473142207,0.1112855124450921
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9507108955492558,1.6911022251002044,0.2018795468991231
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4061023228331488,1.1424516936874054,-0.115558281414117
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.616477556851498,1.245706212151489,0.0515340775444835
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3447169550133011,0.8538675326765627,-0.1713091021318111
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0544377491448722,0.4610816726545459,-0.4173135219371611
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1010019836461205,0.5716815184366777,-0.297855913121789
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3448772915904883,0.8586339974189872,-0.1694671807041915
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0428304325381006,0.4769147887599841,-0.4040074911244811
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1067999942928699,0.5680048236673618,-0.2897856203636264
6,Incidence,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4576927867315482,1.4577761001455047,0.0400934808863512
6,Incidence,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.745933616693137,1.8339350332623776,0.0513038761339202
6,Incidence,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5269328887006999,1.3902771522664188,0.0909427694838694
6,Incidence,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3115404848577941,0.1519993929385544,-0.5140474939330222
6,Incidence,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.205722366471193,0.3177470520814527,-0.5233769310413073
6,Incidence,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.292640344661417,0.1073458328915144,-0.4915616776298435
6,Incidence,263,Western Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.4031113176935736,0.0063977479846357,-0.5741077729596462
6,Incidence,263,Western Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3154298258166492,0.1111690506419187,-0.5877900106146354
6,Incidence,263,Western Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3883823150571633,-0.0425671035975045,-0.5630195039910246
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2662161134048822,0.2324840770004699,-0.4801474391156658
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2363042487990004,0.2678647302591171,-0.5471323161749151
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2913785340366749,0.1191912555961473,-0.5012918558834716
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3276316404442518,0.1250610851287877,-0.5242293577384984
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3046700248613226,0.1434070830474395,-0.5897280295810063
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3517706046912182,0.0177625683597367,-0.544450709800303
6,Incidence,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5168031048650323,1.438074821359018,0.080945675536247
6,Incidence,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7979781245028935,1.9741320834232423,0.0632298972750834
6,Incidence,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6961749831262495,1.541749866881851,0.1183342634614098
6,Incidence,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2835942702643977,0.151023325603998,-0.489883614986397
6,Incidence,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1819248144710878,0.3720061547845161,-0.5159409065627459
6,Incidence,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2141666255474076,0.186548859914146,-0.4796308137782633
6,Incidence,263,Western Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3789071230768742,-0.0016694321795638,-0.5573798225603193
6,Incidence,263,Western Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2950234842261298,0.1661394791456064,-0.5831138887438717
6,Incidence,263,Western Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3205918713818621,0.0181057601089873,-0.5520477564717707
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1741889061170096,0.3063007655296233,-0.4221753579972209
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1149705615846532,0.4881507197497043,-0.4795509291959251
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1254081573832605,0.3343436507507542,-0.4262906256015558
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2433375905390446,0.2045392825957907,-0.4701077101697282
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1942846631248686,0.3516170465623078,-0.5259980699629749
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.19999641511898,0.2120410593456436,-0.4772361205468894
6,Incidence,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5885904368126313,1.6197518035952805,0.1296932722260617
6,Incidence,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1551090332644147,2.625885152768071,0.2675664656258543
6,Incidence,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7270621310131108,1.6772926304340698,0.2203861837082427
6,Incidence,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2498633587077776,0.2281667053946789,-0.4710511483180529
6,Incidence,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.019582999322355,0.6395641457493977,-0.421428992388886
6,Incidence,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2000269367159977,0.2434853479373648,-0.4346000299105146
6,Incidence,263,Western Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3495120088508014,0.0727227412053083,-0.5374189027981862
6,Incidence,263,Western Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.154994581592253,0.4216879764882407,-0.5029947371046138
6,Incidence,263,Western Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.308219928891893,0.0723978327128486,-0.5111705446000359
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1487289396810357,0.3974481723201495,-0.4023193783521112
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0217413183612253,0.7391627442595156,-0.4063959255857726
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1352731430292359,0.3513477224967453,-0.3914831441994294
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2198843075754679,0.2912959323662367,-0.4503936743372954
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0697103253763681,0.5723622083229285,-0.461414585077438
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.208900034970432,0.2384506326104432,-0.4437050887681515
6,Incidence,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6230896068805909,1.7559402156163069,0.1634106265313117
6,Incidence,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9832882606666326,2.250264107802683,0.2052272775934425
6,Incidence,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.825798977171735,1.759175737825494,0.2619992938628651
6,Incidence,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.233537044866529,0.2936605791889968,-0.4552298534262583
6,Incidence,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0977877657803509,0.4800493933816436,-0.446878206081016
6,Incidence,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1542812613181141,0.2727714064511021,-0.4136187424005095
6,Incidence,263,Western Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3353854628803704,0.1284884845337793,-0.5236124907988203
6,Incidence,263,Western Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2223644833462291,0.2744092015563976,-0.5274375615062803
6,Incidence,263,Western Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2686705801857547,0.1051963642981388,-0.4945022847934779
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1728123218967897,0.3755625423164471,-0.4128478337932436
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1068667150749947,0.4802407787107199,-0.4636453324623718
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1267610240129498,0.3290379895476152,-0.4047591430374574
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2419350015927295,0.2769898547277237,-0.4606908079176426
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1867696033748127,0.3355857715583737,-0.5102108301715668
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2010937714049767,0.207842529065532,-0.4562024928632778
6,Incidence,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6444888690825086,-0.4542662546982078,-0.7606496017358491
6,Incidence,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.557589062139199,-0.3830748271699806,-0.6771713299869146
6,Incidence,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6113277733845096,-0.4505366041833343,-0.712715111110968
6,Incidence,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7347213086476894,-0.5940100527532843,-0.8200443318638193
6,Incidence,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6741003207293896,-0.5479755443110242,-0.7631465523383212
6,Incidence,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7118374328011501,-0.5923223309622252,-0.7878495504765236
6,Incidence,9,Southeast Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7649145271992598,-0.6391278236310258,-0.8417270328617862
6,Incidence,9,Southeast Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7026998122148878,-0.5854262315064277,-0.783059106356212
6,Incidence,9,Southeast Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7409015858554564,-0.6337142591168108,-0.8084888653686143
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6133432250930322,-0.4048462571782797,-0.739425414611518
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5211367315161864,-0.3323952316062859,-0.6523797127379198
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.578461351390375,-0.4026909839675689,-0.687808652377329
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6346874487766736,-0.4381115302490558,-0.754331191659744
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5392716419602563,-0.3561643302106794,-0.6647130128160346
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5980869569216498,-0.431627226153749,-0.7035472264000437
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.396822441359593,1.5762039710564102,1.189413597867646
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9469557205470172,1.0642479260883966,0.8055700547078071
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.170978085264846,1.2933417684209023,1.019617777641622
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.123087955892399,1.2917449128858958,0.9450744240176394
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7323366129776584,0.8359821684601972,0.6050762211132756
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9277020825654362,1.0384093281039872,0.7926580725586534
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2016893008334686,1.36646679452073,1.0111662884757262
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.80804942320987,0.916973371678774,0.6767509715435382
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0054591997652031,1.1184936775280363,0.8656388471496881
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3727323761660976,0.4767054473988443,0.2754235634303864
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2373839168568159,0.2973033463312443,0.1653346397362066
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3256038758901357,0.3959608176054369,0.2492412455080273
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4258198718703541,0.5285368432752537,0.3267552622587529
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2891484935919572,0.3542287074741836,0.214451075877545
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3782186962063087,0.4473223395383017,0.2970998001481166
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1728115048493757,1.3463923927385582,1.0010884375503946
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6691525318223293,0.7787307638432621,0.5616212851173822
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0697322147507258,1.2098145391344055,0.9249557491966462
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9247570825506268,1.0867472440017496,0.7680911499254015
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4852250847493001,0.5826213809519416,0.3881920457142842
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8378963783993194,0.9667085290228528,0.7088567729545154
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9959158260555604,1.1553649271237214,0.8381732943376039
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5500662087798998,0.6518265401068708,0.4502068198219977
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9119324784044878,1.0413346994893116,0.7781940050750835
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2871250327543323,0.3862672894121881,0.1926818639578316
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1210743565465189,0.1838636277030294,0.0616144312788435
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3274166050203037,0.4125657377241727,0.2431806002842305
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3369293671444913,0.4352763613234537,0.2392050088128163
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1679570158509238,0.2303149188269344,0.1061993351424661
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3800938837490021,0.4641318659913883,0.288892949994991
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2829841395542776,1.523271812557904,1.0643009755631685
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.837855902961793,0.987210868200471,0.6876272044560277
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.039223024789832,1.1869263563970185,0.8739500582151349
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0222066681690662,1.236009656800023,0.8224031903886825
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6354280941824808,0.7596044900229355,0.4993279833249905
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8108081841761093,0.9380290064579032,0.6627786280815007
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0971189468577929,1.3178440158679754,0.8962394932431454
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7067333736584989,0.84543255202371,0.5672227988588798
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8837493585011879,1.020191548875241,0.731077070586648
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4185896481409724,0.545446367111979,0.2924477198800045
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2470935914724056,0.3299731120284202,0.1573969194526694
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3318476919380065,0.4179188782734679,0.2436437271025082
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4734743101903258,0.6004522848516318,0.3479236956368747
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2991561372855056,0.3883287606726997,0.2068756464327965
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3846393765935985,0.4753498612612204,0.2879321049415607
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5021460464797487,1.4481122764144432,0.0812013055675147
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7772505557547417,1.837539576377472,0.071378248422859
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6754773508466765,1.4725951660670904,0.1226497797654304
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3059511482514686,0.1267029679478064,-0.5036816362288954
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2074554632520145,0.2635068173431253,-0.5162625347380271
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2398959263795801,0.1240908786433214,-0.4906328678998858
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3967943675285412,-0.016929733619197,-0.5658300210673877
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3113907931367307,0.099426229354953,-0.5848863720941582
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3392922782134336,-0.0249568469265684,-0.5572942970681285
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2022357806675035,0.2780211796098916,-0.4377320133227409
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1339647424106542,0.4006633793054236,-0.485508218114146
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1496804261211692,0.2757049098905867,-0.4353402821581003
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2660539103370665,0.1745453698360865,-0.4806571206618761
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2048303815631259,0.2834030174768545,-0.5262884371811933
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2174594333678894,0.1664154830944166,-0.4773701124741696
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6195939892018911,1.7474250576567028,0.1327964403968677
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1444035448477812,2.477137666380145,0.2764237708815012
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7442339311649874,1.7637820469565295,0.2366716121381085
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2518466457698322,0.2756103045063564,-0.477134596086504
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0438832799294179,0.5559349220492279,-0.428308936215809
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.20883621063931,0.250591094749755,-0.437630548022066
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3496316693753162,0.1032630771525235,-0.545111345935815
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1691345829483632,0.3472433601707962,-0.5054399293098717
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3121788090179281,0.0898697847729747,-0.5123309288299291
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.156872196387113,0.4413820893210046,-0.4092185977166433
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0065102874865992,0.6472698540698765,-0.4018988043798409
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1437944142172949,0.3609384808806547,-0.3856835371473294
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2242034724809877,0.3285569278192982,-0.4564791947229684
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0757371501518832,0.5135212648497458,-0.4515175361660167
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2119485727088027,0.2519314385725391,-0.4360178019410233
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6359160892642863,1.8318620256501896,0.1648082405226817
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9662130274025288,2.192166579113773,0.2098135692360379
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8196148636067471,1.7373702578620644,0.2656586500529132
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2442770858121481,0.3077315783185936,-0.4664746604661906
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1233571759225777,0.4250762488295147,-0.4576876820003164
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1746614571320315,0.2391378342981894,-0.4252036750187973
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3430773248663595,0.137169803333938,-0.532256605089082
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2381758503662965,0.2368291511297273,-0.5312485571229637
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2824530928722746,0.0794545601254476,-0.500900180588329
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1921053361536403,0.3856501359585887,-0.4311442810885431
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1234776144878632,0.4325389543898835,-0.4639620441427657
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1468521959906299,0.2820161538535553,-0.4160404444654115
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2566185847318161,0.2771663759485143,-0.47476043376353
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1950769362903077,0.305004250518323,-0.5108257608358091
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2147345999732864,0.181813190577277,-0.45969914218281
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8099861903501316,1.1832501490288905,0.4847273865318224
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1683468427629675,1.709580361517479,0.7270144496379636
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9767667416933288,1.3426134088088335,0.620458808357201
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7632212684155505,1.1380116974641374,0.4439231938476585
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1141777118445653,1.6538641709794155,0.6676780452230433
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9265475382969788,1.2872759896101575,0.5697248058805275
6,Incidence,65,High-income Asia Pacific,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7009091591645522,1.0516787338097051,0.3952517561064381
6,Incidence,65,High-income Asia Pacific,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0171736987999616,1.5206734145324317,0.6066101864119569
6,Incidence,65,High-income Asia Pacific,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8481460534782106,1.1901884703940713,0.5150217212395711
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.204021651362969,-0.0629143338279264,-0.3304985426396809
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.151975714191852,0.0217217211773211,-0.293189883117634
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1790290271162644,-0.0504399877370694,-0.3065767736690657
6,Incidence,65,High-income Asia Pacific,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2030362485980735,-0.0607079099291459,-0.3355808700497609
6,Incidence,65,High-income Asia Pacific,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1489030470981624,0.0243543110411313,-0.2901340966509581
6,Incidence,65,High-income Asia Pacific,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1773677009616187,-0.0470216396088444,-0.3089868639370764
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.913396813872794,2.6090115621962973,0.2428894208605477
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.884502367771037,1.3262219199844223,0.5374701604958607
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8991523648994691,1.799811221779009,0.4218664968880112
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0390701258234942,0.7889945422609055,-0.3711463801551713
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0895683019757842,0.1208165147942373,-0.2627213042325888
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0647396534415348,0.368628526846035,-0.2971163751365506
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1427964276150767,0.616840574554667,-0.4431843703739335
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1563317282866345,0.0414206213899814,-0.3116937313002038
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1494779908971101,0.2538757339684822,-0.3632271049125145
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0793125845300083,0.7662814900728613,-0.3938348481855317
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1320202160405691,0.122739070778557,-0.2973082972229199
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1025150229780284,0.3339392304636225,-0.3242978296037306
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.111084511987663,0.715562453510608,-0.4181195362159094
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.139411633347448,0.1095315479761978,-0.3025496493389412
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1216926425176258,0.309296065247056,-0.340721567140423
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4075984917412104,-0.2102839343253326,-0.5697358823333629
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5818538033919691,-0.4748820685453979,-0.6819400845041881
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4888220796811482,-0.3499240111787012,-0.6165194784847663
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5637351383919301,-0.4180287050524672,-0.6828443483980304
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7072095880584918,-0.63174386816307,-0.7763840607174537
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6333366416502962,-0.5305694920280538,-0.7228752775339651
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5980481131904675,-0.4641677000878506,-0.7080603754185708
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7228479948029708,-0.6519459250182167,-0.7891863083592882
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6572638383195508,-0.564135029403739,-0.7428827873837633
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3895885808140767,-0.1846336866299705,-0.5550333122292441
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5726051102424669,-0.4616083679227806,-0.6746494217504395
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4755975707237167,-0.3318893067813941,-0.6059025158474467
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4107217770729582,-0.2143201494937384,-0.5733191694228545
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5809773158898749,-0.4726127111694553,-0.6819805119158286
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4896164111603603,-0.3504916314787759,-0.6174181916752142
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.658025318967916,6.777760735031136,2.64878487106627
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.799436102903368,5.036714344175146,1.2776824567375134
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.607871902084493,5.558850698667772,1.9568156324570176
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.2433122978308746,3.46412565125889,1.086444806762911
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1793475772574231,2.4545758645363023,0.3041050825732421
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6420674977800254,2.762106439887618,0.6939798558830079
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.011471386510595,3.139695845147681,0.9420576288183136
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0935104196066494,2.326263171016942,0.2550156988010643
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4937340446492124,2.549584196045035,0.6001989558506287
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0204113940193211,1.75870127704493,0.294351777953309
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3481798943324524,1.1628127610008332,-0.1994306880504515
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6356613076463139,1.345956453470332,0.0408817073766626
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.020818332331628,1.764263279863184,0.2996306969700198
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3647966281754231,1.1771959684666098,-0.1900065118091595
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6444192064934319,1.350477774901476,0.0547117449700007
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.789451720952244,2.4386660353012948,1.0473984052279135
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2291757974659578,1.9940837250355723,0.5718279684386283
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.6171780416682706,2.2295749783761165,0.9291200411068532
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6102928390782069,0.9810935716125202,0.1818034934823649
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2830069369130893,0.7522060064382926,-0.1029981642480152
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5086612673312847,0.8644023076491296,0.1168655284366437
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4986747003766077,0.847474810709802,0.0999954465815309
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2309564140127184,0.6533404721212488,-0.1320326904349245
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4249203055146064,0.75833928437541,0.050307726331117
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0495252862516155,0.2914816875248581,-0.2318256760757909
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1597192254824055,0.1416691421806602,-0.4146239786765835
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0149662746719445,0.2207221245807192,-0.2753345440711545
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0464538682407014,0.2882337078992679,-0.2364379917676226
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1544560478296424,0.1413534903505202,-0.4087418449354766
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0142095127888464,0.2178718170778253,-0.2764810186580513
6,Incidence,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.139673967279564,2.559030437335595,1.7681773838019426
6,Incidence,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.571834120824244,1.81333158982873,1.3206163055104625
6,Incidence,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.846303897997487,2.0892895966118807,1.6071655649474907
6,Incidence,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.672731082012303,2.040169902664033,1.3457071606961546
6,Incidence,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2556943571636672,1.4608026389801505,1.044256822545064
6,Incidence,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.462983749149329,1.668296328609029,1.2554502883839116
6,Incidence,73,Western Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.734554418876682,2.0998003330153074,1.41099291709867
6,Incidence,73,Western Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2799977181362268,1.4940914941723875,1.0572866027369874
6,Incidence,73,Western Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.501560033513486,1.715115343892245,1.291386096408674
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7789659225691554,0.9681654869361006,0.6086261322181163
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7001229025930503,0.8197205172240065,0.5683758952880913
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.750950236378083,0.8778550179906353,0.631574493629341
6,Incidence,73,Western Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8161037473931962,1.0019348347116446,0.6458553747677875
6,Incidence,73,Western Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7250087736911782,0.8430531174360321,0.5921155430685276
6,Incidence,73,Western Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7808398480236569,0.9070137116373236,0.6602205780099735
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7376537165360069,2.038148588723129,1.47256039590708
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1903044858328704,1.36956932480244,1.0155927813637513
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4395117519516607,1.624901137416082,1.2465843715694365
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4247956486913669,1.6899688681913438,1.189861616516469
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9487538919448392,1.1054121146191216,0.7912347700649386
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1660070645911016,1.3292753550151644,0.993756866516977
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5147723890907947,1.790802992623705,1.271261181218408
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0340363781624449,1.2005114989267092,0.8717895467837367
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.25351942476653,1.424774423212584,1.0753011403443156
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6010093239415933,0.7373075614505528,0.4758226213012955
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4260811688193558,0.5154110746934999,0.3342479021073986
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.521029483609265,0.6110846929930832,0.4290953832842636
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6630606872003393,0.8003251890359301,0.5329724550119641
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4858445869787779,0.5801885524013168,0.3903303390441773
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5815053156507509,0.6770001209294287,0.4862410520858951
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2911245960463223,0.0721888382435617,-0.4933969662346047
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4984042603581584,-0.0464790513792098,-0.6901319229909053
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4000021661492627,-0.044647876144114,-0.5781020995671452
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5935444188422496,-0.379406422638233,-0.7104938555288937
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7120493866501901,-0.4550549421225335,-0.8232914268081195
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.655765554819518,-0.4532260692782858,-0.7583302750340177
6,Incidence,243,Middle East & North Africa - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.622702643544013,-0.4293298765415386,-0.7303616625062688
6,Incidence,243,Middle East & North Africa - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7236179583154297,-0.4746046552209609,-0.8292609665349293
6,Incidence,243,Middle East & North Africa - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6752871918352367,-0.4829730151982709,-0.7716730890024335
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3861540135410139,-0.0728850772739022,-0.5659921774716351
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5655053936936303,-0.1697049870587117,-0.7331802657921946
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4799558039490441,-0.1792006031280877,-0.6361347037576108
6,Incidence,243,Middle East & North Africa - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3861741247292276,-0.0775803375963839,-0.5626877546628446
6,Incidence,243,Middle East & North Africa - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.560468618676918,-0.1648087709773029,-0.7278423822818794
6,Incidence,243,Middle East & North Africa - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4774506839330977,-0.169441935528613,-0.6321526335648088
6,Incidence,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0816850895426432,0.8961777226010273,-0.4445725055461334
6,Incidence,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0171971130795366,1.055143880386309,-0.43981254692227
6,Incidence,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.043198656453511,0.8728749225008616,-0.4140280562493889
6,Incidence,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5340351297829172,-0.0417635052149345,-0.722164057293537
6,Incidence,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5221462060971428,0.0004890950508267,-0.7217381891969646
6,Incidence,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5248427681970956,-0.0736706229118885,-0.7089232793895921
6,Incidence,248,Eastern Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5841283058676457,-0.1412895152912416,-0.748466925173656
6,Incidence,248,Eastern Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5557145445390265,-0.0709525306785548,-0.7467618979895156
6,Incidence,248,Eastern Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5670849843778483,-0.1525976820564512,-0.7348707180503528
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4480901628094119,0.142399432299386,-0.6703662064321874
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4235124043340801,0.2253883071420018,-0.667560395587004
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4317793973151882,0.1218810302902203,-0.6517205955271981
6,Incidence,248,Eastern Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4681173753432553,0.1062548059983474,-0.679222941236323
6,Incidence,248,Eastern Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4280314483782604,0.213471317345179,-0.6759873901617488
6,Incidence,248,Eastern Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4442458710719547,0.1029813652586477,-0.6608116149705745
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.988423360178581,3.2011494239720677,0.2094628733436765
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8095165786818163,1.2721648347346752,0.4454233381592222
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9212287500257124,2.251740154668137,0.3279649008771508
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.001329465466271,1.096294497864447,-0.3893056342368218
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.125729479448154,0.0949575884084983,-0.3063480282066464
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0537954002688931,0.6023282571001393,-0.3489845054502766
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.109184464298982,0.8821188936040183,-0.4581594951030067
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1899019334325105,0.0172199366540643,-0.3529019488358021
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1395912373230775,0.4562689232021079,-0.4052802732486699
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1223195266078835,0.8574204444535652,-0.4671044402203524
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2363354486782655,-0.0168093493909043,-0.3915621918533539
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.175647801952124,0.3968489152603377,-0.4305861265012687
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1526313969902624,0.802768574343296,-0.487572628267528
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2429329103580007,-0.0190829994314862,-0.3987099243440904
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1933119515826283,0.3748327421811481,-0.4413492749488487
6,Incidence,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,8.258380256474918,10.338219666621312,6.5548340452240295
6,Incidence,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,7.586213031572567,9.353984526231043,6.205715074685568
6,Incidence,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,7.948581779712265,9.40106786916004,6.678409587122536
6,Incidence,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,5.294362262030658,6.766631855089367,4.116460418552996
6,Incidence,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,4.769980554690027,5.939741592320655,3.841674232161059
6,Incidence,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,5.046491293835767,6.004328951056776,4.224514230454307
6,Incidence,70,Australasia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,5.083767617069155,6.4504494017478144,3.964351586717528
6,Incidence,70,Australasia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,4.604304280600781,5.758145830793945,3.703239913726396
6,Incidence,70,Australasia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,4.860313694051296,5.811528571442018,4.028493895419912
6,Incidence,70,Australasia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,3.064262659426612,4.054530826019384,2.3533889274046684
6,Incidence,70,Australasia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.9495035702452608,3.691015742693829,2.333681056504431
6,Incidence,70,Australasia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,3.050591099424268,3.676219529776682,2.530688154986332
6,Incidence,70,Australasia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.9821381224410275,3.91823833505322,2.2863732748259378
6,Incidence,70,Australasia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.9274668353550237,3.637815320367654,2.3108551985169203
6,Incidence,70,Australasia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.9993701008869973,3.609572806531382,2.470696858855985
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.075594732714052,2.3646761685589595,1.7951276522174258
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.610163962360763,1.8320330490516064,1.4000319816723783
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.849506789553768,2.0686633341422502,1.6415816609700031
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2485208538620027,1.4681420876163906,1.0431993021717596
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.84079848977705,1.0037678258390672,0.6862646366191021
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0442412407794912,1.2079802827075097,0.8877411395805904
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0598028574830691,1.2534079385638313,0.8719670260284249
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7203080980925363,0.8665376806224563,0.5818142129346481
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8929109742588696,1.038495406572911,0.7547875070106902
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3042404539806416,0.4265042171965754,0.1860204288324712
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0189373727854532,0.1051602130367397,-0.060859980338522
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1570622691940573,0.2472862506368763,0.0706555664574753
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2577529539058083,0.3756526152693361,0.1432836647460861
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.011210802483818,0.0707744711988578,-0.0893378760860324
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1194973031794358,0.2050218270601551,0.0370046674468759
6,Incidence,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1290102880715829,0.6637086635521652,-0.2173935021133701
6,Incidence,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0649994089787722,0.4903896239743859,-0.220815301776392
6,Incidence,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.095847424388867,0.4908959352881844,-0.2072519490122801
6,Incidence,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4665572873664164,-0.2136636505669287,-0.6338717202190294
6,Incidence,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5155577125992282,-0.3218126224509137,-0.6448375968091732
6,Incidence,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4922831340129006,-0.3091997296758732,-0.6342442391355463
6,Incidence,263,Western Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5376985677013224,-0.3187529766432742,-0.6795422426865414
6,Incidence,263,Western Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5824200737421829,-0.4156271036136847,-0.6944863198211233
6,Incidence,263,Western Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5610549293193827,-0.402817028057099,-0.6824623195452744
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4432819230434515,-0.1532091400724252,-0.6208627384755966
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4480697046122282,-0.2275107816647336,-0.5919407477949163
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4461464119545386,-0.2453686716809537,-0.6026772218895958
6,Incidence,263,Western Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4900553826656527,-0.2283068314605904,-0.6506549891119029
6,Incidence,263,Western Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4974762726639239,-0.2984441083587468,-0.6297572114855454
6,Incidence,263,Western Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4934334942451311,-0.3065113481649736,-0.6359878535110948
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.438281028913613,-0.3610772946220997,-0.5130589302825415
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4422698415364759,-0.3553000075206695,-0.5115499199684208
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4399088172101379,-0.363510259503037,-0.5090914077371734
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5024279167218777,-0.4302686083869163,-0.5661130988850664
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5037345044374946,-0.4250643428379942,-0.5639087595862309
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5026567720471448,-0.4360543617464864,-0.5652790477587615
6,Incidence,240,Europe & Central Asia - WB,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4840124043504246,-0.4130940781361581,-0.5527023926206278
6,Incidence,240,Europe & Central Asia - WB,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4820613120911652,-0.4012963740037401,-0.5463985769436076
6,Incidence,240,Europe & Central Asia - WB,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4826110761517544,-0.4120372682250814,-0.5465190739236928
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3221073453394095,-0.2240812325241176,-0.4140336591277942
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3219008980241549,-0.2124691628490013,-0.405337971002791
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3211659894060941,-0.2249731489870072,-0.4073716539624405
6,Incidence,240,Europe & Central Asia - WB,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2958855726228539,-0.1978298939217622,-0.3898125425935727
6,Incidence,240,Europe & Central Asia - WB,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2935676601156667,-0.1816679896770683,-0.3828020622228734
6,Incidence,240,Europe & Central Asia - WB,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2942440624063451,-0.1965877546328748,-0.3824145994939023
6,Incidence,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5955370583015245,2.825287898223974,0.565556514694018
6,Incidence,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.024254416596852,2.392730845162034,0.0997319185181989
6,Incidence,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.412802873192809,2.555623488959552,0.4379929443193601
6,Incidence,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5804407362119522,1.3277903564945257,-0.0596108062107032
6,Incidence,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2018994047296388,1.074677493944008,-0.3502584648618921
6,Incidence,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.450488492459895,1.166172492657191,-0.1358497289545423
6,Incidence,254,Northern Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4801030880382584,1.1813675950755629,-0.1072425552600813
6,Incidence,254,Northern Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1697391773857716,0.9605293461990556,-0.3645070011135097
6,Incidence,254,Northern Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3848751637536441,1.0408192961919096,-0.1746359653469619
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0313449081951784,0.5325617498193214,-0.3799571493274911
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1861882268275808,0.4092334848189152,-0.5668247002558523
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0343409251864309,0.4481970966152743,-0.4299469392648931
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0264613253094142,0.4916811544624972,-0.3843638409154165
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1719281026921861,0.4053469760789395,-0.5572708363373178
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0283704321170319,0.4281426477591429,-0.4253686877187589
6,Incidence,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.2735599228704166,4.041177361617138,0.8607892646511912
6,Incidence,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8545843584833435,2.3794904620177,-0.0550831887956537
6,Incidence,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6611133828953275,3.2261462163794343,0.5379896770636363
6,Incidence,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9918045156590678,2.06230064243474,0.1271070981452139
6,Incidence,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1005732080104004,1.036344738126355,-0.441809583053771
6,Incidence,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5986454525103648,1.536079202505204,-0.0830306814678512
6,Incidence,254,Northern Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8667451251454745,1.8747276623978384,0.0611137020717206
6,Incidence,254,Northern Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0716933425453312,0.9528782353700308,-0.4539687282518641
6,Incidence,254,Northern Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5273978130784878,1.4256788643949956,-0.1172408945881114
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2783152445802881,0.93499161826333,-0.2773205689121967
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2962195841257106,0.3289940750246328,-0.6512033894573436
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0274813383712717,0.6308588210888693,-0.4176907172261972
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2731878445434684,0.9278558811735156,-0.2765596454599929
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2835371765763276,0.3484529595164686,-0.6449199204690383
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0345336301438559,0.6450563556620544,-0.4047096932806877
6,Incidence,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.8896404238958646,4.826610769408468,1.2533914531057726
6,Incidence,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.592710708335157,3.818016853899202,0.325266944282135
6,Incidence,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.567952180409231,4.3638638260696725,1.1046386496034022
6,Incidence,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.367032077391479,2.5599655309862426,0.3534959177322851
6,Incidence,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5388896402752199,1.85067808432662,-0.2153724632348362
6,Incidence,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1439971700725498,2.2563750812570955,0.2563503329218524
6,Incidence,254,Northern Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.218064575249814,2.322620482345128,0.2849948096997745
6,Incidence,254,Northern Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4982283186843438,1.7841475978032986,-0.2341789389165101
6,Incidence,254,Northern Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0478955885736598,2.0786940271878933,0.2079983105519323
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5110687748195617,1.264792078681394,-0.1326246450385168
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0031685605763242,0.8690231936847586,-0.5022952315613519
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3897721330919393,1.1175143508996666,-0.1894619300547781
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5049643373527273,1.2143626154073548,-0.1228727314396159
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0212082168241813,0.909718083071192,-0.4929853444213735
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3991485394782095,1.1042159661671482,-0.1784559364908965
6,Incidence,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7473232939160925,4.770242255003714,1.08218675330324
6,Incidence,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4308783487420766,3.2838424763192395,0.3086329363881548
6,Incidence,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.9352258169280117,3.6961727895995935,0.6659144750033662
6,Incidence,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2808494572799451,2.5397223645304674,0.2700489282743369
6,Incidence,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4432576000668465,1.5520727802473444,-0.2304944130971684
6,Incidence,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7638487272488834,1.7793473909214017,0.0019814805030345
6,Incidence,254,Northern Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1369083371255726,2.290476378691604,0.1873654562471162
6,Incidence,254,Northern Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4047115899407971,1.475468663037074,-0.2437910956449338
6,Incidence,254,Northern Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6847299789945421,1.6954597631119612,-0.0438159673123477
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5159651257297069,1.3501202090458633,-0.1581164193387286
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0132659356876022,0.8141917736340215,-0.4910244110523098
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1907774073972701,0.9131425321506031,-0.3383790488854648
6,Incidence,254,Northern Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5094273463256073,1.302271200931562,-0.1611478950207415
6,Incidence,254,Northern Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0041547141500098,0.8146038606587824,-0.4794764096468195
6,Incidence,254,Northern Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1986490956098108,0.939137899099321,-0.3292295419504721
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5028821063742797,1.7836774980089698,1.2358676574708072
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0698618313250592,1.3228400505395224,0.8664212873511504
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.33681642731853,1.5893259656297032,1.1048333780893964
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8299179114294356,1.0449690991737897,0.6268832669665056
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4597659890315605,0.6373312272478876,0.3154995351230119
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6764844457330341,0.8608229206984181,0.5075473519366389
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6762428611989436,0.8642985708492256,0.4974165942039742
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3642055141779619,0.5309385184763014,0.2301218242927762
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5523337148434578,0.7200743490916414,0.3982287092552328
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0938565068684379,0.2111032522975828,-0.0208867704960184
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1519209306436356,-0.0514914321259262,-0.2350613615095385
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0117216006672397,0.0950501072096881,-0.1075178696766116
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0547421886318345,0.1674921904877439,-0.0503715297990295
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1770616258029548,-0.0811434701431005,-0.2559078929546003
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0438890169767288,0.0604463318051859,-0.1358697866174096
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.670794440675093,3.0342044269096413,2.336386347513728
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9011024699023489,2.1185203499233896,1.644622319032282
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1958396507466134,2.4317570012964875,1.95236450302344
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6833727156677896,1.954972419463344,1.432479222738166
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0459351848399987,1.206008887487509,0.8652217229012307
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2925603017654637,1.4665509035521211,1.1217362133671598
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4584230157863662,1.7018077895088937,1.2344615365535667
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9120599871646976,1.0553558662986724,0.7430189280954772
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1229779023678843,1.279696441699339,0.9612387618351916
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4241431172449376,0.5612186582298274,0.2971693183574596
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0535815887770303,0.1318510546793032,-0.0336440069818411
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1962826615257037,0.2850634902108813,0.1124379681231819
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.37351870704895,0.5049314546786747,0.2500543309280469
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0224280900754125,0.0991997030832042,-0.0632685725391626
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1575084623731648,0.2391715396685504,0.0771480453896842
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.361754752912132,2.696282942251041,2.052152869913926
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7657238613660715,2.00389594826499,1.5214343729204134
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1665786993456235,2.4485895823714974,1.91065912457468
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.457969547312049,1.7201851698166384,1.2337836749518398
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9508248352567804,1.130394956452954,0.7860144771432689
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2719997976283277,1.4841054337151776,1.0825660388590213
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.251451393303421,1.475493303955565,1.044103254584544
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8228345898594522,0.9798091614726624,0.6618281583432344
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1035400206168215,1.290878228511989,0.93353411875777
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3516897164155643,0.4890748120819154,0.2265592741775684
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0465624727367071,0.1423477309682333,-0.0388521647750344
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2329437965310738,0.3403076083915809,0.1316119863671427
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3034683695857914,0.4291319156503664,0.1851587571805177
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0155154455396319,0.1035499256338884,-0.0712687567115995
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1928520031233295,0.2956387977361761,0.0945311104074284
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8064473993763408,2.113105914461095,1.5372874103149845
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.374756648438641,1.613754557996001,1.1464922280180598
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5280386536832995,1.7543108282217537,1.3088814717911583
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.051779783764533,1.2953048991954494,0.8527301278061232
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6748580561041043,0.8513699951893756,0.5120477918760314
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8136842850507443,0.9761189728963552,0.6561942362981759
6,Incidence,241,Latin America & Caribbean - WB,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8795481443389475,1.0849250358143998,0.6992849553395772
6,Incidence,241,Latin America & Caribbean - WB,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5651557343597385,0.7226745895610234,0.4147111122522602
6,Incidence,241,Latin America & Caribbean - WB,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6793615401973185,0.8296728445688152,0.5337766845261231
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2371942798177832,0.3705111477540661,0.1224152668189516
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0259455722072783,0.0686991479732725,-0.1092639599495509
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0701226906230083,0.1661145844109954,-0.0140162399381668
6,Incidence,241,Latin America & Caribbean - WB,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1930485963639804,0.3186299442776953,0.0828288578722704
6,Incidence,241,Latin America & Caribbean - WB,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0548104538570795,0.0360917948421474,-0.138257942096011
6,Incidence,241,Latin America & Caribbean - WB,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0353284002293298,0.1267109333035007,-0.0460165551757844
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2220716253135359,0.7964376019222679,-0.1501579495744852
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0465417120663584,0.4745800621827344,-0.2314138466943819
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1310522021232421,0.5454165480038384,-0.1771835694094866
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4352217755992939,-0.1692015950020584,-0.6097580632961526
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5334316602565727,-0.3407072586202224,-0.6594209023450537
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4868930154260088,-0.3010669062752887,-0.6246666548296222
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5092617729146927,-0.2786178931120058,-0.6587352390074843
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5945094764709169,-0.4286627713868785,-0.7022054657852588
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.553980885919531,-0.3905804539065273,-0.675530576984946
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4085350525399936,-0.122772410656494,-0.5880890982188829
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4707472622648644,-0.2571051061678697,-0.6104728154228032
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.440361919268481,-0.2345724087540422,-0.5894571409896219
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4559752345491759,-0.1980165619442814,-0.620737301770617
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5139984993696568,-0.3195841901495975,-0.6409596345347099
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4850064266290801,-0.2949561545503616,-0.6230847302547123
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.5177511002041016,1.5275092814893825,0.0844681429823369
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8115070008486951,1.822845284733796,0.1364524660917024
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6230837304392668,1.4390713559116315,0.1652000772152859
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2988036327094771,0.1592813562316364,-0.5059579895122672
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.192314619764515,0.243649518907242,-0.4935845204155212
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2637406829798584,0.1016189945895498,-0.4740551737869324
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3905279619925368,0.0149531320813812,-0.5645181814272892
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2981178736771078,0.0937328146130609,-0.559672872922028
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3599531779612209,-0.0381766258882032,-0.5405150131970407
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.230674328149137,0.2781066255900292,-0.4551838109302273
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1313098763172528,0.3760129373725884,-0.4717247044454823
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2102727882399137,0.21578228225012,-0.4476827307548843
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2921627172607949,0.179930126913811,-0.496318340461792
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.202290930889418,0.2726756238451671,-0.5179363944290307
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2731632560293807,0.1147365416324585,-0.4896594759359215
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.290514003557261,3.653585428084368,2.95097636837409
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2553616125479845,2.476933704912832,2.030979535380371
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.645451762952284,2.8794265688334404,2.419294555324981
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.158684558460434,2.4364141353222424,1.8846360188203248
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2791806170938065,1.4462120163142778,1.1270479640738538
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.61421854414816,1.7931510880294144,1.449464056675663
6,Incidence,134,Tropical Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.9111678060738224,2.1575163418232317,1.680787242888114
6,Incidence,134,Tropical Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1576903147222846,1.304550791256006,1.0089673486359194
6,Incidence,134,Tropical Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4442138346784352,1.601089990142305,1.2925792468030457
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6385160909816714,0.7760645262764763,0.5027572193162075
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1307058033777275,0.2016966088627364,0.0623527418199567
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3195217668866519,0.3944962976208715,0.2460955088211057
6,Incidence,134,Tropical Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5823187970529454,0.7122942901519995,0.4605232637761277
6,Incidence,134,Tropical Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1086721692310049,0.1746306675967701,0.04447364668156
6,Incidence,134,Tropical Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2845609029267586,0.3558643138308512,0.2193252572809428
6,Incidence,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.980776777993929,1.1995393915240045,0.760587426861362
6,Incidence,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6091503218455552,0.7996087463465217,0.4458765850381563
6,Incidence,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7461724498987005,0.9125972903976084,0.6035020906851905
6,Incidence,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.991751999896738,1.2212996898205706,0.7686136098238374
6,Incidence,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5846685658668056,0.7674029767830821,0.4253085053767487
6,Incidence,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7358266221307258,0.8972322863245195,0.5955561277209134
6,Incidence,56,Eastern Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.179882713221921,1.420635151776065,0.9375601226594692
6,Incidence,56,Eastern Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7555979500034554,0.9633898604766108,0.5774647863474199
6,Incidence,56,Eastern Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9128162388008242,1.0951236262897377,0.7565303118782107
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3120620725083844,0.4474690742768344,0.1704216657464957
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1830842661108364,0.3146473754480405,0.0604604553068698
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2547817641378282,0.3682111661555064,0.1501907006925846
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.431673623413577,0.5856541545503013,0.2824038820527222
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.297219524711229,0.4510055620578833,0.1654214647717502
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3723131308213033,0.5049805151296138,0.2562181240816964
6,Incidence,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9129589692610725,1.1223918604618246,0.7014743796500404
6,Incidence,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.5086503575628917,0.6741000166134408,0.3508238072202546
6,Incidence,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.792374402655026,0.9649485690139228,0.625318230417417
6,Incidence,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9238955379588666,1.1456216604421972,0.708012192451812
6,Incidence,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4858255386852722,0.6622154864750707,0.3243420701478221
6,Incidence,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7819653485895308,0.9553899240999084,0.6184099226151586
6,Incidence,56,Eastern Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1052479181517445,1.335732818914248,0.8725050840637842
6,Incidence,56,Eastern Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6459515553349281,0.8264586703723696,0.4737613227158486
6,Incidence,56,Eastern Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9634274172681802,1.1524709838574747,0.7804284476838532
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3077752790541869,0.4424401463222083,0.1640939753875374
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1439402143935383,0.2734075862603322,0.0211122670138373
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3366976609043723,0.4595939009683555,0.214273594701723
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4268726416916275,0.5743927834809148,0.2708900080049116
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2542436652886046,0.3921058867204365,0.1195033003556525
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4618260631909152,0.5970048408399576,0.3316530069297234
6,Incidence,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6482344443594056,0.8420182188872027,0.4597782500997482
6,Incidence,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.3393455311019935,0.5109171110777946,0.1997147406180016
6,Incidence,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.4656627050720238,0.6067230891863142,0.3487380089249359
6,Incidence,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6574684906039394,0.8565852368106783,0.4715633071175931
6,Incidence,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3189542399010521,0.4837723459426176,0.1759894778423323
6,Incidence,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4570055403401868,0.595946217645989,0.3372888465637974
6,Incidence,56,Eastern Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8139135174205981,1.0271762661003652,0.6065138726800738
6,Incidence,56,Eastern Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.461238416838616,0.6484246044776336,0.3088999272623834
6,Incidence,56,Eastern Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.605536396493456,0.7600587023521643,0.4774531378668659
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.20412982651742,0.3436336641304499,0.0801459610741075
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0423110450327499,0.1660903141595707,-0.060827272289207
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1245035330341334,0.2270263587417162,0.0357171005633708
6,Incidence,56,Eastern Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.313848184586518,0.4632573777574889,0.1728572786903464
6,Incidence,56,Eastern Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1428753354627478,0.2844842234330291,0.0272800510050973
6,Incidence,56,Eastern Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2298147014149953,0.3464553045947492,0.1347057488573164
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.1519773606191057,7.060145026401754,0.600959529446604
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.5163287305743194,2.667065966259347,0.5809137103470474
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.8525817945995176,4.056871539725469,0.6771050720345517
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.2260594977444883,4.72112314480014,0.1353664579615594
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8068213733348656,1.6359883499809351,0.1303977242500617
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.03192760306428,2.6010997753059426,0.1956154304727723
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0440517564649052,4.226989826901011,0.0382194298349242
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6527270358988443,1.4085323158385892,0.0383455860782458
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8620163845684728,2.300861584215779,0.0947265837155961
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.6504671242550532,3.1729262477763216,-0.1776646967618745
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2830539271157414,0.8966840715383013,-0.202653642694546
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.4561309345542108,1.56432485056048,-0.1467455949793265
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.591182974172645,3.030349220075112,-0.2070589296450734
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2170123069528411,0.7863052031565334,-0.2415893006927794
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3920623106896144,1.4579354520213743,-0.1878483146480987
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.967315415419096,6.520742238209191,0.5542192989375492
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2349022963596397,2.3089310044433047,0.4272723464944022
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7097535808772453,4.141881902031914,0.5674920739659315
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0956751031746623,4.321464627735772,0.0896070657502753
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6046583684670462,1.3996077554953388,0.0256885124405593
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.9301753049370016,2.6666271895081763,0.1186526744379964
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9242988108523224,3.8771880705741486,0.0079084728263871
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4678858938048843,1.1733089419199991,-0.0625662036995875
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7687855875995692,2.35635190802433,0.0231769444548231
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4944982229105271,2.7548062551984187,-0.2297196575100128
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1526533051835274,0.720326447297367,-0.2733545997662162
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3628867127599706,1.578044255390057,-0.219866120204509
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4407749861892609,2.609349392213677,-0.2570155860381905
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0933589876277199,0.6181487939227839,-0.3107966688302862
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3029291248737166,1.4732151711146684,-0.2530115913624152
6,Incidence,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8146798403914208,2.4483297010196408,1.254899778563473
6,Incidence,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9776851786886058,1.3083006122997891,0.6656556739894766
6,Incidence,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.285810182115768,1.6507863963861769,0.9568690622051772
6,Incidence,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1197630251210546,1.602239823064266,0.6862898792672458
6,Incidence,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4863892837562993,0.7429673494762559,0.2483030125343308
6,Incidence,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7196077059034726,0.9898904158529132,0.4684218308002557
6,Incidence,104,Caribbean,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.089510774925306,1.559908222021266,0.6739514441649059
6,Incidence,104,Caribbean,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4731854081163686,0.7194621349395027,0.2407534122769956
6,Incidence,104,Caribbean,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6998355340055208,0.9712489448555012,0.4552195074455023
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3677324253882499,0.6773482466148342,0.0976621340615775
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0985456756120414,0.0578516141097311,-0.2450034727886803
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0730410619326269,0.2436233247516549,-0.0813280419275115
6,Incidence,104,Caribbean,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3935517629575339,0.7006363721176516,0.1205387513303506
6,Incidence,104,Caribbean,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0841052855887372,0.0678462321609705,-0.231922462884864
6,Incidence,104,Caribbean,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0913281460405832,0.2583530350471644,-0.0607394674658447
6,Incidence,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.107036911803557,3.070900611003012,1.3674344402599932
6,Incidence,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7493694293019442,2.7535205515647982,0.8992449497547759
6,Incidence,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9381204312776328,2.687012681567312,1.203732345391867
6,Incidence,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.318544924438459,2.0418527227733527,0.7576912192828946
6,Incidence,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0254272832077995,1.7468637650138956,0.3910228373196018
6,Incidence,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1784076298345507,1.7534032953608252,0.6397238673526204
6,Incidence,9,Southeast Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0545608221482363,1.6919258263240469,0.5654909124137726
6,Incidence,9,Southeast Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8475764898002975,1.5223661291724335,0.2762927674036864
6,Incidence,9,Southeast Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9586229531723784,1.4578528469696383,0.4690618901744596
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3128693082537356,0.7235725016024322,-0.015421682110143
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1205765897205903,0.5176373948837251,-0.2403399427605551
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2178741069421631,0.5497818339024942,-0.1008075455539357
6,Incidence,9,Southeast Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2404471450666284,0.6275886483336276,-0.0642936032336036
6,Incidence,9,Southeast Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0781191818521942,0.4701141214695894,-0.2647872988743703
6,Incidence,9,Southeast Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.161211862496315,0.4716705344848831,-0.1405155303663343
6,Incidence,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.406756535040265,2.2159899454377374,0.7769730492139584
6,Incidence,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.151760001511203,1.7575364164083649,0.6050857471480839
6,Incidence,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2943790016495451,1.9862905725818565,0.7404242184295754
6,Incidence,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5705962696276516,1.108853823403578,0.1435076221020459
6,Incidence,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4032971059204073,0.8041827376562702,0.0538787371491246
6,Incidence,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4967761541101155,0.941898130339362,0.120980086927647
6,Incidence,120,Andean Latin America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3717894327582433,0.8330317000404184,0.0128290151987135
6,Incidence,120,Andean Latin America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2459480242335821,0.5967148043291057,-0.0705964354853134
6,Incidence,120,Andean Latin America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3181148817941618,0.7156163137178981,-0.0001307276183833
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0258297845218148,0.2934036044715675,-0.2798301512334278
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.160586150227932,0.0811099216544141,-0.3713461570931136
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0871001840753846,0.1804724173208142,-0.3103158185918067
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0887480635039197,0.2116970567100966,-0.3242550489132454
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2228331758891138,0.0031554282235689,-0.4199169776067969
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1512178001969084,0.1065120564213144,-0.3551870608020222
6,Incidence,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.839895177180301,1.017550846410113,0.6842182855827565
6,Incidence,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4804562328334705,0.5913271034663008,0.3736815498193959
6,Incidence,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7360101086464794,0.8832918395403757,0.6027173751327463
6,Incidence,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6590357441012987,0.8188159381066692,0.5149833265012794
6,Incidence,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3400442004224931,0.4407127262186185,0.2416806049767787
6,Incidence,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5686179182557818,0.7022075466017708,0.4501759391701778
6,Incidence,44562,Europe,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.732014243389425,0.8992531999024134,0.5854653546495983
6,Incidence,44562,Europe,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4063429564689263,0.5116635086973671,0.3049135321767613
6,Incidence,44562,Europe,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.6418785753715557,0.7811742610901498,0.5158133627792485
6,Incidence,44562,Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1864824021761312,0.2844932304856135,0.0898215036380845
6,Incidence,44562,Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0215746963862785,0.0854830602690192,-0.0422246715363096
6,Incidence,44562,Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1740035201666633,0.2557648708778435,0.0874711267882446
6,Incidence,44562,Europe,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2451116972645763,0.3472397389652765,0.1406205223121212
6,Incidence,44562,Europe,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0752662205511384,0.1458878455482767,0.0063753425698597
6,Incidence,44562,Europe,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2331409311084735,0.3209400992077892,0.1468868087244859
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.8733655803056903,2.5434710133272462,1.071453037426838
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3903497277467751,2.238695914292737,0.6885241149972734
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.7098592904845755,2.38414321440875,0.9869122510947022
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5469981332056231,0.9131599815078222,0.1138675887165318
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2766582092077457,0.7173792810018724,-0.1007866993974574
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4531456223113846,0.82099497204868,0.0672897218085272
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4280889976634549,0.7611375323614948,0.0295311227369463
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1976910291661728,0.6227571211523018,-0.1539605432677411
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3520928776227796,0.68852897754677,-0.0086238379239987
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.167331797403922,0.4521480673018585,-0.1672885921197159
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0637298239446961,0.2712054436387076,-0.3441238644501874
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0823968274664338,0.3606376289745049,-0.2131420737209422
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1516272665108702,0.4163568212088554,-0.1764742257301364
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0720325428150333,0.2711218756107387,-0.3499683796613538
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0699815970208791,0.3343640790514618,-0.2222944083044609
6,Incidence,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7021751147098052,2.7150098478498585,0.9132392591270228
6,Incidence,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4582630292915917,2.4351338233347444,0.845613874483802
6,Incidence,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5630692757272573,2.270761825785548,1.0113869250626857
6,Incidence,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5159878999777183,2.4504943750922363,0.789126458365913
6,Incidence,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2204747454246925,2.085115645693268,0.6715314740807581
6,Incidence,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.350886069657502,2.0098779867072145,0.8386158063935811
6,Incidence,5,East Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.250492384175583,2.0940264841500715,0.5934312910854793
6,Incidence,5,East Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.016094727302114,1.817255560646044,0.5136429082833716
6,Incidence,5,East Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.118709765014209,1.7037096051027565,0.6626726244623367
6,Incidence,5,East Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1400191203719736,0.5587804740291253,-0.1714619640412725
6,Incidence,5,East Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0605969800808547,0.2968747568470104,-0.2908963912126859
6,Incidence,5,East Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.010356199317295,0.291193041166626,-0.2033214914400079
6,Incidence,5,East Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0487983208102178,0.4296266013119288,-0.2390258011311196
6,Incidence,5,East Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1276574623464044,0.2001596924065101,-0.3394542336548924
6,Incidence,5,East Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0664123402436354,0.1847294307050894,-0.2646412244726141
6,Incidence,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8062437072711024,2.954451504476605,0.9817835075998768
6,Incidence,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5408412097741802,2.592024861479217,0.8919470202866866
6,Incidence,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.7154362167840678,2.634437898636328,1.0554536836693391
6,Incidence,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6137598288078852,2.678289379923162,0.8352135807138095
6,Incidence,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2958004454944876,2.233789957329969,0.6915576133258234
6,Incidence,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4912518332476417,2.293004083840096,0.8796225136082623
6,Incidence,5,East Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3371653661433789,2.2934442131342085,0.6505180092361509
6,Incidence,5,East Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0838195526268972,1.9459265738757296,0.551642101144127
6,Incidence,5,East Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.244660838182461,2.0043351301901877,0.6990995258561548
6,Incidence,5,East Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2892549392699968,0.7803202818124886,-0.0849235343430301
6,Incidence,5,East Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0804870075418193,0.5147054278209882,-0.1995076294358854
6,Incidence,5,East Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2082897289285866,0.5926144087851642,-0.0784799452783317
6,Incidence,5,East Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.185906235583903,0.6377791165139027,-0.1597414597038477
6,Incidence,5,East Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0032377994415874,0.4006527318996953,-0.2568344195057553
6,Incidence,5,East Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1164144750414977,0.4746658959615418,-0.1535751409874283
6,Incidence,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9593259563483062,1.707236101695507,0.3846721687823113
6,Incidence,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.6980359556823392,1.3796727225348175,0.2372711065047864
6,Incidence,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8316831739910294,1.3786325146005791,0.3995771600051493
6,Incidence,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8245889670311872,1.5003070107849004,0.2767847768909388
6,Incidence,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5340344674403927,1.1543983749358768,0.1164575575513202
6,Incidence,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.680260709049174,1.1842802583858063,0.2805063774950931
6,Incidence,5,East Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6318143553597739,1.2547074006657173,0.1532169597228846
6,Incidence,5,East Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3926098616091141,0.9516404759948196,0.0147228853644634
6,Incidence,5,East Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5141241260620476,0.9662488188636992,0.156932363816963
6,Incidence,5,East Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0191415423542987,0.3911662699368855,-0.2663985030175063
6,Incidence,5,East Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.190908827904351,0.1419702485023555,-0.4128987080106513
6,Incidence,5,East Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0887337010148955,0.1839200008791778,-0.2939400732019945
6,Incidence,5,East Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0624381714707978,0.2852566540953309,-0.3221692145568818
6,Incidence,5,East Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2487108068952054,0.0586078879939246,-0.4556790568865807
6,Incidence,5,East Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1579878377644251,0.0912395512632453,-0.3518110048882794
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.564490690971914,1.5196358724335004,0.226759715975203
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7511500879684355,1.2082346284875216,0.425941779414982
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6360179904280401,1.30731570101185,0.3389037505250243
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2341528117717284,0.2381298011598052,-0.3989615572994791
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1623746275611628,0.0554520003603651,-0.3220955012348015
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2084298562482711,0.1174839279712435,-0.3539604416674591
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3037557443568539,0.1213118829134194,-0.4540559363945189
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.209615159325126,-0.0033092040473291,-0.3563985326682792
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2667394587667348,0.0341350581831362,-0.3999055667399092
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2588307725404745,0.2211650881761634,-0.4201914424767168
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.178954832596175,0.0644158467954406,-0.3620587996736817
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2301387213986218,0.105959455903091,-0.3735890463289009
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2730817544770117,0.1988618634074493,-0.4309239328576691
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.174089169438586,0.0693189494612549,-0.3563213449609254
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2353946420863975,0.0963685631651231,-0.3769986528552649
6,Incidence,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.690740188212314,2.600132828170445,1.0088653358013795
6,Incidence,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6082813096995574,2.3390619009419598,0.9590728585330772
6,Incidence,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.646695217794824,2.407894991460407,1.010503572262875
6,Incidence,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7558326078084457,1.3713692552940455,0.2993872137101931
6,Incidence,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7010203815727339,1.1907045549899469,0.2744738208717973
6,Incidence,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.72655419496763,1.2006488709790606,0.3151405002768217
6,Incidence,120,Andean Latin America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5336528239346108,1.051983280530549,0.1450016648404224
6,Incidence,120,Andean Latin America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5102906189273861,0.933439405579826,0.134375095598326
6,Incidence,120,Andean Latin America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5205196489510322,0.9578269765397154,0.1550291719871653
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.109649688431443,0.4922594176257169,-0.1808798234707052
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0172803432765214,0.3020274958534128,-0.238998284069395
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0602230264812996,0.3473918336556643,-0.1931491614144429
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0380491230988817,0.3801109392720107,-0.2258651693162554
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0581224469913101,0.1993646505931419,-0.2954300376843666
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0141788532229531,0.2633765286599495,-0.2507921577222508
6,Incidence,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8340455952829984,1.278160523800982,0.514785938058357
6,Incidence,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9645323117920842,1.409375732401799,0.6122112568115823
6,Incidence,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9065931842255266,1.2946088513739171,0.6141875567119162
6,Incidence,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2941735810717308,0.6126696082431552,0.0700896327195396
6,Incidence,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3778143729690132,0.6898700560005071,0.1269255902340049
6,Incidence,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3411035358838375,0.6291498055493441,0.1265662947107252
6,Incidence,32,Central Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3093128027288128,0.6263634601863599,0.0813954828573122
6,Incidence,32,Central Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4396802474435772,0.7656775761781847,0.1814866506423079
6,Incidence,32,Central Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3793035782225268,0.6600091857596574,0.1677659876873153
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0491337747093639,0.1732381120910562,-0.2169907476351393
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1643530888792838,0.4380109376078516,-0.036397741941294
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0753875550780803,0.3012149457042995,-0.0950680346165822
6,Incidence,32,Central Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0097773769237131,0.2145828354441971,-0.178001420542071
6,Incidence,32,Central Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2320738739816866,0.5084964037787872,0.0259261001157432
6,Incidence,32,Central Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1290430492716055,0.3572412336252185,-0.041352631105445
6,Incidence,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.212372199635719,4.500630219560936,3.932446065366383
6,Incidence,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.974544687919585,3.1056964472370816,2.79754191690059
6,Incidence,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.614335921369081,3.791177524169964,3.424231191612272
6,Incidence,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.263049994333926,3.5167030895801883,3.0226849749349123
6,Incidence,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2223875314927573,2.360644059840241,2.081091055447147
6,Incidence,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.756261690673868,2.9103967672629656,2.5922406383026155
6,Incidence,100,High-income North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.940135434486181,3.158035383891469,2.728533722553476
6,Incidence,100,High-income North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.03795575752139,2.13820201806506,1.902663131689609
6,Incidence,100,High-income North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.5078514789630915,2.642287742056664,2.363332491009256
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6937623188927988,1.8526381240482632,1.5574235025217598
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3537772001271844,1.438709166686165,1.2549272455371832
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5739342100257925,1.6773381301782324,1.4742416054502965
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5299430532421332,1.666776679716862,1.398670544640252
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2573693960265555,1.3300729147421562,1.1667860316367218
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4441649418619935,1.5336939677976724,1.3447544172898265
6,Incidence,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.7009214891900095,3.944383627957936,3.435888622224394
6,Incidence,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.907370502345249,3.1290782691431485,2.6977098101470816
6,Incidence,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.565211232543469,3.7920522318009136,3.3222543462275818
6,Incidence,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.8449359389329816,3.0815968848557187,2.609142251818679
6,Incidence,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.167900846882906,2.3603420964308643,1.981116684101329
6,Incidence,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.716343135005455,2.912082041292816,2.499456001180153
6,Incidence,100,High-income North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.553519707512368,2.73755756267212,2.3531761114607104
6,Incidence,100,High-income North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.9866109570860968,2.156073987324024,1.826356146283424
6,Incidence,100,High-income North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.470506535879841,2.6429527011123493,2.2858089569626623
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5053699600878756,1.6411844043428607,1.3573754172705643
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3458814729633546,1.47632014466587,1.228442560170419
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.5844008439677164,1.704302424631578,1.4491453304291089
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.3529557827219525,1.4668819059774294,1.2283490565495727
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2498434177430469,1.364040585937719,1.141628780174803
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.454125010327833,1.5611282892626053,1.3349355890465562
6,Incidence,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.121796284871892,3.379106805841108,2.90126536514252
6,Incidence,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.348122422887271,2.5152887246884204,2.1769661682594554
6,Incidence,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.7541832581218317,2.929378827151523,2.582832776466371
6,Incidence,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.371192761471778,2.59521283661309,2.1620759829447658
6,Incidence,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7144169627375136,1.8709881546468556,1.5621092656208868
6,Incidence,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.056033758041631,2.214476479692485,1.8955481137001189
6,Incidence,100,High-income North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.1157474895772457,2.3102536112636005,1.9490437972955927
6,Incidence,100,High-income North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.55914792514786,1.6869220147345032,1.4283241025442843
6,Incidence,100,High-income North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.8539572147997985,1.987142151137557,1.7236953416421512
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.272919691626618,1.3938080009274805,1.160615699728043
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0461054402760843,1.1394048690506864,0.9436367626825382
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1850354245920682,1.2727746963620226,1.1005428572065858
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1346259806662762,1.2414639021412186,1.0407893034577624
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9623523509360165,1.0469803841834662,0.8714739846225233
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0748858239851091,1.1562596265513596,0.997775605318004
6,Incidence,100,High-income North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.685677285521057,3.870471547490293,3.5056862889082456
6,Incidence,100,High-income North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.8065660418365157,2.915855962890149,2.6668893088458177
6,Incidence,100,High-income North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.3706074394751027,3.49547940417028,3.233602327810737
6,Incidence,100,High-income North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.832375401456998,2.9970069603743945,2.6669633677132194
6,Incidence,100,High-income North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.086151098691841,2.2054075256285586,1.9747370493671057
6,Incidence,100,High-income North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.557864775803123,2.678923542809414,2.4373822475594684
6,Incidence,100,High-income North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.5419963118786555,2.681685956398969,2.4059375508231406
6,Incidence,100,High-income North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9095607500228464,1.9930968455945268,1.8027983989866183
6,Incidence,100,High-income North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.3225673275171896,2.417495896546695,2.2184150525708204
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.5070608191449804,1.60872312339418,1.4123656222951129
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.2866726188862014,1.3624673372994105,1.2106165302401115
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.485337593949517,1.565070347050536,1.413686467150893
6,Incidence,100,High-income North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3545523852718762,1.4447137225358149,1.2687055124174464
6,Incidence,100,High-income North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.193049764469552,1.255783096910715,1.1228254736896837
6,Incidence,100,High-income North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3600458207039434,1.4265780113977986,1.2900976968216922
6,Incidence,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.774384558863997,6.297183200876392,3.5655711062720417
6,Incidence,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.069760702405903,4.965200694716497,3.183936970604364
6,Incidence,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.395645893398403,5.2261338121933445,3.5721307424830546
6,Incidence,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.554419181528893,4.811305291749389,2.593802273931741
6,Incidence,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.936988190502061,3.6599870331966526,2.246333515732172
6,Incidence,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.2201569443466487,3.8861756180731977,2.5403217613413016
6,Incidence,96,Southern Latin America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.235546273231669,4.352528359774023,2.3488742371098805
6,Incidence,96,Southern Latin America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.7017376940619764,3.355552374256576,2.054944424953969
6,Incidence,96,Southern Latin America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.9485043072438706,3.556250847558521,2.3458604005248915
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.1577392810767866,3.0014728499551917,1.511466432784315
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.730491663271499,2.244951024509793,1.2518967937046224
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.916720905586212,2.3629664325734434,1.4804358994882865
6,Incidence,96,Southern Latin America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.059839050284012,2.8602984724025244,1.4381326822059552
6,Incidence,96,Southern Latin America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.645702874106176,2.134581006510177,1.1962525944924085
6,Incidence,96,Southern Latin America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.8250489273304995,2.2658898750827943,1.4051251609898996
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.9470668735259085,3.227191670573594,2.669621811480352
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.708707529819722,2.9235477458531,2.4872550191173226
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.880511719548082,3.1051950922043026,2.652896550714952
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.0050118891548965,2.231532517290822,1.778239512518342
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.897176813871988,2.0669010982774907,1.7167455002096863
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.995662164108644,2.173447049298301,1.8116429494868989
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.976695477914767,2.187952657826385,1.767459230335554
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.827936170017703,1.9917545387648208,1.6590758433618082
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.9429375643922897,2.113334972072673,1.7703167146187644
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2245376713817866,1.375302058473736,1.0801789762723162
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2792949335251336,1.3953693593056389,1.1571884868419668
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2822804622046846,1.4024725738693733,1.163761094217823
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.220537380337498,1.365572189741076,1.0850540120240888
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.2568302627846473,1.368978714711366,1.1435247961686623
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.268646628193641,1.3786625862349269,1.1591228936340787
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,2.0091725560757454,2.8584953596985665,1.1165265712060002
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2901144621145737,2.306257917251842,0.5267067152224632
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6980666175337822,2.509801418927857,0.9266055767517882
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.620096599339596,1.0782807020265146,0.1419169921967452
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.223108594370703,0.7447002507386865,-0.1790622777094982
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4467678331827969,0.8786227350879655,0.0273843421882032
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4955863078673722,0.917707516401306,0.0519330816512679
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1474678852219013,0.6566092407469082,-0.2350395777803919
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3462088860956588,0.7512265367675552,-0.0387140441345174
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2930463960960339,0.6588273870375417,-0.107854789561737
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0633009661590618,0.3957200785423145,-0.3932995329313386
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1319494913929895,0.4920339837524161,-0.2258333636549584
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2757482660888558,0.6383490171817199,-0.1180867429451087
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0715720673172409,0.383209894741521,-0.4027883451726595
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1190611367697311,0.4772445587685388,-0.2249521445095998
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.8934749317920787,2.2872840932888208,0.3384633691903316
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2618379748282111,2.66638080655168,0.3551813836084659
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1040536915243933,2.203269869541052,0.4167237905072664
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1254114948130129,0.5173624709525696,-0.3822142035303569
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0082169498966265,0.63395529457118,-0.3929825079688826
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0458099831708897,0.4475362574655077,-0.3579061495648858
6,Incidence,199,Western Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2396513331862034,0.3200502609267301,-0.4625232046881282
6,Incidence,199,Western Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.123633722405421,0.4205670500894046,-0.4749246949447719
6,Incidence,199,Western Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1702874883141808,0.2631774083382965,-0.4413291546114479
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0228029272516023,0.6767226011765841,-0.3236485297810479
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0767923665060331,0.751026202033459,-0.3578529622651197
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0416139759599079,0.5914656038815167,-0.3074487455225996
6,Incidence,199,Western Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1007702847155256,0.5389154733715235,-0.3736547010798494
6,Incidence,199,Western Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.010964881889676,0.6009690990501186,-0.4158449481012169
6,Incidence,199,Western Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0411355635228498,0.4691411310708925,-0.3625133584088802
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.837587373056117,1.5116586465098294,0.3403216543772657
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7307004550513874,1.2926168145247745,0.3178792977310758
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.820927175830909,1.4436916165016105,0.35492406187477
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5271683618987463,1.0736708062170015,0.1122640301467991
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4335096509537104,0.9081301338909864,0.0882924675095405
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5105182076964923,1.027104315559607,0.1199485641029988
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4903576005676895,1.037056636731235,0.0870550125104798
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4193688519159969,0.8802034092137109,0.0808091142085457
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4850982976647001,0.9930079070998684,0.1050389298720696
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0056836066150207,0.346831877119305,-0.2711970074909275
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.070412176962985,0.2370009222635177,-0.2892839977291138
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0024088248035856,0.3429018859695406,-0.257006126322036
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0068668621901015,0.3461178094228583,-0.2737071506899204
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0643143676584349,0.2416978058658759,-0.2845546930372641
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0004544578934406,0.3448264538823479,-0.2555736243373843
6,Incidence,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8699050973272409,3.534492774826268,1.1523771876041642
6,Incidence,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.552144290511684,2.646281524124067,0.7206696412467368
6,Incidence,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.682700389425119,2.794327258922848,0.981145504276584
6,Incidence,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4532871483663664,1.3042729095832084,0.0897255604853134
6,Incidence,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2561124550747242,0.7977225210352823,-0.1511940184512524
6,Incidence,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3388582166699309,0.8868564534548324,-0.0068322543601663
6,Incidence,44559,Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3149290661132778,1.0776074983290074,-0.0138268586457187
6,Incidence,44559,Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1589466988081959,0.6558021233437612,-0.2186317960640953
6,Incidence,44559,Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2236473728100795,0.7306884511831596,-0.0963495211695868
6,Incidence,44559,Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.329656687044129,1.1175146944172574,-0.0142189193732988
6,Incidence,44559,Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1105012301676786,0.6276273260361388,-0.266466082195109
6,Incidence,44559,Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2018257475067145,0.7177333921250153,-0.1242828968263719
6,Incidence,44559,Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2811671586462496,1.0349693902206494,-0.0428610788253971
6,Incidence,44559,Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.082916419845921,0.5844932213199957,-0.284794388089472
6,Incidence,44559,Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.165566396018159,0.6627316971046215,-0.1535266485547792
6,Incidence,44559,Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0249126065252208,2.102233297493137,0.5536576388104897
6,Incidence,44559,Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9321161733769872,1.6349609306217867,0.3731462553070637
6,Incidence,44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9868141058949438,1.7790009567327745,0.5387748435322068
6,Incidence,44559,Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.0256419355713626,0.5726655913581967,-0.2185421843440301
6,Incidence,44559,Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0488392699647827,0.2961760906477997,-0.3265453977147521
6,Incidence,44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0081626029983749,0.3941019700754036,-0.2289344033869869
6,Incidence,44559,Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0722284004656024,0.4213768728928238,-0.2881473363131588
6,Incidence,44559,Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1226124364621105,0.1965543184160771,-0.3764446134627074
6,Incidence,44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.0937639288667146,0.267572492682071,-0.2981259472520067
6,Incidence,44559,Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0427570904965974,0.4792454524163487,-0.2674028175926083
6,Incidence,44559,Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1264480527162691,0.2376151533822787,-0.4045810032293837
6,Incidence,44559,Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0867251510718118,0.297400251387729,-0.3115066266413062
6,Incidence,44559,Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0778290362260745,0.4201506705865621,-0.2895669012128755
6,Incidence,44559,Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1482785749799507,0.2008192664409117,-0.417394036150357
6,Incidence,44559,Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1144534230317202,0.2597674546214524,-0.3350056065506964
6,Incidence,44562,Europe,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2275667085110908,1.3794572241867549,1.075459150044854
6,Incidence,44562,Europe,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8469129168729208,0.945865971752645,0.7179593207386625
6,Incidence,44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0896132657781767,1.2031084223308313,0.9630498224517584
6,Incidence,44562,Europe,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0086163618660755,1.1461024915257814,0.8738519602827364
6,Incidence,44562,Europe,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6716864867073498,0.7576522385485178,0.558448065715594
6,Incidence,44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8881046608587533,0.9900018428980728,0.7732582973427038
6,Incidence,44562,Europe,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.0969549325924588,1.2399394568462736,0.9537660916963908
6,Incidence,44562,Europe,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7544544136131057,0.8484537691258562,0.6319563771208949
6,Incidence,44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9763083376100544,1.0836494556278118,0.856607533456951
6,Incidence,44562,Europe,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3218086787345344,0.4106397639769313,0.2372937127235995
6,Incidence,44562,Europe,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1892818843439244,0.2475060668947496,0.124386971421853
6,Incidence,44562,Europe,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3155007186686864,0.3812500897892501,0.2432483917881089
6,Incidence,44562,Europe,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3870961760271171,0.4789512183405078,0.2935482763242714
6,Incidence,44562,Europe,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.251805530324147,0.3121757346745415,0.1837190725649484
6,Incidence,44562,Europe,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3817638767624912,0.4552835724998993,0.3075816353520042
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.46109075528192,3.3699242866140824,1.8164219920022504
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.504121640987196,3.5310560267717177,1.59759461222992
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4833250958074347,3.2343899072866558,1.7747141039247878
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1014809028457957,1.6448217510455767,0.7089351950493068
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0294580944479006,1.620884873601263,0.503790018430904
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0649514918459155,1.4978709497565663,0.6370392827215703
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9702263244557864,1.4875799203550395,0.6032485542168526
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9176296864777548,1.4796192707464089,0.4215329980506698
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9450777212003532,1.3644699374893516,0.5493915835591765
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5375283638096685,0.93470946813525,0.2517293719192409
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3234140625079256,0.7256700370414051,-0.033580001109981
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4184145397061934,0.7487400687456784,0.112330352526645
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5114249172826031,0.9056977989887846,0.2287140970417615
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.30360927978463,0.7101694176221941,-0.0454874294005447
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3973188814199612,0.7212429332404029,0.105021501961518
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.169178150294862,2.4518617961730698,1.9078691833791623
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8591740669222525,2.13468155768067,1.5697452493769826
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0165845940290485,2.246536369735283,1.790771511651724
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.650224899095211,1.88322626434012,1.4120343690593116
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4354149123317417,1.6749175907705751,1.1989045776858909
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.547578777770773,1.7463434603419907,1.3479607547464314
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6084119886760506,1.8410765395290127,1.393340001641164
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.40672718430138,1.6386372925938455,1.16309871439985
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5111895763594811,1.702615503337246,1.3232089509217058
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6586454489183481,0.7667940380689025,0.546578322619353
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6116931834413206,0.7330232099212054,0.4865286538768526
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6444158372447688,0.7383725876354907,0.5415942334394512
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6540187010148495,0.7658128913821691,0.5393788433293325
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6171653754045645,0.7385642252771675,0.4897570656469328
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6434875019399365,0.7365508349183769,0.5421304133735603
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,4.078934587044139,4.401317934434646,3.7709417200383593
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,3.4568826061783144,3.6919647675275966,3.1584450276981766
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.849071911892693,4.074397943835439,3.6132901248513054
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.8664593550866977,3.121892395252745,2.643554011070426
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.481404329314432,2.670626347101635,2.2444964290752907
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.743102376076436,2.9236216692458283,2.5442874576215315
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.830297814126955,3.073424440323465,2.5980238233832607
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.3984290824213663,2.577682189241001,2.170866672635573
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.677483000517898,2.8483677939587446,2.4986686769872746
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.6814532215677362,1.849625526510969,1.521253286498411
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.6541037843389714,1.7806985468162924,1.4974331526948306
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.7338744918400335,1.8641288953703905,1.611083283185428
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.6767824370939313,1.8422329882827992,1.5280615002762143
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.6281455426897804,1.7521507996413035,1.4877781463759978
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.7177316175933903,1.842165082381368,1.594756658938806
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0802941799007275,1.7645639013919192,0.5451349398416713
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.006102188433166,1.6324607326071847,0.5648866274140709
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0585634609479564,1.5891776464703575,0.6204412034554991
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7570471823002389,1.355340175280399,0.2993108562076449
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6373982213384985,1.1484009800622847,0.2887865456953489
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7084410802198351,1.1441245489357947,0.3472903265228347
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6479271875550673,1.1899787341876982,0.2239950966588061
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5686111340416675,1.058373316625632,0.2236159261616823
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6202158450272303,1.037841790152925,0.2753867265110118
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0089763643608647,0.3379359983002203,-0.2400571689882435
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.108013737171629,0.1708249454975917,-0.2983113248343955
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0325517133107222,0.2172080433401197,-0.236307800206483
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0189329590260959,0.3011977082630764,-0.2624674589058076
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1200437863346561,0.1483148117434186,-0.3117990047855644
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0524041292081786,0.1873883310373287,-0.2493456219550316
6,Incidence,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6764741815782352,1.6318431967883182,0.1761137831816037
6,Incidence,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6965378134053914,1.322340392875577,0.3038264215316155
6,Incidence,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6816227626520239,1.4588306046352977,0.2443066519471132
6,Incidence,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2675931408384611,0.1592807635651159,-0.4888011371313339
6,Incidence,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2586156413649674,0.005434771421345,-0.4230262205214176
6,Incidence,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2651679832928976,0.0715368699476914,-0.460899112866504
6,Incidence,94365,Central Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3428867656584025,0.0315810492789248,-0.5390087479351193
6,Incidence,94365,Central Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3086745639139731,-0.0536650747428591,-0.4687012795567765
6,Incidence,94365,Central Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3278607846570467,-0.0172133073089244,-0.5026546290520116
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3549549354743914,0.0208015318724034,-0.5391264324111553
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3000167654607916,-0.0331535937560524,-0.4597210778952107
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3413570513295257,-0.0353285410793152,-0.5080270074424814
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3704416598060222,-0.0047427034447464,-0.5478006247579039
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3011838731276291,-0.0175849203348457,-0.4622403427229583
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3499563813519107,-0.0479873777265206,-0.5148735630152131
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.1568428595571865,4.423811093009389,3.894426370215199
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9137736646166945,3.1087516484458475,2.6977187879068527
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.483943511333893,3.660062035312284,3.285119614188407
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.9221118740496683,3.1326260208540244,2.707993925832908
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.904729663567631,2.06293493193884,1.748817763718471
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.366438060935369,2.5111348777656293,2.2056821569957026
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.6066845625640216,2.793401558313191,2.423151046641987
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.722053203297503,1.8576615677394592,1.5717857326583604
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.127169287465142,2.249996980933356,1.988506527063297
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.34981658253354,1.4655733266310804,1.2355012843770887
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8897051925600822,0.981865480680095,0.7884891216613308
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.115126143407264,1.197083759418732,1.0227326162281338
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.238004479596892,1.3438947787568427,1.136897347690751
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8193024552682999,0.9074531619504972,0.729841146753966
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0259090744798638,1.099725115961955,0.9429444014803756
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.955198481890472,2.217805691963662,0.4855551877781768
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1673506399551166,1.8487286344135605,0.6502080995882975
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.0732973534942416,1.8211124502370368,0.6539126936719228
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0431619746487562,0.5825629579016713,-0.2685254487899966
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0364119221110517,0.3691859984346646,-0.2130914273641211
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0028385129533737,0.372099207358177,-0.2034949927984771
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1298793150295073,0.4320179351234893,-0.3388843590441023
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0217622681132578,0.2857789536755563,-0.2551755130328992
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0707515758045373,0.2644179063088967,-0.2587190825467983
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0750366255415035,0.5386992885454882,-0.2881111305332973
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0369708463640539,0.2988817122334443,-0.2813702475268453
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0465694312760804,0.3214072468611825,-0.2458259278717016
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0926491578288618,0.5040678899224943,-0.2978428159623544
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0310747475140356,0.2963354004736319,-0.2764584570966217
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0528865495847871,0.3046651653777079,-0.2516714570645519
6,Incidence,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.26898888862368,2.5664163320290423,1.982383099527472
6,Incidence,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9931129602412927,2.301393238786529,1.6683064443736475
6,Incidence,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.133649049290619,2.376795811532625,1.883382943577028
6,Incidence,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6684135329201577,1.9178021191850825,1.415374201767294
6,Incidence,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4931025640284057,1.7452866530183004,1.2363064275120226
6,Incidence,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5856347887205058,1.798326365987688,1.3661720534402606
6,Incidence,44635,High SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5962875645629897,1.8325095888593803,1.3686602854517582
6,Incidence,44635,High SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.435160762128672,1.6859738948181036,1.170902081206436
6,Incidence,44635,High SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5192226618252669,1.7146947213809374,1.3180271753226676
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6410526106343044,0.7611051201454158,0.5202044467286608
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6407505762222598,0.7801636128746738,0.4922247784163761
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6495378260745802,0.7546356545224275,0.537167157916114
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6225837177572155,0.7434475474511048,0.5069916175442111
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6316679816039883,0.7723442965307383,0.4836415214442545
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6344393742110027,0.7347654636523994,0.5251172671087645
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.9200007074069432,2.448014747265161,0.4409974657303745
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1695947816267105,2.0946370594657697,0.5740714722427206
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.053504069238352,1.992698249199493,0.5793844561885926
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1443598380604031,0.5470615542038696,-0.3582818546484368
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0396984681907506,0.3736213401559949,-0.3058134870581719
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0880217941596626,0.3358669022271783,-0.2983712252509944
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.236703254293514,0.3707590969015459,-0.427131108900074
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1185476045892653,0.2572740643060136,-0.3604939127315952
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1746460047904,0.202839328850084,-0.3652063853125524
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0010702323179479,0.8266942280342249,-0.2483498929156239
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0248592882057977,0.4823032434437258,-0.2646986469912258
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0224789702384754,0.5100739334204494,-0.2138082093048972
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0309384699889444,0.7733301793061242,-0.2752599090944961
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0084832664182302,0.4577164528410314,-0.2783895383877838
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0023248887783472,0.4709268053008627,-0.2363921709051501
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6400055641564453,2.1083596646825584,1.2176490036776415
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7601882225259984,2.260396234610304,1.3094394026166252
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.6776623009303488,2.061735015064829,1.3252567182873825
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8214353975967923,1.1600301947391918,0.5287335080879092
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8107828838598821,1.1252487075078836,0.5117842744973337
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8011872302197041,1.064363486075625,0.5539002038435603
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6892425135091801,0.9889250856699192,0.41899207634835
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.719406434135564,1.0310014432602803,0.4386210823228822
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.690978087673606,0.93352493290091,0.4684294421569344
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1957028844585868,0.4054168718492116,0.0030699765278477
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1010248608681257,0.3147955273358894,-0.0854233326437416
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1394600967158256,0.3063291678493509,-0.0157627607178066
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.164078152421204,0.3731382168549202,-0.0289098138617438
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.085897598107227,0.293127372541743,-0.0975030577083243
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1171874988355169,0.2846232020920199,-0.0381960178768515
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9959136462003693,2.950489739262711,1.280552018247941
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6337893774140004,2.4329731959959355,1.050030584218972
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.81437498994354,2.421449705162982,1.2940722012987922
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5303036381857102,2.343273623834896,0.92417751827473
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1495202205191757,1.8026579806679897,0.682189784242091
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.335713712684295,1.8363747113737336,0.9003521924193967
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.373244898169353,2.1294225155208526,0.80656356673732
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0594122103814765,1.6843099066213074,0.6029596189431381
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2150859271810197,1.6928910040577834,0.8055756845451798
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3532358611876746,0.7809928819355394,0.0447436606014674
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1434843997881355,0.4844242829038662,-0.0974854229948899
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2452060637084338,0.5072926368110636,0.0251303334190392
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3158524193379062,0.7300263326333554,0.0193711216518837
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1281735818160509,0.4583996022650227,-0.1130021175114277
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2196524925888194,0.4828398223560666,0.0019879612347697
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.50458045692121,2.079054098428128,1.100348106070682
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4755788344614424,2.0754570772435,0.8704424115372589
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4943951718955677,1.9866299884530347,1.048031766543413
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5917053636202214,0.9420821600921584,0.3337723442326441
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5106798455055437,0.8696565145870365,0.1519905313501858
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5529180592246454,0.8546100721807791,0.2763274296383853
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4752244014286108,0.8135954573819615,0.2371272677655131
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4261569090331963,0.7717409351255988,0.0775436964595367
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4532331002876906,0.7400088031093655,0.1931820535556111
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1432705561429405,0.3926609873415857,-0.0562082496330793
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0508842635889502,0.3311154570680243,-0.2240513785777157
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0945928910002461,0.3149764287344014,-0.1164159080853529
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1177377230117934,0.3659849043146131,-0.0725506076415203
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0386160349536467,0.3117131275345844,-0.2354378140723529
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0766421233984259,0.2938246599000454,-0.1316459854460292
6,Incidence,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.467630396458425,4.785467032333715,4.166622175808052
6,Incidence,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.2453885422182744,3.443065753387441,3.030047364478658
6,Incidence,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.8693967564262888,4.0771662701611495,3.655169037332593
6,Incidence,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.471978464737632,3.731624089858828,3.213034656593169
6,Incidence,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.4418676294324726,2.6137546079413445,2.256876409456293
6,Incidence,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.96390440608776,3.1517742788124017,2.772721540785701
6,Incidence,44638,North America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.132995989143009,3.373249526054753,2.9054630949201523
6,Incidence,44638,North America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.244959004585412,2.396053407372285,2.0803631644602367
6,Incidence,44638,North America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.7016996267793068,2.8596453374945856,2.5388444092888878
6,Incidence,44638,North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.864454500944721,2.02970541216696,1.712959952432696
6,Incidence,44638,North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.5867352653671374,1.701187131090912,1.4636091097766415
6,Incidence,44638,North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.7765986523900104,1.885944483405457,1.6619639463841684
6,Incidence,44638,North America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6901106484764832,1.8365667648821196,1.549398278159849
6,Incidence,44638,North America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4808965191737398,1.5940648605115308,1.365619282383887
6,Incidence,44638,North America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6366031098597729,1.7395639690600997,1.5350964717044764
6,Incidence,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7706459809872772,1.961863671506979,0.3342994766761404
6,Incidence,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8354949166916501,1.5719135122348793,0.2794368944235164
6,Incidence,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7887724653807696,1.729069220375929,0.3822424144129632
6,Incidence,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1031794514030035,0.4952145320411264,-0.3237646440076631
6,Incidence,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0964029376761463,0.2660360056565364,-0.3731151468261166
6,Incidence,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1070215710329158,0.3569272900100949,-0.3134612322768053
6,Incidence,44559,Africa,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1887279240121338,0.3570625158151121,-0.3886525493769188
6,Incidence,44559,Africa,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1664888296921007,0.1679240416407637,-0.4189986942986459
6,Incidence,44559,Africa,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1840957206975929,0.244797367195176,-0.3695243398590873
6,Incidence,44559,Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2189219290772817,0.3018576694766226,-0.4092892639878598
6,Incidence,44559,Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2259277591390053,0.0991845585019956,-0.4712463723645321
6,Incidence,44559,Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2345548695363068,0.1754798618898025,-0.4155871315456344
6,Incidence,44559,Africa,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2475329229253002,0.2539677917982131,-0.4298939244620133
6,Incidence,44559,Africa,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2453036148943771,0.0731366543781728,-0.4844927805842374
6,Incidence,44559,Africa,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.257817316583651,0.1390527896309008,-0.4322174955025486
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8819231340106354,2.226809769264027,0.2942792354325653
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0226836783954247,1.5641247899196091,0.6376815343808797
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.971041277540886,1.6153038458366389,0.5794731234601489
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0548230866166391,0.6173524000866122,-0.3467948947993348
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0228181097842449,0.2508833029481113,-0.2091511701269895
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0293270418234252,0.2798412532854013,-0.224167146027972
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1568966657979435,0.4456138118162369,-0.4201616851076347
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0944696741383809,0.1479267773632779,-0.2668303455823101
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1172830477519151,0.1712454053117742,-0.2926440873739721
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0934739648165311,0.5509997203227841,-0.3768619362643048
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1229877443542204,0.1377264338814714,-0.2984931329029193
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0904614246610983,0.2019181129922346,-0.2713475637158637
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1247946688620876,0.5006051374445935,-0.3987015811749664
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1304424508285642,0.1227125068594159,-0.2984608338303443
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1099097268685046,0.1791848986887191,-0.2849367963753319
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0377598156942118,2.6513424775287,0.3400175201762966
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1508514828792935,1.798129012722912,0.7323009872265716
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0723214016932143,2.245232722650803,0.5110785521590031
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0233160617393834,0.8338517636302634,-0.3236892868380964
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0391295726859204,0.3401088293566848,-0.1664804562961727
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0205083194774134,0.6115740789285331,-0.2565316524822759
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0870816858213666,0.6358048644406806,-0.3996708905203223
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0370905421471067,0.2526875575047216,-0.2244703933646814
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0719254575615202,0.4533546156111124,-0.3232741143638606
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0335202192010372,0.7533125915341597,-0.3613447372608175
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0701004583982986,0.2231339573391351,-0.2564340856806198
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0667473224918492,0.4656446504455334,-0.3146444268066061
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0668712176656362,0.6913741746486127,-0.3851389696687467
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.078017403596091,0.217922856186045,-0.2632893277262099
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0866706306606078,0.431426757420602,-0.3321851739341742
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1139605809848574,2.717944283654592,0.4130813375100559
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0981340129759274,1.6363208258740078,0.6884596839282555
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.1037593258510134,1.844892417970064,0.6459795272377349
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0615752059847871,0.8511768275494653,-0.2875576879545651
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0135320788755546,0.2677780834221322,-0.1853630079315105
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0359149468120968,0.3993686273462427,-0.1911635550451446
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0529436712955676,0.6656425362317442,-0.3669382316298693
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0606914977537996,0.1802480447280127,-0.244097599578861
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.057846204674336,0.2740650301333568,-0.2628596629093691
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.044108814559471,0.7071889937721797,-0.3591602288127
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1050959199026548,0.1548712586097269,-0.2932765500724806
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0669262896016518,0.2740452445637383,-0.2843003699616051
6,Incidence,174,Eastern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0770144443122531,0.6605520744407549,-0.3813959077715237
6,Incidence,174,Eastern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1126557389975413,0.1322194670423411,-0.2978908899466062
6,Incidence,174,Eastern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0868016114987895,0.2439285576562619,-0.2957215702981066
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.228543782955553,3.610388131159257,0.9804089144370484
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0681167226157298,2.3283888993969093,0.2272107279524877
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6931565478129704,2.933452537742328,0.6912973918882455
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8636525593524413,1.6513594670502143,0.140426602761868
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1900014219789574,0.8975102816943427,-0.2930966933955642
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5521375803744478,1.252716909588941,-0.0295869433913347
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7345834847150274,1.4770000495747064,0.0640043396965157
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1420191927100235,0.8379446200244883,-0.3223311868738336
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4662867370162395,1.1415648085730887,-0.0791746079188142
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1961125672320821,0.6672335015286689,-0.268061264440966
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2541783295523183,0.1985502155856831,-0.5647044902050717
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0186437769605589,0.4245092325026827,-0.3893241722303986
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1928086022415504,0.6672933889111949,-0.264528143924318
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2493156305205089,0.2118124125109191,-0.5609442664467464
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0176359407956918,0.4395876323645507,-0.3859296101185829
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5808193571816425,3.656150711687297,1.4391982187324412
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.574191070679707,2.849532959055169,0.6207070508294246
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.339001566549709,3.42683095999284,1.3038340057487106
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0672988232012444,1.686506770408927,0.4185055816020947
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.481745374045726,1.2155247745213025,-0.0693388931805534
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9250153016381653,1.5502177939070956,0.3355460653314952
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.923848811190384,1.5015866811145802,0.3104957623608125
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4214747051127726,1.125721664612089,-0.1050415396928415
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8179164950081061,1.410184260889517,0.2543204180460896
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3337860927604919,0.7267647469307232,-0.1005214089732891
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0592391637660983,0.4184083758561677,-0.4100311884671532
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2330716670044522,0.6337952748978269,-0.1492405299366299
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3300716914085133,0.7266754387561529,-0.0990286523704549
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0532916559822234,0.4105790693066282,-0.4067436707529198
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2341077029782357,0.6343348231799429,-0.1485586417856665
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.3973660543604978,3.4654120665361705,1.2364655733684875
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.452358268237426,2.573736688900585,0.6016526699469695
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.82024310754796,2.798236900372986,0.9043571139039072
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.960876151088133,1.5730632327948888,0.2841908753960656
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4115382813844571,1.0586754806088554,-0.071657627620504
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6254521592951421,1.1924502559984558,0.1018139995142861
6,Incidence,138,North Africa and Middle East,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8252857776116124,1.3991094882938633,0.2015746133532001
6,Incidence,138,North Africa and Middle East,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3541983288960803,0.9734262789841396,-0.1155634161590055
6,Incidence,138,North Africa and Middle East,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.535478903785661,1.0679467725651677,0.036825572181235
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3011639982781487,0.7164778962087163,-0.1466077381022635
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0600639035202644,0.3972512437916694,-0.3950984350355979
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0806373320274012,0.4820176878525603,-0.276511844942126
6,Incidence,138,North Africa and Middle East,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2976379084617115,0.7021315423917323,-0.1485610545681153
6,Incidence,138,North Africa and Middle East,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0541715959541069,0.3990820637383965,-0.3911089890694489
6,Incidence,138,North Africa and Middle East,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0816917273113391,0.4703934168660842,-0.2717839428256302
6,Incidence,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.986996985201906,2.7727976048201235,1.4683597620020006
6,Incidence,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.210953209010318,3.039841260980678,1.4517376658891776
6,Incidence,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.1059159541927954,2.7280520939361246,1.5267562931501335
6,Incidence,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.788563222405006,1.2683565146127669,0.481369531416746
6,Incidence,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8271917040101165,1.3157267725964823,0.3980626268938796
6,Incidence,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8123773925993061,1.1819706339587652,0.4733102452891294
6,Incidence,95469,Limited Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6594282161424886,1.0959802873085662,0.371298952409222
6,Incidence,95469,Limited Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7196128293731501,1.1635204279898477,0.3130180572827101
6,Incidence,95469,Limited Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6946302027039982,1.0340761851941174,0.3786327744845383
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3201800415004282,0.6753342167354454,0.0887251379135356
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2165753223917292,0.5575505114090487,-0.0939408221611963
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2653508320345542,0.5405657806870274,0.0162844909149718
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2966983525451028,0.6489911395508173,0.0778024237829677
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2034617034088078,0.5313403869587457,-0.0994120304690043
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2484928177638354,0.5169275960139124,0.0038353899069199
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9429671695105554,1.519445146098636,0.5101660126340283
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9305069121624188,1.3930087185106257,0.5605913311087458
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9393947569883266,1.3970014365885368,0.5644232481302501
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6148080141855509,1.1003374724865436,0.2493394120154126
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5988943203383543,0.9918024640080916,0.2873688088972257
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6088697962378982,0.9855011601240244,0.3021989671455269
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.575824872978766,1.0433718024828886,0.2248056489988692
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5832325989944406,0.9625360515182556,0.2798602551243386
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5817172099641713,0.9549286760208312,0.2759007243467346
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0117458397843563,0.3023723618229,-0.2081397698381543
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.008973737832214,0.2325527753626391,-0.1980903009813349
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0178055444842735,0.2606537383213012,-0.1775933724229704
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0104955396869695,0.302675604643065,-0.2102087876460813
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0024064081320874,0.2334232268140918,-0.1908259870812516
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0197371459135409,0.2633922441808619,-0.1762319884289855
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.926710296397411,5.512459144881705,2.346125606683919
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.535427261651785,4.321226696580476,1.248518698272134
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.124558914302128,4.624594983531571,1.7743080330520176
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6519069048286357,2.510779977463564,0.7850832106351855
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8880551131077078,1.8628134425752951,0.2093015853874997
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2112475903035216,2.002437902374308,0.4908957887732028
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4486201189240535,2.23675181337311,0.6630550586594279
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7714351445724695,1.666214656656774,0.1266262181523857
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0579617365912082,1.8064094853375008,0.3842497818956966
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0808725100672592,1.763515139476735,0.3834421638650739
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3994689915209209,1.151912837169803,-0.1199037082685449
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.687003183014981,1.32805414534229,0.131029452247386
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0533821099240968,1.7163664814546666,0.379298037115449
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3871299363845465,1.1220278014046228,-0.1252187823465421
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6680132772979245,1.2966393253205075,0.1165171188898704
6,Incidence,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0420728247063459,0.1620841940842075,-0.079890283670976
6,Incidence,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0491157316095733,0.1460089898609866,-0.0485227161329393
6,Incidence,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0448897903875008,0.1420352444428568,-0.0492574410533805
6,Incidence,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1493156356177928,-0.0534127583249075,-0.2474852316203654
6,Incidence,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1260889175610076,-0.040798411657634,-0.2066778164913889
6,Incidence,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1377917821366237,-0.0565575543499798,-0.2174632216819724
6,Incidence,44635,High SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1723677233747958,-0.0770526163072093,-0.2692329353421596
6,Incidence,44635,High SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1464520389028051,-0.0676208475168229,-0.2258895075102533
6,Incidence,44635,High SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1599856915534499,-0.0818879130530283,-0.2356731202550369
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2230693333779513,0.3634553855028288,0.0750227002404261
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.224667750183339,0.3405309700962613,0.1090365715678043
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2237790579605641,0.3348583781644,0.111054418312547
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2092024967403985,0.3474866735854164,0.0648864071778365
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2177982469369187,0.3307309326238764,0.1028193888414701
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2124844328813771,0.3255002138017889,0.1019293934524354
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.4695201363504014,3.1764321859191,1.827053625453404
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.6173556236016084,3.342151108545996,2.00542977764704
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.537989818377835,3.0804596233060977,1.9767524866087596
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3935122622527512,1.83547551965074,0.9428434830714724
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3728634190114852,1.8167122811925276,0.9454354980472178
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3796816648235568,1.7370937535111337,1.0050026519980184
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2200183951778838,1.6723454295055231,0.8089276920187409
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2533624638413587,1.7048599414681929,0.8721749679446982
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2342859498042642,1.576862589524501,0.8798573761651767
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4990610044643298,0.7706040311858402,0.2267333820314056
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3681503070791012,0.6392001093405146,0.124595196835419
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4276149719391764,0.6509575209195784,0.2001600371397893
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4595237660801716,0.7382573677116157,0.1962854866105391
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3494635970550913,0.621862488859166,0.1068237892848099
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3997977937179079,0.614771741019668,0.1765367689512464
6,Incidence,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6902480294123429,0.9182601290597164,0.4706387965562576
6,Incidence,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.5436197712260038,0.6897670599571437,0.3897793148660088
6,Incidence,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.6298793688394201,0.8171082874942235,0.44806868416208
6,Incidence,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.3824804133925186,0.5590767513174455,0.1956748908382877
6,Incidence,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.2513677612347352,0.3692325564475757,0.1200627992226357
6,Incidence,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.3267731422466418,0.4764492671468407,0.172526279675837
6,Incidence,44638,North America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2776628666676215,0.4500178038135333,0.1116596783100307
6,Incidence,44638,North America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.1798644167628101,0.2915719685799792,0.0622765990235074
6,Incidence,44638,North America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.2390290118310464,0.3813598287627568,0.1008171188021177
6,Incidence,44638,North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.9142455777518588,1.1739538991315104,0.6642102949886131
6,Incidence,44638,North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.7155119451694067,0.8766378438503037,0.5363497337026593
6,Incidence,44638,North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.8266871728081251,1.03959459155729,0.6159122683673146
6,Incidence,44638,North America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7976924898575894,1.0411812991850218,0.5628043073208344
6,Incidence,44638,North America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.6454065142807385,0.8021262638245317,0.481306132505729
6,Incidence,44638,North America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.7345813836038236,0.9347633043015372,0.5397297160115291
6,Incidence,44566,European Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1582975054608564,1.2972055254637866,1.0144747938347918
6,Incidence,44566,European Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8184512931577288,0.9127065816049504,0.6948064969122442
6,Incidence,44566,European Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0350679687060569,1.135069887929895,0.9150548022005738
6,Incidence,44566,European Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9026012465865224,1.0313794406237395,0.7729638973538067
6,Incidence,44566,European Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6104354143532519,0.6916186756480427,0.5028597817110907
6,Incidence,44566,European Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7984693309373062,0.8942462555493482,0.6916039506995859
6,Incidence,44566,European Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9732181586057966,1.100214472483865,0.8417286000614207
6,Incidence,44566,European Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6811668155369057,0.7683062752093055,0.5668566169938598
6,Incidence,44566,European Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8712747808724081,0.9632280091478216,0.7609209178527165
6,Incidence,44566,European Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2852192140798039,0.3717905911142954,0.1977714396133604
6,Incidence,44566,European Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1765103041873927,0.2346336371955768,0.1131115006913809
6,Incidence,44566,European Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2833019979185518,0.3506354787060689,0.2118520530827209
6,Incidence,44566,European Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3352350915917217,0.4219782889514608,0.247073575659464
6,Incidence,44566,European Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2261767917231686,0.2861545134211357,0.1588415211658524
6,Incidence,44566,European Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3346206832246224,0.3988521838053258,0.2636768718183426
6,Incidence,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.642116183614093,1.467227656960748,0.2222385694171917
6,Incidence,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7195990196074677,1.2812061641158643,0.3784865774626848
6,Incidence,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6733578100054732,1.2653437211914256,0.3187220526382922
6,Incidence,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2825484662058146,0.0829393659673996,-0.4670456503260476
6,Incidence,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2484399579686444,-0.0155301954934768,-0.405708145371413
6,Incidence,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2687535360610064,-0.007230812020553,-0.4295619883284485
6,Incidence,94365,Central Africa,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3563537760160957,-0.0329418947589908,-0.5209296103023234
6,Incidence,94365,Central Africa,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2992773089230466,-0.0704269402377931,-0.4382778699224851
6,Incidence,94365,Central Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3311642596753885,-0.0945493929670544,-0.4729110324851336
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.3187847753101652,0.0295426884584304,-0.4833394873116586
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2313796445133607,0.0137235871175914,-0.3852610886891406
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2817991373852661,-0.0272133988474205,-0.4341187803796959
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.3351979932583838,-0.0060339617828868,-0.4934964423964021
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2327631781766415,0.0249574316541846,-0.3910611447812269
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2912368787236767,-0.0471356394887332,-0.4374314809731915
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2997444372959914,3.0063564173760327,1.7018925919662071
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.26710033211034,3.141827083976951,1.4076708114354677
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.2830546835567915,2.921848351318471,1.6116454055488698
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.096832222596381,1.5250882363687577,0.7108552768259089
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9935305623169276,1.5285894192775882,0.4722426527908166
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0437224779333265,1.453728983442932,0.6226706937106938
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9435844030984984,1.3597863392252592,0.5914433376228864
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8821447518787865,1.3860663330964282,0.3870357568932971
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9127056490305824,1.2848664488528423,0.5215430146433828
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4559690279503113,0.7630479328245564,0.1885048734874875
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3229824125833577,0.6916089851682445,-0.037271632948626
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3819551739921125,0.6682119703637799,0.0850228038569088
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4235544706285289,0.7284542914331558,0.168162645887873
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3076201015279504,0.6805488211267128,-0.0486115197218716
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3593755822021924,0.6456650457129397,0.0692433566353982
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.32557448740952,7.719826723697736,0.6222342579384963
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7708487222519804,3.1794167899141463,0.675049134419884
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9433545552984293,3.834257125003547,0.8049408655196806
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.348512204117668,5.197737015363832,0.1638850341246306
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9895848189025128,2.002184668197838,0.204515648934335
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0965435912583648,2.4530799590619585,0.2808026650637929
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.156629186863552,4.6547922435404345,0.0520160537210885
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8198960016668458,1.7450448103432572,0.1001738196117359
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9212681010359522,2.155550523043724,0.1781711119160717
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7690132362450004,3.646637662443446,-0.1434906464960085
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3564836893680111,1.0526719470284465,-0.1750678684037202
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4772888934863005,1.4183349064902504,-0.0919375608358316
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7056006121617446,3.493724685352835,-0.1795129285760891
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2866493295356622,0.9304404090554264,-0.2182952425083041
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4122773785265683,1.3244011838765442,-0.1335693060873008
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.133470439319909,6.960344426553942,0.5699582919911581
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4475943054196765,2.6150381523799178,0.5463195209786704
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9091996309993464,4.653142586160078,0.6207492166799027
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.212959672976456,4.596870492351246,0.109493774785888
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7577498232395525,1.5765451052025825,0.1156034791482785
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.072353138609688,3.036725979618639,0.1653525367241041
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0320500506592003,4.1622693140052265,0.0181151820490382
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.607582201931101,1.374360399597097,0.0156240905282301
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8989735506118471,2.690076175785768,0.0579404252133612
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.599076010435062,3.0420138583060203,-0.2041147242633993
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1969983935850719,0.7570756761616333,-0.2446734692070794
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4332131823238344,1.7697040404302256,-0.2032982334274765
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5416130694323568,2.88456781361587,-0.2304693800433638
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1352587054496404,0.6662411114868847,-0.2854218189483887
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3701310384085499,1.6621515350303298,-0.2412613685421815
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.120844354848381,7.23376610747937,0.5454997337613021
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3637625200977923,2.521726783211484,0.4641540315488358
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6266347027891468,3.228681763084916,0.6125594418841915
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.204182058385006,4.807937605081984,0.0897986511655791
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6972641701615544,1.5637958691054274,0.0552442419293749
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8710182615506071,2.004798573969357,0.1514156275609755
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0238620571590706,4.33958279161264,0.002253850195907
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5525214078521323,1.3130734060864322,-0.0383422788688059
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7145299258828787,1.7602625603573523,0.0525945680377981
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6352734176622837,3.258114580212961,-0.1999891062017254
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2461461965090982,0.8697574807987839,-0.2249870014098187
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3798208819101688,1.237352419588163,-0.138425487390818
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5764860449743568,3.1008184232515124,-0.2292452283086952
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1820147469483431,0.7594408100643026,-0.2651380429527762
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3190649155363173,1.1455114054401372,-0.1861419829978285
6,Incidence,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7385740710631046,2.036118187384481,1.4724442251390883
6,Incidence,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1869538349044726,1.3672602270702412,1.0123410052431565
6,Incidence,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4377090373640966,1.6229684517497105,1.2442990908177751
6,Incidence,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.413911523138904,1.6748671887113842,1.178079839062356
6,Incidence,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.9366651667378398,1.092384064875471,0.7811485675770471
6,Incidence,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1541330979907924,1.3167550907049903,0.983821925134545
6,Incidence,44566,European Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.5037345741428958,1.7757635468985753,1.260426020435378
6,Incidence,44566,European Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0218491571298265,1.1885432689154078,0.8604187707905495
6,Incidence,44566,European Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.241509136240088,1.411857879078107,1.063665859795555
6,Incidence,44566,European Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5961623607213652,0.7320354584243602,0.4726584602865957
6,Incidence,44566,European Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4181534518421466,0.5076451233551785,0.3275632262904936
6,Incidence,44566,European Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5143158157260382,0.6028606489307862,0.4222505124622132
6,Incidence,44566,European Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6583644933449876,0.7953126568567612,0.5304091930242929
6,Incidence,44566,European Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4781233239126765,0.5733684236012554,0.3834767080788093
6,Incidence,44566,European Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5749653711759677,0.670002864326309,0.4793403288356018
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.0723339066307838,2.330441386342593,1.8251201455014008
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7160475641228123,1.9778507467035973,1.4542054706369871
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8937507844276484,2.1200846469738845,1.682378140983209
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.6238779052857513,1.8475607475392808,1.4022788382683034
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3444958457851468,1.5792434867539071,1.120535444679783
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4855556183720084,1.6825035962022064,1.3020759974225138
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.6233442836902314,1.8437320416804428,1.4122582406957949
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.365482637096497,1.593494432954519,1.1374369526308208
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.4958926945290767,1.6911082041346983,1.3135814051688182
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6433194201169693,0.7434951610532303,0.5369751577524081
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5719084393127173,0.6878783917660007,0.4540041880197557
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6212396236772387,0.7119937216286005,0.5287024291489097
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6637716222797095,0.7649920264483516,0.556239406113177
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.604693653479505,0.7223145423256208,0.4821651297930762
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6471023700168156,0.7402920433430908,0.5535752655971296
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.434477723436065,10.481225863191057,1.1535596195154192
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8591789314463216,3.2803295043418235,0.7963686620007334
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.496024104218307,4.85470830097586,1.1194955491377565
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.131775604589841,7.115826704800302,0.5187408040139624
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0528182477059578,2.0540491158340126,0.2751996140595351
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.4901386617738703,3.1671040208335794,0.5164292130250155
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.875750978685199,6.445554712809352,0.3965796131409245
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.877911364702812,1.8113243744455567,0.1798565974535571
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2820219126493917,2.821647745184686,0.383495977919376
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3679091714400335,5.112749100512504,0.1216957616348363
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4502928780901664,1.1783144515371204,-0.096055966550625
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.7912562476910019,1.9929926010954544,0.086571116598744
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.2830214509737303,4.860111902496629,0.092474096962951
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.375756828697828,1.0628200878573475,-0.1439604591643271
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7125238736408135,1.8763541956340997,0.0258488896574219
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.3401157402418006,2.466076485600664,-0.2868457802257043
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0702178484842548,0.5415741905170621,-0.2889895755587585
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2031682798109902,0.972352599708456,-0.2238198872903041
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0534510934016192,1.4595569447026462,-0.4963181973775662
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2314462765875314,0.1007156968590165,-0.4849123042811498
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1428920174035607,0.4056012520078565,-0.4458834191885817
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1309373071862802,1.2477444847643666,-0.537520746889602
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2970799279918726,0.0125073530952857,-0.5330076960923346
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2146345971069123,0.2874487468707205,-0.4933501679153195
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.2772675286709909,2.297991312491942,-0.3181252913018658
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.0473794926541231,0.4989356380069301,-0.2951509963655288
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.1620842673052499,0.8993018194790288,-0.2490758442446344
6,Incidence,192,Southern Sub-Saharan Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.2312361050695787,2.186123694910141,-0.3434330739961537
6,Incidence,192,Southern Sub-Saharan Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.006663267333858,0.4299853059550272,-0.3372118895176937
6,Incidence,192,Southern Sub-Saharan Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1108290700234578,0.8159924637814309,-0.2814961487188505
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.009465710846932,0.103145960644775,-0.1285652408052479
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0063228739535234,0.0769047803161441,-0.0988348477022763
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0082095985750497,0.0778898226309346,-0.1039086808427143
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1715957249897324,-0.0759200876294052,-0.2703120082011245
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1535354447131234,-0.0758378313350328,-0.2313894045699625
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.1623501571493443,-0.089586985332379,-0.2471638656180212
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1847345297451401,-0.0920487859801537,-0.2827601461845456
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.163566227274559,-0.0935088424046451,-0.2414387446110668
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1743729902614041,-0.1026985643258545,-0.2540387613899201
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.1661554315148302,0.2986634566776504,0.0194119242756622
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.1622322008299392,0.2612764469901095,0.0560579879301463
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.164683958680772,0.2627071612788721,0.0500411914593102
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1627906384033312,0.2944233103605238,0.0209208493076386
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1660875865917304,0.2631590918716354,0.0587990887807993
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.1639282098340636,0.2646282339244282,0.0499390726918607
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6593072115487878,0.9383400841521834,0.4115778226186195
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7053862580004496,0.9167268338947424,0.5103667248007276
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6687310556439937,0.9144448033848616,0.4528333000347673
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4172580543081138,0.655891181179022,0.2002359595016975
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4723737092268714,0.6511928926218186,0.3044298329500354
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4334860525626019,0.6524981310911426,0.2456662878967675
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4168167330080516,0.6550718555147433,0.205290415849149
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4852691227246203,0.669331607268546,0.3154210958445767
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4392993596162176,0.6512302388170317,0.2530851099682924
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0179539661106006,0.1312991851659378,-0.1551624440078709
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.039082472599534,0.1534575177298883,-0.0581708302443663
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0090021255547723,0.1539183680091921,-0.1216693535998954
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0058194301128245,0.1422524767249596,-0.1474445553783738
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0605416951072979,0.1762778398512357,-0.0378443108110194
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0249987894454062,0.1714372462256197,-0.1095034052025072
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1475841906325102,1.2769527714633335,1.018502814930524
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.237790009048516,1.377695813846573,1.0341929298486066
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1752485754530042,1.2898350942181571,1.031271729184449
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8342467496038782,0.9446382214376624,0.712028597954333
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.9317933003403854,1.06058056185586,0.7565042317740771
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8685202326798807,0.970882954056961,0.7451147827667959
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8337371136907323,0.9441998229292056,0.7235196375408102
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9489546066111948,1.0708025287353808,0.7716361523349786
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8761764342231576,0.9750085992515102,0.7519947801854947
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.182378131919476,0.2502800485839493,0.1149950932909352
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2744414790181104,0.3453151020590436,0.1811816118751964
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2294375459224713,0.2911867504237253,0.1574643072288185
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1970305569351067,0.2664881809546893,0.1278232272373853
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.300922266435189,0.3720749094811461,0.2054497624470978
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2489850595132107,0.3119863840204596,0.1789086192024657
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2195002418591501,0.2834255680314084,-0.4438452975190107
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0695870017047465,0.4871983778924715,-0.3623496925390514
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.145368516688058,0.3543673923352449,-0.3700945797595081
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.526093583262584,-0.2115615993279339,-0.6608983030729971
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4613315225910015,-0.1383431831785925,-0.6328494785396032
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4934354414997015,-0.1947998843725768,-0.6292286264240957
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5557004197668822,-0.2694098426179118,-0.6834088694075083
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4908317207523921,-0.1861310618415877,-0.651046029659434
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5227764815786917,-0.2437255298616167,-0.6482628047414217
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3416681206708583,0.097825995286902,-0.5300134889711392
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2096420614956247,0.2737472598767656,-0.4585805544401001
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2775049128518553,0.1489552534396408,-0.4714377365743971
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3528594726492092,0.0719959121801872,-0.5394265933056914
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2212356922561729,0.2502859229260012,-0.4666246483442611
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2881733921150695,0.1325821263144443,-0.4757428715337005
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9316264628450498,1.4575003391395192,0.4874067935639855
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0510901068755916,1.6207775334900263,0.6441132462822903
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.963382921777675,1.4226571899565497,0.5955299941126782
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6958600127580561,1.1656683280779525,0.3110531520330127
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7672484007452265,1.2581770562219954,0.4076833041006876
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7074943114807908,1.0897269647697887,0.4006783854872104
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5537438073410492,0.9767413663678168,0.1964265032345622
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6343895630825677,1.0883389927818383,0.3100943353204697
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.572020259242133,0.9397470262001008,0.2774917450655241
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.063270216473488,0.1840538501036365,-0.2694917099309845
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1259428888397966,0.1078342653641466,-0.3020294870974032
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0877873585107556,0.1239758125053621,-0.2556897685793678
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1102983679922145,0.126657527582358,-0.3058679872992867
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1638332289487969,0.0597812707901028,-0.3299538746631674
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.130729250726616,0.0699299385600455,-0.2906032205171395
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1267293644931363,0.0337810012718477,-0.2775746066117934
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.298246804061203,-0.1844518472408111,-0.3953345383925249
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2045271612362244,-0.0699914665835789,-0.3270422927103306
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3358119519991808,-0.2120062630249581,-0.4499297226635394
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4791938005683558,-0.390157317104355,-0.5531986944797167
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.402783862865022,-0.3019229935292649,-0.4974022245952591
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3892364367500743,-0.2769758396944211,-0.4947372675689355
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5119264171561254,-0.4327813379369405,-0.5794515223063634
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4452253414640417,-0.3513981352733046,-0.5306692270587565
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0341432915908149,0.1458106350772416,-0.2026794970509151
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2256508030638668,-0.0995776828312978,-0.3358034043829508
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.121616475267606,0.0261394655326376,-0.2612696226580128
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0800998238852989,0.090057372641652,-0.2396155159972353
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2544815995858198,-0.1329207871631544,-0.3583063939428436
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1586601704407571,-0.0160262977082588,-0.2888692937268065
6,Incidence,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0163263502569598,0.6292652015007854,-0.2820609148046644
6,Incidence,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0954430307443011,0.3393024159422209,-0.3816260102961983
6,Incidence,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0443268636302697,0.3753500423436735,-0.3154119898349471
6,Incidence,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4851121460379523,-0.1731301531446636,-0.6394647964746962
6,Incidence,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5545576051992456,-0.3399388825305017,-0.6943062726479658
6,Incidence,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5228075640546985,-0.3133250546037961,-0.6592666277442596
6,Incidence,44559,Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5343410275641876,-0.2535055699732054,-0.6710556834435697
6,Incidence,44559,Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.589234308851457,-0.3918133393034457,-0.7191920156472074
6,Incidence,44559,Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5640933563831232,-0.3726681247589072,-0.6877421260317261
6,Incidence,44559,Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4186148692850464,-0.0521744691047514,-0.5926998094685003
6,Incidence,44559,Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4785471481863091,-0.2196540605918286,-0.6426959858822412
6,Incidence,44559,Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.451081340336876,-0.1994952183258514,-0.6094034027311388
6,Incidence,44559,Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4400608826086674,-0.0884713642081436,-0.6056035047560593
6,Incidence,44559,Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4917890451153432,-0.2391000028967215,-0.6554712234567026
6,Incidence,44559,Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4679233914751566,-0.2243650247437901,-0.6206002379600455
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0093598647829682,0.6924613194560356,-0.3140516896930375
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1126599997439152,0.4504435670302019,-0.4241168690572166
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0658770895529058,0.4724494325363951,-0.3556353961193422
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5149028214146213,-0.1753562926248739,-0.6653805407570266
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.575411033021435,-0.3047108169803035,-0.722502893105577
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5478843621958952,-0.2907742309031809,-0.6895876744666263
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5591360769772765,-0.2468050603500586,-0.6947328779421167
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5994974448246776,-0.3453396053761176,-0.7400740805571864
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5813276657711941,-0.3400506142614203,-0.7111968566620286
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4508845440885621,-0.0497738823482142,-0.620284847259511
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5140095113971789,-0.1978260363644703,-0.6850636205459439
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4849535327200198,-0.1796829057745592,-0.6469051541962411
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4616196936173122,-0.0702076333403816,-0.6268028387062479
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5113510710132928,-0.1917561005732609,-0.6857007964045041
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4886760094662182,-0.1835230515478267,-0.648594686112548
6,Incidence,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8246597983312256,2.1450450704397213,1.5381249641466297
6,Incidence,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.2210371934741513,1.4087215800180857,1.03620896264764
6,Incidence,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4952036048349404,1.6864856011114218,1.2982899559261458
6,Incidence,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.546791328751614,1.835514543264115,1.2865148407972833
6,Incidence,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0102234294648924,1.175488808769769,0.8422403549829777
6,Incidence,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2544259710227128,1.432594568218452,1.0766874092069307
6,Incidence,44562,Europe,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.659037897439827,1.9606376089595487,1.389303827700311
6,Incidence,44562,Europe,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.109849615155247,1.2881383137343851,0.934274089979478
6,Incidence,44562,Europe,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3599063850858186,1.540816513417689,1.1736699687589245
6,Incidence,44562,Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6380933283107943,0.7773182550442017,0.5052450902126925
6,Incidence,44562,Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4318481940295183,0.525094624054944,0.3395882236800375
6,Incidence,44562,Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5436019741715729,0.6305626061039644,0.452777553510769
6,Incidence,44562,Europe,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.7190850617169136,0.8606806425042794,0.5799221096810079
6,Incidence,44562,Europe,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5072025190198859,0.6084021173343985,0.4094714092703072
6,Incidence,44562,Europe,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.6214369053481741,0.7148252353204393,0.5213726641251286
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0402478145788847,2.7498979842585864,0.2898309987402757
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2287747725124731,1.9402448153214575,0.7189041884898317
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.111693044959905,2.2786470401546604,0.50342457208032
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2534039674206387,1.3036439820114865,-0.2045267276747059
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.294360122794896,0.7065892742795226,0.0077578550301606
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.2607373551604131,0.975476245828926,-0.0989941454629613
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.126926797667968,1.0712486477307286,-0.2875644289106759
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1745491736175586,0.5494890558977745,-0.094149162572149
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.1391158215314174,0.7686087121285354,-0.1890039508235872
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1178783774984229,0.628845225041835,-0.4349530782656372
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0956690620719497,0.2347178724909942,-0.3414423052772289
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1186198233028173,0.3821897281979065,-0.3726338815179212
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1397484220264573,0.5891936526810133,-0.4486228938615454
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1224509310360669,0.1988302853919514,-0.3611999054843551
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1420678088486062,0.340645436088932,-0.3888842263600172
6,Incidence,44560,America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.127593420791922,3.272859212628079,2.9573934719331048
6,Incidence,44560,America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.244621462626504,2.376194404239145,2.092500039346121
6,Incidence,44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.765439263370521,2.886422548169418,2.6303880694285797
6,Incidence,44560,America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.139314011503335,2.2653996956949314,1.998821647284109
6,Incidence,44560,America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.408176466608442,1.5269760004380002,1.29420786173939
6,Incidence,44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.827046143579118,1.935949669010314,1.7180982685676571
6,Incidence,44560,America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.8868297671163423,1.9884283426698188,1.76779229694007
6,Incidence,44560,America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.2566538084913292,1.3481635834233563,1.1508524405496563
6,Incidence,44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.6260736756526957,1.7104492284587145,1.5318869525454055
6,Incidence,44560,America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.9421960472851358,1.0148423062778056,0.8647977727839229
6,Incidence,44560,America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5789878571616055,0.6509735343376151,0.5088061963804557
6,Incidence,44560,America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.8086116817880181,0.8725194120276929,0.7446897290747365
6,Incidence,44560,America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.8498223503095389,0.9148905622022444,0.7749429969072326
6,Incidence,44560,America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5200956109274524,0.5839120982794499,0.4537702239521974
6,Incidence,44560,America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.7323116998661046,0.7874096578554298,0.6747065707411735
6,Incidence,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3015302486401324,0.2227391010277219,-0.5025637790796362
6,Incidence,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1745798486896045,0.3793602453587428,-0.4408782262529456
6,Incidence,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2377531204903916,0.2648715310109897,-0.4499567249737066
6,Incidence,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5816826053366843,-0.2641347225229508,-0.7004611890529353
6,Incidence,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5303106795303892,-0.2155286934653822,-0.6833624662535299
6,Incidence,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5551628114664672,-0.2661048976099321,-0.6789674851618062
6,Incidence,95469,Limited Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.611964652367988,-0.3207064569270231,-0.7236489675697669
6,Incidence,95469,Limited Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.557949621366805,-0.2612892746022671,-0.7005646259125489
6,Incidence,95469,Limited Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5841076825694196,-0.3098688017948178,-0.699888870014183
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4360110686796466,-0.002365067122571,-0.5977954432591019
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3339699988639766,0.1252048169646856,-0.550880846640525
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3853877927620795,0.0197069773723618,-0.555874585250274
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4461371369319237,-0.023721873681645,-0.6060292076507532
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3411379874711637,0.1073044811206583,-0.5546409787998479
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3936378899945487,0.0110488156499117,-0.5631931684952984
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.638397084305623,2.43720152369031,1.0437400800731875
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.592067315413612,2.338014228954424,1.0407824427005827
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6166790318042024,2.1241755551717407,1.1404981558270535
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.316232654394602,2.037319742029165,0.7853422841904292
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2332086343040187,1.8806263801970051,0.7515816524129992
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.275643165453791,1.7175569408565174,0.852634714636205
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1222494151424267,1.764784333173345,0.6439247205960142
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0654615576946984,1.6598615043464364,0.6261760093771855
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0950943416610248,1.5014311837409076,0.71383097433888
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1895456032600227,0.5459697091842082,-0.066978913027046
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0825387217990144,0.3722287415429989,-0.1402949083700878
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1352391431427578,0.3512413154005614,-0.0591118309287521
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1298969031034196,0.4706225085441926,-0.1146503142800356
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0356989074505127,0.3145804603997212,-0.1805864983212891
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0818099506925869,0.2881081307311895,-0.1050796757412698
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2287883401081694,1.0925369832655971,-0.1669919967414808
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0212192951530588,0.5366550082834283,-0.2978615156987719
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.1197304760713156,0.6781688532355242,-0.2139450543269113
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4520443863356498,-0.0826919777931621,-0.6278175743472929
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.547786967696586,-0.3212822913248985,-0.6900920970964423
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5024319747451302,-0.2634643234923317,-0.6470019252438409
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5114948981277395,-0.1681114160868028,-0.6688374667874946
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5851040011824649,-0.3756952913779752,-0.7147385981296739
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.549952670740903,-0.3255024967308771,-0.6840651062813916
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.430962508049187,-0.0204282124888442,-0.6173769273753069
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.523852220829634,-0.2772965159257045,-0.675152332940401
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4791577984489392,-0.2163726082042734,-0.6341691645048539
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4494640842022596,-0.0412576900965687,-0.630187772959212
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5316580551632801,-0.2879008687550017,-0.679456134878188
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4920558950528818,-0.2277485127617128,-0.6457903468853383
6,Incidence,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.1456603251798594,2.3534984803337533,1.932108691660959
6,Incidence,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.540261204133112,1.7054446089674826,1.379978420940195
6,Incidence,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9399829936479007,2.122495825713053,1.7566908938837629
6,Incidence,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.3924677871868465,1.5484749131844384,1.232131493987199
6,Incidence,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8853474664406491,1.0108933988658673,0.7667840309618829
6,Incidence,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2072521277915076,1.3398128808413956,1.066799100148326
6,Incidence,44560,America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.200067918080896,1.3454294670208853,1.0507103749291806
6,Incidence,44560,America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7667669979071535,0.8816530528484631,0.6552893548926502
6,Incidence,44560,America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.050388123794749,1.177675303385607,0.9225574712522724
6,Incidence,44560,America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5564433307455305,0.64877434479371,0.4639085968324815
6,Incidence,44560,America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2746153100297818,0.3580648400994292,0.1999647827901724
6,Incidence,44560,America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4675259908156746,0.5485630590164328,0.3890293483152222
6,Incidence,44560,America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4823526074342793,0.565231280676107,0.3973226473876423
6,Incidence,44560,America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2270459767814369,0.3042721045464088,0.1511849142697215
6,Incidence,44560,America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4055747852854066,0.4824260632896714,0.3312203336727387
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.4146342130048344,1.9327725112325176,1.0142283383857982
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3496577375658705,1.925740979964584,0.7622806739064567
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3899893463549866,1.8696421528016267,0.974391142905862
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6274601857932839,0.9775971663947344,0.3612700811354934
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5072349176165019,0.8844607436386105,0.1359119760116737
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5708353078980828,0.8829032504864243,0.2944017909438776
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4783219954828459,0.795544057046711,0.2331797671561563
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4022390995015951,0.746036595683305,0.0517016268963622
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4448703585508584,0.734844924122647,0.1936200648428824
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.186819386289613,0.4387122965954151,-0.0231402015195307
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0144894544977056,0.3039221204293933,-0.2621251739914088
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1000271173523406,0.3252336422017414,-0.1116805103724322
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1428949396724818,0.3828506639959834,-0.0638016629842237
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0093537925750296,0.2770425743916813,-0.2827261781840398
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.067482874624278,0.2848257410537971,-0.1352269614487924
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.291012736585575,1.797828384694322,0.8867064694059901
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.3197390607781618,1.8134303112563603,0.8809775411821668
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2973180521269412,1.732055058683439,0.925145421779688
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5805909918022903,0.93119959123256,0.2974291060056888
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5218692818879295,0.8350653190507883,0.2318050786163151
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5452980153911239,0.8341720997011204,0.284417982093308
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4659348321744762,0.7902275347811718,0.2072341141643678
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4450370572798821,0.752572574467121,0.1717189648078979
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4507858161254823,0.7253278118552775,0.2157540264444629
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0371891280024253,0.2638339315215112,-0.1448142178931279
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0655768174230869,0.1323053492572626,-0.2465776587648066
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0174609897480538,0.1676840461920048,-0.1772481943712505
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0097606232226948,0.2264546543880395,-0.1635682433214094
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0784236068514703,0.1231703053695803,-0.2543351653355973
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0366574777143823,0.1357434544821876,-0.1905432435884716
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2243934435677988,-0.144289665691546,-0.3125621943293485
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2182399649987371,-0.1413817386306587,-0.2909362878570354
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2219105690123199,-0.1549132953702816,-0.2954543601783258
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3375377970969792,-0.268487478296666,-0.4120014426618612
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3251154946303546,-0.2564177328648577,-0.3882281125185532
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3316037081307307,-0.2751008359235324,-0.3975158191031195
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.337740269110146,-0.2693428246331203,-0.4130240746272569
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3191430762853092,-0.2522050732866622,-0.3824563598130239
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3288890885340869,-0.2711031842549791,-0.3923214380256178
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0447109337510498,0.053900684877012,-0.1522152955530239
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.041834292139654,0.0529454907268214,-0.1325187753909846
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0434818489237366,0.0386165018984742,-0.136427052159866
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0329210585556938,0.0686602191140125,-0.1452179384476725
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0219506985439472,0.0762808382566664,-0.1133206382541724
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0283213957011499,0.0564669967206497,-0.1213932175385728
6,Incidence,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2945536272862344,1.9914489534852025,0.7549373820397145
6,Incidence,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1362499835643622,1.7265939017078915,0.691550624676372
6,Incidence,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2464002452650893,1.7799829391303987,0.8429886080627993
6,Incidence,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.7250596332156604,1.243800318672139,0.3125256693143514
6,Incidence,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5404377103378905,0.9622482371798868,0.2312654799980911
6,Incidence,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6534413510433155,1.0441517640361953,0.3517698030232883
6,Incidence,44639,Middle SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.6319098590789772,1.1275488975595058,0.2481293013857305
6,Incidence,44639,Middle SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4867652557464648,0.8976267341267121,0.1772679772752286
6,Incidence,44639,Middle SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5806694051656331,0.956122462160482,0.2968106253433449
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0122197705927076,0.3100639255724151,-0.2185722897205667
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1561416488677729,0.075674599912012,-0.3283923824514945
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0579533708021399,0.1635124274440056,-0.222900959782896
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.000354957055361,0.2893411489945805,-0.2313202024880378
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1561725060940169,0.0765876813054582,-0.3306898320524768
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0634607468531578,0.1540650584429113,-0.2291469641485609
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6005495597218224,1.7236554277421623,0.2209574804750469
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8180247855895726,1.4186041417177515,0.4315168717230912
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.677755589657791,1.4670938339226187,0.3369290300135255
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2864738682815569,0.2062811497565615,-0.4545859646924414
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1949882001563381,0.0725205845193294,-0.367345886631734
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.2545883811227013,0.0967106207990456,-0.4063172577886355
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3637011353357396,0.0827898741918363,-0.5146080582692893
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2613817493732645,-0.0173812951978995,-0.4184103011599608
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.3256685975680096,-0.0084140650667219,-0.4626552083519241
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1978710534595261,0.4001448097228798,-0.386733721260648
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1100969081039699,0.2164926245455567,-0.3280741542823702
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1725249823771149,0.2492682060497581,-0.3452624113906836
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2237053965194987,0.3488245780727779,-0.4070915385834085
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1245841030538868,0.2016453929472127,-0.3392297537634882
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1928309824287978,0.2228583996346648,-0.361399994547808
6,Incidence,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.95015500874474,2.107217132138932,0.4077569262977416
6,Incidence,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1025427219582802,2.047374072398622,0.5812436345260947
6,Incidence,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.038624587057816,1.8717078632714608,0.5676094867924398
6,Incidence,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1482103042873998,0.3602798470204067,-0.3755575325519784
6,Incidence,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0815241122476723,0.3222815588434561,-0.3102132872560053
6,Incidence,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1095454484087603,0.2403615807445505,-0.314929936779545
6,Incidence,94365,Central Africa,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.2356144345406235,0.2179093015195085,-0.4482135679921734
6,Incidence,94365,Central Africa,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1432308477524142,0.2417802850438579,-0.3556560092210595
6,Incidence,94365,Central Africa,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1851683024539102,0.1478124064337992,-0.3734315247046442
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1601974330680821,0.3392632939450661,-0.3822292889315096
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.107012830492019,0.3010466056485885,-0.3397733414224162
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.1235016669399778,0.2260782532808828,-0.3300217913873644
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.180326960268763,0.3120712587323771,-0.3926208148354242
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1082682609643872,0.2955382941975494,-0.339587088960135
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.134759123946966,0.2018543640312479,-0.335649866385769
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,5.440235740963301,6.186807313662841,4.7942251712276684
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.424513424202046,4.959872440978237,3.92379480591119
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.882968368100336,5.352182271438772,4.43892633114213
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.902230287428064,4.486494250770893,3.3923171255836686
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.237206960850645,3.62925478612044,2.8487055531865213
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,3.5409343106092006,3.918255073708299,3.20513619683398
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.856928251054792,4.419958038895528,3.3697369256391765
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.136259759958276,3.544477748385121,2.754455511367436
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,3.461578743184518,3.8174254257015834,3.124822128289975
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.3141535956012813,2.665243327769645,2.0171623820848663
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.245770871835806,2.5312195174693937,1.9698582291572488
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,2.2903363308219515,2.536282598696092,2.066029399578729
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.308679796158416,2.647210323672613,2.014475845547803
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.214144813247579,2.490591928651807,1.9507603638246789
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,2.271095394057136,2.507776688892217,2.055520229780417
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0224827597387462,3.0977449737642706,0.9876390501524206
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1631138739929847,2.3841373483556145,0.3140234348249563
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6353640742939195,2.629221288697921,0.7303092310642889
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6272931574932185,1.2041943767622234,0.0651829194618715
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1552291295867,0.8016628252520361,-0.2930816183541881
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4131367884351025,0.9683008410991562,-0.0744338708054347
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5022016009362729,1.0366167648047442,-0.0121251962143535
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0838339059232142,0.6956309348976958,-0.3416050958001521
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3149232535090724,0.8108114591027183,-0.1366567276677228
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2633295663743404,0.6922061105385087,-0.1715263970142793
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1585036024408257,0.3258408158444246,-0.4849170593285586
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0626185816421983,0.4844605180047223,-0.3092911394615052
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2464275693420998,0.6640112492542827,-0.1846825784721666
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1659114718679729,0.3128072397749213,-0.4929506235592047
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0505330224899598,0.4522798172964126,-0.3153640676001863
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2998506813044086,3.245839231374917,1.2999815507995258
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.659692155470013,2.9282568873574606,0.7342743036745768
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.130466181748491,3.046855810189826,1.2113672926044907
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7767279316173453,1.293994089228125,0.2443747447384905
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4205380027721248,1.090949792840576,-0.0661467475719689
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.678805833827252,1.1839637052171357,0.1843745712368688
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6400559971215818,1.1102209665674736,0.1431118859495415
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.332645762238659,0.96826346355736,-0.1310372906886646
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5619560184706982,1.0191915266366407,0.1033687160944211
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3660786233696753,0.781261038212384,-0.0512865282846695
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0348782963188986,0.540429959434614,-0.3249964699112233
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2586824575901038,0.6387219442851875,-0.1164316311136241
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.347827578029056,0.7312395319508063,-0.0568863632552617
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0257908272024129,0.5217984182992292,-0.3296956503127135
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2443420422409604,0.6111097035073975,-0.1237607669954121
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.357390104520835,3.4367226519811807,1.1803384418303104
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5482577478892046,2.675091726889992,0.6733406207595538
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.8592094156017085,2.84951691772656,0.9469234591466954
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8074799751419297,1.416875340057271,0.1713619713030874
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3610617668155198,0.9633499537163486,-0.1015292612909059
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5331460484958168,1.0846109701010866,0.040859032720539
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6686536172053208,1.2050917740528095,0.0836481655179042
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2768112587136088,0.8414143928671394,-0.161568273060927
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.426611595680217,0.9207286610869544,-0.028576372348017
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4111152417014827,0.8806530734387539,-0.0863740061053399
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0233654017321213,0.5228673647254769,-0.3378237294763359
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1766027296446945,0.6286445729189301,-0.2128792909835519
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3923196965593562,0.8469856102310129,-0.1037366756305325
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0143024597167346,0.4960440034632014,-0.3393253388641615
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1632431324506577,0.5936594264819703,-0.2199536455750221
6,Incidence,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.3260885456032594,3.4323649667977287,1.4282938682201447
6,Incidence,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.1338841251558343,3.110142381066686,1.304985780436899
6,Incidence,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.184187775129876,3.080267602116592,1.4115667987757483
6,Incidence,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1704654117014266,1.888491681434705,0.6054925868994906
6,Incidence,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0436269173805504,1.656782745416363,0.5055729376697344
6,Incidence,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.07705470413632,1.6641327160354202,0.5618284406173522
6,Incidence,120,Andean Latin America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8957850754108156,1.5263342324234044,0.3840651597110134
6,Incidence,120,Andean Latin America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8146339420625996,1.3799233071588857,0.334671374597956
6,Incidence,120,Andean Latin America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8293077515999776,1.344103325643123,0.385438972210637
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2144889749991197,0.6130152475284629,-0.1064891965334766
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1030420869960752,0.4409020315768914,-0.1886533785372818
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1376787757422959,0.4548480973798172,-0.1382396386038142
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1361553345768464,0.5066171492794566,-0.1670037881902838
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0213682752476497,0.3440715743939792,-0.2506110518601169
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0579155633292897,0.3576152589161315,-0.1955650346307144
6,Incidence,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.5407988529319727,3.861969314198727,1.5852383969233517
6,Incidence,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.2087905046516183,3.3357701139910634,1.3492985629620304
6,Incidence,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3866735940771755,3.50563959956464,1.5518560380370638
6,Incidence,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.3107505485252018,2.1495704586143054,0.6839527355812951
6,Incidence,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.093037203300382,1.835861516142566,0.528373891835386
6,Incidence,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2095845829930003,1.9326678499955547,0.6541827609669728
6,Incidence,120,Andean Latin America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0181644380133896,1.7711976805751433,0.4735195116031878
6,Incidence,120,Andean Latin America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.858007485334028,1.510570046503421,0.3603301022426305
6,Incidence,120,Andean Latin America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9456353378944874,1.5884784527392442,0.4660347821849154
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3305498637222204,0.8277943443617508,-0.0301894212672422
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.162404139718278,0.5659457033538488,-0.1556082528635219
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2493321369354799,0.6589793267860464,-0.0619320763760079
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2446814616674184,0.7158630260480996,-0.0956002439466951
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0761522939622221,0.460594633312778,-0.2183063676612074
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1616097220421695,0.5411161395874391,-0.1245897246467631
6,Incidence,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.556205115652467,2.478798297045802,0.8210635236769094
6,Incidence,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.499804466314142,2.3167565091919364,0.8265708766082225
6,Incidence,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5129608588551775,2.3180056468313794,0.8725943990548714
6,Incidence,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6679605402849138,1.289754091709658,0.1852381570494698
6,Incidence,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6301590844996431,1.1651483786395076,0.1978452162657575
6,Incidence,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6391035294842273,1.1570251800350428,0.2149655428838257
6,Incidence,120,Andean Latin America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4569712866930886,0.9828257129901012,0.037959453642734
6,Incidence,120,Andean Latin America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4474785448130638,0.92052376500598,0.0576515843933766
6,Incidence,120,Andean Latin America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4436896009952184,0.9061857774243728,0.0758007038872102
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0749034615299095,0.4592856072424355,-0.2252263967725834
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0202332955198929,0.2978061081159797,-0.2814825393989533
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.006192558321162,0.3119995635074042,-0.2503233473800232
6,Incidence,120,Andean Latin America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0055979419556818,0.375834986780138,-0.2784606119129063
6,Incidence,120,Andean Latin America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0928012306597996,0.1972729360694964,-0.3330794556505835
6,Incidence,120,Andean Latin America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0643103848964585,0.2206308560587197,-0.3009510560614672
6,Incidence,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4642004318783737,1.6589399067645785,1.2481706745352334
6,Incidence,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9754810336658832,1.0960132519411503,0.8240617930329226
6,Incidence,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.218929935935376,1.341517726861396,1.0653889340314486
6,Incidence,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2219484746448783,1.4032368066997325,1.0377254850964637
6,Incidence,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7880386387353059,0.896141191321175,0.6494909133409301
6,Incidence,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0049082298950882,1.1231120597170556,0.8587864507108642
6,Incidence,44562,Europe,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.319713807348852,1.5030348728293328,1.116350799849862
6,Incidence,44562,Europe,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8765862682861704,0.9910845104088531,0.7327472423053283
6,Incidence,44562,Europe,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0986130806020378,1.2145538038277155,0.953397519810348
6,Incidence,44562,Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3982267448392203,0.5087318676746677,0.2966178323140455
6,Incidence,44562,Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2411855663064524,0.3007436430204613,0.1652097247917424
6,Incidence,44562,Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3427120412553987,0.412918296020625,0.263320087631778
6,Incidence,44562,Europe,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.467264081254913,0.5794734742306407,0.3620351558918104
6,Incidence,44562,Europe,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3064445434889374,0.369893490481589,0.2255176041655796
6,Incidence,44562,Europe,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4103526342652874,0.4850063119258407,0.3246752393325334
6,Incidence,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2231587510789912,1.4023490119046809,1.0497500263111417
6,Incidence,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6844050234883059,0.7997503373643575,0.5733521619840067
6,Incidence,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1130736158756624,1.2559630974325362,0.9672538464274112
6,Incidence,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0047220523065072,1.1658496021193046,0.8464182910961098
6,Incidence,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.5246593752029782,0.627362306712776,0.4225830346048571
6,Incidence,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.909377863876212,1.0432486889153414,0.7734224637460182
6,Incidence,44562,Europe,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.092805432582165,1.261489001013707,0.9295644039893268
6,Incidence,44562,Europe,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6000818451011328,0.7096528449954151,0.4945884126655285
6,Incidence,44562,Europe,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9984965990746176,1.133638196030582,0.8605836029864966
6,Incidence,44562,Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3101205326024458,0.4110443754231068,0.2155629096223853
6,Incidence,44562,Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1250434496474388,0.191038525603433,0.0626941130552833
6,Incidence,44562,Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3507594921457939,0.4368549899095213,0.2666308052185845
6,Incidence,44562,Europe,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3748158804643526,0.4790337598856188,0.2746229943484269
6,Incidence,44562,Europe,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1841657523232387,0.2525453001680491,0.1180752739716221
6,Incidence,44562,Europe,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4187730803521953,0.5089854072362874,0.3252029845807745
6,Incidence,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3558688001730237,1.6063427426291297,1.1294701838036374
6,Incidence,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8622767317152467,1.0154261114193432,0.7040241674850987
6,Incidence,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.085367055112492,1.233227151718066,0.9169359690168036
6,Incidence,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1242047405633628,1.3498280536003509,0.9088669558975282
6,Incidence,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6857619515853547,0.8188057179811645,0.540383860058687
6,Incidence,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8843346397960503,1.014026454679414,0.7245007980934223
6,Incidence,44562,Europe,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.2177341231524823,1.453521705680267,1.0046102272377238
6,Incidence,44562,Europe,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7690490988924157,0.9145316512690024,0.6187188330511482
6,Incidence,44562,Europe,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9722923688758984,1.1121350596297783,0.8129941077023581
6,Incidence,44562,Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4580629680906735,0.5836345033393995,0.3334315314421856
6,Incidence,44562,Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2579167138190595,0.3414897353178585,0.1664480449828992
6,Incidence,44562,Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3576564632415337,0.4421167682627004,0.2613157890947404
6,Incidence,44562,Europe,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5300803723066637,0.6601339897923326,0.398084581970885
6,Incidence,44562,Europe,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3239256176051929,0.4139019304872838,0.2292657859337888
6,Incidence,44562,Europe,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4259636747870355,0.5216231953490363,0.3250040505910221
6,Incidence,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.16413719290143,1.8184062228510416,0.6420241809058247
6,Incidence,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0869647365229165,1.7156868356051895,0.6237566613150172
6,Incidence,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1415009696126757,1.683407080633053,0.7046956984471313
6,Incidence,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.723361252103283,1.2507579730703635,0.3012070707898321
6,Incidence,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6147382468402255,1.113409640067072,0.2521547886397229
6,Incidence,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6805704074919212,1.0939667329931693,0.3334374544085438
6,Incidence,95468,Basic Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.593319139159509,1.0750165893014922,0.2089199164367087
6,Incidence,95468,Basic Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5239300111648513,0.9830314318579336,0.1856891799377189
6,Incidence,95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5702659400018334,0.9676212159922332,0.2499763629914744
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0150014778218012,0.2805568731839657,-0.2447205968849082
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1382326941467983,0.1294212077498578,-0.3325163139251469
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.0645413860984762,0.1667664271939975,-0.2552233025659171
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0454862792317432,0.2377352013803637,-0.2695512766179718
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1538040906518898,0.1017142741262601,-0.3428594984324018
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0874546870233948,0.1371988044030289,-0.2730498541076976
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6522904273217482,2.3164321610614,1.0950646576395728
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.4506964129915547,1.9819753762799248,1.0174906875041596
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.5553611617821808,2.0236421387969985,1.1438804086730463
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2042689158425468,1.757815068087167,0.7387054255112966
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0295973928493398,1.4823617834275349,0.6562643897916947
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1198630632260322,1.5192039134987891,0.7758698180557295
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.151114692684151,1.689760470972741,0.6991820807959633
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0098464433576444,1.4455548930600697,0.6545690691396797
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0840825276549075,1.4659996581278134,0.7484901030510462
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3219792829853418,0.6500536361539974,0.0541717290470628
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.251236553799634,0.5399555951238575,0.0245581859203882
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2940228439686775,0.5362261750771529,0.0919167001682623
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3203853114757603,0.6552448774001491,0.0590330205461362
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2596141714284857,0.5511508622674856,0.0296288980293897
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2964657715336645,0.5344260828360552,0.0899895049662031
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1877271207674351,1.327760545971711,1.0490528383652091
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.355393578592484,1.519673753690004,1.1309559801010425
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2374019010667303,1.3624642567737797,1.08128920571134
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.829602454509817,0.9483942041636776,0.7059192798750125
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.006420155305474,1.1475108009237371,0.8113727394676404
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8896322564864898,0.9990280925946896,0.7567638859398097
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8006225523265647,0.9158779427766792,0.6864858128992282
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.9826668900328894,1.120950727950672,0.7937451745914395
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8625502308825886,0.9666597873220584,0.7325924720019616
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1717078096364716,0.2450659253182544,0.1018476354058394
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3010495839664686,0.3750963076436217,0.2061529868959001
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2237539138784106,0.2915863690934204,0.1517070080758435
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1683853191362928,0.2404436204639912,0.0985417983911182
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3053724049723025,0.3803531676330313,0.2113693571600153
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2230100861721386,0.2890646762571629,0.1526024571270612
6,Incidence,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.044348493682313,1.7284349824861551,0.5070660468889338
6,Incidence,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7618929858344318,1.331036904343772,0.3648667832679301
6,Incidence,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9914835379359376,1.5731460508420212,0.5410001975483516
6,Incidence,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5369673704269557,1.0496181877242974,0.1274820915998047
6,Incidence,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2705511861863173,0.692350286079321,-0.0118698042436961
6,Incidence,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4657895060562926,0.9030589621214192,0.1304416276935
6,Incidence,44639,Middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4539614252464156,0.9404906883964066,0.0718406887312357
6,Incidence,44639,Middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2262241291215007,0.6223310501604024,-0.0500940771456956
6,Incidence,44639,Middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4012984132909387,0.8105826181962469,0.0843178417350267
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0826640478963895,0.2275101303956907,-0.3273556023123195
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2812008705911012,-0.0563599055441104,-0.4413684222629418
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.142228177273782,0.1117490459546404,-0.3334467178225027
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0940787682785953,0.2102542023834023,-0.3326446065336004
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2812683226435064,-0.0592236063061542,-0.4409633392073037
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1472396908468802,0.0990412052392409,-0.3362088100796274
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0898231285344833,1.7422146624612114,0.7227654064839275
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1405658797045224,1.6991858658136416,0.5945685898595183
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1030415005519003,1.6791211629302345,0.7251495401444711
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4084562893296287,0.858415091595828,0.1499368527555457
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3730618325914643,0.728190473996128,0.0283556335686023
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3821856710043586,0.7635080202584261,0.1416078862324415
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2794614939778947,0.6788779973457044,0.0547361499913597
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2774563391050282,0.6108320362381482,-0.0483863297237118
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2713957623217073,0.6196652764113402,0.0429408141186607
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0127131983503024,0.3287021183972155,-0.1693290362634631
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0732858762019238,0.1766150228934816,-0.315225792839336
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0373354156604579,0.2282437031458278,-0.2115898071728309
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0247463650020049,0.2763515970610253,-0.1961405923126808
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0950360428834654,0.1487348055260719,-0.3306742215342242
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0657999188127227,0.1871534240679711,-0.2363800507676352
6,Incidence,44563,African Region,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.726123257791109,1.9115068979310288,0.3263813074794706
6,Incidence,44563,African Region,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.8966419890971034,1.5319563423522693,0.3870607962114621
6,Incidence,44563,African Region,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7951423548877936,1.6127264384567117,0.4340995733606418
6,Incidence,44563,African Region,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1387067858804422,0.464526146110808,-0.3341598860696961
6,Incidence,44563,African Region,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0812091405701036,0.2309451875847626,-0.3268089826867767
6,Incidence,44563,African Region,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1176975356948262,0.283816802931719,-0.2951702405902359
6,Incidence,44563,African Region,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2348352922785047,0.2906276041001684,-0.412034939634881
6,Incidence,44563,African Region,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1685823022466623,0.1099160121265812,-0.3919638495512597
6,Incidence,44563,African Region,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.208724475972987,0.1516560099537561,-0.3678674628069889
6,Incidence,44563,African Region,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1721723543669797,0.4213442305460125,-0.3688845173723262
6,Incidence,44563,African Region,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.122864996062087,0.2131806639498841,-0.3834879794204702
6,Incidence,44563,African Region,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1594015983402671,0.2431353414489177,-0.34515787373124
6,Incidence,44563,African Region,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2152901324385695,0.3398029683194118,-0.3975397432250281
6,Incidence,44563,African Region,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1596424201725362,0.1653747129071322,-0.4090897063175103
6,Incidence,44563,African Region,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1985176807227911,0.1884430983611491,-0.3720578584538683
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9832782475582534,3.159729865661026,0.1907973698593076
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1083025052507487,1.9665394712224145,0.5125292395681333
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0155973377544822,2.6430856277575883,0.314254092378744
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2184501394723405,1.5435927900134685,-0.2733749397042594
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2245569493760262,0.7052926456372006,-0.113920029507521
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2034598181076699,1.1897801834184072,-0.20920530217833
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0954597713252158,1.2976184673138544,-0.342265455648108
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1110611066754769,0.5633461610390946,-0.2029073595424488
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0872786756355177,0.9651987241598248,-0.2910486523056836
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1932576918567563,0.6715049777874005,-0.5166391489625077
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2178251495515422,0.1165113484660834,-0.4553684437826701
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2212694250642787,0.4073028545326219,-0.4870703081710599
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2132996610182278,0.63658012838787,-0.5262889016543651
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2411432562642803,0.0846286029108926,-0.4674529317791371
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2420678416079733,0.3614919272197977,-0.5062546926788039
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9183208119171764,1.5870598351934555,0.391065485521657
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6791911380266672,1.2954530384388367,0.2658938564429849
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8780695173960359,1.4991583260426795,0.4201384403547649
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6202144224623201,1.1916895493609705,0.1618657430624952
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3706469838134145,0.8776167220222568,0.0318601651996777
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.558565706774431,1.075798370431344,0.1747028702721243
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5196182592607481,1.0493669979168307,0.1019473377414399
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3129928926252607,0.7948603089741823,-0.010172458222427
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4781560286445939,0.9669910575511022,0.1177361528293536
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0445130168013601,0.285337602027738,-0.3015108174858283
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2176870118977845,0.0660598757076973,-0.4102787328717164
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0820314544455927,0.2229263064100778,-0.3026995261424238
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0709309155090499,0.2514154458152962,-0.3194993460523934
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2282859775852133,0.048871998684682,-0.4169205644514467
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1008237869129486,0.1926751470076063,-0.3169836528719376
6,Incidence,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,4.1568428595571865,4.423811093009389,3.894426370215199
6,Incidence,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.9137736646166945,3.1087516484458475,2.6977187879068527
6,Incidence,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,3.483943511333893,3.660062035312284,3.285119614188407
6,Incidence,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.9221118740496683,3.1326260208540244,2.707993925832908
6,Incidence,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.904729663567631,2.06293493193884,1.748817763718471
6,Incidence,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,2.366438060935369,2.5111348777656293,2.2056821569957026
6,Incidence,44560,America,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.6066845625640216,2.793401558313191,2.423151046641987
6,Incidence,44560,America,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.722053203297503,1.8576615677394592,1.5717857326583604
6,Incidence,44560,America,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,2.127169287465142,2.249996980933356,1.988506527063297
6,Incidence,44560,America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.34981658253354,1.4655733266310804,1.2355012843770887
6,Incidence,44560,America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.8897051925600822,0.981865480680095,0.7884891216613308
6,Incidence,44560,America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,1.115126143407264,1.197083759418732,1.0227326162281338
6,Incidence,44560,America,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.238004479596892,1.3438947787568427,1.136897347690751
6,Incidence,44560,America,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.8193024552682999,0.9074531619504972,0.729841146753966
6,Incidence,44560,America,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0259090744798638,1.099725115961955,0.9429444014803756
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.6258207594310228,3.845290012162078,0.6921530249292203
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8128092171588408,2.99418168898715,0.9742947508847606
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7281752917979212,3.073939646727472,0.9854188697087796
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6125052110360577,1.9586161573745868,0.0498518522375226
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.633049021127654,1.3063702942438509,0.1420781556697496
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.6282201807897333,1.4165344515919736,0.1839769318286863
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4503668419742631,1.6762862423677758,-0.0653426628268456
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4823313608460514,1.1049066329792132,0.0404399299239652
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.4716663703635503,1.1976153772100369,0.0709994296994213
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0617836418260919,0.9581102862370654,-0.3095798290072206
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0254971166391294,0.4586610103055346,-0.3027251243384993
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.052578851337277,0.5664836995179482,-0.2417706372639377
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0358092875284947,0.9237205689625136,-0.3281948681184162
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0046476007619795,0.4170810012566258,-0.3202835117395453
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0248587771197296,0.5365505663272535,-0.2545939332589362
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2035497609170125,1.6677611407027977,0.8065181890391633
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.079364837054972,1.5204979414332,0.7294828053634415
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1403937254872605,1.4848603895578347,0.8330350976099614
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8313442895740969,1.2082395407993949,0.4917012347340511
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7220639342765913,1.086368072080087,0.4246985134839097
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7756242499346186,1.0559879512910908,0.5167063700829473
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.787167882499102,1.1636620662739627,0.4651592370928172
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7053128245682349,1.067091540276074,0.4183702423446113
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.745646459805765,1.0265840300740583,0.4949731868206147
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0500944356620764,0.2662485434818467,-0.1370836882612884
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0240635455083535,0.2402143914490196,-0.1508683371157626
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0393534791186463,0.2016133232992401,-0.1062498688751874
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0487391955118403,0.2636614106100927,-0.1421814336347635
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0308842119144558,0.2433142711269659,-0.1452510591435198
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0412532959608783,0.2037179559201933,-0.1038335582212406
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0518413212232085,1.3977847129629382,0.7828108367393364
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9745140151602588,1.4170349253094088,0.6420466980600846
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.032397765054827,1.329562333442246,0.7796456308192191
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7055551576293045,0.9977125306422634,0.4724991253465763
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6355037021315529,0.991914508958612,0.3482208887761436
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6862154325188599,0.9246110330992792,0.4763124585484392
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6641262086809474,0.9447002759635303,0.4459316165685092
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6193233685299108,0.982240240917612,0.3466628091623137
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6575679143693213,0.8999271918275437,0.4514302009744195
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0010625400284876,0.1648853174854457,-0.1283129282776975
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0177118908858209,0.2448462116882695,-0.1548866197503511
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0327257983846144,0.1747556049810905,-0.0927860179054121
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0023887289550875,0.1637504313966974,-0.1302634216941618
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0244448390877511,0.254102892356049,-0.1468979788123692
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0346357604888958,0.1756487901295746,-0.0898084997938183
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8637808140949926,1.4727572977842036,0.3964724844110174
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7256330758098297,1.2652792933642456,0.3226956967773173
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7994013302861837,1.2542775376313435,0.4391853755869823
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5490661611569757,1.0472106015980145,0.1631068587480278
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.429301761053,0.8674041137383517,0.088662006999766
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.492893062517977,0.8601430612007023,0.1951721384733984
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5116015395007155,1.0055060712475656,0.1325956042374511
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4152130315166219,0.8577835699453973,0.0847591026451237
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4675424080066292,0.8385269757273104,0.1737601479492816
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0035899864726886,0.326394362885547,-0.2405510124395216
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0702341006097176,0.2219654153228138,-0.2902484884242454
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0267818338632403,0.214270540220309,-0.2232230773256113
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0023120423330243,0.3202595924551087,-0.2433188919785318
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0641040013980451,0.2316241281143067,-0.2824635781889142
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0250288337282978,0.2149895059863369,-0.2198843976084881
6,Incidence,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.4369973025344084,0.9397965147016272,0.08074532597033
6,Incidence,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7573550489842399,1.3041491214839755,0.3618542322119845
6,Incidence,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6157916868814504,1.0933824319862824,0.2707067601558846
6,Incidence,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3721503059299126,-0.1681822711220336,-0.5345961602746293
6,Incidence,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2318273372774537,0.0097939551820403,-0.4098613404067276
6,Incidence,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2938815937996838,-0.0805764743538357,-0.4481551853683179
6,Incidence,94365,Central Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.4367524680161774,-0.2396745647820398,-0.5763895057546481
6,Incidence,94365,Central Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2838920323512374,-0.0610778706902211,-0.4450554160771998
6,Incidence,94365,Central Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3541732541337502,-0.1632817677675882,-0.4921025906219249
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.3548241184634892,-0.1456384806720303,-0.5049210616702307
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2303809078879506,0.0132926643497695,-0.4001484525791284
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2785225681284352,-0.0654527722598363,-0.4248638404245123
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3703963866327357,-0.1661303785610226,-0.5137167107783762
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2318766970175401,0.0130805564361411,-0.3917043199843977
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2880635325788557,-0.0806156085698899,-0.4331019557456968
6,Incidence,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7655297921625052,1.7644018796948495,0.2962819232656386
6,Incidence,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9116980467372104,1.6300351240875928,0.4633965977062724
6,Incidence,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8015022221565936,1.6805674554441012,0.3663853998382195
6,Incidence,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2284273379955104,0.2129915565164404,-0.4347516456755906
6,Incidence,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1643128751783391,0.1466610733685578,-0.3553002567746633
6,Incidence,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2125208504781576,0.1780932952730007,-0.4032294243184553
6,Incidence,94365,Central Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3079804002933207,0.0835389415160549,-0.4919074707051311
6,Incidence,94365,Central Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2209985092094114,0.0717180393591137,-0.4036777234894713
6,Incidence,94365,Central Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2799453498540178,0.071414199540593,-0.4538601457469841
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2410587552059484,0.1956285335660474,-0.4324817695133526
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1697623417867018,0.1491650042205994,-0.3705637027611613
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.232543047161537,0.139731912939392,-0.4087806827560941
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2594835709261131,0.1686860371088246,-0.4411997120370954
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1713603412030593,0.1572441600247346,-0.3665632233061744
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2427771242530646,0.1219235819428858,-0.4136539575681883
6,Incidence,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8032518309470253,1.7437776791945538,0.3039107775492826
6,Incidence,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9014920397530984,1.678112851955544,0.4634968191861699
6,Incidence,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.861782494692749,1.5328548922166298,0.4652007223950229
6,Incidence,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2121050703113795,0.1841179132262061,-0.4288286522552161
6,Incidence,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1688863285140776,0.1583524876434176,-0.3627311828330614
6,Incidence,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1864070263290047,0.0985583498529137,-0.3625581654384672
6,Incidence,94365,Central Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2931948156514388,0.0754550501890197,-0.4889172539945302
6,Incidence,94365,Central Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22515737450156,0.0913093245764005,-0.40363688404708
6,Incidence,94365,Central Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2558515185959216,0.0123739626045557,-0.4143639788049725
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2883655940622708,0.0689553704573309,-0.4743482729567062
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2042216283697221,0.1072458724617241,-0.3871326829589575
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.235048675380916,0.0320921613241905,-0.4046858183253019
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.3055694442889813,0.0506674246833794,-0.4821314321912774
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2057346530248729,0.1109251252052856,-0.3907185073794142
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2451631908041581,0.0187575385472605,-0.4064353423450257
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.3319403812513606,3.051619312721974,1.7112415701783783
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.219375728773785,3.1570147741212957,1.3160741493586865
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.271732921777993,3.032992698754461,1.5772364882941527
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.2454283915368642,1.7398444097531467,0.811856094708465
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.065030555903855,1.685234968477352,0.4847209055470486
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.150140722865327,1.646632650575906,0.6853302061893629
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0399283364380645,1.4805404955586927,0.659915206483542
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9212732351179252,1.4808415967498982,0.382196937729361
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9779292853257312,1.4381496158422014,0.558070798345241
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.5743100294328407,0.8997366799408109,0.2681302940271985
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3201434923683223,0.7308179409837277,-0.0609483984078128
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.4350360112039333,0.7832485708321286,0.1126583065427484
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.5161831309667917,0.833570011780077,0.2253714807190727
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2891403998476116,0.6882477683687803,-0.0830635402611011
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.3926629567157572,0.7200280980476291,0.0836598297771228
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.732478917901448,2.424273145896734,1.0599467909280604
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4061944427416608,2.1894408630987168,0.6793897615021462
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.572290098655421,2.2450811284819374,0.9017948184686684
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8418376361549084,1.309976690498336,0.3824759490523823
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5435489320942777,1.038425426957657,0.0854638019741364
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6907303420088834,1.1332685466970664,0.2493010330220999
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6729174401534025,1.0964576261101155,0.2611701739965191
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4359793235721063,0.9034085740582264,0.0022336228937464
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5550804537306321,0.9618169180491032,0.149731887065431
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2554304259034159,0.5476661500557543,-0.0526352157266747
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0471404582260995,0.2768186254819093,-0.336735910027814
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0937751077147739,0.3881117093030507,-0.194017670858754
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2089027025451293,0.499158753829822,-0.0858446820324701
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0695483584290186,0.2482064801910914,-0.3538541097419963
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0613851454269504,0.3463564137375677,-0.2174979009679907
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.8898924724630373,2.4850235182203027,1.4358730051026498
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.013004447325847,2.74322879026073,1.3027445410437624
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.9191762110655144,2.4631909945131083,1.472704628210312
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.947897459417124,1.3508174446533,0.6449337127631083
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9329846618427282,1.3968650759183732,0.4815652607758192
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9188023021842552,1.282208170544821,0.6249800246855584
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7692914246029744,1.13365109050982,0.4913251134485337
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7981140723028598,1.233900573758138,0.3742420353359634
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7647907866987163,1.0936754473837902,0.4948759617700599
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3533678059206773,0.6313056406349318,0.1368266133911868
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2296438542899471,0.5308211424886449,-0.0690904663952142
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2786713156215127,0.5217588654159147,0.0758977695773701
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.303268991008161,0.5653181721043283,0.0939659286778276
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2007051107562439,0.5008055366713839,-0.0858377199658254
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2408229738698377,0.4764693101351839,0.045258434334651
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5622104467803557,2.153025932217644,1.0483615865694749
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3651927315862382,2.114442006515305,0.7015245831594554
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.449980473993473,2.0426951240925497,0.9084022717317546
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7268565621920817,1.11982858190692,0.3816199480207307
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5172362937967603,0.997694476939206,0.0899196982976897
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6102370975293924,1.012992712817283,0.2431858247822231
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5686732342857557,0.930390765947378,0.2540773139959363
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4115101416953602,0.8586504259084793,0.0154433393099457
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4811380524772345,0.8394642643965888,0.1537264292921165
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2462284871502352,0.5217402094178255,-0.0061300087886695
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0282271415290819,0.3718588274058921,-0.2713872840865837
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1235335459225789,0.4106228285264113,-0.1328560008330635
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2001018115544759,0.4592973326703098,-0.0428117851563836
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0040141534246277,0.3358766035716462,-0.2911417998198015
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0902661217351679,0.3701631526592414,-0.1554391468032898
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3540374781155216,0.0413461417915972,-0.5304788829988881
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3108590588049472,0.1124516079062385,-0.531210659485623
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3334142829943623,0.0427499466644375,-0.5031685764768004
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5646426170834152,-0.2903583940619701,-0.6834366123131492
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5580029811347004,-0.2869135414228688,-0.6983997712221511
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5619208648890873,-0.3144084966102368,-0.6766209161324779
6,Incidence,44636,Low-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6045195586079924,-0.3624521271045892,-0.7125430465334714
6,Incidence,44636,Low-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5887314320884403,-0.3361062268900713,-0.7202338314260982
6,Incidence,44636,Low-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5970149635170109,-0.3696045166001525,-0.6996400849484472
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3931674186209167,-0.0125050927192621,-0.5600105407722897
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3580360101646322,0.0408954116945997,-0.5620269159040967
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3769289231306292,-0.0186182275865184,-0.537204831665236
6,Incidence,44636,Low-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4156151239757343,-0.0538350701757472,-0.5758683067712937
6,Incidence,44636,Low-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3730450516766053,0.017721784281691,-0.5737587027833052
6,Incidence,44636,Low-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3953324915733081,-0.0509869518559248,-0.5491576127907969
6,Incidence,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5950695951748795,1.5783445358029085,0.2673224709769789
6,Incidence,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8438998314037424,1.406594097429409,0.4140678778442792
6,Incidence,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6592131627034966,1.4374771999575002,0.3394927290806182
6,Incidence,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2059804006778409,0.2906476802673847,-0.3741326220421926
6,Incidence,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1085223281625643,0.1681260798716024,-0.3177060121478386
6,Incidence,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1861135229802163,0.1980236224383707,-0.3434442712418586
6,Incidence,44637,Low SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2801252523908583,0.1636389581841602,-0.4280416060253961
6,Incidence,44637,Low SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1776942716085819,0.0732449119660805,-0.3693821668173681
6,Incidence,44637,Low SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2556134932006817,0.0935455305350576,-0.3990523123269185
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2805394926822153,0.1810193641296225,-0.4347963650502868
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2137404478547321,0.0410294161491479,-0.4100618138443187
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2754200078781927,0.0781875226338941,-0.415589138887441
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2992822795289815,0.1441471706191174,-0.4441380968567789
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2263622042523065,0.0263444719356201,-0.4184453585592956
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2905239294749759,0.0567652987019191,-0.4266749789907063
6,Incidence,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7285713219637825,1.5186094971050923,0.41264982852174
6,Incidence,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.0097849569254338,1.5938109820060529,0.5929677029045308
6,Incidence,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8936641793864961,1.419683938447741,0.5819902547491131
6,Incidence,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1393630091627112,0.2489787727479268,-0.2973051560346605
6,Incidence,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0282214894470989,0.2520915924621854,-0.2297022628114076
6,Incidence,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0709701470904573,0.193337826909255,-0.2245560751184505
6,Incidence,44637,Low SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2198742626106854,0.13667979224175,-0.3624535619991613
6,Incidence,44637,Low SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1037161266745528,0.1567361700143927,-0.2895999853507782
6,Incidence,44637,Low SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1504297969480275,0.0855627926460724,-0.2902586442814424
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1796467309634075,0.1934476587088094,-0.3279173171024192
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1199961354277902,0.1538930816027729,-0.3173282068010747
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1344083502233734,0.1171156481485986,-0.2914799796626849
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2011245895252055,0.1673682445608723,-0.346847299138003
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1341879473446211,0.1371633785596399,-0.3310296830267148
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1525521031980518,0.0860566339252144,-0.3032954981846786
6,Incidence,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8228820262131242,1.8416831384346215,0.4456539473674289
6,Incidence,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2364682578091248,1.9371133973089651,0.7244612950327181
6,Incidence,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9211247144120192,1.7638355743868002,0.5655346162040005
6,Incidence,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0925015253362471,0.4097894501991259,-0.2805882877394232
6,Incidence,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0814302947821222,0.4124160240079612,-0.1649052313029712
6,Incidence,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0575454813131371,0.3680599048078637,-0.2284235798914774
6,Incidence,44637,Low SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1773106687564046,0.2824869449295061,-0.3475583926623666
6,Incidence,44637,Low SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0026244221943644,0.3098353448536697,-0.2309590916253005
6,Incidence,44637,Low SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1381099502869879,0.2399623838767301,-0.2976412733306176
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1378153784883433,0.3467410640291777,-0.3115133455415723
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0192042253086244,0.2966480625271381,-0.2532472150766952
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1263356540822745,0.2698083617034725,-0.2858556604875752
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1603625687931584,0.3090429906912936,-0.3291199700108962
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0350600879834374,0.283975812856293,-0.2655782530879221
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1446373784626629,0.236873301491093,-0.3023198195912151
6,Incidence,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7646517781186024,1.789383135978421,0.3990269983256812
6,Incidence,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.082536660623386,1.7106314296339278,0.6098618752821182
6,Incidence,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9484005771645544,1.5677132477168505,0.590504146710431
6,Incidence,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1215558188610523,0.3948061045446544,-0.3057603663620395
6,Incidence,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.006875854284933,0.3256623033805125,-0.2183835462815753
6,Incidence,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0442388753849725,0.2637799047899489,-0.2216048679616118
6,Incidence,44637,Low SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2035907039831223,0.2588833033191302,-0.3686017147059621
6,Incidence,44637,Low SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0712717705971839,0.2088334269486374,-0.2820658587751788
6,Incidence,44637,Low SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1258729546732267,0.1519744044315072,-0.2864389866034464
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1963594833593163,0.2891549255304725,-0.3620189155479111
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1080694977968166,0.1722415058761007,-0.3231145136326692
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1377696840883805,0.1545430467691642,-0.3061928463382983
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2173006600154807,0.2505458192658652,-0.378806295775903
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1224079857343283,0.1514101586776783,-0.3327850279146014
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1557686818328993,0.1226764745423704,-0.3179869486872609
6,Incidence,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0023162463803172,0.7307144177488275,-0.2976907279128167
6,Incidence,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0171790495491389,0.5537828286709254,-0.3444570939489462
6,Incidence,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0104358344792119,0.5633058324521918,-0.3070923076098661
6,Incidence,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5032089435075386,-0.1371892820096903,-0.6520074218051104
6,Incidence,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5247524620660671,-0.2469932060257484,-0.6872411320220939
6,Incidence,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5144745343049202,-0.2397773542507527,-0.6640484111011836
6,Incidence,44637,Low SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5497329129065578,-0.2189070568272967,-0.6830390902586976
6,Incidence,44637,Low SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.561701083879604,-0.3070748752552156,-0.7076540288841173
6,Incidence,44637,Low SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5560436543152973,-0.2986411909956369,-0.6891350983304365
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4399331304922859,-0.0160694100587677,-0.608626708922303
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4454931749041906,-0.1055567628340254,-0.6365290164851807
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4429682669040171,-0.1114246492588858,-0.6140713547776684
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4546837454820827,-0.0417868419337719,-0.6174094290068473
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4545378840520097,-0.1229890746533658,-0.6389732029895678
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4547527867098124,-0.1235977215899543,-0.6197696091537097
6,Incidence,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.759569851224986,2.978047255905369,2.5039435204759646
6,Incidence,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.224549031327092,2.3767824548485423,2.0570015208953203
6,Incidence,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.605434474254768,2.7885928821853314,2.3841547239213705
6,Incidence,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,2.074676998570514,2.281938314028809,1.872447541820204
6,Incidence,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.6140666181605807,1.747880827805828,1.4723856756658913
6,Incidence,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.9347272037831929,2.1013584284754354,1.7579163416444308
6,Incidence,44638,North America,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.841868595595004,2.007016232100807,1.6486399895814403
6,Incidence,44638,North America,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.464681220782838,1.581040704383053,1.336616428299234
6,Incidence,44638,North America,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.7408395978644964,1.8800760257409617,1.5726234490896074
6,Incidence,44638,North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1458799915454831,1.266449431712178,1.0281954178523995
6,Incidence,44638,North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.0221803469829918,1.1035704636234582,0.9316474254458748
6,Incidence,44638,North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.1470734657082953,1.2430240582574612,1.048415499384565
6,Incidence,44638,North America,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.0153719648709012,1.11979329890248,0.9062905318982696
6,Incidence,44638,North America,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.9394567445340762,1.017687174275992,0.8586347834274907
6,Incidence,44638,North America,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.038890174261091,1.1235767887836865,0.9465157109326434
6,Incidence,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.212543226161235,4.500736938006378,3.932475494993304
6,Incidence,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.9742764928249423,3.1054349524660347,2.797365952621825
6,Incidence,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.6142650364846056,3.791134908463921,3.4242440393415734
6,Incidence,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.263094384507432,3.516785195842925,3.0227728337861897
6,Incidence,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.2221292546868,2.360446987020033,2.080802359749094
6,Incidence,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.756139215058948,2.9101904667407785,2.5921569634648414
6,Incidence,44638,North America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.9401749359125318,3.1580213097134573,2.728471011968581
6,Incidence,44638,North America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.037734747681283,2.137985601144392,1.9025133316131455
6,Incidence,44638,North America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.507749320462335,2.6422052236972293,2.363295974516296
6,Incidence,44638,North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.6938410614358137,1.8527254296345572,1.5574788736985794
6,Incidence,44638,North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.3535889680364268,1.438476643934707,1.2547536602593032
6,Incidence,44638,North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.5738807238568455,1.677337272234381,1.4741807480050413
6,Incidence,44638,North America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.5300144226435788,1.6668078481373132,1.3986909620224122
6,Incidence,44638,North America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.2571994743445951,1.330034327280229,1.1665079551753714
6,Incidence,44638,North America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.4441167981623797,1.5335937307541188,1.344771732724914
6,Incidence,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.7008178526110895,3.944002845691047,3.4359099155137125
6,Incidence,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.906190614626606,3.127710857871476,2.696528129704941
6,Incidence,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.5648894225523584,3.7917377004834463,3.3218664520788304
6,Incidence,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.844764719163512,3.081515664310467,2.60909172118879
6,Incidence,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.16690363102617,2.359325196756536,1.9801375071487493
6,Incidence,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.716016725789104,2.91188442143024,2.499174378158883
6,Incidence,44638,North America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.55336039961992,2.7371845662406606,2.35311580330909
6,Incidence,44638,North America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.9856933664631136,2.155012169881705,1.825438030207173
6,Incidence,44638,North America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.4702141388356336,2.6426634642361133,2.2854688646056243
6,Incidence,44638,North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.505321888870768,1.640988213038575,1.3573138783186425
6,Incidence,44638,North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.345157131189753,1.4755287156819588,1.2277607213675152
6,Incidence,44638,North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.584242513604586,1.704194986755423,1.449105458116454
6,Incidence,44638,North America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.35290847155944,1.4667116821571018,1.2283097498547098
6,Incidence,44638,North America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.2491596606602775,1.3634619730023894,1.1409894312065718
6,Incidence,44638,North America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.453977607703844,1.5609096732941543,1.3349194552155017
6,Incidence,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.1222197208138285,3.3796558765522176,2.901616938661417
6,Incidence,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.3481142888958515,2.5153227344017424,2.177054212963217
6,Incidence,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.754382930888079,2.92951628598546,2.5830122183289754
6,Incidence,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.371463383484386,2.595397886131975,2.162302983115471
6,Incidence,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.7143759235731515,1.870952502795115,1.5620811552415763
6,Incidence,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.056143483552373,2.2146157365795944,1.89565226238799
6,Incidence,44638,North America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.1159965720296854,2.3105932294439016,1.94924235718366
6,Incidence,44638,North America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5591282169091671,1.6869338454143885,1.428378598069186
6,Incidence,44638,North America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.854069731679576,1.9872055404109172,1.723794271606674
6,Incidence,44638,North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2731415265603243,1.3939947336202514,1.160868470481155
6,Incidence,44638,North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0461007403770115,1.139382981078208,0.943677613877188
6,Incidence,44638,North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1851541297064898,1.272939503261133,1.1005904744504649
6,Incidence,44638,North America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1348322526439265,1.2416278330442378,1.0410359188585354
6,Incidence,44638,North America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9623570604341436,1.0470322076818823,0.8715399377874051
6,Incidence,44638,North America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.075000860152369,1.1563141740113827,0.9979282771863984
6,Incidence,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.331198306736237,3.143932213609099,1.6685684417929814
6,Incidence,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.8910207272778496,2.638196889805947,1.3065479998116374
6,Incidence,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.109764590809996,2.679893128125248,1.5857926478854338
6,Incidence,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.50427053794306,2.1430092298173906,0.9963757066081363
6,Incidence,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0844191002030346,1.626624842257831,0.6623559697673685
6,Incidence,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.288802163377807,1.7299291733588338,0.8992178660599761
6,Incidence,44639,Middle SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.36918209043537,1.947206704748797,0.8979129962368689
6,Incidence,44639,Middle SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0120628222488577,1.5320747903778082,0.6052875146707403
6,Incidence,44639,Middle SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.188171834614773,1.5893402095940528,0.8194813391913657
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.370532595732474,0.726170827246697,0.0976000965527466
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0979409589934803,0.3818782453774383,-0.1302902283037678
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2230854685145326,0.4611164656583066,0.024130478840846
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.353576727156539,0.6931634550430559,0.0895548153153244
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0980360650146739,0.3782946217888347,-0.1266839643693012
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2159904614580898,0.4464381430783969,0.0166786937409683
6,Incidence,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,2.171266177074864,3.037947861065905,1.4775454548157154
6,Incidence,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.7973095765006797,2.602779925491315,1.148725445024481
6,Incidence,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.9861165057793524,2.625662055438071,1.4058694454361926
6,Incidence,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.525315381058344,2.225145916699157,0.9631445206165976
6,Incidence,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.1641289828662007,1.776521509405129,0.685679842893404
6,Incidence,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.3433833533341069,1.8416892533582976,0.8787625907352067
6,Incidence,95468,Basic Health System,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.3348053496221783,1.9728889790664743,0.8240620808346936
6,Incidence,95468,Basic Health System,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.0426334664622203,1.6307988611374369,0.5690285198023994
6,Incidence,95468,Basic Health System,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,1.1895843655633227,1.658534232016323,0.7641154031057198
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.3591513477145632,0.7361121005275981,0.0552748366404262
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1219437893123412,0.4508313091272793,-0.1406931918109259
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2332521564205434,0.504393062771989,-0.0056346116937097
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.317114812340063,0.6827715041750769,0.0276680319141949
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1017785439614152,0.4220011639416744,-0.1540909772402966
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2030519650675673,0.4621521874070726,-0.031822954094465
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7851531441197943,2.4867858367715474,1.2912492763778247
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.7763553553770417,2.512711776792981,1.1140672128814997
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.781945446714263,2.348071934674504,1.291784769832132
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6911865197010238,1.110351666681015,0.3881174001663898
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.608026549714885,1.0392948925623011,0.2261547501698868
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.6492347301805859,0.9895897079039842,0.3546023102666749
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.585448758837489,0.9848532526525292,0.3042939233305852
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5193597697660401,0.9223306361363972,0.156922750401078
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.5534295425114143,0.8695527836175153,0.2797253701505174
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.282349436014868,0.607183106074546,0.0433101617727619
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1121595096653708,0.4426491908257843,-0.1818166029120368
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.1921297308053745,0.4521649884998049,-0.0381208024531397
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.2605274753314904,0.5846448664076257,0.0301103433294243
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0954741954063281,0.4236590331511018,-0.1943486843712912
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1743770259270566,0.4351288849544515,-0.0535972445246927
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0065365962824847,0.5343869953090261,-0.2979636139422228
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.009910356330889,0.7770332302655207,-0.379858675104419
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0083308572476965,0.5683363543741238,-0.315153995902481
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4651923427423058,-0.1731227172296537,-0.6204402341680669
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4711025577643113,-0.0553223082899156,-0.6655428222092992
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4682318280713188,-0.1577302606953206,-0.6320103108061659
6,Incidence,44567,Eastern Mediterranean Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5062395936825633,-0.2373956167716089,-0.6510814893307572
6,Incidence,44567,Eastern Mediterranean Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5039129753575342,-0.1096128178593172,-0.6892765552165492
6,Incidence,44567,Eastern Mediterranean Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5052035396886184,-0.2174736076104755,-0.6582939167136257
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2824839285447529,0.1113994858035927,-0.4919786948707776
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2829526649316825,0.2904198812178841,-0.5460817351142428
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.282677912061383,0.1344853466176477,-0.5057166022381208
6,Incidence,44567,Eastern Mediterranean Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2920679944932127,0.0953295077751913,-0.5004040979344051
6,Incidence,44567,Eastern Mediterranean Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2895045286158642,0.2767710634995333,-0.5541488569100987
6,Incidence,44567,Eastern Mediterranean Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2909383719596597,0.1226692223883099,-0.5110541955577843
6,Incidence,44635,High SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.213996331664985,1.3827162160384323,1.0620220384315036
6,Incidence,44635,High SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.481584455626189,1.659825500552331,1.2452547204458515
6,Incidence,44635,High SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.2911154956438298,1.441050613602941,1.1199297002540245
6,Incidence,44635,High SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8073275465341313,0.9508345057234862,0.6774892837847888
6,Incidence,44635,High SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.0671414440167386,1.2259461546614565,0.8624671066941447
6,Incidence,44635,High SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.8905073100968428,1.0173739436331593,0.7422419593018548
6,Incidence,44635,High SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.7583942129304637,0.8923944657969449,0.6376935984290008
6,Incidence,44635,High SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.018987313382979,1.1640020871554857,0.8267122787685053
6,Incidence,44635,High SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.8418878396071727,0.9624246135166636,0.7042670887364875
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.142409184764692,0.2252111055072742,0.0639737341229817
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.3305307304865353,0.4184739210381007,0.2259761463040444
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.2087763784616835,0.2869672490239496,0.1307013337778328
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1295124729447299,0.2130306604448955,0.0530895149251544
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.3230690840326798,0.4078894409267291,0.219474804314758
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.1976712300937274,0.2735592347308747,0.1177159443622718
6,Incidence,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.9489082822743776,1.605501652101712,0.4216846017121937
6,Incidence,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7596825134684132,1.3523448106181315,0.3288201030742125
6,Incidence,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.91644161096301,1.5068924655983658,0.462980275398604
6,Incidence,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5519606794723974,1.0842968951689045,0.1215355748549925
6,Incidence,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3616148166854009,0.8514978537069083,0.0225448671492238
6,Incidence,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5039092136663844,0.9666010158266096,0.1467809030229869
6,Incidence,95468,Basic Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.434859525911624,0.9182682424304454,0.0466976369088159
6,Incidence,95468,Basic Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.284944084328116,0.7177141476197166,-0.0296775028945362
6,Incidence,95468,Basic Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4052400771229859,0.8381910210800931,0.0727373603610502
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0948301971470308,0.2074408091029947,-0.3305463226246431
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2429672454738635,0.0144009974365356,-0.4242408507271813
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.135779043124558,0.1291403146132154,-0.3395598221796079
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1228455821250164,0.1728819373087765,-0.3519066295772164
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2567062875182188,-0.0110524970451576,-0.435812848485606
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1569271217142691,0.1013419070528854,-0.352592099794043
6,Incidence,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4158692832503364,-0.3320752106384237,-0.4855998875722238
6,Incidence,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4297998491216364,-0.3452214344044388,-0.4946236522716341
6,Incidence,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4215347150912864,-0.350131018541108,-0.4851883780311767
6,Incidence,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4732823158683735,-0.3973567714711431,-0.5386897806863526
6,Incidence,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4838870581620662,-0.4100056070586854,-0.5412877392803385
6,Incidence,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4773095983635271,-0.4151184025945478,-0.5368758271208118
6,Incidence,44562,Europe,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4501193687771991,-0.371238501499825,-0.5157613691387373
6,Incidence,44562,Europe,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4583446993022282,-0.37800037356746,-0.5199233511729724
6,Incidence,44562,Europe,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4529007906363358,-0.385368810848801,-0.5131029662483272
6,Incidence,44562,Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.254539621063622,-0.1449007604797857,-0.3494322370833732
6,Incidence,44562,Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2696691059896107,-0.1603254790685707,-0.3562149305172886
6,Incidence,44562,Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2599818312860659,-0.1679294680027584,-0.3456390586458193
6,Incidence,44562,Europe,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2177378198200996,-0.1024952348758969,-0.3127621200675406
6,Incidence,44562,Europe,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2313085633967645,-0.1149217640518746,-0.3208936547051486
6,Incidence,44562,Europe,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2227349596035327,-0.1243238274832073,-0.3099339317392063
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5747673226094928,1.7736197116840309,0.1786099001854832
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7849155067075831,1.4865607000685976,0.3441825086844969
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6223895605012075,1.574027676665169,0.2330792722029119
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2980097780229973,0.2413075411563907,-0.4740528894911626
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2096780650360668,0.1013068420486333,-0.4002672780654315
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2792073801653709,0.1452710465711976,-0.4484165054279387
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3739508699368524,0.1026531873600328,-0.5314433490579177
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2748332258554171,0.0102277641755335,-0.4538920805935936
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3479215719096805,0.03456528698463,-0.5043949905099065
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2620864501167694,0.3134339081595346,-0.4473545829200751
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1946254491003748,0.1294253052723941,-0.4014069302637194
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2605520967575368,0.1838380403752916,-0.4359866508135387
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.285814327154798,0.2687950980025511,-0.465569195367892
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2077170535941912,0.1129878169212243,-0.414012143224043
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2786700490071482,0.1532819827823575,-0.4503548126870847
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.031544516206357,2.594807801012143,1.5326023643845337
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.121018128043059,2.753249186653118,1.5664840539721976
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0772812637291653,2.585859817669516,1.6340377203162053
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0914753879329728,1.4595830412148438,0.7340820294264873
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.047543734562259,1.45822151023068,0.6829756182702
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0699910415256757,1.4134208235134418,0.7646427961367435
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.939773895896202,1.3001853662018696,0.6205191541326247
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9441785189199876,1.3380147584789095,0.5987421290667302
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9433425883340768,1.264516468354369,0.6634286054715997
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2689606334869307,0.4938108719660691,0.0567355006903062
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1176483127833769,0.3561909301350271,-0.0904849511795322
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1869355963135857,0.3879843862119823,0.0073971643947096
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.235438584240248,0.460148763692237,0.0251539274551296
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.102271348276725,0.3358884587620453,-0.1067989012868479
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1637223240169312,0.3618856570862073,-0.0074433532409193
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.296529896074949,2.938973150915426,1.727312977848127
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4381857322288867,3.094691875162063,1.8233936388162848
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.3234269828044765,2.8945140085702388,1.7891210763598262
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2746928342516584,1.7131049546338266,0.8821587075116099
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2559284591527224,1.6833336306142543,0.8594898458337402
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2358448047402737,1.6159910832549325,0.8743368136611872
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.109328299572407,1.520404122035877,0.7451073180970642
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.141752008613885,1.5507099474227843,0.7587790387118873
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0987867670814857,1.4594355488151152,0.7613657339666797
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4048602014303261,0.6651521414514774,0.1608839901744135
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2822192926794307,0.5389075798391649,0.0478829801425686
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.330439654526071,0.5536054003771873,0.1153264681922783
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3676201639514167,0.629143130541203,0.1262409564730316
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2645286679371429,0.5217681422112406,0.0364757242510689
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3043797564615894,0.525033522170947,0.089506720071451
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4887977093913916,1.980339417849995,1.0623831690698975
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.536237285353324,2.048253180799384,1.0573659531245014
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.511281887904295,1.9154851413495495,1.1288863595426228
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.7170220416107628,1.0690430046053636,0.416110296983082
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6639768122588752,0.98902187031516,0.3726257025679748
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6892990726365711,0.9598411733294424,0.4182459084113551
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5924901656680986,0.9070096357649468,0.3196431763778711
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5799004833591376,0.8988509874678661,0.2815967506507248
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5859067227941033,0.8411662617975207,0.3444190418945038
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1309398285564934,0.3499525531809548,-0.0637840295677895
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0434870106664311,0.2497970653208926,-0.1513464313006241
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0838302779911468,0.2581515816942936,-0.0822610809822519
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1010346399348156,0.3081891610764218,-0.0873856655861883
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0290678641826295,0.2357865515758763,-0.1743724831979965
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0625875780710799,0.2341267315010693,-0.1011140643178625
6,Incidence,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.720967967825501,3.922942183738959,3.4963671556583407
6,Incidence,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.4996537496309017,2.636211976592439,2.329197429637168
6,Incidence,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.0666511670580143,3.219492823833578,2.907234130463076
6,Incidence,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.590434506814376,2.7606831119967943,2.4101584873909623
6,Incidence,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.597440597950983,1.7181579587162483,1.4723988973202249
6,Incidence,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.053106731303084,2.1644099019337952,1.9245438878219507
6,Incidence,44560,America,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.3018346212274623,2.4430949439501037,2.144749306812384
6,Incidence,44560,America,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.434030303218342,1.5290073741966397,1.315476903961749
6,Incidence,44560,America,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.8361433636069493,1.9427374216511089,1.7249635373048848
6,Incidence,44560,America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1224567833578407,1.2134291348527046,1.0166169223791224
6,Incidence,44560,America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6589638083988191,0.728895258188927,0.5819522021746487
6,Incidence,44560,America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8885783186101752,0.9584704345844524,0.8163046912098351
6,Incidence,44560,America,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0215805405342222,1.10586060411775,0.9279018658047102
6,Incidence,44560,America,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.597087734398512,0.6594593382905161,0.5251389285177216
6,Incidence,44560,America,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8089307467462482,0.8718095228268696,0.7414670230263953
6,Incidence,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.2951706278101844,3.5045679690629377,3.0662161066317584
6,Incidence,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.336016163970598,2.5077773887888064,2.143763322063131
6,Incidence,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.077589269776368,3.2503045412119302,2.881436220945953
6,Incidence,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.266926953125297,2.441311355604751,2.083125805606811
6,Incidence,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4762262778569732,1.6187931164996168,1.3347107983807078
6,Incidence,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.0615809416326414,2.211042335286536,1.9127966557263976
6,Incidence,44560,America,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.004032897413444,2.150484937684288,1.8439026084842307
6,Incidence,44560,America,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.320219374841597,1.439680343278689,1.186506363052365
6,Incidence,44560,America,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.843771760083744,1.9642259743137576,1.706971689254428
6,Incidence,44560,America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9817688491125496,1.0753796700346443,0.8764632380795583
6,Incidence,44560,America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6015016348626283,0.6848883823773957,0.5196188548510732
6,Incidence,44560,America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.928120324854548,1.0057203379787163,0.8374770411179644
6,Incidence,44560,America,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.887497033436653,0.9744891428280398,0.7920745251854748
6,Incidence,44560,America,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5417054469677791,0.6203367110811997,0.4561177745019247
6,Incidence,44560,America,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8467530178758942,0.9202142511464936,0.7614037923679597
6,Incidence,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.84267775428714,3.035919038599035,2.657164941368308
6,Incidence,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0100808308011384,2.1562465285012724,1.8491640048573852
6,Incidence,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.4062058127345614,2.560370389955973,2.2516509819306645
6,Incidence,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.92265409906464,2.088752080573527,1.7598697803350585
6,Incidence,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2341441002942035,1.3551285611519743,1.1079362930011731
6,Incidence,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.557382445559788,1.6782476481724309,1.4340858288070573
6,Incidence,44560,America,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.687560376134033,1.822712905687283,1.55781312248791
6,Incidence,44560,America,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.093529383608118,1.1951885084660274,0.9816107600339672
6,Incidence,44560,America,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3755388928171473,1.483055575371972,1.2677500415754568
6,Incidence,44560,America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.852144614801451,0.9429023718142304,0.7649537058009785
6,Incidence,44560,America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5013513445993006,0.5699821618336314,0.4268089958179232
6,Incidence,44560,America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6728381638772002,0.7394538380266279,0.6041110893292378
6,Incidence,44560,America,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7640089372724481,0.8453725386304651,0.6840838840686738
6,Incidence,44560,America,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4453525217335994,0.5071102604041133,0.3773227622507297
6,Incidence,44560,America,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6022437085060034,0.6638921375281333,0.5370063979303772
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.661223432233404,5.034859519007311,4.267586583076842
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.5416336295137896,3.799029459460035,3.221632583617924
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,4.040656042340417,4.283821739059684,3.747961541047073
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,3.3095571732184697,3.633423585185128,2.998682546983039
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.547584696263868,2.7540739171222017,2.279220784185617
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.890930796918275,3.094633394369768,2.648416633962714
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,3.2694331588916525,3.5512122332076967,2.972570433640115
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.463052804407886,2.6593203643769803,2.2190479793155182
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.8227783056179505,3.0071925053333586,2.6008020032637864
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.8414027663215708,2.0236231852103685,1.660300710352393
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.665829712831965,1.795636668321932,1.4937034192734138
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.7626083703180255,1.891977701865991,1.6100658809610315
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.836524082482592,2.0111989938938186,1.6691805660284442
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.63973672429247,1.7781545443023314,1.486249576997756
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.7462832207158816,1.867903211376239,1.6060099109096089
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.173501658156312,4.5380549298942245,3.821910668932564
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.37911548701661,3.68431122073102,3.0767170715179737
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,4.014855581268693,4.335861912398379,3.713976796382161
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.9385335585699264,3.256769625694912,2.660634725874831
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.4206843639998623,2.68475141047937,2.173310675047326
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.871100456381217,3.143738176271546,2.6273588835426525
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.901615930074605,3.1765451649248666,2.636462249827229
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.339130675268145,2.5718462634795505,2.108548077403866
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.803211518669676,3.046659202522916,2.575028345324081
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.7388027847042171,1.9328136922578592,1.5434035373334052
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.6557968389303812,1.8291046857972668,1.4704934179587776
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.8585113383338832,2.041917842809853,1.688565221452636
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.7340021312062293,1.917226947665391,1.55353623576905
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.6298543902118523,1.799421400262509,1.4477027618352838
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.8416655325385896,2.01985765442603,1.686825458466599
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.8600664402806895,4.316439104943004,3.428165860910746
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.144454747014811,3.491221877042082,2.80877009928308
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,3.46338980179746,3.744522086579416,3.147143380391934
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.699871063586807,3.070350532095615,2.3490158296392867
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.2372774707009286,2.5016619376305806,1.9669860648576645
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,2.4453873309455427,2.676382594069032,2.1874799429283502
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.665237569746461,3.0094127486003988,2.3395181069873163
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.1601989075300465,2.4246132086558747,1.9042351386409064
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,2.384985914632139,2.598193558686001,2.145148094153313
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.6703024194922578,1.8937882759916955,1.4460189215842163
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5338458470593597,1.714365442776974,1.3519123746412465
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,1.5987054757325403,1.7517075415433754,1.4557916590706883
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.6655607831525554,1.8981399202381384,1.4514654104326188
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.509189909836795,1.6886961652112054,1.324335986871628
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,1.5833614472031372,1.7279815351892442,1.4354501973487048
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8333641302303783,1.4287724988415365,0.3415730710616658
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6879423755155798,1.2750525981040717,0.2981528679463064
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8101431488917568,1.3367368501918284,0.387133438430408
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.6095796143281815,1.1295193810631212,0.180357511378765
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4544662302046158,0.9518867195511796,0.1151416289594549
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5741826237680469,1.026146391367321,0.2095939462991691
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4747044621407029,0.9536335322084468,0.0791221239469978
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3450191156301004,0.8128517169190861,0.0344194492211221
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4493258908505519,0.8709532553605253,0.1106350387882825
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0748127862135456,0.2169062032575298,-0.3151008106813996
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2185387026188614,0.0413643474571375,-0.3939441940488262
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1047011568050892,0.1617398950600324,-0.312776675389498
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1212468699685136,0.1604976879385888,-0.3508095587970197
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2524636010079324,7.11489891948e-05,-0.4221659043452089
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1468138516739394,0.1020551356541996,-0.3424540524113684
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.618955761983292,-0.5076898489599747,-0.7022068494016664
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6642711333366084,-0.5302512602725358,-0.7592233350090253
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6392284934840881,-0.5351337751516501,-0.7216908221527372
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6833117745325485,-0.5876922732999625,-0.7522672920704904
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.72194899888488,-0.6110091796036667,-0.8013298133823697
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7007109871892669,-0.6133500436168298,-0.7692900374048067
6,Incidence,44634,High-middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6909577282650489,-0.6007165775095245,-0.7584777236180588
6,Incidence,44634,High-middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7246646034903086,-0.614753247767442,-0.8025360786386022
6,Incidence,44634,High-middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.705764647107193,-0.6208678478044711,-0.7730186622884407
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4876093122256008,-0.3364670337802443,-0.6018684398339523
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5444914357244377,-0.3601824135052509,-0.674795748859387
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5123890224224558,-0.3652625639490247,-0.6272325060845219
6,Incidence,44634,High-middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4882852781159854,-0.3384477176763535,-0.6022806538711178
6,Incidence,44634,High-middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5414784130818946,-0.3559391382784269,-0.6719551744917993
6,Incidence,44634,High-middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5115021021280067,-0.3653808949927743,-0.6253809713026179
6,Incidence,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.27883883143862,3.0366531713774703,0.7008347994495856
6,Incidence,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.355306263870206,2.349067899993173,0.6094726588380208
6,Incidence,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.323964448592433,2.3496784759710456,0.7537626973342191
6,Incidence,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1368431334786574,1.005165884997313,-0.1561633127857271
6,Incidence,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1406894825642352,0.6218373731446716,-0.2187909639388639
6,Incidence,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1419112760350845,0.6437878267658088,-0.1403469482054437
6,Incidence,44563,African Region,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0101752818240185,0.7893881738217561,-0.2460452888695819
6,Incidence,44563,African Region,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0324791513991525,0.4681074968489316,-0.2944667152259594
6,Incidence,44563,African Region,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0243734608975164,0.4764949332175205,-0.2269640936420879
6,Incidence,44563,African Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0947357744040491,0.9255961450597684,-0.1899614527765162
6,Incidence,44563,African Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.048857528660444,0.5216628212517684,-0.291259580018126
6,Incidence,44563,African Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0743982638615091,0.5608859711211933,-0.2043936654556177
6,Incidence,44563,African Region,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0378786972864661,0.8306377507642082,-0.2341957745846599
6,Incidence,44563,African Region,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0050812082252898,0.4494424285237516,-0.3208077860714056
6,Incidence,44563,African Region,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0246058345035094,0.483147091923037,-0.2389294624546406
6,Incidence,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,0.6493851020772017,1.5525005546306354,0.3331062764205555
6,Incidence,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,0.9067451161085076,1.3830187705262729,0.552582102952282
6,Incidence,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,0.7498232243553536,1.380104546760298,0.4650726879776414
6,Incidence,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1789012523666533,0.277719062015736,-0.3393315404696981
6,Incidence,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.0781049352778919,0.1521173538577571,-0.2492218035089425
6,Incidence,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,-0.1416235212971339,0.1686669812310949,-0.2823314284895707
6,Incidence,44637,Low SDI,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2556119885553159,0.1519752480364121,-0.3983525564167037
6,Incidence,44637,Low SDI,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.1496677830027553,0.062731257140053,-0.3076103510006175
6,Incidence,44637,Low SDI,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,-0.2149623527745807,0.0678059632152764,-0.3427123380375138
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.2183788112005503,0.2365785242647824,-0.3716212318241369
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1248899951117308,0.1426395195416999,-0.3211661521710875
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.1857328208994678,0.1319138335659346,-0.324369489124247
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2387715486865857,0.2004271153958823,-0.3840568915724056
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1389556726614449,0.1277308358672195,-0.3367857429329028
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.2027394764444705,0.1054474019249955,-0.3422812537161934
6,Incidence,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.3100459875674169,1.9243176724420856,0.9362837655114082
6,Incidence,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.468511539430029,1.9911766705826133,0.9812398939979214
6,Incidence,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.369280366014945,1.8530442978953696,1.028467443446056
6,Incidence,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3833909461746401,0.7510477822902419,0.1624885427976075
6,Incidence,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4048167330320849,0.7009360127177493,0.1232462502540814
6,Incidence,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.3826661005261553,0.6666421824674054,0.1790443357373539
6,Incidence,95469,Limited Health System,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2833476268463625,0.6246066811100272,0.0757037689916069
6,Incidence,95469,Limited Health System,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.3220012365013244,0.6019124050832587,0.0610449041189307
6,Incidence,95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.2927117559322295,0.5566599702542339,0.1067595664412708
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0661452192632549,0.3616318444296189,-0.1077688306550457
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0023180985204223,0.2469132252559553,-0.2341986147947566
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.0237690655881748,0.2492426765219869,-0.1493189555705874
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.0470967129327615,0.335529774715896,-0.1225745460786942
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.0085431573882456,0.2345886030852049,-0.2391296478234431
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.01007218964356,0.2359677297741821,-0.1579405101925038
6,Incidence,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6604522711808755,1.8941506372623065,0.2534339208614042
6,Incidence,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7965047245857323,1.546904388363504,0.2569946478141021
6,Incidence,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6973195711832496,1.687484691420689,0.312304600421022
6,Incidence,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.171505540880561,0.4483214660270064,-0.3729871664131055
6,Incidence,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1297533807815385,0.2300364820343769,-0.3908697265940348
6,Incidence,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.165794474705866,0.3165779837518213,-0.3626901309133071
6,Incidence,44563,African Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2639462616421301,0.2829338324869427,-0.4443714286478891
6,Incidence,44563,African Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2124787752752878,0.1164686826210736,-0.4489800383089791
6,Incidence,44563,African Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2518434933739387,0.1846084806190212,-0.421553111064493
6,Incidence,44563,African Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2498488128701203,0.3280462471182785,-0.4337110324305773
6,Incidence,44563,African Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2354147169991919,0.0878829220924341,-0.4760118221658805
6,Incidence,44563,African Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2632315351002144,0.1708103548056411,-0.4388381340407718
6,Incidence,44563,African Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2889030239834189,0.2509051543849628,-0.4636703943576082
6,Incidence,44563,African Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2674666696787611,0.0490590419307091,-0.4968720141781041
6,Incidence,44563,African Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2975091793146895,0.1153692367138174,-0.4612758076928578
6,Incidence,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.975501410887593,2.679387033710904,1.415560093755326
6,Incidence,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5176950647984275,2.20348000512473,1.0118123039514328
6,Incidence,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7133365229290642,2.2728052841811466,1.2889698620360617
6,Incidence,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.236842943100856,1.7655586780798196,0.8108930110660034
6,Incidence,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.815410480673171,1.2984215659659677,0.4466633630545047
6,Incidence,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9971499805405244,1.4006834544567746,0.6778112743350687
6,Incidence,44639,Middle SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1162068431905705,1.6168174516721194,0.7179708878102047
6,Incidence,44639,Middle SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7522394737066417,1.2295250114647716,0.4001604014561801
6,Incidence,44639,Middle SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.909227011861526,1.3028946834712805,0.6106233240905139
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1488379339444559,0.4239378365367181,-0.0689291210578546
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1026916397896769,0.134769514687536,-0.2854329058404909
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0024288011964429,0.1973573879169855,-0.1584883311390106
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1346062182366589,0.4011879274784192,-0.0771933643956832
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1027078977288785,0.1364399116570029,-0.2835451066125654
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0082956643372861,0.190263128254912,-0.1615335670179035
6,Incidence,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.240748628142687,3.001616672769069,1.6507840428681055
6,Incidence,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.681560075322038,2.4036197580175296,1.1440961100519718
6,Incidence,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.081664578168319,2.685650831172269,1.5818811011387914
6,Incidence,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.436632323225023,2.0245886963510853,0.984747632325546
6,Incidence,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9339234409337558,1.4564495218308475,0.546862009934491
6,Incidence,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2684225307724464,1.7057119502753724,0.9023394480409044
6,Incidence,44639,Middle SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.304853359787262,1.8459904457626528,0.8852645509801662
6,Incidence,44639,Middle SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8662845555806937,1.3688162148276917,0.4922259220279009
6,Incidence,44639,Middle SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1683993874023584,1.5933915913857164,0.8167289969574628
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2988842349243326,0.6128421813387404,0.0673940152960761
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0140841061791073,0.2874874628260628,-0.1899255487522043
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2023139082241663,0.4236415167718985,0.0107272630145285
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2827300866604206,0.592842668086047,0.0603304677627183
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0140122548427094,0.2873100072332469,-0.1937215271903551
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1952874676253991,0.4174067814179247,0.0057930589648965
6,Incidence,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.197306929240392,1.869497283845485,0.6457897589802644
6,Incidence,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8184469419749696,1.3747492138656732,0.4097791685439768
6,Incidence,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0020466099765244,1.4624468212086783,0.6295895920302611
6,Incidence,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6519958781541727,1.1794738008887404,0.2269129226849502
6,Incidence,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3114192650185807,0.7103261713794022,0.0097009140641043
6,Incidence,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4737860478051989,0.8138195883665122,0.1886551319215607
6,Incidence,44639,Middle SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5627470191188688,1.0408156307273115,0.1705024026078561
6,Incidence,44639,Middle SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2655839688929065,0.6527534930138186,-0.0188364179321837
6,Incidence,44639,Middle SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4087310713109497,0.7326896043285505,0.1466533697758809
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0087884395281514,0.2978311836908959,-0.2487859935129417
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2392734884262896,0.0030274238882087,-0.4068211484197507
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1330641733101935,0.0574305865362707,-0.2899741190433529
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0211247676434255,0.2860886591902412,-0.2581092181236195
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2393624949076203,-0.0033361181683478,-0.4062796842706001
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1382255977493152,0.0453207242905913,-0.2939820422528945
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5634816292316341,-0.2265881102774499,-0.6865150619887919
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4923111088116781,0.0101585774223896,-0.6622711119376089
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5319715262304953,-0.164607011792961,-0.6668048074488927
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6987923507921406,-0.4616758942353347,-0.782217006757671
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6670158492277719,-0.3359298325592268,-0.7802984339972688
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6851739216276701,-0.4361967215562949,-0.7758958385997891
6,Incidence,44565,South-East Asia Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7206879410251162,-0.5051221625018572,-0.7994125119192582
6,Incidence,44565,South-East Asia Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6837449203918808,-0.3707410446350719,-0.7896182519768518
6,Incidence,44565,South-East Asia Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7044340157171517,-0.4724386129037022,-0.7895829622255393
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.516866581288707,-0.1411091203206224,-0.6524750451499823
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4380039304288123,0.1191561854710132,-0.6287580088753735
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.482298979341728,-0.0739135841037356,-0.6317271312139032
6,Incidence,44565,South-East Asia Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5297141193243049,-0.1673445122436812,-0.6628049378870751
6,Incidence,44565,South-East Asia Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4456113994905667,0.1025102323062322,-0.6316246771684575
6,Incidence,44565,South-East Asia Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4924296519435798,-0.0938735055382969,-0.6387380461852429
6,Incidence,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.7517161919406006,0.9167602383966812,0.5985344604699747
6,Incidence,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.4581124775848327,0.5663848228985793,0.3555728409163564
6,Incidence,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6679639288255371,0.8035538415479131,0.5386054341307069
6,Incidence,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5441627653242626,0.6858764497552164,0.4046437267109036
6,Incidence,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2913514801700985,0.3886114042931156,0.2014501996505967
6,Incidence,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4740479689338308,0.5939834658869867,0.356160845379903
6,Incidence,44566,European Region,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.601502197873747,0.7523933093228987,0.4614561785739324
6,Incidence,44566,European Region,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3480318773780389,0.4481301723759416,0.2532334986186547
6,Incidence,44566,European Region,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5337172435575371,0.6583941526926149,0.4147702144968987
6,Incidence,44566,European Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.128295193715563,0.2165295002243195,0.0355273979119937
6,Incidence,44566,European Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0065016825086302,0.0726509721940976,-0.0546592584042366
6,Incidence,44566,European Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1240633158037121,0.2016636415800151,0.0425944949523565
6,Incidence,44566,European Region,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1722364938365508,0.2618232378207355,0.0794293046376341
6,Incidence,44566,European Region,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0489812072667352,0.1191039650913042,-0.0138251398702314
6,Incidence,44566,European Region,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1690247168721424,0.249624649698745,0.0850196373870679
6,Incidence,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3990693405106285,1.5778241930975407,1.190577905419556
6,Incidence,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9467268671518956,1.0638487166427049,0.8047478697450866
6,Incidence,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.171691936085716,1.2948130173587007,1.0215816855372448
6,Incidence,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1148287867576367,1.2814204718115354,0.936801351773821
6,Incidence,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7240281177702983,0.8278995313821782,0.596868391606336
6,Incidence,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9191848939387296,1.0288156278651497,0.7849176023391011
6,Incidence,44566,European Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1933432135618367,1.3567693956201232,1.002730434464153
6,Incidence,44566,European Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7997581899962586,0.9080378934335348,0.6684979358219216
6,Incidence,44566,European Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9969025183984632,1.1101141545318616,0.8588739461240993
6,Incidence,44566,European Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3696545587163198,0.4727852770522324,0.2730652713312581
6,Incidence,44566,European Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2324658591493799,0.2921195174316698,0.1599362833006351
6,Incidence,44566,European Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3212796953820081,0.3917398871274586,0.2446555393449375
6,Incidence,44566,European Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4229143130903624,0.5254872649627873,0.3238334746140348
6,Incidence,44566,European Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2844918130472308,0.3488152038846257,0.2106253720687818
6,Incidence,44566,European Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.374107024287977,0.4430880212333114,0.2929895395786739
6,Incidence,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1734414937780866,1.347450652353101,1.0043495699335163
6,Incidence,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.666580995127923,0.7762493300882787,0.5580226991819426
6,Incidence,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.069490515967151,1.2120967250889398,0.9235914395677564
6,Incidence,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9160230402609646,1.0775991857568323,0.759608018852902
6,Incidence,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4759987433260562,0.5731755795481241,0.37917199113304
6,Incidence,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8289579487751289,0.9569476567636064,0.6989613127292211
6,Incidence,44566,European Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9870635124857212,1.1461509555259823,0.8324716391413458
6,Incidence,44566,European Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5407620071848263,0.6421509012092478,0.4403993494758618
6,Incidence,44566,European Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9029268168601916,1.0340553132195047,0.768770480847322
6,Incidence,44566,European Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2831708652445802,0.381387918243278,0.1888575164381507
6,Incidence,44566,European Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1146606834802674,0.1780252747506317,0.0547222913967939
6,Incidence,44566,European Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3222485258573671,0.4077729568769183,0.2384441304145292
6,Incidence,44566,European Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3330980496840415,0.4299551874069556,0.2358704205463768
6,Incidence,44566,European Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.161697196688455,0.2251111652227412,0.0991249708912013
6,Incidence,44566,European Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3751068070564888,0.461701114301298,0.2840237035112281
6,Incidence,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.284591000779843,1.5224629405315253,1.066656185771156
6,Incidence,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8356792298767961,0.9842628859556362,0.6856357229972809
6,Incidence,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0384416315209335,1.1859349353684208,0.8741508122334517
6,Incidence,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0138698570848308,1.2255935481792093,0.8156376450807101
6,Incidence,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6258497800582211,0.7500795359083597,0.4925539339894917
6,Incidence,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.8015254301121449,0.9282212248176248,0.6568796479956054
6,Incidence,44566,European Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0886816744773102,1.306155507326212,0.8894353086359523
6,Incidence,44566,European Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6970941244625053,0.8344604167964234,0.5583781931632961
6,Incidence,44566,European Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.8743769132049523,1.0099991646881992,0.7233091004394627
6,Incidence,44566,European Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4144704845846069,0.5390686952469916,0.2892195327047235
6,Incidence,44566,European Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2405078678994882,0.3236375059585389,0.1515594562764103
6,Incidence,44566,European Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3262676822677445,0.4126908613014874,0.2382978927978089
6,Incidence,44566,European Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4694951410951469,0.5952143533089946,0.3446058798986606
6,Incidence,44566,European Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2927621939270654,0.3809576326179021,0.2015044991054505
6,Incidence,44566,European Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3792213953554689,0.4695365394593174,0.2837774519295476
6,Incidence,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4371431967831198,-0.3594491769977272,-0.5114340874419068
6,Incidence,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4407616037098933,-0.3530371351731798,-0.5089053235271626
6,Incidence,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.4386220436290989,-0.3616074816017119,-0.5081729097045004
6,Incidence,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5038253250551358,-0.4312106167132127,-0.5665780476567226
6,Incidence,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.504720986255801,-0.4252464240636512,-0.5646988643510586
6,Incidence,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5038799133634284,-0.4375151051191718,-0.5658716055312369
6,Incidence,44566,European Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4854095591584319,-0.4143779936454662,-0.5533298222806451
6,Incidence,44566,European Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4829814593579759,-0.4018797735611373,-0.5459806504141772
6,Incidence,44566,European Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4838047532326472,-0.4129887363241725,-0.5477577924805129
6,Incidence,44566,European Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3269396585792057,-0.228665170558184,-0.4182910027468957
6,Incidence,44566,European Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3265105885844682,-0.2205835470154106,-0.4100137876180043
6,Incidence,44566,European Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3259332105077304,-0.2298856710307164,-0.4117043923989061
6,Incidence,44566,European Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.300760656915869,-0.2031723774699608,-0.393488452537986
6,Incidence,44566,European Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2981142534137989,-0.1858085953712724,-0.3850565343814019
6,Incidence,44566,European Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2990037799544927,-0.2014741321929632,-0.3865731532464361
6,Incidence,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.2854471901375172,1.1444333381491136,-0.1677719331071175
6,Incidence,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2933987122545824,0.3101733122935154,-0.573728938363917
6,Incidence,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0445777156288297,0.4938210752460502,-0.370158832648282
6,Incidence,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4385594312511455,-0.0539882645028487,-0.6402174382669745
6,Incidence,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.691127479999291,-0.4345458215613598,-0.8129723125043702
6,Incidence,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5825666897387283,-0.3516521985756976,-0.7235327277606716
6,Incidence,94365,Central Africa,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4961542683040922,-0.1594648207856374,-0.6737986884885901
6,Incidence,94365,Central Africa,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7120656907675875,-0.4661149729097391,-0.8262979903849619
6,Incidence,94365,Central Africa,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6181207826149667,-0.4029245157248047,-0.7482545090274353
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3649965133679677,0.0883734353285937,-0.5921578242007843
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6470381505262078,-0.3390995218346609,-0.7879335362149111
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.524389742379013,-0.2505746191009269,-0.6898094300120183
6,Incidence,94365,Central Africa,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3802083218554341,0.0549966513864738,-0.6028992728417847
6,Incidence,94365,Central Africa,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6477154317458494,-0.3344628179099357,-0.7891585475536876
6,Incidence,94365,Central Africa,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.530587523445865,-0.2578364661279214,-0.6923169319318898
6,Incidence,44561,Asia,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,1.036635482261575,1.51996764157363,0.6401034665994936
6,Incidence,44561,Asia,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,1.1882175935014094,1.674595236454978,0.8190529700717557
6,Incidence,44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,1.0786843512565,1.4726595825329762,0.7488192132184259
6,Incidence,44561,Asia,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.492459942566643,0.8578311335139144,0.202950931332649
6,Incidence,44561,Asia,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.5503844660781234,0.8983063306429602,0.2943526487893492
6,Incidence,44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,0.4976234737811275,0.788593412741263,0.2542348476618752
6,Incidence,44561,Asia,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4082262546091975,0.7424250066040219,0.1340452339444859
6,Incidence,44561,Asia,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4924774209329675,0.8242120949939975,0.2406880802786136
6,Incidence,44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,0.4277124115283461,0.6983082464314021,0.2011496092333282
6,Incidence,44561,Asia,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.061253961731042,0.1564360587232909,-0.2354683167534989
6,Incidence,44561,Asia,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.11249915948309,0.08304988022265,-0.2604518612972893
6,Incidence,44561,Asia,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,-0.093297239207563,0.0730996016341114,-0.2340053484973439
6,Incidence,44561,Asia,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.07719649419091,0.1311627967311615,-0.2500086923285013
6,Incidence,44561,Asia,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1138718111676496,0.0801615537676198,-0.2631542950747532
6,Incidence,44561,Asia,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,-0.1015506464334591,0.063186474507029,-0.2396831826222985
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.5775473750651284,1.4918909046549251,0.2175989278966751
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8786353560359973,1.5289015240125066,0.4632192976637695
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7457903942750629,1.33588923104917,0.4197828602513186
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2965730495558102,0.1134691649571003,-0.4587299109174058
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1680404579341363,0.1227183911255675,-0.3495175248497856
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2242638045529005,0.0302358844014969,-0.3685171920842437
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.3728456594105796,-0.0093481680287955,-0.5159432516593051
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2367571821685292,0.0274297877999819,-0.4055303940351886
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2983237295225335,-0.0611484349633712,-0.4293542079645501
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1425094981931889,0.3956538217081023,-0.3297941860426445
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.090843103981261,0.2391404757116465,-0.3012116539319639
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1023104161518122,0.2213243816652521,-0.2752339305356939
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1702778906646347,0.3376231303651636,-0.3532762856149352
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.105745368576943,0.2248828183613773,-0.3067506876780405
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.124450221040184,0.1963133773723432,-0.2911454177306531
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.668710744191351,1.994151863601103,0.2456188948923332
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9644671112249064,1.7800965059943774,0.4515110100132501
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.730230902430529,1.8261772664138631,0.3187580190275474
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2560592011230511,0.3441979879231306,-0.4454630325604481
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.130072104681831,0.2375336748749671,-0.3521505577381128
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2312246808321797,0.2579985207601536,-0.4148003457632552
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3366036399606689,0.1903257977046874,-0.5048039070017325
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2018858749298347,0.1294840610025859,-0.4102871800871769
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.3045774735251356,0.1359104337545293,-0.4699585863870293
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1329029061915481,0.5779374998812468,-0.3539359062791992
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0571498705674554,0.3350948766858705,-0.3121654940986338
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.143734555818275,0.402589838944652,-0.3452186272560059
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1608786996388868,0.516084199338134,-0.3784904454480362
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0725566437973516,0.3129106748056827,-0.32692160321178
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1647976468480635,0.3620685849318945,-0.362101378146577
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.778379552548407,2.124200758315548,0.3314842477068129
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0359067132631945,1.8240998071320988,0.5187017921230164
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9209933367568438,1.7154154459072564,0.4980545462483052
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2072303522526238,0.3951383930820568,-0.4053825833942408
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0985466839015223,0.2438673191426033,-0.3259756280437322
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1465872566135054,0.2067191139123828,-0.3331721445757122
6,Incidence,95470,Minimal Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2930047786677981,0.2420267672591854,-0.4706681152182245
6,Incidence,95470,Minimal Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.172861741539992,0.1473615077600599,-0.3829892365533303
6,Incidence,95470,Minimal Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.227905340430445,0.0913925229106889,-0.3978948845002605
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1470425871198714,0.5295639486595838,-0.3636058648760908
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0745353558930464,0.2958951887340717,-0.3252140286516446
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0988746510006817,0.2705445919130539,-0.3053188146447229
6,Incidence,95470,Minimal Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1744555758721278,0.4740950481313981,-0.3833945310747256
6,Incidence,95470,Minimal Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0895693311655163,0.2724636977606979,-0.3322737493700526
6,Incidence,95470,Minimal Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1209293166732077,0.2463214151207578,-0.3204917503862872
6,Incidence,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,0.992177996533026,2.132031088999621,0.5651023828697428
6,Incidence,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.3500661752990943,2.1023621995778625,0.7721835626675704
6,Incidence,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.1929061076346112,1.929730870186625,0.7651638237766201
6,Incidence,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0084916004012507,0.5543489150882117,-0.216407561545015
6,Incidence,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1359357804429567,0.5039273532211956,-0.1475952668384713
6,Incidence,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0754581346592918,0.4352161913136302,-0.1308402497581928
6,Incidence,44637,Low SDI,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.1009052916656829,0.4135245863365537,-0.2936498280331803
6,Incidence,44637,Low SDI,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0480357149206862,0.383529715014812,-0.2096768650207822
6,Incidence,44637,Low SDI,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0161784188468818,0.3143893607780332,-0.2080799729381052
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0658206402809988,0.4794075323860102,-0.2614521500417735
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.0213043821541685,0.3836833479541428,-0.2476237112327953
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,-0.0077048177241181,0.3378543790748083,-0.2070703882312294
6,Incidence,44637,Low SDI,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0900507182331122,0.4428262075656957,-0.2800290431134687
6,Incidence,44637,Low SDI,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.0051045470688156,0.3606748316070324,-0.2537587962948071
6,Incidence,44637,Low SDI,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,-0.0282525479303913,0.3088087153709408,-0.2238076573284078
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.003075675859179,1.362351397399602,0.7077959480253441
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.375198685937158,1.9390240329461688,0.9285327839082832
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1609955330226729,1.4714674709599789,0.8834975408438892
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7585293590801088,1.0633548639190964,0.499282675249204
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.046323363810009,1.5256478893107477,0.656600938484551
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8793323661302549,1.159138891906586,0.6374203966059319
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6112154636863386,0.9002063416893368,0.3737010904987639
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8926520729294237,1.341930366195951,0.5367310502431493
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7302425932113015,0.9788279154884818,0.5080584941415761
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.121830603060405,0.025941267358276,-0.2385062993287529
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0889983208890668,0.1145394701675268,-0.2481262959072911
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1211471446262784,-0.0005278925041354,-0.2289562602425892
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1659516746049869,-0.0230916724423549,-0.2796902863124257
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1284555362237111,0.0672599186489821,-0.2823659241965768
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1625615073521613,-0.0500361685684312,-0.2628851901478953
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4687934199679311,2.0970664515170663,0.9538800909456572
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4834392919386334,2.197912938028057,0.9752818007709748
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4726217481484756,2.0000882260482475,1.0738190618387895
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.167755041000372,1.7027849864414693,0.707330571722893
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1401383692124851,1.7423441831551831,0.7058606216558434
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1506559244933896,1.6159790578424071,0.7979152241654809
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9858251901507582,1.49118963346609,0.5716439746442363
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9789024605440448,1.5482232652964465,0.5739825122772297
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.979752109696843,1.4020782795602194,0.6604430766166389
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1029234752112233,0.3773886802530595,-0.1152359202531838
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0586367338731286,0.3560937279097461,-0.1553579245917935
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0896279910991098,0.3094201625480485,-0.0815294311402217
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0475004546697819,0.3084849933408314,-0.1591310132773828
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.012695454418776,0.3059168250784104,-0.1922425380167952
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0382941718280116,0.2503822042164461,-0.126676582725649
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8655575891955435,1.4466740506788316,0.3971134977197266
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7108556883103745,1.2778961680944252,0.3043570254605509
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7920627841758755,1.2237780604396964,0.4389614686423998
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6379378065418793,1.1334729660177514,0.2153598119552274
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4742465346469284,0.9626746913758888,0.1209856937550422
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5587326315899529,0.9329292266760488,0.2490959644404694
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5005999385519846,0.9680330167071348,0.1237972180383983
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3632773477584321,0.8151175857361355,0.0393631668349951
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4348494994586372,0.7805106300426652,0.1521321469611987
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0631114488855392,0.2300166351996887,-0.2919058371141685
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1992365525109675,0.071044830386944,-0.3890617566520304
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.130455278465985,0.0757038885903967,-0.2936078123231876
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1101635050593502,0.1695669653496283,-0.3279031735179392
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2339983405740283,0.0249040367969257,-0.4165599695166826
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1714817767573325,0.0273141680276929,-0.3272608385164955
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7194046349658575,-0.597453354255933,-0.7973243779014081
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7389298213777441,-0.6133576429752783,-0.8248356119224755
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7280239075018863,-0.6172204192332693,-0.8026817857057589
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7536268720948455,-0.646474393195302,-0.820883421172506
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7750562812658748,-0.6688473345085824,-0.848581013988726
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7634483064653024,-0.6686019054784164,-0.827573424818185
6,Incidence,44568,Western Pacific Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7742972985841869,-0.6762032566744105,-0.8369736598706232
6,Incidence,44568,Western Pacific Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7919689760376785,-0.6919081073773726,-0.8604221010388722
6,Incidence,44568,Western Pacific Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7822371160031102,-0.6935201742283217,-0.8420133806057666
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5980375293125172,-0.4182688874813115,-0.7118894797980704
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6230808367664671,-0.4384351463312791,-0.7488154006113976
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6086967056117404,-0.4508140289911241,-0.7171528505707576
6,Incidence,44568,Western Pacific Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6182889756276718,-0.4496663735943358,-0.7255254037601947
6,Incidence,44568,Western Pacific Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6394477140995216,-0.4613730115302802,-0.7584637377513233
6,Incidence,44568,Western Pacific Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6271823418835626,-0.4740822554540074,-0.7302462950232723
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6715140660686397,0.9922776722866722,0.3974639569360703
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8134834541789298,1.048339890456747,0.5902942316645121
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.69902475691524,0.981966935327298,0.454354193481324
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3979597034606683,0.6682000058583646,0.1651594083521368
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5450022485732356,0.75132331327933,0.3546117908694288
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4350097552399836,0.6853627741901134,0.2234634528218285
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3757501542689997,0.6397566557375993,0.1501914900793984
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5265107423667319,0.7242025779695973,0.3386398550070282
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4143721571698655,0.6499105374119443,0.2106934107646093
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0370380532095922,0.1330550270904371,-0.1920328410528446
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0712058333194716,0.2019773220883759,-0.0378304817786397
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0045330966971483,0.1527606860595571,-0.1474678371013131
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0398184307764496,0.1287502463381664,-0.1952996743692269
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0746146661214277,0.2007055648962698,-0.0337978133768683
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.00519215659002,0.148603506762024,-0.1508117893120364
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1902816657108153,1.3190615616753665,1.0460781121835216
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4833806877742246,1.6640140732993491,1.2230359793389496
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3000236926946709,1.4308924215351144,1.1332615812043452
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.831641814579242,0.94613854305263,0.7064836336381632
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1154095800360089,1.2712729124301707,0.8903991853041471
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9424639422181392,1.0535498633043767,0.7981400912322933
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8027250865925274,0.9087181890954988,0.6840374458250642
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0904008186773344,1.2424500710698916,0.8712540747525529
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9146804415520708,1.0236235782325476,0.7758574571295158
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1173645128544987,0.1787698646981043,0.0497865979724288
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3138868823724261,0.3946298671133104,0.2046659426805726
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1890381601579026,0.249591175115948,0.1151295926799153
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1142299140053262,0.1772919142129213,0.0473978688446189
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3182728897020357,0.4002817019353469,0.2083204584502578
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1883354971784646,0.2477316718110314,0.1172149038783978
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5463537787563233,1.7069449830038064,1.363581991867464
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.192517287604946,1.3491897715306829,1.010948518924174
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.4841286785463368,1.6281637174667043,1.3203482450762445
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.129641006153093,1.2690401298166591,0.9743175581601944
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8677046812621341,1.0054440834905765,0.7183217840575149
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0980903674707096,1.214434654540984,0.9538939828106614
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0957924764502749,1.227968076107263,0.9453610088887876
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8455647801148837,0.9774447976550518,0.6927281632542225
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.067940695662501,1.1878442743929964,0.9315998424486328
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3618862588195904,0.4358066915039986,0.2778509440099945
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2897954067502402,0.3653422513577078,0.2143628594436938
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.406842745697887,0.4757035989041137,0.3272706244591374
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3579870764860187,0.4308626946160928,0.276688766469662
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.294102430674159,0.3688765076658512,0.2159273962204632
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4059703697111272,0.473538043058866,0.3280076560866066
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5160312162293208,1.7169565317587363,1.3315971481778948
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3566620876032789,1.533889287794557,1.1421368106597214
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4406589092243332,1.6064417993122282,1.2711139922317372
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.1041668442226051,1.271361492312545,0.947691986198405
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.00757386030526,1.1665499755236688,0.8292306902677526
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0613587765766583,1.1990379636963242,0.9160010400232113
6,Incidence,44575,World Bank High Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0708353008445215,1.2362081442129782,0.919035682328007
6,Incidence,44575,World Bank High Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9837346652184392,1.1329167403612486,0.8031567068097653
6,Incidence,44575,World Bank High Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.031753800117048,1.1697616207336146,0.8906142381371549
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4105615404571365,0.4975337457635865,0.3281351385022035
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.413054614489728,0.4938024729244308,0.321681533405121
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4150753968379849,0.4868372883600959,0.3421944114440293
6,Incidence,44575,World Bank High Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4065445471256595,0.4952834586940982,0.3235922203507291
6,Incidence,44575,World Bank High Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4177319270700639,0.5024884645081547,0.3275173751744308
6,Incidence,44575,World Bank High Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4141766778025404,0.4856221542536758,0.3421117255804127
6,Incidence,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.7502998835613541,1.8209774444013724,0.3333444301921666
6,Incidence,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.973318814208866,1.7277398412974665,0.4153724984661392
6,Incidence,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8848057301853031,1.5785534363913325,0.4612045687563776
6,Incidence,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1265086379008045,0.4104001764834168,-0.3333781551183252
6,Incidence,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0439972858997042,0.3264940342618153,-0.3103337566294844
6,Incidence,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.073557465530374,0.265517262821078,-0.2784659414635048
6,Incidence,44563,African Region,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.224118154491453,0.2504972469327141,-0.4089482911402033
6,Incidence,44563,African Region,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1349700181298233,0.1957402567056012,-0.3795530464353446
6,Incidence,44563,African Region,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1692020202293578,0.1365929927823131,-0.3559199315278603
6,Incidence,44563,African Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1360657555059194,0.3934790793416,-0.3335007188383599
6,Incidence,44563,African Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1110961916653909,0.2469725252101675,-0.367949255403979
6,Incidence,44563,African Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1118720322076,0.2243143122300604,-0.3177430846977893
6,Incidence,44563,African Region,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1811639757352518,0.3186517251252687,-0.3707367991757329
6,Incidence,44563,African Region,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1484189045664328,0.1906380991269178,-0.3948031445636087
6,Incidence,44563,African Region,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1532569943033354,0.1695705843575445,-0.3460309992600883
6,Incidence,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.8840771415018677,2.237532296482354,0.4432845258800981
6,Incidence,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1742380355659183,2.0266956420051883,0.5281260632178587
6,Incidence,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9605742277056526,2.0482580432475626,0.5480516959725461
6,Incidence,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0599035529507773,0.6101110262824679,-0.2783597653610152
6,Incidence,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0533230721215207,0.4715822129416933,-0.25927634324964
6,Incidence,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0363629273345981,0.4962121768363614,-0.2451459657164544
6,Incidence,44563,African Region,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1648166903521963,0.4351498030024315,-0.3602134856712247
6,Incidence,44563,African Region,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0468944627981664,0.3267914223885593,-0.3301260540149228
6,Incidence,44563,African Region,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1358042468344445,0.3436327063270907,-0.3176388415011532
6,Incidence,44563,African Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0933546714042294,0.561825426282418,-0.3067489495795294
6,Incidence,44563,African Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0364180879105203,0.3520334111575264,-0.3314304464667928
6,Incidence,44563,African Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1001249278932496,0.4090166722709865,-0.296034455216548
6,Incidence,44563,African Region,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1405879212637666,0.4786413016847904,-0.3404965020678898
6,Incidence,44563,African Region,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0768612009479509,0.2968014164237159,-0.3604589983790205
6,Incidence,44563,African Region,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1420242564590216,0.344876547180563,-0.3216523219140644
6,Incidence,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8949448852738066,2.224777852549493,0.4538492992335057
6,Incidence,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0513350432990096,1.8063133334125991,0.482024082464824
6,Incidence,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.987708434193509,1.771448162880271,0.537066058109394
6,Incidence,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0545108662382115,0.6139863951505644,-0.2730979599931787
6,Incidence,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0062918784447915,0.3697241187348832,-0.2843180038174169
6,Incidence,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0231136833388617,0.3600495012285488,-0.2487902668009953
6,Incidence,44563,African Region,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1599991815507166,0.4294959481458975,-0.3555302791397001
6,Incidence,44563,African Region,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1007705888488142,0.2301839694855248,-0.3503354572232762
6,Incidence,44563,African Region,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1238438396838497,0.2216184924976953,-0.3224811685362591
6,Incidence,44563,African Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1242590253072,0.4934833342245416,-0.3312054187106021
6,Incidence,44563,African Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1061750068738072,0.2559782219518914,-0.3717383379529048
6,Incidence,44563,African Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1060554606095195,0.2601575210206595,-0.3202741122413894
6,Incidence,44563,African Region,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1698318056099469,0.4173979389708202,-0.3655104776120199
6,Incidence,44563,African Region,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1436417597176146,0.1986637399391412,-0.3972756907061623
6,Incidence,44563,African Region,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1476146368076134,0.2027234343336836,-0.3530339384241792
6,Incidence,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6560376819780136,0.9552835233242554,0.3895709758794593
6,Incidence,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8453473885898365,1.1011815591588212,0.6226790020665058
6,Incidence,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6907060843098948,0.9695794507160188,0.4498771446594169
6,Incidence,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3518720414568741,0.6027850685682838,0.1268501146040352
6,Incidence,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5373471915053523,0.7609539129337382,0.3537204683678633
6,Incidence,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3951063327538623,0.6272297817164455,0.1889815781866231
6,Incidence,44635,High SDI,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3152537945693158,0.5529200219885062,0.1036213238009599
6,Incidence,44635,High SDI,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.5013524757944011,0.7094960848251505,0.3201921503971279
6,Incidence,44635,High SDI,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3592029659618519,0.5833965796624188,0.1655942647806604
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.079216696701127,0.0774653910194552,-0.2240056328393306
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0548415410906843,0.1893665892772642,-0.0580638164633066
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0430553630432349,0.106588700728329,-0.1767914529208839
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0896280511786941,0.068528566051304,-0.2336281600063048
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0487831024419252,0.1815364126903946,-0.0641146234577248
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0518717458259633,0.0959100050505311,-0.1834073928369881
6,Incidence,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.0241377446032746,0.705103262606722,-0.3068566872260706
6,Incidence,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0552315392502009,0.3520887136427922,-0.3422740339763148
6,Incidence,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.0192732638627565,0.4246864736059327,-0.3034673531634443
6,Incidence,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4888371125353006,-0.14877061455143,-0.6509052384155678
6,Incidence,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5422129655026909,-0.3447850397096512,-0.6790436585097467
6,Incidence,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5178598005355726,-0.3052220243339656,-0.6580941070646904
6,Incidence,44563,African Region,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5460150053138607,-0.2441531427848174,-0.6927399025916159
6,Incidence,44563,African Region,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5858484505446929,-0.4072943170522585,-0.7116772635175459
6,Incidence,44563,African Region,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5677083436021958,-0.3720166353897903,-0.6929774211906621
6,Incidence,44563,African Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4285849807739382,-0.0352693450682041,-0.6103411598285091
6,Incidence,44563,African Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4655769510400395,-0.2253366714412208,-0.6291661915037192
6,Incidence,44563,African Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4487872714548544,-0.1920903208399018,-0.6102369829474017
6,Incidence,44563,African Region,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4585164355711056,-0.0819650443705189,-0.6336795580018348
6,Incidence,44563,African Region,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4881629754312867,-0.2575386827818799,-0.6466291311072349
6,Incidence,44563,African Region,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4746138930101852,-0.2256542942721129,-0.6289607953624903
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,2.1456603251798594,2.3534984803337533,1.932108691660959
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.540261204133112,1.7054446089674826,1.379978420940195
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.9399829936479007,2.122495825713053,1.7566908938837629
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.3924677871868465,1.5484749131844384,1.232131493987199
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.8853474664406491,1.0108933988658673,0.7667840309618829
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,1.2072521277915076,1.3398128808413956,1.066799100148326
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.200067918080896,1.3454294670208853,1.0507103749291806
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.7667669979071535,0.8816530528484631,0.6552893548926502
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,1.050388123794749,1.177675303385607,0.9225574712522724
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5564433307455305,0.64877434479371,0.4639085968324815
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2746153100297818,0.3580648400994292,0.1999647827901724
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4675259908156746,0.5485630590164328,0.3890293483152222
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4823526074342793,0.565231280676107,0.3973226473876423
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2270459767814369,0.3042721045464088,0.1511849142697215
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4055747852854066,0.4824260632896714,0.3312203336727387
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.720967967825501,3.922942183738959,3.4963671556583407
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.4996537496309017,2.636211976592439,2.329197429637168
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,3.0666511670580143,3.219492823833578,2.907234130463076
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.590434506814376,2.7606831119967943,2.4101584873909623
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.597440597950983,1.7181579587162483,1.4723988973202249
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,2.053106731303084,2.1644099019337952,1.9245438878219507
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,2.3018346212274623,2.4430949439501037,2.144749306812384
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.434030303218342,1.5290073741966397,1.315476903961749
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.8361433636069493,1.9427374216511089,1.7249635373048848
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.1224567833578407,1.2134291348527046,1.0166169223791224
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6589638083988191,0.728895258188927,0.5819522021746487
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8885783186101752,0.9584704345844524,0.8163046912098351
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0215805405342222,1.10586060411775,0.9279018658047102
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.597087734398512,0.6594593382905161,0.5251389285177216
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8089307467462482,0.8718095228268696,0.7414670230263953
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.2951706278101844,3.5045679690629377,3.0662161066317584
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.336016163970598,2.5077773887888064,2.143763322063131
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,3.077589269776368,3.2503045412119302,2.881436220945953
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.266926953125297,2.441311355604751,2.083125805606811
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.4762262778569732,1.6187931164996168,1.3347107983807078
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,2.0615809416326414,2.211042335286536,1.9127966557263976
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,2.004032897413444,2.150484937684288,1.8439026084842307
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.320219374841597,1.439680343278689,1.186506363052365
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.843771760083744,1.9642259743137576,1.706971689254428
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9817688491125496,1.0753796700346443,0.8764632380795583
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.6015016348626283,0.6848883823773957,0.5196188548510732
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.928120324854548,1.0057203379787163,0.8374770411179644
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.887497033436653,0.9744891428280398,0.7920745251854748
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.5417054469677791,0.6203367110811997,0.4561177745019247
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8467530178758942,0.9202142511464936,0.7614037923679597
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.84267775428714,3.035919038599035,2.657164941368308
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.0100808308011384,2.1562465285012724,1.8491640048573852
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,2.4062058127345614,2.560370389955973,2.2516509819306645
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.92265409906464,2.088752080573527,1.7598697803350585
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.2341441002942035,1.3551285611519743,1.1079362930011731
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.557382445559788,1.6782476481724309,1.4340858288070573
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.687560376134033,1.822712905687283,1.55781312248791
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.093529383608118,1.1951885084660274,0.9816107600339672
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.3755388928171473,1.483055575371972,1.2677500415754568
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.852144614801451,0.9429023718142304,0.7649537058009785
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5013513445993006,0.5699821618336314,0.4268089958179232
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6728381638772002,0.7394538380266279,0.6041110893292378
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.7640089372724481,0.8453725386304651,0.6840838840686738
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4453525217335994,0.5071102604041133,0.3773227622507297
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.6022437085060034,0.6638921375281333,0.5370063979303772
6,Incidence,44638,North America,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.6856826516315406,3.870223835156408,3.505549867504965
6,Incidence,44638,North America,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.8061298432231885,2.915366819960748,2.6664669853578573
6,Incidence,44638,North America,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,3.370430236099024,3.4950192858476017,3.233488934849592
6,Incidence,44638,North America,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.832293653572697,2.996762908357022,2.6670438392681293
6,Incidence,44638,North America,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.085758217589881,2.2050842308820258,1.97429932040624
6,Incidence,44638,North America,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.5576589497322635,2.678814976451912,2.4371043149611467
6,Incidence,44638,North America,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.5419196619680227,2.681414820937446,2.4057568235306457
6,Incidence,44638,North America,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.9092120036991704,1.9927071909531089,1.8024608209206376
6,Incidence,44638,North America,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,2.322386895765301,2.4170990874441607,2.2182845625436887
6,Incidence,44638,North America,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.507060394725602,1.608782977629638,1.412469529007336
6,Incidence,44638,North America,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.2863890107291889,1.362281437714577,1.2103659516880332
6,Incidence,44638,North America,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,1.4852391583924862,1.5650124053527523,1.413521878370183
6,Incidence,44638,North America,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3545497718398842,1.4447091804025043,1.2686589686964798
6,Incidence,44638,North America,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.192788136607436,1.255669994037509,1.1226247702545922
6,Incidence,44638,North America,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,1.3599550657578614,1.4265515238830693,1.290060075844851
6,Incidence,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.465782251762889,2.400582474764223,0.7518264664881085
6,Incidence,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.9376963907657136,1.7727899174121666,0.3037314020575529
6,Incidence,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1822747760638663,2.015211260414213,0.5162983688675131
6,Incidence,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2491333038219326,0.7443187502292801,-0.1170508272669067
6,Incidence,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0460776668089786,0.3719988603436447,-0.3576644425237337
6,Incidence,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0894654405763498,0.5097717931518204,-0.2373053334909506
6,Incidence,44559,Africa,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.129768631223686,0.5580740777621045,-0.1973506225982794
6,Incidence,44559,Africa,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1200784204406257,0.25914343214082,-0.4079663872593005
6,Incidence,44559,Africa,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0046093827673068,0.3753139753574444,-0.3083780347687116
6,Incidence,44559,Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1616338834095776,0.5934779568135271,-0.1807184423179397
6,Incidence,44559,Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.152047785141539,0.2358341956885597,-0.4357432649050686
6,Incidence,44559,Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0146294828132671,0.3721180145744754,-0.3117888940340376
6,Incidence,44559,Africa,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1189565547296255,0.5319010111632183,-0.2069848587148682
6,Incidence,44559,Africa,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1732504056412665,0.1996912389764668,-0.4481781049362894
6,Incidence,44559,Africa,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0445769519492428,0.3225752400653077,-0.3348919760991754
6,Incidence,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0873355057925809,2.350843527244191,0.6002653150609752
6,Incidence,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2122423825882025,2.07460135548918,0.5330855166923809
6,Incidence,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.1201554236945006,2.1628335890537547,0.6603416205301297
6,Incidence,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0571838703695223,0.704067085333741,-0.1907449138271622
6,Incidence,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0891034603411704,0.5163214270180343,-0.2448213393005251
6,Incidence,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0584027828078804,0.5775650474638596,-0.1703598841490972
6,Incidence,44559,Africa,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0436275646002786,0.5352847570027235,-0.2667926970037138
6,Incidence,44559,Africa,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0045948482599867,0.3961981320346806,-0.303815068306712
6,Incidence,44559,Africa,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0329435875957939,0.4426482461988449,-0.2426762712908479
6,Incidence,44559,Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0318116464515457,0.5718035729869991,-0.2610455991326644
6,Incidence,44559,Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0388361806081989,0.3568680998333493,-0.3400762935486909
6,Incidence,44559,Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0526489417233352,0.4193463644340164,-0.2628366216051656
6,Incidence,44559,Africa,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0672314916680183,0.5138848249322236,-0.2866049309044487
6,Incidence,44559,Africa,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.06288600139902,0.3244338625378514,-0.3592313025067548
6,Incidence,44559,Africa,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0814105225431606,0.3742476761860027,-0.2858541675851963
6,Incidence,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3052420083497294,2.4867987786630104,0.7288610749787638
6,Incidence,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.144678680181156,1.980033234778438,0.4998380793337243
6,Incidence,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2089242870233812,2.012599793692009,0.65658281280184
6,Incidence,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1675467155201661,0.7732297084396389,-0.1242978643488939
6,Incidence,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.055768356763964,0.4690771237854509,-0.2599326682209871
6,Incidence,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1026119139751875,0.506865711128401,-0.1731123368975942
6,Incidence,44559,Africa,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0562125291276738,0.5975765421728444,-0.2078728732603071
6,Incidence,44559,Africa,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0260863049001325,0.3532540823123838,-0.3189129637955763
6,Incidence,44559,Africa,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0075461319524268,0.3741228194585591,-0.2443907583874131
6,Incidence,44559,Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0538068936482185,0.5789122710279153,-0.2171270858862422
6,Incidence,44559,Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.07370414317265,0.3145625274830903,-0.3674804091953565
6,Incidence,44559,Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0190579850069964,0.3531489871659245,-0.2763787981664048
6,Incidence,44559,Africa,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0152564102586188,0.5205229017440165,-0.2473285743976118
6,Incidence,44559,Africa,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0968299709417106,0.2814442414515264,-0.3866798652517382
6,Incidence,44559,Africa,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0487741901460794,0.3125842264713118,-0.3008829557847212
6,Incidence,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.1267293644931363,0.0337810012718477,-0.2775746066117934
6,Incidence,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.298246804061203,-0.1844518472408111,-0.3953345383925249
6,Incidence,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2045271612362244,-0.0699914665835789,-0.3270422927103306
6,Incidence,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3358119519991808,-0.2120062630249581,-0.4499297226635394
6,Incidence,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4791938005683558,-0.390157317104355,-0.5531986944797167
6,Incidence,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.402783862865022,-0.3019229935292649,-0.4974022245952591
6,Incidence,44560,America,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3892364367500743,-0.2769758396944211,-0.4947372675689355
6,Incidence,44560,America,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5119264171561254,-0.4327813379369405,-0.5794515223063634
6,Incidence,44560,America,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4452253414640417,-0.3513981352733046,-0.5306692270587565
6,Incidence,44560,America,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.0341432915908149,0.1458106350772416,-0.2026794970509151
6,Incidence,44560,America,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.2256508030638668,-0.0995776828312978,-0.3358034043829508
6,Incidence,44560,America,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.121616475267606,0.0261394655326376,-0.2612696226580128
6,Incidence,44560,America,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.0800998238852989,0.090057372641652,-0.2396155159972353
6,Incidence,44560,America,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.2544815995858198,-0.1329207871631544,-0.3583063939428436
6,Incidence,44560,America,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.1586601704407571,-0.0160262977082588,-0.2888692937268065
6,Incidence,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2214251883874585,1.36513347858858,1.074487742134305
6,Incidence,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.654090182937867,1.8573961650048452,1.37193658865747
6,Incidence,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3797073155697384,1.523133047413908,1.2054487762202568
6,Incidence,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8133002385294639,0.9354071722274448,0.6870441981989852
6,Incidence,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2107971038115457,1.3892047448857945,0.9733133773891156
6,Incidence,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9635571563170822,1.0819508285032458,0.812000581243998
6,Incidence,44635,High SDI,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7642943395398264,0.8784299513408413,0.6475940761026144
6,Incidence,44635,High SDI,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.1593359016160147,1.3247432072579717,0.9297791255062976
6,Incidence,44635,High SDI,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.913109127281424,1.028412834961299,0.7730181169479138
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0886118941196931,0.1549896375862576,0.0223527600085014
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3632427149196859,0.4528519450604433,0.246663143382543
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.184507250623343,0.2499254063761496,0.1046202693276117
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0763511460158422,0.1421367439161378,0.011149437531732
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3556194015321589,0.4455401977206087,0.2394397008935117
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1736399367704166,0.2381529768381277,0.0974262101220814
6,Incidence,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.740673113440109,1.93426389828067,1.5305493255335003
6,Incidence,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.408413211264551,1.5838173938453568,1.208264878975231
6,Incidence,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6819617767164057,1.8505694672309827,1.4852925459242443
6,Incidence,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2374547964727485,1.4000587734941248,1.0530997908093358
6,Incidence,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.006227941176938,1.158781424749329,0.8381512292259898
6,Incidence,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.213146571581699,1.354059607935766,1.0421589843039438
6,Incidence,44635,High SDI,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.176690030277982,1.3304431828337149,1.0098060804856446
6,Incidence,44635,High SDI,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9594560676356632,1.1021628042700202,0.7966177879346701
6,Incidence,44635,High SDI,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1560994162963554,1.2916475610378648,0.9979918633119136
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3997084734131589,0.4804641230094317,0.3037016793315387
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3709308668877746,0.4641096715252298,0.2821147522975807
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4562021389778959,0.5354460561244119,0.3642456166140025
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3838245514325842,0.4673061818030153,0.290989453821144
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3632680579851147,0.4525908866329429,0.2750152776389778
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.442772909414723,0.5274299867616473,0.3529952682595982
6,Incidence,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5205577542404036,1.735264413626477,1.3248830636475997
6,Incidence,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3607339190797396,1.546843722653643,1.139445069086436
6,Incidence,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4439471712217005,1.618158341787852,1.265950252724791
6,Incidence,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0576040133402127,1.2344994837856351,0.8957064863200477
6,Incidence,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9665486212530078,1.1243972895923375,0.775343427225812
6,Incidence,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.0167020194941496,1.155257938963023,0.8582166013951391
6,Incidence,44635,High SDI,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0018706016013368,1.172394347256409,0.8464623750228426
6,Incidence,44635,High SDI,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9206647680633424,1.0720814693809255,0.7406268170209501
6,Incidence,44635,High SDI,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9647532321589176,1.1048061614851004,0.8216568407764853
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3565230812239154,0.4472835090160388,0.2730016279549968
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3684374972966501,0.4642167150896357,0.266745596221423
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3651318332859898,0.443868726271111,0.2899745803716528
6,Incidence,44635,High SDI,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3411854257039423,0.4328516789510686,0.2569972458901048
6,Incidence,44635,High SDI,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3607453707913981,0.4539522344055924,0.2571666223066527
6,Incidence,44635,High SDI,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3525404585433641,0.4291904771018571,0.2786900459570319
6,Incidence,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6839655449631526,-0.5766811751188469,-0.7593252558424687
6,Incidence,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.695586581208373,-0.5625525987915183,-0.7815388420512963
6,Incidence,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6891307281539514,-0.5834630469635667,-0.7592458792315246
6,Incidence,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.762376424049215,-0.6834397467696395,-0.8190270495575442
6,Incidence,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7805178812532692,-0.6826790099295124,-0.8426958157643352
6,Incidence,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7711801787638412,-0.6937598306974603,-0.8241546448439956
6,Incidence,44639,Middle SDI,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7752330837465552,-0.6989313495913752,-0.8288296759982453
6,Incidence,44639,Middle SDI,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7881374848802882,-0.6955498643243128,-0.8479576538948221
6,Incidence,44639,Middle SDI,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.781258238353165,-0.7069056508636964,-0.8305944483097341
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.636646982649325,-0.512171160053889,-0.7243289768585601
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6492942044702742,-0.4884770327330887,-0.7489627933685988
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6424491969091096,-0.5192036679447318,-0.7235784876821025
6,Incidence,44639,Middle SDI,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.641212358817521,-0.5172206917028789,-0.7279128544920707
6,Incidence,44639,Middle SDI,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.649276424167777,-0.492147603411858,-0.7484624138197588
6,Incidence,44639,Middle SDI,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6445629469791728,-0.5219225241250098,-0.7254405123953818
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,1,Number,1990,2021,3.127593420791922,3.272859212628079,2.9573934719331048
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,1,Number,1990,2021,2.244621462626504,2.376194404239145,2.092500039346121
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,1,Number,1990,2021,2.765439263370521,2.886422548169418,2.6303880694285797
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,2,Percent,1990,2021,2.139314011503335,2.2653996956949314,1.998821647284109
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.408176466608442,1.5269760004380002,1.29420786173939
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,2,Percent,1990,2021,1.827046143579118,1.935949669010314,1.7180982685676571
6,Incidence,44564,Region of the Americas,1,Male,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.8868297671163423,1.9884283426698188,1.76779229694007
6,Incidence,44564,Region of the Americas,2,Female,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.2566538084913292,1.3481635834233563,1.1508524405496563
6,Incidence,44564,Region of the Americas,3,Both,22,All ages,417,Liver cancer,3,Rate,1990,2021,1.6260736756526957,1.7104492284587145,1.5318869525454055
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.9421960472851358,1.0148423062778056,0.8647977727839229
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.5789878571616055,0.6509735343376151,0.5088061963804557
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,417,Liver cancer,2,Percent,1990,2021,0.8086116817880181,0.8725194120276929,0.7446897290747365
6,Incidence,44564,Region of the Americas,1,Male,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.8498223503095389,0.9148905622022444,0.7749429969072326
6,Incidence,44564,Region of the Americas,2,Female,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.5200956109274524,0.5839120982794499,0.4537702239521974
6,Incidence,44564,Region of the Americas,3,Both,27,Age-standardized,417,Liver cancer,3,Rate,1990,2021,0.7323116998661046,0.7874096578554298,0.6747065707411735
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3461254345143667,2.765201758074915,0.581257868235036
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.615266083238993,2.5955614604039923,0.8925486363488795
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.482871279729883,2.4239714095485585,0.8148476187118867
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4413364308753383,1.3063123269070904,-0.0247098338369016
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5187947247529388,1.0805465823210136,0.0971562519032052
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4823299383731082,1.0275445385031805,0.098390468956405
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2958776889514043,1.0797016565739854,-0.1265953807159511
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3782274704211706,0.8948364788102502,-0.002639717449434
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3393414181652354,0.84700139747917,-0.0210122436698283
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.035679963472507,0.5482182627940817,-0.3391228970565223
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0526385820094212,0.3069380276929987,-0.3294904993826575
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0377452397005836,0.3162720648065636,-0.2917396253157388
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0595899034331698,0.5083198024473614,-0.3590666040285332
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0806734722480655,0.262844977684259,-0.3436254257696469
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0633363605423627,0.2960918639146273,-0.3154590196977187
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.2728224943791404,3.141130480083519,0.4850268841547552
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.568714017095006,2.6145290068406317,0.8514985213410484
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3403810994697016,2.895230934445178,0.6297514899087546
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3962495801672001,1.5452045045108729,-0.0819993072597529
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4918729747541275,1.0877542859060636,0.0701731011717731
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3972648584983888,1.303967552043274,-0.0197388224759482
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2553889566533181,1.287345133909119,-0.1797483722060615
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3536948476124638,0.9048322470087538,-0.0242728493629834
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2624775864948911,1.1012140928983143,-0.1208591079321803
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0858168807574087,0.669059934687029,-0.3970063492136111
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0705438779524865,0.3219756693857968,-0.3405440308435065
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1077168415188662,0.4843293375331953,-0.3731833772822726
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1084812686016597,0.6306818780235277,-0.410324968236282
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0980442979481977,0.281838847967762,-0.3604278043380938
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1314273991323161,0.4427229672460429,-0.3924592935557029
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2790358057650355,3.2938313013072094,0.4591377907691718
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4236496287454168,2.450946091665934,0.7410941345280679
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3615698679224195,2.510519390043422,0.7102055642777342
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4002428546402415,1.6390221323290182,-0.104817732410033
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4075103767795248,0.9823951045482592,0.016156644860114
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4099646304399884,1.0869011479197797,0.0305227486544228
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2588208667639408,1.3716891269442986,-0.1940481611312437
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.277246899816792,0.8186251613013906,-0.0824552116609728
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2739074964625683,0.8936881894533149,-0.0774595668676741
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0683396037468222,0.7955694978082344,-0.4061742424049683
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0919958517972256,0.3015664456561734,-0.3651695247046582
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0727118919291555,0.3822070913068068,-0.3253473568386536
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0915290693175941,0.7485845480693092,-0.4235384869955343
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1189018911040638,0.2740426411433996,-0.381775991398838
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0974387009582871,0.3447349051583177,-0.3454725763886007
6,Incidence,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.891640432013212,1.423462889479803,0.4509111269051504
6,Incidence,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8127392902542796,1.3183830278859845,0.439957093332107
6,Incidence,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.8783154592834929,1.3531434273829888,0.4972623807143843
6,Incidence,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3861886950398576,0.7843460595348791,0.0613416009175708
6,Incidence,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2844181386732337,0.6493615263681629,0.01761707915277
6,Incidence,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3532344271688286,0.7030854008557117,0.0702514445973203
6,Incidence,44561,Asia,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3079698079713416,0.6756970492563628,0.0032286876115777
6,Incidence,44561,Asia,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2363818245394383,0.5812569702711391,-0.0178748880856881
6,Incidence,44561,Asia,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.2900921163733171,0.616220411410832,0.0283716635323942
6,Incidence,44561,Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1173116957489473,0.1319200424661125,-0.3176251992051381
6,Incidence,44561,Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2315483918336752,-0.0209640107275715,-0.389249209491452
6,Incidence,44561,Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1568378906052542,0.0657100153065318,-0.3329445773991618
6,Incidence,44561,Asia,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1322983750752613,0.1107039599952707,-0.3296981080442415
6,Incidence,44561,Asia,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2327768165023482,-0.0278057820035574,-0.3894236107077299
6,Incidence,44561,Asia,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1645014247144375,0.0428265723559147,-0.333310504666999
6,Incidence,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.136436590064321,1.4589429469874535,0.8626337311356866
6,Incidence,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.493963567846511,2.001272045205572,1.0747029888552833
6,Incidence,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.292939199793018,1.58407202178341,1.0215578194481396
6,Incidence,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5655557193842865,0.8037285175454895,0.3601667924166626
6,Incidence,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7669269079824907,1.1275364058351085,0.4747407135713287
6,Incidence,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6519827916482779,0.8735935441652409,0.4584521871761404
6,Incidence,44561,Asia,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4772334684533008,0.700229641825081,0.2879132008410527
6,Incidence,44561,Asia,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7010119673173848,1.047022551527504,0.415054597497304
6,Incidence,44561,Asia,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.574870062617025,0.7748301686849379,0.3884759307990475
6,Incidence,44561,Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0593323162822375,0.0751100842743244,-0.1707650151698811
6,Incidence,44561,Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0774321415832529,0.1024392006091502,-0.225543765702794
6,Incidence,44561,Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0831958207525083,0.032947765918579,-0.1883706071667374
6,Incidence,44561,Asia,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0753143558032638,0.0551624320820164,-0.1850046676077114
6,Incidence,44561,Asia,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0788354146561675,0.0968047329648018,-0.2293576783607471
6,Incidence,44561,Asia,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0915585710452821,0.0224230481876523,-0.1946876084145393
6,Incidence,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.649636850575842,2.179757148202687,1.2348067844384203
6,Incidence,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.642241498586283,2.263955430940689,1.1723925152165031
6,Incidence,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.6478395565244572,2.07152423447522,1.301346379722517
6,Incidence,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9419271714945492,1.3410567125636552,0.6313723954827775
6,Incidence,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.8723387861345264,1.3097940712981644,0.5367840107352806
6,Incidence,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9078959634329252,1.2177199795110325,0.6496690552908568
6,Incidence,44561,Asia,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.832084440568389,1.198634727903258,0.5452512809657244
6,Incidence,44561,Asia,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8021451746862464,1.226186188282916,0.481683900172117
6,Incidence,44561,Asia,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8186279202518543,1.1096292321725598,0.5806444049908677
6,Incidence,44561,Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1381937597463405,0.3529818031905842,-0.0292606910131849
6,Incidence,44561,Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0439216007264319,0.2805858188253157,-0.140666916646207
6,Incidence,44561,Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0962267863214784,0.2655346238243237,-0.0471760020992914
6,Incidence,44561,Asia,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1188127947865606,0.3254965334093928,-0.0439405162338644
6,Incidence,44561,Asia,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0422527362373632,0.279491427174851,-0.141887551384314
6,Incidence,44561,Asia,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0862195067491936,0.253976624080832,-0.0491269169748682
6,Incidence,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9523410578214756,1.4933406840719612,0.523820988495409
6,Incidence,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8420192934120638,1.3401471843839994,0.4561636310466384
6,Incidence,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8994856929264358,1.2820067448031387,0.5521167146390253
6,Incidence,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4307312322008894,0.8341241709153184,0.1092219211279671
6,Incidence,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3052309033408441,0.6762506180982631,0.0339384396969248
6,Incidence,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3686733720759732,0.6345251482503618,0.1237627354366044
6,Incidence,44561,Asia,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3499410962450195,0.7240138667801317,0.0536420198968973
6,Incidence,44561,Asia,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2563522990149278,0.5961012491286926,-0.0068211922913256
6,Incidence,44561,Asia,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3046325661095763,0.5673612738641367,0.0660475200533664
6,Incidence,44561,Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0832968545754064,0.1703150140106941,-0.2743016984067974
6,Incidence,44561,Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2067418942184731,0.0179279163338657,-0.3675230745389374
6,Incidence,44561,Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1477796067231806,0.0206451631829226,-0.2959111269082641
6,Incidence,44561,Asia,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0988899799028106,0.1489556432720524,-0.2856398527211543
6,Incidence,44561,Asia,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2080356329994482,0.009506106815042,-0.3724212572156988
6,Incidence,44561,Asia,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1556203304564618,0.0165338491791194,-0.3009499008620139
6,Incidence,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6160280713126631,-0.4545056916910391,-0.7071728437243723
6,Incidence,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5643365131863535,-0.3378918211952187,-0.6930468008245422
6,Incidence,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.5927340712781207,-0.4233646775249817,-0.6919963587841416
6,Incidence,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7186044018021817,-0.5973803456974267,-0.7849556810087182
6,Incidence,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6913728250577068,-0.5317165884600508,-0.7832955148947547
6,Incidence,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7065773755697636,-0.5875630602436528,-0.7778309603203541
6,Incidence,44561,Asia,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7345036184825773,-0.6228193933616725,-0.7975254319580162
6,Incidence,44561,Asia,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7028549998293954,-0.5484080239479399,-0.7906420639277179
6,Incidence,44561,Asia,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7202756537434981,-0.603946887690961,-0.7884524309359455
6,Incidence,44561,Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5698413299033924,-0.3832782720214002,-0.6720737058474547
6,Incidence,44561,Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5141703074184208,-0.2609337564431425,-0.6586320126647527
6,Incidence,44561,Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5449450096223319,-0.3586676801162381,-0.6560407854272927
6,Incidence,44561,Asia,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5771888862406985,-0.3990573100038422,-0.6780890297919673
6,Incidence,44561,Asia,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5148682523592587,-0.262306307139164,-0.658046566585013
6,Incidence,44561,Asia,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5491043728303118,-0.362914188025966,-0.6590722924303702
6,Incidence,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.882310978793729,2.515852571305269,1.3778017529918474
6,Incidence,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.886127638038052,2.512876807307776,1.4029968140955784
6,Incidence,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,1,Number,1990,2021,1.88411047099846,2.320052662920497,1.4717242048304926
6,Incidence,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.112026667051855,1.5809517415361891,0.7281403689609315
6,Incidence,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.044634688170784,1.4896665462331224,0.6928353422108025
6,Incidence,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,2,Percent,1990,2021,1.0777983209462367,1.4086959719521297,0.768575877901343
6,Incidence,44561,Asia,1,Male,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9929663553629282,1.4310270253906172,0.6441247763692037
6,Incidence,44561,Asia,2,Female,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9684881185924084,1.3959634238369791,0.6389679427962247
6,Incidence,44561,Asia,3,Both,22,All ages,996,Liver cancer due to NASH,3,Rate,1990,2021,0.9809069679936482,1.2803271650715469,0.6976657966267957
6,Incidence,44561,Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.2559056165529521,0.527067570143397,0.0410938415737627
6,Incidence,44561,Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1365611169170609,0.3679422688967809,-0.0526325737615889
6,Incidence,44561,Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,2,Percent,1990,2021,0.1904325941564281,0.376697620729202,0.028874387448463
6,Incidence,44561,Asia,1,Male,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.2346568955920621,0.5023383142138331,0.0295028355725736
6,Incidence,44561,Asia,2,Female,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1349134952504402,0.3662314779098315,-0.0506793826288682
6,Incidence,44561,Asia,3,Both,27,Age-standardized,996,Liver cancer due to NASH,3,Rate,1990,2021,0.1796504419995529,0.3598929248928785,0.0214939671510977
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.666668953647105,2.4596463531662573,1.0494071377814669
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3481661188489864,2.0662591930337006,0.8490734836687416
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4824655661745756,2.0364637263182983,1.0224523221679735
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.2521720726809928,1.9474959339333384,0.726000130793059
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9164673417661584,1.4799111751876803,0.5191883842822906
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.060320036718414,1.5000332265121483,0.6772371581378889
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.11243020885333,1.7405957002583436,0.6234596882257507
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8360777132109907,1.3975689462792888,0.4458272718446974
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9538528305551398,1.3898833995459283,0.5917941614876014
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1252519853282528,0.4635927315571954,-0.1243938162799105
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0397143698575893,0.2437193158054478,-0.2373789283391819
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0238320223991622,0.2515138893848938,-0.1614948316828206
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0941320907121374,0.4205622667293717,-0.1480897512388612
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0526428140189847,0.2294288524867761,-0.2514531847581522
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0027395652317856,0.217769174993309,-0.1788102395852521
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.636933408905999,2.298692702749677,1.103646885142966
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3418745906886282,2.037349457950728,0.8704221022340926
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5455910281829317,2.057529600548774,1.0912208706601492
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.2275803152087417,1.806715075208516,0.7820807999091096
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9116945611070704,1.4770255922014628,0.5188197908600434
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.112956513725943,1.5367421260916454,0.7396081097463805
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0888748804343655,1.6130945520936293,0.6664262816944675
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8311582424186339,1.3749638503899488,0.4625201805963564
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0035364452266542,1.4064635360659126,0.645919231722375
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1587681387152134,0.4509900338052914,-0.0692543186103449
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0130849967641222,0.3091870598008872,-0.1915463350270268
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1184191805879149,0.3424160752475295,-0.0696578254258247
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1266036140011912,0.4104175217456879,-0.0923137034505139
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.0005944382664979,0.28893228563697,-0.2003639276748066
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.0953971899088019,0.3152573845207135,-0.0914743895368374
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.995282595954392,1.685399908732406,0.4493248811485311
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7127653827257754,1.3183948106234014,0.291220298216393
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8534130436539011,1.345166798957918,0.4588044535235668
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6853128601202335,1.2600373131111584,0.2248997360071379
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3980860656851389,0.8908988844208534,0.0540096544187957
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5383970064081912,0.9511839627248116,0.2066638539187443
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5805843560479448,1.1272681343891415,0.1480981383886032
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3392452612013569,0.8127989361741565,0.0096307894787554
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4587498698365942,0.8457902702468442,0.1481686793890524
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0044446613606728,0.3270416152992449,-0.2636252069124293
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.186878006134218,0.0980830176997905,-0.38744208020862
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0982280418337859,0.1371454336593262,-0.2837441952678416
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0320104498874197,0.291346498283524,-0.2839850672713301
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1978834857485457,0.0846967719893881,-0.3974327861635311
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1168347997985078,0.1168949321061167,-0.2997662542322309
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.1798358103569466,1.3080608277817034,1.041609297207576
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.3964824060477068,1.5668332368485012,1.1530463077767348
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.2640614625023476,1.3912680036247442,1.1052596850819838
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.861694264023432,0.9773465318379516,0.7393671386047687
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.0687478889773836,1.2175650605039658,0.856808935049461
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.9447471945103888,1.0562948589831014,0.8054283562573148
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8612754948742544,0.9707617605960012,0.7432493479303193
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0871643031936058,1.2355276594901257,0.8751489205070099
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.9527785511571332,1.062495627828784,0.81581022676837
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1485809760957918,0.2096609665584884,0.0820947419229059
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.3128651862426874,0.3901977832053634,0.2125689219436435
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2147205924660554,0.2745497326497114,0.1419593753148438
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.162842999276721,0.224987832188502,0.0956454620092734
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.340165255830064,0.4199892487675276,0.2348307640065089
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2340549619224276,0.2927183389304852,0.1629049811670096
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.455526175877408,1.6038711438398616,1.2902831609476024
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.0402660029237043,1.1797471330700562,0.882309306394172
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.3770088154809532,1.5078669528673707,1.2348900614350224
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0973943366890022,1.224944420957601,0.9520599718771396
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7613314296080271,0.8811284216011235,0.6282853069671479
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.041932320983036,1.1571199228302294,0.9163644675507716
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0966765829186458,1.2233424778197903,0.955582114735916
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7769253634308085,0.8984034243904491,0.6393564091940291
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0501969172039685,1.1630635368451785,0.9276178886685283
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3378968287345062,0.4054902310189615,0.2607771028683746
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2286426496229795,0.2985890695306972,0.1589285811515046
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3813388393957484,0.4459643664948062,0.3092369830591485
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3544354131314645,0.4212984486043596,0.2812165215951359
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2541784954669323,0.3223065043673018,0.1840250840382756
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4032753517804625,0.4683200807190207,0.3320139155600143
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.46076170093291,1.6471734160791285,1.283986757020419
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.250211923897386,1.426031554415502,1.04913826983443
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3590972060929682,1.5171082726368383,1.1972718616516602
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.101702111105545,1.267532865952377,0.9472598001368866
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.9425815461541556,1.097294841192967,0.7734598822540497
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,1.02648300206264,1.169608288782494,0.8790206730401131
6,Incidence,95467,Advanced Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.1011469904797615,1.2603165736706716,0.9502058647083612
6,Incidence,95467,Advanced Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.9597732035616487,1.1128994921970383,0.7846524716030787
6,Incidence,95467,Advanced Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,1.0347479520548903,1.171034279393066,0.8951717670032171
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4086646219514327,0.4924995843370385,0.3263957527363673
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3793042094335314,0.4605214797765667,0.2914105284987323
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.4008845298868974,0.473918232329639,0.3310623119381106
6,Incidence,95467,Advanced Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4261104720811725,0.5136276582290448,0.3441556128317993
6,Incidence,95467,Advanced Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4079383849277051,0.4905548610828973,0.3164431796745763
6,Incidence,95467,Advanced Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4231237841905467,0.4984720149337344,0.3530765559676722
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.9554544684787142,1.3181803833646626,0.6544079296767245
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,1.010006115402134,1.2828759532634249,0.7849847214938501
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,0.9771046732202372,1.2742094487882565,0.7416230643709105
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.4887066530517285,0.7727388225478278,0.2590936705289632
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.5701108706627045,0.7832817308107228,0.3979114649714554
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,0.5262303641647638,0.7512413043985364,0.3409385873807364
6,Incidence,44535,Commonwealth High Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.474713416342273,0.7482645430803405,0.2476780254031636
6,Incidence,44535,Commonwealth High Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.5326549613306343,0.7407216470938879,0.3610733163115756
6,Incidence,44535,Commonwealth High Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,0.4994145185143261,0.7247355245493964,0.3208278468351252
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.950413900287603,1.3153160846585803,0.653517848125653
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,1.0317811433004471,1.3182550631549113,0.8006907629503812
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,0.984717683316342,1.2820012901566984,0.7424022110264761
6,Incidence,44535,Commonwealth High Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.9468715224901234,1.314094613850177,0.6417895645524998
6,Incidence,44535,Commonwealth High Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,1.0118506775848612,1.2906566592392197,0.7820649208578901
6,Incidence,44535,Commonwealth High Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,0.972876011405958,1.2720165369974066,0.7338383407241915
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.697640098609639,-0.6030178612687476,-0.7678031059057835
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7336129535027686,-0.6248573022513877,-0.8123915890978808
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.7141111746868274,-0.6205394899649377,-0.7854842843068002
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.744589631318867,-0.6672630584303282,-0.8050417906214344
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7826001127789493,-0.6942934302628092,-0.8470365428263846
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7627242145462774,-0.6844160292419917,-0.8221578550949356
6,Incidence,44576,World Bank Upper Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7604823842984451,-0.6855263713614753,-0.8160627576903752
6,Incidence,44576,World Bank Upper Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7917066789970483,-0.7066684758454388,-0.8533052583872736
6,Incidence,44576,World Bank Upper Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7749879401457351,-0.7013412787197696,-0.8311629599150523
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5931533314784582,-0.4676667045335366,-0.6866958417462554
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6422709418943632,-0.4942935888558202,-0.7498906917486474
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6156914888368016,-0.489413368763985,-0.7123080424133652
6,Incidence,44576,World Bank Upper Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.604478953957772,-0.479835137179803,-0.6963234614745326
6,Incidence,44576,World Bank Upper Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6470680102801164,-0.4989312791713235,-0.7533114082610151
6,Incidence,44576,World Bank Upper Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.623614528875396,-0.4986010616418832,-0.7179614417151269
6,Incidence,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.7671782857261356,2.470559351616883,1.167517971487825
6,Incidence,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.380834536082566,2.090033539339876,0.8204919800739543
6,Incidence,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.557865193641322,2.099569355596756,1.075721348846009
6,Incidence,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.20353344176089,1.7830921386486085,0.7190280696272031
6,Incidence,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.8419698355006908,1.392236369627529,0.4161868087420772
6,Incidence,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,1.007355638164062,1.4236728482613978,0.6303405233903069
6,Incidence,95468,Basic Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,1.0373006566200969,1.5551562334671565,0.595808195419268
6,Incidence,95468,Basic Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.7385177323115383,1.2563844820644252,0.3293479832064033
6,Incidence,95468,Basic Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.8755670203677823,1.2727742162299,0.5220327150340138
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1144893975169133,0.4066894584241978,-0.1205251818110486
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1034951953925236,0.1603703540160117,-0.3129289161021955
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0110719331164422,0.2017056186046907,-0.1938373831413283
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0799784217393195,0.3560818876812412,-0.1475543841797126
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1196598634288548,0.1374418284526733,-0.3248020758996826
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0353482875977116,0.1677227848587734,-0.2164217658889401
6,Incidence,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.902003997673234,2.6082510888784705,1.3399411534982186
6,Incidence,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.5526514935063316,2.3196984574440824,0.9971218278156688
6,Incidence,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.800505079551409,2.394447996285374,1.3137289721792578
6,Incidence,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.311183909334513,1.9020624507589845,0.855966712295868
6,Incidence,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.975335170308668,1.5635937717791095,0.539593653648871
6,Incidence,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.1979601908593671,1.657004946741212,0.8069306652220161
6,Incidence,95468,Basic Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.1365644130957693,1.656530065497131,0.722752622432984
6,Incidence,95468,Basic Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8639808095082097,1.4240889262678476,0.4583254983174361
6,Incidence,95468,Basic Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,1.0534838898611678,1.4889954052360044,0.6965529555962127
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2112237725242579,0.5091539942444422,-0.0189653861162254
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.0180483224352093,0.3224496774783314,-0.2074218864757822
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.1467959151552154,0.3855712414847713,-0.0476649381260327
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1737078961336641,0.449177857578534,-0.0545901092024369
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.000373985897694,0.2944323190060898,-0.2209732173534798
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1186953060284907,0.3546519744954272,-0.0710868419583337
6,Incidence,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.0801565193692029,1.7652165341632613,0.5405238697979298
6,Incidence,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7985234048242972,1.4282152292882528,0.3619444298081261
6,Incidence,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9391030412038466,1.4288793864152394,0.5232227005943175
6,Incidence,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6565558040398363,1.193022439805135,0.2223803684269614
6,Incidence,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3916826828593627,0.8602383100925499,0.0560999285591928
6,Incidence,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5219413011059894,0.900136771667915,0.2021876707258859
6,Incidence,95468,Basic Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.5314894109438945,1.035856341388302,0.1341915725732428
6,Incidence,95468,Basic Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.3133062310198007,0.7731157583645516,-0.0054896693743857
6,Incidence,95468,Basic Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4218566804137817,0.7809875535803399,0.116910409904449
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0283766049449109,0.2889700213017121,-0.2689432365065416
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2090609056696812,0.0569668641358797,-0.4015804422867422
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1232326912288039,0.0943222505974154,-0.2997647450348683
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0584731046566897,0.2442484511158992,-0.2920953575270357
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2233951618647947,0.0352685125683294,-0.4105254668624326
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1448000767908288,0.0660749822888192,-0.3186828538724023
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2082580748366905,1.8356659409181204,0.8136861970072451
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2704163671317128,1.8755341308457167,0.696422285593555
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2234049388389632,1.783942402439658,0.8271332897016608
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4033575376056384,0.8011437232534495,0.1504160950765292
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3854638583499,0.7516338618777498,0.0316924236483261
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.3841820877989208,0.7294114670987775,0.1328477406939907
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3006873816524917,0.6702372562168519,0.0682803688600032
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3079648053588839,0.6565672685428912,-0.0227076069813538
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.295354356386311,0.6219231395662439,0.064486736163052
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0058425139719904,0.2712427618935704,-0.1846436824376602
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0512777333446139,0.2123084196421354,-0.2974328125541742
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0371081107672269,0.2021332033868071,-0.2186461767114977
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0280474904842229,0.2483472793541881,-0.2007004896098922
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0623434724412702,0.1973047918649845,-0.3082105269370563
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0528953723976736,0.1858941428545741,-0.227541903647327
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.75004685744388,2.270132833281388,1.1598857561023117
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.5451583425579347,2.2906094227664604,0.8264387416034777
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6502767809744543,2.224224305771826,1.0047222214453178
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7478113559506854,1.085585378644145,0.3553094789466904
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5531879547167345,1.0120121004667406,0.1166811655997482
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.6500391303572636,0.9853090781397484,0.2448771520098451
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6198067097274741,0.9261428548794836,0.2721955738714965
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4662409874788432,0.8956881105460983,0.0521936098352379
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.5440496303194532,0.8784311069440602,0.1679499390919175
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1751824256799737,0.3882599038106007,-0.086998865489934
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.00089579404977,0.3029284027745256,-0.2864239147699484
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0825025304923367,0.3149040084594696,-0.1833977507599767
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1488910997740458,0.3590601199725446,-0.1020437567431042
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0108065988928153,0.2861579286039536,-0.29734625479383
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.064716054377602,0.299940872569418,-0.1959339432479143
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.108478516896379,2.844356312626989,1.585132957875118
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.173067956850462,2.9139677187389186,1.3823655781486055
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.1224073950912703,2.7827528361437426,1.6026931087884049
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9755523148750922,1.4239798530927814,0.6375571149329602
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9365864004765494,1.3788640452302698,0.4563299995601159
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.9439927564952773,1.3527856784099153,0.6104970476592935
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8309267513327129,1.2643665626717215,0.5226706771810702
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8279736142915436,1.254798767103995,0.3724576579112034
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.8191126371053107,1.203829486854607,0.5163274120305783
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3522106099260811,0.6628723819674334,0.1229736613072997
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2708346251412529,0.5671181699959915,-0.0502308073805976
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3046155282747992,0.5810306799498028,0.0818066172930132
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3220250047426796,0.6359065810035308,0.1013876854155415
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2559309847349483,0.5598763526758805,-0.0616332595584295
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2832257592114601,0.558396210749769,0.0656728704004502
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5274447063987513,2.074865976349961,1.047333576098947
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4775317572547482,2.1467675758081515,0.8248995892255115
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.5008145829373123,2.033569352541557,0.966205992084607
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6062175871819899,0.9448341255412394,0.3034172532712867
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5119462445510232,0.9281927379985452,0.1123167515864106
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5569546120450761,0.8753922491467574,0.2322802612271802
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4886916864009931,0.8111286091444452,0.205901148425466
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4272819688760561,0.8128222203583131,0.0513069191076655
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4569730452311839,0.767355647895013,0.1455104074427594
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1491530715286247,0.3853106324933155,-0.0812971575195403
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0494730499100062,0.3535351390759907,-0.2423117627072267
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0936459097415491,0.3258935566024978,-0.1479724961576784
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1234771553965998,0.3582788807193042,-0.0969146867788524
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0371720832936344,0.3315001276651584,-0.2470856832786844
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.075667400991067,0.3078412332676494,-0.1540256356617635
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3733608991679599,-0.005872950834721,-0.5278869905890472
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2560046987149955,0.1972450804588753,-0.4725662253756276
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.318765563609664,0.0613803169687716,-0.4915393217701108
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6017690457657004,-0.3733686438508745,-0.7014326904645929
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5460734089208633,-0.2684648837900269,-0.6816442417307997
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5759204489752104,-0.3386587107947625,-0.6826757090243978
6,Incidence,44577,World Bank Lower Middle Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6309029363053167,-0.4144486446837372,-0.7219204398923238
6,Incidence,44577,World Bank Lower Middle Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5713915370234319,-0.3102787438906649,-0.6961505280030209
6,Incidence,44577,World Bank Lower Middle Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.603113234353345,-0.381640477021644,-0.7037711201000759
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4486748476339394,-0.1285543620806358,-0.586347949629785
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3462418628379984,0.0554539659881352,-0.5395800614793145
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4014826126853361,-0.0679004947929138,-0.5541053402064319
6,Incidence,44577,World Bank Lower Middle Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4609831404477166,-0.1420678386738285,-0.5939880657644512
6,Incidence,44577,World Bank Lower Middle Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3537778003082539,0.0413014786475995,-0.5423423651463828
6,Incidence,44577,World Bank Lower Middle Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4112731640626667,-0.0802832299834999,-0.5609313154591391
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5224258088426966,1.574783277247147,0.1654818094063441
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.6859709404375043,1.219103555848481,0.3017097495312296
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,0.5632296572212626,1.3967849029062271,0.2334066119582078
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2547760782762913,0.259734183477147,-0.4322884176944788
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1935913904886255,0.0677231134396921,-0.3794869905390234
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2436713534837985,0.1660217726402881,-0.4074865935078455
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3224758509805478,0.1458540959394847,-0.4813264025549159
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2390338884737658,0.0015965064794395,-0.4124708898128917
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2993630686016765,0.0742350056095179,-0.4471892087149129
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.31642163781959,0.1683888529327034,-0.4800320866266331
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.2610608450869063,-0.0160130558357433,-0.4451681487998784
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.3104054462411916,0.0693050035810941,-0.4564911819292251
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3295513403866132,0.1356032315643529,-0.4863258962829839
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.2566705318649873,-0.0116768718883363,-0.4373473813324685
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.3151036555163438,0.0529413346277884,-0.460679898464851
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.6263511067215041,1.4689338391387097,0.3067278054074012
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.8669784658685735,1.410740627078455,0.4950842089837789
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,0.765917714150389,1.2983978315100366,0.462618023123416
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2037411580889503,0.2055884699392701,-0.3619523002118377
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1069218393960186,0.1567174193914095,-0.2861008773327058
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1455105653594806,0.1127889313389155,-0.293534960816679
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2762260445217,0.0987479906290904,-0.4184677905377119
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1573358060925103,0.0880922540753661,-0.3251909688197644
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2085186187270857,0.0301380839103553,-0.3444570356023988
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.2088771232047513,0.2056939892398659,-0.3620921625816446
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.1612379492069629,0.0899517757729973,-0.3454079966570992
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.17219666010906,0.0872805374696503,-0.3167570392525451
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.2241788884428827,0.1822076847981276,-0.3762807508955412
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1563102284077317,0.1001239614202408,-0.3374042309566547
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.1779041870403098,0.070568985686975,-0.3176448410737938
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.6736545228442403,1.7755372447809736,0.2944134481177706
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.9507754097535002,1.5771455259462148,0.4981201035931459
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,0.7388085608219818,1.6303620913170316,0.3902686331693529
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1807055675018312,0.3611352855037701,-0.3647550077217276
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.0668192104684161,0.2403109833494164,-0.2814116697861154
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1586602597926508,0.276359816705337,-0.3296537969415714
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2551746365856807,0.2351955011006528,-0.4239480408033853
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1195139000225565,0.1631994138686754,-0.3238207121560915
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2206688961435106,0.1789239128195418,-0.3768839118018059
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.2043117266082263,0.3282206804734732,-0.3830024685266823
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.116692581758087,0.1741851447104909,-0.3268708128851982
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,-0.1984578450915871,0.2126757005013854,-0.3605514532681506
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2196306217020826,0.3028161404005569,-0.3948650662093397
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.1115151854213877,0.1787120292580711,-0.3210874013409021
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,-0.2039622077210342,0.2044394033189303,-0.3664783153189868
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.7411338711547731,1.8291832897823392,0.3593696241295954
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.9283323045930796,1.4843092690110018,0.4874332126826648
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,0.8492635260199187,1.4873179748464334,0.4870318333284261
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1477839901008479,0.3897873849925968,-0.3316460043801731
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0777131205098012,0.1889387878161538,-0.2848797201143821
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1053766260087614,0.2105137798761311,-0.2786340126767699
6,Incidence,44578,World Bank Low Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.22514434691578,0.259069564964191,-0.3950406368298387
6,Incidence,44578,World Bank Low Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1296436371697867,0.121297597085103,-0.3286442601932501
6,Incidence,44578,World Bank Low Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1711631645214822,0.114811777820328,-0.333514806489253
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.2038675509039996,0.3019144952217764,-0.3767628794993543
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1512877305162603,0.1045419867932184,-0.3520752118920429
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.1676592865144339,0.1343037911424829,-0.3370587699704666
6,Incidence,44578,World Bank Low Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.2190779789902974,0.2730270688517395,-0.3879004881449172
6,Incidence,44578,World Bank Low Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1461939193019702,0.1098856546811464,-0.348598553090319
6,Incidence,44578,World Bank Low Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.1732455287452715,0.1238923895413919,-0.3406057710464669
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.556791634448874,2.2785150337118503,1.0694500719637436
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.4723351490623615,2.222348906514443,0.8122263914739363
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.5354982803586676,2.1774323027707334,1.0387536440390273
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5524848253889287,1.004822307136417,0.2476360616696138
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.4319629999285782,0.8738856926199814,0.0524010802303088
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.5030966812539484,0.8877015119977635,0.2155808583605116
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4554539422729463,0.8662950732180406,0.1780346998146798
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.3529847883444833,0.7634296284247626,-0.0082595631783402
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.4158142239446256,0.774268152628194,0.1384335894485706
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.1622372428661774,0.5011338452913242,-0.0658501275197906
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0157216211594259,0.3059458173104767,-0.2864096042163281
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.0779068736754218,0.3568928483932726,-0.1331318644991938
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1424753907728654,0.4671499790011958,-0.0743594096862577
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.0304807904964045,0.2781035862837659,-0.3010246355615269
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.0618827408135135,0.3364794078119075,-0.1514255486369378
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3952102206059452,0.6410235372905497,-0.68429998691411
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.2101160267860413,0.6465217921073076,-0.5437420691642003
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.3019215719922578,0.5069399445886155,-0.5865180427283446
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.6283255020900855,0.0054003199415388,-0.8058554329721707
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5411757454047995,-0.0348847824935507,-0.7357219402160766
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5831245082299638,-0.1059542767220193,-0.7544211198518602
6,Incidence,44537,Commonwealth Low Income,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6659455755890453,-0.0935839330094796,-0.8256237295154023
6,Incidence,44537,Commonwealth Low Income,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5837365087606596,-0.1322941940504592,-0.7595551680551667
6,Incidence,44537,Commonwealth Low Income,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6234338205965456,-0.1871076447045073,-0.7769544013178948
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5028252110819993,0.3564928239894452,-0.7414796230274888
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.3484055724273674,0.3785841134836155,-0.6276570030372415
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.4254861337696644,0.2336183605056918,-0.66288856783121
6,Incidence,44537,Commonwealth Low Income,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5153425579780021,0.325438713187305,-0.7467893461148708
6,Incidence,44537,Commonwealth Low Income,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.3678636338484153,0.3318905986260289,-0.6374560200949302
6,Incidence,44537,Commonwealth Low Income,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.4409445181398749,0.2155479029699271,-0.6703075379568193
6,Incidence,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6581634245935868,-0.5468811508548475,-0.7385285743886933
6,Incidence,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6947362270316345,-0.5669222957148052,-0.7788076180333401
6,Incidence,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,1,Number,1990,2021,-0.6747108771378673,-0.5752292749401327,-0.7508945882328624
6,Incidence,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7277585440839784,-0.6384960942098675,-0.7908861346027399
6,Incidence,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7638355273326246,-0.664294299647981,-0.8284989548810258
6,Incidence,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,2,Percent,1990,2021,-0.7447166370469636,-0.6661918951029979,-0.8052058944394228
6,Incidence,95468,Basic Health System,1,Male,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7483270654714969,-0.6663968730702434,-0.8074949092246424
6,Incidence,95468,Basic Health System,2,Female,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7770922446332402,-0.6837607750736723,-0.8384823168207229
6,Incidence,95468,Basic Health System,3,Both,22,All ages,1005,Hepatoblastoma,3,Rate,1990,2021,-0.7614801779072446,-0.6885348121079621,-0.8173422524114868
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.5848788828401528,-0.4516011250165114,-0.6828789934807545
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.630204352682933,-0.4742294082550089,-0.733224312532512
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,2,Percent,1990,2021,-0.60547957331996,-0.4830573608641771,-0.6988650110154022
6,Incidence,95468,Basic Health System,1,Male,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.5977859990851434,-0.4656942519263898,-0.693264808086832
6,Incidence,95468,Basic Health System,2,Female,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6368610490934348,-0.4839854787587143,-0.7375223685881281
6,Incidence,95468,Basic Health System,3,Both,27,Age-standardized,1005,Hepatoblastoma,3,Rate,1990,2021,-0.6151719675217739,-0.49574506166158,-0.7063850816909403
6,Incidence,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.0894359426423403,1.7720098745719195,0.7194338183281652
6,Incidence,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.2160829727027511,1.7791180541557676,0.6795556439018426
6,Incidence,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,1,Number,1990,2021,1.1218112827240334,1.7078765285795472,0.7479285261098363
6,Incidence,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2512251685301665,0.6649023088928834,0.0279863963485903
6,Incidence,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.2611328121749169,0.5727851302349807,-0.03553489349506
6,Incidence,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,0.23819795850604,0.5709668844246947,0.0194996910109378
6,Incidence,95469,Limited Health System,1,Male,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1607875656455044,0.5399919799314131,-0.0447673673395059
6,Incidence,95469,Limited Health System,2,Female,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1868141522964198,0.4883452822851292,-0.1005208594148624
6,Incidence,95469,Limited Health System,3,Both,22,All ages,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,0.1576892411683894,0.4774544508615838,-0.0463063018447217
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.0588089483535669,0.2510984576734014,-0.2273488557827565
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1245038545702513,0.1088354831982376,-0.3443951521671273
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,2,Percent,1990,2021,-0.1048754865544311,0.1371854444226507,-0.2681142512750464
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.075605232249564,0.2230826361812396,-0.239424686529914
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1339675503613361,0.1022599146505491,-0.3505212327011932
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,418,Liver cancer due to hepatitis B,3,Rate,1990,2021,-0.1168250594590827,0.1269543264891328,-0.2771510186422235
6,Incidence,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.4956493466656569,2.1468982418626874,1.0717852531462069
6,Incidence,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.694881733103126,2.374543244808793,1.047111789422318
6,Incidence,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.6044733731263092,2.165460215244166,1.1347023787210353
6,Incidence,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.4945841915070177,0.8859124997249168,0.2374266192897614
6,Incidence,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5337115822945497,0.9316580118433953,0.1664578458228102
6,Incidence,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.5199806877502154,0.8376789029884294,0.2412392533321401
6,Incidence,95469,Limited Health System,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.3864596998160748,0.748261468540836,0.1509817130352191
6,Incidence,95469,Limited Health System,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4432328658304649,0.807222802488696,0.0963223277042565
6,Incidence,95469,Limited Health System,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.4210362757176608,0.7271183655079911,0.1647227993665712
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0696754498011743,0.3312041001066116,-0.1211092246214541
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,-0.0144595328340526,0.251612998623376,-0.2635728812251711
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.026710024023319,0.246771066142176,-0.1694518168691448
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0505494362903946,0.2989955059866905,-0.1371531056589118
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,-0.0251591661408099,0.2353075025936843,-0.2687903475050063
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.0129477162094296,0.2300908693336448,-0.180052597662062
6,Incidence,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,1.947129541674099,2.695319703108733,1.4588659046013677
6,Incidence,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.213964687118814,2.9783370851314697,1.4718257247112438
6,Incidence,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.0097322037756182,2.6663692894448245,1.5159806535845126
6,Incidence,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7650715196903348,1.206172013867845,0.4676385257510339
6,Incidence,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.829297469240125,1.255011392605022,0.4015314503321067
6,Incidence,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.7565815294801295,1.1424964810474474,0.4716152452428497
6,Incidence,95469,Limited Health System,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6372798306492099,1.0529373860721911,0.3660246334431524
6,Incidence,95469,Limited Health System,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.7212256141300939,1.1305821187197105,0.3237761348438202
6,Incidence,95469,Limited Health System,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.6421510336375373,1.0004212038552516,0.3727534382337609
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2906771478998337,0.6157781491840727,0.0711028496339343
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2126013770749538,0.5115078858323526,-0.0851368483521917
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.2274516100066212,0.4933178735552841,0.0230023620857054
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2675481419179366,0.5898018414931087,0.0613755801343108
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.1993904645937059,0.5060443809438536,-0.0907958128364124
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2109778904308981,0.4756952262634165,0.0065891104447296
6,Incidence,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.2504503774629074,1.96121968220032,0.8719463581636102
6,Incidence,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.4249240602548168,2.0249482874205422,0.8745416302942226
6,Incidence,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.3482327773136076,1.8617614210323064,0.9390775977545208
6,Incidence,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.347669335408471,0.7693422664134574,0.1195114386756778
6,Incidence,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3800766277605347,0.720646167435685,0.0603836798238659
6,Incidence,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.3704090859827003,0.6733067251566117,0.1374327367449746
6,Incidence,95469,Limited Health System,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2502392449311516,0.6451076178463392,0.0399610783778189
6,Incidence,95469,Limited Health System,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.2986581406943263,0.6199986560507953,0.0039030863491001
6,Incidence,95469,Limited Health System,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.281227903814718,0.5614161518014524,0.0579872446662939
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.0150396064244751,0.3361001207405311,-0.1546166061427119
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0345427330547413,0.2133121281917825,-0.2765603282261976
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,-0.0084296154645256,0.2146911506853847,-0.1950625292059844
6,Incidence,95469,Limited Health System,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0031063420728059,0.3053485229982851,-0.1733677602196575
6,Incidence,95469,Limited Health System,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0450605257735029,0.2064160762307735,-0.2832745284851017
6,Incidence,95469,Limited Health System,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,-0.0217418966684065,0.2006953657578037,-0.2083232911045263
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.9707609175135647,2.666832389564271,1.41651843144958
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,2.0029625963893563,2.96048914779726,1.1533530713298092
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,1,Number,1990,2021,1.988443745539152,2.656507725705457,1.3711107925729866
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.803840698445426,1.2254190738489992,0.4707976009153058
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.7393482353820392,1.2804011003073672,0.2536725629706004
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.771690298704698,1.1781026743012248,0.3993345486825125
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6911060059368194,1.087344774262701,0.3756034047673421
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6433705254011113,1.1673766897685027,0.1784219265535411
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.6687375397447181,1.0417823542301454,0.3240207704651133
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.2633906305920754,0.5531152935043921,0.0219456295946516
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.0836778259487629,0.4426357735362602,-0.2290988431304997
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,2,Percent,1990,2021,0.1634533694409098,0.4446623018472226,-0.0869593025963204
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.2418939375770949,0.5220543059774262,0.0128606487696671
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.067401704179336,0.4158851743341778,-0.243436882784733
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,419,Liver cancer due to hepatitis C,3,Rate,1990,2021,0.1460988715468625,0.4075142243826822,-0.1034338186295927
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.393612068755221,3.2790400591569933,1.7661984086873717
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.4967644558597053,3.4902501578959138,1.578463634349414
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,1,Number,1990,2021,2.417598234817078,3.204340404051208,1.7803940678674803
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.060823678265703,1.5976327136117536,0.666862560266293
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0255706838384275,1.6020878019403306,0.4949360962564477
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,2,Percent,1990,2021,1.0262403910736484,1.4756027809496506,0.6386569691870982
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9318140741177432,1.4358440630561455,0.5746587734361945
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9136034687676242,1.4572882692698976,0.4110635752184554
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.9083760498143972,1.347690389882166,0.5525632574679513
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.4930846281617038,0.8718127610447721,0.2042390767614257
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3114549780356961,0.7120531372754589,-0.0449786731823114
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,2,Percent,1990,2021,0.3942566286461545,0.7228124005631587,0.1269805871905615
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.4676183745462243,0.8437651658542413,0.1888745438909409
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.2917016388429939,0.6863947114389426,-0.0531506883793259
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,420,Liver cancer due to alcohol use,3,Rate,1990,2021,0.3734562035380135,0.6956063583602182,0.1043915289308228
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6468038307279609,2.423454237222145,1.1476261905166507
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6295503709847496,2.4238887105539093,0.9289368222803992
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,1,Number,1990,2021,1.6374185790033888,2.249717410676864,1.0864758123957836
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.6071348590350341,1.0924060753297176,0.3009531916694217
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.523117085661822,0.9861544538272088,0.1205102613095449
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,2,Percent,1990,2021,0.5636150085064879,0.9227579683082644,0.2435274916485946
6,Incidence,44536,Commonwealth Middle Income,1,Male,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.506693395719954,0.9488017320699778,0.2225364646070822
6,Incidence,44536,Commonwealth Middle Income,2,Female,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4390207789899518,0.8737222354828065,0.0556101907189673
6,Incidence,44536,Commonwealth Middle Income,3,Both,22,All ages,421,Liver cancer due to other causes,3,Rate,1990,2021,0.4727261964936555,0.8146319283584595,0.1650814973885508
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.2067092154301449,0.5537201700970719,-0.0304472912369505
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.053886517259694,0.3863869375238892,-0.2404575634791537
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,2,Percent,1990,2021,0.1218294251642996,0.3881292961202756,-0.1266210202538653
6,Incidence,44536,Commonwealth Middle Income,1,Male,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1861814539789349,0.5303229252110839,-0.0478537347496692
6,Incidence,44536,Commonwealth Middle Income,2,Female,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.0380075161194856,0.3647701273883403,-0.2563066154317063
6,Incidence,44536,Commonwealth Middle Income,3,Both,27,Age-standardized,421,Liver cancer due to other causes,3,Rate,1990,2021,0.1050672769781921,0.3682843693837219,-0.1382773014662983
